@prefix ns1: <https://1145.am/db/> .
@prefix org: <http://www.w3.org/ns/org#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://1145.am/db/2168593/Canal_Plus> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Poland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/798544/about.rdf> ;
    ns1:basedInHighRaw "Poland" ;
    ns1:buyer <https://1145.am/db/2168593/Merger_Canal_Plus_Completed> ;
    ns1:documentDate "2012-12-04T15:13:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MTV Spain launches second screen app; Rogers invests in interactive TV" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/mtv-spain-launches-second-screen-app-rogers-invests-interactive-tv> ;
    ns1:foundName "Canal Plus" ;
    ns1:industry "pay TV" ;
    ns1:name "Canal Plus" ;
    ns1:sameAsHigh <https://1145.am/db/1627765/Canal_Plus>,
        <https://1145.am/db/2660307/Canal_Plus> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2168593/Rogers_Communications> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2012-12-04T15:13:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MTV Spain launches second screen app; Rogers invests in interactive TV" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/mtv-spain-launches-second-screen-app-rogers-invests-interactive-tv> ;
    ns1:foundName "Rogers' Communications" ;
    ns1:investor <https://1145.am/db/2168593/Investment_Rogers_Communications_Tv_Interactive_Systems_Completed> ;
    ns1:name "Rogers' Communications" ;
    ns1:sameAsMedium <https://1145.am/db/1037171/Rogers_Communications_Inc>,
        <https://1145.am/db/1048884/Rogers_Communications_Inc>,
        <https://1145.am/db/1055022/Rogers_Communications>,
        <https://1145.am/db/1075371/Rogers_Communications>,
        <https://1145.am/db/1097845/Rogers_Communications_Inc>,
        <https://1145.am/db/1110298/Rogers_Communications_Inc>,
        <https://1145.am/db/1138803/Rogers_Communications>,
        <https://1145.am/db/1145201/Rogers_Communications_Inc>,
        <https://1145.am/db/1145207/Rogers_Communications_Inc>,
        <https://1145.am/db/1159518/Rogers_Communications_Inc>,
        <https://1145.am/db/1184794/Rogers_Communications_Inc>,
        <https://1145.am/db/1193673/Rogers_Communications_Inc>,
        <https://1145.am/db/121247/Rogers_Communications_Inc>,
        <https://1145.am/db/1222456/Rogers_Communications>,
        <https://1145.am/db/1225644/Rogers_Communications_Inc>,
        <https://1145.am/db/1227173/Rogers_Communications_Inc>,
        <https://1145.am/db/1231624/Rogers_Communications_Inc>,
        <https://1145.am/db/1240253/Rogers_Communications_Inc>,
        <https://1145.am/db/1240734/Rogers_Communications_Inc>,
        <https://1145.am/db/1257768/Rogers_Communications>,
        <https://1145.am/db/1321896/Rogers_Communications_Inc>,
        <https://1145.am/db/1447379/Rogers_Communications_Inc>,
        <https://1145.am/db/1482449/Rogers_Communications>,
        <https://1145.am/db/1609591/Rogers_Communications_Inc>,
        <https://1145.am/db/1615778/Rogers_Communications_Inc>,
        <https://1145.am/db/1651437/Rogers_Communications_Inc>,
        <https://1145.am/db/1675144/Rogers_Communications>,
        <https://1145.am/db/1676381/Rogers_Communications>,
        <https://1145.am/db/1717967/Rogers_Communications>,
        <https://1145.am/db/1827872/Rogers_Communications>,
        <https://1145.am/db/1953754/Rogers_Communications_Inc>,
        <https://1145.am/db/1954533/Rogers_Communications_Inc>,
        <https://1145.am/db/1954913/Rogers_Communications_Inc>,
        <https://1145.am/db/1954923/Rogers_Communications_Inc>,
        <https://1145.am/db/1955041/Rogers_Communications_Inc>,
        <https://1145.am/db/2159476/Rogers_Communications>,
        <https://1145.am/db/2165843/Rogers_Communications>,
        <https://1145.am/db/2178078/Rogers_Communications>,
        <https://1145.am/db/2603759/Rogers_Communications>,
        <https://1145.am/db/2605255/Rogers_Communications>,
        <https://1145.am/db/2606192/Rogers_Communications>,
        <https://1145.am/db/2611189/Rogers_Communications>,
        <https://1145.am/db/2615024/Rogers_Communications>,
        <https://1145.am/db/2644067/Rogers_Communications>,
        <https://1145.am/db/2648241/Rogers_Communications>,
        <https://1145.am/db/272242/Rogers_Communications_Inc>,
        <https://1145.am/db/273603/Rogers_Communications_Inc>,
        <https://1145.am/db/392586/Rogers_Communications>,
        <https://1145.am/db/508932/Rogers_Communications_Inc>,
        <https://1145.am/db/511861/Rogers_Communications>,
        <https://1145.am/db/563190/Rogers_Communications_Inc>,
        <https://1145.am/db/570934/Rogers_Communications>,
        <https://1145.am/db/598369/Rogers_Communications_Inc>,
        <https://1145.am/db/625841/Rogers_Communications_Inc>,
        <https://1145.am/db/748696/Rogers_Communications_Inc>,
        <https://1145.am/db/809438/Rogers_Communications_Inc>,
        <https://1145.am/db/876122/Rogers_Communications_Inc> ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2239110/The_Hearst_Foundation> a org:Organization ;
    ns1:documentDate "2012-11-15T05:07:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Valley Presbyterian Hospital Awarded $50,000 Grant from Hearst Foundation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/valley-presbyterian-hospital-awarded-50-000-grant-from-hearst-foundation> ;
    ns1:foundName "Hearst Foundation",
        "The Hearst Foundation" ;
    ns1:investor <https://1145.am/db/2239110/Beds_Investment_The_Hearst_Foundation_Valley_Presbyterian_Hospital_Has_Not_Happened> ;
    ns1:name "Hearst Foundation",
        "The Hearst Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/1071179/Hearst_Foundation> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2263385/Aetna> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2263385/Acquisition_Aetna_Has_Not_Happened>,
        <https://1145.am/db/2263385/Coventry_Health_Care_Acquisition>,
        <https://1145.am/db/2263385/Merger_Aetna_Has_Not_Happened> ;
    ns1:description "closing conditions" ;
    ns1:documentDate "2012-11-22T05:04:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Coventry Health Care Announces Stockholder Approval of Merger Agreement with Aetna" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/coventry-health-care-announces-stockholder-approval-merger-agreement-aetna> ;
    ns1:foundName "Aetna" ;
    ns1:industry "Health Care" ;
    ns1:name "Aetna" ;
    ns1:sameAsHigh <https://1145.am/db/1034341/Anthem_Inc>,
        <https://1145.am/db/1895841/Aetna>,
        <https://1145.am/db/1967603/Anthem>,
        <https://1145.am/db/2182699/Aetna>,
        <https://1145.am/db/2184713/Aetna>,
        <https://1145.am/db/2184928/Aetna>,
        <https://1145.am/db/2185068/Anthem>,
        <https://1145.am/db/2185374/Aetna>,
        <https://1145.am/db/2185835/Aetna>,
        <https://1145.am/db/2185852/Anthem>,
        <https://1145.am/db/2186574/Aetna>,
        <https://1145.am/db/2187269/Anthem>,
        <https://1145.am/db/218855/Anthem_Inc>,
        <https://1145.am/db/2189163/Anthem>,
        <https://1145.am/db/2190031/Aetna>,
        <https://1145.am/db/2190760/Aetna>,
        <https://1145.am/db/2190907/Aetna>,
        <https://1145.am/db/2191214/Aetna>,
        <https://1145.am/db/2191753/Aetna>,
        <https://1145.am/db/2192294/Aetna>,
        <https://1145.am/db/2193300/Aetna>,
        <https://1145.am/db/2193303/Aetna>,
        <https://1145.am/db/2194225/Aetna>,
        <https://1145.am/db/2194895/Aetna>,
        <https://1145.am/db/2194913/Aetna>,
        <https://1145.am/db/2195393/Anthem>,
        <https://1145.am/db/2195406/Anthem>,
        <https://1145.am/db/2195461/Aetna>,
        <https://1145.am/db/2197679/Anthem>,
        <https://1145.am/db/2198190/Aetna>,
        <https://1145.am/db/2198190/Anthem>,
        <https://1145.am/db/2203367/Aetna>,
        <https://1145.am/db/2203587/Anthem>,
        <https://1145.am/db/2207608/Aetna>,
        <https://1145.am/db/2212804/Aetna>,
        <https://1145.am/db/2212804/Anthem>,
        <https://1145.am/db/2214130/Aetna>,
        <https://1145.am/db/2214135/Aetna>,
        <https://1145.am/db/2217392/Aetna>,
        <https://1145.am/db/2218776/Aetna>,
        <https://1145.am/db/2220698/Aetna>,
        <https://1145.am/db/2240693/Aetna>,
        <https://1145.am/db/2241120/Aetna>,
        <https://1145.am/db/2245024/Aetna>,
        <https://1145.am/db/2247439/Aetna>,
        <https://1145.am/db/2250503/Aetna>,
        <https://1145.am/db/2253170/Aetna>,
        <https://1145.am/db/2253537/Anthem>,
        <https://1145.am/db/2254700/Aetna>,
        <https://1145.am/db/2254720/Aetna>,
        <https://1145.am/db/2255490/Aetna>,
        <https://1145.am/db/2255659/Anthem>,
        <https://1145.am/db/2256114/Aetna>,
        <https://1145.am/db/2256344/Aetna>,
        <https://1145.am/db/2256365/Aetna>,
        <https://1145.am/db/2256412/Aetna>,
        <https://1145.am/db/2262557/Aetna_Anthem_Or>,
        <https://1145.am/db/2262569/Anthem>,
        <https://1145.am/db/2262593/Anthem>,
        <https://1145.am/db/2263392/Aetna>,
        <https://1145.am/db/2263421/Aetna>,
        <https://1145.am/db/2263445/Aetna>,
        <https://1145.am/db/2264287/Aetna>,
        <https://1145.am/db/2264295/Aetna>,
        <https://1145.am/db/2264927/Aetna>,
        <https://1145.am/db/2264927/Anthem>,
        <https://1145.am/db/2266016/Aetna>,
        <https://1145.am/db/2266806/Aetna>,
        <https://1145.am/db/2266972/Aetna>,
        <https://1145.am/db/2266972/Anthem>,
        <https://1145.am/db/2267801/Aetna>,
        <https://1145.am/db/2267830/Aetna>,
        <https://1145.am/db/2267830/Anthem>,
        <https://1145.am/db/2268568/Aetna>,
        <https://1145.am/db/2269230/Aetna>,
        <https://1145.am/db/2269267/Aetna>,
        <https://1145.am/db/2270653/Aetna>,
        <https://1145.am/db/2272244/Aetna>,
        <https://1145.am/db/2274757/Aetna>,
        <https://1145.am/db/2275398/Aetna>,
        <https://1145.am/db/2276152/Aetna>,
        <https://1145.am/db/2276163/Aetna>,
        <https://1145.am/db/2277343/Aetna>,
        <https://1145.am/db/2277482/Aetna>,
        <https://1145.am/db/2278456/Aetna>,
        <https://1145.am/db/2362850/Aetna>,
        <https://1145.am/db/2559244/Aetna>,
        <https://1145.am/db/2574470/Aetna>,
        <https://1145.am/db/2575500/Aetna>,
        <https://1145.am/db/2584713/Aetna>,
        <https://1145.am/db/285168/Anthem_Inc>,
        <https://1145.am/db/365544/Anthem_Inc>,
        <https://1145.am/db/389816/Anthem_Inc>,
        <https://1145.am/db/458330/Anthem_Blue_Cross_And_Blue_Shield>,
        <https://1145.am/db/772389/Anthem>,
        <https://1145.am/db/774919/Anthem>,
        <https://1145.am/db/830914/Anthem_Blue_Cross_And_Blue_Shield>,
        <https://1145.am/db/831414/Anthem_Blue_Cross_And_Blue_Shield> ;
    ns1:sameAsMedium <https://1145.am/db/2190847/Aetna>,
        <https://1145.am/db/2192282/Aetna>,
        <https://1145.am/db/2197211/Aetna>,
        <https://1145.am/db/2197483/Aetna>,
        <https://1145.am/db/2208704/Aetna>,
        <https://1145.am/db/2213068/Aetna>,
        <https://1145.am/db/2215199/Aetna>,
        <https://1145.am/db/2216382/Aetna>,
        <https://1145.am/db/2223863/Aetna>,
        <https://1145.am/db/2224155/Aetna>,
        <https://1145.am/db/2227027/Aetna>,
        <https://1145.am/db/2232883/Aetna>,
        <https://1145.am/db/2233496/Aetna>,
        <https://1145.am/db/2243700/Aetna>,
        <https://1145.am/db/2250666/Aetna>,
        <https://1145.am/db/2255256/Aetna>,
        <https://1145.am/db/2256300/Aetna>,
        <https://1145.am/db/2256346/Aetna>,
        <https://1145.am/db/2259863/Aetna>,
        <https://1145.am/db/2260831/Aetna>,
        <https://1145.am/db/2261705/Aetna>,
        <https://1145.am/db/2263365/Aetna>,
        <https://1145.am/db/2263407/Aetna>,
        <https://1145.am/db/2263450/Aetna>,
        <https://1145.am/db/2263968/Aetna_Inc>,
        <https://1145.am/db/2266104/Aetna>,
        <https://1145.am/db/2267796/Aetna>,
        <https://1145.am/db/2270165/Aetna>,
        <https://1145.am/db/2270379/Aetna>,
        <https://1145.am/db/2275755/Aetna>,
        <https://1145.am/db/2276552/Aetna>,
        <https://1145.am/db/2276969/Aetna>,
        <https://1145.am/db/2277989/Aetna>,
        <https://1145.am/db/2278258/Aetna>,
        <https://1145.am/db/2278449/Aetna>,
        <https://1145.am/db/2576016/Aetna> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2291004/Founders_Fund> a org:Organization ;
    ns1:documentDate "2012-09-24T12:13:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Medtronic wins CE mark for blood oxygenation system; Researchers develop advanced 'virtual' foot as treatment aid;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/medtronic-wins-ce-mark-for-blood-oxygenation-system-researchers-develop-advanced> ;
    ns1:foundName "Founders Fund" ;
    ns1:investor <https://1145.am/db/2291004/Series_A_Investment_Founders_Fund_Tribogenics_Completed> ;
    ns1:name "Founders Fund" ;
    ns1:sameAsMedium <https://1145.am/db/1014718/Founders_Fund>,
        <https://1145.am/db/1015489/Founders_Fund>,
        <https://1145.am/db/1048355/Founders_Fund>,
        <https://1145.am/db/1119433/Founders_Fund>,
        <https://1145.am/db/1297417/Founders_Fund>,
        <https://1145.am/db/1323598/Founders_Fund>,
        <https://1145.am/db/1376203/Founders_Fund>,
        <https://1145.am/db/1481368/Founders_Fund>,
        <https://1145.am/db/1488858/Founders_Fund>,
        <https://1145.am/db/1494028/Founders_Fund>,
        <https://1145.am/db/1512079/Founders_Fund>,
        <https://1145.am/db/1635018/Founders_Fund>,
        <https://1145.am/db/1694637/Founders_Fund>,
        <https://1145.am/db/1697296/Founders_Fund>,
        <https://1145.am/db/1707285/Founders_Fund>,
        <https://1145.am/db/1708523/Founders_Fund>,
        <https://1145.am/db/1710313/Founders_Fund>,
        <https://1145.am/db/1722513/Founders_Fund>,
        <https://1145.am/db/1723683/Founders_Fund>,
        <https://1145.am/db/1725305/Founders_Fund>,
        <https://1145.am/db/1734908/Founders_Fund>,
        <https://1145.am/db/1737944/Founders_Fund>,
        <https://1145.am/db/1738602/Founders_Fund>,
        <https://1145.am/db/1740000/Founders_Fund>,
        <https://1145.am/db/1740701/Founders_Fund>,
        <https://1145.am/db/1743093/Founders_Fund>,
        <https://1145.am/db/1743316/Founders_Fund>,
        <https://1145.am/db/1743873/Founders_Fund>,
        <https://1145.am/db/1745995/Founders_Fund>,
        <https://1145.am/db/1745998/Founders_Fund>,
        <https://1145.am/db/1747001/Founders_Fund>,
        <https://1145.am/db/1747457/Founders_Fund>,
        <https://1145.am/db/1748490/Founders_Fund>,
        <https://1145.am/db/1748969/Founders_Fund>,
        <https://1145.am/db/1751632/Founders_Fund>,
        <https://1145.am/db/1753641/Founders_Fund>,
        <https://1145.am/db/1759004/Founders_Fund>,
        <https://1145.am/db/1760986/Founders_Fund>,
        <https://1145.am/db/1761460/Founders_Fund>,
        <https://1145.am/db/1764689/Founders_Fund>,
        <https://1145.am/db/1765550/Founders_Fund>,
        <https://1145.am/db/1766096/Founders_Fund>,
        <https://1145.am/db/1772199/Founders_Fund>,
        <https://1145.am/db/1773361/Founders_Fund>,
        <https://1145.am/db/1776563/Founders_Fund>,
        <https://1145.am/db/1779848/Founders_Fund>,
        <https://1145.am/db/1780288/Founders_Fund>,
        <https://1145.am/db/1787451/Founders_Fund>,
        <https://1145.am/db/1797416/Founders_Fund>,
        <https://1145.am/db/1802109/Founders_Fund>,
        <https://1145.am/db/1803147/Founders_Fund>,
        <https://1145.am/db/1806982/Founders_Fund>,
        <https://1145.am/db/1809707/Founders_Fund>,
        <https://1145.am/db/1818475/Founders_Fund>,
        <https://1145.am/db/1827081/Founders_Fund>,
        <https://1145.am/db/1829422/Founders_Fund>,
        <https://1145.am/db/1829549/Founders_Fund>,
        <https://1145.am/db/1834173/Founders_Fund>,
        <https://1145.am/db/1834221/Founders_Fund>,
        <https://1145.am/db/1846718/Founders_Fund>,
        <https://1145.am/db/1847739/Founders_Fund>,
        <https://1145.am/db/1849884/Founders_Fund>,
        <https://1145.am/db/1850812/Founders_Fund>,
        <https://1145.am/db/1852869/Founders_Fund>,
        <https://1145.am/db/1857306/Founders_Fund>,
        <https://1145.am/db/1858452/Founders_Fund>,
        <https://1145.am/db/1858742/Founders_Fund>,
        <https://1145.am/db/1871784/Founders_Fund>,
        <https://1145.am/db/1890157/Founders_Fund>,
        <https://1145.am/db/1892099/Founders_Fund>,
        <https://1145.am/db/1896530/Founders_Fund>,
        <https://1145.am/db/1909651/The_Founders_Fund>,
        <https://1145.am/db/1915630/Founders_Fund>,
        <https://1145.am/db/1916189/Founders_Fund>,
        <https://1145.am/db/1924201/Founders_Fund>,
        <https://1145.am/db/2008515/Founders_Fund>,
        <https://1145.am/db/2029836/Founders_Fund>,
        <https://1145.am/db/2058874/Founders_Fund>,
        <https://1145.am/db/2079011/Founders_Fund>,
        <https://1145.am/db/2087734/Founders_Fund>,
        <https://1145.am/db/2151717/Founders_Fund>,
        <https://1145.am/db/2183141/Founders_Fund>,
        <https://1145.am/db/2185522/Founders_Fund>,
        <https://1145.am/db/2188497/Founders_Fund>,
        <https://1145.am/db/2197248/Founders_Fund>,
        <https://1145.am/db/219754/Founders_Fund>,
        <https://1145.am/db/2246579/Founders_Fund>,
        <https://1145.am/db/2251834/Founders_Fund>,
        <https://1145.am/db/2285971/Founders_Fund>,
        <https://1145.am/db/2295809/Founders_Fund>,
        <https://1145.am/db/2349764/Founders_Fund>,
        <https://1145.am/db/2365279/Founders_Fund>,
        <https://1145.am/db/424834/Founders_Fund>,
        <https://1145.am/db/426637/Founders_Fund>,
        <https://1145.am/db/435549/Founders_Fund>,
        <https://1145.am/db/437536/Founders_Fund>,
        <https://1145.am/db/437556/Founders_Fund>,
        <https://1145.am/db/438632/Founders_Fund>,
        <https://1145.am/db/475105/Founders_Fund>,
        <https://1145.am/db/478867/Founders_Fund>,
        <https://1145.am/db/561809/Founders_Fund>,
        <https://1145.am/db/563972/Founders_Fund>,
        <https://1145.am/db/642123/Founders_Fund>,
        <https://1145.am/db/665662/Founders_Fund>,
        <https://1145.am/db/684792/Founders_Fund>,
        <https://1145.am/db/708842/Founders_Fund>,
        <https://1145.am/db/710123/Founders_Fund>,
        <https://1145.am/db/812291/Founders_Fund>,
        <https://1145.am/db/893359/Founders_Fund>,
        <https://1145.am/db/894233/Founders_Fund>,
        <https://1145.am/db/918904/Founders_Fund>,
        <https://1145.am/db/922498/Founders_Fund>,
        <https://1145.am/db/922613/Founders_Fund>,
        <https://1145.am/db/925994/Founders_Fund>,
        <https://1145.am/db/935448/Founders_Fund>,
        <https://1145.am/db/936245/Founders_Fund>,
        <https://1145.am/db/970382/Founders_Fund>,
        <https://1145.am/db/974922/Founders_Fund>,
        <https://1145.am/db/988084/Founders_Fund>,
        <https://1145.am/db/995137/Founders_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294367/European_Public_Health_Alliance> a org:Organization ;
    ns1:basedInLowRaw "Massachusetts" ;
    ns1:documentDate "2012-12-11T15:14:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Abbott starts trading AbbVie spinout; Grove Instruments raises $3M for glucometer project;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/abbott-starts-trading-abbvie-spinout-grove-instruments-raises-3m-for-glucometer> ;
    ns1:foundName "European Public Health Alliance" ;
    ns1:name "European Public Health Alliance" ;
    ns1:participant <https://1145.am/db/2294367/Series_B-1_Investment_European_Public_Health_Alliance_Massachusetts_Grove_Instruments_Completed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306436/Clinipace> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:buyer <https://1145.am/db/2306436/Paragon_Biomedical_Acquisition> ;
    ns1:documentDate "2012-10-28T22:51:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clinipace raises $9M to staff up after acquisition" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/clinipace-raises-9m-to-staff-up-after-acquisition> ;
    ns1:foundName "Clinipace" ;
    ns1:industry "CRO" ;
    ns1:investor <https://1145.am/db/2306436/Paragon_Biomedical_Acquisition> ;
    ns1:name "Clinipace" ;
    ns1:sameAsHigh <https://1145.am/db/2282041/Clinlogix>,
        <https://1145.am/db/2282188/Clinlogix>,
        <https://1145.am/db/2305368/Clinipace>,
        <https://1145.am/db/2321356/Clinipace_Worldwide>,
        <https://1145.am/db/2334019/Clinipace> ;
    ns1:sameAsMedium <https://1145.am/db/2321775/Clinipace>,
        <https://1145.am/db/2322805/Clinipace>,
        <https://1145.am/db/2322850/Clinipace> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2331148/Bgi> a org:Organization ;
    ns1:basedInHighGeoName "Peopleâ€™s Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:buyer <https://1145.am/db/2331148/Complete_Genomics_Acquisition> ;
    ns1:description "finance" ;
    ns1:documentDate "2012-09-17T13:27:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "China's BGI strikes deal to buy Complete Genomics for $117.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/data-management/china-s-bgi-strikes-deal-to-buy-complete-genomics-for-117-6m> ;
    ns1:foundName "BGI" ;
    ns1:investor <https://1145.am/db/2331148/Complete_Genomics_Acquisition> ;
    ns1:name "BGI" ;
    ns1:sameAsMedium <https://1145.am/db/2326081/Bgi>,
        <https://1145.am/db/2331149/Bgi>,
        <https://1145.am/db/2340834/Bgi>,
        <https://1145.am/db/2360068/Bgi>,
        <https://1145.am/db/2360069/Bgi>,
        <https://1145.am/db/2360628/Bgi>,
        <https://1145.am/db/2364122/Bgi>,
        <https://1145.am/db/2545464/Bgi> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332234/Gld_Invest> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Sweden" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:basedInHighRaw "Sweden" ;
    ns1:documentDate "2012-10-25T13:40:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Swedish bioinformatics group grabs $840K to fuel growth, report says" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/swedish-bioinformatics-group-grabs-840k-to-fuel-growth-report-says> ;
    ns1:foundName "GLD Invest" ;
    ns1:investor <https://1145.am/db/2332234/Investment_Gld_Invest_Qlucore_Qlucore_Completed> ;
    ns1:name "GLD Invest" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332322/Bioadvance> a org:Organization ;
    ns1:basedInLowRaw "RADNOR, Pa" ;
    ns1:documentDate "2012-08-27T22:01:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/novira-therapeutics-secures-23-million-series-a-financing-to-advance-development-of> ;
    ns1:foundName "BioAdvance" ;
    ns1:investor <https://1145.am/db/2332322/Series_A_Investment_5am_Ventures_Bioadvance_Canaan_Partners_Delaware_Crossing_Investment_Group_Mid-Atlantic_Angel_Group_Novira_Therapeutics_Inc_Robin_Hood_Ventures_Wuxi_Pharmatech_Completed> ;
    ns1:name "BioAdvance" ;
    ns1:sameAsMedium <https://1145.am/db/1196322/Bioadvance>,
        <https://1145.am/db/1223133/Bioadvance>,
        <https://1145.am/db/1223149/Bioadvance>,
        <https://1145.am/db/1326655/Bioadvance>,
        <https://1145.am/db/1326957/Bioadvance>,
        <https://1145.am/db/1571871/Bioadvance>,
        <https://1145.am/db/1623159/Bioadvance>,
        <https://1145.am/db/2306250/Bioadvance>,
        <https://1145.am/db/2317455/Bioadvance>,
        <https://1145.am/db/2322984/Bioadvance>,
        <https://1145.am/db/2323003/Bioadvance>,
        <https://1145.am/db/2325387/Bioadvance>,
        <https://1145.am/db/2336032/Bioadvance>,
        <https://1145.am/db/2351683/Bioadvance>,
        <https://1145.am/db/2351684/Bioadvance>,
        <https://1145.am/db/2358806/Bioadvance>,
        <https://1145.am/db/2572398/Bioadvance>,
        <https://1145.am/db/2585002/Bioadvance>,
        <https://1145.am/db/479135/Bioadvance>,
        <https://1145.am/db/577663/Bioadvance>,
        <https://1145.am/db/907506/Bioadvance>,
        <https://1145.am/db/907937/Bioadvance> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332322/Canaan_Partners> a org:Organization ;
    ns1:basedInLowRaw "RADNOR, Pa" ;
    ns1:documentDate "2012-08-27T22:01:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/novira-therapeutics-secures-23-million-series-a-financing-to-advance-development-of> ;
    ns1:foundName "Canaan Partners" ;
    ns1:investor <https://1145.am/db/2332322/Series_A_Investment_5am_Ventures_Bioadvance_Canaan_Partners_Delaware_Crossing_Investment_Group_Mid-Atlantic_Angel_Group_Novira_Therapeutics_Inc_Robin_Hood_Ventures_Wuxi_Pharmatech_Completed> ;
    ns1:name "Canaan Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1043342/Canaan_Partners>,
        <https://1145.am/db/146274/Canaan_Partners>,
        <https://1145.am/db/1695894/Canaan_Partners>,
        <https://1145.am/db/1696766/Canaan_Partners>,
        <https://1145.am/db/1697131/Canaan_Partners>,
        <https://1145.am/db/1702857/Canaan_Partners>,
        <https://1145.am/db/1711633/Canaan_Partners>,
        <https://1145.am/db/1724566/Canaan_Partners>,
        <https://1145.am/db/1734259/Canaan_Partners>,
        <https://1145.am/db/1741014/Canaan_Partners>,
        <https://1145.am/db/1741105/Canaan_Partners>,
        <https://1145.am/db/1741424/Canaan_Partners>,
        <https://1145.am/db/1749744/Canaan_Partners>,
        <https://1145.am/db/1754820/Canaan_Partners>,
        <https://1145.am/db/1768400/Canaan_Partners>,
        <https://1145.am/db/1770648/Canaan_Partners>,
        <https://1145.am/db/1791628/Canaan_Partners>,
        <https://1145.am/db/1792426/Canaan_Partners>,
        <https://1145.am/db/1793543/Canaan_Partners>,
        <https://1145.am/db/1796375/Canaan_Partners>,
        <https://1145.am/db/1814413/Canaan_Partners>,
        <https://1145.am/db/1819543/Canaan_Partners>,
        <https://1145.am/db/1827240/Canaan_Partners>,
        <https://1145.am/db/1829078/Canaan_Partners>,
        <https://1145.am/db/1829544/Canaan_Partners>,
        <https://1145.am/db/1836578/Canaan_Partners>,
        <https://1145.am/db/1842466/Canaan_Partners>,
        <https://1145.am/db/1845119/Canaan_Partners>,
        <https://1145.am/db/1852066/Canaan_Partners>,
        <https://1145.am/db/1858762/Canaan_Partners>,
        <https://1145.am/db/1863401/Canaan_Partners>,
        <https://1145.am/db/1866968/Canaan_Partners>,
        <https://1145.am/db/1894670/Canaan_Partners>,
        <https://1145.am/db/1897255/Canaan_Partners>,
        <https://1145.am/db/1900458/Canaan_Partners>,
        <https://1145.am/db/1906336/Canaan_Partners>,
        <https://1145.am/db/1907151/Canaan_Partners>,
        <https://1145.am/db/1907762/Canaan_Partners>,
        <https://1145.am/db/1910644/Canaan_Partners>,
        <https://1145.am/db/1919135/Canaan_Partners>,
        <https://1145.am/db/1920478/Canaan_Partners>,
        <https://1145.am/db/2164798/Canaan_Partners>,
        <https://1145.am/db/2164838/Canaan_Partners>,
        <https://1145.am/db/2210939/Canaan_Partners>,
        <https://1145.am/db/2238667/Canaan_Partners>,
        <https://1145.am/db/2287025/Canaan_Partners>,
        <https://1145.am/db/2287777/Canaan_Partners>,
        <https://1145.am/db/2297592/Canaan_Partners>,
        <https://1145.am/db/2298642/Canaan_Partners>,
        <https://1145.am/db/2301765/Canaan_Partners>,
        <https://1145.am/db/2304587/Canaan_Partners>,
        <https://1145.am/db/2304605/Canaan_Partners>,
        <https://1145.am/db/2306281/Canaan_Partners>,
        <https://1145.am/db/2308329/Canaan_Partners>,
        <https://1145.am/db/2309376/Canaan_Partners>,
        <https://1145.am/db/2309387/Canaan_Partners>,
        <https://1145.am/db/2313171/Canaan_Partners>,
        <https://1145.am/db/2320925/Canaan_Partners>,
        <https://1145.am/db/2322231/Canaan_Partners>,
        <https://1145.am/db/2329010/Canaan_Partners>,
        <https://1145.am/db/2329011/Canaan_Partners>,
        <https://1145.am/db/2329531/Canaan_Partners>,
        <https://1145.am/db/2337958/Canaan_Partners>,
        <https://1145.am/db/2337974/Canaan_Partners>,
        <https://1145.am/db/2346532/Canaan_Partners>,
        <https://1145.am/db/2347469/Canaan_Partners>,
        <https://1145.am/db/2351129/Canaan_Partners>,
        <https://1145.am/db/2351316/Canaan_Partners>,
        <https://1145.am/db/2351684/Canaan_Partners>,
        <https://1145.am/db/2353588/Canaan_Partners>,
        <https://1145.am/db/2353608/Canaan_Partners>,
        <https://1145.am/db/2355043/Canaan_Partners>,
        <https://1145.am/db/2355238/Canaan_Partners>,
        <https://1145.am/db/2355715/Canaan_Partners>,
        <https://1145.am/db/2358378/Canaan_Partners>,
        <https://1145.am/db/2359185/Canaan_Partners>,
        <https://1145.am/db/2360258/Canaan_Partners>,
        <https://1145.am/db/2360266/Canaan_Partners>,
        <https://1145.am/db/2360647/Canaan_Partners>,
        <https://1145.am/db/2363535/Canaan_Partners>,
        <https://1145.am/db/2365700/Canaan_Partners>,
        <https://1145.am/db/2366187/Canaan_Partners>,
        <https://1145.am/db/2366753/Canaan_Partners>,
        <https://1145.am/db/2368322/Canaan_Partners>,
        <https://1145.am/db/2368973/Canaan_Partners>,
        <https://1145.am/db/2368982/Canaan_Partners>,
        <https://1145.am/db/2370582/Canaan_Partners>,
        <https://1145.am/db/2370802/Canaan_Partners>,
        <https://1145.am/db/2370834/Canaan_Partners>,
        <https://1145.am/db/2572398/Canaan_Partners>,
        <https://1145.am/db/2583466/Canaan_Partners>,
        <https://1145.am/db/2635439/Canaan_Partners>,
        <https://1145.am/db/316299/Canaan_Partners>,
        <https://1145.am/db/319155/Canaan_Partners>,
        <https://1145.am/db/353476/Canaan_Partners>,
        <https://1145.am/db/411041/Canaan_Partners>,
        <https://1145.am/db/523179/Canaan_Partners>,
        <https://1145.am/db/564082/Canaan_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332322/Delaware_Crossing_Investment_Group> a org:Organization ;
    ns1:basedInLowRaw "Delaware" ;
    ns1:documentDate "2012-08-27T22:01:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/novira-therapeutics-secures-23-million-series-a-financing-to-advance-development-of> ;
    ns1:foundName "Delaware Crossing Investment Group",
        "Delaware Crossing Investment Group (DCIG)" ;
    ns1:investor <https://1145.am/db/2332322/Series_A_Investment_5am_Ventures_Bioadvance_Canaan_Partners_Delaware_Crossing_Investment_Group_Mid-Atlantic_Angel_Group_Novira_Therapeutics_Inc_Robin_Hood_Ventures_Wuxi_Pharmatech_Completed> ;
    ns1:name "Delaware Crossing Investment Group" ;
    ns1:sameAsMedium <https://1145.am/db/2351683/Delaware_Crossing_Investment_Group>,
        <https://1145.am/db/2351684/Delaware_Crossing_Investment_Group>,
        <https://1145.am/db/2365344/Delaware_Crossing_Investor_Group>,
        <https://1145.am/db/2572398/Delaware_Crossing_Investment_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332322/Mid-Atlantic_Angel_Group> a org:Organization ;
    ns1:basedInLowRaw "Pa" ;
    ns1:documentDate "2012-08-27T22:01:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/novira-therapeutics-secures-23-million-series-a-financing-to-advance-development-of> ;
    ns1:foundName "Mid-Atlantic Angel Group" ;
    ns1:investor <https://1145.am/db/2332322/Series_A_Investment_5am_Ventures_Bioadvance_Canaan_Partners_Delaware_Crossing_Investment_Group_Mid-Atlantic_Angel_Group_Novira_Therapeutics_Inc_Robin_Hood_Ventures_Wuxi_Pharmatech_Completed> ;
    ns1:name "Mid-Atlantic Angel Group" ;
    ns1:sameAsMedium <https://1145.am/db/2351683/Mid-Atlantic_Angel_Group>,
        <https://1145.am/db/2351684/Mid-Atlantic_Angel_Group>,
        <https://1145.am/db/2572398/Mid-Atlantic_Angel_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332322/Robin_Hood_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Pa" ;
    ns1:documentDate "2012-08-27T22:01:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/novira-therapeutics-secures-23-million-series-a-financing-to-advance-development-of> ;
    ns1:foundName "Robin Hood Ventures" ;
    ns1:investor <https://1145.am/db/2332322/Series_A_Investment_5am_Ventures_Bioadvance_Canaan_Partners_Delaware_Crossing_Investment_Group_Mid-Atlantic_Angel_Group_Novira_Therapeutics_Inc_Robin_Hood_Ventures_Wuxi_Pharmatech_Completed> ;
    ns1:name "Robin Hood Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1428361/Robin_Hood_Ventures>,
        <https://1145.am/db/1867522/Robin_Hood_Ventures>,
        <https://1145.am/db/2290410/Robin_Hood_Ventures>,
        <https://1145.am/db/2351683/Robin_Hood_Ventures>,
        <https://1145.am/db/2351684/Robin_Hood_Ventures>,
        <https://1145.am/db/2365344/Robin_Hood_Ventures>,
        <https://1145.am/db/2572398/Robin_Hood_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332322/Wuxi_Pharmatech> a org:Organization ;
    ns1:basedInLowRaw "China" ;
    ns1:documentDate "2012-08-27T22:01:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/novira-therapeutics-secures-23-million-series-a-financing-to-advance-development-of> ;
    ns1:foundName "WuXi PharmaTech" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2332322/Series_A_Investment_5am_Ventures_Bioadvance_Canaan_Partners_Delaware_Crossing_Investment_Group_Mid-Atlantic_Angel_Group_Novira_Therapeutics_Inc_Robin_Hood_Ventures_Wuxi_Pharmatech_Completed> ;
    ns1:name "WuXi PharmaTech" ;
    ns1:sameAsHigh <https://1145.am/db/1084077/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/1085897/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/1226394/Zhongrun>,
        <https://1145.am/db/1232326/Zhongrun>,
        <https://1145.am/db/137166/Yixintang_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/137230/Yixintang_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/1539584/Shanghai_Fosun_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/1579432/Zhongrun>,
        <https://1145.am/db/1606076/Beijing_Continent>,
        <https://1145.am/db/1616035/Sihuan_Pharmaceutical_Holdings_Group_Co_Ltd>,
        <https://1145.am/db/1981788/Shanghai_Fosun_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/2202794/Shengtai_Pharmaceutical>,
        <https://1145.am/db/2203882/Shengtai_Pharmaceutical>,
        <https://1145.am/db/2290845/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2296208/Shanghai_Pharma>,
        <https://1145.am/db/2297651/Tonghua_Dongbao_Pharmaceuticals>,
        <https://1145.am/db/2302222/China_Pharma_Holdings_Inc>,
        <https://1145.am/db/2303132/China_Health_Holding>,
        <https://1145.am/db/2303514/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2304097/Guangxi_Lingfeng_Pharmaceutical>,
        <https://1145.am/db/2305866/Wuxi_Pharmatech>,
        <https://1145.am/db/2306155/China_Medicine_Corporation>,
        <https://1145.am/db/2308945/Wuxi_Pharmatec>,
        <https://1145.am/db/2308964/Zhangjiakou_Shengda_Pharmaceutical>,
        <https://1145.am/db/2309365/China_Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2312709/Tongjitang_Chinese_Medicines_Company>,
        <https://1145.am/db/2312926/Wuxi_Pharmatech>,
        <https://1145.am/db/2314210/Shijiazhuang_Le_Ren_Tang_Pharmaceutical>,
        <https://1145.am/db/2314211/Shijiazhuang_Le_Ren_Tang_Pharmaceutical>,
        <https://1145.am/db/2314615/Beijing_Med-Pharm>,
        <https://1145.am/db/2315545/China_Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2315545/Shijiazhuang_Lerentang_Pharmaceutical_Company_Ltd>,
        <https://1145.am/db/2317680/Wuxi_Pharmatech>,
        <https://1145.am/db/2318272/Tianyin_Pharmaceutical>,
        <https://1145.am/db/2318280/Tianyin_Pharmaceutical_Co_Inc>,
        <https://1145.am/db/2320000/Beijing_Med-Pharm>,
        <https://1145.am/db/2321775/Wuxi_Pharmatech>,
        <https://1145.am/db/2321858/Changchun_Xinan_Pharmaceutical_Group>,
        <https://1145.am/db/2321867/Changchun_Xinan_Pharmaceutical_Group_Company_Limited>,
        <https://1145.am/db/2321868/Shandong_Simcere_Medgenn_Bio-Pharmaceutical>,
        <https://1145.am/db/2321885/Shandong_Simcere_Medgenn_Bio-Pharmaceutical_Co>,
        <https://1145.am/db/2322489/Shengtai_Pharmaceutical_Inc>,
        <https://1145.am/db/2322490/China_Yongxin_Pharmaceutical_Inc>,
        <https://1145.am/db/2322854/Wuxi_Pharmatech>,
        <https://1145.am/db/2324777/Jiangbo_Pharmaceuticals>,
        <https://1145.am/db/2325432/China_Health_Holdings>,
        <https://1145.am/db/2325432/Xian_Chunhui_Pharmaceuticals>,
        <https://1145.am/db/2327401/Wuxi_Pharmatech>,
        <https://1145.am/db/2327517/Shengtai_Pharmaceutical>,
        <https://1145.am/db/2328605/Shengtai_Pharmaceutical>,
        <https://1145.am/db/2328959/Tianyin_Pharmaceutical_Co_Inc>,
        <https://1145.am/db/2330121/Zhejiang_Hisun_Pharmaceutical>,
        <https://1145.am/db/2330122/Zhejiang_Hisun_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2332622/Wuxi_Pharmatech>,
        <https://1145.am/db/2332973/Wuxi_Pharmatech>,
        <https://1145.am/db/2332977/Wuxi_Pharmatech>,
        <https://1145.am/db/2332992/Wuxi_Pharmatech>,
        <https://1145.am/db/2333380/Wuxi_Pharmatech>,
        <https://1145.am/db/2333547/Beijing_Med-Pharm>,
        <https://1145.am/db/2333559/Beijing_Med-Pharm>,
        <https://1145.am/db/2334018/Wuxi_Pharmatech>,
        <https://1145.am/db/2339255/Wuxi_Pharmatech>,
        <https://1145.am/db/2339514/Yantai_Tianzheng_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2345570/China_Pharmahub_Corp>,
        <https://1145.am/db/2345740/Wuxi_Pharmatech>,
        <https://1145.am/db/2349221/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2351684/Wuxi_Pharmatech>,
        <https://1145.am/db/2351908/Guangxi_Wuzhou_Pharmaceutical_Group_Co_Ltd>,
        <https://1145.am/db/2354127/Wuxi_Pharmatech>,
        <https://1145.am/db/2355454/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2356518/China_Medicine>,
        <https://1145.am/db/2358954/Wuxi_Pharmatech>,
        <https://1145.am/db/2361298/Beijing_Jialin_Pharma_Pharmaceutical>,
        <https://1145.am/db/2363450/Guangdong_Medi-World_Pharmaceutical>,
        <https://1145.am/db/2363450/Jiangyin_Tianjiang_Pharmaceutical>,
        <https://1145.am/db/2367156/Jiangbo_Pharmaceuticals_Inc>,
        <https://1145.am/db/2367164/Jiangbo_Pharmaceuticals>,
        <https://1145.am/db/2536549/Wuxi_Pharmatech>,
        <https://1145.am/db/2536754/Guangxi_Wuzhou_Pharmaceutical>,
        <https://1145.am/db/2536776/Guangxi_Wuzhou_Pharmaceutical>,
        <https://1145.am/db/2536790/Wuxi_Pharmatech>,
        <https://1145.am/db/2537079/Jiangxi_Dongbang_Pharmaceutical>,
        <https://1145.am/db/2537316/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2537340/Zhejiang_Wansheng_Pharma>,
        <https://1145.am/db/2537372/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2537821/Zhejiang_Wansheng_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2538197/Wuxi_Pharmatech>,
        <https://1145.am/db/2539062/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2540165/Beijing_Med-Pharm>,
        <https://1145.am/db/2540242/Zhejiang_Wansheng_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2540502/Shanghai_Fosun_Pharmaceuticals>,
        <https://1145.am/db/2540508/Shanghai_Fosun_Pharmaceutical>,
        <https://1145.am/db/2543972/Shanghai_Pharma>,
        <https://1145.am/db/2545296/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2545361/Tianyi>,
        <https://1145.am/db/2545366/Shanghai_Cp_Guojian_Pharmaceutical>,
        <https://1145.am/db/2546406/Jiangsu_Hansoh_Pharmaceutical>,
        <https://1145.am/db/2546427/Yichang_Hec_Changjiang_Pharmaceutical>,
        <https://1145.am/db/2547546/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2549427/Tianyin_Pharmaceutical>,
        <https://1145.am/db/2549518/Wuxi_Pharmatech>,
        <https://1145.am/db/2550212/Shijiazhuang_Lerentang_Pharmaceutical>,
        <https://1145.am/db/2550511/China_Resources_Pharmaceutical_Group>,
        <https://1145.am/db/2553148/China_Resources_Pharmaceutical_Group>,
        <https://1145.am/db/2553655/Wuxi_Pharmatech>,
        <https://1145.am/db/2553755/Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2555040/Jiangsu_Acebright_Pharmaceutical>,
        <https://1145.am/db/2555291/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2555342/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2555844/Wuxi_Pharmatech>,
        <https://1145.am/db/2556124/Shanghai_Fosun_Pharmaceutical>,
        <https://1145.am/db/2556124/Suzhou_Pharmaceutical_Factory>,
        <https://1145.am/db/2557866/Nanjing_Pharmaceutical_Company>,
        <https://1145.am/db/2559081/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2559665/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2560179/Beijing_Jialin_Pharmaceutical>,
        <https://1145.am/db/2560187/Beijing_Jialin_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2561248/Chongqing_Lummy_Pharmaceutical>,
        <https://1145.am/db/2561248/Tianjin_Zhongxin_Pharmaceutical>,
        <https://1145.am/db/2561426/China_Pharma>,
        <https://1145.am/db/2563016/Shanghai_Pharmaceutical_Industry>,
        <https://1145.am/db/2563847/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2563850/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2565596/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2569364/Liaoning_Tianyi_Biological_Pharmaceutical>,
        <https://1145.am/db/2569370/Tianyi>,
        <https://1145.am/db/2569370/Xiaojun_Zhao>,
        <https://1145.am/db/2570062/Jiangsu_Hansoh>,
        <https://1145.am/db/2572398/Wuxi_Pharmatech>,
        <https://1145.am/db/2572442/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/2572625/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2572679/Nanjing_Meirui_Pharma>,
        <https://1145.am/db/2572938/China_Medical>,
        <https://1145.am/db/2573585/Nanjing_Meirui_Pharma>,
        <https://1145.am/db/2575314/Shanghai_Modern_Pharmaceutical>,
        <https://1145.am/db/2577081/Chinas_Shenzhen_Hepalink_Pharmaceutical>,
        <https://1145.am/db/2580344/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2586048/Sihuan_Pharmaceutical_Holdings_Group_Ltd>,
        <https://1145.am/db/2587281/Jiangsu_Yanshen>,
        <https://1145.am/db/2587657/Shandong_Buchang_Pharmaceutical>,
        <https://1145.am/db/2588092/Shanghai_Pharmaceutical>,
        <https://1145.am/db/2594042/Guangxi_Wuzhou_Pharmaceutical_Co_Ltd>,
        <https://1145.am/db/2595150/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2595154/Shanghai_Pharmaceuticals>,
        <https://1145.am/db/2598064/Jiangzhong_Pharmaceuticals>,
        <https://1145.am/db/2722105/China_Resources_Pharmaceutical_Group>,
        <https://1145.am/db/2722105/Jiangzhong_Group>,
        <https://1145.am/db/2748691/Shanghai_Fosun_Pharmaceutical_Group>,
        <https://1145.am/db/438036/China_Grand_Pharmaceutical_And_Healthcare_Holdings_Limited>,
        <https://1145.am/db/742121/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/742618/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/744958/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/746462/Pharmaron_Beijing_Co_Limited>,
        <https://1145.am/db/773492/China_Sxt_Pharmaceuticals_Inc>,
        <https://1145.am/db/902672/China_Sxt_Pharmaceuticals_Inc>,
        <https://1145.am/db/973707/Zhongrun> ;
    ns1:sameAsMedium <https://1145.am/db/2302864/Wuxi_Pharmatech>,
        <https://1145.am/db/2317074/Wuxi_Pharmatech>,
        <https://1145.am/db/2318655/Wuxi_Pharmatech>,
        <https://1145.am/db/2327243/Wuxi_Pharmatech>,
        <https://1145.am/db/2328360/Wuxi_Pharmatech>,
        <https://1145.am/db/2328362/Wuxi_Pharmatech>,
        <https://1145.am/db/2329324/Wuxi_Pharmatech>,
        <https://1145.am/db/2330685/Wuxi_Pharmatech>,
        <https://1145.am/db/2331490/Wuxi_Pharmatech>,
        <https://1145.am/db/2331539/Wuxi_Pharmatech>,
        <https://1145.am/db/2331756/Wuxi_Pharmatech>,
        <https://1145.am/db/2336182/Wuxi_Pharmatech>,
        <https://1145.am/db/2341599/Wuxi_Pharmatech>,
        <https://1145.am/db/2345752/Wuxi_Pharmatech>,
        <https://1145.am/db/2346592/Wuxi_Pharmatech>,
        <https://1145.am/db/2351683/Wuxi_Pharmatech>,
        <https://1145.am/db/2355454/Wuxi_Pharmatech>,
        <https://1145.am/db/2356066/Wuxi_Pharmatech>,
        <https://1145.am/db/2357202/Wuxi_Pharmatech>,
        <https://1145.am/db/2368287/Wuxi_Pharmatech>,
        <https://1145.am/db/2368649/Wuxi_Pharmatech>,
        <https://1145.am/db/2369000/Wuxi_Pharmatech>,
        <https://1145.am/db/2369317/Wuxi_Pharmatech>,
        <https://1145.am/db/2369637/Wuxi_Pharmatech>,
        <https://1145.am/db/2536809/Wuxi_Pharmatech>,
        <https://1145.am/db/2538401/Wuxi_Pharmatech>,
        <https://1145.am/db/2544511/Wuxi_Pharmatech>,
        <https://1145.am/db/2546416/Wuxi_Pharmatech>,
        <https://1145.am/db/2548494/Wuxi_Pharmatech>,
        <https://1145.am/db/2552704/Wuxi_Pharmatech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333080/Merck_Global_Health_Innovation_Fund> a org:Organization ;
    ns1:description "healthcare and life science research" ;
    ns1:documentDate "2012-11-19T15:17:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/remedy-informatics-announces-growth-capital-investment-from-merck-global-health-innovation-fund> ;
    ns1:foundName "Merck Global Health Innovation Fund",
        "the Merck Global Health Innovation Fund" ;
    ns1:investor <https://1145.am/db/2333080/Growth_Capital_Investment_Merck_Global_Health_Innovation_Fund_Remedy_Informatics_Has_Not_Happened> ;
    ns1:name "Merck Global Health Innovation Fund" ;
    ns1:sameAsMedium <https://1145.am/db/1018050/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/1232627/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/1574442/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/1852302/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/1946588/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2069495/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2231362/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2299782/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2299792/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2308727/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/2317269/The_Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/540904/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/543257/The_Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/543263/The_Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/750997/Merck_Global_Health_Innovation_Fund>,
        <https://1145.am/db/782351/Merck_Global_Innovation_Fund>,
        <https://1145.am/db/784458/Merck_Global_Innovation_Fund>,
        <https://1145.am/db/874503/Merck_Global_Health_Innovation_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337044/Series_D_Investment_Affimed_Affimed_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-08T15:34:37+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Affimed Therapeutics AG: Affimed Raises Eur 15.5 Million in a Series D Financing Round.",
        "HEIDELBERG, Germany, Oct 08, 2012 (BUSINESS WIRE) - Affimed Therapeutics AG, the therapeutic TandAb antibody company, today announced the successful closing of a Series D financing round of EUR 15.5 million." ;
    ns1:documentTitle "Affimed Therapeutics AG: Affimed Raises Eur 15.5 Million in a Series D Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/affimed-therapeutics-ag-affimed-raises-eur-15-5-million-a-series-d-financing-round> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2337044/Affimed> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "EUR 15.5 million",
        "Eur 15.5 Million" ;
    ns1:when "2012-10-08T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct 08, 2012" ;
    ns1:whereGeoName "Federal Republic of Germany" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:whereRaw "Germany" .

<https://1145.am/db/2337071/Nrm_Vii_Holdings_I> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "private placement financing" ;
    ns1:documentDate "2012-10-09T12:15:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Fibrocell Science, Inc. Announces $45 Million Private Placement and Enters Strategic Collaboration with Intrexon" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/fibrocell-science-inc-announces-45-million-private-placement-and-enters-strategic> ;
    ns1:foundName "NRM VII Holdings I, LLC" ;
    ns1:investor <https://1145.am/db/2337071/Investment_Fibrocell_Science_Nrm_Vii_Holdings_I_Third_Security_Llc_Has_Not_Happened> ;
    ns1:name "NRM VII Holdings I" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337071/Third_Security_Llc> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "private placement financing" ;
    ns1:documentDate "2012-10-09T12:15:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Fibrocell Science, Inc. Announces $45 Million Private Placement and Enters Strategic Collaboration with Intrexon" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/fibrocell-science-inc-announces-45-million-private-placement-and-enters-strategic> ;
    ns1:foundName "Third Security, LLC" ;
    ns1:investor <https://1145.am/db/2337071/Investment_Fibrocell_Science_Nrm_Vii_Holdings_I_Third_Security_Llc_Has_Not_Happened> ;
    ns1:name "Third Security, LLC" ;
    ns1:participant <https://1145.am/db/2337071/Investment_Fibrocell_Science_Nrm_Vii_Holdings_I_Third_Security_Llc_Has_Not_Happened> ;
    ns1:sameAsMedium <https://1145.am/db/2336957/Third_Security_Llc>,
        <https://1145.am/db/2348287/Third_Security_Llc>,
        <https://1145.am/db/2353230/Third_Security_Llc>,
        <https://1145.am/db/636070/Third_Security>,
        <https://1145.am/db/637012/Third_Security> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337566/Emerging_Technology_Fund> a org:Organization ;
    ns1:basedInLowRaw "Cambridge MA" ;
    ns1:documentDate "2012-10-10T04:01:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InVivo Therapeutics Awarded $2 Million Loan from MassDevelopment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/invivo-therapeutics-awarded-2-million-loan-from-massdevelopment> ;
    ns1:foundName "Emerging Technology Fund" ;
    ns1:investor <https://1145.am/db/2337566/Investment_Emerging_Technology_Fund_Invivo_Therapeutics_Massdevelopment_Has_Not_Happened> ;
    ns1:name "Emerging Technology Fund" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337566/Massdevelopment> a org:Organization ;
    ns1:basedInLowRaw "Cambridge MA" ;
    ns1:description "Business" ;
    ns1:documentDate "2012-10-10T04:01:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InVivo Therapeutics Awarded $2 Million Loan from MassDevelopment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/invivo-therapeutics-awarded-2-million-loan-from-massdevelopment> ;
    ns1:foundName "MassDevelopment" ;
    ns1:investor <https://1145.am/db/2337566/Investment_Emerging_Technology_Fund_Invivo_Therapeutics_Massdevelopment_Has_Not_Happened> ;
    ns1:name "MassDevelopment" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/Henry> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "Henry" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Henry" ;
    ns1:sameAsMedium <https://1145.am/db/444010/Henry>,
        <https://1145.am/db/445085/Henry>,
        <https://1145.am/db/472558/Henry_Company>,
        <https://1145.am/db/473668/Henry_Company>,
        <https://1145.am/db/797404/Henry_Company> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/Fibrotec_Ventures> a org:Organization ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName "Fibrotec Ventures, LLC" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2338373/Series_D_Investment_Easton_Capital_Investment_Group_Fibrotec_Ventures_Forbion_Capital_Partners_Healthcare_Ventures_Inc_Morgenthaler_Ventures_Polaris_Venture_Partners_Shire_Strategic_Investment_Group_Completed> ;
    ns1:name "Fibrotec Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2343202/Fibrotic_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2343210/Fibrotec_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/Forbion_Capital_Partners> a org:Organization ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName "Forbion Capital Partners" ;
    ns1:investor <https://1145.am/db/2338373/Series_D_Investment_Easton_Capital_Investment_Group_Fibrotec_Ventures_Forbion_Capital_Partners_Healthcare_Ventures_Inc_Morgenthaler_Ventures_Polaris_Venture_Partners_Shire_Strategic_Investment_Group_Completed> ;
    ns1:name "Forbion Capital Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2223193/Forbion_Capital_Partners>,
        <https://1145.am/db/2288529/Forbion_Capital_Partners>,
        <https://1145.am/db/2295207/Forbion_Capital_Partners>,
        <https://1145.am/db/2296065/Forbion_Capital_Partners>,
        <https://1145.am/db/2301966/Forbion_Capital_Partners>,
        <https://1145.am/db/2309865/Forbion_Capital_Partners>,
        <https://1145.am/db/2309872/Forbion_Capital_Partners>,
        <https://1145.am/db/2313401/Forbion_Capital_Partners>,
        <https://1145.am/db/2313410/Forbion_Capital_Partners>,
        <https://1145.am/db/2313915/Forbion_Capital_Partners>,
        <https://1145.am/db/2318829/Forbion_Capital_Partners>,
        <https://1145.am/db/2320503/Forbion_Capital_Partners>,
        <https://1145.am/db/2323586/Forbion_Capital_Partners>,
        <https://1145.am/db/2327009/Forbion_Capital_Partners>,
        <https://1145.am/db/2328040/Forbion_Capital_Partners>,
        <https://1145.am/db/2328763/Forbion_Capital_Partners>,
        <https://1145.am/db/2328769/Forbion_Capital_Partners>,
        <https://1145.am/db/2329919/Forbion_Capital_Partners>,
        <https://1145.am/db/2336126/Forbion_Capital_Partners>,
        <https://1145.am/db/2338987/Forbion_Capital_Partners>,
        <https://1145.am/db/2339427/Forbion_Capital_Partners>,
        <https://1145.am/db/2339428/Forbion_Capital_Partners>,
        <https://1145.am/db/2339932/Forbion_Capital_Partners>,
        <https://1145.am/db/2339933/Forbion_Capital_Partners>,
        <https://1145.am/db/2341942/Forbion_Capital_Partners>,
        <https://1145.am/db/2343202/Forbion_Capital_Partners>,
        <https://1145.am/db/2343210/Forbion_Capital_Partners>,
        <https://1145.am/db/2343244/Forbion_Capital_Partners>,
        <https://1145.am/db/2346397/Forbion_Capital_Partners>,
        <https://1145.am/db/2348506/Forbion_Capital_Partners>,
        <https://1145.am/db/2348523/Forbion_Capital_Partners>,
        <https://1145.am/db/2350101/Forbion_Capital_Partners>,
        <https://1145.am/db/2352566/Forbion_Capital_Partners>,
        <https://1145.am/db/2355511/Forbion_Capital_Partners>,
        <https://1145.am/db/2355512/Forbion_Capital_Partners>,
        <https://1145.am/db/2356989/Forbion_Capital_Partners>,
        <https://1145.am/db/2357941/Forbion_Capital_Partners>,
        <https://1145.am/db/2357956/Forbion_Capital_Partners>,
        <https://1145.am/db/2359960/Forbion_Capital_Partners>,
        <https://1145.am/db/2360313/Forbion_Capital_Partners>,
        <https://1145.am/db/2360317/Forbion_Capital_Partners>,
        <https://1145.am/db/2361390/Forbion_Capital_Partners>,
        <https://1145.am/db/2363593/Forbion_Capital_Partners>,
        <https://1145.am/db/2363597/Forbion_Capital_Partners>,
        <https://1145.am/db/2366539/Forbion_Capital_Partners>,
        <https://1145.am/db/2369872/Forbion_Capital_Partners>,
        <https://1145.am/db/2370054/Forbion_Capital_Partners>,
        <https://1145.am/db/2370056/Forbion_Capital_Partners>,
        <https://1145.am/db/2538923/Forbion_Capital_Partners>,
        <https://1145.am/db/2569491/Forbion_Capital_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/Healthcare_Ventures> a org:Organization ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName "HealthCare Ventures" ;
    ns1:investor <https://1145.am/db/2338373/Series_D_Investment_Easton_Capital_Investment_Group_Fibrotec_Ventures_Forbion_Capital_Partners_Healthcare_Ventures_Inc_Morgenthaler_Ventures_Polaris_Venture_Partners_Shire_Strategic_Investment_Group_Completed> ;
    ns1:name "HealthCare Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2235852/Healthcare_Ventures>,
        <https://1145.am/db/2304650/Healthcare_Ventures>,
        <https://1145.am/db/2308148/Healthcare_Ventures>,
        <https://1145.am/db/2308887/Healthcare_Ventures>,
        <https://1145.am/db/2309845/Healthcare_Ventures>,
        <https://1145.am/db/2311069/Healthcare_Ventures>,
        <https://1145.am/db/2311075/Healthcare_Ventures>,
        <https://1145.am/db/2312192/Healthcare_Ventures>,
        <https://1145.am/db/2313405/Healthcare_Ventures>,
        <https://1145.am/db/2316601/Healthcare_Ventures>,
        <https://1145.am/db/2316605/Healthcare_Ventures>,
        <https://1145.am/db/2316823/Healthcare_Ventures>,
        <https://1145.am/db/2318657/Healthcare_Ventures>,
        <https://1145.am/db/2321097/Healthcare_Ventures>,
        <https://1145.am/db/2323586/Healthcare_Ventures>,
        <https://1145.am/db/2331639/Healthcare_Ventures>,
        <https://1145.am/db/2342269/Healthcare_Ventures>,
        <https://1145.am/db/2343202/Healthcare_Ventures>,
        <https://1145.am/db/2343210/Healthcare_Ventures>,
        <https://1145.am/db/2346204/Healthcare_Ventures>,
        <https://1145.am/db/2347469/Healthcare_Ventures>,
        <https://1145.am/db/2348486/Healthcare_Ventures>,
        <https://1145.am/db/2349717/Healthcare_Ventures>,
        <https://1145.am/db/2349722/Healthcare_Ventures>,
        <https://1145.am/db/2352814/Healthcare_Ventures>,
        <https://1145.am/db/2352820/Healthcare_Ventures>,
        <https://1145.am/db/2363510/Healthcare_Ventures>,
        <https://1145.am/db/2365138/Healthcare_Ventures>,
        <https://1145.am/db/2365171/Healthcare_Ventures>,
        <https://1145.am/db/2367497/Healthcare_Ventures>,
        <https://1145.am/db/2443170/Healthcare_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/Shire_Strategic_Investment_Group> a org:Organization ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName "Shire Strategic Investment Group" ;
    ns1:investor <https://1145.am/db/2338373/Series_D_Investment_Easton_Capital_Investment_Group_Fibrotec_Ventures_Forbion_Capital_Partners_Healthcare_Ventures_Inc_Morgenthaler_Ventures_Polaris_Venture_Partners_Shire_Strategic_Investment_Group_Completed> ;
    ns1:name "Shire Strategic Investment Group" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339163/Hopen_Life_Science_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Grand Rapids" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4994358/about.rdf> ;
    ns1:basedInHighRaw "Grand Rapids, Michigan" ;
    ns1:documentDate "2012-10-17T16:22:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tolera-therapeutics-closes-series-b-3-financing-raises-5-5-million-to-submit-phase-3> ;
    ns1:foundName "Hopen Life Science Ventures",
        "Hopen Life Science Ventures of Grand Rapids, Michigan" ;
    ns1:industry "Life Science" ;
    ns1:investor <https://1145.am/db/2339163/Series_B_Investment_Hopen_Life_Science_Ventures_Swmf_Life_Science_Fund_Tolera_Therapeutics_Inc_Triathlon_Medical_Venture_Partners_Completed> ;
    ns1:name "Hopen Life Science Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2338673/Hopen_Life_Science_Ventures>,
        <https://1145.am/db/2339139/Hopen_Life_Science_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2335743/Hopen_Life_Science_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339163/Swmf_Life_Science_Fund> a org:Organization ;
    ns1:basedInLowRaw "Michigan" ;
    ns1:documentDate "2012-10-17T16:22:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tolera-therapeutics-closes-series-b-3-financing-raises-5-5-million-to-submit-phase-3> ;
    ns1:foundName "SWMF Life Science Fund" ;
    ns1:investor <https://1145.am/db/2339163/Series_B_Investment_Hopen_Life_Science_Ventures_Swmf_Life_Science_Fund_Tolera_Therapeutics_Inc_Triathlon_Medical_Venture_Partners_Completed> ;
    ns1:name "SWMF Life Science Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2293047/Swmf_Life_Science_Fund>,
        <https://1145.am/db/2299047/Swmf_Life_Science_Fund>,
        <https://1145.am/db/2339139/Swmf_Life_Science_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339163/Triathlon_Medical_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Michigan" ;
    ns1:documentDate "2012-10-17T16:22:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tolera-therapeutics-closes-series-b-3-financing-raises-5-5-million-to-submit-phase-3> ;
    ns1:foundName "Triathlon Medical Venture Partners" ;
    ns1:investor <https://1145.am/db/2339163/Series_B_Investment_Hopen_Life_Science_Ventures_Swmf_Life_Science_Fund_Tolera_Therapeutics_Inc_Triathlon_Medical_Venture_Partners_Completed> ;
    ns1:name "Triathlon Medical Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2309865/Triathlon_Medical_Venture_Partners>,
        <https://1145.am/db/2309872/Triathlon_Medical_Venture_Partners>,
        <https://1145.am/db/2339139/Triathlon_Medical_Venture_Partners>,
        <https://1145.am/db/2364820/Triathlon_Medical_Venture_Partners>,
        <https://1145.am/db/2364827/Triathlon_Medical_Venture_Partners>,
        <https://1145.am/db/2365444/Triathlon_Medical_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340887/Devon_Park_Bioventures> a org:Organization ;
    ns1:basedInLowRaw "Texas" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-10-24T12:45:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ZS Pharma raises $46 million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zs-pharma-raises-46-million-series-c-financing> ;
    ns1:foundName "Devon Park Bioventures" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2340887/Investment_3x5_Special_Opportunity_Partners_Alta_Partners_Devon_Park_Bioventures_Rivervest_Venture_Partners_Salem_Partners_Zs_Pharma_Completed> ;
    ns1:name "Devon Park Bioventures" ;
    ns1:sameAsHigh <https://1145.am/db/2137245/Valiant_Laboratories>,
        <https://1145.am/db/2320852/Devon_Park_Bioventures>,
        <https://1145.am/db/2355183/Devon_Park_Bioventures> ;
    ns1:sameAsMedium <https://1145.am/db/2296656/Devon_Park_Bioventures>,
        <https://1145.am/db/2310020/Devon_Park_Bioventures>,
        <https://1145.am/db/2310031/Devon_Park_Bioventures>,
        <https://1145.am/db/2320853/Devon_Park_Bioventures>,
        <https://1145.am/db/2324076/Devon_Park_Bioventures>,
        <https://1145.am/db/2339384/Devon_Park_Bioventures>,
        <https://1145.am/db/2339395/Devon_Park_Bioventures>,
        <https://1145.am/db/2340208/Devon_Park_Bioventures>,
        <https://1145.am/db/2340211/Devon_Park_Bioventures>,
        <https://1145.am/db/2346972/Devon_Park_Bioventures>,
        <https://1145.am/db/2346973/Devon_Park_Bioventures>,
        <https://1145.am/db/2359510/Devon_Park_Bioventures>,
        <https://1145.am/db/2363460/Devon_Park_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340888/Pfizer_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "Austin" ;
    ns1:documentDate "2012-10-24T12:43:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mirna-therapeutics-secures-34-5-million-series-c-financing-to-advance-oncology-microrna-0> ;
    ns1:foundName "Pfizer Ventures" ;
    ns1:investor <https://1145.am/db/2340888/Series_C_Investment_Correlation_Ventures_Mirna_Therapeutics_Inc_New_Enterprise_Associates_Osage_University_Partners_Pfizer_Ventures_Sofinnova_Ventures_Completed> ;
    ns1:name "Pfizer Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1156304/Pfizer_Ventures>,
        <https://1145.am/db/1334624/Pfizer_Ventures>,
        <https://1145.am/db/2154844/Pfizer_Ventures>,
        <https://1145.am/db/2325726/Pfizer_Ventures>,
        <https://1145.am/db/2341896/Pfizer_Ventures>,
        <https://1145.am/db/2365171/Pfizer_Ventures>,
        <https://1145.am/db/2365184/Pfizer_Ventures>,
        <https://1145.am/db/2369202/Pfizer_Ventures>,
        <https://1145.am/db/587045/Pfizer_Ventures>,
        <https://1145.am/db/591613/Pfizer_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340890/Pfizer> a org:Organization ;
    ns1:basedInLowRaw "Austin" ;
    ns1:documentDate "2012-10-24T12:53:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Two Texas biotech outfits lasso venture deals totaling $81M" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/two-texas-biotech-outfits-lasso-venture-deals-totaling-81m> ;
    ns1:foundName "Pfizer" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2340890/Investment_Mirna_New_Enterprise_Associates_Pfizer_Sofinnova_Ventures_Stopped> ;
    ns1:name "Pfizer" ;
    ns1:sameAsHigh <https://1145.am/db/1018723/Pfizer_Inc>,
        <https://1145.am/db/1042002/Pfizer_Inc>,
        <https://1145.am/db/1045477/Pfizer_Inc>,
        <https://1145.am/db/1046923/Pfizer>,
        <https://1145.am/db/1053698/Pfizer>,
        <https://1145.am/db/1054558/Pfizer_Inc>,
        <https://1145.am/db/1065617/Pfizer_Inc>,
        <https://1145.am/db/1066444/Pfizer_Inc>,
        <https://1145.am/db/1097779/GSK>,
        <https://1145.am/db/1097915/GSK>,
        <https://1145.am/db/1097915/Pfizer>,
        <https://1145.am/db/1098950/GSK>,
        <https://1145.am/db/1123210/Pfizer_Inc>,
        <https://1145.am/db/1124362/Pfizer_Inc>,
        <https://1145.am/db/1138594/Pfizer_Inc>,
        <https://1145.am/db/118625/GSK>,
        <https://1145.am/db/1209318/Glaxosmithkline>,
        <https://1145.am/db/1258904/Pfizer_Inc>,
        <https://1145.am/db/1260932/Pfizer_Inc>,
        <https://1145.am/db/1261278/Pfizer_Inc>,
        <https://1145.am/db/1262347/Pfizer_Inc>,
        <https://1145.am/db/1262354/Pfizer_Inc>,
        <https://1145.am/db/1264461/Pfizer_Inc>,
        <https://1145.am/db/1264475/Pfizer_Inc>,
        <https://1145.am/db/1271008/Pfizer>,
        <https://1145.am/db/1361734/GSK>,
        <https://1145.am/db/1369714/GSK>,
        <https://1145.am/db/1385939/Pfizer_Inc>,
        <https://1145.am/db/1390822/Pfizer_Inc>,
        <https://1145.am/db/1394279/Pfizer_Inc>,
        <https://1145.am/db/1395353/Pfizer_Inc>,
        <https://1145.am/db/1549114/Pfizer_Inc>,
        <https://1145.am/db/1550950/Pfizer_Inc>,
        <https://1145.am/db/1684001/Pfizer_Inc>,
        <https://1145.am/db/1936001/Pfizer_Inc>,
        <https://1145.am/db/1936167/Pfizer_Inc>,
        <https://1145.am/db/1952785/Pfizer_Inc>,
        <https://1145.am/db/1972441/GSK>,
        <https://1145.am/db/2009165/Pfizer_Inc>,
        <https://1145.am/db/2013022/Pfizer_Inc>,
        <https://1145.am/db/2057315/Pfizer>,
        <https://1145.am/db/2070468/Pfizer>,
        <https://1145.am/db/2088776/Pfizer>,
        <https://1145.am/db/2119099/Pfizer>,
        <https://1145.am/db/2137303/GSK>,
        <https://1145.am/db/2138577/GSK>,
        <https://1145.am/db/2152849/Pfizer>,
        <https://1145.am/db/2152862/Pfizer>,
        <https://1145.am/db/2207119/Pfizer_Inc>,
        <https://1145.am/db/2221589/Pfizer>,
        <https://1145.am/db/2278803/GSK>,
        <https://1145.am/db/2279140/Pfizer>,
        <https://1145.am/db/2280707/Pfizer>,
        <https://1145.am/db/2280718/Pfizer>,
        <https://1145.am/db/2280933/Pfizer>,
        <https://1145.am/db/2281080/GSK>,
        <https://1145.am/db/2281622/Pfizer>,
        <https://1145.am/db/2281629/Pfizer>,
        <https://1145.am/db/2281879/Pfizer>,
        <https://1145.am/db/2283867/GSK>,
        <https://1145.am/db/2284235/Pfizer>,
        <https://1145.am/db/2285463/Pfizer>,
        <https://1145.am/db/2285764/Pfizer>,
        <https://1145.am/db/2289503/Pfizer>,
        <https://1145.am/db/2290507/Glaxosmithkline>,
        <https://1145.am/db/2291302/Glaxosmithkline>,
        <https://1145.am/db/2293631/Glaxosmithkline>,
        <https://1145.am/db/2293980/Pfizer>,
        <https://1145.am/db/2294613/Pfizer>,
        <https://1145.am/db/2295427/Pfizer>,
        <https://1145.am/db/2295635/Glaxosmithkline>,
        <https://1145.am/db/2296000/Pfizer>,
        <https://1145.am/db/2297455/Pfizer>,
        <https://1145.am/db/2297477/Pfizer>,
        <https://1145.am/db/2298256/Pfizer>,
        <https://1145.am/db/2301922/Pfizer>,
        <https://1145.am/db/230344/GSK>,
        <https://1145.am/db/230344/Glaxosmithkline>,
        <https://1145.am/db/2303447/Pfizer>,
        <https://1145.am/db/2304647/Pfizer>,
        <https://1145.am/db/2306213/Glaxosmithkline>,
        <https://1145.am/db/2306799/Glaxosmithkline>,
        <https://1145.am/db/2308656/Pfizer>,
        <https://1145.am/db/2308807/Pfizer>,
        <https://1145.am/db/2309065/Pfizer>,
        <https://1145.am/db/2309488/P_g>,
        <https://1145.am/db/2310071/Pfizer_Inc>,
        <https://1145.am/db/2310072/Pfizer>,
        <https://1145.am/db/2310168/Pfizer>,
        <https://1145.am/db/2310241/Pfizer>,
        <https://1145.am/db/2311347/Pfizer>,
        <https://1145.am/db/2311570/Pfizer_Inc>,
        <https://1145.am/db/2312314/Pfizer>,
        <https://1145.am/db/2312321/Pfizer_Inc>,
        <https://1145.am/db/2312865/Pfizer>,
        <https://1145.am/db/2312994/Pfizer>,
        <https://1145.am/db/2312995/Pfizer_Inc>,
        <https://1145.am/db/2313383/Pfizer_Inc>,
        <https://1145.am/db/2314928/Pfizer>,
        <https://1145.am/db/2315552/Pfizer>,
        <https://1145.am/db/2316517/Pfizer>,
        <https://1145.am/db/2316538/Pfizer_Inc>,
        <https://1145.am/db/2316843/Pfizer>,
        <https://1145.am/db/2317128/Pfizer-Wyeth>,
        <https://1145.am/db/2317915/Pfizer>,
        <https://1145.am/db/2318333/Pfizer>,
        <https://1145.am/db/2318922/Pfizer>,
        <https://1145.am/db/2320509/Pfizer>,
        <https://1145.am/db/2322306/Pfizer>,
        <https://1145.am/db/2322307/Pfizer>,
        <https://1145.am/db/2322620/Pfizer>,
        <https://1145.am/db/2322633/Pfizer_Inc>,
        <https://1145.am/db/2322733/Pfizer>,
        <https://1145.am/db/2322786/Pfizer>,
        <https://1145.am/db/2324128/Pfizer>,
        <https://1145.am/db/2324155/Pfizer>,
        <https://1145.am/db/2326266/Glaxosmithkline_(gsk)>,
        <https://1145.am/db/2327511/Pfizer_Inc>,
        <https://1145.am/db/2328681/GSK>,
        <https://1145.am/db/2328712/Pfizer>,
        <https://1145.am/db/2329902/Pfizer>,
        <https://1145.am/db/2329920/Pfizer_Inc>,
        <https://1145.am/db/2330817/Pfizer_Inc>,
        <https://1145.am/db/2330955/Pfizer>,
        <https://1145.am/db/2332552/Pfizer>,
        <https://1145.am/db/2332767/Pfizer_Ltd>,
        <https://1145.am/db/2334133/Pfizer_Inc>,
        <https://1145.am/db/2335568/Glaxosmithkline>,
        <https://1145.am/db/2335573/GSK>,
        <https://1145.am/db/2335634/Pfizer>,
        <https://1145.am/db/2335717/Pfizer>,
        <https://1145.am/db/2336060/Glaxosmithkline>,
        <https://1145.am/db/2336333/Pfizer>,
        <https://1145.am/db/2336704/GSK>,
        <https://1145.am/db/2337788/Pfizer>,
        <https://1145.am/db/2339633/Pfizer_Inc>,
        <https://1145.am/db/2340055/Pfizer>,
        <https://1145.am/db/2340072/GSK>,
        <https://1145.am/db/2340260/Glaxosmithkline>,
        <https://1145.am/db/2340321/Pfizer_Inc>,
        <https://1145.am/db/2340324/Pfizer_Inc>,
        <https://1145.am/db/2340325/Pfizer_Inc>,
        <https://1145.am/db/2340331/Pfizer_Inc>,
        <https://1145.am/db/2341325/Pfizer>,
        <https://1145.am/db/2341516/Pfizer>,
        <https://1145.am/db/2342559/Pfizer_Inc>,
        <https://1145.am/db/2343237/Pfizer_Inc>,
        <https://1145.am/db/2343273/Pfizer_Inc>,
        <https://1145.am/db/2343298/Pfizer_Inc>,
        <https://1145.am/db/2343344/Pfizer>,
        <https://1145.am/db/2343861/Glaxosmithkline>,
        <https://1145.am/db/2344023/Glaxosmithkline>,
        <https://1145.am/db/2345065/Pfizer>,
        <https://1145.am/db/2345251/GSK>,
        <https://1145.am/db/2346602/Pfizer_Inc>,
        <https://1145.am/db/2347383/Pfizer_Inc>,
        <https://1145.am/db/2348510/Pfizer_Inc>,
        <https://1145.am/db/2351730/Pfizer_Inc>,
        <https://1145.am/db/2353039/Pfizer_Inc>,
        <https://1145.am/db/2353325/Pfizer>,
        <https://1145.am/db/2353326/Pfizer>,
        <https://1145.am/db/2353337/Pfizer>,
        <https://1145.am/db/2353364/Pfizer>,
        <https://1145.am/db/2353376/Pfizer>,
        <https://1145.am/db/2354567/Pfizer>,
        <https://1145.am/db/2355021/Pfizer>,
        <https://1145.am/db/2355025/Pfizer_Inc>,
        <https://1145.am/db/2355472/Pfizer_Inc>,
        <https://1145.am/db/2355641/GSK>,
        <https://1145.am/db/2355916/Pfizer_Inc>,
        <https://1145.am/db/2356124/Pfizer_Inc>,
        <https://1145.am/db/2356559/Glaxosmithkline>,
        <https://1145.am/db/2356597/Pfizer>,
        <https://1145.am/db/2356599/Pfizer>,
        <https://1145.am/db/2356811/GSK>,
        <https://1145.am/db/2357232/Pfizer>,
        <https://1145.am/db/2357308/Pfizer_Inc>,
        <https://1145.am/db/2358128/Pfizer>,
        <https://1145.am/db/2359697/Pfizer>,
        <https://1145.am/db/2359727/GSK>,
        <https://1145.am/db/2359727/Glaxosmithkline>,
        <https://1145.am/db/2359858/GSK>,
        <https://1145.am/db/2359858/Glaxosmithkline>,
        <https://1145.am/db/2360562/GSK>,
        <https://1145.am/db/2360647/Pfizer_Inc>,
        <https://1145.am/db/2361700/GSK>,
        <https://1145.am/db/2361705/GSK>,
        <https://1145.am/db/2362439/Pfizer_Inc>,
        <https://1145.am/db/2362851/Pfizer_Inc>,
        <https://1145.am/db/2363435/Gsk_Pfizer>,
        <https://1145.am/db/2363446/Pfizer_Inc>,
        <https://1145.am/db/2363896/Pfizer>,
        <https://1145.am/db/2364087/Pfizer_Inc>,
        <https://1145.am/db/2364813/Glaxosmithkline>,
        <https://1145.am/db/2365103/Glaxosmithkline>,
        <https://1145.am/db/2366395/Pfizer_Inc>,
        <https://1145.am/db/2367283/Pfizer_Inc>,
        <https://1145.am/db/2367982/Pfizer>,
        <https://1145.am/db/2368146/Pfizer>,
        <https://1145.am/db/2369451/Glaxosmithkline>,
        <https://1145.am/db/2369755/GSK>,
        <https://1145.am/db/2369761/Glaxosmithkline>,
        <https://1145.am/db/2369876/Pfizer>,
        <https://1145.am/db/2369909/Pfizer_Inc>,
        <https://1145.am/db/2370016/Pfizer>,
        <https://1145.am/db/2370635/GSK>,
        <https://1145.am/db/2370843/Glaxosmithkline>,
        <https://1145.am/db/238329/GSK>,
        <https://1145.am/db/2507041/Pfizer>,
        <https://1145.am/db/2536358/Pfizer_Inc>,
        <https://1145.am/db/2536361/Pfizer_Inc>,
        <https://1145.am/db/2536362/Pfizer_Inc>,
        <https://1145.am/db/2536365/Pfizer_Inc>,
        <https://1145.am/db/2536475/Pfizer>,
        <https://1145.am/db/2536493/Glaxosmithkline>,
        <https://1145.am/db/2536856/Pfizer>,
        <https://1145.am/db/2537054/Pfizer_Inc>,
        <https://1145.am/db/2537057/Pfizer_Inc>,
        <https://1145.am/db/2537171/Pfizer>,
        <https://1145.am/db/2537597/Pfizer>,
        <https://1145.am/db/2537699/Glaxosmithkline>,
        <https://1145.am/db/2538568/Pfizer_Inc>,
        <https://1145.am/db/2538861/Pfizer>,
        <https://1145.am/db/2538924/Pfizer>,
        <https://1145.am/db/2539516/Pfizer>,
        <https://1145.am/db/2539695/GSK>,
        <https://1145.am/db/2540020/Glaxosmithkline>,
        <https://1145.am/db/2540170/Glaxosmithkline>,
        <https://1145.am/db/2540356/Pfizer>,
        <https://1145.am/db/2541091/GSK>,
        <https://1145.am/db/2541139/Pfizer_Inc>,
        <https://1145.am/db/2541146/Pfizer>,
        <https://1145.am/db/2542064/GSK>,
        <https://1145.am/db/2542067/Pfizer_Inc>,
        <https://1145.am/db/2542072/Pfizer>,
        <https://1145.am/db/2542499/Pfizer>,
        <https://1145.am/db/2543278/Pfizer>,
        <https://1145.am/db/2543533/Pfizer>,
        <https://1145.am/db/2543826/Pfizer>,
        <https://1145.am/db/2543957/Pfizer>,
        <https://1145.am/db/2544062/Glaxosmithkline>,
        <https://1145.am/db/2544074/Pfizer>,
        <https://1145.am/db/2545058/Pfizer>,
        <https://1145.am/db/2545122/Pfizer>,
        <https://1145.am/db/2545537/Glaxosmithkline>,
        <https://1145.am/db/2545618/Pfizer>,
        <https://1145.am/db/2545634/Pfizer>,
        <https://1145.am/db/2545818/Pfizer>,
        <https://1145.am/db/2545847/GSK>,
        <https://1145.am/db/2546136/Glaxosmithkline>,
        <https://1145.am/db/2546260/Glaxosmithkline>,
        <https://1145.am/db/2546577/Glaxosmithkline>,
        <https://1145.am/db/2546583/Pfizer>,
        <https://1145.am/db/2546596/Pfizer>,
        <https://1145.am/db/2547000/Pfizer>,
        <https://1145.am/db/2547653/Pfizer>,
        <https://1145.am/db/2547954/Glaxosmithkline>,
        <https://1145.am/db/2548244/Pfizer_Inc>,
        <https://1145.am/db/2548674/Pfizer>,
        <https://1145.am/db/2548752/GSK>,
        <https://1145.am/db/2548752/Pfizer>,
        <https://1145.am/db/2548986/Pfizer>,
        <https://1145.am/db/2549151/Pfizer>,
        <https://1145.am/db/2549598/Glaxosmithkline>,
        <https://1145.am/db/2549673/Pfizer>,
        <https://1145.am/db/2549694/Glaxosmithkline>,
        <https://1145.am/db/2549719/Pfizer>,
        <https://1145.am/db/2549876/Glaxosmithkline>,
        <https://1145.am/db/2550054/Glaxosmithkline>,
        <https://1145.am/db/2550445/Pfizer>,
        <https://1145.am/db/2550460/GSK>,
        <https://1145.am/db/2550662/Glaxosmithkline>,
        <https://1145.am/db/2550685/Pfizer>,
        <https://1145.am/db/2551402/Glaxosmithkline>,
        <https://1145.am/db/2552165/Glaxosmithkline>,
        <https://1145.am/db/2552684/Pfizer>,
        <https://1145.am/db/2552794/Glaxosmithkline>,
        <https://1145.am/db/2553974/Pfizer>,
        <https://1145.am/db/2554044/Glaxosmithkline>,
        <https://1145.am/db/2554937/Pfizer>,
        <https://1145.am/db/2555012/Glaxosmithkline>,
        <https://1145.am/db/2555896/Pfizer>,
        <https://1145.am/db/2555992/Pfizer>,
        <https://1145.am/db/2556407/Glaxosmithkline>,
        <https://1145.am/db/2557064/Pfizer>,
        <https://1145.am/db/2557083/Pfizer>,
        <https://1145.am/db/2557221/Glaxosmithkline>,
        <https://1145.am/db/2557221/Pfizer>,
        <https://1145.am/db/2558268/Pfizer>,
        <https://1145.am/db/2558417/Pfizer>,
        <https://1145.am/db/2558464/Pfizer>,
        <https://1145.am/db/2558862/GSK>,
        <https://1145.am/db/2558970/Pfizer>,
        <https://1145.am/db/2558971/Pfizer>,
        <https://1145.am/db/2559649/Pfizer>,
        <https://1145.am/db/2560282/Pfizer>,
        <https://1145.am/db/2560633/Glaxosmithkline>,
        <https://1145.am/db/2560720/Pfizer>,
        <https://1145.am/db/2561231/Pfizer>,
        <https://1145.am/db/2561650/GSK>,
        <https://1145.am/db/2561650/Pfizer>,
        <https://1145.am/db/2562102/Pfizer_Inc>,
        <https://1145.am/db/2562701/Pfizer>,
        <https://1145.am/db/2562773/GSK>,
        <https://1145.am/db/2562951/Glaxosmithkline>,
        <https://1145.am/db/2563857/Pfizer>,
        <https://1145.am/db/2563889/Pfizer>,
        <https://1145.am/db/2564032/Pfizer>,
        <https://1145.am/db/2564695/Glaxosmithkline>,
        <https://1145.am/db/2564884/GSK>,
        <https://1145.am/db/2566186/GSK>,
        <https://1145.am/db/2568121/Pfizer>,
        <https://1145.am/db/2568519/Pfizer>,
        <https://1145.am/db/2568899/Pfizer>,
        <https://1145.am/db/2568973/Glaxosmithkline>,
        <https://1145.am/db/2570369/Pfizer_Inc>,
        <https://1145.am/db/2570791/Glaxosmithkline>,
        <https://1145.am/db/2571798/Pfizer_Inc>,
        <https://1145.am/db/2572036/Pfizer>,
        <https://1145.am/db/2572429/Glaxosmithkline>,
        <https://1145.am/db/2572927/Pfizer>,
        <https://1145.am/db/2573173/Pfizer>,
        <https://1145.am/db/2573463/Pfizer>,
        <https://1145.am/db/2573465/Pfizer_Inc>,
        <https://1145.am/db/2573466/Pfizer>,
        <https://1145.am/db/2573551/Pfizer_Inc>,
        <https://1145.am/db/2573558/Pfizer_Inc>,
        <https://1145.am/db/2573562/Pfizer>,
        <https://1145.am/db/2573707/Pfizer>,
        <https://1145.am/db/2574332/Pfizer>,
        <https://1145.am/db/2574459/Pfizer_Inc>,
        <https://1145.am/db/2574461/Pfizer_Inc>,
        <https://1145.am/db/2574687/Pfizer>,
        <https://1145.am/db/2574691/Pfizer_Inc>,
        <https://1145.am/db/2575139/Pfizer_Inc>,
        <https://1145.am/db/2575145/Pfizer_Inc>,
        <https://1145.am/db/2575320/Pfizer>,
        <https://1145.am/db/2575471/Pfizer>,
        <https://1145.am/db/2575505/Pfizer_Inc>,
        <https://1145.am/db/2575575/Pfizer>,
        <https://1145.am/db/2575712/GSK>,
        <https://1145.am/db/2575723/Pfizer>,
        <https://1145.am/db/2576330/Pfizer_Inc>,
        <https://1145.am/db/2576526/Pfizer>,
        <https://1145.am/db/2576759/Pfizer>,
        <https://1145.am/db/2576762/Pfizer>,
        <https://1145.am/db/2577077/Pfizer>,
        <https://1145.am/db/2577226/Glaxosmithkline>,
        <https://1145.am/db/2577258/Pfizer_Inc>,
        <https://1145.am/db/2577655/Pfizer>,
        <https://1145.am/db/2577778/Glaxosmithkline>,
        <https://1145.am/db/2578528/GSK>,
        <https://1145.am/db/2579205/Glaxosmithkline>,
        <https://1145.am/db/2579252/Pfizer>,
        <https://1145.am/db/2579709/Pfizer_Inc>,
        <https://1145.am/db/2579716/Pfizer>,
        <https://1145.am/db/2580940/Pfizer>,
        <https://1145.am/db/2581331/Pfizer_Inc>,
        <https://1145.am/db/2581334/Pfizer_Inc>,
        <https://1145.am/db/2581339/Pfizer>,
        <https://1145.am/db/2581394/Pfizer>,
        <https://1145.am/db/2581659/GSK>,
        <https://1145.am/db/2581659/Pfizer>,
        <https://1145.am/db/2581661/Pfizer_Inc>,
        <https://1145.am/db/2582158/Pfizer_Inc>,
        <https://1145.am/db/2582160/Pfizer_Inc>,
        <https://1145.am/db/2582233/Glaxosmithkline>,
        <https://1145.am/db/2582343/Pfizer_Inc>,
        <https://1145.am/db/2582879/Pfizer_Inc>,
        <https://1145.am/db/2583155/Pfizer_Inc>,
        <https://1145.am/db/2583163/Pfizer>,
        <https://1145.am/db/2583165/Pfizer_Inc>,
        <https://1145.am/db/2583172/Pfizer>,
        <https://1145.am/db/2583242/Pfizer_Inc>,
        <https://1145.am/db/2583245/Pfizer_Inc>,
        <https://1145.am/db/2583337/Pfizer_Inc>,
        <https://1145.am/db/2583783/Pfizer>,
        <https://1145.am/db/2584085/Pfizer_Inc>,
        <https://1145.am/db/2584601/Pfizer_Inc>,
        <https://1145.am/db/2584968/Pfizer>,
        <https://1145.am/db/2585700/Pfizer>,
        <https://1145.am/db/2585908/New_York-Pfizer_Inc>,
        <https://1145.am/db/2585908/Pfizer>,
        <https://1145.am/db/2585912/Pfizer>,
        <https://1145.am/db/2586034/Pfizer_Inc>,
        <https://1145.am/db/2586047/Pfizer_Inc>,
        <https://1145.am/db/2586804/GSK>,
        <https://1145.am/db/2587282/Glaxosmithkline>,
        <https://1145.am/db/2587387/Pfizer>,
        <https://1145.am/db/2587673/Pfizer>,
        <https://1145.am/db/2587770/Glaxosmithkline>,
        <https://1145.am/db/2588134/Pfizer_Inc>,
        <https://1145.am/db/2589365/Pfizer>,
        <https://1145.am/db/2589701/GSK>,
        <https://1145.am/db/2590549/Pfizer_Inc>,
        <https://1145.am/db/2590887/Pfizer>,
        <https://1145.am/db/2590988/Pfizer>,
        <https://1145.am/db/2590989/Pfizer>,
        <https://1145.am/db/2591081/Pfizer_Inc>,
        <https://1145.am/db/2591091/Pfizer>,
        <https://1145.am/db/2591092/Pfizer_Inc>,
        <https://1145.am/db/2591281/Pfizer>,
        <https://1145.am/db/2591652/Pfizer>,
        <https://1145.am/db/2591691/Pfizer>,
        <https://1145.am/db/2591733/Pfizer>,
        <https://1145.am/db/2592975/Pfizer_Inc>,
        <https://1145.am/db/2592977/Pfizer_Inc>,
        <https://1145.am/db/2592980/Pfizer>,
        <https://1145.am/db/2592987/Glaxosmithkline>,
        <https://1145.am/db/2592990/Pfizer_Inc>,
        <https://1145.am/db/2592992/Pfizer_Inc>,
        <https://1145.am/db/2593150/Pfizer>,
        <https://1145.am/db/2593886/Pfizer>,
        <https://1145.am/db/2593961/Pfizer_Inc>,
        <https://1145.am/db/2594141/Pfizer_Inc>,
        <https://1145.am/db/2594268/Pfizer_Inc>,
        <https://1145.am/db/2594422/Pfizer>,
        <https://1145.am/db/2594489/Pfizer_Inc>,
        <https://1145.am/db/2594574/Pfizer>,
        <https://1145.am/db/2594581/Pfizer>,
        <https://1145.am/db/2594992/Pfizer>,
        <https://1145.am/db/2595320/Pfizer_Inc>,
        <https://1145.am/db/2595472/Pfizer>,
        <https://1145.am/db/2595499/Pfizer>,
        <https://1145.am/db/2596344/Pfizer>,
        <https://1145.am/db/2596754/Pfizer_Inc>,
        <https://1145.am/db/2596778/Pfizer>,
        <https://1145.am/db/2596874/Pfizer>,
        <https://1145.am/db/2597173/Pfizer>,
        <https://1145.am/db/2597183/Pfizer_Inc>,
        <https://1145.am/db/2597220/Glaxosmithkline>,
        <https://1145.am/db/2597643/Pfizer_Inc>,
        <https://1145.am/db/2597650/Pfizer>,
        <https://1145.am/db/2597651/Pfizer_Inc>,
        <https://1145.am/db/2597712/Pfizer>,
        <https://1145.am/db/2598461/Glaxosmithkline>,
        <https://1145.am/db/274660/Pfizer_Inc>,
        <https://1145.am/db/274739/Pfizer_Inc>,
        <https://1145.am/db/2792911/Pfizer>,
        <https://1145.am/db/2797157/GSK>,
        <https://1145.am/db/286227/Glaxosmithkline>,
        <https://1145.am/db/318295/Pfizer_Inc>,
        <https://1145.am/db/338190/GSK>,
        <https://1145.am/db/338242/Glaxosmithkline>,
        <https://1145.am/db/377761/Glaxosmithkline>,
        <https://1145.am/db/377769/Glaxosmithkline>,
        <https://1145.am/db/385094/GSK>,
        <https://1145.am/db/385100/GSK>,
        <https://1145.am/db/422377/Pfizer_Inc>,
        <https://1145.am/db/422378/Pfizer_Inc>,
        <https://1145.am/db/423571/Pfizer_Inc>,
        <https://1145.am/db/424190/Pfizer_Inc>,
        <https://1145.am/db/424896/Pfizer_Inc>,
        <https://1145.am/db/425689/Pfizer_Inc>,
        <https://1145.am/db/426841/Pfizer_Inc>,
        <https://1145.am/db/428975/Pfizer_Inc>,
        <https://1145.am/db/494811/GSK>,
        <https://1145.am/db/582690/GSK>,
        <https://1145.am/db/582690/Glaxosmithkline>,
        <https://1145.am/db/626832/Pfizer_Inc>,
        <https://1145.am/db/627349/Pfizer_Inc>,
        <https://1145.am/db/631317/Pfizer_Inc>,
        <https://1145.am/db/635031/Pfizer>,
        <https://1145.am/db/661291/GSK>,
        <https://1145.am/db/692994/Pfizer_Inc>,
        <https://1145.am/db/694218/Pfizer_Inc>,
        <https://1145.am/db/694224/Pfizer_Inc>,
        <https://1145.am/db/696927/Pfizer_Inc>,
        <https://1145.am/db/699199/Pfizer>,
        <https://1145.am/db/704642/Glaxosmithkline_Plc>,
        <https://1145.am/db/76007/Pfizer>,
        <https://1145.am/db/761748/Pfizer>,
        <https://1145.am/db/764460/Pfizer>,
        <https://1145.am/db/797138/Pfizer_Inc>,
        <https://1145.am/db/800318/Pfizer_Inc>,
        <https://1145.am/db/87287/Glaxosmithkline>,
        <https://1145.am/db/896566/Pfizer_Inc>,
        <https://1145.am/db/897457/Pfizer_Inc>,
        <https://1145.am/db/962850/Pfizer_Inc>,
        <https://1145.am/db/962851/Pfizer_Inc>,
        <https://1145.am/db/962899/Pfizer_Inc>,
        <https://1145.am/db/965490/Pfizer_Inc>,
        <https://1145.am/db/968220/Pfizer_Inc>,
        <https://1145.am/db/971984/Pfizer_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1146707/Pfizer>,
        <https://1145.am/db/1262545/Pfizer_Inc>,
        <https://1145.am/db/1270781/Pfizer_Inc>,
        <https://1145.am/db/1308148/Pfizer_Inc>,
        <https://1145.am/db/1308675/Pfizer_Inc>,
        <https://1145.am/db/1936264/Pfizer_Inc>,
        <https://1145.am/db/1983382/Pfizer_Inc>,
        <https://1145.am/db/2007025/Pfizer_Inc>,
        <https://1145.am/db/2009856/Pfizer>,
        <https://1145.am/db/2313175/Pfizer_Limited>,
        <https://1145.am/db/2325165/Pfizer_Inc>,
        <https://1145.am/db/2327506/Pfizer>,
        <https://1145.am/db/2332830/Pfizer>,
        <https://1145.am/db/2334165/Pfizer_Inc>,
        <https://1145.am/db/2343454/Pfizer_Inc>,
        <https://1145.am/db/2350231/Pfizer>,
        <https://1145.am/db/2354370/Pfizer_Inc>,
        <https://1145.am/db/2360633/Pfizer>,
        <https://1145.am/db/2371512/Pfizer>,
        <https://1145.am/db/2538915/Pfizer_Inc>,
        <https://1145.am/db/2539787/Pfizer>,
        <https://1145.am/db/2541721/Pfizer>,
        <https://1145.am/db/2548137/Pfizer>,
        <https://1145.am/db/2550761/Pfizer>,
        <https://1145.am/db/2554938/Pfizer>,
        <https://1145.am/db/2569378/Pfizer>,
        <https://1145.am/db/2573245/Pfizer_Inc>,
        <https://1145.am/db/2576064/Pfizer>,
        <https://1145.am/db/2584258/Pfizer_Inc>,
        <https://1145.am/db/2595930/Pfizer>,
        <https://1145.am/db/2596947/Pfizer>,
        <https://1145.am/db/2597185/Pfizer_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341904/Advanced_Technology_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "Venture capital" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "Advanced Technology Ventures (ATV)" ;
    ns1:investor <https://1145.am/db/2341904/Investment_Advanced_Technology_Ventures_Fonds_De_SolidaritÃ©_Ftq_Gsk_Canada_Life_Sciences_Innovation_Fund_Lumira_Capital_Mp_Healthcare_Venture_Management_Pappas_Ventures_Sr_One_Sw_Co_Thrasos_Therapeutics_Completed> ;
    ns1:name "Advanced Technology Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1004004/Kindred_Ventures>,
        <https://1145.am/db/1018112/S3_Ventures>,
        <https://1145.am/db/1018984/S3_Ventures>,
        <https://1145.am/db/1065192/Sevenx_Ventures>,
        <https://1145.am/db/1079459/Obvious_Ventures>,
        <https://1145.am/db/1081175/166_2nd>,
        <https://1145.am/db/1082613/166_2nd>,
        <https://1145.am/db/1086692/468_Capital>,
        <https://1145.am/db/1091554/Switch_Ventures>,
        <https://1145.am/db/1091576/Switch_Ventures>,
        <https://1145.am/db/1138998/First_Rate_Ventures>,
        <https://1145.am/db/1152929/Base_Ventures>,
        <https://1145.am/db/1232111/Upfront_Ventures>,
        <https://1145.am/db/1233008/M12>,
        <https://1145.am/db/1238474/M12>,
        <https://1145.am/db/1287465/Innovation_Endeavors>,
        <https://1145.am/db/1352190/Valar_Ventures>,
        <https://1145.am/db/1381832/Breakout_Ventures>,
        <https://1145.am/db/1381832/Coatue>,
        <https://1145.am/db/1382787/Breakout_Ventures>,
        <https://1145.am/db/1382787/Coatue>,
        <https://1145.am/db/1398917/Upfront_Ventures>,
        <https://1145.am/db/1406168/Kindred_Ventures>,
        <https://1145.am/db/1429403/Venture_Capital_Firm>,
        <https://1145.am/db/1499092/Sourcenext>,
        <https://1145.am/db/1526876/M13>,
        <https://1145.am/db/1528201/M13>,
        <https://1145.am/db/1545833/S3_Ventures>,
        <https://1145.am/db/1546945/S3_Ventures>,
        <https://1145.am/db/1557307/Am_Ventures>,
        <https://1145.am/db/1558854/Am_Ventures>,
        <https://1145.am/db/1575612/Snr_Vc>,
        <https://1145.am/db/1575612/V1_Vc>,
        <https://1145.am/db/1584937/Venture_Catalysts>,
        <https://1145.am/db/1614343/Partners_Group>,
        <https://1145.am/db/1664845/S3_Ventures>,
        <https://1145.am/db/1682224/M13>,
        <https://1145.am/db/1693658/Upfront_Ventures>,
        <https://1145.am/db/1701485/Aum_Ventures>,
        <https://1145.am/db/1705761/Obvious_Ventures>,
        <https://1145.am/db/1711784/Venture_Catalysts>,
        <https://1145.am/db/1712520/Vspring_Capital>,
        <https://1145.am/db/1719240/K3>,
        <https://1145.am/db/1722058/Upfront_Ventures>,
        <https://1145.am/db/1726625/Sourcenext>,
        <https://1145.am/db/1737467/Index>,
        <https://1145.am/db/1739763/Invent>,
        <https://1145.am/db/1743316/Founders_Fund>,
        <https://1145.am/db/1748890/Newgen_Vc>,
        <https://1145.am/db/1749533/Afore_Capital>,
        <https://1145.am/db/1751312/Kindred_Ventures>,
        <https://1145.am/db/1751916/S3_Ventures>,
        <https://1145.am/db/1753024/S28_Capital>,
        <https://1145.am/db/1753730/Strong_Ventures>,
        <https://1145.am/db/1757392/K5_Global>,
        <https://1145.am/db/1757788/Strong_Ventures>,
        <https://1145.am/db/1758221/Valar_Ventures>,
        <https://1145.am/db/1760608/Upfront_Ventures>,
        <https://1145.am/db/1761491/A16z>,
        <https://1145.am/db/1761520/Novator>,
        <https://1145.am/db/1761999/Coatue>,
        <https://1145.am/db/1765092/S28_Capital>,
        <https://1145.am/db/1765372/468_Capital>,
        <https://1145.am/db/1766096/Founders_Fund>,
        <https://1145.am/db/1770139/Morningside>,
        <https://1145.am/db/1788333/Outbound_Ventures>,
        <https://1145.am/db/1790953/Venture_Capital>,
        <https://1145.am/db/1791220/Capital-E>,
        <https://1145.am/db/1795198/K1_Capital>,
        <https://1145.am/db/1796199/Generation_Ventures>,
        <https://1145.am/db/1799113/Upfront_Ventures>,
        <https://1145.am/db/1806746/K2_Global>,
        <https://1145.am/db/1819543/Base_Ventures>,
        <https://1145.am/db/1820422/Valar_Ventures>,
        <https://1145.am/db/1829422/Founders_Fund>,
        <https://1145.am/db/1859652/A16z>,
        <https://1145.am/db/1859806/Strong_Ventures>,
        <https://1145.am/db/1871784/Founders_Fund>,
        <https://1145.am/db/1884049/S3_Ventures>,
        <https://1145.am/db/2008536/Incite_Ventures>,
        <https://1145.am/db/2023596/Building_Ventures>,
        <https://1145.am/db/2023596/Concrete_Ventures>,
        <https://1145.am/db/2058874/Founders_Fund>,
        <https://1145.am/db/2064584/Concrete_Ventures>,
        <https://1145.am/db/2073480/SantÃ©_Ventures>,
        <https://1145.am/db/2100049/K5_Global>,
        <https://1145.am/db/2120116/Capital_T>,
        <https://1145.am/db/2138006/Innovation_Endeavors>,
        <https://1145.am/db/2176223/Sig_Capital>,
        <https://1145.am/db/2183141/Founders_Fund>,
        <https://1145.am/db/219754/Founders_Fund>,
        <https://1145.am/db/2292800/Ws_Investments>,
        <https://1145.am/db/2298916/Breakout_Ventures>,
        <https://1145.am/db/2301736/SantÃ©_Ventures>,
        <https://1145.am/db/2303695/Sigvion_Capital>,
        <https://1145.am/db/2305610/Techno_Venture_Management>,
        <https://1145.am/db/2305615/Techno_Venture_Management>,
        <https://1145.am/db/2310170/Apposite>,
        <https://1145.am/db/2314573/3i>,
        <https://1145.am/db/2317918/Advanced_Technology_Ventures>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2319874/Advanced_Technology_Ventures>,
        <https://1145.am/db/2343722/Advanced_Technology_Ventures>,
        <https://1145.am/db/2343737/Advanced_Technology_Ventures>,
        <https://1145.am/db/2355531/Leerink_Swann>,
        <https://1145.am/db/2355543/Leerink_Swann>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2367204/Advanced_Technology_Ventures>,
        <https://1145.am/db/2595958/Sr_One>,
        <https://1145.am/db/2621506/D1>,
        <https://1145.am/db/336270/Sbi_Investment>,
        <https://1145.am/db/396305/Obvious_Ventures>,
        <https://1145.am/db/435691/Concrete_Ventures>,
        <https://1145.am/db/437556/Founders_Fund>,
        <https://1145.am/db/438632/Founders_Fund>,
        <https://1145.am/db/478867/Founders_Fund>,
        <https://1145.am/db/508145/Snz_Capital>,
        <https://1145.am/db/508161/Snz_Capital>,
        <https://1145.am/db/517818/Strong_Ventures>,
        <https://1145.am/db/539214/Sosv>,
        <https://1145.am/db/571520/G___M_Capital>,
        <https://1145.am/db/606173/Impellent_Ventures>,
        <https://1145.am/db/6743/S28_Capital>,
        <https://1145.am/db/676953/Upfront_Ventures>,
        <https://1145.am/db/678418/Sjf_Ventures>,
        <https://1145.am/db/678978/Inp_Capital>,
        <https://1145.am/db/683067/Lofty_Ventures>,
        <https://1145.am/db/690348/L37_Ventures>,
        <https://1145.am/db/700308/Afore_Capital>,
        <https://1145.am/db/714710/2b_Ahead_Ventures>,
        <https://1145.am/db/731044/Sempervirensvc>,
        <https://1145.am/db/733491/Build_Ventures>,
        <https://1145.am/db/749201/Trust_Ventures>,
        <https://1145.am/db/750485/A16z>,
        <https://1145.am/db/750849/Trust_Ventures>,
        <https://1145.am/db/753541/A16z>,
        <https://1145.am/db/768306/Coatue>,
        <https://1145.am/db/773235/Innovation_Endeavors>,
        <https://1145.am/db/815627/Xyz_Capital>,
        <https://1145.am/db/821222/Afore_Capital>,
        <https://1145.am/db/838181/Addition_Ventures>,
        <https://1145.am/db/840680/Afore_Capital>,
        <https://1145.am/db/846931/Myasiavc>,
        <https://1145.am/db/922498/Founders_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/1800080/Advanced_Technology_Ventures>,
        <https://1145.am/db/1830593/Advanced_Technology_Ventures>,
        <https://1145.am/db/1850376/Advanced_Technology_Ventures>,
        <https://1145.am/db/1854846/Advanced_Technology_Ventures>,
        <https://1145.am/db/1861352/Advanced_Technology_Ventures>,
        <https://1145.am/db/1872490/Advanced_Technology_Ventures>,
        <https://1145.am/db/2287777/Advanced_Technology_Ventures>,
        <https://1145.am/db/2291818/Advanced_Technology_Ventures>,
        <https://1145.am/db/2300322/Advanced_Technology_Ventures>,
        <https://1145.am/db/2316391/Advanced_Technology_Ventures>,
        <https://1145.am/db/2317467/Advanced_Technology_Ventures>,
        <https://1145.am/db/2322012/Advanced_Technology_Ventures>,
        <https://1145.am/db/2322022/Advanced_Technology_Ventures>,
        <https://1145.am/db/2328599/Advanced_Technology_Ventures>,
        <https://1145.am/db/2336313/Advanced_Technology_Ventures>,
        <https://1145.am/db/2338703/Advanced_Technology_Ventures>,
        <https://1145.am/db/2338704/Advanced_Technology_Ventures>,
        <https://1145.am/db/2347389/Advanced_Technology_Ventures>,
        <https://1145.am/db/2360756/Advanced_Technology_Ventures>,
        <https://1145.am/db/2360758/Advanced_Technology_Ventures>,
        <https://1145.am/db/2362553/Advanced_Technology_Ventures>,
        <https://1145.am/db/2362871/Advanced_Technology_Ventures>,
        <https://1145.am/db/2364939/Advanced_Technology_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341904/Fonds_De_SolidaritÃ©_Ftq> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "Fonds de solidaritÃ© FTQ" ;
    ns1:investor <https://1145.am/db/2341904/Investment_Advanced_Technology_Ventures_Fonds_De_SolidaritÃ©_Ftq_Gsk_Canada_Life_Sciences_Innovation_Fund_Lumira_Capital_Mp_Healthcare_Venture_Management_Pappas_Ventures_Sr_One_Sw_Co_Thrasos_Therapeutics_Completed> ;
    ns1:name "Fonds de solidaritÃ© FTQ" ;
    ns1:sameAsMedium <https://1145.am/db/1084305/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/1139252/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/1185297/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/1422234/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/1422725/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/1523124/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/1524137/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/2284506/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/2304242/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/2304258/Fonds_De_Solidarite_Ftq>,
        <https://1145.am/db/2306251/Fonds_De_Solidarite_Ftq>,
        <https://1145.am/db/2350915/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/2353983/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/2368517/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/2369027/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/2610112/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/2702871/Fonds_De_SolidaritÃ©_Ftq>,
        <https://1145.am/db/764838/Fonds_De_SolidaritÃ©_Ftq> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341904/Gsk_Canada_Life_Sciences_Innovation_Fund> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "GSK Canada Life Sciences Innovation Fund" ;
    ns1:investor <https://1145.am/db/2341904/Investment_Advanced_Technology_Ventures_Fonds_De_SolidaritÃ©_Ftq_Gsk_Canada_Life_Sciences_Innovation_Fund_Lumira_Capital_Mp_Healthcare_Venture_Management_Pappas_Ventures_Sr_One_Sw_Co_Thrasos_Therapeutics_Completed> ;
    ns1:name "GSK Canada Life Sciences Innovation Fund" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341904/Lumira_Capital> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "Lumira Capital" ;
    ns1:investor <https://1145.am/db/2341904/Investment_Advanced_Technology_Ventures_Fonds_De_SolidaritÃ©_Ftq_Gsk_Canada_Life_Sciences_Innovation_Fund_Lumira_Capital_Mp_Healthcare_Venture_Management_Pappas_Ventures_Sr_One_Sw_Co_Thrasos_Therapeutics_Completed> ;
    ns1:name "Lumira Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2298869/Lumira_Capital>,
        <https://1145.am/db/2300233/Lumira_Capital>,
        <https://1145.am/db/2347977/Lumira_Capital>,
        <https://1145.am/db/2347983/Lumira_Capital>,
        <https://1145.am/db/2353522/Lumira_Capital>,
        <https://1145.am/db/2359637/Lumira_Capital>,
        <https://1145.am/db/2360317/Lumira_Capital>,
        <https://1145.am/db/2363442/Lumira_Capital>,
        <https://1145.am/db/2369027/Lumira_Capital>,
        <https://1145.am/db/2572436/Lumira_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341904/Mp_Healthcare_Venture_Management> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "MP Healthcare Venture Management" ;
    ns1:investor <https://1145.am/db/2341904/Investment_Advanced_Technology_Ventures_Fonds_De_SolidaritÃ©_Ftq_Gsk_Canada_Life_Sciences_Innovation_Fund_Lumira_Capital_Mp_Healthcare_Venture_Management_Pappas_Ventures_Sr_One_Sw_Co_Thrasos_Therapeutics_Completed> ;
    ns1:name "MP Healthcare Venture Management" ;
    ns1:sameAsMedium <https://1145.am/db/2062003/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2287244/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2327441/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2327442/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2356567/Mp_Healthcare_Venture_Management_Inc>,
        <https://1145.am/db/2364468/Mp_Healthcare_Venture_Management_Inc>,
        <https://1145.am/db/2364471/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2365296/Mp_Healthcare_Venture_Management>,
        <https://1145.am/db/2367740/Mp_Healthcare_Venture_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341904/Sw_Co> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "SW Co" ;
    ns1:investor <https://1145.am/db/2341904/Investment_Advanced_Technology_Ventures_Fonds_De_SolidaritÃ©_Ftq_Gsk_Canada_Life_Sciences_Innovation_Fund_Lumira_Capital_Mp_Healthcare_Venture_Management_Pappas_Ventures_Sr_One_Sw_Co_Thrasos_Therapeutics_Completed> ;
    ns1:name "SW Co" ;
    ns1:sameAsHigh <https://1145.am/db/1079492/Collison>,
        <https://1145.am/db/1124269/1809>,
        <https://1145.am/db/1139893/Inveready>,
        <https://1145.am/db/1168440/Wafra_Inc>,
        <https://1145.am/db/1169892/Wafra_Inc>,
        <https://1145.am/db/1198825/Fp>,
        <https://1145.am/db/1222789/E14>,
        <https://1145.am/db/1223294/E14>,
        <https://1145.am/db/1246071/J>,
        <https://1145.am/db/1264905/Sosv>,
        <https://1145.am/db/1355546/Creadev>,
        <https://1145.am/db/1356171/Creadev>,
        <https://1145.am/db/1376828/8vc>,
        <https://1145.am/db/1388463/Wille_Ag>,
        <https://1145.am/db/1394567/Finsight>,
        <https://1145.am/db/1396120/Finsight>,
        <https://1145.am/db/1412353/Next47>,
        <https://1145.am/db/1412391/Next47>,
        <https://1145.am/db/1415790/M13>,
        <https://1145.am/db/1419390/M13>,
        <https://1145.am/db/1506974/M3_Inc>,
        <https://1145.am/db/1671401/Ifm>,
        <https://1145.am/db/1678887/Wafra_Inc>,
        <https://1145.am/db/1686477/Wafra_Inc>,
        <https://1145.am/db/1693737/Untitled>,
        <https://1145.am/db/1734273/Bux>,
        <https://1145.am/db/1741251/Enern>,
        <https://1145.am/db/1759173/Syfe>,
        <https://1145.am/db/1760589/Victress_Captial>,
        <https://1145.am/db/1762669/Coatue>,
        <https://1145.am/db/1762854/A16z>,
        <https://1145.am/db/1763412/M13>,
        <https://1145.am/db/1768386/Innogest>,
        <https://1145.am/db/1829735/Co>,
        <https://1145.am/db/1947183/Gv>,
        <https://1145.am/db/2073127/Prosperity7>,
        <https://1145.am/db/2078670/Next47>,
        <https://1145.am/db/2094589/Spacecadet>,
        <https://1145.am/db/2095130/Sr_One>,
        <https://1145.am/db/2125294/Aminvest>,
        <https://1145.am/db/2280707/8vc>,
        <https://1145.am/db/2293593/LSP>,
        <https://1145.am/db/2342937/Srone>,
        <https://1145.am/db/2788692/Sw>,
        <https://1145.am/db/323273/Coatue>,
        <https://1145.am/db/455999/CHR>,
        <https://1145.am/db/489949/Investx_Capital_Ltd>,
        <https://1145.am/db/522611/Upper90>,
        <https://1145.am/db/528889/Coatue>,
        <https://1145.am/db/547840/Coatue>,
        <https://1145.am/db/563438/Andeniac>,
        <https://1145.am/db/564585/LSP>,
        <https://1145.am/db/566971/LSP>,
        <https://1145.am/db/572836/Upper90>,
        <https://1145.am/db/581789/Sfermion>,
        <https://1145.am/db/645903/40north>,
        <https://1145.am/db/663254/Arctaris>,
        <https://1145.am/db/665906/Arctaris>,
        <https://1145.am/db/668624/JLL>,
        <https://1145.am/db/668727/Swc_Global>,
        <https://1145.am/db/696893/NFX>,
        <https://1145.am/db/700341/Next47>,
        <https://1145.am/db/75445/Gv>,
        <https://1145.am/db/769427/A16z>,
        <https://1145.am/db/803566/8vc>,
        <https://1145.am/db/854386/Amoon>,
        <https://1145.am/db/904635/Amoon>,
        <https://1145.am/db/905913/22nw>,
        <https://1145.am/db/911077/Wahed>,
        <https://1145.am/db/928310/Wahed>,
        <https://1145.am/db/981321/8vc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342925/Mission_Bay_Capital> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-10-29T15:15:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/principia-biopharma-secures-12-5m-second-tranche-series-a-financing-expands-senior-0> ;
    ns1:foundName "Mission Bay Capital" ;
    ns1:investor <https://1145.am/db/2342925/Investment_Mission_Bay_Capital_Morgenthaler_Ventures_New_Leaf_Venture_Partners_Orbimed_Advisors_Principia_Biopharma_Srone_Completed> ;
    ns1:name "Mission Bay Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2342937/Mission_Bay_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2344017/Mission_Bay_Capital>,
        <https://1145.am/db/2355051/Mission_Bay_Capital>,
        <https://1145.am/db/2358430/Mission_Bay_Capital>,
        <https://1145.am/db/2367204/Mission_Bay_Capital>,
        <https://1145.am/db/2367621/Mission_Bay_Capital>,
        <https://1145.am/db/2370208/Mission_Bay_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342933/Investment_Synthetic_Biologics_Inc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-29T16:05:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ROCKVILLE, Md., Oct. 29, 2012 - /PRNewswire/ - Synthetic Biologics, Inc. (NYSE MKT: SYN) , a developer of synthetic biologics and innovative medicines for serious diseases and unmet medical needs, announced today that it has entered into definitive stock purchase agreements with accredited investors to raise approximately $ 10.8 million in a private placement financing.",
        "Synthetic Biologics Announces $ 10.8 Million Financing." ;
    ns1:documentTitle "Synthetic Biologics Announces $10.8 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/synthetic-biologics-announces-10-8-million-financing-0> ;
    ns1:foundName "financing",
        "private placement financing",
        "raise" ;
    ns1:name "financing",
        "private placement financing",
        "raise" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2342933/Synthetic_Biologics_Inc> ;
    ns1:valueRaw "$ 10.8 Million",
        "approximately $ 10.8 million" ;
    ns1:when "2012-10-29T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Oct. 29, 2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2343989/Research_Foundation> a org:Organization ;
    ns1:basedInHighGeoName "Seattle" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:basedInHighRaw "Seattle" ;
    ns1:documentDate "2012-11-01T13:46:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing-0> ;
    ns1:foundName "Research Foundation" ;
    ns1:investor <https://1145.am/db/2343989/Series_B_Investment_Easton_Capital_New_Science_Ventures_Research_Foundation_Resolve_Therapeutics_Wrf_Capital_Completed> ;
    ns1:name "Research Foundation" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344978/Washington_Research_Foundation> a org:Organization ;
    ns1:basedInLowRaw "Washington" ;
    ns1:description "venture investment" ;
    ns1:documentDate "2012-11-02T04:00:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing> ;
    ns1:foundName "Washington Research Foundation" ;
    ns1:investor <https://1145.am/db/2344978/Series_B_Investment_Easton_Capital_New_Science_Ventures_Resolve_Therapeutics_Wrf_Capital_Washington_Research_Foundation_Completed> ;
    ns1:name "Washington Research Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/1278078/The_Washington_Research_Foundation>,
        <https://1145.am/db/1278479/The_Washington_Research_Foundation>,
        <https://1145.am/db/1345918/Washington_Research_Foundation>,
        <https://1145.am/db/1817118/Washington_Research_Foundation>,
        <https://1145.am/db/2081200/Washington_Research_Foundation>,
        <https://1145.am/db/674484/Washington_Research_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345002/Bdc_Venture_Capital> a org:Organization ;
    ns1:basedInLowRaw "QUEBEC" ;
    ns1:documentDate "2012-11-02T13:44:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/alethia-biotherapeutics-closes-a-4-7-million-financing-to-advance-its-bone-antiresorptive> ;
    ns1:foundName "BDC Venture Capital" ;
    ns1:investor <https://1145.am/db/2345002/Investment_Agechem_Venture_Fund_Alethia_Biotherapeutics_Inc_Bdc_Venture_Capital_Cellscript_Of_Wisconsin_Go_Capital_Completed> ;
    ns1:name "BDC Venture Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1697910/Bdc_Venture_Capital>,
        <https://1145.am/db/1729122/Bdc_Venture_Capital>,
        <https://1145.am/db/1828449/Bdc_Venture_Capital>,
        <https://1145.am/db/1830077/Bdc_Venture_Capital>,
        <https://1145.am/db/1852909/Bdc_Venture_Capital>,
        <https://1145.am/db/1890839/Bdc_Venture_Capital>,
        <https://1145.am/db/1906920/Bdc_Venture_Capital>,
        <https://1145.am/db/2163356/Bdc_Venture_Capital>,
        <https://1145.am/db/2293047/Bdc_Venture_Capital>,
        <https://1145.am/db/2317961/Bdc_Venture_Capital>,
        <https://1145.am/db/2318781/Bdc_Venture_Capital_Inc>,
        <https://1145.am/db/2318796/Bdc_Venture_Capital_Inc>,
        <https://1145.am/db/2333504/Bdc_Venture_Capital>,
        <https://1145.am/db/2333525/Bdc_Venture_Capital>,
        <https://1145.am/db/2344786/Bdc_Venture_Capital>,
        <https://1145.am/db/2355034/Bdc_Venture_Capital>,
        <https://1145.am/db/2355936/Bdc_Venture_Capital>,
        <https://1145.am/db/2355938/Bdc_Venture_Capital>,
        <https://1145.am/db/2358031/Bdc_Venture_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345002/Cellscript_Of_Wisconsin> a org:Organization ;
    ns1:basedInLowRaw "QUEBEC" ;
    ns1:description "a long-term partner and shareholder of the company" ;
    ns1:documentDate "2012-11-02T13:44:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/alethia-biotherapeutics-closes-a-4-7-million-financing-to-advance-its-bone-antiresorptive> ;
    ns1:foundName "Cellscript of Wisconsin" ;
    ns1:investor <https://1145.am/db/2345002/Investment_Agechem_Venture_Fund_Alethia_Biotherapeutics_Inc_Bdc_Venture_Capital_Cellscript_Of_Wisconsin_Go_Capital_Completed> ;
    ns1:name "Cellscript of Wisconsin" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345002/Go_Capital> a org:Organization ;
    ns1:basedInLowRaw "QUEBEC" ;
    ns1:documentDate "2012-11-02T13:44:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/alethia-biotherapeutics-closes-a-4-7-million-financing-to-advance-its-bone-antiresorptive> ;
    ns1:foundName "GO Capital" ;
    ns1:investor <https://1145.am/db/2345002/Investment_Agechem_Venture_Fund_Alethia_Biotherapeutics_Inc_Bdc_Venture_Capital_Cellscript_Of_Wisconsin_Go_Capital_Completed> ;
    ns1:name "GO Capital" ;
    ns1:sameAsMedium <https://1145.am/db/2295712/Go_Capital>,
        <https://1145.am/db/2301320/Go_Capital>,
        <https://1145.am/db/2358031/Go_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345017/Biotechnology_Value_Fund_Lp> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:documentDate "2012-11-05T03:24:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ziarco Founded with Series A Financing to Develop First-in Class Anti-inflammatory and Anti-allergic Medicines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ziarco-founded-series-a-financing-to-develop-first-class-anti-inflammatory-and-anti> ;
    ns1:foundName "Biotechnology Value Fund L.P" ;
    ns1:investor <https://1145.am/db/2345017/Series_A_Investment_Biotechnology_Value_Fund_Lp_Venture_Investments_Ziarco_Completed> ;
    ns1:name "Biotechnology Value Fund L.P" ;
    ns1:sameAsMedium <https://1145.am/db/2303882/Biotechnology_Value_Fund_Lp>,
        <https://1145.am/db/2332714/Biotechnology_Value_Fund_Lp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346030/Apposite_Healthcare> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "Apposite Healthcare" ;
    ns1:investor <https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> ;
    ns1:name "Apposite Healthcare" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346030/Forward_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "Forward Ventures" ;
    ns1:investor <https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> ;
    ns1:name "Forward Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2315932/Forward_Ventures>,
        <https://1145.am/db/2315934/Forward_Ventures>,
        <https://1145.am/db/2317737/Forward_Ventures>,
        <https://1145.am/db/2328030/Forward_Ventures>,
        <https://1145.am/db/2328034/Forward_Ventures>,
        <https://1145.am/db/2343723/Forward_Ventures>,
        <https://1145.am/db/2343724/Forward_Ventures>,
        <https://1145.am/db/2347984/Forward_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352442/Forward_Ventures>,
        <https://1145.am/db/2365748/Forward_Ventures>,
        <https://1145.am/db/2551315/Forward_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346030/Gimv> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "GIMV" ;
    ns1:investor <https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> ;
    ns1:name "GIMV" ;
    ns1:sameAsMedium <https://1145.am/db/1724232/Gimv>,
        <https://1145.am/db/1806589/Gimv>,
        <https://1145.am/db/1830149/Gimv>,
        <https://1145.am/db/1854030/Gimv>,
        <https://1145.am/db/1866824/Gimv>,
        <https://1145.am/db/1883525/Gimv>,
        <https://1145.am/db/1914674/Gimv>,
        <https://1145.am/db/1919300/Gimv>,
        <https://1145.am/db/2154009/Gimv>,
        <https://1145.am/db/2280718/Gimv>,
        <https://1145.am/db/2281044/Gimv>,
        <https://1145.am/db/2286782/Gimv>,
        <https://1145.am/db/2294771/Gimv>,
        <https://1145.am/db/2299772/Gimv>,
        <https://1145.am/db/2301160/Gimv>,
        <https://1145.am/db/2302541/Gimv>,
        <https://1145.am/db/2302549/Gimv>,
        <https://1145.am/db/2316478/Gimv>,
        <https://1145.am/db/2328763/Gimv>,
        <https://1145.am/db/2328769/Gimv>,
        <https://1145.am/db/2336923/Gimv>,
        <https://1145.am/db/2352436/Gimv>,
        <https://1145.am/db/2352441/Gimv>,
        <https://1145.am/db/2352442/Gimv>,
        <https://1145.am/db/2356685/Gimv>,
        <https://1145.am/db/2365748/Gimv> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346030/Growthworks> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "GrowthWorks" ;
    ns1:investor <https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> ;
    ns1:name "GrowthWorks" ;
    ns1:sameAsMedium <https://1145.am/db/1702003/Growthworks>,
        <https://1145.am/db/1902756/Growthworks>,
        <https://1145.am/db/2352436/Growthworks>,
        <https://1145.am/db/2352442/Growthworks>,
        <https://1145.am/db/2612761/Growthworks>,
        <https://1145.am/db/2615691/Growthworks> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346030/Radius_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "Radius Ventures" ;
    ns1:investor <https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> ;
    ns1:name "Radius Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2232329/Radius_Ventures>,
        <https://1145.am/db/2252477/Radius_Ventures>,
        <https://1145.am/db/2303098/Radius_Ventures>,
        <https://1145.am/db/2352436/Radius_Ventures>,
        <https://1145.am/db/2352442/Radius_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346030/Roche_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "Roche Ventures" ;
    ns1:investor <https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> ;
    ns1:name "Roche Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2337645/Roche_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347043/Ra_Capital_Management> a org:Organization ;
    ns1:basedInLowRaw "San Diego" ;
    ns1:documentDate "2012-11-07T16:22:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MEI Pharma Announces $27.5 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mei-pharma-announces-27-5-million-private-placement> ;
    ns1:foundName "RA Capital Management" ;
    ns1:investor <https://1145.am/db/2347043/Investment_Mei_Pharma_New_Leaf_Venture_Partners_Ra_Capital_Management_Three_Arch_Opportunity_Fund_Vivo_Ventures_Has_Not_Happened> ;
    ns1:name "RA Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/1134574/Ra_Capital_Management_Lp>,
        <https://1145.am/db/1164709/Ra_Capital_Management>,
        <https://1145.am/db/1166452/Ra_Capital_Management>,
        <https://1145.am/db/1198548/Ra_Capital_Management>,
        <https://1145.am/db/1219334/Ra_Capital_Management>,
        <https://1145.am/db/1219771/Ra_Capital_Management>,
        <https://1145.am/db/1293978/Ra_Capital_Management>,
        <https://1145.am/db/1294718/Ra_Capital_Management>,
        <https://1145.am/db/1334624/Ra_Capital_Management>,
        <https://1145.am/db/1503165/Ra_Capital_Management>,
        <https://1145.am/db/1735850/Ra_Capital_Management>,
        <https://1145.am/db/1926411/Ra_Capital_Management>,
        <https://1145.am/db/1928388/Ra_Capital_Management>,
        <https://1145.am/db/2011094/Ra_Capital_Management>,
        <https://1145.am/db/2075754/Ra_Capital_Management>,
        <https://1145.am/db/2089412/Ra_Capital_Management>,
        <https://1145.am/db/2109798/Ra_Capital_Management>,
        <https://1145.am/db/2153910/Ra_Capital_Management>,
        <https://1145.am/db/2155505/Ra_Capital_Management>,
        <https://1145.am/db/2280400/Ra_Capital_Management>,
        <https://1145.am/db/2282268/Ra_Capital_Management>,
        <https://1145.am/db/2282806/Ra_Capital_Management>,
        <https://1145.am/db/2285762/Ra_Capital_Management>,
        <https://1145.am/db/2286204/Ra_Capital_Management>,
        <https://1145.am/db/2298395/Ra_Capital_Management>,
        <https://1145.am/db/2298642/Ra_Capital_Management>,
        <https://1145.am/db/2335743/Ra_Capital_Management>,
        <https://1145.am/db/2336510/Ra_Capital_Management>,
        <https://1145.am/db/2336511/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2336957/Ra_Capital_Management>,
        <https://1145.am/db/2337599/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2338126/Ra_Capital_Management>,
        <https://1145.am/db/2338127/Ra_Capital_Management>,
        <https://1145.am/db/2339214/Ra_Capital_Management>,
        <https://1145.am/db/2339223/Ra_Capital_Management>,
        <https://1145.am/db/2339666/Ra_Capital_Management>,
        <https://1145.am/db/2340942/Ra_Capital_Management>,
        <https://1145.am/db/2346773/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2346775/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2348149/Ra_Capital_Management>,
        <https://1145.am/db/2355029/Ra_Capital_Management>,
        <https://1145.am/db/2356216/Ra_Capital_Management>,
        <https://1145.am/db/2357144/Ra_Capital_Management>,
        <https://1145.am/db/2357566/Ra_Capital_Management>,
        <https://1145.am/db/2360277/Ra_Capital_Management>,
        <https://1145.am/db/2360682/Ra_Capital_Management>,
        <https://1145.am/db/2363391/Ra_Capital_Management_Llc>,
        <https://1145.am/db/2363442/Ra_Capital_Management>,
        <https://1145.am/db/2366735/Ra_Capital_Management>,
        <https://1145.am/db/2367678/Ra_Capital_Management>,
        <https://1145.am/db/2368322/Ra_Capital_Management>,
        <https://1145.am/db/2369974/Ra_Capital_Management>,
        <https://1145.am/db/2370436/Ra_Capital_Management>,
        <https://1145.am/db/2371160/Ra_Capital_Management>,
        <https://1145.am/db/2371163/Ra_Capital_Management>,
        <https://1145.am/db/2570481/Ra_Capital_Management>,
        <https://1145.am/db/2570483/Ra_Capital_Management>,
        <https://1145.am/db/387629/Ra_Capital_Management>,
        <https://1145.am/db/425953/Ra_Capital_Management>,
        <https://1145.am/db/441151/Ra_Capital_Management>,
        <https://1145.am/db/509733/Ra_Capital_Management>,
        <https://1145.am/db/572554/Ra_Capital_Management>,
        <https://1145.am/db/633100/Ra_Capital_Management>,
        <https://1145.am/db/677591/Ra_Capital_Management>,
        <https://1145.am/db/681970/Ra_Capital_Management>,
        <https://1145.am/db/820519/Ra_Capital_Management_Lp>,
        <https://1145.am/db/922552/Ra_Capital_Management>,
        <https://1145.am/db/923335/Ra_Capital_Management>,
        <https://1145.am/db/941871/Ra_Capital_Management>,
        <https://1145.am/db/979509/Ra_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347043/Three_Arch_Opportunity_Fund> a org:Organization ;
    ns1:basedInLowRaw "San Diego" ;
    ns1:documentDate "2012-11-07T16:22:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MEI Pharma Announces $27.5 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mei-pharma-announces-27-5-million-private-placement> ;
    ns1:foundName "Three Arch Opportunity Fund" ;
    ns1:investor <https://1145.am/db/2347043/Investment_Mei_Pharma_New_Leaf_Venture_Partners_Ra_Capital_Management_Three_Arch_Opportunity_Fund_Vivo_Ventures_Has_Not_Happened> ;
    ns1:name "Three Arch Opportunity Fund" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347102/Omega_Funds> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:documentDate "2012-11-09T12:33:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/visterra-secures-financing-from-gates-foundation-and-omega-to-close-26m-series-a-financing> ;
    ns1:foundName "Omega Funds" ;
    ns1:investor <https://1145.am/db/2347102/Series_A_Investment_Flagship_Ventures_Lux_Capital_Omega_Funds_Polaris_Venture_Partners_The_Bill___Melinda_Gates_Foundation_Visterra_Completed> ;
    ns1:name "Omega Funds" ;
    ns1:sameAsMedium <https://1145.am/db/1297146/Omega_Fund>,
        <https://1145.am/db/1325968/Omega_Funds>,
        <https://1145.am/db/1628463/Omega_Funds>,
        <https://1145.am/db/1926411/Omega_Funds>,
        <https://1145.am/db/2032047/Omega_Funds>,
        <https://1145.am/db/2152399/Omega_Funds>,
        <https://1145.am/db/2282268/Omega_Fund_Management>,
        <https://1145.am/db/2282400/Omega_Funds>,
        <https://1145.am/db/2284412/Omega_Funds>,
        <https://1145.am/db/2286541/Omega_Funds>,
        <https://1145.am/db/2307682/Omega_Fund>,
        <https://1145.am/db/2307691/Omega_Fund>,
        <https://1145.am/db/2318310/Omega_Funds>,
        <https://1145.am/db/2347094/Omega_Funds>,
        <https://1145.am/db/2355609/Omega_Funds>,
        <https://1145.am/db/2361688/Omega_Funds>,
        <https://1145.am/db/474852/Omega_Fund>,
        <https://1145.am/db/545988/Omega_Funds>,
        <https://1145.am/db/704421/Omega_Funds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347537/Series_C_Investment_Relypsa_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-15T14:03:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Relypsa Announces $ 80 Million Private Financing Transaction.",
        "SANTA CLARA, Calif., Aug 15, 2012 (BUSINESS WIRE) - Relypsa, Inc. today announced an $ 80 million Series C preferred stock financing, including participation from both new and existing investors." ;
    ns1:documentTitle "Relypsa Announces $80 Million Private Financing Transaction" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/relypsa-announces-80-million-private-financing-transaction> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2347537/Relypsa_Inc> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 80 Million",
        "$ 80 million" ;
    ns1:when "2012-08-15T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012-Aug-15" ;
    ns1:whereRaw "Relypsa Announces $ 80 Million Private Financing Transaction" .

<https://1145.am/db/2348128/Tavistock> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-11-12T16:59:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MethylGene Announces Cdn.$26.1 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/methylgene-announces-cdn-26-1-million-private-placement> ;
    ns1:foundName "Tavistock Life Sciences" ;
    ns1:investor <https://1145.am/db/2348128/Investment_Methylgene_Inc_Tavistock_Has_Not_Happened> ;
    ns1:name "Tavistock" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348135/Norwegian_Research_Councils_Bia_Program> a org:Organization ;
    ns1:basedInLowRaw "Norway" ;
    ns1:description "Research" ;
    ns1:documentDate "2012-11-13T05:01:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vaccibody Receives Euros 2 Million to Develop Therapeutic Cervical Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaccibody-receives-euros-2-million-to-develop-therapeutic-cervical-cancer-vaccine> ;
    ns1:foundName "BIA Program",
        "Norwegian Research Council" ;
    ns1:investor <https://1145.am/db/2348135/Investment_Norwegian_Research_Councils_Bia_Program_Vaccibody_Has_Not_Happened> ;
    ns1:name "Norwegian Research Council",
        "Norwegian Research Council's BIA Program" ;
    ns1:participant <https://1145.am/db/2348135/Investment_Norwegian_Research_Councils_Bia_Program_Vaccibody_Has_Not_Happened> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350199/Alta_Partners_And_Sr> a org:Organization ;
    ns1:basedInLowRaw "GAINESVILLE, Fla",
        "GAINESVILLE, Fla." ;
    ns1:description "Investing",
        "financing" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "Alta Partners",
        "Alta Partners and S.R.",
        "S.R." ;
    ns1:investor <https://1145.am/db/2350199/Series_B_Investment_Alta_Partners_And_Sr_Applied_Genetic_Technologies_Corporation_Interwest_Intersouth_Partners_Medimmune_Ventures_Osage_University_Partners_Sr_One_Limited_Completed> ;
    ns1:name "Alta Partners",
        "Alta Partners and S.R.",
        "S.R." ;
    ns1:sameAsHigh <https://1145.am/db/2325257/Alta_Partners_Cidc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350199/Series_B_Investment_Agtc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "AGTC Secures $ 37.5M Series B Funding. Clinical stage gene therapy company will use financing, led by Alta Partners and S.R." ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "Funding" ;
    ns1:name "Funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2350199/Agtc> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 37.5M" .

<https://1145.am/db/2350199/Sr_One_Limited> a org:Organization ;
    ns1:basedInLowRaw "Fla",
        "GAINESVILLE, Fla" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "One, Limited",
        "S.R. One, Limited" ;
    ns1:investor <https://1145.am/db/2350199/Series_B_Investment_Alta_Partners_And_Sr_Applied_Genetic_Technologies_Corporation_Interwest_Intersouth_Partners_Medimmune_Ventures_Osage_University_Partners_Sr_One_Limited_Completed> ;
    ns1:name "One, Limited",
        "S.R. One, Limited" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350664/Investment_3dr_Laboratories_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-23T13:02:12+00:00"^^xsd:dateTime ;
    ns1:documentExtract "3DR Laboratories, Inc. Receives $ 7.2 Million in Funding from Advantage Capital Partners." ;
    ns1:documentTitle "3DR Laboratories, Inc. Receives $7.2 Million in Funding from Advantage Capital Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/3dr-laboratories-inc-receives-7-2-million-funding-from-advantage-capital-partners> ;
    ns1:foundName "Funding",
        "invested" ;
    ns1:name "Funding",
        "invested" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2350664/3dr_Laboratories> ;
    ns1:valueRaw "$ 7.2 Million",
        "$ 7.2 million" ;
    ns1:whereGeoName "Kentucky" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6254925/about.rdf> ;
    ns1:whereRaw "Kentucky" .

<https://1145.am/db/2351210/GMS> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:documentDate "2012-11-20T17:16:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TauRx Pharmaceuticals receives $111.8m commitment from Genting to prepare for Market Leadership in Alzheimer's" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taurx-pharmaceuticals-receives-111-8m-commitment-from-genting-to-prepare-for-market> ;
    ns1:foundName "GMS" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2351210/Equity_Investment_Genting_Berhad_Genting_Management_(singapore)_Pte_Ltd_Taurx_Pharmaceuticals_Ltd_Completed> ;
    ns1:name "GMS" ;
    ns1:sameAsMedium <https://1145.am/db/1106079/Gms_Inc>,
        <https://1145.am/db/1226217/Gms_Inc>,
        <https://1145.am/db/1281480/Gms_Inc>,
        <https://1145.am/db/1958833/Gms_Inc>,
        <https://1145.am/db/1990972/Gms_Inc>,
        <https://1145.am/db/2133451/Gms_Inc>,
        <https://1145.am/db/401251/Gms_Inc>,
        <https://1145.am/db/588157/Gms_Inc>,
        <https://1145.am/db/592352/Gms_Inc>,
        <https://1145.am/db/665287/Gms_Inc>,
        <https://1145.am/db/666824/Gms_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351210/Genting_Berhad> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Singapore" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1880251/about.rdf> ;
    ns1:basedInHighRaw "SINGAPORE" ;
    ns1:description "business" ;
    ns1:documentDate "2012-11-20T17:16:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TauRx Pharmaceuticals receives $111.8m commitment from Genting to prepare for Market Leadership in Alzheimer's" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taurx-pharmaceuticals-receives-111-8m-commitment-from-genting-to-prepare-for-market> ;
    ns1:foundName "Genting Berhad" ;
    ns1:name "Genting Berhad" ;
    ns1:participant <https://1145.am/db/2351210/Equity_Investment_Genting_Berhad_Genting_Management_(singapore)_Pte_Ltd_Taurx_Pharmaceuticals_Ltd_Completed> ;
    ns1:sameAsMedium <https://1145.am/db/2289819/Genting_Berhad> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351210/Genting_Management_(singapore)_Pte_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Singapore" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1880251/about.rdf> ;
    ns1:basedInHighRaw "SINGAPORE" ;
    ns1:basedInLowRaw "Malaysia" ;
    ns1:documentDate "2012-11-20T17:16:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TauRx Pharmaceuticals receives $111.8m commitment from Genting to prepare for Market Leadership in Alzheimer's" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taurx-pharmaceuticals-receives-111-8m-commitment-from-genting-to-prepare-for-market> ;
    ns1:foundName "Genting",
        "Genting Management (Singapore) Pte. Ltd." ;
    ns1:investor <https://1145.am/db/2351210/Equity_Investment_Genting_Berhad_Genting_Management_(singapore)_Pte_Ltd_Taurx_Pharmaceuticals_Ltd_Completed> ;
    ns1:name "Genting",
        "Genting Management (Singapore) Pte. Ltd." ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351224/DFJ-Esprit> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of the Netherlands" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2750405/about.rdf> ;
    ns1:basedInHighRaw "The Netherlands" ;
    ns1:documentDate "2012-11-21T15:02:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kiadis Pharma Raises EUR 10 Million in Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/kiadis-pharma-raises-eur-10-million-financing-round> ;
    ns1:foundName "DFJ-Esprit" ;
    ns1:investor <https://1145.am/db/2351224/Equity_Investment_Alta_Partners_Dfj-Esprit_Kiadis_Pharma_Lsp_Nom_Quest_For_Growth_Completed> ;
    ns1:name "DFJ-Esprit" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351224/LSP> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of the Netherlands" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2750405/about.rdf> ;
    ns1:basedInHighRaw "The Netherlands" ;
    ns1:description "Life Sciences Partners" ;
    ns1:documentDate "2012-11-21T15:02:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kiadis Pharma Raises EUR 10 Million in Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/kiadis-pharma-raises-eur-10-million-financing-round> ;
    ns1:foundName "LSP" ;
    ns1:industry "Life Sciences" ;
    ns1:investor <https://1145.am/db/2351224/Equity_Investment_Alta_Partners_Dfj-Esprit_Kiadis_Pharma_Lsp_Nom_Quest_For_Growth_Completed> ;
    ns1:name "LSP" ;
    ns1:sameAsHigh <https://1145.am/db/2311395/LSP>,
        <https://1145.am/db/2311570/LSP>,
        <https://1145.am/db/2317934/Lsp_(life_Science_Partners)>,
        <https://1145.am/db/2336810/Lsp_5>,
        <https://1145.am/db/2337308/Lsp_5>,
        <https://1145.am/db/2347574/Lsp_Life_Sciences_Partners>,
        <https://1145.am/db/2356290/LSP>,
        <https://1145.am/db/2363907/LSP> ;
    ns1:sameAsMedium <https://1145.am/db/2193677/LSP>,
        <https://1145.am/db/2289899/LSP>,
        <https://1145.am/db/2293593/LSP>,
        <https://1145.am/db/2296061/LSP>,
        <https://1145.am/db/2316478/LSP>,
        <https://1145.am/db/2321608/LSP>,
        <https://1145.am/db/2336812/LSP>,
        <https://1145.am/db/2343250/LSP>,
        <https://1145.am/db/2352357/LSP>,
        <https://1145.am/db/2352361/LSP>,
        <https://1145.am/db/426688/LSP>,
        <https://1145.am/db/564585/LSP>,
        <https://1145.am/db/566971/LSP>,
        <https://1145.am/db/571769/LSP> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351224/Nom> a org:Organization ;
    ns1:basedInLowRaw "The Netherlands" ;
    ns1:documentDate "2012-11-21T15:02:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kiadis Pharma Raises EUR 10 Million in Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/kiadis-pharma-raises-eur-10-million-financing-round> ;
    ns1:foundName "NOM" ;
    ns1:investor <https://1145.am/db/2351224/Equity_Investment_Alta_Partners_Dfj-Esprit_Kiadis_Pharma_Lsp_Nom_Quest_For_Growth_Completed> ;
    ns1:name "NOM" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351224/Quest_For_Growth> a org:Organization ;
    ns1:basedInLowRaw "The Netherlands" ;
    ns1:documentDate "2012-11-21T15:02:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kiadis Pharma Raises EUR 10 Million in Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/kiadis-pharma-raises-eur-10-million-financing-round> ;
    ns1:foundName "Quest for Growth" ;
    ns1:investor <https://1145.am/db/2351224/Equity_Investment_Alta_Partners_Dfj-Esprit_Kiadis_Pharma_Lsp_Nom_Quest_For_Growth_Completed> ;
    ns1:name "Quest for Growth" ;
    ns1:sameAsMedium <https://1145.am/db/2317934/Quest_For_Growth>,
        <https://1145.am/db/2324015/Quest_For_Growth>,
        <https://1145.am/db/2356685/Quest_For_Growth>,
        <https://1145.am/db/2358747/Quest_For_Growth> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352723/Citibank> a org:Organization ;
    ns1:basedInLowRaw "N.A." ;
    ns1:description "Loan Agreement" ;
    ns1:documentDate "2012-08-28T15:16:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resverlogix Secures $25 Million, Five-Year Term Loan" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resverlogix-secures-25-million-five-year-term-loan> ;
    ns1:foundName "Citibank, N.A",
        "Citibank, N.A." ;
    ns1:name "Citibank" ;
    ns1:protagonist <https://1145.am/db/2352723/Investment_Citibank_Resverlogix_Corp_Completed> ;
    ns1:sameAsHigh <https://1145.am/db/2352682/Citibank> ;
    ns1:sameAsMedium <https://1145.am/db/1026018/Citibank>,
        <https://1145.am/db/2333351/Citibank>,
        <https://1145.am/db/2536552/Citibank>,
        <https://1145.am/db/2734293/Citibank>,
        <https://1145.am/db/2783567/Citibank>,
        <https://1145.am/db/846832/Citibank> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353260/Abs_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Conn" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-11-29T17:21:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rib-x-pharmaceuticals-closes-first-tranche-67-5-million-financing> ;
    ns1:foundName "ABS Ventures" ;
    ns1:investor <https://1145.am/db/2353260/Series_2_Investment_Abs_Ventures_Rib-X_Pharmaceuticals_Inc_Vatera_Healthcare_Partners_Vox_Equity_Partners_Warburg_Pincus_Completed> ;
    ns1:name "ABS Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1232111/Abs_Capital>,
        <https://1145.am/db/1537849/Abs_Capital>,
        <https://1145.am/db/2127882/Abs_Capital>,
        <https://1145.am/db/2324159/Abs_Ventures>,
        <https://1145.am/db/2327379/Abs_Ventures>,
        <https://1145.am/db/2352277/Abs_Ventures>,
        <https://1145.am/db/2353256/Abs_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2326571/Abs_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353260/Vox_Equity_Partners> a org:Organization ;
    ns1:basedInLowRaw "Conn" ;
    ns1:description "investing" ;
    ns1:documentDate "2012-11-29T17:21:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rib-x-pharmaceuticals-closes-first-tranche-67-5-million-financing> ;
    ns1:foundName "Vox Equity Partners" ;
    ns1:investor <https://1145.am/db/2353260/Series_2_Investment_Abs_Ventures_Rib-X_Pharmaceuticals_Inc_Vatera_Healthcare_Partners_Vox_Equity_Partners_Warburg_Pincus_Completed> ;
    ns1:name "Vox Equity Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2324159/Vox_Equity_Partners_I>,
        <https://1145.am/db/2352277/Vox_Equity_Partners>,
        <https://1145.am/db/2353256/Vox_Equity_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353260/Warburg_Pincus> a org:Organization ;
    ns1:basedInLowRaw "Conn" ;
    ns1:description "finance" ;
    ns1:documentDate "2012-11-29T17:21:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rib-x-pharmaceuticals-closes-first-tranche-67-5-million-financing> ;
    ns1:foundName "Warburg Pincus" ;
    ns1:investor <https://1145.am/db/2353260/Series_2_Investment_Abs_Ventures_Rib-X_Pharmaceuticals_Inc_Vatera_Healthcare_Partners_Vox_Equity_Partners_Warburg_Pincus_Completed> ;
    ns1:name "Warburg Pincus" ;
    ns1:sameAsHigh <https://1145.am/db/1361475/Warburg_Pincus>,
        <https://1145.am/db/2352277/Warburg_Pincus>,
        <https://1145.am/db/721581/Warburg_Pincus> ;
    ns1:sameAsMedium <https://1145.am/db/107233/Warburg_Pincus>,
        <https://1145.am/db/1077261/Warburg_Pincus>,
        <https://1145.am/db/108315/Warburg_Pincus>,
        <https://1145.am/db/1106851/Warburg_Pincus>,
        <https://1145.am/db/1121839/Warburg_Pincus>,
        <https://1145.am/db/1138823/Warburg_Pincus>,
        <https://1145.am/db/1141070/Warburg_Pincus>,
        <https://1145.am/db/1149542/Warburg_Pincus>,
        <https://1145.am/db/1153239/Warburg_Pincus>,
        <https://1145.am/db/1153356/Warburg_Pincus>,
        <https://1145.am/db/1216854/Warburg_Pincus>,
        <https://1145.am/db/1244609/Warburg_Pincus>,
        <https://1145.am/db/1245131/Warburg_Pincus>,
        <https://1145.am/db/129974/Warburg_Pincus>,
        <https://1145.am/db/1317266/Warburg_Pincus>,
        <https://1145.am/db/1349968/Warburg_Pincus_Llc>,
        <https://1145.am/db/1405696/Warburg_Pincus>,
        <https://1145.am/db/1655979/Warburg_Pincus>,
        <https://1145.am/db/1656176/Warburg_Pincus>,
        <https://1145.am/db/1674046/Warbug_Pincus>,
        <https://1145.am/db/1676487/Warburg_Pincus>,
        <https://1145.am/db/1716813/Warburg_Pincus>,
        <https://1145.am/db/1721480/Warburg_Pincus>,
        <https://1145.am/db/1722916/Warburg_Pincus>,
        <https://1145.am/db/1742050/Warburg_Pincus>,
        <https://1145.am/db/1742981/Warburg_Pincus>,
        <https://1145.am/db/1748765/Warburg_Pincus>,
        <https://1145.am/db/1754511/Warburg_Pincus>,
        <https://1145.am/db/1758165/Warburg_Pincus>,
        <https://1145.am/db/1762611/Warburg_Pincus>,
        <https://1145.am/db/1766425/Warburg_Pincus>,
        <https://1145.am/db/1777495/Warburg_Pincus>,
        <https://1145.am/db/1783572/Warburg_Pincus>,
        <https://1145.am/db/1788883/Warburg_Pincus>,
        <https://1145.am/db/1789335/Warburg_Pincus>,
        <https://1145.am/db/1790731/Warburg_Pincus>,
        <https://1145.am/db/1802244/Warburg_Pincus>,
        <https://1145.am/db/1807465/Warburg_Pincus>,
        <https://1145.am/db/1812233/Warburg_Pincus>,
        <https://1145.am/db/1831318/Warburg_Pincus>,
        <https://1145.am/db/1854800/Warburg_Pincus>,
        <https://1145.am/db/1862907/Warburg_Pincus>,
        <https://1145.am/db/1870054/Warburg_Pincus>,
        <https://1145.am/db/1874806/Warburg_Pincus>,
        <https://1145.am/db/1887816/Warburg_Pincus>,
        <https://1145.am/db/1969536/Warburg_Pincus>,
        <https://1145.am/db/196955/Warburg_Pincus>,
        <https://1145.am/db/1993235/Warburg_Pincus>,
        <https://1145.am/db/1997451/Warburg_Pincus>,
        <https://1145.am/db/1997970/Warburg_Pincus>,
        <https://1145.am/db/1998744/Warburg_Pincus>,
        <https://1145.am/db/2001027/Warburg_Pincus>,
        <https://1145.am/db/2065567/Warburg_Pincus>,
        <https://1145.am/db/2069862/Warburg_Pincus>,
        <https://1145.am/db/2076122/Warburg_Pincus>,
        <https://1145.am/db/2081192/Warburg_Pincus>,
        <https://1145.am/db/2097376/Warburg_Pincus>,
        <https://1145.am/db/2132018/Warburg_Pincus>,
        <https://1145.am/db/2134779/Warburg_Pincus>,
        <https://1145.am/db/2183196/Warburg_Pincus>,
        <https://1145.am/db/2183330/Warburg_Pincus>,
        <https://1145.am/db/2207195/Warburg_Pincus>,
        <https://1145.am/db/2238793/Warburg_Pincus>,
        <https://1145.am/db/2270672/Warburg_Pincus>,
        <https://1145.am/db/2288758/Warburg_Pincus>,
        <https://1145.am/db/2291095/Warburg_Pincus>,
        <https://1145.am/db/2296562/Warburg_Pincus>,
        <https://1145.am/db/2300064/Warburg_Pincus>,
        <https://1145.am/db/2300214/Warburg_Pincus>,
        <https://1145.am/db/2308601/Warburg_Pincus>,
        <https://1145.am/db/2309051/Warburg_Pincus>,
        <https://1145.am/db/2315159/Warburg_Pincus>,
        <https://1145.am/db/2318581/Warburg_Pincus>,
        <https://1145.am/db/2319236/Warburg_Pincus>,
        <https://1145.am/db/2319237/Warburg_Pincus>,
        <https://1145.am/db/2324159/Warburg_Pincus>,
        <https://1145.am/db/2326119/Warburg_Pincus>,
        <https://1145.am/db/2327248/Warburg_Pincus>,
        <https://1145.am/db/2327264/Warburg_Pincus>,
        <https://1145.am/db/2348272/Warburg_Pincus_Llc>,
        <https://1145.am/db/2353256/Warburg_Pincus>,
        <https://1145.am/db/235654/Warburg_Pincus_Llc>,
        <https://1145.am/db/2360639/Warburg_Pincus>,
        <https://1145.am/db/2362453/Warburg_Pincus>,
        <https://1145.am/db/2367969/Warburg_Pincus>,
        <https://1145.am/db/2367976/Warburg_Pincus>,
        <https://1145.am/db/238604/Warburg_Pincus>,
        <https://1145.am/db/2543471/Warburg_Pincus>,
        <https://1145.am/db/2544488/Warburg_Pincus>,
        <https://1145.am/db/2547596/Warburg_Pincus>,
        <https://1145.am/db/254889/Warburg_Pincus>,
        <https://1145.am/db/2560285/Warburg_Pincus>,
        <https://1145.am/db/2562224/Warburg_Pincus>,
        <https://1145.am/db/2579025/Warburg_Pincus>,
        <https://1145.am/db/2596296/Warburg_Pincus>,
        <https://1145.am/db/2638371/Warburg_Pincus>,
        <https://1145.am/db/2668430/Warburg_Pincus>,
        <https://1145.am/db/268598/Warburg_Pincus>,
        <https://1145.am/db/2688027/Warburg_Pincus>,
        <https://1145.am/db/2695363/Warburg_Pincus>,
        <https://1145.am/db/271314/Warburg_Pincus>,
        <https://1145.am/db/2722001/Warburg_Pincus>,
        <https://1145.am/db/272400/Warburg_Pincus>,
        <https://1145.am/db/2732060/Warburg_Pincus>,
        <https://1145.am/db/2735857/Warburg_Pincus>,
        <https://1145.am/db/2747164/Warburg_Pincus>,
        <https://1145.am/db/2800144/Warburg_Pincus>,
        <https://1145.am/db/299488/Warburg_Pincus>,
        <https://1145.am/db/359185/Warburg_Pincus>,
        <https://1145.am/db/405249/Warburg_Pincus>,
        <https://1145.am/db/455601/Warburg_Pincus_Llc>,
        <https://1145.am/db/460556/Warburg_Pincus>,
        <https://1145.am/db/463733/Warburg_Pincus>,
        <https://1145.am/db/478732/Warburg_Pincus>,
        <https://1145.am/db/489663/Warburg_Pincus>,
        <https://1145.am/db/505222/Warburg_Pincus>,
        <https://1145.am/db/539514/Warburg_Pincus>,
        <https://1145.am/db/542434/Warburg_Pincus>,
        <https://1145.am/db/547444/Warburg_Pincus>,
        <https://1145.am/db/556611/Warburg_Pincus>,
        <https://1145.am/db/582835/Warburg_Pincus>,
        <https://1145.am/db/601860/Warburg_Pincus>,
        <https://1145.am/db/606291/Warburg_Pincus>,
        <https://1145.am/db/627360/Warburg_Pincus>,
        <https://1145.am/db/745350/Warburg_Pincus_Llc>,
        <https://1145.am/db/768222/Warburg_Pincus>,
        <https://1145.am/db/817588/Warburg_Pincus>,
        <https://1145.am/db/823283/Warburg_Pincus>,
        <https://1145.am/db/829348/Warburg_Pincus>,
        <https://1145.am/db/85758/Warburg_Pincus>,
        <https://1145.am/db/867907/Warburg_Pincus>,
        <https://1145.am/db/934889/Warburg_Pincus>,
        <https://1145.am/db/944277/Warburg_Pincus>,
        <https://1145.am/db/962121/Warburg_Pincus>,
        <https://1145.am/db/963964/Warburg_Pincus> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354295/Alliancebernstein_Alternative_Investment_Management_Group> a org:Organization ;
    ns1:description "Alternative Investment Management" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "AllianceBernstein Alternative Investment Management Group" ;
    ns1:investor <https://1145.am/db/2354295/Preferred_Stock_Investment_Alliancebernstein_Alternative_Investment_Management_Group_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Morgan_Stanley_Expansion_Capital_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "AllianceBernstein Alternative Investment Management Group" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354295/Biomed_Ventures> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "BioMed Ventures" ;
    ns1:investor <https://1145.am/db/2354295/Preferred_Stock_Investment_Alliancebernstein_Alternative_Investment_Management_Group_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Morgan_Stanley_Expansion_Capital_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "BioMed Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1223133/Bioadvance>,
        <https://1145.am/db/1223149/Bioadvance>,
        <https://1145.am/db/1422234/Forbion_Ventures>,
        <https://1145.am/db/1422725/Forbion_Ventures>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/1926411/Bioqube_Ventures>,
        <https://1145.am/db/1990861/Bioqube_Ventures>,
        <https://1145.am/db/2060484/Healthtech_Capital>,
        <https://1145.am/db/2155146/Biomatics_Capital_Partners>,
        <https://1145.am/db/2280492/Biovision_Ventures>,
        <https://1145.am/db/2285038/Time_Bioventures>,
        <https://1145.am/db/2286671/Forbion>,
        <https://1145.am/db/2298954/Biossom_Investment_Management>,
        <https://1145.am/db/2298978/Advent_Life_Sciences>,
        <https://1145.am/db/2301741/Bio_*_One_Capital>,
        <https://1145.am/db/2301792/Fonds_Bio-Innovation_Sec>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2309840/Bio_Fund>,
        <https://1145.am/db/2310285/Medventure_Associates>,
        <https://1145.am/db/2313322/Biomedinvest>,
        <https://1145.am/db/2313322/Hbm_Bioventures>,
        <https://1145.am/db/2313401/Biogen_Idec_New_Ventures>,
        <https://1145.am/db/2313438/Biomedinvest>,
        <https://1145.am/db/2313438/Hbm_Biocapital>,
        <https://1145.am/db/2313438/Hbm_Bioventures>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314400/Hbm_Biocapital>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314573/Avlar_Bioventures>,
        <https://1145.am/db/2316709/Bioadvance_Ventures>,
        <https://1145.am/db/2317737/Mc_Life_Sciences_Ventures>,
        <https://1145.am/db/2317779/Bio_*_One_Capital>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2321097/Healthcare_Ventures>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324015/Medsciences_Capital>,
        <https://1145.am/db/2324195/Lotus_Bioscience_Ventures>,
        <https://1145.am/db/2325831/Bb_Biotech>,
        <https://1145.am/db/2325831/Hbm_Bioventures>,
        <https://1145.am/db/2336109/Biomed_Ventures>,
        <https://1145.am/db/2338673/Hopen_Life_Science_Ventures>,
        <https://1145.am/db/2339295/Biomedinvest>,
        <https://1145.am/db/2345037/Biomed_Ventures>,
        <https://1145.am/db/2347571/Advent_Life_Sciences>,
        <https://1145.am/db/2352382/Biomedinvest>,
        <https://1145.am/db/2352633/Advanced_Biotechnologies_Venture_Fund>,
        <https://1145.am/db/2359240/Frontline_Bioventures>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2365171/Healthcare_Ventures>,
        <https://1145.am/db/2366049/Biomed_Ventures>,
        <https://1145.am/db/2366055/Biomed_Ventures>,
        <https://1145.am/db/2366133/Biopacificventures>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2369916/Biomed_Ventures>,
        <https://1145.am/db/363714/Palliare>,
        <https://1145.am/db/564585/Bioqube_Ventures>,
        <https://1145.am/db/566971/Bioqube_Ventures>,
        <https://1145.am/db/684123/Biourja_Ventures>,
        <https://1145.am/db/938108/Bioeconomy_Capital>,
        <https://1145.am/db/971939/I___I_Biotech_Fund>,
        <https://1145.am/db/975114/I___I_Biotech_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2335675/Biomed_Ventures>,
        <https://1145.am/db/2336102/Biomed_Ventures>,
        <https://1145.am/db/2366046/Biomed_Ventures>,
        <https://1145.am/db/2368333/Biomed_Ventures>,
        <https://1145.am/db/2569522/Biomed_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354295/Draper_Fisher_Jurvetson> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "Draper Fisher Jurvetson" ;
    ns1:investor <https://1145.am/db/2354295/Preferred_Stock_Investment_Alliancebernstein_Alternative_Investment_Management_Group_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Morgan_Stanley_Expansion_Capital_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Draper Fisher Jurvetson" ;
    ns1:sameAsHigh <https://1145.am/db/1208519/Draper_Associates>,
        <https://1145.am/db/1578475/Draper_Associates>,
        <https://1145.am/db/1580426/Draper_Associates>,
        <https://1145.am/db/1696744/Draper_Associates>,
        <https://1145.am/db/1701580/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1726544/Draper_Associates>,
        <https://1145.am/db/1777036/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1871793/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2005131/Draper_Goren_Holm>,
        <https://1145.am/db/2305625/Draper_Triangle_Ventures>,
        <https://1145.am/db/517818/Draper_Associates>,
        <https://1145.am/db/661747/Draper_Associates>,
        <https://1145.am/db/663618/Draper_Associates>,
        <https://1145.am/db/881298/Draper_Associates>,
        <https://1145.am/db/882723/Draper_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1700208/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1715860/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1718217/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1720974/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1721069/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1725158/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1731011/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1731784/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1802109/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1803082/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1808823/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1831887/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1832969/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1839922/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1842882/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1850727/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1854396/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1863426/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1867543/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1870436/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1872742/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1875271/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1879085/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1885322/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1885417/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1892674/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1895406/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1896251/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1903583/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1904289/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1907762/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1907901/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/1922530/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2325015/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2366049/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2366055/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2447981/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2621727/Draper_Fisher_Jurvetson>,
        <https://1145.am/db/2636386/Draper_Fisher_Jervetson>,
        <https://1145.am/db/2645160/Draper_Fisher_Jurvetson> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354295/Ge_Healthymagination_Fund> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "GE healthymagination Fund" ;
    ns1:investor <https://1145.am/db/2354295/Preferred_Stock_Investment_Alliancebernstein_Alternative_Investment_Management_Group_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Morgan_Stanley_Expansion_Capital_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "GE healthymagination Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2349628/Ge_Healthymagination_Fund>,
        <https://1145.am/db/2366055/Ge_Healthymagination_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354295/Henri_Termeer> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "Henri Termeer" ;
    ns1:investor <https://1145.am/db/2354295/Preferred_Stock_Investment_Alliancebernstein_Alternative_Investment_Management_Group_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Morgan_Stanley_Expansion_Capital_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Henri Termeer" ;
    ns1:sameAsMedium <https://1145.am/db/2337664/Henri_Termeer>,
        <https://1145.am/db/2363396/Henri_Termeer>,
        <https://1145.am/db/2365079/Henri_Termeer>,
        <https://1145.am/db/2366049/Henri_Termeer>,
        <https://1145.am/db/2366055/Henri_Termeer> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354295/Morgan_Stanley_Expansion_Capital> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "Morgan Stanley Expansion Capital" ;
    ns1:investor <https://1145.am/db/2354295/Preferred_Stock_Investment_Alliancebernstein_Alternative_Investment_Management_Group_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Morgan_Stanley_Expansion_Capital_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Morgan Stanley Expansion Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1723004/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/1733045/Morgan_Stanley_Investment_Management> ;
    ns1:sameAsMedium <https://1145.am/db/1148267/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/1326421/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/1326785/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/1352908/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/1448312/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/1713153/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/1751279/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/176554/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/1798651/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/2319640/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/2323511/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/2332459/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/2353670/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/2353671/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/2353674/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/495996/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/496377/Morgan_Stanley_Expansion_Capital>,
        <https://1145.am/db/532477/Morgan_Stanley_Expansion_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354295/Ovp_Venture_Partners> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "OVP Venture Partners" ;
    ns1:investor <https://1145.am/db/2354295/Preferred_Stock_Investment_Alliancebernstein_Alternative_Investment_Management_Group_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Morgan_Stanley_Expansion_Capital_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "OVP Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1722057/Ventures_Platform>,
        <https://1145.am/db/1771229/Partners_Lp>,
        <https://1145.am/db/2366049/Ovp_Venture_Partners>,
        <https://1145.am/db/2366055/Ovp_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1907771/Ovp_Venture_Partners>,
        <https://1145.am/db/2302602/Ovp_Venture_Partners>,
        <https://1145.am/db/2302603/Ovp_Venture_Partners>,
        <https://1145.am/db/2326159/Ovp_Venture_Partners>,
        <https://1145.am/db/2329125/Ovp_Venture_Partners>,
        <https://1145.am/db/2329131/Ovp_Venture_Partners>,
        <https://1145.am/db/2345223/Ovp_Venture_Partners>,
        <https://1145.am/db/2345769/Ovp_Venture_Partners>,
        <https://1145.am/db/2347368/Ovp_Venture_Partners>,
        <https://1145.am/db/2352804/Ovp_Venture_Partners>,
        <https://1145.am/db/2352807/Ovp_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354296/Pfizer_Venture_Investments> a org:Organization ;
    ns1:basedInLowRaw "WOBURN, Mass" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-12-04T10:37:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Flexion Therapeutics Secures $20 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flexion-therapeutics-secures-20-million-series-b-financing> ;
    ns1:foundName "Pfizer Venture Investments" ;
    ns1:investor <https://1145.am/db/2354296/Series_B_Investment_5am_Ventures_Flexion_Therapeutics_Novo_Ventures_Pfizer_Venture_Investments_Sofinnova_Partners_Versant_Ventures_Completed> ;
    ns1:name "Pfizer Venture Investments" ;
    ns1:sameAsHigh <https://1145.am/db/1334624/Pfizer_Ventures>,
        <https://1145.am/db/2154844/Pfizer_Ventures>,
        <https://1145.am/db/2306549/Pfizer_Venture_Investments>,
        <https://1145.am/db/2318310/Pfizer_Venture_Investments>,
        <https://1145.am/db/2318333/Pfizer>,
        <https://1145.am/db/2319442/Pfizer_Venture_Investments>,
        <https://1145.am/db/2322984/Pfizer_Venture_Investments>,
        <https://1145.am/db/2323003/Pfizer_Venture_Investments>,
        <https://1145.am/db/2325726/Pfizer_Ventures>,
        <https://1145.am/db/2341896/Pfizer_Ventures>,
        <https://1145.am/db/2348066/Pfizer_Venture_Investments>,
        <https://1145.am/db/2355043/Pfizer_Venture_Investments>,
        <https://1145.am/db/2356290/Pfizer_Venture_Investments>,
        <https://1145.am/db/2359321/Pfizer_Venture_Investments>,
        <https://1145.am/db/2364458/Pfizer_Venture_Investments>,
        <https://1145.am/db/2369000/Pfizer_Venture_Investments>,
        <https://1145.am/db/587045/Pfizer_Ventures>,
        <https://1145.am/db/591613/Pfizer_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2299758/Pfizer_Venture_Investments>,
        <https://1145.am/db/2336335/Pfizer_Venture_Investments>,
        <https://1145.am/db/2337971/Pfizer_Venture_Investments>,
        <https://1145.am/db/2338527/Pfizer_Venture_Investments>,
        <https://1145.am/db/2338528/Pfizer_Venture_Investments>,
        <https://1145.am/db/2340096/Pfizer_Venture_Investments>,
        <https://1145.am/db/2346978/Pfizer_Venture_Investments>,
        <https://1145.am/db/2349143/Pfizer_Venture_Investments>,
        <https://1145.am/db/2352226/Pfizer_Venture_Investments>,
        <https://1145.am/db/2356287/Pfizer_Venture_Investments>,
        <https://1145.am/db/2362862/Pfizer_Venture_Investments>,
        <https://1145.am/db/2364457/Pfizer_Venture_Investments>,
        <https://1145.am/db/2367549/Pfizer_Venture_Investments>,
        <https://1145.am/db/2587938/Pfizer_Venture_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354296/Versant_Ventures> a org:Organization ;
    ns1:basedInLowRaw "WOBURN, Mass" ;
    ns1:documentDate "2012-12-04T10:37:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Flexion Therapeutics Secures $20 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flexion-therapeutics-secures-20-million-series-b-financing> ;
    ns1:foundName "Versant Ventures" ;
    ns1:investor <https://1145.am/db/2354296/Series_B_Investment_5am_Ventures_Flexion_Therapeutics_Novo_Ventures_Pfizer_Venture_Investments_Sofinnova_Partners_Versant_Ventures_Completed> ;
    ns1:name "Versant Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1540787/Versant_Ventures>,
        <https://1145.am/db/1541055/Versant_Ventures>,
        <https://1145.am/db/1571794/Versant_Ventures>,
        <https://1145.am/db/1928388/Versant_Ventures>,
        <https://1145.am/db/1975490/Versant_Ventures>,
        <https://1145.am/db/2069394/Versant_Ventures>,
        <https://1145.am/db/2110276/Versant_Ventures>,
        <https://1145.am/db/2151802/Versant_Ventures>,
        <https://1145.am/db/2154338/Versant_Ventures>,
        <https://1145.am/db/2154566/Versant_Ventures>,
        <https://1145.am/db/2281211/Versant_Ventures>,
        <https://1145.am/db/2287023/Versant_Ventures>,
        <https://1145.am/db/2288016/Versant_Ventures>,
        <https://1145.am/db/2290283/Versant_Ventures>,
        <https://1145.am/db/2291315/Versant_Ventures>,
        <https://1145.am/db/2291344/Versant_Ventures>,
        <https://1145.am/db/2293059/Versant_Ventures>,
        <https://1145.am/db/2293893/Versant_Ventures>,
        <https://1145.am/db/2294202/Versant_Ventures>,
        <https://1145.am/db/2296209/Versant_Ventures>,
        <https://1145.am/db/2298176/Versant_Ventures>,
        <https://1145.am/db/2299080/Versant_Ventures>,
        <https://1145.am/db/2299776/Versant_Ventures>,
        <https://1145.am/db/2300337/Versant_Ventures>,
        <https://1145.am/db/2303767/Versant_Ventures>,
        <https://1145.am/db/2304598/Versant_Ventures>,
        <https://1145.am/db/2304606/Versant_Ventures>,
        <https://1145.am/db/2304769/Versant_Ventures>,
        <https://1145.am/db/2305015/Versant_Ventures>,
        <https://1145.am/db/2308758/Versant_Ventures>,
        <https://1145.am/db/2310285/Versant_Ventures>,
        <https://1145.am/db/2310302/Versant_Ventures>,
        <https://1145.am/db/2311353/Versant_Ventures>,
        <https://1145.am/db/2313143/Versant_Ventures>,
        <https://1145.am/db/2317750/Versant_Ventures>,
        <https://1145.am/db/2317753/Versant_Ventures>,
        <https://1145.am/db/2318733/Versant_Ventures>,
        <https://1145.am/db/2319784/Versant_Ventures>,
        <https://1145.am/db/2322646/Versant_Ventures>,
        <https://1145.am/db/2323226/Versant_Ventures>,
        <https://1145.am/db/2324226/Versant_Ventures>,
        <https://1145.am/db/2325681/Versant_Ventures>,
        <https://1145.am/db/2326361/Versant_Ventures>,
        <https://1145.am/db/2326373/Versant_Ventures>,
        <https://1145.am/db/2326903/Versant_Ventures>,
        <https://1145.am/db/2330075/Versant_Ventures>,
        <https://1145.am/db/2330712/Versant_Ventures>,
        <https://1145.am/db/2330852/Versant_Ventures>,
        <https://1145.am/db/2331754/Versant_Ventures>,
        <https://1145.am/db/2331868/Versant_Ventures>,
        <https://1145.am/db/2335675/Versant_Ventures>,
        <https://1145.am/db/2335760/Versant_Ventures>,
        <https://1145.am/db/2339885/Versant_Ventures>,
        <https://1145.am/db/2339886/Versant_Ventures>,
        <https://1145.am/db/2342445/Versant_Ventures>,
        <https://1145.am/db/2343184/Versant_Ventures>,
        <https://1145.am/db/2343185/Versant_Ventures>,
        <https://1145.am/db/2343206/Versant_Ventures>,
        <https://1145.am/db/2343467/Versant_Ventures>,
        <https://1145.am/db/2343547/Versant_Ventures>,
        <https://1145.am/db/2343641/Versant_Ventures>,
        <https://1145.am/db/2343647/Versant_Ventures>,
        <https://1145.am/db/2344915/Versant_Ventures>,
        <https://1145.am/db/2344916/Versant_Ventures>,
        <https://1145.am/db/2344922/Versant_Ventures>,
        <https://1145.am/db/2344926/Versant_Ventures>,
        <https://1145.am/db/2345769/Versant_Ventures>,
        <https://1145.am/db/2347368/Versant_Ventures>,
        <https://1145.am/db/2348012/Versant_Ventures>,
        <https://1145.am/db/2348857/Versant_Ventures>,
        <https://1145.am/db/2349233/Versant_Ventures>,
        <https://1145.am/db/2349834/Versant_Ventures>,
        <https://1145.am/db/2350917/Versant_Ventures>,
        <https://1145.am/db/2351904/Versant_Ventures>,
        <https://1145.am/db/2360189/Versant_Ventures>,
        <https://1145.am/db/2360191/Versant_Ventures>,
        <https://1145.am/db/2360415/Versant_Ventures>,
        <https://1145.am/db/2362457/Versant_Ventures>,
        <https://1145.am/db/2362527/Versant_Ventures>,
        <https://1145.am/db/2362528/Versant_Ventures>,
        <https://1145.am/db/2362565/Versant_Ventures>,
        <https://1145.am/db/2362566/Versant_Ventures>,
        <https://1145.am/db/2364480/Versant_Ventures>,
        <https://1145.am/db/2365134/Versant_Ventures>,
        <https://1145.am/db/2365135/Versant_Ventures>,
        <https://1145.am/db/2367275/Versant_Ventures>,
        <https://1145.am/db/2368517/Versant_Ventures>,
        <https://1145.am/db/2370609/Versant_Ventures>,
        <https://1145.am/db/2370782/Versant_Ventures>,
        <https://1145.am/db/2370799/Versant_Ventures>,
        <https://1145.am/db/2371160/Versant_Ventures>,
        <https://1145.am/db/2371163/Versant_Ventures>,
        <https://1145.am/db/2541575/Versant_Ventures>,
        <https://1145.am/db/2584561/Versant_Ventures>,
        <https://1145.am/db/456081/Versant_Ventures>,
        <https://1145.am/db/488687/Versant_Ventures>,
        <https://1145.am/db/547640/Versant_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354307/Third_Rock_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-12-04T15:50:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zafgen Secures $21 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zafgen-secures-21-million-series-d-financing-0> ;
    ns1:foundName "Third Rock Ventures" ;
    ns1:investor <https://1145.am/db/2354307/Equity_Investment_Alta_Partners_Atlas_Venture_Third_Rock_Ventures_Zafgen_Completed> ;
    ns1:name "Third Rock Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Third_Rock_Ventures>,
        <https://1145.am/db/1086582/Third_Rock_Ventures>,
        <https://1145.am/db/1089269/Third_Rock_Ventures>,
        <https://1145.am/db/1325987/Third_Rock_Ventures>,
        <https://1145.am/db/1326547/Third_Rock_Ventures>,
        <https://1145.am/db/1503058/Third_Rock_Ventures>,
        <https://1145.am/db/159801/Third_Rock_Ventures>,
        <https://1145.am/db/1928208/Third_Rock_Ventures>,
        <https://1145.am/db/2095032/Third_Rock_Ventures>,
        <https://1145.am/db/2152566/Third_Rock_Ventures>,
        <https://1145.am/db/2153763/Third_Rock_Ventures>,
        <https://1145.am/db/2281272/Third_Rock_Ventures>,
        <https://1145.am/db/2291199/Third_Rock_Ventures>,
        <https://1145.am/db/2291940/Third_Rock_Ventures>,
        <https://1145.am/db/2294789/Third_Rock_Ventures>,
        <https://1145.am/db/2298193/Third_Rock_Ventures>,
        <https://1145.am/db/2298844/Third_Rock_Ventures>,
        <https://1145.am/db/2300971/Third_Rock_Ventures>,
        <https://1145.am/db/2303250/Third_Rock_Ventures>,
        <https://1145.am/db/2303251/Third_Rock_Ventures>,
        <https://1145.am/db/2303257/Third_Rock_Ventures>,
        <https://1145.am/db/2303294/Third_Rock_Ventures>,
        <https://1145.am/db/2311551/Third_Rock_Ventures>,
        <https://1145.am/db/2315931/Third_Rock_Ventures>,
        <https://1145.am/db/2315933/Third_Rock_Ventures>,
        <https://1145.am/db/2322522/Third_Rock_Ventures>,
        <https://1145.am/db/2322531/Third_Rock_Ventures>,
        <https://1145.am/db/2327474/Third_Rock_Ventures>,
        <https://1145.am/db/2335531/Third_Rock_Ventures>,
        <https://1145.am/db/2335750/Third_Rock_Ventures>,
        <https://1145.am/db/2335755/Third_Rock_Ventures>,
        <https://1145.am/db/2336126/Third_Rock_Ventures>,
        <https://1145.am/db/2337555/Third_Rock_Ventures>,
        <https://1145.am/db/2337559/Third_Rock_Ventures>,
        <https://1145.am/db/2337889/Third_Rock_Ventures>,
        <https://1145.am/db/2337958/Third_Rock_Ventures>,
        <https://1145.am/db/2337974/Third_Rock_Ventures>,
        <https://1145.am/db/2338625/Third_Rock_Ventures>,
        <https://1145.am/db/2338633/Third_Rock_Ventures>,
        <https://1145.am/db/2339127/Third_Rock_Ventures>,
        <https://1145.am/db/2339128/Third_Rock_Ventures>,
        <https://1145.am/db/2339413/Third_Rock_Ventures>,
        <https://1145.am/db/2339704/Third_Rock_Ventures>,
        <https://1145.am/db/2339925/Third_Rock_Ventures>,
        <https://1145.am/db/2339926/Third_Rock_Ventures>,
        <https://1145.am/db/2341662/Third_Rock_Ventures>,
        <https://1145.am/db/2341792/Third_Rock_Ventures>,
        <https://1145.am/db/2341800/Third_Rock_Ventures>,
        <https://1145.am/db/2342754/Third_Rock_Ventures>,
        <https://1145.am/db/2342768/Third_Rock_Ventures>,
        <https://1145.am/db/2342771/Third_Rock_Ventures>,
        <https://1145.am/db/2344256/Third_Rock_Ventures>,
        <https://1145.am/db/2344912/Third_Rock_Ventures>,
        <https://1145.am/db/2344918/Third_Rock_Ventures>,
        <https://1145.am/db/2345224/Third_Rock_Ventures>,
        <https://1145.am/db/2346212/Third_Rock_Ventures>,
        <https://1145.am/db/2346216/Third_Rock_Ventures>,
        <https://1145.am/db/2346988/Third_Rock_Ventures>,
        <https://1145.am/db/2347885/Third_Rock_Ventures>,
        <https://1145.am/db/2350364/Third_Rock_Ventures>,
        <https://1145.am/db/2351009/Third_Rock_Ventures>,
        <https://1145.am/db/2351011/Third_Rock_Ventures>,
        <https://1145.am/db/2351348/Third_Rock_Ventures>,
        <https://1145.am/db/2351372/Third_Rock_Ventures>,
        <https://1145.am/db/2351520/Third_Rock_Ventures>,
        <https://1145.am/db/2351644/Third_Rock_Ventures>,
        <https://1145.am/db/2354314/Third_Rock_Ventures>,
        <https://1145.am/db/2354608/Third_Rock_Ventures>,
        <https://1145.am/db/2354613/Third_Rock_Ventures>,
        <https://1145.am/db/2355043/Third_Rock_Ventures>,
        <https://1145.am/db/2357253/Third_Rock_Ventures>,
        <https://1145.am/db/2357256/Third_Rock_Ventures>,
        <https://1145.am/db/2357722/Third_Rock_Ventures>,
        <https://1145.am/db/2358551/Third_Rock_Ventures>,
        <https://1145.am/db/2358737/Third_Rock_Ventures>,
        <https://1145.am/db/2359321/Third_Rock_Ventures>,
        <https://1145.am/db/2359334/Third_Rock_Ventures>,
        <https://1145.am/db/2359447/Third_Rock_Ventures>,
        <https://1145.am/db/2359575/Third_Rock_Ventures>,
        <https://1145.am/db/2359818/Third_Rock_Ventures>,
        <https://1145.am/db/2359864/Third_Rock_Ventures>,
        <https://1145.am/db/2359873/Third_Rock_Ventures>,
        <https://1145.am/db/2359875/Third_Rock_Ventures>,
        <https://1145.am/db/2359887/Third_Rock_Ventures>,
        <https://1145.am/db/2359984/Third_Rock_Ventures>,
        <https://1145.am/db/2359987/Third_Rock_Ventures>,
        <https://1145.am/db/2360006/Third_Rock_Ventures>,
        <https://1145.am/db/2360169/Third_Rock_Ventures>,
        <https://1145.am/db/2360814/Third_Rock_Ventures>,
        <https://1145.am/db/2360877/Third_Rock_Ventures>,
        <https://1145.am/db/2362102/Third_Rock_Ventures>,
        <https://1145.am/db/2362109/Third_Rock_Ventures>,
        <https://1145.am/db/2362128/Third_Rock_Ventures>,
        <https://1145.am/db/2363422/Third_Rock_Ventures>,
        <https://1145.am/db/2364240/Third_Rock_Ventures>,
        <https://1145.am/db/2364249/Third_Rock_Ventures>,
        <https://1145.am/db/2364255/Third_Rock_Ventures>,
        <https://1145.am/db/2364283/Third_Rock_Ventures>,
        <https://1145.am/db/2364481/Third_Rock_Ventures>,
        <https://1145.am/db/2365109/Third_Rock_Ventures>,
        <https://1145.am/db/2365111/Third_Rock_Ventures>,
        <https://1145.am/db/2365315/Third_Rock_Ventures>,
        <https://1145.am/db/2366539/Third_Rock_Ventures>,
        <https://1145.am/db/2366641/Third_Rock_Ventures>,
        <https://1145.am/db/2367442/Third_Rock_Ventures>,
        <https://1145.am/db/2367448/Third_Rock_Ventures>,
        <https://1145.am/db/2368166/Third_Rock_Ventures>,
        <https://1145.am/db/2368501/Third_Rock_Ventures>,
        <https://1145.am/db/2369130/Third_Rock_Ventures>,
        <https://1145.am/db/2369202/Third_Rock_Ventures>,
        <https://1145.am/db/2370105/Third_Rock_Ventures_Llc>,
        <https://1145.am/db/2371191/Third_Rock_Ventures>,
        <https://1145.am/db/2580088/Third_Rock_Ventures>,
        <https://1145.am/db/2584533/Third_Rock_Ventures>,
        <https://1145.am/db/441151/Third_Rock_Ventures>,
        <https://1145.am/db/572554/Third_Rock_Ventures>,
        <https://1145.am/db/768794/Third_Rock_Ventures>,
        <https://1145.am/db/769408/Third_Rock_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355800/Merck> a org:Organization ;
    ns1:basedInHighGeoName "Regierungsbezirk Darmstadt" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2938912/about.rdf> ;
    ns1:basedInHighRaw "Darmstadt, Germany" ;
    ns1:description "pharmaceutical industry" ;
    ns1:documentDate "2012-09-04T13:15:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck Serono Announces the Creation of Quartz Bio, a Bioinformatics Company Formed Through its Entrepreneur Partnership Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merck-serono-announces-creation-of-quartz-bio-a-bioinformatics-company-formed-through-its> ;
    ns1:foundName "Merck Serono",
        "Merck, Darmstadt, Germany" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Merck" ;
    ns1:participant <https://1145.am/db/2355800/Quartz_Bio_Joint_Venture> ;
    ns1:protagonist <https://1145.am/db/2355800/Quartz_Bio_Joint_Venture> ;
    ns1:sameAsHigh <https://1145.am/db/1145060/Merck>,
        <https://1145.am/db/1186122/Merck___Co>,
        <https://1145.am/db/1217756/Merck_Kgaa>,
        <https://1145.am/db/1362602/Merck___Co_Inc>,
        <https://1145.am/db/141850/Merck>,
        <https://1145.am/db/1451511/Merck___Co>,
        <https://1145.am/db/1514452/Merck_Kgaa>,
        <https://1145.am/db/1519366/Merck>,
        <https://1145.am/db/1522616/Merck>,
        <https://1145.am/db/154793/Merck>,
        <https://1145.am/db/1554738/Merck>,
        <https://1145.am/db/1570995/Merck>,
        <https://1145.am/db/1571146/Merck>,
        <https://1145.am/db/159841/Merck>,
        <https://1145.am/db/1635899/Merck>,
        <https://1145.am/db/1966692/Merck_Kgaa>,
        <https://1145.am/db/1970288/Merck>,
        <https://1145.am/db/1970357/Merck>,
        <https://1145.am/db/1972206/Merck>,
        <https://1145.am/db/1998846/Germanys_Merck_Kgaa>,
        <https://1145.am/db/2010010/Merck___Co_Inc>,
        <https://1145.am/db/2040537/Merck>,
        <https://1145.am/db/2151833/Merck_Kgaa>,
        <https://1145.am/db/2151908/Merck_Kgaa>,
        <https://1145.am/db/2152045/Merck_Kgaa>,
        <https://1145.am/db/2152482/Merck>,
        <https://1145.am/db/2152633/Merck>,
        <https://1145.am/db/2152721/Merck>,
        <https://1145.am/db/2153637/Merck>,
        <https://1145.am/db/2153796/Merck>,
        <https://1145.am/db/2154708/Merck_Kgaa>,
        <https://1145.am/db/2154806/Merck>,
        <https://1145.am/db/2155194/Merck>,
        <https://1145.am/db/2155657/Merck>,
        <https://1145.am/db/2204455/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2217406/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2220801/Merck_Kgaa>,
        <https://1145.am/db/223588/Merck___Co_Inc>,
        <https://1145.am/db/223595/Merck___Co_Inc>,
        <https://1145.am/db/224121/Merck___Co_Inc>,
        <https://1145.am/db/2278879/Merck>,
        <https://1145.am/db/2279118/Merck>,
        <https://1145.am/db/2279238/Merck>,
        <https://1145.am/db/2280487/Merck___Co>,
        <https://1145.am/db/2281134/Merck>,
        <https://1145.am/db/2283230/Merck>,
        <https://1145.am/db/2284577/Merck>,
        <https://1145.am/db/2285024/Merck>,
        <https://1145.am/db/2285322/Merck>,
        <https://1145.am/db/2286215/Merck>,
        <https://1145.am/db/2286469/Merck>,
        <https://1145.am/db/2286759/Merck>,
        <https://1145.am/db/2287351/Merck>,
        <https://1145.am/db/2288192/Merck>,
        <https://1145.am/db/2288199/Merck>,
        <https://1145.am/db/2294623/Merck>,
        <https://1145.am/db/2298415/Merck_Kgaa>,
        <https://1145.am/db/2302117/Merck___Co_Inc>,
        <https://1145.am/db/2302462/Merck_Kgaa>,
        <https://1145.am/db/2302856/Merck_Kgaa>,
        <https://1145.am/db/2303618/Merck_Sharp___Dohme>,
        <https://1145.am/db/2303818/Merck_Kgaa>,
        <https://1145.am/db/2304609/Merck_Kgaa>,
        <https://1145.am/db/2304616/Merck___Co_Inc>,
        <https://1145.am/db/2304619/Merck___Co_Inc>,
        <https://1145.am/db/2304635/Merck>,
        <https://1145.am/db/2305804/Merck>,
        <https://1145.am/db/2306238/Merck>,
        <https://1145.am/db/2307377/Merck_Kgaa>,
        <https://1145.am/db/2307669/Merck>,
        <https://1145.am/db/2309914/Merck>,
        <https://1145.am/db/2310391/Merck>,
        <https://1145.am/db/2312786/Merck>,
        <https://1145.am/db/2312813/Merck>,
        <https://1145.am/db/2313223/Merck>,
        <https://1145.am/db/2316418/Merck___Co>,
        <https://1145.am/db/2316435/Merck___Co>,
        <https://1145.am/db/2316525/Merck>,
        <https://1145.am/db/2317494/Merck>,
        <https://1145.am/db/2317795/Merck_Kgaa>,
        <https://1145.am/db/2317895/Merck_Kgaa>,
        <https://1145.am/db/2318333/Merck_Kgaa>,
        <https://1145.am/db/2319111/Merck>,
        <https://1145.am/db/2319215/Merck_Kgaa>,
        <https://1145.am/db/2320352/Merck_Kgaa>,
        <https://1145.am/db/2320534/Merck_Kgaa>,
        <https://1145.am/db/2320820/Merck_Kgaa>,
        <https://1145.am/db/2321072/Merck___Co_Inc>,
        <https://1145.am/db/2323722/Merck___Co>,
        <https://1145.am/db/2325084/Merck>,
        <https://1145.am/db/2325864/Merck>,
        <https://1145.am/db/2326224/Merck___Co_Inc>,
        <https://1145.am/db/2326286/Merck>,
        <https://1145.am/db/2328359/Merck>,
        <https://1145.am/db/2328367/Merck>,
        <https://1145.am/db/2329475/Merck>,
        <https://1145.am/db/2329586/Merck>,
        <https://1145.am/db/2329589/Merck___Co_Inc>,
        <https://1145.am/db/2329775/Merck_Kgaa>,
        <https://1145.am/db/2329787/Merck_Kgaa>,
        <https://1145.am/db/2329795/Merck_Kgaa>,
        <https://1145.am/db/2330990/Merck_Kgaa>,
        <https://1145.am/db/2331199/Merck_Kgaa>,
        <https://1145.am/db/2331307/Merck_Kgaa>,
        <https://1145.am/db/2331756/Merck>,
        <https://1145.am/db/2332096/Merck___Co_Inc>,
        <https://1145.am/db/2335784/Merck_Kgaa>,
        <https://1145.am/db/2335812/Merck_Kgaa>,
        <https://1145.am/db/2335824/Merck_Kgaa>,
        <https://1145.am/db/2337047/Merck>,
        <https://1145.am/db/2337072/Merck>,
        <https://1145.am/db/2337245/Boston-Merck>,
        <https://1145.am/db/2337246/Merck>,
        <https://1145.am/db/2337247/Merck___Co_Inc>,
        <https://1145.am/db/2337402/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2338348/Merck>,
        <https://1145.am/db/2339972/Merck_Serono>,
        <https://1145.am/db/2340479/Merck_Kgaa>,
        <https://1145.am/db/2341435/Merck>,
        <https://1145.am/db/2342387/Merck_Kgaa>,
        <https://1145.am/db/2342487/Merck>,
        <https://1145.am/db/2343123/Merck>,
        <https://1145.am/db/2343159/Merck>,
        <https://1145.am/db/2343161/Merck>,
        <https://1145.am/db/2343358/Merck_Kgaa>,
        <https://1145.am/db/2343584/Merck>,
        <https://1145.am/db/2343585/Merck>,
        <https://1145.am/db/2344286/Merck___Co_Inc>,
        <https://1145.am/db/2344290/Merck___Co_Inc>,
        <https://1145.am/db/2344563/Merck>,
        <https://1145.am/db/2344564/Merck>,
        <https://1145.am/db/2344792/Merck>,
        <https://1145.am/db/2346099/Merck_Kgaa>,
        <https://1145.am/db/2347933/Merck_Kgaa>,
        <https://1145.am/db/2348683/Merck>,
        <https://1145.am/db/2349084/Merck>,
        <https://1145.am/db/2350145/Merck>,
        <https://1145.am/db/2350594/Merck_Kgaa>,
        <https://1145.am/db/2350594/Merck_Serono>,
        <https://1145.am/db/2350645/Merck_Kgaa>,
        <https://1145.am/db/2350687/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350706/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2350881/Merck>,
        <https://1145.am/db/2351858/Merck_Kgaa>,
        <https://1145.am/db/2352882/Merck_Kgaa>,
        <https://1145.am/db/2352961/Merck>,
        <https://1145.am/db/2355245/Merck_Kgaa>,
        <https://1145.am/db/2356800/Merck>,
        <https://1145.am/db/2357401/Merck_Kgaa>,
        <https://1145.am/db/2358644/Merck>,
        <https://1145.am/db/2358663/Merck>,
        <https://1145.am/db/2359414/Merck>,
        <https://1145.am/db/2360369/Merck_Kgaa>,
        <https://1145.am/db/2360455/Merck>,
        <https://1145.am/db/2360816/Merck_Kgaa>,
        <https://1145.am/db/2360819/Merck_Kgaa>,
        <https://1145.am/db/2361274/Merck>,
        <https://1145.am/db/2361352/Merck_Kgaa>,
        <https://1145.am/db/2361913/Merck>,
        <https://1145.am/db/2362994/Merck>,
        <https://1145.am/db/2363210/And_Merck>,
        <https://1145.am/db/2363211/Merck>,
        <https://1145.am/db/2363215/Merck>,
        <https://1145.am/db/2365367/Merck>,
        <https://1145.am/db/2367207/Merck_Kgaa>,
        <https://1145.am/db/2367218/Merck_Kgaa>,
        <https://1145.am/db/2367613/Merck_Kgaa>,
        <https://1145.am/db/2368041/Merck>,
        <https://1145.am/db/2368712/Merck>,
        <https://1145.am/db/2368719/Merck>,
        <https://1145.am/db/2368808/Merck>,
        <https://1145.am/db/2369162/Merck>,
        <https://1145.am/db/2369441/Merck_Kgaa>,
        <https://1145.am/db/2369641/Merck>,
        <https://1145.am/db/2370722/Merck>,
        <https://1145.am/db/2371269/Merck_Kgaa>,
        <https://1145.am/db/2536301/Merck>,
        <https://1145.am/db/2537455/Merck>,
        <https://1145.am/db/2538076/Merck___Co>,
        <https://1145.am/db/2539243/Merck>,
        <https://1145.am/db/2539257/Merck>,
        <https://1145.am/db/2539515/Merck_Kgaa>,
        <https://1145.am/db/2539561/Merck>,
        <https://1145.am/db/2540776/Merck>,
        <https://1145.am/db/2541112/Merck_Kgaa>,
        <https://1145.am/db/2541756/Merck>,
        <https://1145.am/db/2542057/Merck>,
        <https://1145.am/db/2542499/Merck>,
        <https://1145.am/db/2542731/Merck>,
        <https://1145.am/db/2542740/Merck>,
        <https://1145.am/db/2544107/Merck_Kgaa>,
        <https://1145.am/db/2544235/Merck>,
        <https://1145.am/db/2544391/Merck>,
        <https://1145.am/db/2545522/Merck_Kgaa>,
        <https://1145.am/db/2545618/Merck_Kgaa>,
        <https://1145.am/db/2546209/And_Merck_Kgaa>,
        <https://1145.am/db/2546686/Merck>,
        <https://1145.am/db/2548696/Merck>,
        <https://1145.am/db/2549220/Merck_Manufacturing_Division>,
        <https://1145.am/db/2549220/Merck___Co>,
        <https://1145.am/db/2551075/Merck_Kgaa>,
        <https://1145.am/db/2551126/Merck>,
        <https://1145.am/db/2552135/Merck_Kgaa>,
        <https://1145.am/db/2552707/Merck___Co_Inc>,
        <https://1145.am/db/2553766/Merck_Kgaa>,
        <https://1145.am/db/2553841/Merck_Kgaas_Merck_Serono>,
        <https://1145.am/db/2556052/Merck>,
        <https://1145.am/db/2557023/Merck_Serono>,
        <https://1145.am/db/2557506/Merck___Co>,
        <https://1145.am/db/2557870/Merck_Millipore>,
        <https://1145.am/db/2558101/Merck_Kgaa>,
        <https://1145.am/db/2558555/Merck___Co>,
        <https://1145.am/db/2558691/Merck>,
        <https://1145.am/db/2558927/Merck>,
        <https://1145.am/db/2558947/Merck_Sharp_And_Dohme>,
        <https://1145.am/db/2559298/Merck>,
        <https://1145.am/db/2559346/Merck_Kgaa>,
        <https://1145.am/db/2559511/Merck>,
        <https://1145.am/db/2559601/Merck>,
        <https://1145.am/db/2559783/Merck_Kgaa>,
        <https://1145.am/db/2559822/Merck>,
        <https://1145.am/db/2560113/Merck_Kgaa>,
        <https://1145.am/db/2560263/Merck_Kgaa>,
        <https://1145.am/db/2560758/Merck>,
        <https://1145.am/db/2561492/Merck_Kgaa>,
        <https://1145.am/db/2561650/Merck___Co>,
        <https://1145.am/db/2562041/Merck>,
        <https://1145.am/db/2563423/Merck>,
        <https://1145.am/db/2563450/Merck>,
        <https://1145.am/db/2564473/Merck_Kgaa>,
        <https://1145.am/db/2564583/Merck_Kgaa>,
        <https://1145.am/db/2565433/Merck>,
        <https://1145.am/db/2566424/Merck___Co>,
        <https://1145.am/db/2566606/Merck_Kgaa>,
        <https://1145.am/db/2566939/Merck>,
        <https://1145.am/db/2567245/Merck___Co>,
        <https://1145.am/db/2568284/Merck_Kgaa>,
        <https://1145.am/db/2568357/Merck>,
        <https://1145.am/db/2568495/Merck>,
        <https://1145.am/db/2568729/Merck___Co>,
        <https://1145.am/db/2568891/Merck_Kgaa>,
        <https://1145.am/db/2568903/Merck_Kgaa>,
        <https://1145.am/db/2569029/Merck_Serono>,
        <https://1145.am/db/2570392/Merck_Kgaa>,
        <https://1145.am/db/2570807/Merck_Kgaa>,
        <https://1145.am/db/2571023/Merck_Kgaa>,
        <https://1145.am/db/2571569/Merck>,
        <https://1145.am/db/2571683/Merck>,
        <https://1145.am/db/2572436/Merck_Canada>,
        <https://1145.am/db/2572620/Merck>,
        <https://1145.am/db/2572634/Merck>,
        <https://1145.am/db/2572675/Merck___Co_Inc>,
        <https://1145.am/db/2573613/Merck_Kgaa>,
        <https://1145.am/db/2574609/Merck_Specialities_Private_Ltd>,
        <https://1145.am/db/2575021/Merck>,
        <https://1145.am/db/2575032/Merck>,
        <https://1145.am/db/2575427/Merck>,
        <https://1145.am/db/2575623/Merck_Kgaa>,
        <https://1145.am/db/2576127/Merck>,
        <https://1145.am/db/2576129/Merck_Sharp___Dohme_Bv>,
        <https://1145.am/db/2577464/Sanofi-Aventis_And_Merck>,
        <https://1145.am/db/2577485/Sanofi-Aventis_And_Merck___Co_Inc>,
        <https://1145.am/db/2578485/Merck>,
        <https://1145.am/db/2579483/Merck>,
        <https://1145.am/db/2579763/Merck>,
        <https://1145.am/db/2580399/Merck>,
        <https://1145.am/db/2581295/Merck_Kgaa>,
        <https://1145.am/db/2581441/Merck_Kgaa>,
        <https://1145.am/db/2583045/Merck>,
        <https://1145.am/db/2583206/Merck_Consumer_Care>,
        <https://1145.am/db/2584116/Merck___Co_Inc>,
        <https://1145.am/db/2584136/Merck___Co_Inc>,
        <https://1145.am/db/2586198/Merck>,
        <https://1145.am/db/2586373/Merck>,
        <https://1145.am/db/2586732/Merck>,
        <https://1145.am/db/2586790/Merck>,
        <https://1145.am/db/2587758/Merck_Millipore>,
        <https://1145.am/db/2587981/Merck>,
        <https://1145.am/db/2588111/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588119/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2588121/Merck_Biomanufacturing_Network>,
        <https://1145.am/db/2590952/Merck_Kgaa>,
        <https://1145.am/db/2591137/Merck___Co_Inc>,
        <https://1145.am/db/2591395/Merck_Kgaa>,
        <https://1145.am/db/2591656/Merck___Co_Inc>,
        <https://1145.am/db/2592574/Merck>,
        <https://1145.am/db/2592875/Merck>,
        <https://1145.am/db/2592986/Merck>,
        <https://1145.am/db/2594591/Merck>,
        <https://1145.am/db/2594604/Merck>,
        <https://1145.am/db/2594687/Merck_Sharp_Dohme>,
        <https://1145.am/db/2595812/Merck>,
        <https://1145.am/db/2596015/Theramex>,
        <https://1145.am/db/2596156/Merck_Serono>,
        <https://1145.am/db/2596183/Merck_Kgaa>,
        <https://1145.am/db/2596909/Merck>,
        <https://1145.am/db/2597131/Merck>,
        <https://1145.am/db/2597135/Merck_Serono>,
        <https://1145.am/db/2597451/Merck>,
        <https://1145.am/db/2598195/Merck_Kgaa>,
        <https://1145.am/db/2598430/Merck>,
        <https://1145.am/db/2598439/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598439/Merck_Sharp___Dohme_Corp>,
        <https://1145.am/db/2598446/Johnson___Johnson-Merck_Consumer_Pharmaceuticals_Co>,
        <https://1145.am/db/2598446/Merck>,
        <https://1145.am/db/2598455/Merck>,
        <https://1145.am/db/2598458/Merck>,
        <https://1145.am/db/2598523/Merck>,
        <https://1145.am/db/275241/Merck>,
        <https://1145.am/db/335436/Merck_Kgaa>,
        <https://1145.am/db/420173/Merck>,
        <https://1145.am/db/508163/Merck>,
        <https://1145.am/db/510419/Merck>,
        <https://1145.am/db/511540/Merck>,
        <https://1145.am/db/512986/Merck>,
        <https://1145.am/db/514478/Merck>,
        <https://1145.am/db/514938/Merck___Co>,
        <https://1145.am/db/515012/Merck>,
        <https://1145.am/db/515636/Merck>,
        <https://1145.am/db/516867/Merck>,
        <https://1145.am/db/517460/Merck___Co_Inc>,
        <https://1145.am/db/518115/Merck>,
        <https://1145.am/db/539381/Merck>,
        <https://1145.am/db/540665/Merck_Kgaa>,
        <https://1145.am/db/545265/Merck___Co>,
        <https://1145.am/db/546225/Merck___Co>,
        <https://1145.am/db/550927/Merck>,
        <https://1145.am/db/555027/Merck___Co_Inc>,
        <https://1145.am/db/557111/Merck___Co_Inc>,
        <https://1145.am/db/580628/Merck>,
        <https://1145.am/db/602160/Merck>,
        <https://1145.am/db/607613/Merck>,
        <https://1145.am/db/626833/Merck>,
        <https://1145.am/db/641350/Merck>,
        <https://1145.am/db/678858/Merck>,
        <https://1145.am/db/680862/Merck>,
        <https://1145.am/db/701833/Healthcare_Business_Sector_Of_Merck_Kgaa>,
        <https://1145.am/db/708442/Merck>,
        <https://1145.am/db/746997/Merck_Kgaa>,
        <https://1145.am/db/866117/Merck>,
        <https://1145.am/db/868747/Merck>,
        <https://1145.am/db/884408/Merck_Kgaa> ;
    ns1:sameAsMedium <https://1145.am/db/1098407/Merck_Kgaa>,
        <https://1145.am/db/1149563/Merck>,
        <https://1145.am/db/1153272/Merck>,
        <https://1145.am/db/1153273/Merck>,
        <https://1145.am/db/1467892/Merck_Kgaa>,
        <https://1145.am/db/1524293/Merck>,
        <https://1145.am/db/1525563/Merck>,
        <https://1145.am/db/1968247/Merck>,
        <https://1145.am/db/2287767/Merck>,
        <https://1145.am/db/2293662/Merck>,
        <https://1145.am/db/2303087/Merck_Kgaa>,
        <https://1145.am/db/2305972/Merck___Co>,
        <https://1145.am/db/2306562/Merck>,
        <https://1145.am/db/2306873/Merck_Kgaa>,
        <https://1145.am/db/2307697/Merck_Kgaa>,
        <https://1145.am/db/2315288/Merck_Kgaa>,
        <https://1145.am/db/2317398/Merck>,
        <https://1145.am/db/2318574/Merck>,
        <https://1145.am/db/2325702/Merck___Co>,
        <https://1145.am/db/2330692/Merck___Co>,
        <https://1145.am/db/2333619/Merck_Kgaa>,
        <https://1145.am/db/2348727/Merck>,
        <https://1145.am/db/2358017/Merck_Kgaa>,
        <https://1145.am/db/2362458/Merck_Kgaa>,
        <https://1145.am/db/2368838/Merck>,
        <https://1145.am/db/2537077/Merck>,
        <https://1145.am/db/2540072/Merck_Kgaa>,
        <https://1145.am/db/2542394/Merck_Kgaa>,
        <https://1145.am/db/2545631/Merck>,
        <https://1145.am/db/2551984/Merck>,
        <https://1145.am/db/2553618/Merck_Kgaa>,
        <https://1145.am/db/2554244/Merck>,
        <https://1145.am/db/2554269/Merck>,
        <https://1145.am/db/2562722/Merck___Co>,
        <https://1145.am/db/2565626/Merck_Kgaa>,
        <https://1145.am/db/2575465/Merck_Kgaa>,
        <https://1145.am/db/2578046/Merck>,
        <https://1145.am/db/2588540/Merck>,
        <https://1145.am/db/2590687/Merck>,
        <https://1145.am/db/2591687/Merck_Kgaa>,
        <https://1145.am/db/2592013/Merck>,
        <https://1145.am/db/2594711/Merck>,
        <https://1145.am/db/2598420/Merck>,
        <https://1145.am/db/2598428/Merck>,
        <https://1145.am/db/769856/Merck>,
        <https://1145.am/db/990890/Merck> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355826/National_Science_Foundation> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "funding" ;
    ns1:documentDate "2012-09-05T13:01:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akonni Awarded $500,000 Phase 2 National Science Foundation Grant to Develop Lab-on-a-Filmâ„¢ Microarray Device" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akonni-awarded-500-000-phase-2-national-science-foundation-grant-to-develop-lab-on-a-film%E2%84%A2> ;
    ns1:foundName "NS",
        "National Science Foundation" ;
    ns1:investor <https://1145.am/db/2355826/Investment_Akonni_Biosystems_National_Science_Foundation_Has_Not_Happened> ;
    ns1:name "National Science Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/1349046/National_Science_Foundation>,
        <https://1145.am/db/2051634/National_Science_Foundation>,
        <https://1145.am/db/2120320/National_Science_Foundation>,
        <https://1145.am/db/2362844/National_Science_Foundation>,
        <https://1145.am/db/2448669/National_Science_Foundation>,
        <https://1145.am/db/2594002/National_Science_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356391/Fred_Hutchinson_Cancer_Research_Center> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "cancer research" ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:foundName "The Fred Hutchinson Cancer Research Center" ;
    ns1:name "Fred Hutchinson Cancer Research Center" ;
    ns1:protagonist <https://1145.am/db/2356391/Joint_Venture_Fred_Hutchinson_Cancer_Research_Center_Glaxosmithkline_Has_Not_Happened> ;
    ns1:sameAsHigh <https://1145.am/db/1414243/Fred_Hutchinson_Cancer_Center>,
        <https://1145.am/db/2231480/The_University_Of_Texas_Md_Anderson_Cancer_Center>,
        <https://1145.am/db/2346768/The_Fred_Hutchinson_Cancer_Research_Center>,
        <https://1145.am/db/2354164/Fred_Hutchinson_Cancer_Research_Center>,
        <https://1145.am/db/923059/Fred_Hutchinson_Cancer_Research_Center> ;
    ns1:sameAsMedium <https://1145.am/db/2347644/Fred_Hutchinson_Cancer_Research_Center>,
        <https://1145.am/db/2347657/Fred_Hutchinson_Cancer_Research_Center>,
        <https://1145.am/db/2347763/Fred_Hutchinson_Cancer_Research_Center> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356391/Glaxosmithkline> a org:Organization ;
    ns1:basedInLowRaw "United Kingdom" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:foundName "GlaxoSmithKline" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "GlaxoSmithKline" ;
    ns1:protagonist <https://1145.am/db/2356391/Joint_Venture_Fred_Hutchinson_Cancer_Research_Center_Glaxosmithkline_Has_Not_Happened> ;
    ns1:sameAsHigh <https://1145.am/db/1002406/Glaxosmithkline_Plc>,
        <https://1145.am/db/1003861/Glaxosmithkline_Plc>,
        <https://1145.am/db/1034874/Glaxosmithkline_Plc>,
        <https://1145.am/db/1035942/GSK>,
        <https://1145.am/db/1036772/Glaxosmithkline_Plc>,
        <https://1145.am/db/1037557/GSK>,
        <https://1145.am/db/118625/GSK>,
        <https://1145.am/db/1368193/GSK>,
        <https://1145.am/db/1369714/GSK>,
        <https://1145.am/db/1972441/GSK>,
        <https://1145.am/db/1983958/Gsk_Plc>,
        <https://1145.am/db/2153110/Glaxosmithkline>,
        <https://1145.am/db/2156284/Glaxosmithkline>,
        <https://1145.am/db/2190363/Glaxosmithkline>,
        <https://1145.am/db/2192331/Glaxosmithkline>,
        <https://1145.am/db/2200884/Glaxosmithkline>,
        <https://1145.am/db/2204941/Glaxosmithkline>,
        <https://1145.am/db/2224597/Glaxosmithkline>,
        <https://1145.am/db/2278803/GSK>,
        <https://1145.am/db/2279371/Glaxosmithkline>,
        <https://1145.am/db/2282253/Glaxosmithkline>,
        <https://1145.am/db/2282592/Glaxosmithkline>,
        <https://1145.am/db/2283644/Glaxosmithkline>,
        <https://1145.am/db/2286031/Glaxosmithkline>,
        <https://1145.am/db/2287351/Glaxosmithkline>,
        <https://1145.am/db/2289482/Glaxosmithkline>,
        <https://1145.am/db/2290507/Glaxosmithkline>,
        <https://1145.am/db/2290596/Glaxosmithkline>,
        <https://1145.am/db/2291302/Glaxosmithkline>,
        <https://1145.am/db/2291743/Glaxosmithkline>,
        <https://1145.am/db/2292884/Glaxosmithkline>,
        <https://1145.am/db/2293175/Glaxosmithkline>,
        <https://1145.am/db/2297702/Glaxosmithkline>,
        <https://1145.am/db/2302462/Glaxosmithkline>,
        <https://1145.am/db/2303242/Glaxosmithkline>,
        <https://1145.am/db/2303245/Glaxosmithkline>,
        <https://1145.am/db/230344/Glaxosmithkline>,
        <https://1145.am/db/2305277/Glaxosmithkline>,
        <https://1145.am/db/2305279/Glaxosmithkline>,
        <https://1145.am/db/2306213/Glaxosmithkline>,
        <https://1145.am/db/2306799/Glaxosmithkline>,
        <https://1145.am/db/2307723/Glaxosmithkline>,
        <https://1145.am/db/2308007/Glaxosmithkline>,
        <https://1145.am/db/2309511/Glaxo>,
        <https://1145.am/db/2310192/Glaxosmithkline>,
        <https://1145.am/db/2311402/Glaxosmithkline_Plc>,
        <https://1145.am/db/2312131/Glaxosmithkline>,
        <https://1145.am/db/2312187/Glaxosmithkline>,
        <https://1145.am/db/2312416/Glaxosmithkline>,
        <https://1145.am/db/2312656/Glaxosmithkline>,
        <https://1145.am/db/2313289/Glaxosmithkline>,
        <https://1145.am/db/2314290/Glaxosmithkline>,
        <https://1145.am/db/2314853/Glaxosmithkline>,
        <https://1145.am/db/2315422/Glaxosmithkline>,
        <https://1145.am/db/2316364/Glaxosmithkline>,
        <https://1145.am/db/2316660/Glaxosmithkline>,
        <https://1145.am/db/2316797/Glaxosmithkline>,
        <https://1145.am/db/2317846/Glaxosmithkline>,
        <https://1145.am/db/2318310/Glaxosmithkline>,
        <https://1145.am/db/2318589/Glaxosmithkline>,
        <https://1145.am/db/2318644/Glaxosmithkline>,
        <https://1145.am/db/2318658/Glaxosmithkline_Plc>,
        <https://1145.am/db/2318681/Glaxosmithkline>,
        <https://1145.am/db/2318708/Glaxosmithkline>,
        <https://1145.am/db/2318919/Glaxosmithkline>,
        <https://1145.am/db/2319445/Glaxosmithkline>,
        <https://1145.am/db/2319763/Glaxosmithkline>,
        <https://1145.am/db/2319782/Glaxosmithkline>,
        <https://1145.am/db/2319892/Glaxosmithkline>,
        <https://1145.am/db/2320824/Glaxosmithkline>,
        <https://1145.am/db/2320992/Glaxosmithkline>,
        <https://1145.am/db/2321971/Glaxosmithkline>,
        <https://1145.am/db/2324095/Glaxosmithkline>,
        <https://1145.am/db/2324141/Glaxosmithkline>,
        <https://1145.am/db/2325359/Glaxosmithkline>,
        <https://1145.am/db/2325364/Glaxosmithkline>,
        <https://1145.am/db/2325490/Glaxosmithkline>,
        <https://1145.am/db/2325729/Glaxosmithkline_Plc>,
        <https://1145.am/db/2326266/Glaxosmithkline_(gsk)>,
        <https://1145.am/db/2326590/Glaxosmithkline>,
        <https://1145.am/db/2327305/Glaxosmithkline>,
        <https://1145.am/db/2327507/Glaxosmithkline>,
        <https://1145.am/db/2327529/Glaxosmithkline>,
        <https://1145.am/db/2327656/Glaxosmithkline>,
        <https://1145.am/db/2328471/Glaxosmithkline>,
        <https://1145.am/db/2328637/Glaxosmithkline>,
        <https://1145.am/db/2328666/Glaxosmithkline>,
        <https://1145.am/db/2328681/Glaxosmithkline>,
        <https://1145.am/db/2328981/Glaxosmithkline>,
        <https://1145.am/db/2330949/Glaxosmithkline>,
        <https://1145.am/db/2330955/Glaxosmithkline>,
        <https://1145.am/db/2330986/Glaxosmithkline>,
        <https://1145.am/db/2331010/Glaxosmithkline>,
        <https://1145.am/db/2331763/Glaxosmithkline>,
        <https://1145.am/db/2331819/Glaxosmithkline>,
        <https://1145.am/db/2331823/Glaxosmithkline>,
        <https://1145.am/db/2332005/Glaxosmithkline_Pliva>,
        <https://1145.am/db/2332660/Glaxosmithkline>,
        <https://1145.am/db/2332695/Glaxosmithkline>,
        <https://1145.am/db/2333658/Glaxosmithkline>,
        <https://1145.am/db/2335573/GSK>,
        <https://1145.am/db/2335582/Glaxosmithkline>,
        <https://1145.am/db/2335587/Glaxosmithkline>,
        <https://1145.am/db/2336060/Glaxosmithkline>,
        <https://1145.am/db/2336704/GSK>,
        <https://1145.am/db/2336990/Glaxosmithkline>,
        <https://1145.am/db/2337186/Glaxosmithkline>,
        <https://1145.am/db/2338296/Glaxosmithkline>,
        <https://1145.am/db/2339979/Glaxosmithkline>,
        <https://1145.am/db/2340071/Glaxosmithkline>,
        <https://1145.am/db/2340591/Glaxosmithkline>,
        <https://1145.am/db/2342074/Glaxosmithkline>,
        <https://1145.am/db/2342876/Glaxosmithkline>,
        <https://1145.am/db/2343855/Glaxosmithkline>,
        <https://1145.am/db/2343861/Glaxosmithkline>,
        <https://1145.am/db/2344023/Glaxosmithkline>,
        <https://1145.am/db/2344939/Glaxosmithkline>,
        <https://1145.am/db/2345251/GSK>,
        <https://1145.am/db/2345410/Glaxosmithkline>,
        <https://1145.am/db/2345604/Glaxosmithkline>,
        <https://1145.am/db/2348686/Glaxosmithkline>,
        <https://1145.am/db/2348693/Glaxosmithkline>,
        <https://1145.am/db/2349724/GSK>,
        <https://1145.am/db/2349724/Glaxosmithkline_Biologicals>,
        <https://1145.am/db/2352499/Glaxosmithkline>,
        <https://1145.am/db/2352506/Glaxosmithkline_Plc>,
        <https://1145.am/db/2353506/Glaxosmithkline>,
        <https://1145.am/db/2353547/Glaxosmithkline>,
        <https://1145.am/db/2354253/Glaxosmithkline>,
        <https://1145.am/db/2354577/Glaxosmithkline>,
        <https://1145.am/db/2355587/Glaxosmithkline>,
        <https://1145.am/db/2355595/Glaxosmithkline>,
        <https://1145.am/db/2355640/Cellzome>,
        <https://1145.am/db/2356559/Glaxosmithkline>,
        <https://1145.am/db/2356560/Glaxosmithkline>,
        <https://1145.am/db/2356639/Glaxosmithkline>,
        <https://1145.am/db/2356654/Glaxosmithkline>,
        <https://1145.am/db/2357361/Glaxosmithkline_Plc>,
        <https://1145.am/db/2359072/Glaxosmithkline>,
        <https://1145.am/db/2359553/Glaxosmithkline>,
        <https://1145.am/db/2359727/GSK>,
        <https://1145.am/db/2359727/Glaxosmithkline>,
        <https://1145.am/db/2359836/Glaxosmithkline>,
        <https://1145.am/db/2359838/Glaxosmithkline>,
        <https://1145.am/db/2359858/Glaxosmithkline>,
        <https://1145.am/db/2360093/Glaxosmithkline>,
        <https://1145.am/db/2360094/Glaxosmithkline>,
        <https://1145.am/db/2360371/Glaxosmithkline>,
        <https://1145.am/db/2360552/Glaxosmithkline>,
        <https://1145.am/db/2360562/GSK>,
        <https://1145.am/db/2361700/GSK>,
        <https://1145.am/db/2364819/Glaxosmithkline>,
        <https://1145.am/db/2364846/Glaxosmithkline>,
        <https://1145.am/db/2367620/Glaxosmithkline>,
        <https://1145.am/db/2367621/Glaxosmithkline>,
        <https://1145.am/db/2368765/Glaxosmithkline>,
        <https://1145.am/db/2368770/Glaxosmithkline_Plc>,
        <https://1145.am/db/2369276/Glaxosmithkline>,
        <https://1145.am/db/2369449/Glaxosmithkline>,
        <https://1145.am/db/2369451/Glaxosmithkline>,
        <https://1145.am/db/2369755/GSK>,
        <https://1145.am/db/2369761/Glaxosmithkline>,
        <https://1145.am/db/2370635/GSK>,
        <https://1145.am/db/238329/Glaxosmithkline>,
        <https://1145.am/db/2536540/Glaxosmithkline>,
        <https://1145.am/db/2536585/Glaxosmithkline>,
        <https://1145.am/db/2536945/Glaxosmithkline>,
        <https://1145.am/db/2537064/Glaxosmithkline>,
        <https://1145.am/db/2537699/Glaxosmithkline>,
        <https://1145.am/db/2539219/Glaxosmithkline>,
        <https://1145.am/db/2539221/Glaxosmithkline>,
        <https://1145.am/db/2539308/Glaxosmithkline>,
        <https://1145.am/db/2539972/Glaxosmithkline>,
        <https://1145.am/db/2540020/Glaxosmithkline>,
        <https://1145.am/db/2540027/Glaxosmithkline>,
        <https://1145.am/db/2540091/Glaxosmithkline>,
        <https://1145.am/db/2540172/Glaxosmithkline>,
        <https://1145.am/db/2540527/Glaxosmithkline>,
        <https://1145.am/db/2541499/Glaxosmithkline>,
        <https://1145.am/db/2542064/GSK>,
        <https://1145.am/db/2542065/Glaxosmithkline>,
        <https://1145.am/db/2542090/Glaxosmithkline>,
        <https://1145.am/db/2542192/GSK>,
        <https://1145.am/db/2542499/Glaxosmithkline>,
        <https://1145.am/db/2542503/Glaxosmithkline>,
        <https://1145.am/db/2542506/Glaxosmithkline>,
        <https://1145.am/db/2543552/Glaxosmithkline>,
        <https://1145.am/db/2544274/Glaxosmithkline>,
        <https://1145.am/db/2544350/Glaxosmithkline>,
        <https://1145.am/db/2545023/Glaxosmithkline>,
        <https://1145.am/db/2545242/Glaxosmithkline>,
        <https://1145.am/db/2545284/Glaxosmithkline>,
        <https://1145.am/db/2545518/Glaxosmithkline>,
        <https://1145.am/db/2545537/Glaxosmithkline>,
        <https://1145.am/db/2546260/Glaxosmithkline>,
        <https://1145.am/db/2546574/Glaxosmithkline>,
        <https://1145.am/db/2546577/Glaxosmithkline>,
        <https://1145.am/db/2546616/Glaxosmithkline>,
        <https://1145.am/db/2546929/Glaxosmithkline>,
        <https://1145.am/db/2547142/Glaxosmithkline>,
        <https://1145.am/db/2547143/Glaxosmithkline>,
        <https://1145.am/db/2547835/Glaxosmithkline>,
        <https://1145.am/db/2547954/Glaxosmithkline>,
        <https://1145.am/db/2547976/Glaxosmithkline>,
        <https://1145.am/db/2548034/Glaxosmithkline>,
        <https://1145.am/db/2548208/Glaxosmithkline>,
        <https://1145.am/db/2548518/Glaxosmithkline>,
        <https://1145.am/db/2548523/Glaxosmithkline>,
        <https://1145.am/db/2549082/Glaxosmithkline>,
        <https://1145.am/db/2549876/Glaxosmithkline>,
        <https://1145.am/db/2550054/Glaxosmithkline>,
        <https://1145.am/db/2550318/Glaxosmithkline>,
        <https://1145.am/db/2550460/GSK>,
        <https://1145.am/db/2550460/Glaxosmithkline>,
        <https://1145.am/db/2550543/Glaxosmithkline>,
        <https://1145.am/db/2550662/Glaxosmithkline>,
        <https://1145.am/db/2551402/Glaxosmithkline>,
        <https://1145.am/db/2551695/Glaxosmithkline>,
        <https://1145.am/db/2552794/Glaxosmithkline>,
        <https://1145.am/db/2553168/GSK>,
        <https://1145.am/db/2553206/Glaxosmithkline>,
        <https://1145.am/db/2553462/Glaxosmithkline>,
        <https://1145.am/db/2554044/Glaxosmithkline>,
        <https://1145.am/db/2554324/Glaxosmithkline>,
        <https://1145.am/db/2554578/Glaxosmithkline>,
        <https://1145.am/db/2554641/Glaxosmithkline>,
        <https://1145.am/db/2554937/Glaxosmithkline>,
        <https://1145.am/db/2555012/Glaxosmithkline>,
        <https://1145.am/db/2556628/Glaxosmithkline>,
        <https://1145.am/db/2556820/Glaxosmithkline>,
        <https://1145.am/db/2556995/Glaxosmithkline>,
        <https://1145.am/db/2557515/Glaxosmithkline>,
        <https://1145.am/db/2558165/Glaxosmithkline>,
        <https://1145.am/db/2558862/GSK>,
        <https://1145.am/db/2558862/Glaxosmithkline>,
        <https://1145.am/db/2558927/Glaxosmithkline>,
        <https://1145.am/db/2558940/Glaxosmithkline>,
        <https://1145.am/db/2560234/Glaxosmithkline>,
        <https://1145.am/db/2560260/Glaxosmithkline>,
        <https://1145.am/db/2560633/Glaxosmithkline>,
        <https://1145.am/db/2560853/Glaxosmithkline>,
        <https://1145.am/db/2560873/Glaxosmithkline>,
        <https://1145.am/db/2561334/Glaxo>,
        <https://1145.am/db/2561353/Glaxosmithkline>,
        <https://1145.am/db/2561599/Glaxosmithkline>,
        <https://1145.am/db/2561650/GSK>,
        <https://1145.am/db/2561960/Glaxosmithkline>,
        <https://1145.am/db/2562951/Glaxosmithkline>,
        <https://1145.am/db/2563194/Glaxosmithkline>,
        <https://1145.am/db/2563381/Glaxosmithkline>,
        <https://1145.am/db/2564238/Glaxosmithkline>,
        <https://1145.am/db/2564695/Glaxosmithkline>,
        <https://1145.am/db/2564786/Glaxosmithkline>,
        <https://1145.am/db/2566186/GSK>,
        <https://1145.am/db/2566825/Glaxosmithkline>,
        <https://1145.am/db/2567009/Glaxosmithkline>,
        <https://1145.am/db/2567104/GSK>,
        <https://1145.am/db/2568932/Glaxosmithkline>,
        <https://1145.am/db/2568968/Glaxosmithkline>,
        <https://1145.am/db/2569734/Glaxosmithkline_Plc>,
        <https://1145.am/db/2569735/Glaxosmithkline_Plc>,
        <https://1145.am/db/2572429/Glaxosmithkline>,
        <https://1145.am/db/2572963/Glaxosmithkline>,
        <https://1145.am/db/2573002/Glaxosmithkline>,
        <https://1145.am/db/2573201/Glaxosmithkline>,
        <https://1145.am/db/2573585/Glaxosmithkline>,
        <https://1145.am/db/2574333/Glaxosmithkline>,
        <https://1145.am/db/2575289/Glaxosmithkline>,
        <https://1145.am/db/2575462/First_Glaxosmithkline>,
        <https://1145.am/db/2576042/Glaxosmithkline>,
        <https://1145.am/db/2576046/Glaxosmithkline>,
        <https://1145.am/db/2576156/Glaxosmithkline>,
        <https://1145.am/db/2576230/Glaxosmithkline_Plc>,
        <https://1145.am/db/2576242/Glaxosmithkline>,
        <https://1145.am/db/2576256/Glaxo>,
        <https://1145.am/db/2576263/Glaxosmithkline>,
        <https://1145.am/db/2576267/GSK>,
        <https://1145.am/db/2576267/Glaxosmithkline>,
        <https://1145.am/db/2576516/Glaxosmithkline>,
        <https://1145.am/db/2577566/First_Glaxosmithkline>,
        <https://1145.am/db/2577566/Glaxo>,
        <https://1145.am/db/2577747/Glaxosmithkline>,
        <https://1145.am/db/2577778/Glaxosmithkline>,
        <https://1145.am/db/2578161/Glaxosmithkline>,
        <https://1145.am/db/2578420/Glaxosmithkline>,
        <https://1145.am/db/2578528/GSK>,
        <https://1145.am/db/2578536/Glaxosmithkline>,
        <https://1145.am/db/2579172/Glaxosmithkline>,
        <https://1145.am/db/2579177/Glaxosmithkline>,
        <https://1145.am/db/2579180/GSK>,
        <https://1145.am/db/2579205/Glaxosmithkline>,
        <https://1145.am/db/2580047/Glaxosmithkline>,
        <https://1145.am/db/2580053/Glaxosmithkline>,
        <https://1145.am/db/2580140/Glaxosmithkline>,
        <https://1145.am/db/2580509/Glaxosmithkline>,
        <https://1145.am/db/2580916/Glaxosmithkline>,
        <https://1145.am/db/2581141/Glaxosmithkline_Plc>,
        <https://1145.am/db/2581145/Glaxosmithkline>,
        <https://1145.am/db/2581176/Glaxosmithkline>,
        <https://1145.am/db/2581659/GSK>,
        <https://1145.am/db/2581661/Glaxosmithkline>,
        <https://1145.am/db/2582227/Glaxosmithkline>,
        <https://1145.am/db/2582344/Glaxosmithkline>,
        <https://1145.am/db/2582416/Glaxosmithkline>,
        <https://1145.am/db/2583228/Glaxosmithkline_Plc>,
        <https://1145.am/db/2583281/Glaxosmithkline>,
        <https://1145.am/db/2583584/Glaxosmithkline>,
        <https://1145.am/db/2584216/Glaxosmithkline>,
        <https://1145.am/db/2584538/Glaxosmithkline>,
        <https://1145.am/db/2585246/Glaxosmithkline_Plc>,
        <https://1145.am/db/2585251/Glaxosmithkline>,
        <https://1145.am/db/2586067/Glaxosmithkline>,
        <https://1145.am/db/2586099/Glaxosmithkline>,
        <https://1145.am/db/2586139/Glaxosmithkline>,
        <https://1145.am/db/2586802/GSK>,
        <https://1145.am/db/2586802/Glaxosmithkline>,
        <https://1145.am/db/2587282/Glaxosmithkline>,
        <https://1145.am/db/2587657/Glaxosmithkline>,
        <https://1145.am/db/2587770/Glaxosmithkline>,
        <https://1145.am/db/2587966/Glaxosmithkline>,
        <https://1145.am/db/2587967/GSK>,
        <https://1145.am/db/2587968/GSK>,
        <https://1145.am/db/2588258/Glaxosmithkline>,
        <https://1145.am/db/2588918/Glaxosmithkline>,
        <https://1145.am/db/2589035/Glaxosmithkline>,
        <https://1145.am/db/2589642/Glaxosmithkline>,
        <https://1145.am/db/2589701/GSK>,
        <https://1145.am/db/2589701/Glaxosmithkline>,
        <https://1145.am/db/2590051/Glaxosmithkline>,
        <https://1145.am/db/2590712/Glaxosmithkline>,
        <https://1145.am/db/2592987/Glaxosmithkline>,
        <https://1145.am/db/2593710/Glaxosmithkline>,
        <https://1145.am/db/2594208/Glaxosmithkline>,
        <https://1145.am/db/2594422/Glaxosmithkline>,
        <https://1145.am/db/2595001/Glaxosmithkline>,
        <https://1145.am/db/2595150/Glaxosmithkline>,
        <https://1145.am/db/2596213/Glaxosmithkline>,
        <https://1145.am/db/2596402/Glaxosmithkline_Plc>,
        <https://1145.am/db/2596577/Glaxosmithkline>,
        <https://1145.am/db/2596835/Glaxosmithkline>,
        <https://1145.am/db/2597004/GSK>,
        <https://1145.am/db/2597220/Glaxosmithkline>,
        <https://1145.am/db/2597554/Glaxosmithkline>,
        <https://1145.am/db/2597558/Glaxosmithkline_Pte>,
        <https://1145.am/db/2597960/Glaxosmithkline>,
        <https://1145.am/db/286227/Glaxosmithkline>,
        <https://1145.am/db/338242/Glaxosmithkline>,
        <https://1145.am/db/377761/Glaxosmithkline>,
        <https://1145.am/db/377769/Glaxosmithkline>,
        <https://1145.am/db/446194/Glaxosmithkline>,
        <https://1145.am/db/494811/Glaxosmithkline>,
        <https://1145.am/db/538122/Glaxosmithkline>,
        <https://1145.am/db/576236/Glaxosmithkline>,
        <https://1145.am/db/582690/GSK>,
        <https://1145.am/db/702938/Glaxosmithkline>,
        <https://1145.am/db/761748/Glaxosmithkline>,
        <https://1145.am/db/761841/Glaxosmithkline_Plc>,
        <https://1145.am/db/763207/Glaxosmithkline>,
        <https://1145.am/db/771701/Glaxosmithkline>,
        <https://1145.am/db/85758/Glaxosmithkline>,
        <https://1145.am/db/922192/Glaxosmithkline>,
        <https://1145.am/db/970746/Glaxosmithkline>,
        <https://1145.am/db/973116/Glaxosmithkline>,
        <https://1145.am/db/975768/Glaxosmithkline>,
        <https://1145.am/db/977067/Glaxosmithkline> ;
    ns1:sameAsMedium <https://1145.am/db/1022812/Glaxosmithkline_Plc>,
        <https://1145.am/db/1026879/Glaxosmithkline>,
        <https://1145.am/db/1209318/Glaxosmithkline>,
        <https://1145.am/db/2293631/Glaxosmithkline>,
        <https://1145.am/db/2295635/Glaxosmithkline>,
        <https://1145.am/db/2329533/Glaxosmithkline>,
        <https://1145.am/db/2335568/Glaxosmithkline>,
        <https://1145.am/db/2340260/Glaxosmithkline>,
        <https://1145.am/db/2364813/Glaxosmithkline>,
        <https://1145.am/db/2365103/Glaxosmithkline>,
        <https://1145.am/db/2370843/Glaxosmithkline>,
        <https://1145.am/db/2536493/Glaxosmithkline>,
        <https://1145.am/db/2540170/Glaxosmithkline>,
        <https://1145.am/db/2541733/Glaxosmithkline>,
        <https://1145.am/db/2544062/Glaxosmithkline>,
        <https://1145.am/db/2546136/Glaxosmithkline>,
        <https://1145.am/db/2549598/Glaxosmithkline>,
        <https://1145.am/db/2549694/Glaxosmithkline>,
        <https://1145.am/db/2552165/Glaxosmithkline>,
        <https://1145.am/db/2554902/Glaxosmithkline>,
        <https://1145.am/db/2556407/Glaxosmithkline>,
        <https://1145.am/db/2557221/Glaxosmithkline>,
        <https://1145.am/db/2560668/Glaxosmithkline>,
        <https://1145.am/db/2568973/Glaxosmithkline>,
        <https://1145.am/db/2570721/Glaxosmithkline>,
        <https://1145.am/db/2570791/Glaxosmithkline>,
        <https://1145.am/db/2577226/Glaxosmithkline>,
        <https://1145.am/db/2582233/Glaxosmithkline>,
        <https://1145.am/db/2594187/Glaxosmithkline>,
        <https://1145.am/db/2598461/Glaxosmithkline>,
        <https://1145.am/db/582690/Glaxosmithkline>,
        <https://1145.am/db/704642/Glaxosmithkline_Plc>,
        <https://1145.am/db/87287/Glaxosmithkline> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356391/Investment_Infinity_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Shares of Infinity Pharmaceuticals ($ INFI) shot up after it announced positive results from an early-stage study of IPI-145 for blood cancers." ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2356391/Infinity_Pharmaceuticals> ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2356402/Lundbeckfond_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Denmark" ;
    ns1:documentDate "2012-12-12T13:09:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "River Vision Announces Completion of $17 million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/river-vision-announces-completion-of-17-million-series-a-financing> ;
    ns1:foundName "Lundbeckfond Ventures" ;
    ns1:investor <https://1145.am/db/2356402/Series_A_Investment_Lundbeckfond_Ventures_River_Vision_Development_Corp_Sr_One_Completed> ;
    ns1:name "Lundbeckfond Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2296062/Lundbeckfonden_Ventures>,
        <https://1145.am/db/2300680/Lundbeckfond_Ventures>,
        <https://1145.am/db/2301536/Lundbeckfonden_Ventures>,
        <https://1145.am/db/2326981/Lundbeckfond_Ventures>,
        <https://1145.am/db/2336716/Lundbeckfond_Ventures>,
        <https://1145.am/db/2338527/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349048/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349050/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349405/Lundbeckfond_Ventures>,
        <https://1145.am/db/2349406/Lundbeckfond_Ventures>,
        <https://1145.am/db/2352357/Lundbeckfond_Ventures>,
        <https://1145.am/db/2352361/Lundbeckfond_Ventures>,
        <https://1145.am/db/2353098/Lundbeckfond_Ventures>,
        <https://1145.am/db/2353917/Lundbeckfond_Ventures>,
        <https://1145.am/db/2354401/Lundbeckfond_Ventures>,
        <https://1145.am/db/2356411/Lundbeckfond_Ventures>,
        <https://1145.am/db/2359401/Lundbeckfond_Ventures>,
        <https://1145.am/db/2362148/Lundbeckfond_Ventures>,
        <https://1145.am/db/2362156/Lundbeckfond_Ventures>,
        <https://1145.am/db/2363947/Lundbeckfond_Ventures>,
        <https://1145.am/db/2363950/Lundbeckfond_Ventures>,
        <https://1145.am/db/2364492/Lundbeckfond_Ventures>,
        <https://1145.am/db/2365826/Lundbeckfond_Ventures>,
        <https://1145.am/db/2366303/Lundbeckfond_Ventures>,
        <https://1145.am/db/2369169/Lundbeckfond_Ventures>,
        <https://1145.am/db/2369953/Lundbeckfond_Ventures>,
        <https://1145.am/db/2544138/Lundbeckfond_Ventures>,
        <https://1145.am/db/2544140/Lundbeckfond_Ventures>,
        <https://1145.am/db/2573068/Lundbeckfond_Ventures>,
        <https://1145.am/db/281538/Lundbeckfonden_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356419/Korys> a org:Organization ;
    ns1:basedInLowRaw "Flemish" ;
    ns1:description "investment holding" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "Korys" ;
    ns1:investor <https://1145.am/db/2356419/Series_D_Investment_Biocartis_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Philips_Johnson___Johnson_Development_Corporation_Rmm_(rudi_MariÃ«n)_Valiance_Debiopharm_Groupâ„¢_Completed> ;
    ns1:name "Korys" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/Korys>,
        <https://1145.am/db/2339425/Korys> ;
    ns1:sameAsMedium <https://1145.am/db/2332543/Korys> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356419/Luc_Verelst> a org:Organization ;
    ns1:basedInLowRaw "Flemish" ;
    ns1:description "family office" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "Luc Verelst" ;
    ns1:industry "life sciences" ;
    ns1:investor <https://1145.am/db/2356419/Series_D_Investment_Biocartis_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Philips_Johnson___Johnson_Development_Corporation_Rmm_(rudi_MariÃ«n)_Valiance_Debiopharm_Groupâ„¢_Completed> ;
    ns1:name "Luc Verelst" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356419/New_Rhein_Healthcare> a org:Organization ;
    ns1:basedInLowRaw "Switzerland" ;
    ns1:description "healthcare" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "New Rhein Healthcare" ;
    ns1:industry "Healthcare" ;
    ns1:investor <https://1145.am/db/2356419/Series_D_Investment_Biocartis_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Philips_Johnson___Johnson_Development_Corporation_Rmm_(rudi_MariÃ«n)_Valiance_Debiopharm_Groupâ„¢_Completed> ;
    ns1:name "New Rhein Healthcare" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/New_Rhein_Healthcare>,
        <https://1145.am/db/2339425/New_Rhein_Healthcare> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356419/PMV> a org:Organization ;
    ns1:basedInLowRaw "Flemish" ;
    ns1:description "investment" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "PMV" ;
    ns1:investor <https://1145.am/db/2356419/Series_D_Investment_Biocartis_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Philips_Johnson___Johnson_Development_Corporation_Rmm_(rudi_MariÃ«n)_Valiance_Debiopharm_Groupâ„¢_Completed> ;
    ns1:name "PMV" ;
    ns1:sameAsHigh <https://1145.am/db/1549508/PMV> ;
    ns1:sameAsMedium <https://1145.am/db/1297146/PMV>,
        <https://1145.am/db/1545620/PMV>,
        <https://1145.am/db/1546297/PMV>,
        <https://1145.am/db/2301464/PMV>,
        <https://1145.am/db/2339419/PMV>,
        <https://1145.am/db/2339425/PMV>,
        <https://1145.am/db/2346397/PMV>,
        <https://1145.am/db/2370680/PMV>,
        <https://1145.am/db/2370764/PMV>,
        <https://1145.am/db/2370786/PMV>,
        <https://1145.am/db/938290/PMV> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356419/Philips_Johnson___Johnson_Development_Corporation> a org:Organization ;
    ns1:basedInLowRaw "Flemish" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "JJDC",
        "Philips, Johnson & Johnson Development Corporation",
        "Philips, Johnson & Johnson Development Corporation (JJDC)" ;
    ns1:investor <https://1145.am/db/2356419/Series_D_Investment_Biocartis_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Philips_Johnson___Johnson_Development_Corporation_Rmm_(rudi_MariÃ«n)_Valiance_Debiopharm_Groupâ„¢_Completed> ;
    ns1:name "Johnson & Johnson Development Corporation",
        "Philips, Johnson & Johnson Development Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/2339419/Philips_Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2339425/Philips_Johnson___Johnson_Development_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356419/Rmm_(rudi_MariÃ«n)> a org:Organization ;
    ns1:basedInLowRaw "Flemish" ;
    ns1:description "investment" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "RMM (Rudi MariÃ«n)" ;
    ns1:investor <https://1145.am/db/2356419/Series_D_Investment_Biocartis_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Philips_Johnson___Johnson_Development_Corporation_Rmm_(rudi_MariÃ«n)_Valiance_Debiopharm_Groupâ„¢_Completed> ;
    ns1:name "RMM (Rudi MariÃ«n)" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356419/Rudi_Pauwels> a org:Organization ;
    ns1:basedInLowRaw "Belgium" ;
    ns1:description "Biocartis" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "Benaruca" ;
    ns1:industry "life sciences" ;
    ns1:investor <https://1145.am/db/2356419/Series_D_Investment_Biocartis_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Philips_Johnson___Johnson_Development_Corporation_Rmm_(rudi_MariÃ«n)_Valiance_Debiopharm_Groupâ„¢_Completed> ;
    ns1:name "Rudi Pauwels" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356419/Valiance_Debiopharm_Groupâ„¢> a org:Organization ;
    ns1:basedInLowRaw "Flemish" ;
    ns1:description "Investing",
        "pharmaceuticals" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "Debiopharm Groupâ„¢",
        "Valiance",
        "Valiance, Debiopharm Groupâ„¢" ;
    ns1:investor <https://1145.am/db/2356419/Series_D_Investment_Biocartis_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Philips_Johnson___Johnson_Development_Corporation_Rmm_(rudi_MariÃ«n)_Valiance_Debiopharm_Groupâ„¢_Completed> ;
    ns1:name "Debiopharm Group",
        "Valiance",
        "Valiance, Debiopharm Groupâ„¢" ;
    ns1:sameAsHigh <https://1145.am/db/2295330/Debiopharm>,
        <https://1145.am/db/2323185/Debiopharm_Group>,
        <https://1145.am/db/2339419/Debiopharm_Group>,
        <https://1145.am/db/2339425/Debiopharm_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356420/Henry_Crown_And_Company> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "private equity financing" ;
    ns1:documentDate "2012-12-13T05:00:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerapedics Secures $19 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerapedics-secures-19-million-series-c-financing> ;
    ns1:foundName "Henry Crown and Company" ;
    ns1:name "Henry Crown and Company" ;
    ns1:participant <https://1145.am/db/2356420/Equity_Private_Equity_Investment_Cvf_Llc_Cerapedics_Inc_Henry_Crown_And_Company_Medimmune_Ventures_Ngn_Capital_Orbimed_Advisors_Completed> ;
    ns1:sameAsHigh <https://1145.am/db/1109007/Crown_Capital_Investments>,
        <https://1145.am/db/1238569/Henry_Crown_And_Company>,
        <https://1145.am/db/1238666/Henry_Crown_And_Company>,
        <https://1145.am/db/1534984/Crown_Capital_Investments>,
        <https://1145.am/db/2606403/Crown_Castle> ;
    ns1:sameAsMedium <https://1145.am/db/129908/Henry_Crown_And_Company>,
        <https://1145.am/db/1741884/Henry_Crown_And_Company>,
        <https://1145.am/db/1763414/Henry_Crown_And_Company>,
        <https://1145.am/db/2348448/Henry_Crown_And_Company>,
        <https://1145.am/db/683167/Henry_Crown_And_Company> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356420/Ngn_Capital> a org:Organization ;
    ns1:basedInLowRaw "LLC" ;
    ns1:description "private equity financing" ;
    ns1:documentDate "2012-12-13T05:00:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerapedics Secures $19 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerapedics-secures-19-million-series-c-financing> ;
    ns1:foundName "NGN Capital" ;
    ns1:investor <https://1145.am/db/2356420/Equity_Private_Equity_Investment_Cvf_Llc_Cerapedics_Inc_Henry_Crown_And_Company_Medimmune_Ventures_Ngn_Capital_Orbimed_Advisors_Completed> ;
    ns1:name "NGN Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2311011/Ngn_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2309821/Ngn_Capital>,
        <https://1145.am/db/2314255/Ngn_Capital>,
        <https://1145.am/db/2316674/Ngn_Capital>,
        <https://1145.am/db/2318905/Ngn_Capital>,
        <https://1145.am/db/2319822/Ngn_Capital_Llc>,
        <https://1145.am/db/2323303/Ngn_Capital>,
        <https://1145.am/db/2326551/Ngn_Capital>,
        <https://1145.am/db/2327406/Ngn_Capital>,
        <https://1145.am/db/2358268/Ngn_Capital>,
        <https://1145.am/db/2358269/Ngn_Capital>,
        <https://1145.am/db/2369872/Ngn_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356861/International_Biotechnology_Trust> a org:Organization ;
    ns1:basedInLowRaw "England" ;
    ns1:documentDate "2012-09-06T15:44:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karus-therapeutics-secures-series-b-financing-from-a-syndicate-of-leading-vc-investors-0> ;
    ns1:foundName "International Biotechnology Trust" ;
    ns1:investor <https://1145.am/db/2356861/Series_B_Investment_Ip_Group_International_Biotechnology_Trust_Karus_Therapeutics_New_Leaf_Ventures_Novo_A_S_Sv_Life_Sciences_Completed> ;
    ns1:name "International Biotechnology Trust" ;
    ns1:sameAsMedium <https://1145.am/db/2356876/International_Biotechnology_Trust> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356861/Ip_Group> a org:Organization ;
    ns1:basedInLowRaw "England" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-09-06T15:44:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karus-therapeutics-secures-series-b-financing-from-a-syndicate-of-leading-vc-investors-0> ;
    ns1:foundName "IP Group" ;
    ns1:investor <https://1145.am/db/2356861/Series_B_Investment_Ip_Group_International_Biotechnology_Trust_Karus_Therapeutics_New_Leaf_Ventures_Novo_A_S_Sv_Life_Sciences_Completed> ;
    ns1:name "IP Group" ;
    ns1:sameAsHigh <https://1145.am/db/2356876/Ip_Group> ;
    ns1:sameAsMedium <https://1145.am/db/1050773/Ip_Group>,
        <https://1145.am/db/1052134/Ip_Group>,
        <https://1145.am/db/1326655/Ip_Group_Inc>,
        <https://1145.am/db/1326957/Ip_Group_Inc>,
        <https://1145.am/db/1520407/Ip_Group>,
        <https://1145.am/db/1743462/Ip_Group>,
        <https://1145.am/db/1743749/Ip_Group_Plc>,
        <https://1145.am/db/1805749/Ip_Group>,
        <https://1145.am/db/1951986/Ip_Group>,
        <https://1145.am/db/2002735/Ip_Group>,
        <https://1145.am/db/2297062/Ip_Group>,
        <https://1145.am/db/2311597/Ip_Group>,
        <https://1145.am/db/2318529/Ip_Group>,
        <https://1145.am/db/2356920/Ip_Group_Plc>,
        <https://1145.am/db/2367043/Ip_Group>,
        <https://1145.am/db/2367681/Ip_Group>,
        <https://1145.am/db/323567/Ip_Group>,
        <https://1145.am/db/881549/Ip_Group>,
        <https://1145.am/db/907465/Ip_Group_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356861/New_Leaf_Ventures> a org:Organization ;
    ns1:basedInLowRaw "England" ;
    ns1:documentDate "2012-09-06T15:44:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karus-therapeutics-secures-series-b-financing-from-a-syndicate-of-leading-vc-investors-0> ;
    ns1:foundName "New Leaf Ventures" ;
    ns1:investor <https://1145.am/db/2356861/Series_B_Investment_Ip_Group_International_Biotechnology_Trust_Karus_Therapeutics_New_Leaf_Ventures_Novo_A_S_Sv_Life_Sciences_Completed> ;
    ns1:name "New Leaf Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1389956/New_Leaf_Ventures_Inc>,
        <https://1145.am/db/1594031/New_Leaf_Ventures_Inc>,
        <https://1145.am/db/1640525/New_Leaf_Ventures_Inc>,
        <https://1145.am/db/2089412/New_Leaf_Ventures>,
        <https://1145.am/db/2191533/New_Leaf_Ventures>,
        <https://1145.am/db/2303581/New_Leaf_Ventures>,
        <https://1145.am/db/2306754/New_Leaf_Ventures>,
        <https://1145.am/db/2356876/New_Leaf_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356861/Novo_A_S> a org:Organization ;
    ns1:basedInLowRaw "England" ;
    ns1:documentDate "2012-09-06T15:44:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karus-therapeutics-secures-series-b-financing-from-a-syndicate-of-leading-vc-investors-0> ;
    ns1:foundName "Novo A/S" ;
    ns1:investor <https://1145.am/db/2356861/Series_B_Investment_Ip_Group_International_Biotechnology_Trust_Karus_Therapeutics_New_Leaf_Ventures_Novo_A_S_Sv_Life_Sciences_Completed> ;
    ns1:name "Novo A/S" ;
    ns1:sameAsMedium <https://1145.am/db/1753148/Novo>,
        <https://1145.am/db/1754034/Novo>,
        <https://1145.am/db/2288016/Novo_A_S>,
        <https://1145.am/db/2296606/Novo_A_S>,
        <https://1145.am/db/2298077/Novo_A_S>,
        <https://1145.am/db/2298277/Novo_A_S>,
        <https://1145.am/db/2299423/Novo_As>,
        <https://1145.am/db/2299645/Novo>,
        <https://1145.am/db/2300653/Novo_A_S>,
        <https://1145.am/db/2301290/Novo>,
        <https://1145.am/db/2301494/Novo_A_S>,
        <https://1145.am/db/2302994/Novo_A_S>,
        <https://1145.am/db/2302995/Novo_A_S>,
        <https://1145.am/db/2303767/Novo_A_S>,
        <https://1145.am/db/2304335/Novo_A_S>,
        <https://1145.am/db/2304340/Novo_A_S>,
        <https://1145.am/db/2308758/Novo_A_S>,
        <https://1145.am/db/2309506/Novo_A_S>,
        <https://1145.am/db/2309507/Novo_A_S>,
        <https://1145.am/db/2311133/Novo_A_S>,
        <https://1145.am/db/2311274/Novo>,
        <https://1145.am/db/2312120/Novo_A_S>,
        <https://1145.am/db/2314546/Novo_A_S>,
        <https://1145.am/db/2318733/Novo_A_S>,
        <https://1145.am/db/2319236/Novo_A_S>,
        <https://1145.am/db/2319416/Novo_A_S>,
        <https://1145.am/db/2319433/Novo_A_S>,
        <https://1145.am/db/2319784/Novo_A_S>,
        <https://1145.am/db/2321216/Novo_A_S>,
        <https://1145.am/db/2321861/Novo_A_S>,
        <https://1145.am/db/2321870/Novo_A_S>,
        <https://1145.am/db/2325116/Novo_A_S>,
        <https://1145.am/db/2329010/Novo_A_S>,
        <https://1145.am/db/2329011/Novo_A_S>,
        <https://1145.am/db/2329224/Novo_A_S>,
        <https://1145.am/db/2335700/Novo_A_S>,
        <https://1145.am/db/2338817/Novo_A_S>,
        <https://1145.am/db/2339692/Novo_A_S>,
        <https://1145.am/db/2340612/Novo_A_S>,
        <https://1145.am/db/2341934/Novo>,
        <https://1145.am/db/2342284/Novo_A_S>,
        <https://1145.am/db/2345268/Novo_A_S>,
        <https://1145.am/db/2345273/Novo_A_S>,
        <https://1145.am/db/2346452/Novo_A_S>,
        <https://1145.am/db/2349013/Novo_A_S>,
        <https://1145.am/db/2349048/Novo_A_S>,
        <https://1145.am/db/2349050/Novo_A_S>,
        <https://1145.am/db/2349406/Novo_A_S>,
        <https://1145.am/db/2353241/Novo_A_S>,
        <https://1145.am/db/2355183/Novo_A_S>,
        <https://1145.am/db/2356876/Novo_A_S>,
        <https://1145.am/db/2357109/Novo_A_S>,
        <https://1145.am/db/2358233/Novo_A_S>,
        <https://1145.am/db/2358246/Novo_As>,
        <https://1145.am/db/2358271/Novo_A_S>,
        <https://1145.am/db/2358272/Novo_A_S>,
        <https://1145.am/db/2358459/Novo>,
        <https://1145.am/db/2358464/Novo_A_S>,
        <https://1145.am/db/2358542/Novo_A_S>,
        <https://1145.am/db/2359510/Novo_A_S>,
        <https://1145.am/db/2359683/Novo_A_S>,
        <https://1145.am/db/2360562/Novo>,
        <https://1145.am/db/2361588/Novo_A_S>,
        <https://1145.am/db/2363535/Novo_A_S>,
        <https://1145.am/db/2364505/Novo_A_S>,
        <https://1145.am/db/2364508/Novo_A_S>,
        <https://1145.am/db/2365700/Novo_A_S>,
        <https://1145.am/db/2365701/Novo_A_S>,
        <https://1145.am/db/2366187/Novo_A_S>,
        <https://1145.am/db/2366333/Novo_A_S>,
        <https://1145.am/db/2367275/Novo_A_S>,
        <https://1145.am/db/2367364/Novo_A_S>,
        <https://1145.am/db/2367368/Novo_A_S>,
        <https://1145.am/db/2368297/Novo_A_S>,
        <https://1145.am/db/2368333/Novo_A_S>,
        <https://1145.am/db/2368572/Novo_A_S>,
        <https://1145.am/db/2543793/Novo>,
        <https://1145.am/db/2544115/Novo>,
        <https://1145.am/db/2552947/Novo>,
        <https://1145.am/db/2557027/Novo>,
        <https://1145.am/db/2581901/Novo_A_S>,
        <https://1145.am/db/2581902/Novo_A_S>,
        <https://1145.am/db/2584056/Novo_A_S>,
        <https://1145.am/db/360351/Novo>,
        <https://1145.am/db/751135/Novo> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356861/Sv_Life_Sciences> a org:Organization ;
    ns1:basedInLowRaw "England" ;
    ns1:documentDate "2012-09-06T15:44:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karus-therapeutics-secures-series-b-financing-from-a-syndicate-of-leading-vc-investors-0> ;
    ns1:foundName "SV Life Sciences" ;
    ns1:investor <https://1145.am/db/2356861/Series_B_Investment_Ip_Group_International_Biotechnology_Trust_Karus_Therapeutics_New_Leaf_Ventures_Novo_A_S_Sv_Life_Sciences_Completed> ;
    ns1:name "SV Life Sciences" ;
    ns1:sameAsMedium <https://1145.am/db/2236188/Sv_Life_Sciences>,
        <https://1145.am/db/2246177/Sv_Life_Sciences>,
        <https://1145.am/db/2293662/Sv_Life_Sciences>,
        <https://1145.am/db/2293765/Sv_Life_Sciences>,
        <https://1145.am/db/2297439/Sv_Life_Sciences>,
        <https://1145.am/db/2297604/Sv_Life_Sciences>,
        <https://1145.am/db/2298869/Sv_Life_Sciences>,
        <https://1145.am/db/2300322/Sv_Life_Sciences>,
        <https://1145.am/db/2302994/Sv_Life_Sciences>,
        <https://1145.am/db/2302995/Sv_Life_Sciences>,
        <https://1145.am/db/2305587/Sv_Life_Sciences>,
        <https://1145.am/db/2310485/Sv_Life_Sciences>,
        <https://1145.am/db/2311540/Sv_Life_Sciences>,
        <https://1145.am/db/2312831/Sv_Life_Sciences>,
        <https://1145.am/db/2312833/Sv_Life_Sciences>,
        <https://1145.am/db/2313287/Sv_Life_Sciences>,
        <https://1145.am/db/2313322/Sv_Life_Sciences>,
        <https://1145.am/db/2313438/Sv_Life_Sciences>,
        <https://1145.am/db/2314515/Sv_Life_Sciences>,
        <https://1145.am/db/2314625/Sv_Life_Sciences>,
        <https://1145.am/db/2316038/Sv_Life_Sciences>,
        <https://1145.am/db/2317635/Sv_Life_Sciences>,
        <https://1145.am/db/2319338/Sv_Life_Sciences>,
        <https://1145.am/db/2321713/Sv_Life_Sciences>,
        <https://1145.am/db/2321861/Sv_Life_Sciences>,
        <https://1145.am/db/2321870/Sv_Life_Sciences>,
        <https://1145.am/db/2327405/Sv_Life_Sciences>,
        <https://1145.am/db/2327677/Sv_Life_Sciences>,
        <https://1145.am/db/2328815/Sv_Life_Sciences>,
        <https://1145.am/db/2329550/Sv_Life_Sciences>,
        <https://1145.am/db/2336313/Sv_Life_Sciences>,
        <https://1145.am/db/2336890/Sv_Life_Sciences>,
        <https://1145.am/db/2337166/Sv_Life_Sciences>,
        <https://1145.am/db/2338193/Sv_Life_Sciences>,
        <https://1145.am/db/2338196/Sv_Life_Sciences>,
        <https://1145.am/db/2339295/Sv_Life_Sciences>,
        <https://1145.am/db/2342260/Sv_Life_Sciences>,
        <https://1145.am/db/2342261/Sv_Life_Sciences>,
        <https://1145.am/db/2342266/Sv_Life_Sciences>,
        <https://1145.am/db/2342284/Sv_Life_Sciences>,
        <https://1145.am/db/2342445/Sv_Life_Sciences>,
        <https://1145.am/db/2342862/Sv_Life_Sciences>,
        <https://1145.am/db/2343467/Sv_Life_Sciences>,
        <https://1145.am/db/2343722/Sv_Life_Sciences>,
        <https://1145.am/db/2343725/Sv_Life_Sciences>,
        <https://1145.am/db/2343737/Sv_Life_Sciences>,
        <https://1145.am/db/2346832/Sv_Life_Sciences>,
        <https://1145.am/db/2347389/Sv_Life_Sciences>,
        <https://1145.am/db/2349406/Sv_Life_Sciences>,
        <https://1145.am/db/2349426/Sv_Life_Sciences>,
        <https://1145.am/db/2350034/Sv_Life_Sciences>,
        <https://1145.am/db/2350720/Sv_Life_Sciences>,
        <https://1145.am/db/2351394/Sv_Life_Sciences>,
        <https://1145.am/db/2351397/Sv_Life_Sciences>,
        <https://1145.am/db/2352382/Sv_Life_Sciences>,
        <https://1145.am/db/2352383/Sv_Life_Sciences>,
        <https://1145.am/db/2353098/Sv_Life_Sciences>,
        <https://1145.am/db/2353439/Sv_Life_Sciences>,
        <https://1145.am/db/2355586/Sv_Life_Sciences>,
        <https://1145.am/db/2356876/Sv_Life_Sciences>,
        <https://1145.am/db/2358271/Sv_Life_Sciences>,
        <https://1145.am/db/2358272/Sv_Life_Sciences>,
        <https://1145.am/db/2359125/Sv_Life_Sciences>,
        <https://1145.am/db/2360756/Sv_Life_Sciences>,
        <https://1145.am/db/2360758/Sv_Life_Sciences>,
        <https://1145.am/db/2361065/Sv_Life_Sciences>,
        <https://1145.am/db/2365315/Sv_Life_Sciences>,
        <https://1145.am/db/2366519/Sv_Life_Sciences>,
        <https://1145.am/db/2366860/Sv_Life_Sciences>,
        <https://1145.am/db/2368251/Sv_Life_Sciences>,
        <https://1145.am/db/2368572/Sv_Life_Sciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Adams_Street_Partners> a org:Organization ;
    ns1:basedInLowRaw "Ill" ;
    ns1:description "private investors" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Adams Street Partners" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "Adams Street Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1296619/Hamilton_Lane>,
        <https://1145.am/db/1296889/Hamilton_Lane>,
        <https://1145.am/db/1304061/Hamilton_Lane>,
        <https://1145.am/db/1480201/Adams_Street_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1151052/Adams_Street_Partners>,
        <https://1145.am/db/1163164/Adams_Street_Partners>,
        <https://1145.am/db/1166225/Adams_Street_Partners>,
        <https://1145.am/db/1248471/Adams_Street_Partners>,
        <https://1145.am/db/1249040/Adams_Street_Partners>,
        <https://1145.am/db/1351661/Adams_Street_Partners>,
        <https://1145.am/db/1352625/Adams_Street_Partners>,
        <https://1145.am/db/1352945/Adams_Street_Partners>,
        <https://1145.am/db/1354185/Adams_Street_Partners>,
        <https://1145.am/db/1369238/Adams_Street_Partners>,
        <https://1145.am/db/1369876/Adams_Street_Partners>,
        <https://1145.am/db/1395257/Adams_Street_Partners>,
        <https://1145.am/db/1528582/Adams_Street_Partners>,
        <https://1145.am/db/1747870/Adams_Street_Partners>,
        <https://1145.am/db/1749294/Adams_Street_Partners>,
        <https://1145.am/db/1755127/Adams_Street_Partners>,
        <https://1145.am/db/1796380/Adams_Street_Partners>,
        <https://1145.am/db/1823041/Adams_Street_Partners>,
        <https://1145.am/db/1843607/Adams_Street_Partners>,
        <https://1145.am/db/1844474/Adams_Street_Partners>,
        <https://1145.am/db/1845463/Adams_Street_Partners>,
        <https://1145.am/db/1846040/Adams_Street_Partners>,
        <https://1145.am/db/1847894/Adams_Street_Partners>,
        <https://1145.am/db/1864601/Adams_Street_Partners>,
        <https://1145.am/db/1880209/Adams_Street_Partners>,
        <https://1145.am/db/1886915/Adams_Street_Partners>,
        <https://1145.am/db/1902164/Adams_Street_Partners>,
        <https://1145.am/db/1932511/Adams_Street_Partners>,
        <https://1145.am/db/2257512/Adams_Street_Partners>,
        <https://1145.am/db/2294721/Adams_Street_Partners>,
        <https://1145.am/db/2308828/Adams_Street_Partners>,
        <https://1145.am/db/2308841/Adams_Street_Partners>,
        <https://1145.am/db/2329550/Adams_Street_Partners>,
        <https://1145.am/db/2331820/Adams_Street_Partners>,
        <https://1145.am/db/2335743/Adams_Street_Partners>,
        <https://1145.am/db/2337166/Adams_Street_Partners>,
        <https://1145.am/db/2341068/Adams_Street_Partners>,
        <https://1145.am/db/2341074/Adams_Street_Partners>,
        <https://1145.am/db/2366519/Adams_Street_Partners>,
        <https://1145.am/db/2369359/Adams_Street_Partners>,
        <https://1145.am/db/2370694/Adams_Street_Partners>,
        <https://1145.am/db/396100/Adams_Street_Partners>,
        <https://1145.am/db/731028/Adams_Street_Partners>,
        <https://1145.am/db/936906/Adams_Street_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Druid_Bioventures> a org:Organization ;
    ns1:basedInHighGeoName "Evanston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4891382/about.rdf> ;
    ns1:basedInHighRaw "EVANSTON, Ill." ;
    ns1:description "investing" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Druid Bioventures" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "Druid Bioventures" ;
    ns1:sameAsMedium <https://1145.am/db/2341068/Druid_Bioventures>,
        <https://1145.am/db/2341074/Druid_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Genesys_Capital> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:description "private investors" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Genesys Capital" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "Genesys Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2351492/Genesys_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1422234/Genesys_Capital>,
        <https://1145.am/db/1422725/Genesys_Capital>,
        <https://1145.am/db/2301792/Genesys_Capital>,
        <https://1145.am/db/2341074/Genesys_Capital>,
        <https://1145.am/db/2556160/Genesys_Capital>,
        <https://1145.am/db/756048/Genesys_Capital>,
        <https://1145.am/db/756874/Genesys_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Latterell_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Ill" ;
    ns1:description "private investors" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Latterell Venture Partners" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "Latterell Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2308828/Latterell_Venture_Partners>,
        <https://1145.am/db/2308841/Latterell_Venture_Partners>,
        <https://1145.am/db/2319658/Latterell_Venture_Partners>,
        <https://1145.am/db/2319874/Latterell_Venture_Partners_Us_Venture_Partners>,
        <https://1145.am/db/2349717/Latterell_Venture_Partners>,
        <https://1145.am/db/2365171/Latterell_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2223193/Latterell_Venture_Partners>,
        <https://1145.am/db/2257512/Latterell_Venture_Partners>,
        <https://1145.am/db/2312120/Latterell_Venture_Partners>,
        <https://1145.am/db/2324226/Latterell_Venture_Partners>,
        <https://1145.am/db/2329531/Latterell_Venture_Partners>,
        <https://1145.am/db/2341068/Latterell_Venture_Partners>,
        <https://1145.am/db/2341074/Latterell_Venture_Partners>,
        <https://1145.am/db/2345568/Latterell_Venture_Partners>,
        <https://1145.am/db/2349722/Latterell_Venture_Partners>,
        <https://1145.am/db/2366693/Latterell_Venture_Partners>,
        <https://1145.am/db/2366700/Latterell_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Lundbeck_Takeda_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Ill",
        "Japan" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Lundbeck",
        "Lundbeck, Takeda Ventures",
        "Takeda Ventures" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "Lundbeck",
        "Lundbeck, Takeda Ventures",
        "Takeda Ventures" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Northwestern_University> a org:Organization ;
    ns1:basedInHighGeoName "Evanston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4891382/about.rdf> ;
    ns1:basedInHighRaw "EVANSTON, Ill." ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Northwestern University" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "Northwestern University" ;
    ns1:sameAsMedium <https://1145.am/db/1199516/Northwestern_University>,
        <https://1145.am/db/2368723/Northwestern_University>,
        <https://1145.am/db/2572524/Northwestern_University>,
        <https://1145.am/db/493296/Northwestern_University>,
        <https://1145.am/db/543841/Northwestern_University>,
        <https://1145.am/db/718563/Northwestern_University> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Pathocapital> a org:Organization ;
    ns1:basedInLowRaw "Ill" ;
    ns1:description "private investors" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "PathoCapital" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "PathoCapital" ;
    ns1:sameAsMedium <https://1145.am/db/2341074/Pathocapital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Shire> a org:Organization ;
    ns1:basedInLowRaw "Ill" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Shire" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "Shire" ;
    ns1:sameAsMedium <https://1145.am/db/142937/Shire_Plc>,
        <https://1145.am/db/2155273/Shire>,
        <https://1145.am/db/2225348/Shire_Plc>,
        <https://1145.am/db/2225352/Shire_Plc>,
        <https://1145.am/db/2288537/Shire>,
        <https://1145.am/db/2290932/Shire>,
        <https://1145.am/db/2291354/Shire>,
        <https://1145.am/db/2292991/Shire>,
        <https://1145.am/db/2293472/Shire>,
        <https://1145.am/db/2296208/Shire>,
        <https://1145.am/db/2296243/Shire>,
        <https://1145.am/db/2297066/Shire>,
        <https://1145.am/db/2298391/Shire>,
        <https://1145.am/db/2300483/Shire>,
        <https://1145.am/db/2302783/Shire_Limited>,
        <https://1145.am/db/2303789/Shire>,
        <https://1145.am/db/2305581/Shire_Plc>,
        <https://1145.am/db/2306762/Shire>,
        <https://1145.am/db/2310002/Shire>,
        <https://1145.am/db/2314408/Shire_Limited>,
        <https://1145.am/db/2320137/Shire>,
        <https://1145.am/db/2320509/Shire>,
        <https://1145.am/db/2324621/Shire_Plc>,
        <https://1145.am/db/2326381/Shire_Plc>,
        <https://1145.am/db/2328189/Shire>,
        <https://1145.am/db/2328788/Shire_Plc>,
        <https://1145.am/db/2331795/Shire_Plc>,
        <https://1145.am/db/2332620/Shire>,
        <https://1145.am/db/2333419/Shire>,
        <https://1145.am/db/2335641/Shire>,
        <https://1145.am/db/2336126/Shire_Plc>,
        <https://1145.am/db/2336575/Shire>,
        <https://1145.am/db/2336581/Shire>,
        <https://1145.am/db/2336708/Shire>,
        <https://1145.am/db/2338009/Shire>,
        <https://1145.am/db/2338011/Shire>,
        <https://1145.am/db/2339117/Shire>,
        <https://1145.am/db/2339733/Shire_Plc>,
        <https://1145.am/db/2340560/Shire>,
        <https://1145.am/db/2340566/Shire_Plc>,
        <https://1145.am/db/2340575/Shire>,
        <https://1145.am/db/2341068/Shire>,
        <https://1145.am/db/2341074/Shire>,
        <https://1145.am/db/2341522/Shire>,
        <https://1145.am/db/2341828/Shire_Plc>,
        <https://1145.am/db/2341829/Shire>,
        <https://1145.am/db/2341838/Shire>,
        <https://1145.am/db/2341902/Shire>,
        <https://1145.am/db/2342514/Shire>,
        <https://1145.am/db/2342570/Shire>,
        <https://1145.am/db/2344160/Shire>,
        <https://1145.am/db/2344202/Shire>,
        <https://1145.am/db/2344205/Shire>,
        <https://1145.am/db/2344913/Shire>,
        <https://1145.am/db/2344914/Shire_Plc>,
        <https://1145.am/db/2344928/Shire_Plc>,
        <https://1145.am/db/2345096/Shire>,
        <https://1145.am/db/2345238/Shire>,
        <https://1145.am/db/2345248/Shire_Plc>,
        <https://1145.am/db/2345825/Shire_Plc>,
        <https://1145.am/db/2345826/Shire_Plc>,
        <https://1145.am/db/2346202/Shire>,
        <https://1145.am/db/2346640/Shire>,
        <https://1145.am/db/2346644/Shire_Plc>,
        <https://1145.am/db/2346646/Shire_Plc>,
        <https://1145.am/db/2346752/Shire_Plc>,
        <https://1145.am/db/2346863/Shire_Plc>,
        <https://1145.am/db/2346872/Shire_Plc>,
        <https://1145.am/db/2346879/Shire>,
        <https://1145.am/db/2347646/Shire_Plc>,
        <https://1145.am/db/2347772/Shire>,
        <https://1145.am/db/2348523/Shire>,
        <https://1145.am/db/2348661/Shire>,
        <https://1145.am/db/2348742/Shire>,
        <https://1145.am/db/2348750/Shire>,
        <https://1145.am/db/2348805/Shire>,
        <https://1145.am/db/2350265/Shire_Plc>,
        <https://1145.am/db/2351482/Shire>,
        <https://1145.am/db/2351483/Shire>,
        <https://1145.am/db/2351734/Shire_Llc>,
        <https://1145.am/db/2351737/Shire_Llc>,
        <https://1145.am/db/2351754/Shire>,
        <https://1145.am/db/2352906/Shire>,
        <https://1145.am/db/2353283/Shire_Plc>,
        <https://1145.am/db/2354266/Shire_Llc>,
        <https://1145.am/db/2354277/Shire>,
        <https://1145.am/db/2356384/Shire>,
        <https://1145.am/db/2357032/Shire>,
        <https://1145.am/db/2357116/Shire>,
        <https://1145.am/db/2359634/Shire>,
        <https://1145.am/db/2359681/Shire>,
        <https://1145.am/db/2360712/Shire_Plc>,
        <https://1145.am/db/2361514/Shire_Plc>,
        <https://1145.am/db/2361640/Shire_Plc>,
        <https://1145.am/db/2361641/Shire>,
        <https://1145.am/db/2362744/Shire>,
        <https://1145.am/db/2364136/Shire_Plc>,
        <https://1145.am/db/2364149/Shire_Plc>,
        <https://1145.am/db/2364556/Shire>,
        <https://1145.am/db/2364813/Shire>,
        <https://1145.am/db/2365002/Shire_Plc>,
        <https://1145.am/db/2365826/Shire_Plc>,
        <https://1145.am/db/2366303/Shire>,
        <https://1145.am/db/2367132/Shire_Plc>,
        <https://1145.am/db/2367297/Shire>,
        <https://1145.am/db/2368144/Shire>,
        <https://1145.am/db/2368862/Shire>,
        <https://1145.am/db/2368885/Shire>,
        <https://1145.am/db/2368915/Shire>,
        <https://1145.am/db/2368936/Shire>,
        <https://1145.am/db/2369141/Shire>,
        <https://1145.am/db/2369701/Shire>,
        <https://1145.am/db/2369949/Shire>,
        <https://1145.am/db/2370010/Shire>,
        <https://1145.am/db/2370189/Shire>,
        <https://1145.am/db/2370358/Shire>,
        <https://1145.am/db/2370514/Shire>,
        <https://1145.am/db/2370740/Shire>,
        <https://1145.am/db/2371519/Shire>,
        <https://1145.am/db/2371522/Shire>,
        <https://1145.am/db/2537396/Shire>,
        <https://1145.am/db/2539292/Shire>,
        <https://1145.am/db/2541146/Shire>,
        <https://1145.am/db/2544223/Shire>,
        <https://1145.am/db/2544434/Shire>,
        <https://1145.am/db/2544459/Shire>,
        <https://1145.am/db/2544726/Shire>,
        <https://1145.am/db/2546262/Shire>,
        <https://1145.am/db/2546291/Shire>,
        <https://1145.am/db/2547036/Shire>,
        <https://1145.am/db/2547277/Shire>,
        <https://1145.am/db/2547575/Shire_Plc>,
        <https://1145.am/db/2548051/Shire>,
        <https://1145.am/db/2548805/Shire>,
        <https://1145.am/db/2548859/Shire>,
        <https://1145.am/db/2548979/Shire>,
        <https://1145.am/db/2550985/Shire>,
        <https://1145.am/db/2552180/Shire>,
        <https://1145.am/db/2552455/Shire>,
        <https://1145.am/db/2554269/Shire>,
        <https://1145.am/db/2554294/Shire>,
        <https://1145.am/db/2556988/Shire>,
        <https://1145.am/db/2558927/Shire>,
        <https://1145.am/db/2559769/Shire>,
        <https://1145.am/db/2561541/Shire>,
        <https://1145.am/db/2563175/Shire>,
        <https://1145.am/db/2564899/Shire>,
        <https://1145.am/db/2565613/Shire>,
        <https://1145.am/db/2566716/Shire>,
        <https://1145.am/db/2569388/Shire>,
        <https://1145.am/db/2569952/Shire>,
        <https://1145.am/db/2570020/Shire>,
        <https://1145.am/db/2570036/Shire>,
        <https://1145.am/db/2570363/Shire>,
        <https://1145.am/db/2570733/Shire_Plc>,
        <https://1145.am/db/2570807/Shire>,
        <https://1145.am/db/2571521/Shire>,
        <https://1145.am/db/2571526/Shire>,
        <https://1145.am/db/2572113/Shire_Plc>,
        <https://1145.am/db/2572335/Shire>,
        <https://1145.am/db/2572559/Shire>,
        <https://1145.am/db/2573463/Shire>,
        <https://1145.am/db/2573508/Shire>,
        <https://1145.am/db/2574443/Shire>,
        <https://1145.am/db/2574731/Shire>,
        <https://1145.am/db/2575050/Shire>,
        <https://1145.am/db/2575259/Shire>,
        <https://1145.am/db/2576815/Shire>,
        <https://1145.am/db/2576959/Shire>,
        <https://1145.am/db/2577114/Shire>,
        <https://1145.am/db/2577117/Shire>,
        <https://1145.am/db/2577176/Shire_Plc>,
        <https://1145.am/db/2577652/Shire_Plc>,
        <https://1145.am/db/2577793/Shire_Plc>,
        <https://1145.am/db/2578085/Shire_Plc>,
        <https://1145.am/db/2578319/Shire>,
        <https://1145.am/db/2578503/Shire>,
        <https://1145.am/db/2578568/Shire>,
        <https://1145.am/db/2579035/Shire_Plc>,
        <https://1145.am/db/2579062/Shire_Plc>,
        <https://1145.am/db/2580279/Shire>,
        <https://1145.am/db/2580603/Shire>,
        <https://1145.am/db/2580620/Shire>,
        <https://1145.am/db/2580622/Shire>,
        <https://1145.am/db/2580747/Shire>,
        <https://1145.am/db/2581261/Shire>,
        <https://1145.am/db/2582265/Shire>,
        <https://1145.am/db/2583177/Shire>,
        <https://1145.am/db/2583624/Shire_Plc>,
        <https://1145.am/db/2583662/Shire>,
        <https://1145.am/db/2584216/Shire>,
        <https://1145.am/db/2585066/Shire>,
        <https://1145.am/db/2585132/Shire>,
        <https://1145.am/db/2586132/Shire>,
        <https://1145.am/db/2586884/Shire>,
        <https://1145.am/db/2586889/Shire>,
        <https://1145.am/db/2587094/Shire>,
        <https://1145.am/db/2587511/Shire>,
        <https://1145.am/db/2588152/Shire>,
        <https://1145.am/db/2589981/Shire_Plc>,
        <https://1145.am/db/2591412/Shire>,
        <https://1145.am/db/2592333/Shire>,
        <https://1145.am/db/2592336/Shire>,
        <https://1145.am/db/2592562/Shire>,
        <https://1145.am/db/2595190/Shire>,
        <https://1145.am/db/2595210/Shire>,
        <https://1145.am/db/2597158/Shire>,
        <https://1145.am/db/2598205/Shire>,
        <https://1145.am/db/2976/Shire> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357905/Partners_Innovation_Fund> a org:Organization ;
    ns1:basedInLowRaw "Massachusetts" ;
    ns1:description "Investing in new companies" ;
    ns1:documentDate "2012-09-10T12:03:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Annovation Biopharma, Inc. Raises $8M to Develop Novel Anesthetics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/annovation-biopharma-inc-raises-8m-to-develop-novel-anesthetics-0> ;
    ns1:foundName "Partners Innovation Fund" ;
    ns1:investor <https://1145.am/db/2357905/Series_A_Investment_Annovation_Biopharma_Atlas_Venture_Partners_Innovation_Fund_The_Medicines_Company_Completed> ;
    ns1:name "Partners Innovation Fund" ;
    ns1:sameAsHigh <https://1145.am/db/1835811/Innovation_Works_Development_Fund>,
        <https://1145.am/db/2367541/Partners_Innovation_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2335531/Partners_Innovation_Fund>,
        <https://1145.am/db/2358860/Partners_Innovation_Fund>,
        <https://1145.am/db/2363396/Partners_Innovation_Fund>,
        <https://1145.am/db/2573068/Partners_Innovation_Fund>,
        <https://1145.am/db/471253/Partners_Innovation_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358502/Roche_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-12-17T17:21:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Allakos Inc. Completes Series A Financing of $32 Million to Develop Antibody Therapeutics for Allergic and Inflammatory Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allakos-inc-completes-series-a-financing-of-32-million-to-develop-antibody-therapeutics-for> ;
    ns1:foundName "Roche Venture Fund" ;
    ns1:investor <https://1145.am/db/2358502/Series_A_Investment_Allakos_Inc_Alta_Partners_Novo_Ventures_Rivervest_Venture_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "Roche Venture Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2299180/Roche_($_Rhhby)_Venture_Fund>,
        <https://1145.am/db/2302731/Roche_Venture_Fund>,
        <https://1145.am/db/2306549/Roche_Venture_Fund>,
        <https://1145.am/db/2313985/Roche_Venture_Fund>,
        <https://1145.am/db/2317779/Roche_Venture_Fund>,
        <https://1145.am/db/2326222/Roche_Venture_Fund>,
        <https://1145.am/db/2327441/Roche_Venture_Fund>,
        <https://1145.am/db/2327442/Roche_Venture_Fund>,
        <https://1145.am/db/2330668/Roche_Venture_Fund>,
        <https://1145.am/db/2336328/Roche_Venture_Fund>,
        <https://1145.am/db/2336333/Roche_Venture_Fund>,
        <https://1145.am/db/2336335/Roche_Venture_Fund>,
        <https://1145.am/db/2337958/Roche_Venture_Fund>,
        <https://1145.am/db/2337974/Roche_Venture_Fund>,
        <https://1145.am/db/2343301/Roche_Venture_Fund>,
        <https://1145.am/db/2346534/Roche_Venture_Fund>,
        <https://1145.am/db/2349143/Roche_Venture_Fund>,
        <https://1145.am/db/2352203/Roche_Venture_Fund>,
        <https://1145.am/db/2352204/Roche_Venture_Fund>,
        <https://1145.am/db/2352216/Roche_Venture_Fund>,
        <https://1145.am/db/2352436/Roche_Venture_Fund>,
        <https://1145.am/db/2352442/Roche_Venture_Fund>,
        <https://1145.am/db/2355043/Roche_Venture_Fund>,
        <https://1145.am/db/2358496/Roche_Venture_Fund>,
        <https://1145.am/db/2362533/Roche_Venture_Fund>,
        <https://1145.am/db/2362715/Roche_Venture_Fund>,
        <https://1145.am/db/2363396/Roche_Venture_Fund>,
        <https://1145.am/db/2364249/Roche_Venture_Fund>,
        <https://1145.am/db/2364255/Roche_Venture_Fund>,
        <https://1145.am/db/2364283/Roche_Venture_Fund>,
        <https://1145.am/db/2365748/Roche_Venture_Fund>,
        <https://1145.am/db/2367549/Roche_Venture_Fund>,
        <https://1145.am/db/2370694/Roche_Venture_Fund>,
        <https://1145.am/db/2371169/Roche_Venture_Fund>,
        <https://1145.am/db/829447/Roche_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358541/Aurora_Funds> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:documentDate "2012-12-19T14:00:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Regado Biosciences, Inc. Secures $51 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/regado-biosciences-inc-secures-51-million-series-e-financing> ;
    ns1:foundName "Aurora Funds" ;
    ns1:investor <https://1145.am/db/2358541/Series_E_Investment_Aurora_Funds_Baxter_Ventures_Caxton_Advantage_Life_Sciences_Fund_Domain_Associates_Edmond_De_Rothschild_Investment_Partners_Quaker_Partners_Regado_Biosciences_Rusnanomedinvest_Completed> ;
    ns1:name "Aurora Funds" ;
    ns1:sameAsMedium <https://1145.am/db/2303641/Aurora_Funds>,
        <https://1145.am/db/2303642/Aurora_Funds>,
        <https://1145.am/db/2309809/Aurora_Funds>,
        <https://1145.am/db/2328655/Aurora_Funds>,
        <https://1145.am/db/2344356/Aurora_Funds>,
        <https://1145.am/db/2347977/Aurora_Funds>,
        <https://1145.am/db/2347983/Aurora_Funds>,
        <https://1145.am/db/2353522/Aurora_Funds>,
        <https://1145.am/db/2353525/Aurora_Funds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358541/Caxton_Advantage_Life_Sciences_Fund> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:documentDate "2012-12-19T14:00:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Regado Biosciences, Inc. Secures $51 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/regado-biosciences-inc-secures-51-million-series-e-financing> ;
    ns1:foundName "Caxton Advantage Life Sciences Fund" ;
    ns1:investor <https://1145.am/db/2358541/Series_E_Investment_Aurora_Funds_Baxter_Ventures_Caxton_Advantage_Life_Sciences_Fund_Domain_Associates_Edmond_De_Rothschild_Investment_Partners_Quaker_Partners_Regado_Biosciences_Rusnanomedinvest_Completed> ;
    ns1:name "Caxton Advantage Life Sciences Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2251983/Caxton_Advantage_Life_Sciences_Fund_Lp>,
        <https://1145.am/db/2303641/Caxton_Advantage_Life_Sciences_Fund>,
        <https://1145.am/db/2303642/Caxton_Advantage_Life_Sciences_Fund>,
        <https://1145.am/db/2305703/Caxton_Advantage_Life_Sciences_Fund>,
        <https://1145.am/db/2309809/Caxton_Advantage_Life_Sciences_Fund>,
        <https://1145.am/db/2314397/Caxton_Advantage_Life_Sciences_Fund>,
        <https://1145.am/db/2314400/Caxton_Advantage_Life_Sciences_Fund>,
        <https://1145.am/db/2331026/Caxton_Advantage_Life_Sciences_Fund>,
        <https://1145.am/db/2331047/Caxton_Advantage_Life_Sciences_Fund>,
        <https://1145.am/db/2343704/Caxton_Advantage_Life_Sciences_Fund_Lp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358541/Domain_Associates> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:documentDate "2012-12-19T14:00:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Regado Biosciences, Inc. Secures $51 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/regado-biosciences-inc-secures-51-million-series-e-financing> ;
    ns1:foundName "Domain Associates" ;
    ns1:investor <https://1145.am/db/2358541/Series_E_Investment_Aurora_Funds_Baxter_Ventures_Caxton_Advantage_Life_Sciences_Fund_Domain_Associates_Edmond_De_Rothschild_Investment_Partners_Quaker_Partners_Regado_Biosciences_Rusnanomedinvest_Completed> ;
    ns1:name "Domain Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1859331/Domain_Associates>,
        <https://1145.am/db/2153759/Domain_Associates>,
        <https://1145.am/db/2155032/Domain_Associates>,
        <https://1145.am/db/2155189/Domain_Associates>,
        <https://1145.am/db/2289515/Domain_Associates>,
        <https://1145.am/db/2289819/Domain_Associates>,
        <https://1145.am/db/2290405/Domain_Associates>,
        <https://1145.am/db/2294753/Domain_Associates>,
        <https://1145.am/db/2296841/Domain_Associates>,
        <https://1145.am/db/2297408/Domain_Associates>,
        <https://1145.am/db/2299776/Domain_Associates>,
        <https://1145.am/db/2300270/Domain_Associates>,
        <https://1145.am/db/2300293/Domain_Associates>,
        <https://1145.am/db/2300337/Domain_Associates>,
        <https://1145.am/db/2300455/Domain_Associates>,
        <https://1145.am/db/2302292/Domain_Associates_Llc>,
        <https://1145.am/db/2302508/Domain_Associates>,
        <https://1145.am/db/2303641/Domain_Associates>,
        <https://1145.am/db/2303642/Domain_Associates>,
        <https://1145.am/db/2303793/Domain_Associates>,
        <https://1145.am/db/2304578/Domain_Associates>,
        <https://1145.am/db/2304587/Domain_Associates>,
        <https://1145.am/db/2305524/Domain_Associates>,
        <https://1145.am/db/2305530/Domain_Associates>,
        <https://1145.am/db/2305706/Domain_Associates>,
        <https://1145.am/db/2305713/Domain_Associates>,
        <https://1145.am/db/2305729/Domain_Associates>,
        <https://1145.am/db/2306290/Domain_Associates_Llc>,
        <https://1145.am/db/2306873/Domain_Associates>,
        <https://1145.am/db/2307237/Domain_Associates>,
        <https://1145.am/db/2307644/Domain_Associates>,
        <https://1145.am/db/2309809/Domain_Associates>,
        <https://1145.am/db/2310073/Domain_Associates>,
        <https://1145.am/db/2311099/Domain_Associates>,
        <https://1145.am/db/2311221/Domain_Associates>,
        <https://1145.am/db/2312051/Domain_Associates>,
        <https://1145.am/db/2312120/Domain_Associates>,
        <https://1145.am/db/2312297/Domain_Associates>,
        <https://1145.am/db/2313171/Domain_Associates>,
        <https://1145.am/db/2316210/Domain_Associates>,
        <https://1145.am/db/2316214/Domain_Associates>,
        <https://1145.am/db/2317145/Domain_Associates>,
        <https://1145.am/db/2317951/Domain_Associates>,
        <https://1145.am/db/2318934/Domain_Associates>,
        <https://1145.am/db/2320925/Domain_Associates>,
        <https://1145.am/db/2322231/Domain_Associates>,
        <https://1145.am/db/2326423/Domain_Associates>,
        <https://1145.am/db/2326430/Domain_Associates_Llc>,
        <https://1145.am/db/2328030/Domain_Associates_Llc>,
        <https://1145.am/db/2328034/Domain_Associates_Llc>,
        <https://1145.am/db/2330075/Domain_Associates>,
        <https://1145.am/db/2330539/Domain_Associates>,
        <https://1145.am/db/2330549/Domain_Associates>,
        <https://1145.am/db/2331026/Domain_Associates>,
        <https://1145.am/db/2331047/Domain_Associates>,
        <https://1145.am/db/2331784/Domain_Associates>,
        <https://1145.am/db/2336221/Domain_Associates>,
        <https://1145.am/db/2340284/Domain_Associates>,
        <https://1145.am/db/2340634/Domain_Associates>,
        <https://1145.am/db/2341764/Domain_Associates>,
        <https://1145.am/db/2343206/Domain_Associates>,
        <https://1145.am/db/2344090/Domain_Associates>,
        <https://1145.am/db/2344092/Domain_Associates>,
        <https://1145.am/db/2344100/Domain_Associates>,
        <https://1145.am/db/2344782/Domain_Associates>,
        <https://1145.am/db/2347984/Domain_Associates>,
        <https://1145.am/db/2349143/Domain_Associates>,
        <https://1145.am/db/2349753/Domain_Associates>,
        <https://1145.am/db/2350044/Domain_Associates>,
        <https://1145.am/db/2352167/Domain_Associates>,
        <https://1145.am/db/2352170/Domain_Associates>,
        <https://1145.am/db/2352808/Domain_Associates>,
        <https://1145.am/db/2354899/Domain_Associates>,
        <https://1145.am/db/2354903/Domain_Associates>,
        <https://1145.am/db/2355936/Domain_Associates>,
        <https://1145.am/db/2355938/Domain_Associates>,
        <https://1145.am/db/2356301/Domain_Associates>,
        <https://1145.am/db/2357325/Domain_Associates>,
        <https://1145.am/db/2357981/Domain_Associates>,
        <https://1145.am/db/2358883/Domain_Associates>,
        <https://1145.am/db/2361625/Domain_Associates>,
        <https://1145.am/db/2362278/Domain_Associates>,
        <https://1145.am/db/2365700/Domain_Associates>,
        <https://1145.am/db/2366128/Domain_Associates>,
        <https://1145.am/db/2366133/Domain_Associates>,
        <https://1145.am/db/2366187/Domain_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358541/Edmond_De_Rothschild_Investment_Partners> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:documentDate "2012-12-19T14:00:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Regado Biosciences, Inc. Secures $51 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/regado-biosciences-inc-secures-51-million-series-e-financing> ;
    ns1:foundName "Edmond de Rothschild Investment Partners" ;
    ns1:investor <https://1145.am/db/2358541/Series_E_Investment_Aurora_Funds_Baxter_Ventures_Caxton_Advantage_Life_Sciences_Fund_Domain_Associates_Edmond_De_Rothschild_Investment_Partners_Quaker_Partners_Regado_Biosciences_Rusnanomedinvest_Completed> ;
    ns1:name "Edmond de Rothschild Investment Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2289591/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2297507/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2299423/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2301041/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2301096/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303210/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303641/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303642/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2303849/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2313401/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2313410/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2320503/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2325831/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2336923/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338023/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338193/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2338196/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2348331/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2350101/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2351191/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2351192/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2353607/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2353610/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2356567/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358268/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2358269/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2363938/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2363941/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2367201/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2368740/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369953/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369982/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2369999/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2555540/Edmond_De_Rothschild_Investment_Partners>,
        <https://1145.am/db/2701527/Edmond_De_Rothschild_Investment_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358541/Quaker_Partners> a org:Organization ;
    ns1:basedInLowRaw "US" ;
    ns1:documentDate "2012-12-19T14:00:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Regado Biosciences, Inc. Secures $51 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/regado-biosciences-inc-secures-51-million-series-e-financing> ;
    ns1:foundName "Quaker Partners" ;
    ns1:investor <https://1145.am/db/2358541/Series_E_Investment_Aurora_Funds_Baxter_Ventures_Caxton_Advantage_Life_Sciences_Fund_Domain_Associates_Edmond_De_Rothschild_Investment_Partners_Quaker_Partners_Regado_Biosciences_Rusnanomedinvest_Completed> ;
    ns1:name "Quaker Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2296696/Quaker_Partners>,
        <https://1145.am/db/2345273/Quaker_Partners>,
        <https://1145.am/db/2564563/Quaker_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358541/Rusnanomedinvest> a org:Organization ;
    ns1:basedInHighGeoName "Basking Ridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5095409/about.rdf> ;
    ns1:basedInHighRaw "Basking Ridge, NJ" ;
    ns1:description "Russian investment firm" ;
    ns1:documentDate "2012-12-19T14:00:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Regado Biosciences, Inc. Secures $51 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/regado-biosciences-inc-secures-51-million-series-e-financing> ;
    ns1:foundName "RusnanoMedInvest" ;
    ns1:investor <https://1145.am/db/2358541/Series_E_Investment_Aurora_Funds_Baxter_Ventures_Caxton_Advantage_Life_Sciences_Fund_Domain_Associates_Edmond_De_Rothschild_Investment_Partners_Quaker_Partners_Regado_Biosciences_Rusnanomedinvest_Completed> ;
    ns1:name "RusnanoMedInvest" ;
    ns1:sameAsMedium <https://1145.am/db/2297408/Rusnanomedinvest>,
        <https://1145.am/db/2336125/Rusnanomedinvest>,
        <https://1145.am/db/2339894/Rusnanomedinvest>,
        <https://1145.am/db/2347984/Rusnanomedinvest>,
        <https://1145.am/db/2356301/Rusnanomedinvest>,
        <https://1145.am/db/2357325/Rusnanomedinvest>,
        <https://1145.am/db/2360258/Rusnanomedinvest>,
        <https://1145.am/db/2361625/Rusnanomedinvest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359562/Adage_Capital_Partners> a org:Organization ;
    ns1:basedInLowRaw "NOVATO, Calif" ;
    ns1:documentDate "2012-12-20T11:39:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Raises $75 Million in Oversubscribed Crossover Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-raises-75-million-oversubscribed-crossover-financing> ;
    ns1:foundName "Adage Capital Partners, LP" ;
    ns1:investor <https://1145.am/db/2359562/Series_B_Investment_Adage_Capital_Partners_Fidelity_Biosciences_Healthcap_Pappas_Ventures_Tpg_Biotech_Ultragenyx_Pharmaceutical_Inc_Completed> ;
    ns1:name "Adage Capital Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1007995/Adage_Capital_Partners>,
        <https://1145.am/db/1192327/Adage_Capital_Partners_Lp>,
        <https://1145.am/db/1452525/Adage_Capital_Partners>,
        <https://1145.am/db/2152126/Adage_Capital_Partners>,
        <https://1145.am/db/2362553/Adage_Capital_Partners>,
        <https://1145.am/db/2364496/Adage_Capital_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359562/Healthcap> a org:Organization ;
    ns1:basedInLowRaw "NOVATO, Calif" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-12-20T11:39:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Raises $75 Million in Oversubscribed Crossover Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-raises-75-million-oversubscribed-crossover-financing> ;
    ns1:foundName "HealthCap" ;
    ns1:investor <https://1145.am/db/2359562/Series_B_Investment_Adage_Capital_Partners_Fidelity_Biosciences_Healthcap_Pappas_Ventures_Tpg_Biotech_Ultragenyx_Pharmaceutical_Inc_Completed> ;
    ns1:name "HealthCap" ;
    ns1:sameAsMedium <https://1145.am/db/1334395/Healthcap>,
        <https://1145.am/db/1669813/Healthcap>,
        <https://1145.am/db/2286782/Healthcap>,
        <https://1145.am/db/2291206/Healthcap>,
        <https://1145.am/db/2301093/Healthcap>,
        <https://1145.am/db/2315943/Healthcap>,
        <https://1145.am/db/2315957/Healthcap>,
        <https://1145.am/db/2336511/Healthcap>,
        <https://1145.am/db/2337599/Healthcap>,
        <https://1145.am/db/2342611/Healthcap>,
        <https://1145.am/db/2343545/Healthcap>,
        <https://1145.am/db/2347822/Healthcap>,
        <https://1145.am/db/2354537/Healthcap>,
        <https://1145.am/db/2354540/Healthcap>,
        <https://1145.am/db/2357144/Healthcap>,
        <https://1145.am/db/2364492/Healthcap>,
        <https://1145.am/db/2364517/Healthcap>,
        <https://1145.am/db/2368579/Healthcap> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359591/Healthcare_Royalty_Partners> a org:Organization ;
    ns1:documentDate "2012-12-21T12:42:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raptor Pharmaceutical Corp. Signs $50 Million Loan Agreement With HealthCare Royalty Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raptor-pharmaceutical-corp-signs-50-million-loan-agreement-healthcare-royalty-partners> ;
    ns1:foundName "HealthCare Royalty Partners" ;
    ns1:investor <https://1145.am/db/2359591/Investment_Healthcare_Royalty_Partners_Raptor_Pharmaceutical_Corp_Has_Not_Happened> ;
    ns1:name "HealthCare Royalty Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1142402/Healthcare_Royalty_Partners>,
        <https://1145.am/db/1270274/Healthcare_Royalty_Partners>,
        <https://1145.am/db/2318404/Healthcare_Royalty_Partners>,
        <https://1145.am/db/2349759/Healthcare_Royalty_Partners>,
        <https://1145.am/db/2359564/Healthcare_Royalty_Partners_Ii>,
        <https://1145.am/db/2359580/Healthcare_Royalty_Partners>,
        <https://1145.am/db/2359581/Healthcare_Royalty_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360052/Biomedical_Advanced_Research_And_Development_Authority> a org:Organization ;
    ns1:basedInLowRaw "U.S" ;
    ns1:description "a biopharmaceutical company developing countermeasures for biodefense" ;
    ns1:documentDate "2012-09-14T15:42:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elusys-awarded-additional-14-5-million-under-existing-u-s-government-contracts-supporting> ;
    ns1:foundName "Biomedical Advanced Research and Development Authority" ;
    ns1:investor <https://1145.am/db/2360052/Investment_Biomedical_Advanced_Research_And_Development_Authority_Elusys_Therapeutics_Inc_Us_Government_Has_Not_Happened> ;
    ns1:name "Biomedical Advanced Research and Development Authority" ;
    ns1:sameAsMedium <https://1145.am/db/1300001/Biomedical_Advanced_Research_And_Development_Authority>,
        <https://1145.am/db/2544401/Biomedical_Advanced_Research_And_Development_Authority>,
        <https://1145.am/db/2578709/Biomedical_Advanced_Research_And_Development_Authority>,
        <https://1145.am/db/74947/Biomedical_Advanced_Research_And_Development_Authority>,
        <https://1145.am/db/76287/Biomedical_Advanced_Research_And_Development_Authority>,
        <https://1145.am/db/931593/Biomedical_Advanced_Research_And_Development_Authority> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360052/Us_Government> a org:Organization ;
    ns1:basedInLowRaw "U.S." ;
    ns1:description "funding" ;
    ns1:documentDate "2012-09-14T15:42:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elusys-awarded-additional-14-5-million-under-existing-u-s-government-contracts-supporting> ;
    ns1:foundName ".S. Government",
        "U.S. Government" ;
    ns1:investor <https://1145.am/db/2360052/Investment_Biomedical_Advanced_Research_And_Development_Authority_Elusys_Therapeutics_Inc_Us_Government_Has_Not_Happened> ;
    ns1:name "U.S. Government" ;
    ns1:sameAsMedium <https://1145.am/db/156875/Us_Government>,
        <https://1145.am/db/2341297/Us_Government>,
        <https://1145.am/db/2350340/Us_Government>,
        <https://1145.am/db/2542788/Us_Government>,
        <https://1145.am/db/2591761/Us_Government> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361079/Dievini_Hopp_Biotech_Holding> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-09-18T12:01:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CureVac Secures EUR80 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/curevac-secures-eur80-million-series-d-financing-0> ;
    ns1:foundName "dievini Hopp BioTech Holding" ;
    ns1:investor <https://1145.am/db/2361079/Investment_Curevac_Gmbh_Dievini_Hopp_Biotech_Holding_Completed> ;
    ns1:name "dievini Hopp BioTech Holding" ;
    ns1:sameAsHigh <https://1145.am/db/2351879/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2361082/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2361094/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2363262/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2363274/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2579135/Dievini_Hopp_Biotech_Holding> ;
    ns1:sameAsMedium <https://1145.am/db/2331155/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2351883/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2354625/Dievini_Hopp_Biotech_Holding_Gmbh___Co_Kg>,
        <https://1145.am/db/2359443/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2363275/Dievini_Hopp_Biotech_Holding>,
        <https://1145.am/db/2368133/Dievini_Hopp_Biotech_Holding_Gmbh___Co_Kg>,
        <https://1145.am/db/2562086/Dievini_Hopp_Biotech_Holding> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362106/Casdin_Capital> a org:Organization ;
    ns1:basedInLowRaw "America" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-09-20T11:51:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Announces $42.5 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-announces-42-5-million-series-b-financing-0> ;
    ns1:foundName "Casdin Capital" ;
    ns1:investor <https://1145.am/db/2362106/Series_B_Investment_Casdin_Capital_Deerfield_Management_Company_Foundation_Medicine_Laboratory_Corporation_Of_AmericaÂ®_Holdings_Redmile_Group_Completed> ;
    ns1:name "Casdin Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1247997/Casdin_Capital>,
        <https://1145.am/db/1503471/Cardumen_Capital>,
        <https://1145.am/db/1505059/Cardumen_Capital>,
        <https://1145.am/db/1682195/Catalus_Capital>,
        <https://1145.am/db/1984721/Casdin_Capital>,
        <https://1145.am/db/2069495/Casdin_Capital>,
        <https://1145.am/db/2152471/Casdin_Capital>,
        <https://1145.am/db/2345099/Casdin_Capital>,
        <https://1145.am/db/365631/Casdin_Capital>,
        <https://1145.am/db/571769/Casdin_Capital>,
        <https://1145.am/db/604944/Casdin_Capital>,
        <https://1145.am/db/769568/Casdin_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1042269/Casdin_Capital>,
        <https://1145.am/db/1045411/Casdin_Capital>,
        <https://1145.am/db/1220031/Casdin_Capital>,
        <https://1145.am/db/1519613/Casdin_Capital>,
        <https://1145.am/db/1519799/Casdin_Capital>,
        <https://1145.am/db/1779452/Casdin_Capital>,
        <https://1145.am/db/2181257/Casdin_Capital>,
        <https://1145.am/db/2181449/Casdin_Capital>,
        <https://1145.am/db/2286541/Casdin_Capital_Llc>,
        <https://1145.am/db/2287519/Casdin_Capital>,
        <https://1145.am/db/2291403/Casdin_Capital>,
        <https://1145.am/db/230667/Casdin_Capital>,
        <https://1145.am/db/2308713/Casdin_Capital>,
        <https://1145.am/db/2309619/Casdin_Capital>,
        <https://1145.am/db/2330486/Casdin_Capital>,
        <https://1145.am/db/2342754/Casdin_Capital>,
        <https://1145.am/db/2342768/Casdin_Capital>,
        <https://1145.am/db/2342771/Casdin_Capital>,
        <https://1145.am/db/2346063/Casdin_Capital>,
        <https://1145.am/db/2351302/Casdin_Capital>,
        <https://1145.am/db/2361695/Casdin_Capital>,
        <https://1145.am/db/2369304/Casdin_Capital>,
        <https://1145.am/db/2541350/Casdin_Capital>,
        <https://1145.am/db/2584561/Casdin_Capital>,
        <https://1145.am/db/471253/Casdin_Capital>,
        <https://1145.am/db/490696/Casdin_Capital>,
        <https://1145.am/db/522651/Casdin_Capital>,
        <https://1145.am/db/527072/Casdin_Capital>,
        <https://1145.am/db/641046/Casdin_Capital>,
        <https://1145.am/db/645428/Casdin_Capital>,
        <https://1145.am/db/683648/Casdin_Capital>,
        <https://1145.am/db/708134/Casdin_Capital>,
        <https://1145.am/db/711539/Casdin_Capital>,
        <https://1145.am/db/745407/Casdin_Capital>,
        <https://1145.am/db/912943/Casdin_Capital>,
        <https://1145.am/db/915003/Casdin_Capital>,
        <https://1145.am/db/922439/Casdin_Capital>,
        <https://1145.am/db/932769/Casdin_Capital>,
        <https://1145.am/db/936819/Casdin_Capital>,
        <https://1145.am/db/937281/Casdin_Capital>,
        <https://1145.am/db/938108/Casdin_Capital>,
        <https://1145.am/db/948499/Casdin_Capital>,
        <https://1145.am/db/953800/Casdin_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362106/Deerfield_Management_Company> a org:Organization ;
    ns1:basedInLowRaw "America" ;
    ns1:documentDate "2012-09-20T11:51:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Announces $42.5 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-announces-42-5-million-series-b-financing-0> ;
    ns1:foundName "Deerfield Management Company, L.P." ;
    ns1:investor <https://1145.am/db/2362106/Series_B_Investment_Casdin_Capital_Deerfield_Management_Company_Foundation_Medicine_Laboratory_Corporation_Of_AmericaÂ®_Holdings_Redmile_Group_Completed> ;
    ns1:name "Deerfield Management Company" ;
    ns1:sameAsMedium <https://1145.am/db/1004121/Deerfield_Management_Company>,
        <https://1145.am/db/1006175/Deerfield_Management_Company>,
        <https://1145.am/db/1102553/Deerfield_Management>,
        <https://1145.am/db/1106975/Deerfield_Management>,
        <https://1145.am/db/1177932/Deerfield_Management_Company>,
        <https://1145.am/db/1217674/Deerfield_Management>,
        <https://1145.am/db/1219334/Deerfield_Management>,
        <https://1145.am/db/1219771/Deerfield_Management>,
        <https://1145.am/db/1232497/Deerfield_Management>,
        <https://1145.am/db/1269807/Deerfield_Management_Company>,
        <https://1145.am/db/1279924/Deerfield_Management_Company>,
        <https://1145.am/db/1326655/Deerfield_Management>,
        <https://1145.am/db/1326957/Deerfield_Management>,
        <https://1145.am/db/1411936/Deerfield_Management_Company>,
        <https://1145.am/db/1468795/Deerfield_Management>,
        <https://1145.am/db/1519613/Deerfield_Management>,
        <https://1145.am/db/1519799/Deerfield_Management>,
        <https://1145.am/db/1620209/Deerfield_Management>,
        <https://1145.am/db/1624707/Deerfield_Management>,
        <https://1145.am/db/1771229/Deerfield_Management_Company>,
        <https://1145.am/db/1969781/Deerfield_Management>,
        <https://1145.am/db/2036223/Deerfield_Management>,
        <https://1145.am/db/2049332/Deerfield_Management>,
        <https://1145.am/db/2069495/Deerfield_Management>,
        <https://1145.am/db/2114372/Deerfield_Management>,
        <https://1145.am/db/2182698/Deerfield_Management>,
        <https://1145.am/db/2185095/Deerfield_Management_Company>,
        <https://1145.am/db/2198647/Deerfield_Management>,
        <https://1145.am/db/2198816/Deerfield_Management_Company>,
        <https://1145.am/db/2214553/Deerfield_Management>,
        <https://1145.am/db/2293172/Deerfield_Management>,
        <https://1145.am/db/2295295/Deerfield_Management>,
        <https://1145.am/db/2298642/Deerfield_Management>,
        <https://1145.am/db/2299549/Deerfield_Management>,
        <https://1145.am/db/2299794/Deerfield_Management_Company>,
        <https://1145.am/db/2302751/Deerfield_Management>,
        <https://1145.am/db/2305700/Deerfield_Management>,
        <https://1145.am/db/2311805/Deerfield_Management>,
        <https://1145.am/db/2311833/Deerfield_Management>,
        <https://1145.am/db/2313135/Deerfield_Management>,
        <https://1145.am/db/2317927/Deerfield_Management>,
        <https://1145.am/db/2317937/Deerfield_Management>,
        <https://1145.am/db/2321950/Deerfield_Management>,
        <https://1145.am/db/2324112/Deerfield_Management>,
        <https://1145.am/db/2325221/Deerfield_Management>,
        <https://1145.am/db/2325880/Deerfield_Management_Company>,
        <https://1145.am/db/2327266/Deerfield_Management>,
        <https://1145.am/db/2328305/Deerfield_Management>,
        <https://1145.am/db/2328427/Deerfield_Management>,
        <https://1145.am/db/2328594/Deerfield_Management>,
        <https://1145.am/db/2331436/Deerfield_Management>,
        <https://1145.am/db/2336511/Deerfield_Management_Company>,
        <https://1145.am/db/2337599/Deerfield_Management_Company>,
        <https://1145.am/db/2342543/Deerfield_Management_Company>,
        <https://1145.am/db/2346773/Deerfield_Management_Company>,
        <https://1145.am/db/2346775/Deerfield_Management_Company>,
        <https://1145.am/db/2347552/Deerfield_Management_Company>,
        <https://1145.am/db/2348857/Deerfield_Management>,
        <https://1145.am/db/2349834/Deerfield_Management>,
        <https://1145.am/db/2355531/Deerfield_Management>,
        <https://1145.am/db/2355543/Deerfield_Management>,
        <https://1145.am/db/2359227/Deerfield_Management>,
        <https://1145.am/db/2359404/Deerfield_Management>,
        <https://1145.am/db/2360370/Deerfield_Management>,
        <https://1145.am/db/2361142/Deerfield_Management>,
        <https://1145.am/db/2361147/Deerfield_Management>,
        <https://1145.am/db/2362453/Deerfield_Management>,
        <https://1145.am/db/2365724/Deerfield_Management_Company>,
        <https://1145.am/db/2366527/Deerfield_Management_Company>,
        <https://1145.am/db/2368667/Deerfield_Management>,
        <https://1145.am/db/2368723/Deerfield_Management>,
        <https://1145.am/db/2369202/Deerfield_Management>,
        <https://1145.am/db/2369304/Deerfield_Management_Company>,
        <https://1145.am/db/2369305/Deerfield_Management>,
        <https://1145.am/db/2370094/Deerfield_Management_Company>,
        <https://1145.am/db/2370436/Deerfield_Management>,
        <https://1145.am/db/2371160/Deerfield_Management_Company>,
        <https://1145.am/db/2371163/Deerfield_Management_Company>,
        <https://1145.am/db/2569551/Deerfield_Management>,
        <https://1145.am/db/2573058/Deerfield_Management>,
        <https://1145.am/db/2597025/Deerfield_Management_Company>,
        <https://1145.am/db/542015/Deerfield_Management_Company>,
        <https://1145.am/db/544859/Deerfield_Management_Company>,
        <https://1145.am/db/951064/Deerfield_Management_Company>,
        <https://1145.am/db/971622/Deerfield_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362106/Laboratory_Corporation_Of_AmericaÂ®_Holdings> a org:Organization ;
    ns1:basedInLowRaw "America" ;
    ns1:description "a company that makes medical equipment" ;
    ns1:documentDate "2012-09-20T11:51:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Announces $42.5 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-announces-42-5-million-series-b-financing-0> ;
    ns1:foundName "Laboratory Corporation of AmericaÂ® Holdings" ;
    ns1:investor <https://1145.am/db/2362106/Series_B_Investment_Casdin_Capital_Deerfield_Management_Company_Foundation_Medicine_Laboratory_Corporation_Of_AmericaÂ®_Holdings_Redmile_Group_Completed> ;
    ns1:name "Laboratory Corporation of AmericaÂ® Holdings" ;
    ns1:sameAsHigh <https://1145.am/db/2360158/Laboratory_Corporation_Of_America_Holdings> ;
    ns1:sameAsMedium <https://1145.am/db/1234003/Laboratory_Corp_Of_America_Holdings>,
        <https://1145.am/db/1827884/Laboratory_Corporation_Of_America>,
        <https://1145.am/db/1857105/Laboratory_Corporation_Of_America>,
        <https://1145.am/db/2234246/Laboratory_Corporation_Of_America_Holdings>,
        <https://1145.am/db/2240180/Laboratory_Corporation_Of_AmericaÂ®_Holdings>,
        <https://1145.am/db/2240671/Laboratory_Corporation_Of_AmericaÂ®_Holdings>,
        <https://1145.am/db/2290452/Laboratory_Corporation_Of_America_Holdings>,
        <https://1145.am/db/2295417/Laboratory_Corporation_Of_America_Holdings>,
        <https://1145.am/db/2297908/Laboratory_Corporation_Of_America_Holdings>,
        <https://1145.am/db/2304966/Laboratory_Corporation_Of_AmericaÂ®_Holdings>,
        <https://1145.am/db/2318487/Laboratory_Corporation_Of_AmericaÂ®_Holdings>,
        <https://1145.am/db/2325726/Laboratory_Corporation_Of_America_Holdings>,
        <https://1145.am/db/2329539/Laboratory_Corporation_Of_America_Â®_Holdings>,
        <https://1145.am/db/2329540/Laboratory_Corporation_Of_America_(r)_Holdings>,
        <https://1145.am/db/2330413/Laboratory_Corporation_Of_America>,
        <https://1145.am/db/2339557/Laboratory_Corporation_Of_AmericaÂ®_Holdings>,
        <https://1145.am/db/2349611/Laboratory_Corporation_Of_Americaholdings>,
        <https://1145.am/db/2354443/Laboratory_Corp_Of_America>,
        <https://1145.am/db/2357615/Laboratory_Corporation_Of_America_Holdings>,
        <https://1145.am/db/2359149/Laboratory_Corporation_Of_America_Holdings>,
        <https://1145.am/db/2360450/Laboratory_Corporation_Of_AmericaÂ®_Holdings>,
        <https://1145.am/db/2363251/Laboratory_Corporation_Of_America>,
        <https://1145.am/db/237243/Laboratory_Corp_Of_America_Holdings>,
        <https://1145.am/db/2578837/Laboratory_Corporation_Of_AmericaÂ®_Holdings>,
        <https://1145.am/db/2589830/Laboratory_Corporation_Of_AmericaÂ®_Holdings>,
        <https://1145.am/db/2592445/Laboratory_Corporation_Of_AmericaÂ®_Holdings> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362106/Redmile_Group> a org:Organization ;
    ns1:basedInLowRaw "America" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-09-20T11:51:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Announces $42.5 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-announces-42-5-million-series-b-financing-0> ;
    ns1:foundName "Redmile Group" ;
    ns1:investor <https://1145.am/db/2362106/Series_B_Investment_Casdin_Capital_Deerfield_Management_Company_Foundation_Medicine_Laboratory_Corporation_Of_AmericaÂ®_Holdings_Redmile_Group_Completed> ;
    ns1:name "Redmile Group" ;
    ns1:sameAsHigh <https://1145.am/db/1086604/Tdf_Ventures>,
        <https://1145.am/db/1147828/Sixthirty_Ventures>,
        <https://1145.am/db/1199050/Rre_Ventures>,
        <https://1145.am/db/1356216/Trestle_Partners>,
        <https://1145.am/db/1358977/Tlv_Partners>,
        <https://1145.am/db/1427471/Twm_Venture_Co>,
        <https://1145.am/db/1546965/Ttv_Capital>,
        <https://1145.am/db/1569853/Titan_Capital>,
        <https://1145.am/db/168364/Trog_Hawley_Capital>,
        <https://1145.am/db/1693922/Remus_Capital>,
        <https://1145.am/db/1700572/Rre_Ventures>,
        <https://1145.am/db/1703609/Ttv_Capital>,
        <https://1145.am/db/1711383/Knollwood_Capital>,
        <https://1145.am/db/1713710/Remus_Capital>,
        <https://1145.am/db/1717313/Titan_Capital>,
        <https://1145.am/db/1741365/Translink_Capital>,
        <https://1145.am/db/1743285/Redline_Capital>,
        <https://1145.am/db/1746842/Tlcom_Capital>,
        <https://1145.am/db/1750867/Ttv_Capital>,
        <https://1145.am/db/1753054/Tahoma_Ventures>,
        <https://1145.am/db/1757065/Ttv_Capital>,
        <https://1145.am/db/1761607/Trousdale_Capital>,
        <https://1145.am/db/1762653/Tlv_Partners>,
        <https://1145.am/db/1763847/Tq_Ventures>,
        <https://1145.am/db/1788126/Translink_Capital>,
        <https://1145.am/db/1790574/Rre_Ventures>,
        <https://1145.am/db/1790953/T5_Capital>,
        <https://1145.am/db/1794935/Rre_Ventures>,
        <https://1145.am/db/1794935/Translink_Capital>,
        <https://1145.am/db/1805165/Translink_Capital>,
        <https://1145.am/db/1813349/Rre_Ventures>,
        <https://1145.am/db/1820363/Rre_Ventures>,
        <https://1145.am/db/1845022/Translink_Capital>,
        <https://1145.am/db/1849600/Sevenventures>,
        <https://1145.am/db/1851689/Translink_Capital>,
        <https://1145.am/db/1853156/T5_Capital>,
        <https://1145.am/db/1854396/Ttv_Capital>,
        <https://1145.am/db/1882330/Rre_Ventures>,
        <https://1145.am/db/1890000/Rre_Ventures>,
        <https://1145.am/db/1892428/T-Venture_Holding>,
        <https://1145.am/db/1984721/Redmile_Group>,
        <https://1145.am/db/2063249/Tlv_Partners>,
        <https://1145.am/db/2069147/Knollwood_Capital>,
        <https://1145.am/db/2142825/Ttv_Capital>,
        <https://1145.am/db/2291818/Delphi_Ventures>,
        <https://1145.am/db/2300306/Delphi_Ventures>,
        <https://1145.am/db/2302333/Delphi_Ventures>,
        <https://1145.am/db/2306568/Delphi_Ventures>,
        <https://1145.am/db/2315943/Truffle_Capital>,
        <https://1145.am/db/2315957/Truffle_Capital>,
        <https://1145.am/db/2317467/Delphi_Ventures>,
        <https://1145.am/db/2317919/Delphi_Ventures>,
        <https://1145.am/db/2332658/Truffle_Capital>,
        <https://1145.am/db/2332659/Truffle_Capital>,
        <https://1145.am/db/2333504/Delphi_Ventures>,
        <https://1145.am/db/2338059/Teralys_Capital>,
        <https://1145.am/db/2343206/Delphi_Ventures>,
        <https://1145.am/db/2352508/Delphi_Ventures>,
        <https://1145.am/db/2360174/Delphi_Ventures>,
        <https://1145.am/db/2365679/Delphi_Ventures>,
        <https://1145.am/db/2367204/Delphi_Ventures>,
        <https://1145.am/db/254241/Tkc_Capital>,
        <https://1145.am/db/506560/Tdf_Ventures>,
        <https://1145.am/db/539638/Tdf_Ventures>,
        <https://1145.am/db/601455/Tlv_Partners>,
        <https://1145.am/db/669408/Tdf_Ventures>,
        <https://1145.am/db/759595/Redblue_Capital>,
        <https://1145.am/db/885068/Tt_Capital_Partners>,
        <https://1145.am/db/892831/Ttv_Capital>,
        <https://1145.am/db/904252/Trinity_Capital>,
        <https://1145.am/db/952434/Tdf_Ventures>,
        <https://1145.am/db/991859/Ttv_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1086649/Redmile_Group>,
        <https://1145.am/db/1192327/Redmile_Group>,
        <https://1145.am/db/1533327/Redmile_Group>,
        <https://1145.am/db/1533685/Redmile_Group>,
        <https://1145.am/db/1752458/Redmile_Group>,
        <https://1145.am/db/1813216/Redmile_Group>,
        <https://1145.am/db/1822362/Redmile_Group>,
        <https://1145.am/db/1837663/Redmile_Group>,
        <https://1145.am/db/2075963/Redmile_Group>,
        <https://1145.am/db/2080575/Redmile_Group>,
        <https://1145.am/db/2089412/Redmile_Group>,
        <https://1145.am/db/2152126/Redmile_Group>,
        <https://1145.am/db/2224478/Redmile_Group>,
        <https://1145.am/db/2236068/Redmile_Group>,
        <https://1145.am/db/2281211/Redmile_Group>,
        <https://1145.am/db/2285762/Redmile_Group>,
        <https://1145.am/db/2291414/Redmile_Group>,
        <https://1145.am/db/2291716/Redmile_Group>,
        <https://1145.am/db/2292160/Redmile_Group>,
        <https://1145.am/db/2307889/Redmile_Group>,
        <https://1145.am/db/2308540/Redmile_Group>,
        <https://1145.am/db/2321658/Redmile_Group>,
        <https://1145.am/db/2335748/Redmile_Group>,
        <https://1145.am/db/2341595/Redmile_Group>,
        <https://1145.am/db/2341599/Redmile_Group>,
        <https://1145.am/db/2360277/Redmile_Group>,
        <https://1145.am/db/2361695/Redmile_Group>,
        <https://1145.am/db/2367043/Redmile_Group>,
        <https://1145.am/db/2368070/Redmile_Group>,
        <https://1145.am/db/2369304/Redmile_Group>,
        <https://1145.am/db/2371160/Redmile_Group>,
        <https://1145.am/db/2371163/Redmile_Group>,
        <https://1145.am/db/2584561/Redmile_Group>,
        <https://1145.am/db/342182/Redmile_Group>,
        <https://1145.am/db/577785/Redmile_Group>,
        <https://1145.am/db/585936/Redmile_Group>,
        <https://1145.am/db/602316/Redmile_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362134/Series_B_Investment_Foundation_Medicine_Pure_Communications_Incdan_Budwick_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-21T04:01:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Foundation Medicine Announces $ 42.5 Million Series B Financing.",
        "Pure Communications, Inc.Dan Budwick, 973-271-6085." ;
    ns1:documentTitle "Foundation Medicine Announces $42.5 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-announces-42-5-million-series-b-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2362134/Foundation_Medicine>,
        <https://1145.am/db/2362134/Pure_Communications_Incdan_Budwick> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 42.5 Million",
        "$ 42.5 million" .

<https://1145.am/db/2364127/Clinipace_Worldwide> a org:Organization ;
    ns1:basedInLowRaw "Irvine, CA" ;
    ns1:buyer <https://1145.am/db/2364127/Acquisition_Clinipace_Worldwide_Clinipace_Worldwide_Completed>,
        <https://1145.am/db/2364127/Acquisition_Clinipace_Worldwide_Paragon_Biomedical_Inc_Completed>,
        <https://1145.am/db/2364127/Merger_Clinipace_Worldwide_Completed>,
        <https://1145.am/db/2364127/Paragon_Biomedical_Inc_Acquisition> ;
    ns1:description "therapeutic expertise" ;
    ns1:documentDate "2012-09-26T04:01:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clinipace Worldwide Acquires Paragon Biomedical, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-paragon-biomedical-inc> ;
    ns1:foundName "Clinipace Worldwide",
        "Clinipace Worldwide, a",
        "Clinipace Worldwide, a," ;
    ns1:name "Clinipace Worldwide" ;
    ns1:protagonist <https://1145.am/db/2364127/Acquisition_Clinipace_Worldwide_Clinipace_Worldwide_Completed>,
        <https://1145.am/db/2364127/Acquisition_Clinipace_Worldwide_Paragon_Biomedical_Inc_Completed>,
        <https://1145.am/db/2364127/Merger_Clinipace_Worldwide_Completed>,
        <https://1145.am/db/2364127/Paragon_Biomedical_Inc_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2363181/Clinipace_Worldwide> ;
    ns1:sameAsMedium <https://1145.am/db/2305367/Clinipace_Worldwide>,
        <https://1145.am/db/2307546/Clinipace_Worldwide>,
        <https://1145.am/db/2319640/Clinipace_Worldwide>,
        <https://1145.am/db/2321356/Clinipace_Worldwide>,
        <https://1145.am/db/2322803/Clinipace_Worldwide>,
        <https://1145.am/db/2323511/Clinipace_Worldwide>,
        <https://1145.am/db/2329111/Clinipace_Worldwide>,
        <https://1145.am/db/2332459/Clinipace_Worldwide>,
        <https://1145.am/db/2334020/Clinipace_Worldwide>,
        <https://1145.am/db/2339913/Clinipace_Worldwide>,
        <https://1145.am/db/2344639/Clinipace_Worldwide>,
        <https://1145.am/db/2345206/Clinipace_Worldwide>,
        <https://1145.am/db/2353670/Clinipace_Worldwide>,
        <https://1145.am/db/2353671/Clinipace_Worldwide>,
        <https://1145.am/db/2353674/Clinipace_Worldwide>,
        <https://1145.am/db/2354137/Clinipace_Worldwide>,
        <https://1145.am/db/2365481/Clinipace_Worldwide> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365032/Cm-Cic_Capital_Prive> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:documentDate "2012-10-01T19:25:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biophytis completes a EUR two million B round financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biophytis-completes-a-eur-two-million-b-round-financing> ;
    ns1:foundName "CM-CIC Capital Prive" ;
    ns1:investor <https://1145.am/db/2365032/B_Investment_Biophytis_Cm-Cic_Capital_Prive_Metabrain_Research_Seventure_Partners_Completed> ;
    ns1:name "CM-CIC Capital Prive" ;
    ns1:sameAsMedium <https://1145.am/db/1716136/Cm-Cic_Capital_PrivÃ©>,
        <https://1145.am/db/1808668/Cm-Cic_Capital_PrivÃ©>,
        <https://1145.am/db/1824461/Cm-Cic_Capital_PrivÃ©>,
        <https://1145.am/db/1846397/Cm-Cic_Capital_PrivÃ©> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365032/Metabrain_Research> a org:Organization ;
    ns1:basedInHighGeoName "Chilly-Mazarin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6446124/about.rdf> ;
    ns1:basedInHighRaw "Chilly-Mazarin" ;
    ns1:documentDate "2012-10-01T19:25:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biophytis completes a EUR two million B round financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biophytis-completes-a-eur-two-million-b-round-financing> ;
    ns1:foundName "Metabrain Research" ;
    ns1:industry "health and nutrition" ;
    ns1:investor <https://1145.am/db/2365032/B_Investment_Biophytis_Cm-Cic_Capital_Prive_Metabrain_Research_Seventure_Partners_Completed> ;
    ns1:name "Metabrain Research" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365032/Seventure_Partners> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:documentDate "2012-10-01T19:25:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biophytis completes a EUR two million B round financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biophytis-completes-a-eur-two-million-b-round-financing> ;
    ns1:foundName "Seventure partners" ;
    ns1:investor <https://1145.am/db/2365032/B_Investment_Biophytis_Cm-Cic_Capital_Prive_Metabrain_Research_Seventure_Partners_Completed> ;
    ns1:name "Seventure partners" ;
    ns1:sameAsMedium <https://1145.am/db/1023024/Seventure_Partners>,
        <https://1145.am/db/1023822/Seventure_Partners>,
        <https://1145.am/db/1340145/Seventure_Partners>,
        <https://1145.am/db/1746321/Seventure_Partners>,
        <https://1145.am/db/1750172/Seventure_Partners>,
        <https://1145.am/db/1792086/Seventure_Partners>,
        <https://1145.am/db/1798194/Seventure_Partners>,
        <https://1145.am/db/1854186/Seventure_Partners>,
        <https://1145.am/db/1854191/Seventure_Partners>,
        <https://1145.am/db/1855692/Seventure_Partners>,
        <https://1145.am/db/1857633/Seventure_Partners>,
        <https://1145.am/db/1895222/Seventure_Partners>,
        <https://1145.am/db/2153759/Seventure_Partners>,
        <https://1145.am/db/2288440/Seventure_Partners>,
        <https://1145.am/db/2296842/Seventure_Partners>,
        <https://1145.am/db/2340937/Seventure_Partners>,
        <https://1145.am/db/2343244/Seventure_Partners>,
        <https://1145.am/db/2358268/Seventure_Partners>,
        <https://1145.am/db/2358269/Seventure_Partners>,
        <https://1145.am/db/2368646/Seventure_Partners>,
        <https://1145.am/db/2368659/Seventure_Partners>,
        <https://1145.am/db/545842/Seventure_Partners>,
        <https://1145.am/db/881549/Seventure_Partners>,
        <https://1145.am/db/978075/Seventure_Partners>,
        <https://1145.am/db/978699/Seventure_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2560070/Series_B_Investment_Innovent_Biologics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-16T17:50:16+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Innovent Biologics Adds $ 25 Million to Expand its Antibody Pipeline and its Manufacturing Capabilities.",
        "Suzhou, China, November 16, 2012 - Innovent Biologics, Inc., a company dedicated to the development and manufacturing of monoclonal antibodies to be marketed in the rapidly growing China market and elsewhere around the world, has raised $ 25 Million in a Series B financing to put toward the continued expansion of its pipeline and manufacturing capabilities." ;
    ns1:documentTitle "Innovent Biologics Adds $25 Million to Expand its Antibody Pipeline and its Manufacturing Capabilities" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/innovent-biologics-adds-25-million-to-expand-its-antibody-pipeline-and-its> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2560070/Innovent_Biologics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 25 Million" ;
    ns1:when "2012-11-16T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "November 16, 2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2572803/Convertible_Preferred_Stock_Investment_Alimera_Sciences_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-10T12:06:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "ATLANTA, Oct. 2, 2012 /PRNewswire/ - Alimera Sciences, Inc. (Nasdaq: ALIM) (\"Alimera\") , a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that it has completed the sale of $ 40 million of Series A Convertible Preferred Stock (the \"Series A Preferred\") and warrants to purchase Series A Preferred (the \"Warrants\") to a group of institutional investors, including both existing and new investors, in a private placement.",
        "Alimera Sciences Closes $ 40 Million Financing." ;
    ns1:documentTitle "Alimera Sciences Closes $40 Million Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/alimera-sciences-closes-40-million-financing> ;
    ns1:foundName "Financing",
        "private",
        "private placement",
        "sale" ;
    ns1:name "Financing",
        "private",
        "private placement",
        "sale" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2572803/Alimera_Sciences> ;
    ns1:targetDetails "Convertible Preferred Stock",
        "Series A" ;
    ns1:valueRaw "$ 40 Million",
        "$ 40 million" ;
    ns1:when "2012-10-01T00:00:00"^^xsd:dateTime,
        "2012-10-02T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012-Oct-2",
        "October 1, 2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2594303/Pernix_Therapeutics_Holdings> a org:Organization ;
    ns1:basedInHighGeoName "Texas" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:basedInHighRaw "Texas" ;
    ns1:basedInLowRaw "EST" ;
    ns1:buyer <https://1145.am/db/2594303/Somaxon_Pharmaceuticals_Acquisition> ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-12-11T14:50:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc." ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/pernix-therapeutics-announces-agreement-to-acquire-somaxon-pharmaceuticals-inc> ;
    ns1:foundName "Pernix",
        "Pernix Therapeutics",
        "Pernix Therapeutics Holdings, Inc",
        "Pernix Therapeutics Holdings, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Pernix",
        "Pernix Therapeutics",
        "Pernix Therapeutics Holdings" ;
    ns1:protagonist <https://1145.am/db/2594303/Somaxon_Pharmaceuticals_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2244405/Pernixâ„¢_Therapeutics_Holdings_Inc>,
        <https://1145.am/db/2335045/Pernix_Therapeutics>,
        <https://1145.am/db/2339199/Pernix_Therapeutics>,
        <https://1145.am/db/2344301/Pernix_Therapeutics_Holdings>,
        <https://1145.am/db/2348728/Pernix_Therapeutics_Holdings_Inc>,
        <https://1145.am/db/2349958/Pernix_Therapeutics_Holdings_Inc>,
        <https://1145.am/db/2357283/Pernix_Therapeutics_Holdings>,
        <https://1145.am/db/2551716/Pernix_Therapeutics>,
        <https://1145.am/db/2554614/Pernix_Therapeutics>,
        <https://1145.am/db/2554617/Pernix_Therapeutics_Holdings>,
        <https://1145.am/db/2560066/Pernix_Therapeutics>,
        <https://1145.am/db/2560067/Pernix_Therapeutics_Holdings>,
        <https://1145.am/db/2569228/Pernix_Therapeutics>,
        <https://1145.am/db/2569431/Pernix_Therapeutics>,
        <https://1145.am/db/2569432/Pernix_Ireland_Limited>,
        <https://1145.am/db/2570309/Pernix_Ireland_Limited>,
        <https://1145.am/db/2580980/Pernix_Therapeutics_Holdings>,
        <https://1145.am/db/2594304/Pernix_Therapeutics_Holdings> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2597020/Golden_Seeds> a org:Organization ;
    ns1:basedInHighGeoName "Dallas County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4684904/about.rdf> ;
    ns1:basedInHighRaw "DALLAS" ;
    ns1:documentDate "2012-08-16T01:10:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Golden Seeds Invests In DxUpClose, Disruptive Technology That Performs An Antibiotic Sensitivity Test At The Patient's Bedside In Less Than An Hour" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/golden-seeds-invests-dxupclose-disruptive-technology-performs-an-antibiotic-sensitivity-test> ;
    ns1:foundName "Golden Seeds" ;
    ns1:investor <https://1145.am/db/2597020/Series_A_Investment_Dxupclose_Golden_Seeds_Has_Not_Happened> ;
    ns1:name "Golden Seeds" ;
    ns1:sameAsMedium <https://1145.am/db/1334108/Golden_Seeds>,
        <https://1145.am/db/1713906/Golden_Seeds>,
        <https://1145.am/db/1736646/Golden_Seeds>,
        <https://1145.am/db/1822737/Golden_Seeds>,
        <https://1145.am/db/1873676/Golden_Seeds>,
        <https://1145.am/db/1889112/Golden_Seeds>,
        <https://1145.am/db/1892363/Golden_Seeds>,
        <https://1145.am/db/2295771/Golden_Seeds>,
        <https://1145.am/db/2299828/Golden_Seeds_Llc>,
        <https://1145.am/db/2339616/Golden_Seeds>,
        <https://1145.am/db/2362638/Golden_Seeds>,
        <https://1145.am/db/417590/Golden_Seeds>,
        <https://1145.am/db/614070/Golden_Seeds> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2654050/HTC> a org:Organization ;
    ns1:basedInLowRaw "Taiwan" ;
    ns1:buyer <https://1145.am/db/2654050/Onlive_Acquisition> ;
    ns1:description "vendor" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "HTC" ;
    ns1:investor <https://1145.am/db/2654050/Magnet_Systems_Investment>,
        <https://1145.am/db/2654050/Onlive_Acquisition> ;
    ns1:name "HTC" ;
    ns1:sameAsMedium <https://1145.am/db/1705316/HTC>,
        <https://1145.am/db/1763823/HTC>,
        <https://1145.am/db/1769806/HTC>,
        <https://1145.am/db/1773437/HTC>,
        <https://1145.am/db/1795912/HTC>,
        <https://1145.am/db/1800784/HTC>,
        <https://1145.am/db/1811519/HTC>,
        <https://1145.am/db/1812840/HTC>,
        <https://1145.am/db/1828050/HTC>,
        <https://1145.am/db/1833831/HTC>,
        <https://1145.am/db/1838906/HTC>,
        <https://1145.am/db/1854602/HTC>,
        <https://1145.am/db/1868477/HTC>,
        <https://1145.am/db/1878212/HTC>,
        <https://1145.am/db/1879817/HTC>,
        <https://1145.am/db/1887516/HTC>,
        <https://1145.am/db/2623618/HTC>,
        <https://1145.am/db/2626210/HTC>,
        <https://1145.am/db/2638567/HTC>,
        <https://1145.am/db/2655542/HTC>,
        <https://1145.am/db/2656198/HTC>,
        <https://1145.am/db/2661446/HTC>,
        <https://1145.am/db/2662006/HTC>,
        <https://1145.am/db/2667468/HTC>,
        <https://1145.am/db/2672736/HTC>,
        <https://1145.am/db/2676313/HTC>,
        <https://1145.am/db/2677536/HTC>,
        <https://1145.am/db/2686310/HTC>,
        <https://1145.am/db/2686485/HTC> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654050/Hutchison_Whampoa> a org:Organization ;
    ns1:basedInLowRaw "Israel" ;
    ns1:buyer <https://1145.am/db/2654050/Scailex_Acquisition> ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "Hutchison Whampoa" ;
    ns1:name "Hutchison Whampoa" ;
    ns1:sameAsMedium <https://1145.am/db/1800033/Hutchison_Whampoa>,
        <https://1145.am/db/1895346/Hutchison_Whampoa>,
        <https://1145.am/db/1895791/Hutchison_Whampoa>,
        <https://1145.am/db/2601305/Hutchison_Whampoa>,
        <https://1145.am/db/2602241/Hutchison_Whampoa>,
        <https://1145.am/db/2624724/Hutchison_Whampoa>,
        <https://1145.am/db/2642568/Hutchison_Whampoa>,
        <https://1145.am/db/2645112/Hutchison_Whampoa>,
        <https://1145.am/db/2645972/Hutchison_Whampoa>,
        <https://1145.am/db/2650867/Hutchison_Whampoa>,
        <https://1145.am/db/2651389/Hutchison_Whampoa>,
        <https://1145.am/db/2651408/Hutchison_Whampoa>,
        <https://1145.am/db/2651412/Hutchison_Whampoa>,
        <https://1145.am/db/2651420/Hutchison_Whampoa>,
        <https://1145.am/db/2651472/Hutchison_Whampoa>,
        <https://1145.am/db/2651481/Hutchison_Whampoa>,
        <https://1145.am/db/2651763/Hutchison_Whampoa>,
        <https://1145.am/db/2651770/Hutchison_Whampoa>,
        <https://1145.am/db/2651778/Hutchison_Whampoa>,
        <https://1145.am/db/2651999/Hutchison_Whampoa>,
        <https://1145.am/db/2652007/Hutchison_Whampoa>,
        <https://1145.am/db/2652389/Hutchison_Whampoa>,
        <https://1145.am/db/2652520/Hutchison_Whampoa>,
        <https://1145.am/db/2653163/Hutchison_Whampoa>,
        <https://1145.am/db/2653171/Hutchison_Whampoa>,
        <https://1145.am/db/2653724/Hutchison_Whampoa>,
        <https://1145.am/db/2653986/Hutchison_Whampoa>,
        <https://1145.am/db/2654031/Hutchison_Whampoa>,
        <https://1145.am/db/2654071/Hutchison_Whampoa>,
        <https://1145.am/db/2654093/Hutchison_Whampoa>,
        <https://1145.am/db/2654860/Hutchison_Whampoa>,
        <https://1145.am/db/2654874/Hutchison_Whampoa>,
        <https://1145.am/db/2655754/Hutchison_Whampoa>,
        <https://1145.am/db/2656471/Hutchison_Whampoa>,
        <https://1145.am/db/2656911/Hutchison_Whampoa>,
        <https://1145.am/db/2657893/Hutchison_Whampoa>,
        <https://1145.am/db/2658692/Hutchison_Whampoa>,
        <https://1145.am/db/2658722/Hutchison_Whampoa>,
        <https://1145.am/db/2659767/Hutchison_Whampoa>,
        <https://1145.am/db/2659780/Hutchison_Whampoa>,
        <https://1145.am/db/2659872/Hutchison_Whampoa>,
        <https://1145.am/db/2659970/Hutchison_Whampoa>,
        <https://1145.am/db/2660604/Hutchison_Whampoa>,
        <https://1145.am/db/2661115/Hutchison_Whampoa>,
        <https://1145.am/db/2661611/Hutchison_Whampoa>,
        <https://1145.am/db/2661995/Hutchison_Whampoa>,
        <https://1145.am/db/2662060/Hutchison_Whampoa>,
        <https://1145.am/db/2662671/Hutchison_Whampoa>,
        <https://1145.am/db/2663091/Hutchison_Whampoa>,
        <https://1145.am/db/2663180/Hutchison_Whampoa>,
        <https://1145.am/db/2663183/Hutchison_Whampoa>,
        <https://1145.am/db/2663765/Hutchison_Whampoa>,
        <https://1145.am/db/2663773/Hutchison_Whampoa>,
        <https://1145.am/db/2664160/Hutchison_Whampoa>,
        <https://1145.am/db/2664193/Hutchison_Whampoa>,
        <https://1145.am/db/2665345/Hutchison_Whampoa>,
        <https://1145.am/db/2666404/Hutchison_Whampoa>,
        <https://1145.am/db/2666405/Hutchison_Whampoa>,
        <https://1145.am/db/2666440/Hutchison_Whampoa>,
        <https://1145.am/db/2666446/Hutchison_Whampoa>,
        <https://1145.am/db/2667500/Hutchison_Whampoa>,
        <https://1145.am/db/2667525/Hutchison_Whampoa>,
        <https://1145.am/db/2668564/Hutchison_Whampoa>,
        <https://1145.am/db/2668609/Hutchison_Whampoa>,
        <https://1145.am/db/2669163/Hutchison_Whampoa>,
        <https://1145.am/db/2669627/Hutchison_Whampoa>,
        <https://1145.am/db/2669644/Hutchison_Whampoa>,
        <https://1145.am/db/2669657/Hutchison_Whampoa>,
        <https://1145.am/db/2669661/Hutchison_Whampoa>,
        <https://1145.am/db/2669679/Hutchison_Whampoa>,
        <https://1145.am/db/2669683/Hutchison_Whampoa>,
        <https://1145.am/db/2670738/Hutchison_Whampoa>,
        <https://1145.am/db/2670759/Hutchison_Whampoa>,
        <https://1145.am/db/2670760/Hutchison_Whampoa>,
        <https://1145.am/db/2671957/Hutchison_Whampoa>,
        <https://1145.am/db/2671975/Hutchison_Whampoa>,
        <https://1145.am/db/2674259/Hutchison_Whampoa>,
        <https://1145.am/db/2675045/Hutchison_Whampoa>,
        <https://1145.am/db/2675046/Hutchison_Whampoa>,
        <https://1145.am/db/2676214/Hutchison_Whampoa>,
        <https://1145.am/db/2676230/Hutchison_Whampoa>,
        <https://1145.am/db/2676888/Hutchison_Whampoa>,
        <https://1145.am/db/2677417/Hutchison_Whampoa>,
        <https://1145.am/db/2679024/Hutchison_Whampoa>,
        <https://1145.am/db/2680055/Hutchison_Whampoa>,
        <https://1145.am/db/2680659/Hutchison_Whampoa>,
        <https://1145.am/db/2681845/Hutchison_Whampoa> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654050/Samsung> a org:Organization ;
    ns1:basedInLowRaw "South Korea" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "Samsung" ;
    ns1:industry "electronics" ;
    ns1:investor <https://1145.am/db/2654050/Investment_Samsung_Has_Not_Happened> ;
    ns1:name "Samsung" ;
    ns1:sameAsHigh <https://1145.am/db/1290793/Samsung_Electronics>,
        <https://1145.am/db/1449479/Samsung_Electronics>,
        <https://1145.am/db/1451663/Samsung>,
        <https://1145.am/db/1603183/Samsung>,
        <https://1145.am/db/1697653/Samsung_Electronics>,
        <https://1145.am/db/1727143/Samsung>,
        <https://1145.am/db/1734134/Samsung>,
        <https://1145.am/db/1765169/Samsung_Electronics>,
        <https://1145.am/db/1790627/Samsung>,
        <https://1145.am/db/1793783/Samsung_Electronics>,
        <https://1145.am/db/1820996/Samsung>,
        <https://1145.am/db/1837435/Samsung>,
        <https://1145.am/db/1955019/Samsung_Electronics_Co_Ltd>,
        <https://1145.am/db/2088748/Samsung_Electronics>,
        <https://1145.am/db/2090145/Samsung_Electronics>,
        <https://1145.am/db/2158283/Samsung>,
        <https://1145.am/db/224117/Samsung_Electronics>,
        <https://1145.am/db/2378775/Samsung_Electronics_Co>,
        <https://1145.am/db/2564116/Samsung_Group>,
        <https://1145.am/db/2663344/Samsung>,
        <https://1145.am/db/2665514/Samsung_Electronics>,
        <https://1145.am/db/2723824/Samsung>,
        <https://1145.am/db/2751106/Samsung_Electronics_Co>,
        <https://1145.am/db/648777/Samsung_Electronics_Co_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/1562073/Samsung>,
        <https://1145.am/db/1668508/Samsung>,
        <https://1145.am/db/1707159/Samsung>,
        <https://1145.am/db/1769562/Samsung>,
        <https://1145.am/db/1770734/Samsung>,
        <https://1145.am/db/1788188/Samsung>,
        <https://1145.am/db/1796199/Samsung>,
        <https://1145.am/db/1796418/Samsung>,
        <https://1145.am/db/1796956/Samsung>,
        <https://1145.am/db/1803603/Samsung>,
        <https://1145.am/db/1804219/Samsung>,
        <https://1145.am/db/1805409/Samsung>,
        <https://1145.am/db/1807067/Samsung>,
        <https://1145.am/db/1820787/Samsung>,
        <https://1145.am/db/1823745/Samsung>,
        <https://1145.am/db/1830530/Samsung>,
        <https://1145.am/db/1835088/Samsung>,
        <https://1145.am/db/1852041/Samsung>,
        <https://1145.am/db/1862338/Samsung>,
        <https://1145.am/db/2062640/Samsung>,
        <https://1145.am/db/2075166/Samsung>,
        <https://1145.am/db/2163941/Samsung>,
        <https://1145.am/db/2168661/Samsung>,
        <https://1145.am/db/2333983/Samsung>,
        <https://1145.am/db/2564619/Samsung>,
        <https://1145.am/db/2608775/Samsung>,
        <https://1145.am/db/2609535/Samsung>,
        <https://1145.am/db/2610843/Samsung>,
        <https://1145.am/db/2638289/Samsung>,
        <https://1145.am/db/2645664/Samsung>,
        <https://1145.am/db/2651403/Samsung>,
        <https://1145.am/db/2651415/Samsung>,
        <https://1145.am/db/2651878/Samsung>,
        <https://1145.am/db/2656975/Samsung>,
        <https://1145.am/db/2676222/Samsung>,
        <https://1145.am/db/2676293/Samsung>,
        <https://1145.am/db/2681897/Samsung>,
        <https://1145.am/db/2718151/Samsung>,
        <https://1145.am/db/613111/Samsung>,
        <https://1145.am/db/837305/Samsung> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654050/Youku> a org:Organization ;
    ns1:basedInHighGeoName "Peopleâ€™s Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:buyer <https://1145.am/db/2654050/Tudou_Acquisition> ;
    ns1:description "online video" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "Youku" ;
    ns1:industry "online video" ;
    ns1:name "Youku" ;
    ns1:sameAsHigh <https://1145.am/db/1773881/Youku>,
        <https://1145.am/db/1791088/Youku_Tudou>,
        <https://1145.am/db/1830302/Youku>,
        <https://1145.am/db/2178040/Youku>,
        <https://1145.am/db/2668108/Youku> ;
    ns1:sameAsMedium <https://1145.am/db/1790408/Youku>,
        <https://1145.am/db/2657684/Youku> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2662018/Bharti_Infratel> a org:Organization ;
    ns1:basedInLowRaw "India" ;
    ns1:buyer <https://1145.am/db/2662018/Ipo_Bharti_Infratel_Has_Not_Happened> ;
    ns1:documentDate "2012-12-02T20:25:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: iPhone 5 China debut, Bharti tower IPO coming in Dec" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-iphone-5-china-debut-bharti-tower-ipo-coming-dec> ;
    ns1:foundName "Bharti Infratel" ;
    ns1:name "Bharti Infratel" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2662018/Globe_Telecom> a org:Organization ;
    ns1:basedInHighGeoName "Republic of the Philippines" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1694008/about.rdf> ;
    ns1:basedInHighRaw "Philippines" ;
    ns1:documentDate "2012-12-02T20:25:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: iPhone 5 China debut, Bharti tower IPO coming in Dec" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-iphone-5-china-debut-bharti-tower-ipo-coming-dec> ;
    ns1:foundName "Globe Telecom" ;
    ns1:investor <https://1145.am/db/2662018/Investment_Bayantel_Globe_Telecom_Ideas_Interactivas_Sa_Worldwide_Directories_Sa_Completed> ;
    ns1:name "Globe Telecom" ;
    ns1:sameAsMedium <https://1145.am/db/1274013/Globe_Telecom_Inc>,
        <https://1145.am/db/1274615/Globe_Telecom_Inc>,
        <https://1145.am/db/1372878/Globe_Telecom_Inc>,
        <https://1145.am/db/1809073/Globe_Telecom>,
        <https://1145.am/db/194793/Globe_Telecom_Inc>,
        <https://1145.am/db/195901/Globe_Telecom_Inc>,
        <https://1145.am/db/2613008/Globe_Telecom>,
        <https://1145.am/db/2653043/Globe_Telecom> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663114/Barclays> a org:Organization ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:foundName "Barclays" ;
    ns1:name "Barclays" ;
    ns1:participant <https://1145.am/db/2663114/Linksys_Unit_Acquisition> ;
    ns1:sameAsMedium <https://1145.am/db/1052007/Barclays>,
        <https://1145.am/db/1119958/Barclays_Plc>,
        <https://1145.am/db/1138209/Barclays>,
        <https://1145.am/db/1158639/Barclays>,
        <https://1145.am/db/1256453/Barclays>,
        <https://1145.am/db/1318729/Barclays>,
        <https://1145.am/db/1320328/Barclays>,
        <https://1145.am/db/1325657/Barclays>,
        <https://1145.am/db/1369750/Barclays>,
        <https://1145.am/db/1386448/Barclays>,
        <https://1145.am/db/1390900/Barclays>,
        <https://1145.am/db/1398305/Barclays>,
        <https://1145.am/db/1398785/Barclays>,
        <https://1145.am/db/1535433/Barclays_Plc>,
        <https://1145.am/db/1560422/Barclays>,
        <https://1145.am/db/1560681/Barclays>,
        <https://1145.am/db/1561709/Barclays>,
        <https://1145.am/db/1664523/Barclays>,
        <https://1145.am/db/1711849/Barclays>,
        <https://1145.am/db/1738503/Barclays>,
        <https://1145.am/db/1757788/Barclays>,
        <https://1145.am/db/1761801/Barclays>,
        <https://1145.am/db/1782187/Barclays>,
        <https://1145.am/db/2006859/Barclays>,
        <https://1145.am/db/2017075/Barclays>,
        <https://1145.am/db/2030556/Barclays>,
        <https://1145.am/db/203894/Barclays_Plc>,
        <https://1145.am/db/2039617/Barclays>,
        <https://1145.am/db/2040062/Barclays>,
        <https://1145.am/db/2048950/Barclays>,
        <https://1145.am/db/2057312/Barclays_Plc>,
        <https://1145.am/db/2057876/Barclays>,
        <https://1145.am/db/2067142/Barclays>,
        <https://1145.am/db/2067243/Barclays>,
        <https://1145.am/db/2076122/Barclays>,
        <https://1145.am/db/2079516/Barclays>,
        <https://1145.am/db/2083901/Barclays>,
        <https://1145.am/db/2098284/Barclays>,
        <https://1145.am/db/2098501/Barclays_Plc>,
        <https://1145.am/db/2107397/Barclays_Plc>,
        <https://1145.am/db/2117967/Barclays>,
        <https://1145.am/db/2118316/Barclays>,
        <https://1145.am/db/2145936/Barclays>,
        <https://1145.am/db/2507499/Barclays>,
        <https://1145.am/db/2717698/Barclays>,
        <https://1145.am/db/273673/Barclays>,
        <https://1145.am/db/2792596/Barclays_Plc>,
        <https://1145.am/db/2794241/Barclays>,
        <https://1145.am/db/367126/Barclays>,
        <https://1145.am/db/371012/Barclays>,
        <https://1145.am/db/400742/Barclays>,
        <https://1145.am/db/400782/Barclays>,
        <https://1145.am/db/431419/Barclays>,
        <https://1145.am/db/440744/Barclays>,
        <https://1145.am/db/442259/Barclays>,
        <https://1145.am/db/472446/Barclays>,
        <https://1145.am/db/473489/Barclays>,
        <https://1145.am/db/526031/Barclays>,
        <https://1145.am/db/543219/Barclays>,
        <https://1145.am/db/582345/Barclays>,
        <https://1145.am/db/582464/Barclays>,
        <https://1145.am/db/607859/Barclays>,
        <https://1145.am/db/623014/Barclays>,
        <https://1145.am/db/626235/Barclays>,
        <https://1145.am/db/762584/Barclays_Plc>,
        <https://1145.am/db/769854/Barclays>,
        <https://1145.am/db/895766/Barclays>,
        <https://1145.am/db/905833/Barclays>,
        <https://1145.am/db/913573/Barclays>,
        <https://1145.am/db/935939/Barclays>,
        <https://1145.am/db/937286/Barclays>,
        <https://1145.am/db/943889/Barclays_Plc> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663114/Dbs_Bank> a org:Organization ;
    ns1:basedInHighGeoName "Republic of Singapore" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1880251/about.rdf> ;
    ns1:basedInHighRaw "Singapore" ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:foundName "DBS bank" ;
    ns1:investor <https://1145.am/db/2663114/Bharat_Sanchar_Nigam_Limited_Investment> ;
    ns1:name "DBS bank" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663114/Investment_Alcatel-Lucent_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Alcatel-Lucent secured a 1.615 billion euros ($ 2.1 billion) financing pact from banking giants Credit Suisse and Goldman Sachs, as the struggling telecom-equipment company attempts to climb out of the red and refinance debt." ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2663114/Alcatel-Lucent> ;
    ns1:valueRaw "$ 2.1 billion",
        "1.615 billion euros" ;
    ns1:whereRaw "Alcatel-Lucent" .

<https://1145.am/db/2168593/Investment_Rogers_Communications_Tv_Interactive_Systems_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-04T15:13:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Rogers' Communications has invested $ 2.5 million in automatic content recognition services provider TV Interactive Systems (aka Cognitive Networks) ." ;
    ns1:documentTitle "MTV Spain launches second screen app; Rogers invests in interactive TV" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/mtv-spain-launches-second-screen-app-rogers-invests-interactive-tv> ;
    ns1:foundName "invested" ;
    ns1:name "invested" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2168593/Tv_Interactive_Systems> ;
    ns1:targetName "TV Interactive Systems" ;
    ns1:valueRaw "$ 2.5 million" ;
    ns1:whereGeoName "Canada",
        "Europe" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf>,
        <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Canada",
        "Europe" .

<https://1145.am/db/2168593/Merger_Canal_Plus_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2012-12-04T15:13:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Canal Plus has wrapped up the merger of Poland's multiple pay TV interests." ;
    ns1:documentTitle "MTV Spain launches second screen app; Rogers invests in interactive TV" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/mtv-spain-launches-second-screen-app-rogers-invests-interactive-tv> ;
    ns1:foundName "merger" ;
    ns1:name "merger" ;
    ns1:sourceName "StreamTV Insider" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2168593/Tv_Interactive_Systems> a org:Organization ;
    ns1:documentDate "2012-12-04T15:13:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MTV Spain launches second screen app; Rogers invests in interactive TV" ;
    ns1:documentURL <https://www.streamtvinsider.com/cable/mtv-spain-launches-second-screen-app-rogers-invests-interactive-tv> ;
    ns1:foundName "TV Interactive Systems",
        "TV Interactive Systems (aka Cognitive Networks)" ;
    ns1:name "TV Interactive Systems" ;
    ns1:sourceName "StreamTV Insider" .

<https://1145.am/db/2239110/Beds_Investment_The_Hearst_Foundation_Valley_Presbyterian_Hospital_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-15T05:07:54+00:00"^^xsd:dateTime ;
    ns1:documentExtract "< 0 > Valley Presbyterian Hospital Awarded $ 50,000 Grant from Hearst Foundation < /0 >",
        "Valley Presbyterian Hospital (VPH) today announced it received a $ 50,000 grant from The Hearst Foundation to help purchase four state-of-the-art beds for its neonatal intensive care unit (NICU) ." ;
    ns1:documentTitle "Valley Presbyterian Hospital Awarded $50,000 Grant from Hearst Foundation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/valley-presbyterian-hospital-awarded-50-000-grant-from-hearst-foundation> ;
    ns1:foundName "grant",
        "purchase" ;
    ns1:name "grant",
        "purchase" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2239110/Valley_Presbyterian_Hospital> ;
    ns1:targetDetails "beds" ;
    ns1:valueRaw "$ 50,000" ;
    ns1:whereGeoName "California" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:whereRaw "California" .

<https://1145.am/db/2239110/Valley_Presbyterian_Hospital> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "medical services" ;
    ns1:documentDate "2012-11-15T05:07:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Valley Presbyterian Hospital Awarded $50,000 Grant from Hearst Foundation" ;
    ns1:documentURL <https://www.fiercehealthcare.com/healthcare/valley-presbyterian-hospital-awarded-50-000-grant-from-hearst-foundation> ;
    ns1:foundName "Valley Presbyterian Hospital" ;
    ns1:industry "Hospital" ;
    ns1:name "Valley Presbyterian Hospital" ;
    ns1:sameAsHigh <https://1145.am/db/2235176/Valley_Presbyterian_Hospital> ;
    ns1:sameAsMedium <https://1145.am/db/2240122/Valley_Presbyterian_Hospital> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2263385/Acquisition_Aetna_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2012-11-22T05:04:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Coventry Health Care, Inc. (NYSE: CVH) announced that its stockholders voted at the stockholder special meeting held earlier today to approve the adoption of the previously announced merger agreement, dated as of August 19, 2012, as amended, providing for the acquisition of Coventry by Aetna." ;
    ns1:documentTitle "Coventry Health Care Announces Stockholder Approval of Merger Agreement with Aetna" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/coventry-health-care-announces-stockholder-approval-merger-agreement-aetna> ;
    ns1:foundName "merger" ;
    ns1:name "merger" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2263385/Coventry_Health_Care> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "health care" ;
    ns1:documentDate "2012-11-22T05:04:40+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Coventry Health Care Announces Stockholder Approval of Merger Agreement with Aetna" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/coventry-health-care-announces-stockholder-approval-merger-agreement-aetna> ;
    ns1:foundName "Coventry" ;
    ns1:industry "Health Care" ;
    ns1:name "Coventry Health Care" ;
    ns1:sameAsHigh <https://1145.am/db/1074076/Coventry>,
        <https://1145.am/db/2207608/Coventry_Health_Care>,
        <https://1145.am/db/2239579/Coventry_Health_Care_Inc>,
        <https://1145.am/db/2247776/Coventry_Health_Care>,
        <https://1145.am/db/2247783/Coventry_Health_Care>,
        <https://1145.am/db/2256365/Coventry>,
        <https://1145.am/db/2256412/Coventry>,
        <https://1145.am/db/2259863/Coventry>,
        <https://1145.am/db/2263365/Coventry>,
        <https://1145.am/db/2263392/Coventry_Health_Care>,
        <https://1145.am/db/2264203/Coventry_Health_Care>,
        <https://1145.am/db/2264872/Coventry_Health_Care>,
        <https://1145.am/db/2266016/Coventry_Health_Care>,
        <https://1145.am/db/2267796/Coventry_Health_Care>,
        <https://1145.am/db/2267801/Coventry_Health_Care>,
        <https://1145.am/db/2268582/Coventry_Health_Care>,
        <https://1145.am/db/2270379/Coventry>,
        <https://1145.am/db/2271277/Coventry_Health_Care> ;
    ns1:sourceName "Fierce Healthcare" .

<https://1145.am/db/2263385/Coventry_Health_Care_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2012-11-22T05:04:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Coventry Health Care, Inc. (NYSE: CVH) announced that its stockholders voted at the stockholder special meeting held earlier today to approve the adoption of the previously announced merger agreement, dated as of August 19, 2012, as amended, providing for the acquisition of Coventry by Aetna." ;
    ns1:documentTitle "Coventry Health Care Announces Stockholder Approval of Merger Agreement with Aetna" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/coventry-health-care-announces-stockholder-approval-merger-agreement-aetna> ;
    ns1:foundName "acquisition",
        "merger" ;
    ns1:name "acquisition",
        "merger" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2263385/Coventry_Health_Care> ;
    ns1:targetName "Coventry Health Care" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2263385/Merger_Aetna_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2012-11-22T05:04:40+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Coventry Health Care, Inc. (NYSE: CVH) announced that its stockholders voted at the stockholder special meeting held earlier today to approve the adoption of the previously announced merger agreement, dated as of August 19, 2012, as amended, providing for the acquisition of Coventry by Aetna." ;
    ns1:documentTitle "Coventry Health Care Announces Stockholder Approval of Merger Agreement with Aetna" ;
    ns1:documentURL <https://www.fiercehealthcare.com/payer/coventry-health-care-announces-stockholder-approval-merger-agreement-aetna> ;
    ns1:foundName "acquisition" ;
    ns1:name "acquisition" ;
    ns1:sourceName "Fierce Healthcare" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2291004/Series_A_Investment_Founders_Fund_Tribogenics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-24T12:13:54+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Tribogenics closed a $ 6.2 million Series A round led by Founders Fund.",
        "@ FierceMedDev: Tribogenics pulled in a $ 6.2M Series A round, to help develop portable X-ray sources for medical imaging." ;
    ns1:documentTitle "Medtronic wins CE mark for blood oxygenation system; Researchers develop advanced 'virtual' foot as treatment aid;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/medtronic-wins-ce-mark-for-blood-oxygenation-system-researchers-develop-advanced> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2291004/Tribogenics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 6.2 million",
        "$ 6.2M" ;
    ns1:whereGeoName "Commonwealth of Australia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2077456/about.rdf> ;
    ns1:whereRaw "Australia" .

<https://1145.am/db/2291004/Tribogenics> a org:Organization ;
    ns1:description "medical imaging" ;
    ns1:documentDate "2012-09-24T12:13:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Medtronic wins CE mark for blood oxygenation system; Researchers develop advanced 'virtual' foot as treatment aid;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/medtronic-wins-ce-mark-for-blood-oxygenation-system-researchers-develop-advanced> ;
    ns1:foundName "Tribogenics" ;
    ns1:industry "medical imaging" ;
    ns1:name "Tribogenics" ;
    ns1:sameAsMedium <https://1145.am/db/2295226/Tribogenics>,
        <https://1145.am/db/2295809/Tribogenics>,
        <https://1145.am/db/2335353/Tribogenics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294367/Investment_Sofinnova_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-11T15:14:23+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Sofinnova Partners, a French VC outfit, has amassed a $ 312 million fund it plans to spend on life sciences investments." ;
    ns1:documentTitle "Abbott starts trading AbbVie spinout; Grove Instruments raises $3M for glucometer project;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/abbott-starts-trading-abbvie-spinout-grove-instruments-raises-3m-for-glucometer> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:valueRaw "$ 312 million" ;
    ns1:whereGeoName "Republic of France" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:whereRaw "France" .

<https://1145.am/db/2294367/Massachusetts_Grove_Instruments> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "looking to fund the development of its noninvasive glucometer" ;
    ns1:documentDate "2012-12-11T15:14:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Abbott starts trading AbbVie spinout; Grove Instruments raises $3M for glucometer project;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/abbott-starts-trading-abbvie-spinout-grove-instruments-raises-3m-for-glucometer> ;
    ns1:foundName "Massachusetts' Grove Instruments" ;
    ns1:industry "medical devices" ;
    ns1:name "Massachusetts' Grove Instruments" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2294367/Series_B-1_Investment_European_Public_Health_Alliance_Massachusetts_Grove_Instruments_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-11T15:14:23+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Massachusetts' Grove Instruments closed a $ 3 million tranche of a Series B-1 round, looking to fund the development of its noninvasive glucometer, which the company says is the first of its kind." ;
    ns1:documentTitle "Abbott starts trading AbbVie spinout; Grove Instruments raises $3M for glucometer project;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/abbott-starts-trading-abbvie-spinout-grove-instruments-raises-3m-for-glucometer> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2294367/Massachusetts_Grove_Instruments> ;
    ns1:targetDetails "Series B-1" ;
    ns1:valueRaw "$ 3 million" ;
    ns1:whereGeoName "Republic of France" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:whereRaw "France" .

<https://1145.am/db/2294367/Sofinnova_Partners> a org:Organization ;
    ns1:basedInHighGeoName "Republic of France" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/3017382/about.rdf> ;
    ns1:basedInHighRaw "France" ;
    ns1:description "life sciences investments" ;
    ns1:documentDate "2012-12-11T15:14:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Abbott starts trading AbbVie spinout; Grove Instruments raises $3M for glucometer project;" ;
    ns1:documentURL <https://www.fiercebiotech.com/medical-devices/abbott-starts-trading-abbvie-spinout-grove-instruments-raises-3m-for-glucometer> ;
    ns1:foundName "Sofinnova Partners" ;
    ns1:industry "VC" ;
    ns1:investor <https://1145.am/db/2294367/Investment_Sofinnova_Partners_Completed> ;
    ns1:name "Sofinnova Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1586510/Sopris_Capital>,
        <https://1145.am/db/1707724/Sofinnova_Partners>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/2079459/Sopris_Capital>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2286182/Sofinnova_Partners>,
        <https://1145.am/db/2292168/Sofinnova>,
        <https://1145.am/db/2321542/Sofinnova_Partners>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2335582/Sofinnova_Partners>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2370118/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/798753/Sofinnova_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1039135/Sofinnova_Partners>,
        <https://1145.am/db/1054859/Sofinnova_Partners>,
        <https://1145.am/db/1112260/Sofinnova_Partners>,
        <https://1145.am/db/1113007/Sofinnova_Partners>,
        <https://1145.am/db/1118732/Sofinnova_Partners>,
        <https://1145.am/db/1196006/Sofinnova_Partners>,
        <https://1145.am/db/1196618/Sofinnova_Partners>,
        <https://1145.am/db/1199155/Sofinnova_Partners>,
        <https://1145.am/db/1419128/Sofinnova_Partners>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490997/Sofinnova_Partners>,
        <https://1145.am/db/1583413/Sofinnova_Partners>,
        <https://1145.am/db/1584328/Sofinnova_Partners>,
        <https://1145.am/db/1618717/Sofinnova_Partners>,
        <https://1145.am/db/1619418/Sofinnova_Partners>,
        <https://1145.am/db/1722774/Sofinnova_Partners>,
        <https://1145.am/db/1735325/Sofinnova_Partners>,
        <https://1145.am/db/1773491/Sofinnova_Partners>,
        <https://1145.am/db/1802402/Sofinnova_Partners>,
        <https://1145.am/db/1876390/Sofinnova_Partners>,
        <https://1145.am/db/1892777/Sofinnova_Partners>,
        <https://1145.am/db/1919228/Sofinnova_Partners>,
        <https://1145.am/db/1928060/Sofinnova_Partners>,
        <https://1145.am/db/1975388/Sofinnova_Partners>,
        <https://1145.am/db/2066938/Sofinnova_Partners>,
        <https://1145.am/db/2075963/Sofinnova_Partners>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2152180/Sofinnova_Partners>,
        <https://1145.am/db/2153042/Sofinnova_Partners>,
        <https://1145.am/db/2153373/Sofinnova_Partners>,
        <https://1145.am/db/2280230/Sofinnova_Partners>,
        <https://1145.am/db/2282400/Sofinnova_Partners>,
        <https://1145.am/db/2282747/Sofinnova_Partners>,
        <https://1145.am/db/2286404/Sofinnova_Partners>,
        <https://1145.am/db/2288699/Sofinnova_Partners>,
        <https://1145.am/db/2291023/Sofinnova_Partners>,
        <https://1145.am/db/2291790/Sofinnova_Partners>,
        <https://1145.am/db/2294502/Sofinnova_Partners>,
        <https://1145.am/db/2297649/Sofinnova_Partners>,
        <https://1145.am/db/2298624/Sofinnova_Partners>,
        <https://1145.am/db/2298631/Sofinnova_Partners>,
        <https://1145.am/db/2298641/Sofinnova_Partners>,
        <https://1145.am/db/2299758/Sofinnova_Partners>,
        <https://1145.am/db/2302741/Sofinnova_Partners>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2303849/Sofinnova_Partners>,
        <https://1145.am/db/2306395/Sofinnova_Partners>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2322646/Sofinnova_Partners>,
        <https://1145.am/db/2323100/Sofinnova_Partners>,
        <https://1145.am/db/2323102/Sofinnova_Partners>,
        <https://1145.am/db/2323243/Sofinnova_Partners>,
        <https://1145.am/db/2324027/Sofinnova_Partners>,
        <https://1145.am/db/2324034/Sofinnova_Partners>,
        <https://1145.am/db/2325549/Sofinnova_Partners>,
        <https://1145.am/db/2327222/Sofinnova_Partners>,
        <https://1145.am/db/2328763/Sofinnova_Partners>,
        <https://1145.am/db/2328769/Sofinnova_Partners>,
        <https://1145.am/db/2328825/Sofinnova_Partners>,
        <https://1145.am/db/2330876/Sofinnova_Partners>,
        <https://1145.am/db/2336333/Sofinnova_Partners>,
        <https://1145.am/db/2336335/Sofinnova_Partners>,
        <https://1145.am/db/2339692/Sofinnova_Partners>,
        <https://1145.am/db/2343301/Sofinnova_Partners>,
        <https://1145.am/db/2343545/Sofinnova_Partners>,
        <https://1145.am/db/2349013/Sofinnova_Partners>,
        <https://1145.am/db/2354296/Sofinnova_Partners>,
        <https://1145.am/db/2355740/Sofinnova_Partners>,
        <https://1145.am/db/2355741/Sofinnova_Partners>,
        <https://1145.am/db/2355885/Sofinnova_Partners>,
        <https://1145.am/db/2358268/Sofinnova_Partners>,
        <https://1145.am/db/2358269/Sofinnova_Partners>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/236357/Sofinnova_Partners>,
        <https://1145.am/db/2363593/Sofinnova_Partners>,
        <https://1145.am/db/2363597/Sofinnova_Partners>,
        <https://1145.am/db/2365826/Sofinnova_Partners>,
        <https://1145.am/db/2366303/Sofinnova_Partners>,
        <https://1145.am/db/2367549/Sofinnova_Partners>,
        <https://1145.am/db/2538923/Sofinnova_Partners>,
        <https://1145.am/db/2555540/Sofinnova_Partners>,
        <https://1145.am/db/2571050/Sofinnova_Partners>,
        <https://1145.am/db/2578627/Sofinnova_Partners>,
        <https://1145.am/db/2765863/Sofinnova_Partners>,
        <https://1145.am/db/2765866/Sofinnova_Partners>,
        <https://1145.am/db/2765873/Sofinnova_Partners>,
        <https://1145.am/db/530060/Sofinnova_Partners>,
        <https://1145.am/db/555385/Sofinnova_Partners>,
        <https://1145.am/db/577785/Sofinnova_Partners>,
        <https://1145.am/db/595282/Sofinnova_Partners>,
        <https://1145.am/db/602316/Sofinnova_Partners>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/695229/Sofinnova_Partners>,
        <https://1145.am/db/695704/Sofinnova_Partners>,
        <https://1145.am/db/810584/Sofinnova_Partners>,
        <https://1145.am/db/955355/Sofinnova_Partners>,
        <https://1145.am/db/992046/Sofinnova_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2331148/Complete_Genomics> a org:Organization ;
    ns1:basedInHighGeoName "Mountain View" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5375480/about.rdf> ;
    ns1:basedInHighRaw "Mountain View, CA" ;
    ns1:documentDate "2012-09-17T13:27:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "China's BGI strikes deal to buy Complete Genomics for $117.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/data-management/china-s-bgi-strikes-deal-to-buy-complete-genomics-for-117-6m> ;
    ns1:foundName "Complete",
        "Complete Genomics" ;
    ns1:name "Complete Genomics" ;
    ns1:sameAsMedium <https://1145.am/db/2309490/Complete_Genomics>,
        <https://1145.am/db/2309491/Complete_Genomics_Inc>,
        <https://1145.am/db/2328257/Complete_Genomics>,
        <https://1145.am/db/2331149/Complete_Genomics>,
        <https://1145.am/db/2340834/Complete_Genomics>,
        <https://1145.am/db/2352804/Complete_Genomics>,
        <https://1145.am/db/2352807/Complete_Genomics>,
        <https://1145.am/db/2360068/Complete_Genomics>,
        <https://1145.am/db/2360069/Complete_Genomics>,
        <https://1145.am/db/2360075/Complete_Genomics>,
        <https://1145.am/db/2360628/Complete_Genomics>,
        <https://1145.am/db/2360631/Complete_Genomics>,
        <https://1145.am/db/2364122/Complete_Genomics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332234/Investment_Gld_Invest_Qlucore_Qlucore_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-25T13:40:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Qlucore, a Swedish maker of software for analyzing scientific data in academic and pharma labs, is eyeing expansion in the U.S.",
        "The bioinformatics outfit has raised $ 840,000 from Stockholm - based venture firm GLD Invest, GenomeWeb reports." ;
    ns1:documentTitle "Swedish bioinformatics group grabs $840K to fuel growth, report says" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/swedish-bioinformatics-group-grabs-840k-to-fuel-growth-report-says> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2332234/Qlucore> ;
    ns1:valueRaw "$ 840,000" ;
    ns1:whereGeoName "Kingdom of Sweden" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:whereRaw "Sweden" .

<https://1145.am/db/2332234/Qlucore> a org:Organization ;
    ns1:basedInHighGeoName "Kingdom of Sweden" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2661886/about.rdf> ;
    ns1:basedInHighRaw "Sweden" ;
    ns1:description "analyzing scientific data" ;
    ns1:documentDate "2012-10-25T13:40:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Swedish bioinformatics group grabs $840K to fuel growth, report says" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/swedish-bioinformatics-group-grabs-840k-to-fuel-growth-report-says> ;
    ns1:foundName "Qlucore",
        "bioinformatics outfit" ;
    ns1:industry "bioinformatics" ;
    ns1:name "Qlucore" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2332322/Novira_Therapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Radnor" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5207490/about.rdf> ;
    ns1:basedInHighRaw "RADNOR, Pa." ;
    ns1:description "developing antivirals for treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentDate "2012-08-27T22:01:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/novira-therapeutics-secures-23-million-series-a-financing-to-advance-development-of> ;
    ns1:foundName "Novira Therapeutics",
        "Novira Therapeutics Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Novira Therapeutics",
        "Novira Therapeutics Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2344915/Novira_Therapeutics>,
        <https://1145.am/db/2347776/Novira_Therapeutics>,
        <https://1145.am/db/2351683/Novira_Therapeutics>,
        <https://1145.am/db/2351684/Novira_Therapeutics_Inc>,
        <https://1145.am/db/2367617/Novira_Therapeutics>,
        <https://1145.am/db/2572398/Novira_Therapeutics_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2344916/Novira_Therapeutics>,
        <https://1145.am/db/2344922/Novira_Therapeutics>,
        <https://1145.am/db/2359355/Novira_Therapeutics>,
        <https://1145.am/db/2361614/Novira_Therapeutics_Inc>,
        <https://1145.am/db/2362653/Novira_Therapeutics_Inc>,
        <https://1145.am/db/2365344/Novira_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333080/Growth_Capital_Investment_Merck_Global_Health_Innovation_Fund_Remedy_Informatics_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-19T15:17:22+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund.",
        "SALT LAKE CITY, Nov. 13, 2012 - Remedy Informatics, Inc., the leader in registries for healthcare and life science research, announced today that the Merck Global Health Innovation Fund (GHIF) has made an investment of growth capital in the company." ;
    ns1:documentTitle "Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/remedy-informatics-announces-growth-capital-investment-from-merck-global-health-innovation-fund> ;
    ns1:foundName "Investment",
        "investment" ;
    ns1:name "Investment",
        "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2333080/Remedy_Informatics> ;
    ns1:targetDetails "Growth Capital",
        "growth capital" ;
    ns1:valueRaw "roughly $ 6 million" ;
    ns1:when "2012-11-13T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Nov. 13, 2012" ;
    ns1:whereGeoName "Salt Lake City" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5780993/about.rdf> ;
    ns1:whereRaw "SALT LAKE CITY" .

<https://1145.am/db/2333080/Remedy_Informatics> a org:Organization ;
    ns1:basedInHighGeoName "Salt Lake City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5780993/about.rdf> ;
    ns1:basedInHighRaw "SALT LAKE CITY" ;
    ns1:description "healthcare and life science research" ;
    ns1:documentDate "2012-11-19T15:17:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Remedy Informatics Announces Growth Capital Investment from Merck Global Health Innovation Fund" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/remedy-informatics-announces-growth-capital-investment-from-merck-global-health-innovation-fund> ;
    ns1:foundName "Remedy Informatics",
        "Remedy Informatics, Inc." ;
    ns1:industry "healthcare" ;
    ns1:name "Remedy",
        "Remedy Informatics" ;
    ns1:sameAsHigh <https://1145.am/db/2346674/Remedy_Informatics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333119/Google_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-12-16T22:22:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "Google Ventures" ;
    ns1:investor <https://1145.am/db/2333119/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Sergey_Brin_Yuri_Milner_Completed> ;
    ns1:name "Google Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1114979/Google_Ventures>,
        <https://1145.am/db/1150887/Google_Ventures>,
        <https://1145.am/db/1153184/Google_Ventures>,
        <https://1145.am/db/1156925/Google_Ventures>,
        <https://1145.am/db/1157294/Google_Ventures>,
        <https://1145.am/db/1187183/Google_Ventures>,
        <https://1145.am/db/1189383/Google_Ventures>,
        <https://1145.am/db/1202509/Google_Ventures>,
        <https://1145.am/db/1202633/Google_Ventures>,
        <https://1145.am/db/1203099/Google_Ventures>,
        <https://1145.am/db/1397630/Google_Ventures>,
        <https://1145.am/db/1425239/Google_Ventures>,
        <https://1145.am/db/1427745/Google_Ventures>,
        <https://1145.am/db/1557175/Google_Ventures>,
        <https://1145.am/db/1558567/Google_Ventures>,
        <https://1145.am/db/1632690/Google_Ventures>,
        <https://1145.am/db/1714555/Google_Ventures>,
        <https://1145.am/db/1739125/Google_Ventures>,
        <https://1145.am/db/1752659/Google_Ventures>,
        <https://1145.am/db/1756840/Google_Ventures>,
        <https://1145.am/db/1758916/Google_Ventures>,
        <https://1145.am/db/1760954/Google_Ventures>,
        <https://1145.am/db/1760999/Google_Ventures>,
        <https://1145.am/db/1764012/Google_Ventures>,
        <https://1145.am/db/1768021/Google_Ventures>,
        <https://1145.am/db/1768511/Google_Ventures>,
        <https://1145.am/db/1769528/Google_Ventures>,
        <https://1145.am/db/1772778/Google_Ventures>,
        <https://1145.am/db/1773605/Google_Ventures>,
        <https://1145.am/db/1773703/Google_Ventures>,
        <https://1145.am/db/1776575/Google_Ventures>,
        <https://1145.am/db/1779277/Google_Ventures>,
        <https://1145.am/db/1780470/Google_Ventures>,
        <https://1145.am/db/1780582/Google_Ventures>,
        <https://1145.am/db/1786716/Google_Ventures>,
        <https://1145.am/db/1786818/Google_Ventures>,
        <https://1145.am/db/1793129/Google_Ventures>,
        <https://1145.am/db/1794049/Google_Ventures>,
        <https://1145.am/db/1798836/Google_Ventures>,
        <https://1145.am/db/1799162/Google_Ventures>,
        <https://1145.am/db/1803296/Google_Ventures>,
        <https://1145.am/db/1804887/Google_Ventures>,
        <https://1145.am/db/1805764/Google_Ventures>,
        <https://1145.am/db/1807288/Google_Ventures>,
        <https://1145.am/db/1808484/Google_Ventures>,
        <https://1145.am/db/1811851/Google_Ventures>,
        <https://1145.am/db/1813266/Google_Ventures>,
        <https://1145.am/db/1814186/Google_Ventures>,
        <https://1145.am/db/1816707/Google_Ventures>,
        <https://1145.am/db/1817262/Google_Ventures>,
        <https://1145.am/db/1818901/Google_Ventures>,
        <https://1145.am/db/1820380/Google_Ventures>,
        <https://1145.am/db/1821425/Google_Ventures>,
        <https://1145.am/db/1821752/Google_Ventures>,
        <https://1145.am/db/1824026/Google_Ventures>,
        <https://1145.am/db/1826007/Google_Ventures>,
        <https://1145.am/db/1827884/Google_Ventures>,
        <https://1145.am/db/1828072/Google_Ventures>,
        <https://1145.am/db/1830066/Google_Ventures>,
        <https://1145.am/db/1830101/Google_Ventures>,
        <https://1145.am/db/1830452/Google_Ventures>,
        <https://1145.am/db/1831764/Google_Ventures>,
        <https://1145.am/db/1832133/Google_Ventures>,
        <https://1145.am/db/1833010/Google_Ventures>,
        <https://1145.am/db/1833657/Google_Ventures>,
        <https://1145.am/db/1833931/Google_Ventures>,
        <https://1145.am/db/1834481/Google_Ventures>,
        <https://1145.am/db/1834503/Google_Ventures>,
        <https://1145.am/db/1837499/Google_Ventures>,
        <https://1145.am/db/1838965/Google_Ventures>,
        <https://1145.am/db/1840663/Google_Ventures>,
        <https://1145.am/db/1841061/Google_Ventures>,
        <https://1145.am/db/1842342/Google_Ventures>,
        <https://1145.am/db/1842817/Google_Ventures>,
        <https://1145.am/db/1843360/Google_Ventures>,
        <https://1145.am/db/1844180/Google_Ventures>,
        <https://1145.am/db/1844551/Google_Ventures>,
        <https://1145.am/db/1845023/Google_Ventures>,
        <https://1145.am/db/1848084/Google_Ventures>,
        <https://1145.am/db/1848585/Google_Ventures>,
        <https://1145.am/db/1849884/Google_Ventures>,
        <https://1145.am/db/1849967/Google_Ventures>,
        <https://1145.am/db/1853335/Google_Ventures>,
        <https://1145.am/db/1854208/Google_Ventures>,
        <https://1145.am/db/1854279/Google_Ventures>,
        <https://1145.am/db/1854797/Google_Ventures>,
        <https://1145.am/db/1856811/Google_Ventures>,
        <https://1145.am/db/1857105/Google_Ventures>,
        <https://1145.am/db/1857240/Google_Ventures>,
        <https://1145.am/db/1858438/Google_Ventures>,
        <https://1145.am/db/1858646/Google_Ventures>,
        <https://1145.am/db/1860878/Google_Ventures>,
        <https://1145.am/db/1861342/Google_Ventures>,
        <https://1145.am/db/1862168/Google_Ventures>,
        <https://1145.am/db/1864594/Google_Ventures>,
        <https://1145.am/db/1873505/Google_Ventures>,
        <https://1145.am/db/1876848/Google_Ventures>,
        <https://1145.am/db/1877178/Google_Ventures>,
        <https://1145.am/db/1877473/Google_Ventures>,
        <https://1145.am/db/1879716/Google_Ventures>,
        <https://1145.am/db/1882810/Google_Ventures>,
        <https://1145.am/db/1883008/Google_Ventures>,
        <https://1145.am/db/1885998/Google_Ventures>,
        <https://1145.am/db/1886357/Google_Ventures>,
        <https://1145.am/db/1886978/Google_Ventures>,
        <https://1145.am/db/1887982/Google_Ventures>,
        <https://1145.am/db/1896364/Google_Ventures>,
        <https://1145.am/db/1896419/Google_Ventures>,
        <https://1145.am/db/1911314/Google_Ventures>,
        <https://1145.am/db/1947312/Google_Ventures>,
        <https://1145.am/db/2097368/Google_Ventures>,
        <https://1145.am/db/2154341/Google_Ventures>,
        <https://1145.am/db/2180867/Google_Ventures>,
        <https://1145.am/db/2181184/Google_Ventures>,
        <https://1145.am/db/2183352/Google_Ventures>,
        <https://1145.am/db/2191183/Google_Ventures>,
        <https://1145.am/db/2194249/Google_Ventures>,
        <https://1145.am/db/2196786/Google_Ventures>,
        <https://1145.am/db/2198042/Google_Ventures>,
        <https://1145.am/db/2249658/Google_Ventures>,
        <https://1145.am/db/2269634/Google_Ventures>,
        <https://1145.am/db/2286291/Google_Ventures>,
        <https://1145.am/db/2292675/Google_Ventures>,
        <https://1145.am/db/2307494/Google_Ventures>,
        <https://1145.am/db/2308700/Google_Ventures>,
        <https://1145.am/db/2311992/Google_Ventures>,
        <https://1145.am/db/2319338/Google_Ventures>,
        <https://1145.am/db/2323524/Google_Ventures>,
        <https://1145.am/db/2342724/Google_Ventures>,
        <https://1145.am/db/2342725/Google_Ventures>,
        <https://1145.am/db/2349008/Google_Ventures>,
        <https://1145.am/db/2349426/Google_Ventures>,
        <https://1145.am/db/2350327/Google_Ventures>,
        <https://1145.am/db/2352489/Google_Ventures>,
        <https://1145.am/db/2356396/Google_Ventures>,
        <https://1145.am/db/2358888/Google_Ventures>,
        <https://1145.am/db/2359987/Google_Ventures>,
        <https://1145.am/db/2367199/Google_Ventures>,
        <https://1145.am/db/2367201/Google_Ventures>,
        <https://1145.am/db/2367681/Google_Ventures>,
        <https://1145.am/db/2370208/Google_Ventures>,
        <https://1145.am/db/2370240/Google_Ventures>,
        <https://1145.am/db/2541350/Google_Ventures>,
        <https://1145.am/db/2583442/Google_Ventures>,
        <https://1145.am/db/490110/Google_Ventures>,
        <https://1145.am/db/494920/Google_Ventures>,
        <https://1145.am/db/658803/Google_Ventures>,
        <https://1145.am/db/773684/Google_Ventures>,
        <https://1145.am/db/8080/Google_Ventures>,
        <https://1145.am/db/823763/Google_Ventures>,
        <https://1145.am/db/923065/Google_Ventures>,
        <https://1145.am/db/962870/Google_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2334847/Nanodimension> a org:Organization ;
    ns1:basedInLowRaw "MA" ;
    ns1:documentDate "2012-12-18T21:04:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/blend-therapeutics-closes-16-million-series-b-financing> ;
    ns1:foundName "NanoDimension" ;
    ns1:investor <https://1145.am/db/2334847/Series_B_Investment_Blend_Therapeutics_Flagship_Ventures_Nanodimension_New_Enterprise_Associates_Completed> ;
    ns1:name "NanoDimension" ;
    ns1:sameAsMedium <https://1145.am/db/2302116/Nanodimension>,
        <https://1145.am/db/2324431/Nanodimension>,
        <https://1145.am/db/2341484/Nanodimension>,
        <https://1145.am/db/2341487/Nanodimension>,
        <https://1145.am/db/2358506/Nanodimension>,
        <https://1145.am/db/2358529/Nanodimension>,
        <https://1145.am/db/2366654/Nanodimension> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336503/The_Column_Group> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:06:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-1> ;
    ns1:foundName "The Column Group" ;
    ns1:investor <https://1145.am/db/2336503/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "The Column Group" ;
    ns1:sameAsMedium <https://1145.am/db/1503058/The_Column_Group>,
        <https://1145.am/db/1533327/The_Column_Group>,
        <https://1145.am/db/1533685/The_Column_Group>,
        <https://1145.am/db/1536915/The_Column_Group>,
        <https://1145.am/db/1624208/The_Column_Group>,
        <https://1145.am/db/2283431/The_Column_Group>,
        <https://1145.am/db/2287253/The_Column_Group>,
        <https://1145.am/db/2291277/The_Column_Group>,
        <https://1145.am/db/2294202/The_Column_Group>,
        <https://1145.am/db/2304335/The_Column_Group>,
        <https://1145.am/db/2304340/The_Column_Group>,
        <https://1145.am/db/2304769/The_Column_Group>,
        <https://1145.am/db/2305256/The_Column_Group>,
        <https://1145.am/db/2327474/The_Column_Group>,
        <https://1145.am/db/2335700/The_Column_Group>,
        <https://1145.am/db/2336505/The_Column_Group>,
        <https://1145.am/db/2336524/The_Column_Group>,
        <https://1145.am/db/2339704/The_Column_Group>,
        <https://1145.am/db/2339883/The_Column_Group>,
        <https://1145.am/db/2344735/The_Column_Group>,
        <https://1145.am/db/2347885/The_Column_Group>,
        <https://1145.am/db/2350364/The_Column_Group>,
        <https://1145.am/db/2351394/The_Column_Group>,
        <https://1145.am/db/2351397/The_Column_Group>,
        <https://1145.am/db/2359334/The_Column_Group>,
        <https://1145.am/db/2359468/The_Column_Group>,
        <https://1145.am/db/2359864/The_Column_Group>,
        <https://1145.am/db/2362475/The_Column_Group>,
        <https://1145.am/db/2362481/The_Column_Group>,
        <https://1145.am/db/2362565/The_Column_Group>,
        <https://1145.am/db/2362566/The_Column_Group>,
        <https://1145.am/db/2365363/The_Column_Group>,
        <https://1145.am/db/2368280/The_Column_Group>,
        <https://1145.am/db/2368501/The_Column_Group>,
        <https://1145.am/db/2583013/The_Column_Group>,
        <https://1145.am/db/2584056/The_Column_Group>,
        <https://1145.am/db/2584561/The_Column_Group>,
        <https://1145.am/db/425281/The_Column_Group>,
        <https://1145.am/db/426160/The_Column_Group>,
        <https://1145.am/db/490696/The_Column_Group>,
        <https://1145.am/db/75445/The_Column_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336503/Topspin_Fund> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:06:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-1> ;
    ns1:foundName "Topspin Fund" ;
    ns1:investor <https://1145.am/db/2336503/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "Topspin Fund" ;
    ns1:sameAsMedium <https://1145.am/db/1653506/Topspin_Fund>,
        <https://1145.am/db/2336505/Topspin_Fund>,
        <https://1145.am/db/2336524/Topspin_Fund>,
        <https://1145.am/db/2339883/Topspin_Fund>,
        <https://1145.am/db/2359468/Topspin_Fund>,
        <https://1145.am/db/2583013/Topspin_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336503/Venbio> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:06:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-1> ;
    ns1:foundName "venBio" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2336503/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "venBio" ;
    ns1:sameAsHigh <https://1145.am/db/1172738/Verrica_Pharmaceuticals_Inc>,
        <https://1145.am/db/1173163/Verrica_Pharmaceuticals_Inc>,
        <https://1145.am/db/1592042/Venatorx_Pharmaceuticals>,
        <https://1145.am/db/1928985/Venatorx_Pharmaceuticals>,
        <https://1145.am/db/1957136/Vect-Horus>,
        <https://1145.am/db/2015251/Vectivbio_Holding_Ag>,
        <https://1145.am/db/2015407/Vectivbio>,
        <https://1145.am/db/2040146/Vectivbio>,
        <https://1145.am/db/2307347/The_Vectura_Group>,
        <https://1145.am/db/2323288/Vectura>,
        <https://1145.am/db/2336505/Venbio>,
        <https://1145.am/db/2336524/Venbio>,
        <https://1145.am/db/2357248/Vectura>,
        <https://1145.am/db/2357255/Vectura_Group_Plc>,
        <https://1145.am/db/2359468/Venbio>,
        <https://1145.am/db/2367790/Vectura>,
        <https://1145.am/db/2370755/Vectura>,
        <https://1145.am/db/2537626/Vectura>,
        <https://1145.am/db/2549943/Vectura>,
        <https://1145.am/db/2550933/Vectura>,
        <https://1145.am/db/2555127/Vectura>,
        <https://1145.am/db/2572820/Vectura_Group_Plc>,
        <https://1145.am/db/2583013/Venbio>,
        <https://1145.am/db/341447/Vectura_Group>,
        <https://1145.am/db/341462/Vectura_Group>,
        <https://1145.am/db/391980/Vectura>,
        <https://1145.am/db/392803/Vectura>,
        <https://1145.am/db/393331/Vectura>,
        <https://1145.am/db/393962/Vectura>,
        <https://1145.am/db/951050/Venatorx_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2346293/Venbio>,
        <https://1145.am/db/2352349/Venbio>,
        <https://1145.am/db/2352350/Venbio>,
        <https://1145.am/db/2360647/Venbio>,
        <https://1145.am/db/2360667/Venbio>,
        <https://1145.am/db/2364514/Venbio>,
        <https://1145.am/db/2364518/Venbio>,
        <https://1145.am/db/2570520/Venbio>,
        <https://1145.am/db/2570523/Venbio>,
        <https://1145.am/db/2575687/Venbio>,
        <https://1145.am/db/428737/Venbio>,
        <https://1145.am/db/560096/Venbio>,
        <https://1145.am/db/704198/Venbio> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336505/The_Column_Group> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:29:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-0> ;
    ns1:foundName "The Column Group" ;
    ns1:investor <https://1145.am/db/2336505/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "The Column Group" ;
    ns1:sameAsMedium <https://1145.am/db/1503058/The_Column_Group>,
        <https://1145.am/db/1533327/The_Column_Group>,
        <https://1145.am/db/1533685/The_Column_Group>,
        <https://1145.am/db/1536915/The_Column_Group>,
        <https://1145.am/db/1624208/The_Column_Group>,
        <https://1145.am/db/2283431/The_Column_Group>,
        <https://1145.am/db/2287253/The_Column_Group>,
        <https://1145.am/db/2291277/The_Column_Group>,
        <https://1145.am/db/2294202/The_Column_Group>,
        <https://1145.am/db/2304335/The_Column_Group>,
        <https://1145.am/db/2304340/The_Column_Group>,
        <https://1145.am/db/2304769/The_Column_Group>,
        <https://1145.am/db/2305256/The_Column_Group>,
        <https://1145.am/db/2327474/The_Column_Group>,
        <https://1145.am/db/2335700/The_Column_Group>,
        <https://1145.am/db/2336503/The_Column_Group>,
        <https://1145.am/db/2336524/The_Column_Group>,
        <https://1145.am/db/2339704/The_Column_Group>,
        <https://1145.am/db/2339883/The_Column_Group>,
        <https://1145.am/db/2344735/The_Column_Group>,
        <https://1145.am/db/2347885/The_Column_Group>,
        <https://1145.am/db/2350364/The_Column_Group>,
        <https://1145.am/db/2351394/The_Column_Group>,
        <https://1145.am/db/2351397/The_Column_Group>,
        <https://1145.am/db/2359334/The_Column_Group>,
        <https://1145.am/db/2359468/The_Column_Group>,
        <https://1145.am/db/2359864/The_Column_Group>,
        <https://1145.am/db/2362475/The_Column_Group>,
        <https://1145.am/db/2362481/The_Column_Group>,
        <https://1145.am/db/2362565/The_Column_Group>,
        <https://1145.am/db/2362566/The_Column_Group>,
        <https://1145.am/db/2365363/The_Column_Group>,
        <https://1145.am/db/2368280/The_Column_Group>,
        <https://1145.am/db/2368501/The_Column_Group>,
        <https://1145.am/db/2583013/The_Column_Group>,
        <https://1145.am/db/2584056/The_Column_Group>,
        <https://1145.am/db/2584561/The_Column_Group>,
        <https://1145.am/db/425281/The_Column_Group>,
        <https://1145.am/db/426160/The_Column_Group>,
        <https://1145.am/db/490696/The_Column_Group>,
        <https://1145.am/db/75445/The_Column_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336505/Topspin_Fund> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:29:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-0> ;
    ns1:foundName "Topspin Fund" ;
    ns1:investor <https://1145.am/db/2336505/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "Topspin Fund" ;
    ns1:sameAsMedium <https://1145.am/db/1653506/Topspin_Fund>,
        <https://1145.am/db/2336503/Topspin_Fund>,
        <https://1145.am/db/2336524/Topspin_Fund>,
        <https://1145.am/db/2339883/Topspin_Fund>,
        <https://1145.am/db/2359468/Topspin_Fund>,
        <https://1145.am/db/2583013/Topspin_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336505/Venbio> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:29:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-0> ;
    ns1:foundName "venBio" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2336505/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "venBio" ;
    ns1:sameAsHigh <https://1145.am/db/1172738/Verrica_Pharmaceuticals_Inc>,
        <https://1145.am/db/1173163/Verrica_Pharmaceuticals_Inc>,
        <https://1145.am/db/1592042/Venatorx_Pharmaceuticals>,
        <https://1145.am/db/1928985/Venatorx_Pharmaceuticals>,
        <https://1145.am/db/1957136/Vect-Horus>,
        <https://1145.am/db/2015251/Vectivbio_Holding_Ag>,
        <https://1145.am/db/2015407/Vectivbio>,
        <https://1145.am/db/2040146/Vectivbio>,
        <https://1145.am/db/2307347/The_Vectura_Group>,
        <https://1145.am/db/2323288/Vectura>,
        <https://1145.am/db/2336503/Venbio>,
        <https://1145.am/db/2336524/Venbio>,
        <https://1145.am/db/2357248/Vectura>,
        <https://1145.am/db/2357255/Vectura_Group_Plc>,
        <https://1145.am/db/2359468/Venbio>,
        <https://1145.am/db/2367790/Vectura>,
        <https://1145.am/db/2370755/Vectura>,
        <https://1145.am/db/2537626/Vectura>,
        <https://1145.am/db/2549943/Vectura>,
        <https://1145.am/db/2550933/Vectura>,
        <https://1145.am/db/2555127/Vectura>,
        <https://1145.am/db/2572820/Vectura_Group_Plc>,
        <https://1145.am/db/2583013/Venbio>,
        <https://1145.am/db/341447/Vectura_Group>,
        <https://1145.am/db/341462/Vectura_Group>,
        <https://1145.am/db/391980/Vectura>,
        <https://1145.am/db/392803/Vectura>,
        <https://1145.am/db/393331/Vectura>,
        <https://1145.am/db/393962/Vectura>,
        <https://1145.am/db/951050/Venatorx_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2346293/Venbio>,
        <https://1145.am/db/2352349/Venbio>,
        <https://1145.am/db/2352350/Venbio>,
        <https://1145.am/db/2360647/Venbio>,
        <https://1145.am/db/2360667/Venbio>,
        <https://1145.am/db/2364514/Venbio>,
        <https://1145.am/db/2364518/Venbio>,
        <https://1145.am/db/2570520/Venbio>,
        <https://1145.am/db/2570523/Venbio>,
        <https://1145.am/db/2575687/Venbio>,
        <https://1145.am/db/428737/Venbio>,
        <https://1145.am/db/560096/Venbio>,
        <https://1145.am/db/704198/Venbio> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337044/Affimed> a org:Organization ;
    ns1:description "pharmaceutical" ;
    ns1:documentDate "2012-10-08T15:34:37+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Affimed Therapeutics AG: Affimed Raises Eur 15.5 Million in a Series D Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/affimed-therapeutics-ag-affimed-raises-eur-15-5-million-a-series-d-financing-round> ;
    ns1:foundName "Affimed",
        "Affimed Therapeutics AG" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Affimed" ;
    ns1:sameAsHigh <https://1145.am/db/1615580/Apnimed>,
        <https://1145.am/db/2307114/Afraxis>,
        <https://1145.am/db/2348791/Aciex>,
        <https://1145.am/db/2368360/Affimed>,
        <https://1145.am/db/2553354/Acambis>,
        <https://1145.am/db/970806/Affyxell>,
        <https://1145.am/db/973558/Affyxell> ;
    ns1:sameAsMedium <https://1145.am/db/2299576/Affimed>,
        <https://1145.am/db/2359285/Affimed_Nv>,
        <https://1145.am/db/2364333/Affimed>,
        <https://1145.am/db/2369277/Affimed>,
        <https://1145.am/db/972079/Affimed>,
        <https://1145.am/db/974507/Affimed>,
        <https://1145.am/db/985351/Affimed> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337071/Fibrocell_Science> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "commercializing LAVIV" ;
    ns1:documentDate "2012-10-09T12:15:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Fibrocell Science, Inc. Announces $45 Million Private Placement and Enters Strategic Collaboration with Intrexon" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/fibrocell-science-inc-announces-45-million-private-placement-and-enters-strategic> ;
    ns1:foundName "Fibrocell",
        "Fibrocell Science, Inc",
        "Fibrocell Science, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Fibrocell Science" ;
    ns1:sameAsHigh <https://1145.am/db/2312675/Fibrocell_Science>,
        <https://1145.am/db/2329026/Fibrocell_Science_Inc>,
        <https://1145.am/db/2357016/Fibrocell_Science_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2312670/Fibrocell_Science>,
        <https://1145.am/db/2312685/Fibrocell_Science>,
        <https://1145.am/db/2320450/Fibrocell_Science>,
        <https://1145.am/db/2340792/Fibrocell_Science>,
        <https://1145.am/db/2340915/Fibrocell_Science>,
        <https://1145.am/db/2343786/Fibrocell_Science>,
        <https://1145.am/db/2365957/Fibrocell_Science> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337566/Invivo_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge MA" ;
    ns1:basedInLowRaw "Massachusetts" ;
    ns1:documentDate "2012-10-10T04:01:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "InVivo Therapeutics Awarded $2 Million Loan from MassDevelopment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/invivo-therapeutics-awarded-2-million-loan-from-massdevelopment> ;
    ns1:foundName "InVivo",
        "InVivo Therapeutics" ;
    ns1:industry "Life Sciences" ;
    ns1:name "InVivo",
        "InVivo Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1202730/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/1203294/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/1401216/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/1401662/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/1407151/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/1408379/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/2291139/Invivo_Therapeutics>,
        <https://1145.am/db/2335647/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/2336868/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/2339814/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/2340633/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/2349792/Invivo_Therapeutics>,
        <https://1145.am/db/2358356/Invivo_Therapeutics_Holdings_Corp>,
        <https://1145.am/db/2365015/Invivo_Therapeutics_Holdings_Corplauren_Mitarotondo>,
        <https://1145.am/db/2589272/Invivo_Therapeutics_Holdings_Corp> ;
    ns1:sameAsMedium <https://1145.am/db/2301045/Invivo_Therapeutics>,
        <https://1145.am/db/2303010/Invivo_Therapeutics_Corporation>,
        <https://1145.am/db/2361236/Invivo_Therapeutics_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/Inc> a org:Organization ;
    ns1:description "a biotechnology company" ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName ", Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1048034/Exicure>,
        <https://1145.am/db/1054185/Exicure>,
        <https://1145.am/db/1064384/Celcuity_Inc>,
        <https://1145.am/db/1070403/Projenx_Inc>,
        <https://1145.am/db/1070709/Celularity_Inc>,
        <https://1145.am/db/1079148/Bioage>,
        <https://1145.am/db/1105043/Celularity>,
        <https://1145.am/db/1195567/Sqz_Biotechnologies>,
        <https://1145.am/db/1198717/Sqz_Biotechnologies>,
        <https://1145.am/db/1215930/Enavate_Sciences>,
        <https://1145.am/db/1322507/Gro_Biosciences_Inc>,
        <https://1145.am/db/1343489/Celcuity_Inc>,
        <https://1145.am/db/1354258/Cellistic>,
        <https://1145.am/db/1354263/Cellistic>,
        <https://1145.am/db/1359764/Aspect_Biosystems>,
        <https://1145.am/db/1360407/Aspect_Biosystems>,
        <https://1145.am/db/1381832/Coatue>,
        <https://1145.am/db/1382787/Coatue>,
        <https://1145.am/db/1415520/Obatala_Sciences>,
        <https://1145.am/db/1573937/Celcuity_Inc>,
        <https://1145.am/db/1586786/Bioasis>,
        <https://1145.am/db/1621368/Celularity>,
        <https://1145.am/db/1663393/Concerto_Biosciences>,
        <https://1145.am/db/1683183/Exicure>,
        <https://1145.am/db/1945773/Morphimmune>,
        <https://1145.am/db/1966379/Dyve_Biosciences>,
        <https://1145.am/db/1984401/Exicure_Inc>,
        <https://1145.am/db/2021165/Exicure>,
        <https://1145.am/db/2052967/Morphimmune>,
        <https://1145.am/db/2095258/Exicure_Inc>,
        <https://1145.am/db/2114372/Actio_Biosciences>,
        <https://1145.am/db/2133590/Morphimmune>,
        <https://1145.am/db/2234316/Intercell_Ag>,
        <https://1145.am/db/2301876/Genizon_Biosciences>,
        <https://1145.am/db/2307362/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2309472/Cel-Sci_Corporation>,
        <https://1145.am/db/2312827/Biotime_Inc>,
        <https://1145.am/db/2313884/Com)>,
        <https://1145.am/db/2321137/Le_@_P_Technology>,
        <https://1145.am/db/2334165/Genizon_Biosciences_Inc>,
        <https://1145.am/db/2336754/Biotime>,
        <https://1145.am/db/2337993/Progderm>,
        <https://1145.am/db/2338371/Inc>,
        <https://1145.am/db/2339726/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2340408/Group_Inc>,
        <https://1145.am/db/2341747/Techne_Corporation>,
        <https://1145.am/db/2343807/Cortice_Biosciences>,
        <https://1145.am/db/2347124/Orgenesis_Inc>,
        <https://1145.am/db/2347571/Advent_Life_Sciences>,
        <https://1145.am/db/2348618/Advent_Life_Sciences>,
        <https://1145.am/db/2348868/Biotime_Inc>,
        <https://1145.am/db/2349406/Allocure>,
        <https://1145.am/db/2351955/Biotime>,
        <https://1145.am/db/2357417/Biotime_Inc>,
        <https://1145.am/db/2357488/Intercell>,
        <https://1145.am/db/2359274/Neostem_Inc>,
        <https://1145.am/db/2361237/Discovery_Laboratories>,
        <https://1145.am/db/2361671/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2367144/Allocure_Inc>,
        <https://1145.am/db/2367147/Allocure_Inc>,
        <https://1145.am/db/2367461/Discovery_Laboratories_Inc>,
        <https://1145.am/db/2369874/Biotime>,
        <https://1145.am/db/2370050/M3_Biotechnology_Inc>,
        <https://1145.am/db/2581359/Group_Inc>,
        <https://1145.am/db/407158/Altasciences>,
        <https://1145.am/db/446643/Curative_Biotechnology>,
        <https://1145.am/db/464787/Biosight_Ltd>,
        <https://1145.am/db/504446/Acrigen_Biosciences_Inc>,
        <https://1145.am/db/549304/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/585936/Gro_Biosciences_Inc>,
        <https://1145.am/db/591585/Pascal_Biosciences>,
        <https://1145.am/db/622178/Gro_Biosciences_Inc>,
        <https://1145.am/db/632040/Biosight>,
        <https://1145.am/db/660979/Celcuity>,
        <https://1145.am/db/683685/Gro_Biosciences_Inc>,
        <https://1145.am/db/704448/Biosight>,
        <https://1145.am/db/764965/Gro_Biosciences_Inc>,
        <https://1145.am/db/769568/Oxford_Science_Enterprises>,
        <https://1145.am/db/812748/Altasciences>,
        <https://1145.am/db/922231/Ocugen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/Morgenthaler_Ventures> a org:Organization ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName "Morgenthaler Ventures" ;
    ns1:investor <https://1145.am/db/2338373/Series_D_Investment_Easton_Capital_Investment_Group_Fibrotec_Ventures_Forbion_Capital_Partners_Healthcare_Ventures_Inc_Morgenthaler_Ventures_Polaris_Venture_Partners_Shire_Strategic_Investment_Group_Completed> ;
    ns1:name "Morgenthaler Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1695894/Morgenthaler_Ventures>,
        <https://1145.am/db/1699268/Morgenthaler_Ventures>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1724566/Morgenthaler_Ventures>,
        <https://1145.am/db/1826128/Morgenthaler_Ventures>,
        <https://1145.am/db/1829487/Morgenthaler_Ventures>,
        <https://1145.am/db/1830084/Morgenthaler_Ventures>,
        <https://1145.am/db/1836989/Morgenthaler_Ventures>,
        <https://1145.am/db/1837117/Morgenthaler_Ventures>,
        <https://1145.am/db/1839836/Morgenthaler_Ventures>,
        <https://1145.am/db/1846752/Morgenthaler_Ventures>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/2246579/Morgenthaler_Ventures>,
        <https://1145.am/db/2257512/Morgenthaler_Ventures>,
        <https://1145.am/db/2297408/Morgenthaler_Ventures>,
        <https://1145.am/db/2297592/Morgenthaler_Ventures>,
        <https://1145.am/db/2307644/Morgenthaler_Ventures>,
        <https://1145.am/db/2308142/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311075/Morgenthaler_Ventures>,
        <https://1145.am/db/2312192/Morgenthaler_Ventures>,
        <https://1145.am/db/2323586/Morgenthaler_Ventures>,
        <https://1145.am/db/2329524/Morgenthaler_Ventures>,
        <https://1145.am/db/2329531/Morgenthaler_Ventures>,
        <https://1145.am/db/2338251/Morgenthaler_Ventures>,
        <https://1145.am/db/2338254/Morgenthaler_Ventures>,
        <https://1145.am/db/2338703/Morgenthaler_Ventures>,
        <https://1145.am/db/2338704/Morgenthaler_Ventures>,
        <https://1145.am/db/2342925/Morgenthaler_Ventures>,
        <https://1145.am/db/2342937/Morgenthaler_Ventures>,
        <https://1145.am/db/2343202/Morgenthaler_Ventures>,
        <https://1145.am/db/2343210/Morgenthaler_Ventures>,
        <https://1145.am/db/2352207/Morgenthaler_Ventures>,
        <https://1145.am/db/2362553/Morgenthaler_Ventures>,
        <https://1145.am/db/2363510/Morgenthaler_Ventures>,
        <https://1145.am/db/2364939/Morgenthaler_Ventures>,
        <https://1145.am/db/2367204/Morgenthaler_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/Promedior> a org:Organization ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName ", Inc.",
        "Promedior" ;
    ns1:industry "biotechnology" ;
    ns1:name "Promedior" ;
    ns1:sameAsHigh <https://1145.am/db/1013406/Moderna>,
        <https://1145.am/db/1042080/Section32>,
        <https://1145.am/db/1048034/Exicure>,
        <https://1145.am/db/1060047/Entera_Bio_Ltd>,
        <https://1145.am/db/1062535/20045078>,
        <https://1145.am/db/1086800/Senti_Biosciences>,
        <https://1145.am/db/1087133/Evelo_Biosciences>,
        <https://1145.am/db/1102964/Biontech_Se>,
        <https://1145.am/db/1123329/Senti_Biosciences>,
        <https://1145.am/db/1198669/Bioventus_Inc>,
        <https://1145.am/db/1201180/Agomab>,
        <https://1145.am/db/1201808/Agomab>,
        <https://1145.am/db/1202868/Brii_Biosciences_Limited>,
        <https://1145.am/db/1216158/Evelo_Biosciences>,
        <https://1145.am/db/1219346/Section_32>,
        <https://1145.am/db/1219817/Section_32>,
        <https://1145.am/db/1297445/Ansa_Biotechnologies>,
        <https://1145.am/db/1313715/Evelo_Biosciences>,
        <https://1145.am/db/133486/Devacell_Inc>,
        <https://1145.am/db/1380232/Moderna>,
        <https://1145.am/db/1394919/Morningside>,
        <https://1145.am/db/1453380/Peak_Bio>,
        <https://1145.am/db/1476593/Bioatla>,
        <https://1145.am/db/1514071/Moderna>,
        <https://1145.am/db/1556688/Ron_Alfa>,
        <https://1145.am/db/1563057/Moderna>,
        <https://1145.am/db/1573937/Celcuity_Inc>,
        <https://1145.am/db/1576796/Gri_Bio>,
        <https://1145.am/db/1586050/Evelo_Biosciences>,
        <https://1145.am/db/1596811/Moderna>,
        <https://1145.am/db/159841/Moderna>,
        <https://1145.am/db/1617793/Moderna>,
        <https://1145.am/db/1689320/Innamed>,
        <https://1145.am/db/1690056/Zura>,
        <https://1145.am/db/1696383/Biontech>,
        <https://1145.am/db/1936265/Provention_Bio>,
        <https://1145.am/db/1940289/Zura>,
        <https://1145.am/db/2023773/Genentech>,
        <https://1145.am/db/222819/Bioventus_Inc>,
        <https://1145.am/db/2232759/Genentech>,
        <https://1145.am/db/2302708/Promosome>,
        <https://1145.am/db/2303846/Cha_Biotech_Co>,
        <https://1145.am/db/2305822/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2307654/Bioton_Sa>,
        <https://1145.am/db/2308972/Genentech>,
        <https://1145.am/db/2309520/Biopure>,
        <https://1145.am/db/2311730/Bionj>,
        <https://1145.am/db/2314943/Esbatech_Ag>,
        <https://1145.am/db/2314947/Esbatech_Ag>,
        <https://1145.am/db/2316631/Engene_Inc>,
        <https://1145.am/db/2317455/Bioadvance>,
        <https://1145.am/db/2318603/Bioenvision>,
        <https://1145.am/db/2320759/Ily101>,
        <https://1145.am/db/2322984/Bioadvance>,
        <https://1145.am/db/2323003/Bioadvance>,
        <https://1145.am/db/2323586/Promedior>,
        <https://1145.am/db/2324320/3i>,
        <https://1145.am/db/2325387/Bioadvance>,
        <https://1145.am/db/2327447/Biosystems>,
        <https://1145.am/db/2327640/Applied_Biosystems>,
        <https://1145.am/db/2327677/Fundamental_Applied_Biology>,
        <https://1145.am/db/2328815/Fundamental_Applied_Biology>,
        <https://1145.am/db/2330716/Gpc_Biotech>,
        <https://1145.am/db/2330797/Meridian_Bioscience>,
        <https://1145.am/db/2336178/Biocon_Limited>,
        <https://1145.am/db/2336178/Biocon_Ltd>,
        <https://1145.am/db/2338371/Promedior>,
        <https://1145.am/db/2338682/Genentech>,
        <https://1145.am/db/2340408/Biovex_Group>,
        <https://1145.am/db/2340408/Group_Inc>,
        <https://1145.am/db/2340450/Promosome>,
        <https://1145.am/db/2341484/Armo_Biosciences_Inc>,
        <https://1145.am/db/2343210/Promedior>,
        <https://1145.am/db/2343742/Promedior>,
        <https://1145.am/db/2343749/Promedior>,
        <https://1145.am/db/2343791/Bioniche_Life_Sciences_Inc>,
        <https://1145.am/db/2344535/Biovex_Inc>,
        <https://1145.am/db/2344691/GTX>,
        <https://1145.am/db/2345213/Biocritica>,
        <https://1145.am/db/2345214/Biocritica>,
        <https://1145.am/db/2346347/Biospecifics_Technologies_Corp>,
        <https://1145.am/db/2346485/Pracinostat>,
        <https://1145.am/db/2348001/Ceregene>,
        <https://1145.am/db/2348776/Genentech>,
        <https://1145.am/db/2350491/Aviir_Inc>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352800/Biovex_Group>,
        <https://1145.am/db/2353227/Moderna>,
        <https://1145.am/db/2354237/Biodelivery_Sciences_International>,
        <https://1145.am/db/2354248/Moderna>,
        <https://1145.am/db/2355643/Promedior>,
        <https://1145.am/db/2357356/Life_Sciences_Fund>,
        <https://1145.am/db/2357505/Regenxbio>,
        <https://1145.am/db/2359227/Regenxbio_Inc>,
        <https://1145.am/db/2359685/Bioatla_Llc>,
        <https://1145.am/db/2360317/Engene_Inc>,
        <https://1145.am/db/2362433/Leonardo_Biosystems>,
        <https://1145.am/db/2366745/Biocontrol_Limited>,
        <https://1145.am/db/2367302/Biocept>,
        <https://1145.am/db/2369154/Bioatla>,
        <https://1145.am/db/2536788/Biomics_Biotechnologies>,
        <https://1145.am/db/2540757/Biontech>,
        <https://1145.am/db/2543372/Ocata>,
        <https://1145.am/db/2543375/Ocata>,
        <https://1145.am/db/2548438/Bioatla>,
        <https://1145.am/db/2562317/Bioatla_Llc>,
        <https://1145.am/db/2576944/Biocritica>,
        <https://1145.am/db/2581359/Biovex_Group>,
        <https://1145.am/db/2581359/Group_Inc>,
        <https://1145.am/db/2589106/Biovex_Group>,
        <https://1145.am/db/2594353/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/468723/Abcellera>,
        <https://1145.am/db/487431/Omniome>,
        <https://1145.am/db/506326/Acrigen>,
        <https://1145.am/db/527072/Amplo_Biotechnology>,
        <https://1145.am/db/548508/Gv20>,
        <https://1145.am/db/591858/Pascal_Biosciences>,
        <https://1145.am/db/611340/Genenta_Science>,
        <https://1145.am/db/693678/Iveric_Bio>,
        <https://1145.am/db/697934/Iveric_Bio>,
        <https://1145.am/db/705474/Senti_Biosciences_Inc>,
        <https://1145.am/db/705671/Genenta_Science_Spa>,
        <https://1145.am/db/706523/Senti_Biosciences_Inc>,
        <https://1145.am/db/710299/Bioatla>,
        <https://1145.am/db/730321/Biosion>,
        <https://1145.am/db/737781/Accro_Bioscience>,
        <https://1145.am/db/769568/Section_32>,
        <https://1145.am/db/780157/Explora_Biolabs>,
        <https://1145.am/db/781794/Biontech>,
        <https://1145.am/db/830101/2seventy_Bio>,
        <https://1145.am/db/887924/Avm0703>,
        <https://1145.am/db/906544/Precirix>,
        <https://1145.am/db/913978/Engene_Inc>,
        <https://1145.am/db/977143/Moderna> ;
    ns1:sameAsMedium <https://1145.am/db/2286671/Promedior>,
        <https://1145.am/db/2319795/Promedior>,
        <https://1145.am/db/2323591/Promedior>,
        <https://1145.am/db/2336372/Promedior>,
        <https://1145.am/db/2343202/Promedior>,
        <https://1145.am/db/2369703/Promedior>,
        <https://1145.am/db/2369708/Promedior>,
        <https://1145.am/db/2369710/Promedior> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/The_Yates_Network> a org:Organization ;
    ns1:description "Business" ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName "The Yates" ;
    ns1:industry "biotechnology" ;
    ns1:name "The Yates Network" ;
    ns1:sameAsHigh <https://1145.am/db/2355789/The_Yates_Networkkathryn_Morris> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339163/Tolera_Therapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Michigan" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5001836/about.rdf> ;
    ns1:basedInHighRaw "Michigan" ;
    ns1:description "a biotechnology company",
        "pharmaceutical" ;
    ns1:documentDate "2012-10-17T16:22:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tolera-therapeutics-closes-series-b-3-financing-raises-5-5-million-to-submit-phase-3> ;
    ns1:foundName "Tolera Therapeutics",
        "Tolera Therapeutics Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Tolera Therapeutics",
        "Tolera Therapeutics Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2339139/Tolera_Therapeutics_Inc>,
        <https://1145.am/db/2365040/Tolera_Therapeutics>,
        <https://1145.am/db/2365043/Tolera_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2338169/Tolera_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339196/Neurovance> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:description "CNS disorders" ;
    ns1:documentDate "2012-10-18T15:24:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Neurovance Closes $7M Series A1 Round for Development of EB-1020 for ADHD; Reports Phase 1 Clinical Trial Results" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neurovance-closes-7m-series-a1-round-for-development-of-eb-1020-for-adhd-reports-phase-1> ;
    ns1:foundName "Neurovance",
        "Neurovance, Inc." ;
    ns1:industry "Bioscience" ;
    ns1:name "Neurovance" ;
    ns1:sameAsHigh <https://1145.am/db/2292944/Neurotech_Sa>,
        <https://1145.am/db/2299679/Neurometrix>,
        <https://1145.am/db/2326208/Proximagen_Neuroscience>,
        <https://1145.am/db/2360221/Neuroderm> ;
    ns1:sameAsMedium <https://1145.am/db/2339193/Neurovance>,
        <https://1145.am/db/2361443/Neurovance>,
        <https://1145.am/db/2361451/Neurovance> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339196/Series_A1_Investment_Neurovance_Novartis_Venture_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-18T15:24:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Neurovance Closes $ 7M Series A1 Round for Development of EB-1020 for ADHD; Reports Phase 1 Clinical Trial Results.",
        "Neurovance, Inc. today announced that it has closed a $ 7 million series A1 round led by existing investor Novartis Venture Fund to further advance development of EB-1020." ;
    ns1:documentTitle "Neurovance Closes $7M Series A1 Round for Development of EB-1020 for ADHD; Reports Phase 1 Clinical Trial Results" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neurovance-closes-7m-series-a1-round-for-development-of-eb-1020-for-adhd-reports-phase-1> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339196/Neurovance> ;
    ns1:targetDetails "Series A1",
        "series A1" ;
    ns1:valueRaw "$ 7 million",
        "$ 7M" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass" .

<https://1145.am/db/2340887/3x5_Special_Opportunity_Partners> a org:Organization ;
    ns1:basedInLowRaw "Texas" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-10-24T12:45:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ZS Pharma raises $46 million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zs-pharma-raises-46-million-series-c-financing> ;
    ns1:foundName "3x5 Special Opportunity Partners" ;
    ns1:investor <https://1145.am/db/2340887/Investment_3x5_Special_Opportunity_Partners_Alta_Partners_Devon_Park_Bioventures_Rivervest_Venture_Partners_Salem_Partners_Zs_Pharma_Completed> ;
    ns1:name "3x5 Special Opportunity Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2340890/3x5_Special_Opportunity_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340887/Rivervest_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Texas" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-10-24T12:45:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ZS Pharma raises $46 million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zs-pharma-raises-46-million-series-c-financing> ;
    ns1:foundName "RiverVest Venture Partners" ;
    ns1:investor <https://1145.am/db/2340887/Investment_3x5_Special_Opportunity_Partners_Alta_Partners_Devon_Park_Bioventures_Rivervest_Venture_Partners_Salem_Partners_Zs_Pharma_Completed> ;
    ns1:name "RiverVest Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2100049/Four_River_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1283038/Rivervest_Venture_Partners>,
        <https://1145.am/db/1669813/Rivervest_Venture_Partners>,
        <https://1145.am/db/2155730/Rivervest_Venture_Partners>,
        <https://1145.am/db/2286035/Rivervest_Venture_Partners>,
        <https://1145.am/db/2288553/Rivervest_Venture_Partners>,
        <https://1145.am/db/2294113/Rivervest_Venture_Partners>,
        <https://1145.am/db/2294893/Rivervest_Venture_Partners>,
        <https://1145.am/db/2296631/Rivervest_Venture_Partners>,
        <https://1145.am/db/2299423/Rivervest_Venture_Partners>,
        <https://1145.am/db/2329550/Rivervest_Venture_Partners>,
        <https://1145.am/db/2336221/Rivervest_Venture_Partners>,
        <https://1145.am/db/2337106/Rivervest_Venture_Partners>,
        <https://1145.am/db/2350044/Rivervest_Venture_Partners>,
        <https://1145.am/db/2354899/Rivervest_Venture_Partners>,
        <https://1145.am/db/2355274/Rivervest_Venture_Partners>,
        <https://1145.am/db/2356216/Rivervest_Venture_Partners>,
        <https://1145.am/db/2358496/Rivervest_Venture_Partners>,
        <https://1145.am/db/2358502/Rivervest_Venture_Partners>,
        <https://1145.am/db/2369916/Rivervest_Venture_Partners>,
        <https://1145.am/db/583798/Rivervest_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340887/Salem_Partners> a org:Organization ;
    ns1:basedInLowRaw "Texas" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-10-24T12:45:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ZS Pharma raises $46 million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zs-pharma-raises-46-million-series-c-financing> ;
    ns1:foundName "Salem Partners" ;
    ns1:investor <https://1145.am/db/2340887/Investment_3x5_Special_Opportunity_Partners_Alta_Partners_Devon_Park_Bioventures_Rivervest_Venture_Partners_Salem_Partners_Zs_Pharma_Completed> ;
    ns1:name "Salem Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2355183/Salem_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1810636/Salem_Partners>,
        <https://1145.am/db/2338817/Salem_Partners>,
        <https://1145.am/db/2340890/Salem_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340888/Osage_University_Partners> a org:Organization ;
    ns1:basedInLowRaw "TX" ;
    ns1:documentDate "2012-10-24T12:43:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mirna-therapeutics-secures-34-5-million-series-c-financing-to-advance-oncology-microrna-0> ;
    ns1:foundName "Osage University Partners" ;
    ns1:investor <https://1145.am/db/2340888/Series_C_Investment_Correlation_Ventures_Mirna_Therapeutics_Inc_New_Enterprise_Associates_Osage_University_Partners_Pfizer_Ventures_Sofinnova_Ventures_Completed> ;
    ns1:name "Osage University Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1441781/Osage_University_Partners>,
        <https://1145.am/db/1533327/Osage_University_Partners>,
        <https://1145.am/db/1533685/Osage_University_Partners>,
        <https://1145.am/db/1619110/Osage_University_Partners>,
        <https://1145.am/db/1696377/Osage_University_Partners>,
        <https://1145.am/db/1759759/Osage_University_Partners>,
        <https://1145.am/db/1774684/Osage_University_Partners>,
        <https://1145.am/db/1782234/Osage_University_Partners>,
        <https://1145.am/db/1802088/Osage_University_Partners>,
        <https://1145.am/db/1810714/Osage_University_Partners>,
        <https://1145.am/db/1823287/Osage_University_Partners>,
        <https://1145.am/db/1858399/Osage_University_Partners>,
        <https://1145.am/db/2153910/Osage_University_Partners>,
        <https://1145.am/db/2278799/Osage_University_Partners>,
        <https://1145.am/db/2292287/Osage_University_Partners>,
        <https://1145.am/db/2294753/Osage_University_Partners>,
        <https://1145.am/db/2301464/Osage_University_Partners>,
        <https://1145.am/db/2319360/Osage_University_Partners>,
        <https://1145.am/db/2336032/Osage_University_Partners>,
        <https://1145.am/db/2336221/Osage_University_Partners>,
        <https://1145.am/db/2340284/Osage_University_Partners>,
        <https://1145.am/db/2341896/Osage_University_Partners>,
        <https://1145.am/db/2349691/Osage_University_Partners>,
        <https://1145.am/db/2349838/Osage_University_Partners>,
        <https://1145.am/db/2350044/Osage_University_Partners>,
        <https://1145.am/db/2350199/Osage_University_Partners>,
        <https://1145.am/db/2352349/Osage_University_Partners>,
        <https://1145.am/db/2352350/Osage_University_Partners>,
        <https://1145.am/db/2353771/Osage_University_Partners>,
        <https://1145.am/db/2353789/Osage_University_Partners>,
        <https://1145.am/db/2358430/Osage_University_Partners>,
        <https://1145.am/db/2359404/Osage_University_Partners>,
        <https://1145.am/db/2360521/Osage_University_Partners>,
        <https://1145.am/db/2360526/Osage_University_Partners>,
        <https://1145.am/db/2368351/Osage_University_Partners>,
        <https://1145.am/db/2369165/Osage_University_Partners>,
        <https://1145.am/db/2369169/Osage_University_Partners>,
        <https://1145.am/db/2370626/Osage_University_Partners>,
        <https://1145.am/db/2569831/Osage_University_Partners>,
        <https://1145.am/db/425953/Osage_University_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340890/3x5_Special_Opportunity_Partners> a org:Organization ;
    ns1:documentDate "2012-10-24T12:53:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Two Texas biotech outfits lasso venture deals totaling $81M" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/two-texas-biotech-outfits-lasso-venture-deals-totaling-81m> ;
    ns1:foundName "3x5 Special Opportunity Partners" ;
    ns1:investor <https://1145.am/db/2340890/Investment_Mirna_New_Enterprise_Associates_Pfizer_Sofinnova_Ventures_Stopped> ;
    ns1:name "3x5 Special Opportunity Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2340887/3x5_Special_Opportunity_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340890/Salem_Partners> a org:Organization ;
    ns1:documentDate "2012-10-24T12:53:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Two Texas biotech outfits lasso venture deals totaling $81M" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/two-texas-biotech-outfits-lasso-venture-deals-totaling-81m> ;
    ns1:foundName "Salem Partners" ;
    ns1:investor <https://1145.am/db/2340890/Investment_Mirna_New_Enterprise_Associates_Pfizer_Sofinnova_Ventures_Stopped> ;
    ns1:name "Salem Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1810636/Salem_Partners>,
        <https://1145.am/db/2338817/Salem_Partners>,
        <https://1145.am/db/2340887/Salem_Partners>,
        <https://1145.am/db/2355183/Salem_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341904/Pappas_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "Pappas Ventures" ;
    ns1:investor <https://1145.am/db/2341904/Investment_Advanced_Technology_Ventures_Fonds_De_SolidaritÃ©_Ftq_Gsk_Canada_Life_Sciences_Innovation_Fund_Lumira_Capital_Mp_Healthcare_Venture_Management_Pappas_Ventures_Sr_One_Sw_Co_Thrasos_Therapeutics_Completed> ;
    ns1:name "Pappas Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Pappas_Ventures>,
        <https://1145.am/db/2305706/Pappas_Ventures>,
        <https://1145.am/db/2305713/Pappas_Ventures>,
        <https://1145.am/db/2308329/Pappas_Ventures>,
        <https://1145.am/db/2312277/Pappas_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314492/Pappas_Ventures>,
        <https://1145.am/db/2319029/Pappas_Ventures>,
        <https://1145.am/db/2324289/Pappas_Ventures>,
        <https://1145.am/db/2328388/Pappas_Ventures>,
        <https://1145.am/db/2332753/Pappas_Ventures>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346542/Pappas_Ventures>,
        <https://1145.am/db/2350779/Pappas_Ventures>,
        <https://1145.am/db/2350780/Pappas_Ventures>,
        <https://1145.am/db/2352805/Pappas_Ventures>,
        <https://1145.am/db/2352808/Pappas_Ventures>,
        <https://1145.am/db/2354537/Pappas_Ventures>,
        <https://1145.am/db/2354540/Pappas_Ventures>,
        <https://1145.am/db/2355274/Pappas_Ventures>,
        <https://1145.am/db/2356216/Pappas_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2539913/Pappas_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341904/Thrasos_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Canada" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:basedInHighRaw "Canada" ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "Thrasos TherapeuticsTM" ;
    ns1:industry "Life Sciences" ;
    ns1:name "Thrasos Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2341909/Thrasos_Therapeutics>,
        <https://1145.am/db/2342983/Thrasos_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342925/Principia_Biopharma> a org:Organization ;
    ns1:description "a biopharmaceutical company" ;
    ns1:documentDate "2012-10-29T15:15:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/principia-biopharma-secures-12-5m-second-tranche-series-a-financing-expands-senior-0> ;
    ns1:foundName "Principia Biopharma",
        "Principia Biopharma, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Principia Biopharma" ;
    ns1:sameAsHigh <https://1145.am/db/2280255/Principia_Biopharma>,
        <https://1145.am/db/2287400/Principia_Biopharma>,
        <https://1145.am/db/2335745/Principia_Biopharma_Inc>,
        <https://1145.am/db/2342924/Principia_Biopharma>,
        <https://1145.am/db/2342937/Principia_Biopharma> ;
    ns1:sameAsMedium <https://1145.am/db/137297/Principia_Biopharma>,
        <https://1145.am/db/138669/Principia_Biopharma>,
        <https://1145.am/db/194991/Principia_Biopharma>,
        <https://1145.am/db/195055/Principia_Biopharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342925/Srone> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "The investment was led by existing investors New Leaf Venture Partners, OrbiMed Advisors," ;
    ns1:documentDate "2012-10-29T15:15:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/principia-biopharma-secures-12-5m-second-tranche-series-a-financing-expands-senior-0> ;
    ns1:foundName "SROne" ;
    ns1:investor <https://1145.am/db/2342925/Investment_Mission_Bay_Capital_Morgenthaler_Ventures_New_Leaf_Venture_Partners_Orbimed_Advisors_Principia_Biopharma_Srone_Completed> ;
    ns1:name "SROne" ;
    ns1:sameAsHigh <https://1145.am/db/2342925/Morgenthaler_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2337645/Srone>,
        <https://1145.am/db/2342937/Srone>,
        <https://1145.am/db/2352357/Srone>,
        <https://1145.am/db/2352361/Srone>,
        <https://1145.am/db/2354401/Srone> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342933/Synthetic_Biologics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "City of Rockville" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/7316547/about.rdf> ;
    ns1:basedInHighRaw "ROCKVILLE, Md." ;
    ns1:description "developing synthetic biologics and innovative medicines for serious diseases and unmet medical needs" ;
    ns1:documentDate "2012-10-29T16:05:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Synthetic Biologics Announces $10.8 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/synthetic-biologics-announces-10-8-million-financing-0> ;
    ns1:foundName "Synthetic Biologics",
        "Synthetic Biologics, Inc." ;
    ns1:industry "Biotechnology" ;
    ns1:name "Synthetic Biologics",
        "Synthetic Biologics, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1242152/Synthetic_Biologics>,
        <https://1145.am/db/2337088/Synthetic_Biologics_Inc>,
        <https://1145.am/db/2338892/Synthetic_Biologics>,
        <https://1145.am/db/2340864/Synthetic_Biologics>,
        <https://1145.am/db/2342942/Synthetic_Biologics_Inc>,
        <https://1145.am/db/2343834/Synthetic_Biologics>,
        <https://1145.am/db/2343969/Synthetic_Biologics_Inc>,
        <https://1145.am/db/2344845/Synthetic_Biologics>,
        <https://1145.am/db/2348114/Synthetic_Biologics_Inc>,
        <https://1145.am/db/2352309/Synthetic_Biologics>,
        <https://1145.am/db/2352327/Synthetic_Biologics_Inc>,
        <https://1145.am/db/897402/Synthetic_Biologics>,
        <https://1145.am/db/922901/Synthetic_Biologics> ;
    ns1:sameAsMedium <https://1145.am/db/2370803/Synthetic_Biologics_Inc>,
        <https://1145.am/db/909527/Synthetic_Biologics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343989/New_Science_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Seattle" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:basedInHighRaw "Seattle" ;
    ns1:description "venture investment" ;
    ns1:documentDate "2012-11-01T13:46:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing-0> ;
    ns1:foundName "New Science Ventures" ;
    ns1:investor <https://1145.am/db/2343989/Series_B_Investment_Easton_Capital_New_Science_Ventures_Research_Foundation_Resolve_Therapeutics_Wrf_Capital_Completed> ;
    ns1:name "New Science Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2154415/New_Science_Ventures>,
        <https://1145.am/db/2309865/New_Science_Ventures>,
        <https://1145.am/db/2326139/New_Science_Ventures>,
        <https://1145.am/db/2339427/New_Science_Ventures>,
        <https://1145.am/db/2339932/New_Science_Ventures>,
        <https://1145.am/db/2339933/New_Science_Ventures>,
        <https://1145.am/db/2343140/New_Science_Ventures>,
        <https://1145.am/db/2344978/New_Science_Ventures>,
        <https://1145.am/db/2364827/New_Science_Ventures>,
        <https://1145.am/db/2370056/New_Science_Ventures>,
        <https://1145.am/db/704198/New_Science_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2304650/New_Science_Ventures>,
        <https://1145.am/db/2309872/New_Science_Ventures>,
        <https://1145.am/db/2314677/New_Science_Ventures>,
        <https://1145.am/db/2320692/New_Science_Ventures>,
        <https://1145.am/db/2322312/New_Science_Ventures>,
        <https://1145.am/db/2326130/New_Science_Ventures>,
        <https://1145.am/db/2331639/New_Science_Ventures>,
        <https://1145.am/db/2333573/New_Science_Ventures>,
        <https://1145.am/db/2333577/New_Science_Ventures>,
        <https://1145.am/db/2338987/New_Science_Ventures>,
        <https://1145.am/db/2339428/New_Science_Ventures>,
        <https://1145.am/db/2342717/New_Science_Ventures>,
        <https://1145.am/db/2363484/New_Science_Ventures>,
        <https://1145.am/db/2363485/New_Science_Ventures>,
        <https://1145.am/db/2364820/New_Science_Ventures>,
        <https://1145.am/db/2365444/New_Science_Ventures>,
        <https://1145.am/db/2370054/New_Science_Ventures>,
        <https://1145.am/db/2447981/New_Science_Ventures_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343989/Wrf_Capital> a org:Organization ;
    ns1:basedInHighGeoName "Seattle" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:basedInHighRaw "Seattle" ;
    ns1:description "venture investment" ;
    ns1:documentDate "2012-11-01T13:46:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing-0> ;
    ns1:foundName "WRF Capital" ;
    ns1:investor <https://1145.am/db/2343989/Series_B_Investment_Easton_Capital_New_Science_Ventures_Research_Foundation_Resolve_Therapeutics_Wrf_Capital_Completed> ;
    ns1:name "WRF Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1355348/Sws_Venture_Capital>,
        <https://1145.am/db/1769784/Webb_Investment_Network>,
        <https://1145.am/db/1873680/Webb_Investment_Network>,
        <https://1145.am/db/2344978/Wrf_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2060484/Wrf_Capital>,
        <https://1145.am/db/2287843/Wrf_Capital>,
        <https://1145.am/db/2296113/Wrf_Capital>,
        <https://1145.am/db/2302333/Wrf_Capital>,
        <https://1145.am/db/2303548/Wrf_Capital>,
        <https://1145.am/db/2303560/Wrf_Capital>,
        <https://1145.am/db/2308148/Wrf_Capital>,
        <https://1145.am/db/2345223/Wrf_Capital>,
        <https://1145.am/db/2345769/Wrf_Capital>,
        <https://1145.am/db/2347368/Wrf_Capital>,
        <https://1145.am/db/2359510/Wrf_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344978/New_Science_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Washington" ;
    ns1:description "venture investment" ;
    ns1:documentDate "2012-11-02T04:00:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing> ;
    ns1:foundName "New Science Ventures" ;
    ns1:investor <https://1145.am/db/2344978/Series_B_Investment_Easton_Capital_New_Science_Ventures_Resolve_Therapeutics_Wrf_Capital_Washington_Research_Foundation_Completed> ;
    ns1:name "New Science Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2154415/New_Science_Ventures>,
        <https://1145.am/db/2309865/New_Science_Ventures>,
        <https://1145.am/db/2326139/New_Science_Ventures>,
        <https://1145.am/db/2339427/New_Science_Ventures>,
        <https://1145.am/db/2339932/New_Science_Ventures>,
        <https://1145.am/db/2339933/New_Science_Ventures>,
        <https://1145.am/db/2343140/New_Science_Ventures>,
        <https://1145.am/db/2343989/New_Science_Ventures>,
        <https://1145.am/db/2364827/New_Science_Ventures>,
        <https://1145.am/db/2370056/New_Science_Ventures>,
        <https://1145.am/db/704198/New_Science_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2304650/New_Science_Ventures>,
        <https://1145.am/db/2309872/New_Science_Ventures>,
        <https://1145.am/db/2314677/New_Science_Ventures>,
        <https://1145.am/db/2320692/New_Science_Ventures>,
        <https://1145.am/db/2322312/New_Science_Ventures>,
        <https://1145.am/db/2326130/New_Science_Ventures>,
        <https://1145.am/db/2331639/New_Science_Ventures>,
        <https://1145.am/db/2333573/New_Science_Ventures>,
        <https://1145.am/db/2333577/New_Science_Ventures>,
        <https://1145.am/db/2338987/New_Science_Ventures>,
        <https://1145.am/db/2339428/New_Science_Ventures>,
        <https://1145.am/db/2342717/New_Science_Ventures>,
        <https://1145.am/db/2363484/New_Science_Ventures>,
        <https://1145.am/db/2363485/New_Science_Ventures>,
        <https://1145.am/db/2364820/New_Science_Ventures>,
        <https://1145.am/db/2365444/New_Science_Ventures>,
        <https://1145.am/db/2370054/New_Science_Ventures>,
        <https://1145.am/db/2447981/New_Science_Ventures_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344978/Wrf_Capital> a org:Organization ;
    ns1:basedInLowRaw "Washington" ;
    ns1:description "venture investment" ;
    ns1:documentDate "2012-11-02T04:00:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing> ;
    ns1:foundName "WRF Capital" ;
    ns1:investor <https://1145.am/db/2344978/Series_B_Investment_Easton_Capital_New_Science_Ventures_Resolve_Therapeutics_Wrf_Capital_Washington_Research_Foundation_Completed> ;
    ns1:name "WRF Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1355348/Sws_Venture_Capital>,
        <https://1145.am/db/1769784/Webb_Investment_Network>,
        <https://1145.am/db/1873680/Webb_Investment_Network>,
        <https://1145.am/db/2343989/Wrf_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2060484/Wrf_Capital>,
        <https://1145.am/db/2287843/Wrf_Capital>,
        <https://1145.am/db/2296113/Wrf_Capital>,
        <https://1145.am/db/2302333/Wrf_Capital>,
        <https://1145.am/db/2303548/Wrf_Capital>,
        <https://1145.am/db/2303560/Wrf_Capital>,
        <https://1145.am/db/2308148/Wrf_Capital>,
        <https://1145.am/db/2345223/Wrf_Capital>,
        <https://1145.am/db/2345769/Wrf_Capital>,
        <https://1145.am/db/2347368/Wrf_Capital>,
        <https://1145.am/db/2359510/Wrf_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345002/Alethia_Biotherapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "MontrÃ©al" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6077246/about.rdf> ;
    ns1:basedInHighRaw "MONTREAL, QUEBEC" ;
    ns1:description "Biotechnology",
        "Biotherapeutics" ;
    ns1:documentDate "2012-11-02T13:44:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/alethia-biotherapeutics-closes-a-4-7-million-financing-to-advance-its-bone-antiresorptive> ;
    ns1:foundName "Alethia",
        "Alethia Biotherapeutics",
        "Alethia Biotherapeutics Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Alethia Biotherapeutics",
        "Alethia Biotherapeutics Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2314578/Alethia_Biotherapeutics>,
        <https://1145.am/db/2358026/Alethia_Biotherapeutics>,
        <https://1145.am/db/2358031/Alethia_Biotherapeutics_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345017/Ziarco> a org:Organization ;
    ns1:basedInHighGeoName "Canterbury" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2192628/about.rdf> ;
    ns1:basedInHighRaw "Canterbury" ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2012-11-05T03:24:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ziarco Founded with Series A Financing to Develop First-in Class Anti-inflammatory and Anti-allergic Medicines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ziarco-founded-series-a-financing-to-develop-first-class-anti-inflammatory-and-anti> ;
    ns1:foundName "Ziarco" ;
    ns1:industry "biotechnology" ;
    ns1:name "Ziarco" ;
    ns1:sameAsHigh <https://1145.am/db/1501484/Azenta_Inc>,
        <https://1145.am/db/2789800/Azenta>,
        <https://1145.am/db/800980/Azenta> ;
    ns1:sameAsMedium <https://1145.am/db/2288871/Ziarco>,
        <https://1145.am/db/2320498/Ziarco>,
        <https://1145.am/db/2342869/Ziarco>,
        <https://1145.am/db/2343918/Ziarco> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346021/Investment_Biomedical_Catalyst_Psioxus_Therapeutics_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-06T05:01:54+00:00"^^xsd:dateTime ;
    ns1:documentExtract "(PsiOxus) , a development stage biotechnology company, today announced the award of a Â£1.7 million ($ 2.7 million) grant from the UK government-backed Biomedical Catalyst to initiate a Phase I/II clinical trial to assess the use of in the treatment of platinum-resistant, recurrent ovarian cancer.",
        "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine." ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "award",
        "grant" ;
    ns1:name "award",
        "grant" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2346021/Psioxus_Therapeutics> ;
    ns1:valueRaw "$ 2.7 million",
        "Â£1.7 million",
        "Â£1.7M" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2346030/Ambit_Biosciences_Inc> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "SAN DIEGO" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "Ambit Biosciences",
        "Ambit Biosciences Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Ambit Biosciences",
        "Ambit Biosciences Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1171159/Amolyt_Pharma>,
        <https://1145.am/db/1320003/Amneal_Pharmaceuticals>,
        <https://1145.am/db/1320891/Amneal_Pharmaceuticals>,
        <https://1145.am/db/1460832/Amneal_Pharmaceuticals>,
        <https://1145.am/db/1461738/Amneal_Pharmaceuticals>,
        <https://1145.am/db/1626867/Amryt_Pharma_Plc>,
        <https://1145.am/db/1627110/Amryt_Pharma_Plc>,
        <https://1145.am/db/1633105/Amryt>,
        <https://1145.am/db/1633172/Amryt>,
        <https://1145.am/db/1645224/Amryt>,
        <https://1145.am/db/1683116/Amryt>,
        <https://1145.am/db/2289496/Amryt_Pharma>,
        <https://1145.am/db/2344092/Atyr_Pharma>,
        <https://1145.am/db/2344100/Atyr_Pharma>,
        <https://1145.am/db/2361788/Amneal_Pharmaceuticals>,
        <https://1145.am/db/2367483/Amneal_Pharmaceuticals>,
        <https://1145.am/db/2367484/Amneal_Pharmaceuticals>,
        <https://1145.am/db/2551604/Amneal_Pharmaceuticals_Pty_Ltd>,
        <https://1145.am/db/2553569/Amneal_Pharmaceuticals>,
        <https://1145.am/db/2553750/Amneal_Pharmaceuticals>,
        <https://1145.am/db/2566271/Amneal_Pharmaceuticals>,
        <https://1145.am/db/2574538/Amneal_Pharmaceuticals>,
        <https://1145.am/db/2577103/Amneal_Pharmaceuticals_Llc>,
        <https://1145.am/db/476668/Atyr_Pharma>,
        <https://1145.am/db/487439/Atyr_Pharma>,
        <https://1145.am/db/708041/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713127/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/733721/Amneal_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2321248/Ambit_Biosciences>,
        <https://1145.am/db/2321254/Ambit_Biosciences>,
        <https://1145.am/db/2336763/Ambit_Biosciences>,
        <https://1145.am/db/2338641/Ambit_Biosciences_Inc>,
        <https://1145.am/db/2342017/Ambit_Biosciences>,
        <https://1145.am/db/2343542/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2344530/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2346035/Ambit_Biosciences>,
        <https://1145.am/db/2349093/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2349307/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2350138/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2350288/Ambit_Biosciences>,
        <https://1145.am/db/2351335/Ambit_Biosciences_Corporation>,
        <https://1145.am/db/2352436/Ambit_Biosciences>,
        <https://1145.am/db/2352441/Ambit_Biosciences>,
        <https://1145.am/db/2352442/Ambit_Biosciences>,
        <https://1145.am/db/2354434/Ambit_Biosciences>,
        <https://1145.am/db/2354455/Ambit_Biosciences>,
        <https://1145.am/db/2357387/Ambit_Biosciences_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347043/Mei_Pharma> a org:Organization ;
    ns1:description "cancer" ;
    ns1:documentDate "2012-11-07T16:22:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MEI Pharma Announces $27.5 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mei-pharma-announces-27-5-million-private-placement> ;
    ns1:foundName "- MEI Pharma, Inc",
        "MEI Pharma",
        "MEI Pharma, Inc",
        "San Diego - MEI Pharma, Inc" ;
    ns1:industry "Pharmaceutical" ;
    ns1:investor <https://1145.am/db/2347043/Investment_Mei_Pharma_New_Leaf_Venture_Partners_Ra_Capital_Management_Three_Arch_Opportunity_Fund_Vivo_Ventures_Has_Not_Happened> ;
    ns1:name "MEI Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1150398/Mei_Pharma>,
        <https://1145.am/db/1152234/Mei_Pharma>,
        <https://1145.am/db/1362662/Mei_Pharma>,
        <https://1145.am/db/1680583/Mei_Pharma>,
        <https://1145.am/db/1687234/Mei_Pharma>,
        <https://1145.am/db/2023840/Mei_Pharma>,
        <https://1145.am/db/2038168/Mei_Pharma>,
        <https://1145.am/db/2039291/Mei_Pharma>,
        <https://1145.am/db/2039678/Mei_Pharma>,
        <https://1145.am/db/2052904/Mei_Pharma>,
        <https://1145.am/db/2056005/Mei_Pharma>,
        <https://1145.am/db/2056049/Mei_Pharma>,
        <https://1145.am/db/2056755/Mei_Pharma>,
        <https://1145.am/db/2061803/Mei_Pharma>,
        <https://1145.am/db/2062156/Mei_Pharma>,
        <https://1145.am/db/2062633/Mei_Pharma>,
        <https://1145.am/db/2066480/Mei_Pharma>,
        <https://1145.am/db/2067011/Mei_Pharma>,
        <https://1145.am/db/2152615/Ayala_Pharmaceuticals>,
        <https://1145.am/db/2156296/Ayala_Pharmaceuticals>,
        <https://1145.am/db/2306777/Agios_Pharmaceuticals>,
        <https://1145.am/db/2306779/Agios_Pharmaceuticals>,
        <https://1145.am/db/2330566/Semafore_Pharmaceuticals>,
        <https://1145.am/db/2336432/Mei_Pharma>,
        <https://1145.am/db/2342581/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2342628/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2363719/Mei_Pharma>,
        <https://1145.am/db/2543358/Indus_Pharmaceuticals>,
        <https://1145.am/db/2578209/Meizler_Biopharma>,
        <https://1145.am/db/411389/Oric_Pharmaceuticals>,
        <https://1145.am/db/640920/Mei_Pharma>,
        <https://1145.am/db/661749/Mei_Pharma>,
        <https://1145.am/db/663640/Mei_Pharma>,
        <https://1145.am/db/665488/Mei_Pharma>,
        <https://1145.am/db/667249/Mei_Pharma>,
        <https://1145.am/db/675023/Mei_Pharma>,
        <https://1145.am/db/680465/Mei_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2346485/Mei_Pharma>,
        <https://1145.am/db/2363564/Mei_Pharma>,
        <https://1145.am/db/2594353/Mei_Pharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347102/Visterra> a org:Organization ;
    ns1:description "developing novel medicines to prevent and treat infectious and other major diseases" ;
    ns1:documentDate "2012-11-09T12:33:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/visterra-secures-financing-from-gates-foundation-and-omega-to-close-26m-series-a-financing> ;
    ns1:foundName "Visterra",
        "Visterra, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Visterra" ;
    ns1:sameAsHigh <https://1145.am/db/1615485/The_Vistria_Group>,
        <https://1145.am/db/2293820/Visterra>,
        <https://1145.am/db/2337395/Visterra>,
        <https://1145.am/db/2339055/Visterra_Inc>,
        <https://1145.am/db/2339905/Visterra_Inc>,
        <https://1145.am/db/2358969/Visterra_Inc>,
        <https://1145.am/db/2537098/Vistin_Pharma>,
        <https://1145.am/db/2556430/Vistin_Pharma>,
        <https://1145.am/db/2580122/Visudyne>,
        <https://1145.am/db/604901/The_Vistria_Group> ;
    ns1:sameAsMedium <https://1145.am/db/2336819/Visterra>,
        <https://1145.am/db/2347094/Visterra> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347537/Relypsa_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Santa Clara County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5393021/about.rdf> ;
    ns1:basedInHighRaw "SANTA CLARA, Calif." ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-08-15T14:03:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Relypsa Announces $80 Million Private Financing Transaction" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/relypsa-announces-80-million-private-financing-transaction> ;
    ns1:foundName "Relypsa",
        "Relypsa, Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Relypsa",
        "Relypsa, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2317919/Relypsa>,
        <https://1145.am/db/2335879/Relypsa>,
        <https://1145.am/db/2344671/Relypsa_Inc>,
        <https://1145.am/db/2347532/Relypsa_Inc>,
        <https://1145.am/db/2353972/Relypsa_Inc>,
        <https://1145.am/db/2357402/Relypsa>,
        <https://1145.am/db/2357443/Relypsa>,
        <https://1145.am/db/2357502/Relypsa_Inc>,
        <https://1145.am/db/2360174/Relypsa>,
        <https://1145.am/db/2360488/Relypsa>,
        <https://1145.am/db/2360659/Relypsa_Inc>,
        <https://1145.am/db/2360664/Relypsa>,
        <https://1145.am/db/2361474/Relypsa_Inc>,
        <https://1145.am/db/2363586/Relypsa>,
        <https://1145.am/db/2596405/Relypsa_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2300798/Relypsa>,
        <https://1145.am/db/2317903/Relypsa>,
        <https://1145.am/db/2323794/Relypsa>,
        <https://1145.am/db/2347540/Relypsa>,
        <https://1145.am/db/2355260/Relypsa>,
        <https://1145.am/db/2371094/Relypsa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348128/Investment_Methylgene_Inc_Tavistock_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-12T16:59:30+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MethylGene Announces Cdn. $ 26.1 Million Private Placement.",
        "MethylGene Inc. (TSX: MYG) announced today its intention to complete a private placement in the United States of Cdn. $ 26.1 million (the \"Offering\") ." ;
    ns1:documentTitle "MethylGene Announces Cdn.$26.1 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/methylgene-announces-cdn-26-1-million-private-placement> ;
    ns1:foundName "Private Placement",
        "private placement" ;
    ns1:name "Private Placement",
        "private placement" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2348128/Methylgene_Inc> ;
    ns1:valueRaw "$ 26.1 million",
        "Cdn. $ 26.1 Million",
        "Cdn. $ 26.1 million" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2348128/Methylgene_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Canada" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:basedInHighRaw "Canada" ;
    ns1:basedInLowRaw "Canada",
        "United States" ;
    ns1:description "Pharmaceuticals",
        "a company" ;
    ns1:documentDate "2012-11-12T16:59:30+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MethylGene Announces Cdn.$26.1 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/methylgene-announces-cdn-26-1-million-private-placement> ;
    ns1:foundName "MethylGene",
        "MethylGene Inc",
        "MethylGene Inc." ;
    ns1:name "MethylGene",
        "MethylGene Inc",
        "MethylGene Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2363184/Methylgene_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2342856/Methylgene_Inc>,
        <https://1145.am/db/2349122/Methylgene_Inc>,
        <https://1145.am/db/2355914/Methylgene_Inc>,
        <https://1145.am/db/2360090/Methylgene_Inc>,
        <https://1145.am/db/2360091/Methylgene>,
        <https://1145.am/db/2361256/Methylgene_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348135/Vaccibody> a org:Organization ;
    ns1:basedInLowRaw "United Kingdom" ;
    ns1:description "Research" ;
    ns1:documentDate "2012-11-13T05:01:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vaccibody Receives Euros 2 Million to Develop Therapeutic Cervical Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaccibody-receives-euros-2-million-to-develop-therapeutic-cervical-cancer-vaccine> ;
    ns1:foundName "Vaccibody" ;
    ns1:industry "Therapeutic vaccine" ;
    ns1:name "Vaccibody" ;
    ns1:sameAsMedium <https://1145.am/db/2367967/Vaccibody> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2349120/Clarus_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CALIF" ;
    ns1:documentDate "2012-11-13T12:24:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PEARL THERAPEUTICS RAISES $65 MILLION SERIES D TO START PT003 PHASE 3" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pearl-therapeutics-raises-65-million-series-d-to-start-pt003-phase-3> ;
    ns1:foundName "Clarus Ventures" ;
    ns1:investor <https://1145.am/db/2349120/Series_D_Investment_5am_Ventures_Clarus_Ventures_New_Leaf_Venture_Partners_Pearl_Therapeutics_Inc_Vatera_Healthcare_Partners_Completed> ;
    ns1:name "Clarus Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Clarus_Ventures>,
        <https://1145.am/db/2302292/Clarus_Ventures>,
        <https://1145.am/db/2302994/Clarus_Ventures>,
        <https://1145.am/db/2303563/Clarus_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304261/Clarus_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2306754/Clarus_Ventures>,
        <https://1145.am/db/2311011/Clarus_Ventures>,
        <https://1145.am/db/2311595/Clarus_Ventures>,
        <https://1145.am/db/2312277/Clarus_Ventures>,
        <https://1145.am/db/2312288/Clarus_Ventures>,
        <https://1145.am/db/2312945/Clarus_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2315059/Clarus_Ventures>,
        <https://1145.am/db/2317145/Clarus_Ventures>,
        <https://1145.am/db/2318851/Clarus_Ventures>,
        <https://1145.am/db/2321137/Clarus_Ventures>,
        <https://1145.am/db/2324936/Clarus_Ventures>,
        <https://1145.am/db/2325880/Clarus_Ventures>,
        <https://1145.am/db/2327405/Clarus_Ventures>,
        <https://1145.am/db/2329773/Clarus_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335928/Clarus_Ventures>,
        <https://1145.am/db/2336313/Clarus_Ventures>,
        <https://1145.am/db/2336944/Clarus_Ventures>,
        <https://1145.am/db/2341003/Clarus_Ventures>,
        <https://1145.am/db/2341600/Clarus_Ventures>,
        <https://1145.am/db/2342624/Clarus_Ventures>,
        <https://1145.am/db/2342629/Clarus_Ventures_Llc>,
        <https://1145.am/db/2343722/Clarus_Ventures>,
        <https://1145.am/db/2343725/Clarus_Ventures>,
        <https://1145.am/db/2343737/Clarus_Ventures>,
        <https://1145.am/db/2347389/Clarus_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2349717/Clarus_Ventures>,
        <https://1145.am/db/2349722/Clarus_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2351958/Clarus_Ventures>,
        <https://1145.am/db/2352808/Clarus_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2353771/Clarus_Ventures>,
        <https://1145.am/db/2353789/Clarus_Ventures>,
        <https://1145.am/db/2354295/Clarus_Ventures>,
        <https://1145.am/db/2355435/Clarus_Ventures>,
        <https://1145.am/db/2356084/Clarus_Ventures>,
        <https://1145.am/db/2357858/Clarus_Ventures>,
        <https://1145.am/db/2359654/Clarus_Ventures>,
        <https://1145.am/db/2360756/Clarus_Ventures>,
        <https://1145.am/db/2360758/Clarus_Ventures>,
        <https://1145.am/db/2364468/Clarus_Ventures>,
        <https://1145.am/db/2364471/Clarus_Ventures>,
        <https://1145.am/db/2365171/Clarus_Ventures>,
        <https://1145.am/db/2365184/Clarus_Ventures>,
        <https://1145.am/db/2366049/Clarus_Ventures>,
        <https://1145.am/db/2366055/Clarus_Ventures>,
        <https://1145.am/db/2368297/Clarus_Ventures>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2584561/Clarus_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2349120/Pearl_Therapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Redwood City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5386834/about.rdf> ;
    ns1:basedInHighRaw "REDWOOD CITY, CALIF." ;
    ns1:description "Pharmaceuticals",
        "pharmaceuticals" ;
    ns1:documentDate "2012-11-13T12:24:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PEARL THERAPEUTICS RAISES $65 MILLION SERIES D TO START PT003 PHASE 3" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pearl-therapeutics-raises-65-million-series-d-to-start-pt003-phase-3> ;
    ns1:foundName "PEARL THERAPEUTICS",
        "Pearl Therapeutics Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Pearl Therapeutics",
        "Pearl Therapeutics Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2302085/Pearl_Therapeutics>,
        <https://1145.am/db/2303563/Upstart_Pearl_Therapeutics>,
        <https://1145.am/db/2306754/Pearl_Therapeutics>,
        <https://1145.am/db/2331041/Pearl_Therapeutics_Inc>,
        <https://1145.am/db/2340097/Pearl_Therapeutics>,
        <https://1145.am/db/2341003/Pearl_Therapeutics_Inc>,
        <https://1145.am/db/2341005/Pearl_Therapeutics>,
        <https://1145.am/db/2349118/Pearl_Therapeutics>,
        <https://1145.am/db/2349678/Pearl_Therapeutics>,
        <https://1145.am/db/2350681/Pearl_Therapeutics>,
        <https://1145.am/db/2354978/Pearl_Therapeutics>,
        <https://1145.am/db/2362667/Pearl_Therapeutics>,
        <https://1145.am/db/2362670/Pearl_Therapeutics>,
        <https://1145.am/db/2363750/Pearl_Therapeutics>,
        <https://1145.am/db/2580556/Pearl_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2303581/Pearl_Therapeutics>,
        <https://1145.am/db/2305724/Pearl_Therapeutics>,
        <https://1145.am/db/2311595/Pearl_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2349120/Vatera_Healthcare_Partners> a org:Organization ;
    ns1:basedInLowRaw "CALIF" ;
    ns1:documentDate "2012-11-13T12:24:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PEARL THERAPEUTICS RAISES $65 MILLION SERIES D TO START PT003 PHASE 3" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pearl-therapeutics-raises-65-million-series-d-to-start-pt003-phase-3> ;
    ns1:foundName "Vatera Healthcare Partners" ;
    ns1:investor <https://1145.am/db/2349120/Series_D_Investment_5am_Ventures_Clarus_Ventures_New_Leaf_Venture_Partners_Pearl_Therapeutics_Inc_Vatera_Healthcare_Partners_Completed> ;
    ns1:name "Vatera Healthcare Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2341003/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2341005/Vatera_Healthcare>,
        <https://1145.am/db/2347397/Vatera_Healthcare_Partners_Llc>,
        <https://1145.am/db/2350011/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2352277/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2353256/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2353260/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2354004/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2354009/Vatera_Healthcare_Partners_Llc>,
        <https://1145.am/db/2359662/Vatera_Healthcare_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350164/Farallon_Capital_Management> a org:Organization ;
    ns1:basedInLowRaw "Boston" ;
    ns1:documentDate "2012-11-15T16:09:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intarcia-therapeutics-secures-landmark-210-million-financing-to-fund-its-global-phase-3> ;
    ns1:foundName "Farallon Capital Management, LLC" ;
    ns1:investor <https://1145.am/db/2350164/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_Inc_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Completed> ;
    ns1:name "Farallon Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/1519613/Farallon_Capital_Management>,
        <https://1145.am/db/1519799/Farallon_Capital_Management>,
        <https://1145.am/db/2284202/Farallon_Capital_Management>,
        <https://1145.am/db/2285718/Farallon_Capital_Management>,
        <https://1145.am/db/2285850/Farallon_Capital_Management>,
        <https://1145.am/db/2285893/Farallon_Capital_Management>,
        <https://1145.am/db/2286196/Farallon_Capital_Management>,
        <https://1145.am/db/2350167/Farallon_Capital_Management>,
        <https://1145.am/db/2361416/Farallon_Capital_Management>,
        <https://1145.am/db/2364496/Farallon_Capital_Management>,
        <https://1145.am/db/2721240/Farallon_Capital_Management>,
        <https://1145.am/db/842953/Farallon_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350164/The_Baupost_Group> a org:Organization ;
    ns1:basedInLowRaw "Boston" ;
    ns1:documentDate "2012-11-15T16:09:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intarcia-therapeutics-secures-landmark-210-million-financing-to-fund-its-global-phase-3> ;
    ns1:foundName "The Baupost Group, LLC" ;
    ns1:investor <https://1145.am/db/2350164/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_Inc_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Completed> ;
    ns1:name "The Baupost Group" ;
    ns1:sameAsMedium <https://1145.am/db/2041444/The_Baupost_Group>,
        <https://1145.am/db/2053860/The_Baupost_Group>,
        <https://1145.am/db/2057811/The_Baupost_Group>,
        <https://1145.am/db/2344782/The_Baupost_Group>,
        <https://1145.am/db/2350167/The_Baupost_Group>,
        <https://1145.am/db/404773/The_Baupost_Group>,
        <https://1145.am/db/405286/The_Baupost_Group>,
        <https://1145.am/db/702197/The_Baupost_Group>,
        <https://1145.am/db/709230/The_Baupost_Group>,
        <https://1145.am/db/866464/The_Baupost_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350164/Venrock> a org:Organization ;
    ns1:basedInLowRaw "HAYWARD" ;
    ns1:description "financings" ;
    ns1:documentDate "2012-11-15T16:09:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intarcia-therapeutics-secures-landmark-210-million-financing-to-fund-its-global-phase-3> ;
    ns1:foundName "Venrock" ;
    ns1:investor <https://1145.am/db/2350164/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_Inc_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Completed> ;
    ns1:name "Venrock" ;
    ns1:sameAsHigh <https://1145.am/db/1224684/Verisk>,
        <https://1145.am/db/1834607/Venrock>,
        <https://1145.am/db/2282806/Venrock>,
        <https://1145.am/db/2331784/Venrock>,
        <https://1145.am/db/2345037/Venrock>,
        <https://1145.am/db/2348857/Venrock>,
        <https://1145.am/db/2360682/Venrock>,
        <https://1145.am/db/676854/Venrock>,
        <https://1145.am/db/678071/Venrock>,
        <https://1145.am/db/922552/Venrock>,
        <https://1145.am/db/923335/Venrock> ;
    ns1:sameAsMedium <https://1145.am/db/1263825/Venrock>,
        <https://1145.am/db/1700286/Venrock>,
        <https://1145.am/db/1718033/Venrock>,
        <https://1145.am/db/1719688/Venrock>,
        <https://1145.am/db/1735836/Venrock>,
        <https://1145.am/db/1736582/Venrock>,
        <https://1145.am/db/1746940/Venrock>,
        <https://1145.am/db/1750203/Venrock>,
        <https://1145.am/db/1757897/Venrock>,
        <https://1145.am/db/1758165/Venrock>,
        <https://1145.am/db/1793754/Venrock>,
        <https://1145.am/db/1796590/Venrock>,
        <https://1145.am/db/1801792/Venrock>,
        <https://1145.am/db/1821534/Venrock>,
        <https://1145.am/db/1828008/Venrock>,
        <https://1145.am/db/1829024/Venrock>,
        <https://1145.am/db/1830635/Venrock>,
        <https://1145.am/db/1835080/Venrock>,
        <https://1145.am/db/1846413/Venrock>,
        <https://1145.am/db/1848371/Venrock>,
        <https://1145.am/db/1856457/Venrock>,
        <https://1145.am/db/1870276/Venrock>,
        <https://1145.am/db/1870808/Venrock>,
        <https://1145.am/db/1877870/Venrock>,
        <https://1145.am/db/1881935/Venrock>,
        <https://1145.am/db/1889137/Venrock>,
        <https://1145.am/db/1891984/Venrock>,
        <https://1145.am/db/1895986/Venrock>,
        <https://1145.am/db/1903951/Venrock>,
        <https://1145.am/db/1911226/Venrock>,
        <https://1145.am/db/2242614/Venrock>,
        <https://1145.am/db/2290283/Venrock>,
        <https://1145.am/db/2291211/Venrock>,
        <https://1145.am/db/2291384/Venrock>,
        <https://1145.am/db/2296169/Venrock>,
        <https://1145.am/db/2296869/Venrock>,
        <https://1145.am/db/2298631/Venrock>,
        <https://1145.am/db/2299758/Venrock>,
        <https://1145.am/db/2303675/Venrock>,
        <https://1145.am/db/2307476/Venrock>,
        <https://1145.am/db/2317918/Venrock>,
        <https://1145.am/db/2326903/Venrock>,
        <https://1145.am/db/2327474/Venrock>,
        <https://1145.am/db/2328599/Venrock>,
        <https://1145.am/db/2335748/Venrock>,
        <https://1145.am/db/2338126/Venrock>,
        <https://1145.am/db/2338127/Venrock>,
        <https://1145.am/db/2339666/Venrock>,
        <https://1145.am/db/2340942/Venrock>,
        <https://1145.am/db/2345047/Venrock>,
        <https://1145.am/db/2348448/Venrock>,
        <https://1145.am/db/2349834/Venrock>,
        <https://1145.am/db/2350167/Venrock>,
        <https://1145.am/db/2352414/Venrock>,
        <https://1145.am/db/2356064/Venrock>,
        <https://1145.am/db/2358173/Venrock>,
        <https://1145.am/db/2359334/Venrock>,
        <https://1145.am/db/2366775/Venrock>,
        <https://1145.am/db/2366984/Venrock>,
        <https://1145.am/db/2368501/Venrock>,
        <https://1145.am/db/2370436/Venrock>,
        <https://1145.am/db/2371160/Venrock>,
        <https://1145.am/db/2371163/Venrock>,
        <https://1145.am/db/2538407/Venrock>,
        <https://1145.am/db/2569515/Venrock>,
        <https://1145.am/db/2569522/Venrock>,
        <https://1145.am/db/437679/Venrock>,
        <https://1145.am/db/773235/Venrock>,
        <https://1145.am/db/893359/Venrock>,
        <https://1145.am/db/894233/Venrock> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350167/Farallon_Capital_Management> a org:Organization ;
    ns1:description "Big Pharma" ;
    ns1:documentDate "2012-11-15T16:38:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia raises $210M for PhIII, once-yearly diabetes drug" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/intarcia-raises-210m-for-phiii-once-yearly-diabetes-drug> ;
    ns1:foundName "Farallon Capital Management" ;
    ns1:investor <https://1145.am/db/2350167/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Has_Not_Happened> ;
    ns1:name "Farallon Capital Management" ;
    ns1:sameAsMedium <https://1145.am/db/1519613/Farallon_Capital_Management>,
        <https://1145.am/db/1519799/Farallon_Capital_Management>,
        <https://1145.am/db/2284202/Farallon_Capital_Management>,
        <https://1145.am/db/2285718/Farallon_Capital_Management>,
        <https://1145.am/db/2285850/Farallon_Capital_Management>,
        <https://1145.am/db/2285893/Farallon_Capital_Management>,
        <https://1145.am/db/2286196/Farallon_Capital_Management>,
        <https://1145.am/db/2350164/Farallon_Capital_Management>,
        <https://1145.am/db/2361416/Farallon_Capital_Management>,
        <https://1145.am/db/2364496/Farallon_Capital_Management>,
        <https://1145.am/db/2721240/Farallon_Capital_Management>,
        <https://1145.am/db/842953/Farallon_Capital_Management> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350167/The_Baupost_Group> a org:Organization ;
    ns1:description "Big Pharma" ;
    ns1:documentDate "2012-11-15T16:38:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia raises $210M for PhIII, once-yearly diabetes drug" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/intarcia-raises-210m-for-phiii-once-yearly-diabetes-drug> ;
    ns1:foundName "The Baupost Group" ;
    ns1:investor <https://1145.am/db/2350167/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Has_Not_Happened> ;
    ns1:name "The Baupost Group" ;
    ns1:sameAsMedium <https://1145.am/db/2041444/The_Baupost_Group>,
        <https://1145.am/db/2053860/The_Baupost_Group>,
        <https://1145.am/db/2057811/The_Baupost_Group>,
        <https://1145.am/db/2344782/The_Baupost_Group>,
        <https://1145.am/db/2350164/The_Baupost_Group>,
        <https://1145.am/db/404773/The_Baupost_Group>,
        <https://1145.am/db/405286/The_Baupost_Group>,
        <https://1145.am/db/702197/The_Baupost_Group>,
        <https://1145.am/db/709230/The_Baupost_Group>,
        <https://1145.am/db/866464/The_Baupost_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350167/Venrock> a org:Organization ;
    ns1:description "venture cash" ;
    ns1:documentDate "2012-11-15T16:38:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia raises $210M for PhIII, once-yearly diabetes drug" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/intarcia-raises-210m-for-phiii-once-yearly-diabetes-drug> ;
    ns1:foundName "Venrock" ;
    ns1:investor <https://1145.am/db/2350167/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Has_Not_Happened> ;
    ns1:name "Venrock" ;
    ns1:sameAsMedium <https://1145.am/db/1263825/Venrock>,
        <https://1145.am/db/1700286/Venrock>,
        <https://1145.am/db/1718033/Venrock>,
        <https://1145.am/db/1719688/Venrock>,
        <https://1145.am/db/1735836/Venrock>,
        <https://1145.am/db/1736582/Venrock>,
        <https://1145.am/db/1746940/Venrock>,
        <https://1145.am/db/1750203/Venrock>,
        <https://1145.am/db/1757897/Venrock>,
        <https://1145.am/db/1758165/Venrock>,
        <https://1145.am/db/1793754/Venrock>,
        <https://1145.am/db/1796590/Venrock>,
        <https://1145.am/db/1801792/Venrock>,
        <https://1145.am/db/1821534/Venrock>,
        <https://1145.am/db/1828008/Venrock>,
        <https://1145.am/db/1829024/Venrock>,
        <https://1145.am/db/1830635/Venrock>,
        <https://1145.am/db/1834607/Venrock>,
        <https://1145.am/db/1835080/Venrock>,
        <https://1145.am/db/1846413/Venrock>,
        <https://1145.am/db/1848371/Venrock>,
        <https://1145.am/db/1856457/Venrock>,
        <https://1145.am/db/1870276/Venrock>,
        <https://1145.am/db/1870808/Venrock>,
        <https://1145.am/db/1877870/Venrock>,
        <https://1145.am/db/1881935/Venrock>,
        <https://1145.am/db/1889137/Venrock>,
        <https://1145.am/db/1891984/Venrock>,
        <https://1145.am/db/1895986/Venrock>,
        <https://1145.am/db/1903951/Venrock>,
        <https://1145.am/db/1911226/Venrock>,
        <https://1145.am/db/2242614/Venrock>,
        <https://1145.am/db/2282806/Venrock>,
        <https://1145.am/db/2290283/Venrock>,
        <https://1145.am/db/2291211/Venrock>,
        <https://1145.am/db/2291384/Venrock>,
        <https://1145.am/db/2296169/Venrock>,
        <https://1145.am/db/2296869/Venrock>,
        <https://1145.am/db/2298631/Venrock>,
        <https://1145.am/db/2299758/Venrock>,
        <https://1145.am/db/2303675/Venrock>,
        <https://1145.am/db/2307476/Venrock>,
        <https://1145.am/db/2317918/Venrock>,
        <https://1145.am/db/2326903/Venrock>,
        <https://1145.am/db/2327474/Venrock>,
        <https://1145.am/db/2328599/Venrock>,
        <https://1145.am/db/2331784/Venrock>,
        <https://1145.am/db/2335748/Venrock>,
        <https://1145.am/db/2338126/Venrock>,
        <https://1145.am/db/2338127/Venrock>,
        <https://1145.am/db/2339666/Venrock>,
        <https://1145.am/db/2340942/Venrock>,
        <https://1145.am/db/2345037/Venrock>,
        <https://1145.am/db/2345047/Venrock>,
        <https://1145.am/db/2348448/Venrock>,
        <https://1145.am/db/2348857/Venrock>,
        <https://1145.am/db/2349834/Venrock>,
        <https://1145.am/db/2350164/Venrock>,
        <https://1145.am/db/2352414/Venrock>,
        <https://1145.am/db/2356064/Venrock>,
        <https://1145.am/db/2358173/Venrock>,
        <https://1145.am/db/2359334/Venrock>,
        <https://1145.am/db/2360682/Venrock>,
        <https://1145.am/db/2366775/Venrock>,
        <https://1145.am/db/2366984/Venrock>,
        <https://1145.am/db/2368501/Venrock>,
        <https://1145.am/db/2370436/Venrock>,
        <https://1145.am/db/2371160/Venrock>,
        <https://1145.am/db/2371163/Venrock>,
        <https://1145.am/db/2538407/Venrock>,
        <https://1145.am/db/2569515/Venrock>,
        <https://1145.am/db/2569522/Venrock>,
        <https://1145.am/db/437679/Venrock>,
        <https://1145.am/db/676854/Venrock>,
        <https://1145.am/db/678071/Venrock>,
        <https://1145.am/db/773235/Venrock>,
        <https://1145.am/db/893359/Venrock>,
        <https://1145.am/db/894233/Venrock>,
        <https://1145.am/db/922552/Venrock>,
        <https://1145.am/db/923335/Venrock> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350199/Agtc> a org:Organization ;
    ns1:description "gene therapy" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "AGTC" ;
    ns1:name "AGTC" ;
    ns1:sameAsHigh <https://1145.am/db/1187617/Genespire>,
        <https://1145.am/db/124996/Askbio>,
        <https://1145.am/db/1553518/Aavantibio>,
        <https://1145.am/db/1989183/Avrobio>,
        <https://1145.am/db/2033933/Avrobio>,
        <https://1145.am/db/2153153/Askbio>,
        <https://1145.am/db/2153670/Biogen>,
        <https://1145.am/db/2155885/Orchard_Therapeutics>,
        <https://1145.am/db/2156318/Passage_Bio>,
        <https://1145.am/db/2279515/Aavantibio>,
        <https://1145.am/db/2281205/Orchard_Therapeutics>,
        <https://1145.am/db/2283486/Spark_Therapeutics>,
        <https://1145.am/db/2284442/Tevard_Biosciences>,
        <https://1145.am/db/2284603/Kriya_Therapeutics>,
        <https://1145.am/db/2285399/Aavantibio>,
        <https://1145.am/db/2286274/Affinia_Therapeutics>,
        <https://1145.am/db/2286545/Senti_Biosciences>,
        <https://1145.am/db/2286821/Ucb>,
        <https://1145.am/db/2286937/Asklepios>,
        <https://1145.am/db/2298592/Scout_Bio>,
        <https://1145.am/db/2317564/Applied_Genetic_Technologies>,
        <https://1145.am/db/2322526/Genetix_Pharmaceuticals>,
        <https://1145.am/db/2322531/Genetix_Pharmaceuticals>,
        <https://1145.am/db/2337674/Genenta_Science>,
        <https://1145.am/db/2347997/Ceregene>,
        <https://1145.am/db/2348012/Gensight_Biologics>,
        <https://1145.am/db/2350198/Applied_Genetic>,
        <https://1145.am/db/2353337/Juventas_Therapeutics>,
        <https://1145.am/db/2357505/Regenxbio>,
        <https://1145.am/db/2359227/Regenxbio_Inc>,
        <https://1145.am/db/2359228/Regenx>,
        <https://1145.am/db/2361441/Chatham_Therapeutics>,
        <https://1145.am/db/2361442/Chatham_Therapeutics>,
        <https://1145.am/db/2366745/Targeted_Genetics>,
        <https://1145.am/db/2368546/Engene>,
        <https://1145.am/db/2370525/Spark_Therapeutics>,
        <https://1145.am/db/2540755/Spark_Therapeutics>,
        <https://1145.am/db/2541672/Spark_Therapeutics>,
        <https://1145.am/db/2542648/Audentes_Therapeutics>,
        <https://1145.am/db/2545742/Spark_Therapeutics>,
        <https://1145.am/db/2553947/Spark_Therapeutics>,
        <https://1145.am/db/2556204/Vigene_Biosciences>,
        <https://1145.am/db/2558369/Forge_Biologics>,
        <https://1145.am/db/2562761/Biomarin>,
        <https://1145.am/db/2565794/Spark_Therapeutics>,
        <https://1145.am/db/2573996/Spark_Therapeutics>,
        <https://1145.am/db/2583475/Medgenics_Inc>,
        <https://1145.am/db/488391/Arctos_Medical>,
        <https://1145.am/db/595407/Avrobio>,
        <https://1145.am/db/595839/Avrobio>,
        <https://1145.am/db/701826/Kriya_Therapeutics>,
        <https://1145.am/db/742595/Kriya_Therapeutics>,
        <https://1145.am/db/768089/64x_Bio>,
        <https://1145.am/db/949208/Aavantgarde_Bio> ;
    ns1:sameAsMedium <https://1145.am/db/1451006/Agtc>,
        <https://1145.am/db/2364540/Agtc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350199/Applied_Genetic_Technologies_Corporation> a org:Organization ;
    ns1:basedInHighGeoName "Gainesville" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4156404/about.rdf> ;
    ns1:basedInHighRaw "GAINESVILLE, Fla." ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "Applied Genetic Technologies Corporation" ;
    ns1:industry "biotechnology" ;
    ns1:name "Applied Genetic Technologies Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/1201441/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/1201696/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/1440532/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/1747516/Geneme>,
        <https://1145.am/db/2307362/Discovery_Labs>,
        <https://1145.am/db/2317561/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/2358622/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/2362372/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/2371062/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/415349/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/549304/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/678000/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/919888/Applied_Genetic_Technologies_Corporation> ;
    ns1:sameAsMedium <https://1145.am/db/1447280/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/1447735/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/1451006/Applied_Genetic_Technologies_Corporation>,
        <https://1145.am/db/2317564/Applied_Genetic_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350199/Interwest> a org:Organization ;
    ns1:basedInLowRaw "GAINESVILLE, Fla" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "InterWest" ;
    ns1:investor <https://1145.am/db/2350199/Series_B_Investment_Alta_Partners_And_Sr_Applied_Genetic_Technologies_Corporation_Interwest_Intersouth_Partners_Medimmune_Ventures_Osage_University_Partners_Sr_One_Limited_Completed> ;
    ns1:name "InterWest" ;
    ns1:sameAsHigh <https://1145.am/db/1711300/Interwest_Partners>,
        <https://1145.am/db/1886261/Interwest_Partners>,
        <https://1145.am/db/2312792/Interwest>,
        <https://1145.am/db/2315289/Interwest_Partners>,
        <https://1145.am/db/2320852/Intersouth_Partners>,
        <https://1145.am/db/2325257/Interwest_Partners>,
        <https://1145.am/db/2326361/Interwest_Partners>,
        <https://1145.am/db/2326373/Interwest_Partners>,
        <https://1145.am/db/2328655/Intersouth_Partners>,
        <https://1145.am/db/2346204/Brookside_Capital>,
        <https://1145.am/db/2348754/Interwest_Partners>,
        <https://1145.am/db/2350199/Intersouth_Partners>,
        <https://1145.am/db/2578837/Intersouth_Partners>,
        <https://1145.am/db/317537/Starbridge_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1886135/Interwest>,
        <https://1145.am/db/1909430/Interwest>,
        <https://1145.am/db/2296275/Interwest>,
        <https://1145.am/db/2330389/Interwest> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350199/Osage_University_Partners> a org:Organization ;
    ns1:basedInLowRaw "GAINESVILLE, Fla" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "Osage University Partners" ;
    ns1:investor <https://1145.am/db/2350199/Series_B_Investment_Alta_Partners_And_Sr_Applied_Genetic_Technologies_Corporation_Interwest_Intersouth_Partners_Medimmune_Ventures_Osage_University_Partners_Sr_One_Limited_Completed> ;
    ns1:name "Osage University Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1441781/Osage_University_Partners>,
        <https://1145.am/db/1533327/Osage_University_Partners>,
        <https://1145.am/db/1533685/Osage_University_Partners>,
        <https://1145.am/db/1619110/Osage_University_Partners>,
        <https://1145.am/db/1696377/Osage_University_Partners>,
        <https://1145.am/db/1759759/Osage_University_Partners>,
        <https://1145.am/db/1774684/Osage_University_Partners>,
        <https://1145.am/db/1782234/Osage_University_Partners>,
        <https://1145.am/db/1802088/Osage_University_Partners>,
        <https://1145.am/db/1810714/Osage_University_Partners>,
        <https://1145.am/db/1823287/Osage_University_Partners>,
        <https://1145.am/db/1858399/Osage_University_Partners>,
        <https://1145.am/db/2153910/Osage_University_Partners>,
        <https://1145.am/db/2278799/Osage_University_Partners>,
        <https://1145.am/db/2292287/Osage_University_Partners>,
        <https://1145.am/db/2294753/Osage_University_Partners>,
        <https://1145.am/db/2301464/Osage_University_Partners>,
        <https://1145.am/db/2319360/Osage_University_Partners>,
        <https://1145.am/db/2336032/Osage_University_Partners>,
        <https://1145.am/db/2336221/Osage_University_Partners>,
        <https://1145.am/db/2340284/Osage_University_Partners>,
        <https://1145.am/db/2340888/Osage_University_Partners>,
        <https://1145.am/db/2341896/Osage_University_Partners>,
        <https://1145.am/db/2349691/Osage_University_Partners>,
        <https://1145.am/db/2349838/Osage_University_Partners>,
        <https://1145.am/db/2350044/Osage_University_Partners>,
        <https://1145.am/db/2352349/Osage_University_Partners>,
        <https://1145.am/db/2352350/Osage_University_Partners>,
        <https://1145.am/db/2353771/Osage_University_Partners>,
        <https://1145.am/db/2353789/Osage_University_Partners>,
        <https://1145.am/db/2358430/Osage_University_Partners>,
        <https://1145.am/db/2359404/Osage_University_Partners>,
        <https://1145.am/db/2360521/Osage_University_Partners>,
        <https://1145.am/db/2360526/Osage_University_Partners>,
        <https://1145.am/db/2368351/Osage_University_Partners>,
        <https://1145.am/db/2369165/Osage_University_Partners>,
        <https://1145.am/db/2369169/Osage_University_Partners>,
        <https://1145.am/db/2370626/Osage_University_Partners>,
        <https://1145.am/db/2569831/Osage_University_Partners>,
        <https://1145.am/db/425953/Osage_University_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350625/Investment_Rarecyte_Inc_Telegraph_Hill_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-22T01:02:27+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform.",
        "RareCyte Inc., a Seattle - based life science company, closed the second tranche of its funding led by Telegraph Hill Partners (THP) ." ;
    ns1:documentTitle "RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rarecyte-completes-final-tranche-of-funding-for-launch-of-its-accucyte-rare-cell-detection> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2350625/Rarecyte_Inc> ;
    ns1:whereGeoName "Seattle" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:whereRaw "Seattle" .

<https://1145.am/db/2350625/Telegraph_Hill_Partners> a org:Organization ;
    ns1:basedInLowRaw "Seattle" ;
    ns1:description "funding" ;
    ns1:documentDate "2012-08-22T01:02:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rarecyte-completes-final-tranche-of-funding-for-launch-of-its-accucyte-rare-cell-detection> ;
    ns1:foundName "Telegraph Hill Partners" ;
    ns1:investor <https://1145.am/db/2350625/Investment_Rarecyte_Inc_Telegraph_Hill_Partners_Completed> ;
    ns1:name "Telegraph Hill Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2571001/Telegraph_Hill_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1133740/Telegraph_Hill_Partners>,
        <https://1145.am/db/1135234/Telegraph_Hill_Partners>,
        <https://1145.am/db/1177907/Telegraph_Hill_Partners>,
        <https://1145.am/db/1445365/Telegraph_Hill_Partners>,
        <https://1145.am/db/781996/Telegraph_Hill_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350664/3dr_Laboratories> a org:Organization ;
    ns1:basedInHighGeoName "Kentucky" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6254925/about.rdf> ;
    ns1:basedInHighRaw "Kentucky" ;
    ns1:description "3D imaging services" ;
    ns1:documentDate "2012-08-23T13:02:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "3DR Laboratories, Inc. Receives $7.2 Million in Funding from Advantage Capital Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/3dr-laboratories-inc-receives-7-2-million-funding-from-advantage-capital-partners> ;
    ns1:foundName "3DR Laboratories, Inc." ;
    ns1:name "3DR Laboratories" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351210/Taurx_Pharmaceuticals_Ltd> a org:Organization ;
    ns1:basedInLowRaw "SINGAPORE",
        "US" ;
    ns1:description "pharmaceutical company",
        "pharmaceuticals" ;
    ns1:documentDate "2012-11-20T17:16:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "TauRx Pharmaceuticals receives $111.8m commitment from Genting to prepare for Market Leadership in Alzheimer's" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taurx-pharmaceuticals-receives-111-8m-commitment-from-genting-to-prepare-for-market> ;
    ns1:foundName "TauRx",
        "TauRx Pharmaceuticals",
        "TauRx Pharmaceuticals Ltd" ;
    ns1:industry "Pharmaceuticals",
        "pharmaceutical" ;
    ns1:name "TauRx",
        "TauRx Pharmaceuticals",
        "TauRx Pharmaceuticals Ltd" ;
    ns1:sameAsHigh <https://1145.am/db/2340765/Taurx_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2541314/Taurx_Pharmaceuticals>,
        <https://1145.am/db/2541323/Taurx_Pharmaceuticals_Ltd> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351224/Kiadis_Pharma> a org:Organization ;
    ns1:description "developing treatments for blood cancers" ;
    ns1:documentDate "2012-11-21T15:02:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kiadis Pharma Raises EUR 10 Million in Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/kiadis-pharma-raises-eur-10-million-financing-round> ;
    ns1:foundName "Kiadis Pharma",
        "Kiadis Pharma B.V." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Kiadis Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1077454/Kala_Pharmaceuticals_Inc>,
        <https://1145.am/db/1078071/Kala_Pharmaceuticals_Inc>,
        <https://1145.am/db/1094206/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/1422341/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/1422954/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/1538298/Kala_Pharmaceuticals_Inc>,
        <https://1145.am/db/1618823/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/1977836/Satsuma_Pharmaceuticals_Inc>,
        <https://1145.am/db/2002431/Satsuma_Pharmaceuticals_Inc>,
        <https://1145.am/db/2067943/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/2074565/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/2153542/Karuna_Pharmaceuticals>,
        <https://1145.am/db/2154053/Kiadis_Pharma>,
        <https://1145.am/db/2286420/Karuna_Therapeutics>,
        <https://1145.am/db/2291222/Karo_Pharma>,
        <https://1145.am/db/2291678/Karo_Pharma>,
        <https://1145.am/db/2291936/Karuna_Pharmaceuticals>,
        <https://1145.am/db/2292829/Karuna_Pharmaceuticals>,
        <https://1145.am/db/2308413/Kolltan_Pharmaceuticals>,
        <https://1145.am/db/2308422/Kolltan_Pharmaceuticals>,
        <https://1145.am/db/2308446/Kolltan_Pharmaceuticals>,
        <https://1145.am/db/2309368/Kolltan_Pharmaceuticals>,
        <https://1145.am/db/2319821/Kolltan_Pharmaceuticals>,
        <https://1145.am/db/2324013/Kadmus_Pharmaceuticals>,
        <https://1145.am/db/2324195/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2324214/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2328061/Kala_Pharmaceuticals>,
        <https://1145.am/db/2328338/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2335750/Kala_Pharmaceuticals>,
        <https://1145.am/db/2335755/Kala_Pharmaceuticals>,
        <https://1145.am/db/2336389/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2336546/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2336549/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2339127/Kala_Pharmaceuticals>,
        <https://1145.am/db/2339128/Kala_Pharmaceuticals>,
        <https://1145.am/db/2339953/Kala_Pharmaceuticals>,
        <https://1145.am/db/2342275/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/2342284/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/2343806/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2344256/Kala_Pharmaceuticals>,
        <https://1145.am/db/2344840/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2345224/Kala_Pharmaceuticals>,
        <https://1145.am/db/2352124/Kolltan_Pharmaceuticals>,
        <https://1145.am/db/2352248/Kala_Pharmaceuticals>,
        <https://1145.am/db/2356879/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2356952/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2358210/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2359411/Kolltan_Pharmaceuticals>,
        <https://1145.am/db/2361499/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2361510/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2364793/Kala_Pharmaceuticals>,
        <https://1145.am/db/2364794/Kala_Pharmaceuticals>,
        <https://1145.am/db/2365954/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2367880/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2368095/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2368282/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2368384/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2368560/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/2368572/Kalvista_Pharmaceuticals>,
        <https://1145.am/db/2368798/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2370708/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/2571270/Kalobios_Pharmaceuticals>,
        <https://1145.am/db/543141/Satsuma_Pharmaceuticals_Inc>,
        <https://1145.am/db/718170/Karo_Pharma>,
        <https://1145.am/db/718312/Karo_Pharma> ;
    ns1:sameAsMedium <https://1145.am/db/2295144/Kiadis_Pharma>,
        <https://1145.am/db/2324012/Kiadis_Pharma>,
        <https://1145.am/db/2324015/Kiadis_Pharma>,
        <https://1145.am/db/2325377/Kiadis_Pharma>,
        <https://1145.am/db/2352322/Kiadis_Pharma>,
        <https://1145.am/db/2368046/Kiadis_Pharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352249/Curis_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Lexington" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4941935/about.rdf> ;
    ns1:basedInHighRaw "LEXINGTON, Mass." ;
    ns1:description "Business",
        "drug development" ;
    ns1:documentDate "2012-11-28T15:31:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Curis Announces $30 Million Secured Debt Financing to Support Development of Proprietary Pipeline" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/curis-announces-30-million-secured-debt-financing-to-support-development-of-proprietary> ;
    ns1:foundName "Curis",
        "Curis, Inc",
        "Curis, Inc." ;
    ns1:industry "drug development" ;
    ns1:name "Curis",
        "Curis, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2343556/Curis_Inc>,
        <https://1145.am/db/2345916/Curis>,
        <https://1145.am/db/2360390/Curis>,
        <https://1145.am/db/2366081/Curis_Inc>,
        <https://1145.am/db/2578298/Curis_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2290042/Curis>,
        <https://1145.am/db/2315618/Curis>,
        <https://1145.am/db/2352246/Curis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352249/Pharmakon_Advisors> a org:Organization ;
    ns1:basedInLowRaw "LEXINGTON, Mass" ;
    ns1:description "Investment" ;
    ns1:documentDate "2012-11-28T15:31:06+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Curis Announces $30 Million Secured Debt Financing to Support Development of Proprietary Pipeline" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/curis-announces-30-million-secured-debt-financing-to-support-development-of-proprietary> ;
    ns1:foundName "Pharmakon Advisors" ;
    ns1:investor <https://1145.am/db/2352249/Investment_Curis_Inc_Pharmakon_Advisors_Has_Not_Happened> ;
    ns1:name "Pharmakon Advisors" ;
    ns1:participant <https://1145.am/db/2352249/Investment_Curis_Inc_Pharmakon_Advisors_Has_Not_Happened> ;
    ns1:sameAsHigh <https://1145.am/db/1563989/Pharmakon_Advisors_Lp>,
        <https://1145.am/db/2593583/Pharmakon_Advisors> ;
    ns1:sameAsMedium <https://1145.am/db/2344934/Pharmakon_Advisors>,
        <https://1145.am/db/2344939/Pharmakon_Advisers>,
        <https://1145.am/db/694818/Pharmakon_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352723/Investment_Citibank_Resverlogix_Corp_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-28T15:16:52+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CALGARY, Aug. 27, 2012 /PRNewswire/ - Resverlogix Corp. (TSX: RVX) today announced that it has entered into a $ 25 million Loan Agreement with Citibank, N.A.",
        "Resverlogix Secures $ 25 Million, Five-Year Term Loan." ;
    ns1:documentTitle "Resverlogix Secures $25 Million, Five-Year Term Loan" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resverlogix-secures-25-million-five-year-term-loan> ;
    ns1:foundName "Loan" ;
    ns1:name "Loan" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2352723/Resverlogix_Corp> ;
    ns1:valueRaw "$ 25 Million",
        "$ 25 million" ;
    ns1:when "2012-08-27T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012-Aug-27" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2352723/Resverlogix_Corp> a org:Organization ;
    ns1:basedInHighGeoName "Canada" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:basedInHighRaw "Canada" ;
    ns1:documentDate "2012-08-28T15:16:52+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resverlogix Secures $25 Million, Five-Year Term Loan" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resverlogix-secures-25-million-five-year-term-loan> ;
    ns1:foundName "Resverlogix",
        "Resverlogix Corp." ;
    ns1:name "Resverlogix",
        "Resverlogix Corp." ;
    ns1:sameAsMedium <https://1145.am/db/1280070/Resverlogix_Corp>,
        <https://1145.am/db/2303796/Resverlogix>,
        <https://1145.am/db/2311598/Resverlogix_Corp>,
        <https://1145.am/db/2311605/Resverlogix_Corp>,
        <https://1145.am/db/2314255/Resverlogix_Corp>,
        <https://1145.am/db/2348021/Resverlogix_Corp>,
        <https://1145.am/db/2349221/Resverlogix>,
        <https://1145.am/db/2349226/Resverlogix>,
        <https://1145.am/db/2352682/Resverlogix_Corp>,
        <https://1145.am/db/2537316/Resverlogix>,
        <https://1145.am/db/2537321/Resverlogix_Corp>,
        <https://1145.am/db/2537372/Resverlogix> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353260/Rib-X_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInHighGeoName "New Haven County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4839373/about.rdf> ;
    ns1:basedInHighRaw "NEW HAVEN, Conn." ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-11-29T17:21:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rib-x-pharmaceuticals-closes-first-tranche-67-5-million-financing> ;
    ns1:foundName "Rib-X Pharmaceuticals",
        "Rib-X Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Rib-X Pharmaceuticals",
        "Rib-X Pharmaceuticals, Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2309051/Rib-X>,
        <https://1145.am/db/2309367/Rib-X_Pharmaceuticals>,
        <https://1145.am/db/2313886/Rib-X_Pharmaceuticals_Inc>,
        <https://1145.am/db/2324159/Rib-X_Pharmaceuticals_Inc>,
        <https://1145.am/db/2325749/Rib-X_Pharmaceuticals>,
        <https://1145.am/db/2327379/Rib-X_Pharmaceuticals_Inc>,
        <https://1145.am/db/2328605/Rib-X_Pharmaceuticals>,
        <https://1145.am/db/2331731/Rib-X_Pharmaceuticals>,
        <https://1145.am/db/2342190/Rib-X_Pharmaceuticals>,
        <https://1145.am/db/2347021/Rib-X_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347032/Rib-X_Pharmaceuticals>,
        <https://1145.am/db/2352277/Rib-X_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353256/Rib-X>,
        <https://1145.am/db/2355610/Rib-X_Pharmaceuticals>,
        <https://1145.am/db/2356667/Rib-X_Pharmaceuticals>,
        <https://1145.am/db/2357414/Rib-X_Pharmaceuticals_Inc>,
        <https://1145.am/db/2367000/Rib-X_Pharmaceuticals>,
        <https://1145.am/db/2582203/Rib-X_Pharmaceuticals_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353260/Vatera_Healthcare_Partners> a org:Organization ;
    ns1:basedInLowRaw "Conn" ;
    ns1:documentDate "2012-11-29T17:21:12+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rib-x-pharmaceuticals-closes-first-tranche-67-5-million-financing> ;
    ns1:foundName "Vatera Healthcare Partners" ;
    ns1:investor <https://1145.am/db/2353260/Series_2_Investment_Abs_Ventures_Rib-X_Pharmaceuticals_Inc_Vatera_Healthcare_Partners_Vox_Equity_Partners_Warburg_Pincus_Completed> ;
    ns1:name "Vatera Healthcare Partners" ;
    ns1:sameAsMedium <https://1145.am/db/2341003/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2341005/Vatera_Healthcare>,
        <https://1145.am/db/2347397/Vatera_Healthcare_Partners_Llc>,
        <https://1145.am/db/2349120/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2350011/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2352277/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2353256/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2354004/Vatera_Healthcare_Partners>,
        <https://1145.am/db/2354009/Vatera_Healthcare_Partners_Llc>,
        <https://1145.am/db/2359662/Vatera_Healthcare_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354295/Clarus_Ventures> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "Clarus Ventures" ;
    ns1:investor <https://1145.am/db/2354295/Preferred_Stock_Investment_Alliancebernstein_Alternative_Investment_Management_Group_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Morgan_Stanley_Expansion_Capital_Nanostring_Technologies_Ovp_Venture_Partners_Completed> ;
    ns1:name "Clarus Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1696744/Cloquet_Capital_Partners>,
        <https://1145.am/db/2294202/Clarus_Funds>,
        <https://1145.am/db/2336944/Clarus_Ventures>,
        <https://1145.am/db/2366049/Clarus_Ventures>,
        <https://1145.am/db/2366055/Clarus_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Clarus_Ventures>,
        <https://1145.am/db/2302292/Clarus_Ventures>,
        <https://1145.am/db/2302994/Clarus_Ventures>,
        <https://1145.am/db/2303563/Clarus_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304261/Clarus_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2306754/Clarus_Ventures>,
        <https://1145.am/db/2311011/Clarus_Ventures>,
        <https://1145.am/db/2311595/Clarus_Ventures>,
        <https://1145.am/db/2312277/Clarus_Ventures>,
        <https://1145.am/db/2312288/Clarus_Ventures>,
        <https://1145.am/db/2312945/Clarus_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2315059/Clarus_Ventures>,
        <https://1145.am/db/2317145/Clarus_Ventures>,
        <https://1145.am/db/2318851/Clarus_Ventures>,
        <https://1145.am/db/2321137/Clarus_Ventures>,
        <https://1145.am/db/2324936/Clarus_Ventures>,
        <https://1145.am/db/2325880/Clarus_Ventures>,
        <https://1145.am/db/2327405/Clarus_Ventures>,
        <https://1145.am/db/2329773/Clarus_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335928/Clarus_Ventures>,
        <https://1145.am/db/2336313/Clarus_Ventures>,
        <https://1145.am/db/2341003/Clarus_Ventures>,
        <https://1145.am/db/2341600/Clarus_Ventures>,
        <https://1145.am/db/2342624/Clarus_Ventures>,
        <https://1145.am/db/2342629/Clarus_Ventures_Llc>,
        <https://1145.am/db/2343722/Clarus_Ventures>,
        <https://1145.am/db/2343725/Clarus_Ventures>,
        <https://1145.am/db/2343737/Clarus_Ventures>,
        <https://1145.am/db/2347389/Clarus_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2349120/Clarus_Ventures>,
        <https://1145.am/db/2349717/Clarus_Ventures>,
        <https://1145.am/db/2349722/Clarus_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2351958/Clarus_Ventures>,
        <https://1145.am/db/2352808/Clarus_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2353771/Clarus_Ventures>,
        <https://1145.am/db/2353789/Clarus_Ventures>,
        <https://1145.am/db/2355435/Clarus_Ventures>,
        <https://1145.am/db/2356084/Clarus_Ventures>,
        <https://1145.am/db/2357858/Clarus_Ventures>,
        <https://1145.am/db/2359654/Clarus_Ventures>,
        <https://1145.am/db/2360756/Clarus_Ventures>,
        <https://1145.am/db/2360758/Clarus_Ventures>,
        <https://1145.am/db/2364468/Clarus_Ventures>,
        <https://1145.am/db/2364471/Clarus_Ventures>,
        <https://1145.am/db/2365171/Clarus_Ventures>,
        <https://1145.am/db/2365184/Clarus_Ventures>,
        <https://1145.am/db/2368297/Clarus_Ventures>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2584561/Clarus_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354295/Nanostring_Technologies> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "life science tools for translational research and developer of molecular diagnostic products" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "NanoString Technologies",
        "NanoString Technologies, Inc." ;
    ns1:industry "life science tools" ;
    ns1:name "NanoString Technologies" ;
    ns1:sameAsHigh <https://1145.am/db/2099366/Nanostring_Technologies>,
        <https://1145.am/db/2203079/Nanostring_Technologies>,
        <https://1145.am/db/2327269/Nanostring_Technologies>,
        <https://1145.am/db/2327272/Nanostring_Technologies>,
        <https://1145.am/db/2336016/Nanostring_Technologies>,
        <https://1145.am/db/2336931/Nanostring_Technologies>,
        <https://1145.am/db/2343413/Nanostring_Technologiesnicole_Litchfield>,
        <https://1145.am/db/2346566/Nanostring_Technologies>,
        <https://1145.am/db/2365955/Nanostring_Technologies>,
        <https://1145.am/db/2366049/Nanostring_Technologies>,
        <https://1145.am/db/2366051/Nanostring_Technologies>,
        <https://1145.am/db/2366055/Nanostring_Technologies>,
        <https://1145.am/db/2366660/Nanostring_Technologies>,
        <https://1145.am/db/2368191/Nanostring_Technologies>,
        <https://1145.am/db/744099/Nanostring_Technologies>,
        <https://1145.am/db/746300/Nanostring_Technologies>,
        <https://1145.am/db/984298/Nanostring_Technologies>,
        <https://1145.am/db/985727/Nanostring_Technologies> ;
    ns1:sameAsMedium <https://1145.am/db/2294717/Nanostring_Technologies> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354296/Flexion_Therapeutics> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-12-04T10:37:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Flexion Therapeutics Secures $20 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flexion-therapeutics-secures-20-million-series-b-financing> ;
    ns1:foundName "Flexion Therapeutics",
        "Flexion Therapeutics, Inc." ;
    ns1:name "Flexion Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2311567/Flexion_Therapeutics>,
        <https://1145.am/db/2322646/Flexion_Therapeutics>,
        <https://1145.am/db/538295/Flexion_Therapeutics>,
        <https://1145.am/db/540353/Flexion_Therapeutics_Inc>,
        <https://1145.am/db/540880/Flexion_Therapeutics>,
        <https://1145.am/db/541684/Flexion_Therapeutics>,
        <https://1145.am/db/541749/Flexion_Therapeutics>,
        <https://1145.am/db/545562/Flexion_Therapeutics_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/2353937/Flexion_Therapeutics_Inc>,
        <https://1145.am/db/2358434/Flexion_Therapeutics>,
        <https://1145.am/db/2541719/Flexion_Therapeutics>,
        <https://1145.am/db/539542/Flexion_Therapeutics>,
        <https://1145.am/db/539565/Flexion_Therapeutics>,
        <https://1145.am/db/632458/Flexion_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354296/Sofinnova_Partners> a org:Organization ;
    ns1:basedInLowRaw "WOBURN, Mass" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-12-04T10:37:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Flexion Therapeutics Secures $20 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flexion-therapeutics-secures-20-million-series-b-financing> ;
    ns1:foundName "Sofinnova Partners" ;
    ns1:investor <https://1145.am/db/2354296/Series_B_Investment_5am_Ventures_Flexion_Therapeutics_Novo_Ventures_Pfizer_Venture_Investments_Sofinnova_Partners_Versant_Ventures_Completed> ;
    ns1:name "Sofinnova Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1196006/Sofinnova_Partners>,
        <https://1145.am/db/1278788/Angel_Star_Ventures>,
        <https://1145.am/db/1584328/Sofinnova_Partners>,
        <https://1145.am/db/1741725/Vii_Ventures>,
        <https://1145.am/db/1853335/Shasta_Ventures>,
        <https://1145.am/db/1886834/Shasta_Ventures>,
        <https://1145.am/db/2066938/Sofinnova_Partners>,
        <https://1145.am/db/2288699/Sofinnova_Partners>,
        <https://1145.am/db/2345037/Sofinnova_Ventures_Janus_Capital_Management_Llc>,
        <https://1145.am/db/2765873/Sofinnova_Partners>,
        <https://1145.am/db/458931/Shasta_Ventures>,
        <https://1145.am/db/704198/Sofinnova>,
        <https://1145.am/db/793714/Sceptre_Ventures_Inc>,
        <https://1145.am/db/958771/Sozo_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1039135/Sofinnova_Partners>,
        <https://1145.am/db/1054859/Sofinnova_Partners>,
        <https://1145.am/db/1112260/Sofinnova_Partners>,
        <https://1145.am/db/1113007/Sofinnova_Partners>,
        <https://1145.am/db/1118732/Sofinnova_Partners>,
        <https://1145.am/db/1196618/Sofinnova_Partners>,
        <https://1145.am/db/1199155/Sofinnova_Partners>,
        <https://1145.am/db/1419128/Sofinnova_Partners>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490997/Sofinnova_Partners>,
        <https://1145.am/db/1583413/Sofinnova_Partners>,
        <https://1145.am/db/1618717/Sofinnova_Partners>,
        <https://1145.am/db/1619418/Sofinnova_Partners>,
        <https://1145.am/db/1707724/Sofinnova_Partners>,
        <https://1145.am/db/1722774/Sofinnova_Partners>,
        <https://1145.am/db/1735325/Sofinnova_Partners>,
        <https://1145.am/db/1773491/Sofinnova_Partners>,
        <https://1145.am/db/1802402/Sofinnova_Partners>,
        <https://1145.am/db/1876390/Sofinnova_Partners>,
        <https://1145.am/db/1892777/Sofinnova_Partners>,
        <https://1145.am/db/1919228/Sofinnova_Partners>,
        <https://1145.am/db/1928060/Sofinnova_Partners>,
        <https://1145.am/db/1975388/Sofinnova_Partners>,
        <https://1145.am/db/2075963/Sofinnova_Partners>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2152180/Sofinnova_Partners>,
        <https://1145.am/db/2153042/Sofinnova_Partners>,
        <https://1145.am/db/2153373/Sofinnova_Partners>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2280230/Sofinnova_Partners>,
        <https://1145.am/db/2282400/Sofinnova_Partners>,
        <https://1145.am/db/2282747/Sofinnova_Partners>,
        <https://1145.am/db/2286182/Sofinnova_Partners>,
        <https://1145.am/db/2286404/Sofinnova_Partners>,
        <https://1145.am/db/2291023/Sofinnova_Partners>,
        <https://1145.am/db/2291790/Sofinnova_Partners>,
        <https://1145.am/db/2294367/Sofinnova_Partners>,
        <https://1145.am/db/2294502/Sofinnova_Partners>,
        <https://1145.am/db/2297649/Sofinnova_Partners>,
        <https://1145.am/db/2298624/Sofinnova_Partners>,
        <https://1145.am/db/2298631/Sofinnova_Partners>,
        <https://1145.am/db/2298641/Sofinnova_Partners>,
        <https://1145.am/db/2299758/Sofinnova_Partners>,
        <https://1145.am/db/2302741/Sofinnova_Partners>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2303849/Sofinnova_Partners>,
        <https://1145.am/db/2306395/Sofinnova_Partners>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2321542/Sofinnova_Partners>,
        <https://1145.am/db/2322646/Sofinnova_Partners>,
        <https://1145.am/db/2323100/Sofinnova_Partners>,
        <https://1145.am/db/2323102/Sofinnova_Partners>,
        <https://1145.am/db/2323243/Sofinnova_Partners>,
        <https://1145.am/db/2324027/Sofinnova_Partners>,
        <https://1145.am/db/2324034/Sofinnova_Partners>,
        <https://1145.am/db/2325549/Sofinnova_Partners>,
        <https://1145.am/db/2327222/Sofinnova_Partners>,
        <https://1145.am/db/2328763/Sofinnova_Partners>,
        <https://1145.am/db/2328769/Sofinnova_Partners>,
        <https://1145.am/db/2328825/Sofinnova_Partners>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330876/Sofinnova_Partners>,
        <https://1145.am/db/2335582/Sofinnova_Partners>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2336333/Sofinnova_Partners>,
        <https://1145.am/db/2336335/Sofinnova_Partners>,
        <https://1145.am/db/2339692/Sofinnova_Partners>,
        <https://1145.am/db/2343301/Sofinnova_Partners>,
        <https://1145.am/db/2343545/Sofinnova_Partners>,
        <https://1145.am/db/2349013/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2355740/Sofinnova_Partners>,
        <https://1145.am/db/2355741/Sofinnova_Partners>,
        <https://1145.am/db/2355885/Sofinnova_Partners>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2358268/Sofinnova_Partners>,
        <https://1145.am/db/2358269/Sofinnova_Partners>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/236357/Sofinnova_Partners>,
        <https://1145.am/db/2363593/Sofinnova_Partners>,
        <https://1145.am/db/2363597/Sofinnova_Partners>,
        <https://1145.am/db/2365826/Sofinnova_Partners>,
        <https://1145.am/db/2366303/Sofinnova_Partners>,
        <https://1145.am/db/2367549/Sofinnova_Partners>,
        <https://1145.am/db/2370118/Sofinnova_Partners>,
        <https://1145.am/db/2538923/Sofinnova_Partners>,
        <https://1145.am/db/2555540/Sofinnova_Partners>,
        <https://1145.am/db/2571050/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2578627/Sofinnova_Partners>,
        <https://1145.am/db/2765863/Sofinnova_Partners>,
        <https://1145.am/db/2765866/Sofinnova_Partners>,
        <https://1145.am/db/530060/Sofinnova_Partners>,
        <https://1145.am/db/555385/Sofinnova_Partners>,
        <https://1145.am/db/577785/Sofinnova_Partners>,
        <https://1145.am/db/595282/Sofinnova_Partners>,
        <https://1145.am/db/602316/Sofinnova_Partners>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/695229/Sofinnova_Partners>,
        <https://1145.am/db/695704/Sofinnova_Partners>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/810584/Sofinnova_Partners>,
        <https://1145.am/db/955355/Sofinnova_Partners>,
        <https://1145.am/db/992046/Sofinnova_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354307/Atlas_Venture> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-12-04T15:50:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zafgen Secures $21 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zafgen-secures-21-million-series-d-financing-0> ;
    ns1:foundName "Atlas Venture" ;
    ns1:investor <https://1145.am/db/2354307/Equity_Investment_Alta_Partners_Atlas_Venture_Third_Rock_Ventures_Zafgen_Completed> ;
    ns1:name "Atlas Venture" ;
    ns1:sameAsMedium <https://1145.am/db/1334624/Atlas_Venture>,
        <https://1145.am/db/1608803/Atlas_Venture>,
        <https://1145.am/db/1698345/Atlas_Venture>,
        <https://1145.am/db/1788233/Atlas_Venture>,
        <https://1145.am/db/1814782/Atlas_Venture>,
        <https://1145.am/db/1824026/Atlas_Venture>,
        <https://1145.am/db/1824878/Atlas_Venture>,
        <https://1145.am/db/1827753/Atlas_Venture>,
        <https://1145.am/db/1828416/Atlas_Venture>,
        <https://1145.am/db/1830149/Atlas_Venture>,
        <https://1145.am/db/1833567/Atlas_Venture>,
        <https://1145.am/db/1834305/Atlas_Venture>,
        <https://1145.am/db/1838696/Atlas_Venture>,
        <https://1145.am/db/1838850/Atlas_Venture>,
        <https://1145.am/db/1838944/Atlas_Venture>,
        <https://1145.am/db/1838979/Atlas_Venture>,
        <https://1145.am/db/1840388/Atlas_Venture>,
        <https://1145.am/db/1840776/Atlas_Venture>,
        <https://1145.am/db/1841385/Atlas_Venture>,
        <https://1145.am/db/1843823/Atlas_Venture>,
        <https://1145.am/db/1847483/Atlas_Venture>,
        <https://1145.am/db/1855553/Atlas_Venture>,
        <https://1145.am/db/1855780/Atlas_Venture>,
        <https://1145.am/db/1857243/Atlas_Venture>,
        <https://1145.am/db/1857978/Atlas_Venture>,
        <https://1145.am/db/1858399/Atlas_Venture>,
        <https://1145.am/db/1863373/Atlas_Venture>,
        <https://1145.am/db/1868932/Atlas_Venture>,
        <https://1145.am/db/1877727/Atlas_Venture>,
        <https://1145.am/db/1878546/Atlas_Venture>,
        <https://1145.am/db/1880181/Atlas_Venture>,
        <https://1145.am/db/1880537/Atlas_Venture>,
        <https://1145.am/db/1891067/Atlas_Venture>,
        <https://1145.am/db/1893502/Atlas_Venture>,
        <https://1145.am/db/1895072/Atlas_Venture>,
        <https://1145.am/db/1901641/Atlas_Venture>,
        <https://1145.am/db/1913598/Atlas_Venture>,
        <https://1145.am/db/1917671/Atlas_Venture>,
        <https://1145.am/db/2062003/Atlas_Venture>,
        <https://1145.am/db/2109798/Atlas_Venture>,
        <https://1145.am/db/2110113/Atlas_Venture>,
        <https://1145.am/db/2178988/Atlas_Venture>,
        <https://1145.am/db/2286541/Atlas_Venture>,
        <https://1145.am/db/2287244/Atlas_Venture>,
        <https://1145.am/db/2290028/Atlas_Venture>,
        <https://1145.am/db/2292284/Atlas_Venture>,
        <https://1145.am/db/2297439/Atlas_Venture>,
        <https://1145.am/db/2298485/Atlas_Venture>,
        <https://1145.am/db/2299411/Atlas_Venture>,
        <https://1145.am/db/2299772/Atlas_Venture>,
        <https://1145.am/db/2303656/Atlas_Venture>,
        <https://1145.am/db/2304044/Atlas_Venture>,
        <https://1145.am/db/2304237/Atlas_Venture>,
        <https://1145.am/db/2309821/Atlas_Venture>,
        <https://1145.am/db/2309840/Atlas_Venture>,
        <https://1145.am/db/2309847/Atlas_Venture>,
        <https://1145.am/db/2310940/Atlas_Venture>,
        <https://1145.am/db/2318778/Atlas_Venture>,
        <https://1145.am/db/2319412/Atlas_Venture>,
        <https://1145.am/db/2325326/Atlas_Venture>,
        <https://1145.am/db/2327406/Atlas_Venture>,
        <https://1145.am/db/2330852/Atlas_Venture>,
        <https://1145.am/db/2330882/Atlas_Venture>,
        <https://1145.am/db/2331870/Atlas_Venture>,
        <https://1145.am/db/2333601/Atlas_Venture>,
        <https://1145.am/db/2336782/Atlas_Venture>,
        <https://1145.am/db/2337455/Atlas_Venture>,
        <https://1145.am/db/2340096/Atlas_Venture>,
        <https://1145.am/db/2340581/Atlas_Venture>,
        <https://1145.am/db/2341478/Atlas_Venture>,
        <https://1145.am/db/2347106/Atlas_Venture>,
        <https://1145.am/db/2347682/Atlas_Venture>,
        <https://1145.am/db/2352967/Atlas_Venture>,
        <https://1145.am/db/2353524/Atlas_Venture>,
        <https://1145.am/db/2353525/Atlas_Venture>,
        <https://1145.am/db/2354314/Atlas_Venture>,
        <https://1145.am/db/2354856/Atlas_Venture>,
        <https://1145.am/db/2355609/Atlas_Venture>,
        <https://1145.am/db/2356048/Atlas_Venture>,
        <https://1145.am/db/2357676/Atlas_Venture>,
        <https://1145.am/db/2357679/Atlas_Venture>,
        <https://1145.am/db/2357682/Atlas_Venture>,
        <https://1145.am/db/2357905/Atlas_Venture>,
        <https://1145.am/db/2358301/Atlas_Venture>,
        <https://1145.am/db/2358860/Atlas_Venture>,
        <https://1145.am/db/2359683/Atlas_Venture>,
        <https://1145.am/db/2359818/Atlas_Venture>,
        <https://1145.am/db/2360814/Atlas_Venture>,
        <https://1145.am/db/2361018/Atlas_Venture>,
        <https://1145.am/db/2361022/Atlas_Venture>,
        <https://1145.am/db/2361027/Atlas_Venture>,
        <https://1145.am/db/2363396/Atlas_Venture>,
        <https://1145.am/db/2365103/Atlas_Venture>,
        <https://1145.am/db/2367740/Atlas_Venture>,
        <https://1145.am/db/2369004/Atlas_Venture>,
        <https://1145.am/db/2369718/Atlas_Venture>,
        <https://1145.am/db/2370094/Atlas_Venture>,
        <https://1145.am/db/2370540/Atlas_Venture>,
        <https://1145.am/db/2570138/Atlas_Venture>,
        <https://1145.am/db/2573068/Atlas_Venture>,
        <https://1145.am/db/2638432/Atlas_Venture>,
        <https://1145.am/db/2787561/Atlas_Venture>,
        <https://1145.am/db/545988/Atlas_Venture>,
        <https://1145.am/db/75445/Atlas_Venture>,
        <https://1145.am/db/979509/Atlas_Venture> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354307/Zafgen> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "addressing the unmet needs of severely obese patients" ;
    ns1:documentDate "2012-12-04T15:50:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zafgen Secures $21 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zafgen-secures-21-million-series-d-financing-0> ;
    ns1:foundName "Zafgen",
        "Zafgen, Inc." ;
    ns1:industry "life sciences" ;
    ns1:name "Zafgen" ;
    ns1:sameAsHigh <https://1145.am/db/2311219/Zapaq>,
        <https://1145.am/db/2325947/ZFHN>,
        <https://1145.am/db/2360668/Zafgen>,
        <https://1145.am/db/2547469/Zai_Lab>,
        <https://1145.am/db/2552203/Zai_Lab> ;
    ns1:sameAsMedium <https://1145.am/db/2153666/Zafgen>,
        <https://1145.am/db/2318655/Zafgen>,
        <https://1145.am/db/2338126/Zafgen>,
        <https://1145.am/db/2338127/Zafgen>,
        <https://1145.am/db/2343776/Zafgen>,
        <https://1145.am/db/2345676/Zafgen>,
        <https://1145.am/db/2351635/Zafgen>,
        <https://1145.am/db/2351649/Zafgen>,
        <https://1145.am/db/2351964/Zafgen>,
        <https://1145.am/db/2354299/Zafgen>,
        <https://1145.am/db/2354314/Zafgen_Inc>,
        <https://1145.am/db/2357503/Zafgen>,
        <https://1145.am/db/2358919/Zafgen_Inc>,
        <https://1145.am/db/2359818/Zafgen>,
        <https://1145.am/db/2360814/Zafgen>,
        <https://1145.am/db/2360815/Zafgen> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354351/Investment_Flagship_Ventures_Moderna_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-06T05:03:11+00:00"^^xsd:dateTime ;
    ns1:documentExtract "- MODERNA ANNOUNCES $ 40 MILLION IN FINANCING TO ADVANCE DEVELOPMENT OF NEW BIOTHERAPEUTIC MODALITY: MESSENGER RNA THERAPEUTICSâ„¢ -",
        "CAMBRIDGE, MA-December 6, 2012-Moderna Therapeutics announced today that it has closed more than $ 40 million in financing to date, led by Flagship Ventures and private investors, which will be used to advance multiple programs toward clinical stage development." ;
    ns1:documentTitle "MODERNA ANNOUNCES $40 MILLION IN FINANCING TO ADVANCE DEVELOPMENT OF NEW BIOTHERAPEUTIC MODALITY: MESSENGER RNA THERAPEUTICSâ„¢" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/moderna-announces-40-million-financing-to-advance-development-of-new-biotherapeutic> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2354351/Moderna> ;
    ns1:valueRaw "$ 40 MILLION",
        "more than $ 40 million" ;
    ns1:when "2012-12-06T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "December 6, 2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2354351/Moderna> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, MA" ;
    ns1:description "biotherapeutic modality" ;
    ns1:documentDate "2012-12-06T05:03:11+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MODERNA ANNOUNCES $40 MILLION IN FINANCING TO ADVANCE DEVELOPMENT OF NEW BIOTHERAPEUTIC MODALITY: MESSENGER RNA THERAPEUTICSâ„¢" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/moderna-announces-40-million-financing-to-advance-development-of-new-biotherapeutic> ;
    ns1:foundName "MODERNA",
        "Moderna Therapeutics" ;
    ns1:name "MODERNA",
        "Moderna" ;
    ns1:sameAsMedium <https://1145.am/db/1013406/Moderna>,
        <https://1145.am/db/1019870/Moderna>,
        <https://1145.am/db/1285582/Moderna_Inc>,
        <https://1145.am/db/1380232/Moderna>,
        <https://1145.am/db/1384852/Moderna_Inc>,
        <https://1145.am/db/1514071/Moderna>,
        <https://1145.am/db/1563057/Moderna>,
        <https://1145.am/db/1596811/Moderna>,
        <https://1145.am/db/159841/Moderna>,
        <https://1145.am/db/1617793/Moderna>,
        <https://1145.am/db/1618047/Moderna_Inc>,
        <https://1145.am/db/2154135/Moderna>,
        <https://1145.am/db/2155104/Moderna>,
        <https://1145.am/db/2281484/Moderna>,
        <https://1145.am/db/2281867/Moderna>,
        <https://1145.am/db/2282102/Moderna>,
        <https://1145.am/db/2286212/Moderna>,
        <https://1145.am/db/2286216/Moderna>,
        <https://1145.am/db/2294571/Moderna>,
        <https://1145.am/db/2295041/Moderna>,
        <https://1145.am/db/2301130/Moderna>,
        <https://1145.am/db/2344827/Moderna>,
        <https://1145.am/db/2347970/Moderna>,
        <https://1145.am/db/2353195/Moderna>,
        <https://1145.am/db/2353227/Moderna>,
        <https://1145.am/db/2354248/Moderna>,
        <https://1145.am/db/2355029/Moderna>,
        <https://1145.am/db/2355036/Moderna>,
        <https://1145.am/db/2355194/Moderna>,
        <https://1145.am/db/2363722/Moderna>,
        <https://1145.am/db/2363725/Moderna>,
        <https://1145.am/db/2371158/Moderna>,
        <https://1145.am/db/252780/Moderna>,
        <https://1145.am/db/2552839/Moderna>,
        <https://1145.am/db/2554305/Moderna>,
        <https://1145.am/db/2556342/Moderna>,
        <https://1145.am/db/2557428/Moderna>,
        <https://1145.am/db/2559549/Moderna>,
        <https://1145.am/db/2563661/Moderna>,
        <https://1145.am/db/2567104/Moderna>,
        <https://1145.am/db/2567216/Moderna>,
        <https://1145.am/db/2739044/Moderna>,
        <https://1145.am/db/2756198/Moderna>,
        <https://1145.am/db/968888/Moderna_Inc>,
        <https://1145.am/db/977143/Moderna> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354806/Wikicell_Designs_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge",
        "Paris" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2988507/about.rdf>,
        <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass.",
        "Cambridge, Mass. and Paris, France" ;
    ns1:description "Business" ;
    ns1:documentDate "2012-09-04T12:13:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Startup WikiCell Designs Secures $10 Million in Investment Capital from Flagship Ventures and Polaris Venture Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/startup-wikicell-designs-secures-10-million-investment-capital-from-flagship-ventures> ;
    ns1:foundName "WikiCell Designs",
        "WikiCell Designs Inc." ;
    ns1:name "WikiCell Designs",
        "WikiCell Designs Inc." ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355800/Quartz_Bio> a org:Organization ;
    ns1:basedInHighGeoName "Switzerland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2658434/about.rdf> ;
    ns1:basedInHighRaw "Switzerland" ;
    ns1:description "Bioinformatics" ;
    ns1:documentDate "2012-09-04T13:15:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Merck Serono Announces the Creation of Quartz Bio, a Bioinformatics Company Formed Through its Entrepreneur Partnership Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merck-serono-announces-creation-of-quartz-bio-a-bioinformatics-company-formed-through-its> ;
    ns1:foundName "Quartz Bio" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Quartz Bio" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355826/Akonni_Biosystems> a org:Organization ;
    ns1:description "life science tools / molecular diagnostics" ;
    ns1:documentDate "2012-09-05T13:01:56+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Akonni Awarded $500,000 Phase 2 National Science Foundation Grant to Develop Lab-on-a-Filmâ„¢ Microarray Device" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akonni-awarded-500-000-phase-2-national-science-foundation-grant-to-develop-lab-on-a-film%E2%84%A2> ;
    ns1:foundName "Akonni",
        "Akonni Biosystems" ;
    ns1:industry "life science tools / molecular diagnostics" ;
    ns1:name "Akonni Biosystems" ;
    ns1:sameAsHigh <https://1145.am/db/797121/Ikonisys> ;
    ns1:sameAsMedium <https://1145.am/db/2362844/Akonni_Biosystems>,
        <https://1145.am/db/2365186/Akonni_Biosystems> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2355826/Investment_Akonni_Biosystems_National_Science_Foundation_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-05T13:01:56+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Akonni Awarded $ 500,000 Phase 2 National Science Foundation Grant to Develop Lab-on-a-Filmâ„¢ Microarray Device.",
        "Akonni Biosystems, a life science tools / molecular diagnostics company that develops, manufactures, and plans to market molecular testing devices for diagnosing infectious diseases and human genetic disorders, announced today the receipt of a $ 498,780 Phase 2 SBIR Grant from the National Science Foundation (NSF) ." ;
    ns1:documentTitle "Akonni Awarded $500,000 Phase 2 National Science Foundation Grant to Develop Lab-on-a-Filmâ„¢ Microarray Device" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/akonni-awarded-500-000-phase-2-national-science-foundation-grant-to-develop-lab-on-a-film%E2%84%A2> ;
    ns1:foundName "Grant" ;
    ns1:name "Grant" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2355826/Akonni_Biosystems> ;
    ns1:targetDetails "SBIR" ;
    ns1:valueRaw "$ 498,780",
        "$ 500,000" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2356396/Google_Ventures> a org:Organization ;
    ns1:description "investing" ;
    ns1:documentDate "2012-12-12T05:00:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "Google Ventures" ;
    ns1:investor <https://1145.am/db/2356396/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Yuri_Milner_Completed> ;
    ns1:name "Google Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1114979/Google_Ventures>,
        <https://1145.am/db/1187183/Google_Ventures>,
        <https://1145.am/db/1189383/Google_Ventures>,
        <https://1145.am/db/1202509/Google_Ventures>,
        <https://1145.am/db/1397630/Google_Ventures>,
        <https://1145.am/db/1425239/Google_Ventures>,
        <https://1145.am/db/1427745/Google_Ventures>,
        <https://1145.am/db/1557175/Google_Ventures>,
        <https://1145.am/db/1558567/Google_Ventures>,
        <https://1145.am/db/1632690/Google_Ventures>,
        <https://1145.am/db/1758916/Google_Ventures>,
        <https://1145.am/db/1760954/Google_Ventures>,
        <https://1145.am/db/1760999/Google_Ventures>,
        <https://1145.am/db/1768511/Google_Ventures>,
        <https://1145.am/db/1773605/Google_Ventures>,
        <https://1145.am/db/1776575/Google_Ventures>,
        <https://1145.am/db/1780470/Google_Ventures>,
        <https://1145.am/db/1780582/Google_Ventures>,
        <https://1145.am/db/1781621/Gv>,
        <https://1145.am/db/1817262/Google_Ventures>,
        <https://1145.am/db/1820380/Google_Ventures>,
        <https://1145.am/db/1821752/Google_Ventures>,
        <https://1145.am/db/1827884/Google_Ventures>,
        <https://1145.am/db/1830101/Google_Ventures>,
        <https://1145.am/db/1831764/Google_Ventures>,
        <https://1145.am/db/1833010/Google_Ventures>,
        <https://1145.am/db/1838965/Google_Ventures>,
        <https://1145.am/db/1844180/Google_Ventures>,
        <https://1145.am/db/1853335/Google_Ventures>,
        <https://1145.am/db/1856811/Google_Ventures>,
        <https://1145.am/db/1857240/Google_Ventures>,
        <https://1145.am/db/1877178/Google_Ventures>,
        <https://1145.am/db/1877473/Google_Ventures>,
        <https://1145.am/db/1879716/Google_Ventures>,
        <https://1145.am/db/2056308/Googles_Venture_Capital_Arm>,
        <https://1145.am/db/2062655/Gv_(google_Ventures)>,
        <https://1145.am/db/2096258/Gv>,
        <https://1145.am/db/2191183/Google_Ventures>,
        <https://1145.am/db/2196786/Google_Ventures>,
        <https://1145.am/db/2198042/Google_Ventures>,
        <https://1145.am/db/2292675/Google_Ventures>,
        <https://1145.am/db/2323524/Google_Ventures>,
        <https://1145.am/db/2342725/Google_Ventures>,
        <https://1145.am/db/2352489/Google_Ventures>,
        <https://1145.am/db/2367681/Google_Ventures>,
        <https://1145.am/db/2370208/Google_Ventures>,
        <https://1145.am/db/2370240/Google_Ventures>,
        <https://1145.am/db/2679166/Google>,
        <https://1145.am/db/2718151/Gv>,
        <https://1145.am/db/658803/Google_Ventures>,
        <https://1145.am/db/773684/Google_Ventures>,
        <https://1145.am/db/8080/Google_Ventures>,
        <https://1145.am/db/823763/Google_Ventures>,
        <https://1145.am/db/962870/Google_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1150887/Google_Ventures>,
        <https://1145.am/db/1153184/Google_Ventures>,
        <https://1145.am/db/1156925/Google_Ventures>,
        <https://1145.am/db/1157294/Google_Ventures>,
        <https://1145.am/db/1202633/Google_Ventures>,
        <https://1145.am/db/1203099/Google_Ventures>,
        <https://1145.am/db/1714555/Google_Ventures>,
        <https://1145.am/db/1739125/Google_Ventures>,
        <https://1145.am/db/1752659/Google_Ventures>,
        <https://1145.am/db/1756840/Google_Ventures>,
        <https://1145.am/db/1764012/Google_Ventures>,
        <https://1145.am/db/1768021/Google_Ventures>,
        <https://1145.am/db/1769528/Google_Ventures>,
        <https://1145.am/db/1772778/Google_Ventures>,
        <https://1145.am/db/1773703/Google_Ventures>,
        <https://1145.am/db/1779277/Google_Ventures>,
        <https://1145.am/db/1786716/Google_Ventures>,
        <https://1145.am/db/1786818/Google_Ventures>,
        <https://1145.am/db/1793129/Google_Ventures>,
        <https://1145.am/db/1794049/Google_Ventures>,
        <https://1145.am/db/1798836/Google_Ventures>,
        <https://1145.am/db/1799162/Google_Ventures>,
        <https://1145.am/db/1803296/Google_Ventures>,
        <https://1145.am/db/1804887/Google_Ventures>,
        <https://1145.am/db/1805764/Google_Ventures>,
        <https://1145.am/db/1807288/Google_Ventures>,
        <https://1145.am/db/1808484/Google_Ventures>,
        <https://1145.am/db/1811851/Google_Ventures>,
        <https://1145.am/db/1813266/Google_Ventures>,
        <https://1145.am/db/1814186/Google_Ventures>,
        <https://1145.am/db/1816707/Google_Ventures>,
        <https://1145.am/db/1818901/Google_Ventures>,
        <https://1145.am/db/1821425/Google_Ventures>,
        <https://1145.am/db/1824026/Google_Ventures>,
        <https://1145.am/db/1826007/Google_Ventures>,
        <https://1145.am/db/1828072/Google_Ventures>,
        <https://1145.am/db/1830066/Google_Ventures>,
        <https://1145.am/db/1830452/Google_Ventures>,
        <https://1145.am/db/1832133/Google_Ventures>,
        <https://1145.am/db/1833657/Google_Ventures>,
        <https://1145.am/db/1833931/Google_Ventures>,
        <https://1145.am/db/1834481/Google_Ventures>,
        <https://1145.am/db/1834503/Google_Ventures>,
        <https://1145.am/db/1837499/Google_Ventures>,
        <https://1145.am/db/1840663/Google_Ventures>,
        <https://1145.am/db/1841061/Google_Ventures>,
        <https://1145.am/db/1842342/Google_Ventures>,
        <https://1145.am/db/1842817/Google_Ventures>,
        <https://1145.am/db/1843360/Google_Ventures>,
        <https://1145.am/db/1844551/Google_Ventures>,
        <https://1145.am/db/1845023/Google_Ventures>,
        <https://1145.am/db/1848084/Google_Ventures>,
        <https://1145.am/db/1848585/Google_Ventures>,
        <https://1145.am/db/1849884/Google_Ventures>,
        <https://1145.am/db/1849967/Google_Ventures>,
        <https://1145.am/db/1854208/Google_Ventures>,
        <https://1145.am/db/1854279/Google_Ventures>,
        <https://1145.am/db/1854797/Google_Ventures>,
        <https://1145.am/db/1857105/Google_Ventures>,
        <https://1145.am/db/1858438/Google_Ventures>,
        <https://1145.am/db/1858646/Google_Ventures>,
        <https://1145.am/db/1860878/Google_Ventures>,
        <https://1145.am/db/1861342/Google_Ventures>,
        <https://1145.am/db/1862168/Google_Ventures>,
        <https://1145.am/db/1864594/Google_Ventures>,
        <https://1145.am/db/1873505/Google_Ventures>,
        <https://1145.am/db/1876848/Google_Ventures>,
        <https://1145.am/db/1882810/Google_Ventures>,
        <https://1145.am/db/1883008/Google_Ventures>,
        <https://1145.am/db/1885998/Google_Ventures>,
        <https://1145.am/db/1886357/Google_Ventures>,
        <https://1145.am/db/1886978/Google_Ventures>,
        <https://1145.am/db/1887982/Google_Ventures>,
        <https://1145.am/db/1896364/Google_Ventures>,
        <https://1145.am/db/1896419/Google_Ventures>,
        <https://1145.am/db/1911314/Google_Ventures>,
        <https://1145.am/db/1947312/Google_Ventures>,
        <https://1145.am/db/2097368/Google_Ventures>,
        <https://1145.am/db/2154341/Google_Ventures>,
        <https://1145.am/db/2180867/Google_Ventures>,
        <https://1145.am/db/2181184/Google_Ventures>,
        <https://1145.am/db/2183352/Google_Ventures>,
        <https://1145.am/db/2194249/Google_Ventures>,
        <https://1145.am/db/2249658/Google_Ventures>,
        <https://1145.am/db/2269634/Google_Ventures>,
        <https://1145.am/db/2286291/Google_Ventures>,
        <https://1145.am/db/2307494/Google_Ventures>,
        <https://1145.am/db/2308700/Google_Ventures>,
        <https://1145.am/db/2311992/Google_Ventures>,
        <https://1145.am/db/2319338/Google_Ventures>,
        <https://1145.am/db/2333119/Google_Ventures>,
        <https://1145.am/db/2342724/Google_Ventures>,
        <https://1145.am/db/2349008/Google_Ventures>,
        <https://1145.am/db/2349426/Google_Ventures>,
        <https://1145.am/db/2350327/Google_Ventures>,
        <https://1145.am/db/2358888/Google_Ventures>,
        <https://1145.am/db/2359987/Google_Ventures>,
        <https://1145.am/db/2367199/Google_Ventures>,
        <https://1145.am/db/2367201/Google_Ventures>,
        <https://1145.am/db/2541350/Google_Ventures>,
        <https://1145.am/db/2583442/Google_Ventures>,
        <https://1145.am/db/490110/Google_Ventures>,
        <https://1145.am/db/494920/Google_Ventures>,
        <https://1145.am/db/923065/Google_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356402/River_Vision_Development_Corp> a org:Organization ;
    ns1:basedInLowRaw "NEW YORK" ;
    ns1:documentDate "2012-12-12T13:09:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "River Vision Announces Completion of $17 million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/river-vision-announces-completion-of-17-million-series-a-financing> ;
    ns1:foundName "River Vision",
        "River Vision Development Corp." ;
    ns1:name "River Vision",
        "River Vision Development Corp." ;
    ns1:sameAsMedium <https://1145.am/db/2356411/River_Vision_Development> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356419/Biocartis> a org:Organization ;
    ns1:basedInLowRaw "Flemish" ;
    ns1:description "developing and commercializing innovative, high quality, easy to use platforms and clinically relevant onc" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "Biocartis" ;
    ns1:industry "molecular diagnostics" ;
    ns1:name "Biocartis" ;
    ns1:sameAsHigh <https://1145.am/db/2290774/Biocartis>,
        <https://1145.am/db/2322621/Biocartis_Sa> ;
    ns1:sameAsMedium <https://1145.am/db/2299864/Biocartis>,
        <https://1145.am/db/2322622/Biocartis_Sa>,
        <https://1145.am/db/2339419/Biocartis>,
        <https://1145.am/db/2339424/Biocartis>,
        <https://1145.am/db/2339425/Biocartis> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356420/Cerapedics_Inc> a org:Organization ;
    ns1:basedInLowRaw "303-974-6275",
        "United States" ;
    ns1:documentDate "2012-12-13T05:00:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerapedics Secures $19 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerapedics-secures-19-million-series-c-financing> ;
    ns1:foundName "Cerapedics",
        "Cerapedics, Inc." ;
    ns1:name "Cerapedics",
        "Cerapedics, Inc." ;
    ns1:sameAsMedium <https://1145.am/db/2288015/Cerapedics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356861/Karus_Therapeutics> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "PI3K and HDAC6 programmes" ;
    ns1:documentDate "2012-09-06T15:44:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karus-therapeutics-secures-series-b-financing-from-a-syndicate-of-leading-vc-investors-0> ;
    ns1:foundName "Karus Therapeutics" ;
    ns1:industry "Biotechnology" ;
    ns1:name "Karus Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1138594/Akero_Therapeutics>,
        <https://1145.am/db/1330554/Akero_Therapeutics>,
        <https://1145.am/db/2356876/Karus_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2336315/Karus_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356885/Department_Of_Defense> a org:Organization ;
    ns1:documentDate "2012-09-07T04:01:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aduro Awarded CDMRP Grant for Prostate Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aduro-awarded-cdmrp-grant-for-prostate-cancer-vaccine-development> ;
    ns1:foundName "Department of Defense" ;
    ns1:investor <https://1145.am/db/2356885/Investment_Aduro_Biotech_Department_Of_Defense_Has_Not_Happened> ;
    ns1:name "Department of Defense" ;
    ns1:sameAsMedium <https://1145.am/db/1233032/Department_Of_Defense>,
        <https://1145.am/db/1238505/Department_Of_Defense>,
        <https://1145.am/db/1386969/Us_Department_Of_Defense>,
        <https://1145.am/db/1598435/Department_Of_Defense>,
        <https://1145.am/db/1764017/Us_Department_Of_Defense>,
        <https://1145.am/db/1948781/Us_Department_Of_Defense>,
        <https://1145.am/db/2317692/United_States_Department_Of_Defense1>,
        <https://1145.am/db/2422755/Us_Department_Of_Defense>,
        <https://1145.am/db/2577162/Department_Of_Defense> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356885/Investment_Aduro_Biotech_Department_Of_Defense_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-07T04:01:34+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aduro BioTech, Inc. announces the award of a Congressionally Directed Medical Research Programs (CDMRP) grant from the Department of Defense." ;
    ns1:documentTitle "Aduro Awarded CDMRP Grant for Prostate Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aduro-awarded-cdmrp-grant-for-prostate-cancer-vaccine-development> ;
    ns1:foundName "award" ;
    ns1:name "award" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2356885/Aduro_Biotech> ;
    ns1:valueRaw "$ 867,846" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2357487/Baxter_Ventures> a org:Organization ;
    ns1:basedInLowRaw "EVANSTON, Ill" ;
    ns1:description "investing" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Baxter Ventures" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "Baxter Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2335936/Baxter_Ventures>,
        <https://1145.am/db/2352203/Baxter_Ventures>,
        <https://1145.am/db/2352204/Baxter_Ventures>,
        <https://1145.am/db/2352349/Baxter_Ventures>,
        <https://1145.am/db/2352350/Baxter_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2327046/Baxter_Ventures>,
        <https://1145.am/db/2350231/Baxter_Ventures>,
        <https://1145.am/db/2352216/Baxter_Ventures>,
        <https://1145.am/db/2357494/Baxter_Ventures>,
        <https://1145.am/db/2358541/Baxter_Ventures>,
        <https://1145.am/db/2371033/Baxter_Ventures>,
        <https://1145.am/db/2569831/Baxter_Ventures>,
        <https://1145.am/db/2580551/Baxter_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Naurex_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Evanston" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4891382/about.rdf> ;
    ns1:basedInHighRaw "EVANSTON, Ill." ;
    ns1:description "psychiatry and neurology" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Naurex",
        "Naurex Inc",
        "Naurex Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Naurex",
        "Naurex Inc",
        "Naurex Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2337253/Naurex>,
        <https://1145.am/db/2341068/Naurex_Inc>,
        <https://1145.am/db/2341074/Naurex>,
        <https://1145.am/db/2343793/Naurex>,
        <https://1145.am/db/2357494/Naurex>,
        <https://1145.am/db/2368702/Naurex>,
        <https://1145.am/db/2368707/Naurex>,
        <https://1145.am/db/2585617/Naurex_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357905/Annovation_Biopharma> a org:Organization ;
    ns1:description "Anesthetics" ;
    ns1:documentDate "2012-09-10T12:03:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Annovation Biopharma, Inc. Raises $8M to Develop Novel Anesthetics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/annovation-biopharma-inc-raises-8m-to-develop-novel-anesthetics-0> ;
    ns1:foundName "Annovation Biopharma",
        "Annovation Biopharma, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Annovation Biopharma" ;
    ns1:sameAsHigh <https://1145.am/db/2250347/Annovation_Biopharma>,
        <https://1145.am/db/2357928/Annovation_Biopharma> ;
    ns1:sameAsMedium <https://1145.am/db/2363425/Annovation_Biopharma>,
        <https://1145.am/db/2363433/Annovation_Biopharma> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357905/Atlas_Venture> a org:Organization ;
    ns1:basedInLowRaw "Massachusetts" ;
    ns1:description "Venture creation and virtual development" ;
    ns1:documentDate "2012-09-10T12:03:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Annovation Biopharma, Inc. Raises $8M to Develop Novel Anesthetics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/annovation-biopharma-inc-raises-8m-to-develop-novel-anesthetics-0> ;
    ns1:foundName "Atlas Venture" ;
    ns1:investor <https://1145.am/db/2357905/Series_A_Investment_Annovation_Biopharma_Atlas_Venture_Partners_Innovation_Fund_The_Medicines_Company_Completed> ;
    ns1:name "Atlas Venture" ;
    ns1:sameAsMedium <https://1145.am/db/1334624/Atlas_Venture>,
        <https://1145.am/db/1608803/Atlas_Venture>,
        <https://1145.am/db/1698345/Atlas_Venture>,
        <https://1145.am/db/1788233/Atlas_Venture>,
        <https://1145.am/db/1814782/Atlas_Venture>,
        <https://1145.am/db/1824026/Atlas_Venture>,
        <https://1145.am/db/1824878/Atlas_Venture>,
        <https://1145.am/db/1827753/Atlas_Venture>,
        <https://1145.am/db/1828416/Atlas_Venture>,
        <https://1145.am/db/1830149/Atlas_Venture>,
        <https://1145.am/db/1833567/Atlas_Venture>,
        <https://1145.am/db/1834305/Atlas_Venture>,
        <https://1145.am/db/1838696/Atlas_Venture>,
        <https://1145.am/db/1838850/Atlas_Venture>,
        <https://1145.am/db/1838944/Atlas_Venture>,
        <https://1145.am/db/1838979/Atlas_Venture>,
        <https://1145.am/db/1840388/Atlas_Venture>,
        <https://1145.am/db/1840776/Atlas_Venture>,
        <https://1145.am/db/1841385/Atlas_Venture>,
        <https://1145.am/db/1843823/Atlas_Venture>,
        <https://1145.am/db/1847483/Atlas_Venture>,
        <https://1145.am/db/1855553/Atlas_Venture>,
        <https://1145.am/db/1855780/Atlas_Venture>,
        <https://1145.am/db/1857243/Atlas_Venture>,
        <https://1145.am/db/1857978/Atlas_Venture>,
        <https://1145.am/db/1858399/Atlas_Venture>,
        <https://1145.am/db/1863373/Atlas_Venture>,
        <https://1145.am/db/1868932/Atlas_Venture>,
        <https://1145.am/db/1877727/Atlas_Venture>,
        <https://1145.am/db/1878546/Atlas_Venture>,
        <https://1145.am/db/1880181/Atlas_Venture>,
        <https://1145.am/db/1880537/Atlas_Venture>,
        <https://1145.am/db/1891067/Atlas_Venture>,
        <https://1145.am/db/1893502/Atlas_Venture>,
        <https://1145.am/db/1895072/Atlas_Venture>,
        <https://1145.am/db/1901641/Atlas_Venture>,
        <https://1145.am/db/1913598/Atlas_Venture>,
        <https://1145.am/db/1917671/Atlas_Venture>,
        <https://1145.am/db/2062003/Atlas_Venture>,
        <https://1145.am/db/2109798/Atlas_Venture>,
        <https://1145.am/db/2110113/Atlas_Venture>,
        <https://1145.am/db/2178988/Atlas_Venture>,
        <https://1145.am/db/2286541/Atlas_Venture>,
        <https://1145.am/db/2287244/Atlas_Venture>,
        <https://1145.am/db/2290028/Atlas_Venture>,
        <https://1145.am/db/2292284/Atlas_Venture>,
        <https://1145.am/db/2297439/Atlas_Venture>,
        <https://1145.am/db/2298485/Atlas_Venture>,
        <https://1145.am/db/2299411/Atlas_Venture>,
        <https://1145.am/db/2299772/Atlas_Venture>,
        <https://1145.am/db/2303656/Atlas_Venture>,
        <https://1145.am/db/2304044/Atlas_Venture>,
        <https://1145.am/db/2304237/Atlas_Venture>,
        <https://1145.am/db/2309821/Atlas_Venture>,
        <https://1145.am/db/2309840/Atlas_Venture>,
        <https://1145.am/db/2309847/Atlas_Venture>,
        <https://1145.am/db/2310940/Atlas_Venture>,
        <https://1145.am/db/2318778/Atlas_Venture>,
        <https://1145.am/db/2319412/Atlas_Venture>,
        <https://1145.am/db/2325326/Atlas_Venture>,
        <https://1145.am/db/2327406/Atlas_Venture>,
        <https://1145.am/db/2330852/Atlas_Venture>,
        <https://1145.am/db/2330882/Atlas_Venture>,
        <https://1145.am/db/2331870/Atlas_Venture>,
        <https://1145.am/db/2333601/Atlas_Venture>,
        <https://1145.am/db/2336782/Atlas_Venture>,
        <https://1145.am/db/2337455/Atlas_Venture>,
        <https://1145.am/db/2340096/Atlas_Venture>,
        <https://1145.am/db/2340581/Atlas_Venture>,
        <https://1145.am/db/2341478/Atlas_Venture>,
        <https://1145.am/db/2347106/Atlas_Venture>,
        <https://1145.am/db/2347682/Atlas_Venture>,
        <https://1145.am/db/2352967/Atlas_Venture>,
        <https://1145.am/db/2353524/Atlas_Venture>,
        <https://1145.am/db/2353525/Atlas_Venture>,
        <https://1145.am/db/2354307/Atlas_Venture>,
        <https://1145.am/db/2354314/Atlas_Venture>,
        <https://1145.am/db/2354856/Atlas_Venture>,
        <https://1145.am/db/2355609/Atlas_Venture>,
        <https://1145.am/db/2356048/Atlas_Venture>,
        <https://1145.am/db/2357676/Atlas_Venture>,
        <https://1145.am/db/2357679/Atlas_Venture>,
        <https://1145.am/db/2357682/Atlas_Venture>,
        <https://1145.am/db/2358301/Atlas_Venture>,
        <https://1145.am/db/2358860/Atlas_Venture>,
        <https://1145.am/db/2359683/Atlas_Venture>,
        <https://1145.am/db/2359818/Atlas_Venture>,
        <https://1145.am/db/2360814/Atlas_Venture>,
        <https://1145.am/db/2361018/Atlas_Venture>,
        <https://1145.am/db/2361022/Atlas_Venture>,
        <https://1145.am/db/2361027/Atlas_Venture>,
        <https://1145.am/db/2363396/Atlas_Venture>,
        <https://1145.am/db/2365103/Atlas_Venture>,
        <https://1145.am/db/2367740/Atlas_Venture>,
        <https://1145.am/db/2369004/Atlas_Venture>,
        <https://1145.am/db/2369718/Atlas_Venture>,
        <https://1145.am/db/2370094/Atlas_Venture>,
        <https://1145.am/db/2370540/Atlas_Venture>,
        <https://1145.am/db/2570138/Atlas_Venture>,
        <https://1145.am/db/2573068/Atlas_Venture>,
        <https://1145.am/db/2638432/Atlas_Venture>,
        <https://1145.am/db/2787561/Atlas_Venture>,
        <https://1145.am/db/545988/Atlas_Venture>,
        <https://1145.am/db/75445/Atlas_Venture>,
        <https://1145.am/db/979509/Atlas_Venture> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358502/Allakos_Inc> a org:Organization ;
    ns1:description "developing antibody therapeutics for allergic and inflammatory diseases" ;
    ns1:documentDate "2012-12-17T17:21:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Allakos Inc. Completes Series A Financing of $32 Million to Develop Antibody Therapeutics for Allergic and Inflammatory Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allakos-inc-completes-series-a-financing-of-32-million-to-develop-antibody-therapeutics-for> ;
    ns1:foundName "Allakos Inc." ;
    ns1:name "Allakos Inc." ;
    ns1:sameAsMedium <https://1145.am/db/1230702/Allakos_Inc>,
        <https://1145.am/db/1352333/Allakos_Inc>,
        <https://1145.am/db/2294825/Allakos> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358502/Rivervest_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-12-17T17:21:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Allakos Inc. Completes Series A Financing of $32 Million to Develop Antibody Therapeutics for Allergic and Inflammatory Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allakos-inc-completes-series-a-financing-of-32-million-to-develop-antibody-therapeutics-for> ;
    ns1:foundName "RiverVest Venture Partners" ;
    ns1:investor <https://1145.am/db/2358502/Series_A_Investment_Allakos_Inc_Alta_Partners_Novo_Ventures_Rivervest_Venture_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "RiverVest Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1669813/Rivervest_Venture_Partners>,
        <https://1145.am/db/2218908/Rivervest_Venture_Fund_Ii>,
        <https://1145.am/db/2294113/Rivervest_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1283038/Rivervest_Venture_Partners>,
        <https://1145.am/db/2155730/Rivervest_Venture_Partners>,
        <https://1145.am/db/2286035/Rivervest_Venture_Partners>,
        <https://1145.am/db/2288553/Rivervest_Venture_Partners>,
        <https://1145.am/db/2294893/Rivervest_Venture_Partners>,
        <https://1145.am/db/2296631/Rivervest_Venture_Partners>,
        <https://1145.am/db/2299423/Rivervest_Venture_Partners>,
        <https://1145.am/db/2329550/Rivervest_Venture_Partners>,
        <https://1145.am/db/2336221/Rivervest_Venture_Partners>,
        <https://1145.am/db/2337106/Rivervest_Venture_Partners>,
        <https://1145.am/db/2340887/Rivervest_Venture_Partners>,
        <https://1145.am/db/2350044/Rivervest_Venture_Partners>,
        <https://1145.am/db/2354899/Rivervest_Venture_Partners>,
        <https://1145.am/db/2355274/Rivervest_Venture_Partners>,
        <https://1145.am/db/2356216/Rivervest_Venture_Partners>,
        <https://1145.am/db/2358496/Rivervest_Venture_Partners>,
        <https://1145.am/db/2369916/Rivervest_Venture_Partners>,
        <https://1145.am/db/583798/Rivervest_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358506/Nanodimension> a org:Organization ;
    ns1:basedInLowRaw "MA" ;
    ns1:documentDate "2012-12-18T12:40:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/blend-therapeutics-closes-16-million-series-b-financing-0> ;
    ns1:foundName "NanoDimension" ;
    ns1:investor <https://1145.am/db/2358506/Series_B_Investment_Blend_Therapeutics_Flagship_Ventures_Nanodimension_New_Enterprise_Associates_Completed> ;
    ns1:name "NanoDimension" ;
    ns1:sameAsMedium <https://1145.am/db/2302116/Nanodimension>,
        <https://1145.am/db/2324431/Nanodimension>,
        <https://1145.am/db/2334847/Nanodimension>,
        <https://1145.am/db/2341484/Nanodimension>,
        <https://1145.am/db/2341487/Nanodimension>,
        <https://1145.am/db/2358529/Nanodimension>,
        <https://1145.am/db/2366654/Nanodimension> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358515/Series_A_Investment_Tpg_Biotech_Trevi_Therapeutics_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-18T14:24:41+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NEW HAVEN, Conn.- (BUSINESS WIRE) -Trevi Therapeutics, Inc. (\"Trevi\") today announced the closing of a $ 10 million Series A financing to advance the clinical development of T111 in the lead indication of uremic pruritus.",
        "Trevi Therapeutics Announces $ 10 Million Series A Financing from TPG Biotech." ;
    ns1:documentTitle "Trevi Therapeutics Announces $10 Million Series A Financing from TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/trevi-therapeutics-announces-10-million-series-a-financing-from-tpg-biotech> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2358515/Trevi_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 10 Million",
        "$ 10 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2358515/Tpg_Biotech> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-12-18T14:24:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Trevi Therapeutics Announces $10 Million Series A Financing from TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/trevi-therapeutics-announces-10-million-series-a-financing-from-tpg-biotech> ;
    ns1:foundName "TPG Biotech" ;
    ns1:investor <https://1145.am/db/2358515/Series_A_Investment_Tpg_Biotech_Trevi_Therapeutics_Has_Not_Happened> ;
    ns1:name "TPG Biotech" ;
    ns1:sameAsHigh <https://1145.am/db/1263299/Biolab>,
        <https://1145.am/db/2243599/Biogen_Idec>,
        <https://1145.am/db/2283468/Biohaven>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285651/Biogen>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2301691/Biogen_Idec>,
        <https://1145.am/db/2301844/Biogen_Idec>,
        <https://1145.am/db/2302669/Medigen_Biotechnology_Corporation>,
        <https://1145.am/db/2303552/Biodelivery_Sciences>,
        <https://1145.am/db/2303604/Biogen_Idec>,
        <https://1145.am/db/2305545/Genentech>,
        <https://1145.am/db/2306117/Biogen_Idec>,
        <https://1145.am/db/2306462/Bioseek>,
        <https://1145.am/db/2306665/Biovitrum>,
        <https://1145.am/db/2314398/Genentech>,
        <https://1145.am/db/2315688/Biovitrum>,
        <https://1145.am/db/2318658/Biovail_Corporation>,
        <https://1145.am/db/2318658/Biovail_International_Laboratories_Srl>,
        <https://1145.am/db/2319577/Genentech>,
        <https://1145.am/db/2320110/Biovail>,
        <https://1145.am/db/2321048/Abraxis_Bioscience>,
        <https://1145.am/db/2321911/Biovail_Corporation>,
        <https://1145.am/db/2322040/Biovitrum_Ab>,
        <https://1145.am/db/2322091/Biovail>,
        <https://1145.am/db/2322201/Genentech>,
        <https://1145.am/db/2323128/Biogenerix>,
        <https://1145.am/db/2323710/Biovitrum>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2326815/Biovail_Corporation>,
        <https://1145.am/db/2331044/Genentech>,
        <https://1145.am/db/2336625/Biota>,
        <https://1145.am/db/2338202/Biodelivery_Sciences_International>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2340402/Biolinerx>,
        <https://1145.am/db/2344638/Coherus_Biosciences>,
        <https://1145.am/db/2344940/Biodelivery_Sciences_International>,
        <https://1145.am/db/2348159/Biocon>,
        <https://1145.am/db/2350245/Biodelivery_Sciences_International>,
        <https://1145.am/db/2352262/Biodelivery_Sciences_International>,
        <https://1145.am/db/2353663/Biotie>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2356510/Unigene_Laboratories_Inc>,
        <https://1145.am/db/2356945/Biovail_Laboratories_International_Srl>,
        <https://1145.am/db/2359670/Biotie>,
        <https://1145.am/db/2360719/Biodelivery_Sciences_International_Inc>,
        <https://1145.am/db/2362341/Biontech_Ag>,
        <https://1145.am/db/2362377/Columbia_Laboratories>,
        <https://1145.am/db/2364364/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364671/Biogen_Idec>,
        <https://1145.am/db/2364672/Biogen_Idec>,
        <https://1145.am/db/2364678/Biogen_Idec>,
        <https://1145.am/db/2365199/Biovail>,
        <https://1145.am/db/2366933/Lux_Biosciences>,
        <https://1145.am/db/2367158/Lux_Biosciences>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2369048/Rentschler_Biotechnologie>,
        <https://1145.am/db/2369049/Rentschler_Biotechnologie>,
        <https://1145.am/db/2370133/Rentschler_Biotechnologie>,
        <https://1145.am/db/2370134/Rentschler_Biotechnologie>,
        <https://1145.am/db/2371269/Biogen_Biogen>,
        <https://1145.am/db/2546113/Biodelivery_Sciences_International>,
        <https://1145.am/db/2554333/Genentech>,
        <https://1145.am/db/2554810/Armo_Biosciences>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2565174/Biocon_Viatris>,
        <https://1145.am/db/2570514/Ctx_Technology_Inc>,
        <https://1145.am/db/2581523/Biodelivery_Sciences_International>,
        <https://1145.am/db/2585066/Advanced_Bio-Technologies>,
        <https://1145.am/db/2587321/Biodelivery_Sciences>,
        <https://1145.am/db/2588178/Biovail>,
        <https://1145.am/db/2594877/Biogen_Idec>,
        <https://1145.am/db/2598012/Afexa_Life_Sciences>,
        <https://1145.am/db/2598558/Biovail>,
        <https://1145.am/db/522502/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/832408/Biodelivery_Sciences_International>,
        <https://1145.am/db/833269/Biodelivery_Sciences_International>,
        <https://1145.am/db/862305/Biocon_Ltd>,
        <https://1145.am/db/906534/Kither_Biotech> ;
    ns1:sameAsMedium <https://1145.am/db/1863540/Tpg_Biotech>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/2299423/Tpg_Biotech>,
        <https://1145.am/db/2300337/Tpg_Biotech>,
        <https://1145.am/db/2302333/Tpg_Biotech>,
        <https://1145.am/db/2308700/Tpg_Biotech>,
        <https://1145.am/db/2336221/Tpg_Biotech>,
        <https://1145.am/db/2342557/Tpg_Biotech>,
        <https://1145.am/db/2342558/Tpg_Biotech>,
        <https://1145.am/db/2342724/Tpg_Biotech>,
        <https://1145.am/db/2344678/Tpg_Biotech>,
        <https://1145.am/db/2350044/Tpg_Biotech>,
        <https://1145.am/db/2351897/Tpg_Biotech>,
        <https://1145.am/db/2352508/Tpg_Biotech>,
        <https://1145.am/db/2353588/Tpg_Biotech>,
        <https://1145.am/db/2353608/Tpg_Biotech>,
        <https://1145.am/db/2353771/Tpg_Biotech>,
        <https://1145.am/db/2353789/Tpg_Biotech>,
        <https://1145.am/db/2354537/Tpg_Biotech>,
        <https://1145.am/db/2354899/Tpg_Biotech>,
        <https://1145.am/db/2354903/Tpg_Biotech>,
        <https://1145.am/db/2358888/Tpg_Biotech>,
        <https://1145.am/db/2359562/Tpg_Biotech>,
        <https://1145.am/db/2362457/Tpg_Biotech>,
        <https://1145.am/db/2364035/Tpg_Biotech>,
        <https://1145.am/db/2365868/Tpg_Biotech>,
        <https://1145.am/db/2368351/Tpg_Biotech>,
        <https://1145.am/db/316299/Tpg_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358515/Trevi_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "New Haven County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4839373/about.rdf> ;
    ns1:basedInHighRaw "NEW HAVEN, Conn." ;
    ns1:description "developing T111 for uremic pruritus and other itching conditions",
        "life science" ;
    ns1:documentDate "2012-12-18T14:24:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Trevi Therapeutics Announces $10 Million Series A Financing from TPG Biotech" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/trevi-therapeutics-announces-10-million-series-a-financing-from-tpg-biotech> ;
    ns1:foundName "Trevi Therapeutics",
        "Trevi Therapeutics, Inc" ;
    ns1:industry "Biotech" ;
    ns1:name "Trevi",
        "Trevi Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2342557/Trevi_Therapeutics>,
        <https://1145.am/db/2342558/Trevi_Therapeutics>,
        <https://1145.am/db/2344678/Trevi_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/1365037/Trevi_Therapeutics_Inc>,
        <https://1145.am/db/1365617/Trevi_Therapeutics>,
        <https://1145.am/db/1501458/Trevi_Therapeutics>,
        <https://1145.am/db/401324/Trevi_Therapeutics>,
        <https://1145.am/db/515342/Trevi_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358541/Baxter_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "United States" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:basedInHighRaw "US" ;
    ns1:documentDate "2012-12-19T14:00:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Regado Biosciences, Inc. Secures $51 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/regado-biosciences-inc-secures-51-million-series-e-financing> ;
    ns1:foundName "Baxter Ventures" ;
    ns1:investor <https://1145.am/db/2358541/Series_E_Investment_Aurora_Funds_Baxter_Ventures_Caxton_Advantage_Life_Sciences_Fund_Domain_Associates_Edmond_De_Rothschild_Investment_Partners_Quaker_Partners_Regado_Biosciences_Rusnanomedinvest_Completed> ;
    ns1:name "Baxter Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2327046/Baxter_Ventures>,
        <https://1145.am/db/2335936/Baxter_Ventures>,
        <https://1145.am/db/2350231/Baxter_Ventures>,
        <https://1145.am/db/2352203/Baxter_Ventures>,
        <https://1145.am/db/2352204/Baxter_Ventures>,
        <https://1145.am/db/2352216/Baxter_Ventures>,
        <https://1145.am/db/2352349/Baxter_Ventures>,
        <https://1145.am/db/2352350/Baxter_Ventures>,
        <https://1145.am/db/2357487/Baxter_Ventures>,
        <https://1145.am/db/2357494/Baxter_Ventures>,
        <https://1145.am/db/2371033/Baxter_Ventures>,
        <https://1145.am/db/2569831/Baxter_Ventures>,
        <https://1145.am/db/2580551/Baxter_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358541/Regado_Biosciences> a org:Organization ;
    ns1:description "developing drugs" ;
    ns1:documentDate "2012-12-19T14:00:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Regado Biosciences, Inc. Secures $51 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/regado-biosciences-inc-secures-51-million-series-e-financing> ;
    ns1:foundName "Regado Biosciences, Inc." ;
    ns1:industry "Life Sciences" ;
    ns1:name "Regado Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/2297997/Regulus>,
        <https://1145.am/db/2303642/Regado_Biosciences>,
        <https://1145.am/db/2309799/Regado> ;
    ns1:sameAsMedium <https://1145.am/db/2303022/Regado_Biosciences>,
        <https://1145.am/db/2303641/Regado_Biosciences>,
        <https://1145.am/db/2309809/Regado_Biosciences>,
        <https://1145.am/db/2313303/Regado_Biosciences>,
        <https://1145.am/db/2336725/Regado_Biosciences>,
        <https://1145.am/db/2338879/Regado_Biosciences>,
        <https://1145.am/db/2338880/Regado_Biosciences>,
        <https://1145.am/db/2338940/Regado_Biosciences>,
        <https://1145.am/db/2339818/Regado_Biosciences>,
        <https://1145.am/db/2340497/Regado_Biosciences>,
        <https://1145.am/db/2346672/Regado_Biosciences>,
        <https://1145.am/db/2347947/Regado_Biosciences>,
        <https://1145.am/db/2348941/Regado_Biosciences>,
        <https://1145.am/db/2348952/Regado_Biosciences>,
        <https://1145.am/db/2351273/Regado_Biosciences_Inc>,
        <https://1145.am/db/2351285/Regado_Biosciences>,
        <https://1145.am/db/2357147/Regado_Biosciences>,
        <https://1145.am/db/2364530/Regado_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358979/Intersouth_Partners> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:documentDate "2012-09-12T14:43:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Pharmaceuticals, Inc. Completes $16 Million Equity Financing, Signs Agreement with Janssen Biotech, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-pharmaceuticals-inc-completes-16-million-equity-financing-signs-agreement-janssen> ;
    ns1:foundName "Intersouth Partners" ;
    ns1:investor <https://1145.am/db/2358979/Series_A_Investment_Intersouth_Partners_Mpm_Capital_Vascular_Pharmaceuticals_Completed> ;
    ns1:name "Intersouth Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1698991/Intersouth_Partners>,
        <https://1145.am/db/1719350/Intersouth_Partners>,
        <https://1145.am/db/1826128/Intersouth_Partners>,
        <https://1145.am/db/1831452/Intersouth_Partners>,
        <https://1145.am/db/1872380/Intersouth_Partners>,
        <https://1145.am/db/1875214/Intersouth_Partners>,
        <https://1145.am/db/2289983/Intersouth_Partners>,
        <https://1145.am/db/2295654/Intersouth_Partners>,
        <https://1145.am/db/2303598/Intersouth_Partners>,
        <https://1145.am/db/2305031/Intersouth_Partners>,
        <https://1145.am/db/2317561/Intersouth_Partners>,
        <https://1145.am/db/2317564/Intersouth_Partners>,
        <https://1145.am/db/2320082/Intersouth_Partners>,
        <https://1145.am/db/2320852/Intersouth_Partners>,
        <https://1145.am/db/2320853/Intersouth_Partners>,
        <https://1145.am/db/2324042/Intersouth_Partners>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2326412/Intersouth_Partners>,
        <https://1145.am/db/2328655/Intersouth_Partners>,
        <https://1145.am/db/2347983/Intersouth_Partners>,
        <https://1145.am/db/2350199/Intersouth_Partners>,
        <https://1145.am/db/2359001/Intersouth_Partners>,
        <https://1145.am/db/2578837/Intersouth_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358979/Vascular_Pharmaceuticals> a org:Organization ;
    ns1:description "drug discovery" ;
    ns1:documentDate "2012-09-12T14:43:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Pharmaceuticals, Inc. Completes $16 Million Equity Financing, Signs Agreement with Janssen Biotech, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-pharmaceuticals-inc-completes-16-million-equity-financing-signs-agreement-janssen> ;
    ns1:foundName "Vascular Pharmaceuticals, Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Vascular Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/2298037/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2306907/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2311233/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2326555/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2329854/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2329855/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2330795/Angiotech_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338111/Angiotech_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345450/Angiotech_Pharmaceuticals_(us)_Inc>,
        <https://1145.am/db/2346530/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2350440/Angiotech_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358981/Vascular_Pharmaceuticals>,
        <https://1145.am/db/2359001/Vascular_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552666/Angionetics_Inc>,
        <https://1145.am/db/2559783/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2574384/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2586160/Angiotech_Pharmaceuticals>,
        <https://1145.am/db/2590138/Angiotech_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359562/Tpg_Biotech> a org:Organization ;
    ns1:basedInHighGeoName "Novato" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5285048/about.rdf> ;
    ns1:basedInHighRaw "NOVATO, Calif." ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2012-12-20T11:39:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Raises $75 Million in Oversubscribed Crossover Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-raises-75-million-oversubscribed-crossover-financing> ;
    ns1:foundName "TPG Biotech" ;
    ns1:investor <https://1145.am/db/2359562/Series_B_Investment_Adage_Capital_Partners_Fidelity_Biosciences_Healthcap_Pappas_Ventures_Tpg_Biotech_Ultragenyx_Pharmaceutical_Inc_Completed> ;
    ns1:name "TPG Biotech" ;
    ns1:sameAsHigh <https://1145.am/db/2358888/Tpg_Biotech> ;
    ns1:sameAsMedium <https://1145.am/db/1863540/Tpg_Biotech>,
        <https://1145.am/db/1867543/Tpg_Biotech>,
        <https://1145.am/db/2299423/Tpg_Biotech>,
        <https://1145.am/db/2300337/Tpg_Biotech>,
        <https://1145.am/db/2302333/Tpg_Biotech>,
        <https://1145.am/db/2308700/Tpg_Biotech>,
        <https://1145.am/db/2336221/Tpg_Biotech>,
        <https://1145.am/db/2342557/Tpg_Biotech>,
        <https://1145.am/db/2342558/Tpg_Biotech>,
        <https://1145.am/db/2342724/Tpg_Biotech>,
        <https://1145.am/db/2344678/Tpg_Biotech>,
        <https://1145.am/db/2350044/Tpg_Biotech>,
        <https://1145.am/db/2351897/Tpg_Biotech>,
        <https://1145.am/db/2352508/Tpg_Biotech>,
        <https://1145.am/db/2353588/Tpg_Biotech>,
        <https://1145.am/db/2353608/Tpg_Biotech>,
        <https://1145.am/db/2353771/Tpg_Biotech>,
        <https://1145.am/db/2353789/Tpg_Biotech>,
        <https://1145.am/db/2354537/Tpg_Biotech>,
        <https://1145.am/db/2354899/Tpg_Biotech>,
        <https://1145.am/db/2354903/Tpg_Biotech>,
        <https://1145.am/db/2358515/Tpg_Biotech>,
        <https://1145.am/db/2362457/Tpg_Biotech>,
        <https://1145.am/db/2364035/Tpg_Biotech>,
        <https://1145.am/db/2365868/Tpg_Biotech>,
        <https://1145.am/db/2368351/Tpg_Biotech>,
        <https://1145.am/db/316299/Tpg_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359562/Ultragenyx_Pharmaceutical_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Novato" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5285048/about.rdf> ;
    ns1:basedInHighRaw "NOVATO, Calif." ;
    ns1:description "Biotechnology" ;
    ns1:documentDate "2012-12-20T11:39:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Raises $75 Million in Oversubscribed Crossover Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-raises-75-million-oversubscribed-crossover-financing> ;
    ns1:foundName "Ultragenyx",
        "Ultragenyx Pharmaceutical Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Ultragenyx",
        "Ultragenyx Pharmaceutical Inc." ;
    ns1:sameAsHigh <https://1145.am/db/1206173/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/1218047/Ultragenyx>,
        <https://1145.am/db/1218109/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/1492184/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2151837/Ultragenyx>,
        <https://1145.am/db/2279911/Ultragenyx>,
        <https://1145.am/db/2335687/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2340312/Ultragenyx_Pharmaceutical>,
        <https://1145.am/db/2350796/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2351964/Ultragenyx_Pharmaceutical>,
        <https://1145.am/db/2353954/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2354244/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2354537/Ultragenyx_Therapeutics>,
        <https://1145.am/db/2354540/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2358607/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2367797/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2367814/Ultragenyx_Pharmaceutical_Inc>,
        <https://1145.am/db/2544609/Ultragenyx>,
        <https://1145.am/db/2547355/Ultragenyx_Pharmaceutical>,
        <https://1145.am/db/998834/Ultragenyx_Pharmaceutical_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359591/Investment_Healthcare_Royalty_Partners_Raptor_Pharmaceutical_Corp_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-21T12:42:16+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NOVATO, Calif., Dec. 20, 2012 (GLOBE NEWSWIRE) - Raptor Pharmaceutical Corp. (\"Raptor\" or the \"Company\") (Nasdaq: RPTP) , today announced that it has signed a $ 50 million loan agreement with HealthCare Royalty Partners (\"HC Royalty\") to help fund the commercialization of PROCYSBIâ„¢, the branded name of RP103 for the potential treatment of nephropathic cystinosis, and advance the Company's development programs.",
        "Raptor Pharmaceutical Corp. Signs $ 50 Million Loan Agreement With HealthCare Royalty Partners." ;
    ns1:documentTitle "Raptor Pharmaceutical Corp. Signs $50 Million Loan Agreement With HealthCare Royalty Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raptor-pharmaceutical-corp-signs-50-million-loan-agreement-healthcare-royalty-partners> ;
    ns1:foundName "Loan",
        "loan" ;
    ns1:name "Loan",
        "loan" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2359591/Procysbi>,
        <https://1145.am/db/2359591/Raptor_Pharmaceutical_Corp> ;
    ns1:targetName "PROCYSBI" ;
    ns1:valueRaw "$ 25 million",
        "$ 50 Million",
        "$ 50 million" ;
    ns1:whereGeoName "Novato",
        "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5285048/about.rdf>,
        <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "NOVATO, Calif",
        "United States" .

<https://1145.am/db/2359591/Procysbi> a org:Organization ;
    ns1:basedInHighGeoName "Novato" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5285048/about.rdf> ;
    ns1:basedInHighRaw "NOVATO, Calif." ;
    ns1:description "nephropathic cystinosis" ;
    ns1:documentDate "2012-12-21T12:42:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raptor Pharmaceutical Corp. Signs $50 Million Loan Agreement With HealthCare Royalty Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raptor-pharmaceutical-corp-signs-50-million-loan-agreement-healthcare-royalty-partners> ;
    ns1:foundName "PROCYSBI" ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "PROCYSBI" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2359591/Raptor_Pharmaceutical_Corp> a org:Organization ;
    ns1:basedInHighGeoName "Novato" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5285048/about.rdf> ;
    ns1:basedInHighRaw "NOVATO, Calif" ;
    ns1:description "Pharmaceutical" ;
    ns1:documentDate "2012-12-21T12:42:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Raptor Pharmaceutical Corp. Signs $50 Million Loan Agreement With HealthCare Royalty Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/raptor-pharmaceutical-corp-signs-50-million-loan-agreement-healthcare-royalty-partners> ;
    ns1:foundName "Raptor",
        "Raptor Pharmaceutical Corp." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "Raptor Pharmaceutical Corp",
        "Raptor Pharmaceutical Corp." ;
    ns1:sameAsHigh <https://1145.am/db/2294580/Raptor_Pharmaceutical>,
        <https://1145.am/db/2303686/Raptor_Pharmaceuticals>,
        <https://1145.am/db/2305687/Raptor_Pharmaceuticals_Corp>,
        <https://1145.am/db/2309520/Raptor_Pharmaceuticals>,
        <https://1145.am/db/2309522/Raptor_Pharmaceuticals_Corp>,
        <https://1145.am/db/2313227/Raptor_Pharmaceuticals>,
        <https://1145.am/db/2315719/Raptor_Pharmaceutical_Inc>,
        <https://1145.am/db/2315719/Raptor_Pharmaceuticals>,
        <https://1145.am/db/2318271/Raptor_Pharmaceutical_Corp>,
        <https://1145.am/db/2341556/Raptor_Pharmaceutical_Corp>,
        <https://1145.am/db/2341558/Raptor_Pharmaceutical>,
        <https://1145.am/db/2349759/Raptor_Pharmaceutical_Corp>,
        <https://1145.am/db/2350806/Raptor_Pharmaceuticals>,
        <https://1145.am/db/2357099/Raptor_Pharmaceutical_Corp>,
        <https://1145.am/db/2359580/Raptor_Pharmaceutical>,
        <https://1145.am/db/2368342/Raptor_Pharmaceutical_Corp>,
        <https://1145.am/db/2369477/Raptor_Pharmaceutical_Corp> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360052/Elusys_Therapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Pine Brook" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5102677/about.rdf> ;
    ns1:basedInHighRaw "PINE BROOK, N.J." ;
    ns1:basedInLowRaw "U.S." ;
    ns1:description "developing countermeasures for biodefense",
        "pharmaceutical" ;
    ns1:documentDate "2012-09-14T15:42:47+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elusys-awarded-additional-14-5-million-under-existing-u-s-government-contracts-supporting> ;
    ns1:foundName "Elusys",
        "Elusys Therapeutics, Inc",
        "Elusys Therapeutics, Inc. (Elusys)" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Elusys",
        "Elusys Therapeutics",
        "Elusys Therapeutics, Inc" ;
    ns1:sameAsHigh <https://1145.am/db/1137091/Avilar_Therapeutics>,
        <https://1145.am/db/2327511/Esperion_Therapeutics>,
        <https://1145.am/db/2336926/Esperion_Therapeutics_Inc>,
        <https://1145.am/db/2341297/Elusys_Therapeutics>,
        <https://1145.am/db/2347668/Elusys_Therapeutics_Inc>,
        <https://1145.am/db/2352167/Esperion_Therapeutics>,
        <https://1145.am/db/2352170/Esperion_Therapeutics>,
        <https://1145.am/db/2360051/Elusys_Therapeutics>,
        <https://1145.am/db/2591761/Elusys_Therapeutics>,
        <https://1145.am/db/505996/Elevar>,
        <https://1145.am/db/633100/Avilar_Therapeutics>,
        <https://1145.am/db/734840/Elevar>,
        <https://1145.am/db/991384/Elusys_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2305956/Elusys_Therapeutics>,
        <https://1145.am/db/2315530/Elusys_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361079/Curevac_Gmbh> a org:Organization ;
    ns1:basedInHighGeoName "Federal Republic of Germany" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2921044/about.rdf> ;
    ns1:basedInHighRaw "Germany" ;
    ns1:description "developing a new class of therapies and vaccines based on mRNA" ;
    ns1:documentDate "2012-09-18T12:01:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "CureVac Secures EUR80 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/curevac-secures-eur80-million-series-d-financing-0> ;
    ns1:foundName "CureVac",
        "CureVac GmbH" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "CureVac",
        "CureVac GmbH" ;
    ns1:sameAsHigh <https://1145.am/db/1122469/Curevac_Nv>,
        <https://1145.am/db/1122481/Curevac_Nv>,
        <https://1145.am/db/118488/Curevac>,
        <https://1145.am/db/118625/Curevac>,
        <https://1145.am/db/1631230/Curevac_Nv>,
        <https://1145.am/db/1807438/Curevac>,
        <https://1145.am/db/2151889/Curevac>,
        <https://1145.am/db/2152152/Curevac>,
        <https://1145.am/db/2280874/Curevac>,
        <https://1145.am/db/2331155/Curevac>,
        <https://1145.am/db/2338383/Curevac>,
        <https://1145.am/db/2351974/Curevac>,
        <https://1145.am/db/2351977/Curevac_Gmbh___Curevac>,
        <https://1145.am/db/2361082/Curevac>,
        <https://1145.am/db/2361094/Curevac_Gmbh>,
        <https://1145.am/db/2367566/Curevac>,
        <https://1145.am/db/2546182/Curevac>,
        <https://1145.am/db/2555209/Curevac>,
        <https://1145.am/db/2578745/Curevac>,
        <https://1145.am/db/2579135/Curevac_Gmbh>,
        <https://1145.am/db/764420/Curevac_Nv> ;
    ns1:sameAsMedium <https://1145.am/db/2152377/Curevac>,
        <https://1145.am/db/2299902/Curevac> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2361079/Investment_Curevac_Gmbh_Dievini_Hopp_Biotech_Holding_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-18T12:01:18+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CureVac Secures EUR80 Million in Series D Financing.",
        "TUBINGEN, Germany, Sept. 18, 2012 /PRNewswire/ - CureVac GmbH, a clinical stage biopharmaceutical company developing a new class of therapies and vaccines based on mRNA, today announced the completion of an EUR80 million financing round with its main investor, dievini Hopp BioTech Holding." ;
    ns1:documentTitle "CureVac Secures EUR80 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/curevac-secures-eur80-million-series-d-financing-0> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2361079/Curevac_Gmbh> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "EUR80 Million",
        "EUR80 million" ;
    ns1:when "2012-09-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Sept. 18, 2012" ;
    ns1:whereGeoName "Europe" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Europe" .

<https://1145.am/db/2362134/Pure_Communications_Incdan_Budwick> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2012-09-21T04:01:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Announces $42.5 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-announces-42-5-million-series-b-financing> ;
    ns1:foundName "Pure Communications",
        "Pure Communications, Inc.Dan Budwick" ;
    ns1:name "Pure Communications",
        "Pure Communications, Inc.Dan Budwick" ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2365032/Biophytis> a org:Organization ;
    ns1:description "nutraceuticals" ;
    ns1:documentDate "2012-10-01T19:25:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Biophytis completes a EUR two million B round financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biophytis-completes-a-eur-two-million-b-round-financing> ;
    ns1:foundName "Biophytis" ;
    ns1:industry "health and nutrition" ;
    ns1:name "Biophytis" ;
    ns1:sameAsMedium <https://1145.am/db/1176858/Biophytis_Sa>,
        <https://1145.am/db/1347283/Biophytis>,
        <https://1145.am/db/2292734/Biophytis>,
        <https://1145.am/db/524534/Biophytis_Sa>,
        <https://1145.am/db/644071/Biophytis>,
        <https://1145.am/db/716198/Biophytis_Sa>,
        <https://1145.am/db/957938/Biophytis_Sa> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2547216/Investment_Biomedical_Catalyst_Oxford_England-Psioxus_Therapeutics_Ltd_Psioxus_Therapeutics_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-05T18:17:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "OXFORD, England-PsiOxus Therapeutics, Ltd. (PsiOxus) , a development stage biotechnology company, today announced the award of a Â£1.7 million ($ 2.7 million) grant from the UK government-backed Biomedical Catalyst to initiate a Phase I/II clinical trial to assess the use of ColoAd1 in the treatment of platinum-resistant, recurrent ovarian cancer." ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "award",
        "grant" ;
    ns1:name "award",
        "grant" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2547216/Oxford_England-Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2547216/Psioxus_Therapeutics> ;
    ns1:valueRaw "$ 2.7 million",
        "Â£1.7 million" ;
    ns1:whereGeoName "England" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6269131/about.rdf> ;
    ns1:whereRaw "England" .

<https://1145.am/db/2560070/Innovent_Biologics> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-11-16T17:50:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Innovent Biologics Adds $25 Million to Expand its Antibody Pipeline and its Manufacturing Capabilities" ;
    ns1:documentURL <https://www.fiercepharma.com/manufacturing/innovent-biologics-adds-25-million-to-expand-its-antibody-pipeline-and-its> ;
    ns1:foundName "Innovent Biologics",
        "Innovent Biologics, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Innovent Biologics" ;
    ns1:sameAsHigh <https://1145.am/db/1205635/Innoviva_Inc>,
        <https://1145.am/db/2309121/Inimex_Pharmaceuticals>,
        <https://1145.am/db/2321297/Inovio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337322/Inovio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2340432/Inovio_Pharmaceuticals>,
        <https://1145.am/db/2352982/Inovio_Pharmaceuticals>,
        <https://1145.am/db/2361462/Inovio_Pharmaceuticals>,
        <https://1145.am/db/2362373/Inovio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369226/Innocoll_Ag>,
        <https://1145.am/db/2537151/Inovio_Pharmaceuticals>,
        <https://1145.am/db/2550996/Innovent_Biologics>,
        <https://1145.am/db/2551522/Invagen_Pharmaceuticals>,
        <https://1145.am/db/2558820/Inovio_Pharmaceuticals>,
        <https://1145.am/db/2560075/Innovent_Biologics_Inc>,
        <https://1145.am/db/2596054/Mikah_Pharma_Llc> ;
    ns1:sameAsMedium <https://1145.am/db/2301308/Innovent_Biologics>,
        <https://1145.am/db/2359240/Innovent_Biologics>,
        <https://1145.am/db/2536882/Innovent_Biologics>,
        <https://1145.am/db/2758736/Innovent_Biologics>,
        <https://1145.am/db/694561/Innovent_Biologics> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2571001/Investment_Rarecyte_Inc_Telegraph_Hill_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-22T01:10:07+00:00"^^xsd:dateTime ;
    ns1:documentExtract "RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform.",
        "RareCyte Inc., a Seattle - based life science company, closed the second tranche of its funding led by Telegraph Hill Partners (THP) ." ;
    ns1:documentTitle "RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/rarecyte-completes-final-tranche-of-funding-for-launch-of-its-accucyte-rare-cell-detection> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2571001/Rarecyte_Inc> ;
    ns1:whereGeoName "Seattle" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:whereRaw "Seattle" .

<https://1145.am/db/2571001/Telegraph_Hill_Partners> a org:Organization ;
    ns1:basedInLowRaw "Seattle" ;
    ns1:description "funding" ;
    ns1:documentDate "2012-08-22T01:10:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/rarecyte-completes-final-tranche-of-funding-for-launch-of-its-accucyte-rare-cell-detection> ;
    ns1:foundName "Telegraph Hill Partners" ;
    ns1:investor <https://1145.am/db/2571001/Investment_Rarecyte_Inc_Telegraph_Hill_Partners_Completed> ;
    ns1:name "Telegraph Hill Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2350625/Telegraph_Hill_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1133740/Telegraph_Hill_Partners>,
        <https://1145.am/db/1135234/Telegraph_Hill_Partners>,
        <https://1145.am/db/1177907/Telegraph_Hill_Partners>,
        <https://1145.am/db/1445365/Telegraph_Hill_Partners>,
        <https://1145.am/db/781996/Telegraph_Hill_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2572803/Alimera_Sciences> a org:Organization ;
    ns1:description "research, development and commercialization of prescription ophthalmic pharmaceuticals" ;
    ns1:documentDate "2012-10-10T12:06:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alimera Sciences Closes $40 Million Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/drug-delivery/alimera-sciences-closes-40-million-financing> ;
    ns1:foundName "Alimera Sciences",
        "Alimera Sciences, Inc" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Alimera Sciences" ;
    ns1:sameAsHigh <https://1145.am/db/1620094/Sellas_Life_Sciences_Group>,
        <https://1145.am/db/2310900/Ardea_Biosciences>,
        <https://1145.am/db/2331218/Ardea_Biosciences_Inc>,
        <https://1145.am/db/2347899/Alimera_Sciences>,
        <https://1145.am/db/2350157/Alimera_Sciences_Inc>,
        <https://1145.am/db/2350503/Premier_Research_Group_Limited>,
        <https://1145.am/db/2351832/Alimera>,
        <https://1145.am/db/2352532/Ardea_Biosciences>,
        <https://1145.am/db/2357813/Premier_Research_Group>,
        <https://1145.am/db/2365397/Alimera_Sciences>,
        <https://1145.am/db/2587972/Premier_Research_Group_Limited> ;
    ns1:sameAsMedium <https://1145.am/db/1628939/Alimera_Sciences>,
        <https://1145.am/db/2310610/Alimera_Sciences>,
        <https://1145.am/db/2316658/Alimera_Sciences>,
        <https://1145.am/db/2324334/Alimera_Sciences_Inc>,
        <https://1145.am/db/2351840/Alimera_Sciences>,
        <https://1145.am/db/2352946/Alimera_Sciences> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577162/Department_Of_Defense> a org:Organization ;
    ns1:documentDate "2012-09-07T04:03:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aduro Awarded CDMRP Grant for Prostate Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aduro-awarded-cdmrp-grant-for-prostate-cancer-vaccine-development> ;
    ns1:foundName "Department of Defense" ;
    ns1:investor <https://1145.am/db/2577162/Investment_Aduro_Biotech_Department_Of_Defense_Has_Not_Happened> ;
    ns1:name "Department of Defense" ;
    ns1:sameAsMedium <https://1145.am/db/1233032/Department_Of_Defense>,
        <https://1145.am/db/1238505/Department_Of_Defense>,
        <https://1145.am/db/1386969/Us_Department_Of_Defense>,
        <https://1145.am/db/1598435/Department_Of_Defense>,
        <https://1145.am/db/1764017/Us_Department_Of_Defense>,
        <https://1145.am/db/1948781/Us_Department_Of_Defense>,
        <https://1145.am/db/2317692/United_States_Department_Of_Defense1>,
        <https://1145.am/db/2356885/Department_Of_Defense>,
        <https://1145.am/db/2422755/Us_Department_Of_Defense> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577162/Investment_Aduro_Biotech_Department_Of_Defense_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-07T04:03:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aduro BioTech, Inc. announces the award of a Congressionally Directed Medical Research Programs (CDMRP) grant from the Department of Defense." ;
    ns1:documentTitle "Aduro Awarded CDMRP Grant for Prostate Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aduro-awarded-cdmrp-grant-for-prostate-cancer-vaccine-development> ;
    ns1:foundName "award" ;
    ns1:name "award" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2577162/Aduro_Biotech> ;
    ns1:valueRaw "$ 867,846" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2588827/Investment_Biomedical_Catalyst_Psioxus_Therapeutics_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-06T05:03:26+00:00"^^xsd:dateTime ;
    ns1:documentExtract "(PsiOxus) , a development stage biotechnology company, today announced the award of a Â£1.7 million ($ 2.7 million) grant from the UK government-backed Biomedical Catalyst to initiate a Phase I/II clinical trial to assess the use of in the treatment of platinum-resistant, recurrent ovarian cancer.",
        "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine." ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "award",
        "grant" ;
    ns1:name "award",
        "grant" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2588827/Psioxus_Therapeutics> ;
    ns1:valueRaw "$ 2.7 million",
        "Â£1.7 million",
        "Â£1.7M" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2593583/Amarin_Corporation> a org:Organization ;
    ns1:basedInHighGeoName "Bedminster" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5095528/about.rdf> ;
    ns1:basedInHighRaw "BEDMINSTER, N.J." ;
    ns1:description "Business",
        "commercialization and development of therapeutics to improve cardiovascular health" ;
    ns1:documentDate "2012-12-07T00:03:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amarin Announces $100 Million NonÂ­Equity Financing and Vascepa Sales Force Hiring While Continuing to Assess Strategic Alternatives" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/amarin-announces-100-million-non%C2%ADequity-financing-and-vascepa-sales-force-hiring-while> ;
    ns1:foundName "Amarin",
        "Amarin Corporation plc" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Amarin",
        "Amarin Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/1113107/Amarin_Corporation_Plc>,
        <https://1145.am/db/2281324/Amarin>,
        <https://1145.am/db/2315928/Amarin_Corporation>,
        <https://1145.am/db/2326918/Amarin_Corporation_Plc>,
        <https://1145.am/db/2328007/Amarin_Corporation_Plc>,
        <https://1145.am/db/2339845/Amarin_Corporation_Plc>,
        <https://1145.am/db/2339846/Amarin_Corporation>,
        <https://1145.am/db/2340692/Amarin_Corporation_Plc>,
        <https://1145.am/db/2341866/Amarin>,
        <https://1145.am/db/2350003/Amarin_Corporation_Plc>,
        <https://1145.am/db/2351353/Amarin_Corporation>,
        <https://1145.am/db/2351831/Amarin_Corporation>,
        <https://1145.am/db/2356520/Amarin_Corporation_Plc>,
        <https://1145.am/db/2366345/Amarin_Corporation>,
        <https://1145.am/db/2538031/Amareg> ;
    ns1:sameAsMedium <https://1145.am/db/1637295/Amarin_Corporation>,
        <https://1145.am/db/2303946/Amarin_Corporation>,
        <https://1145.am/db/2310900/Amarin_Corporation>,
        <https://1145.am/db/2311995/Amarin_Corporation>,
        <https://1145.am/db/2324223/Amarin>,
        <https://1145.am/db/2326541/Amarin>,
        <https://1145.am/db/2326577/Amarin_Corporation>,
        <https://1145.am/db/2326585/Amarin_Corporation>,
        <https://1145.am/db/2328009/Amarin_Corporation>,
        <https://1145.am/db/2330799/Amarin_Corporation>,
        <https://1145.am/db/2336625/Amarin>,
        <https://1145.am/db/2369524/Amarin_Corporation>,
        <https://1145.am/db/2561154/Amarin> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2593583/Investment_Amarin_Corporation_Amarin_Corporation_Pharmakon_Advisors_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-07T00:03:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Amarin Announces $ 100 Million NonÂ­Equity Financing and.",
        "BEDMINSTER, N.J., and DUBLIN, Ireland, Dec. 6, 2012 - Amarin Corporation plc (AMRN) , a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health, announced today a $ 100 million nonÂ­equity financing with an investment fund managed by Pharmakon Advisors and that Amarin is continuing its preparations to commercialize Vascepa (R) (icosapent ethyl) capsules with the hiring of a." ;
    ns1:documentTitle "Amarin Announces $100 Million NonÂ­Equity Financing and Vascepa Sales Force Hiring While Continuing to Assess Strategic Alternatives" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/amarin-announces-100-million-non%C2%ADequity-financing-and-vascepa-sales-force-hiring-while> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "stopped" ;
    ns1:target <https://1145.am/db/2593583/Amarin_Corporation> ;
    ns1:targetDetails "non" ;
    ns1:valueRaw "$ 100 Million",
        "$ 100 million" ;
    ns1:when "2012-12-06T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Dec. 6, 2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2593583/Pharmakon_Advisors> a org:Organization ;
    ns1:basedInLowRaw "Ireland" ;
    ns1:description "investment fund" ;
    ns1:documentDate "2012-12-07T00:03:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Amarin Announces $100 Million NonÂ­Equity Financing and Vascepa Sales Force Hiring While Continuing to Assess Strategic Alternatives" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/amarin-announces-100-million-non%C2%ADequity-financing-and-vascepa-sales-force-hiring-while> ;
    ns1:foundName "Pharmakon Advisors" ;
    ns1:name "Pharmakon Advisors" ;
    ns1:participant <https://1145.am/db/2593583/Investment_Amarin_Corporation_Amarin_Corporation_Pharmakon_Advisors_Completed> ;
    ns1:sameAsHigh <https://1145.am/db/1563989/Pharmakon_Advisors_Lp>,
        <https://1145.am/db/2352249/Pharmakon_Advisors> ;
    ns1:sameAsMedium <https://1145.am/db/2344934/Pharmakon_Advisors>,
        <https://1145.am/db/2344939/Pharmakon_Advisers>,
        <https://1145.am/db/694818/Pharmakon_Advisors> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2594303/Somaxon_Pharmaceuticals> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-12-11T14:50:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc." ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/pernix-therapeutics-announces-agreement-to-acquire-somaxon-pharmaceuticals-inc> ;
    ns1:foundName "Somaxon",
        "Somaxon Pharmaceuticals, Inc" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Somaxon Pharmaceuticals" ;
    ns1:protagonist <https://1145.am/db/2594303/Somaxon_Pharmaceuticals_Acquisition> ;
    ns1:sameAsHigh <https://1145.am/db/2155622/Sotio>,
        <https://1145.am/db/2299915/Sosei>,
        <https://1145.am/db/2303792/Somanta_Pharmaceuticals>,
        <https://1145.am/db/2310900/Somaxon_Pharmaceuticals>,
        <https://1145.am/db/2320303/Sucampo_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320312/Sucampo_Pharmaceuticals_Inc>,
        <https://1145.am/db/2323264/Somaxon_Pharmaceuticals>,
        <https://1145.am/db/2326620/Somaxon>,
        <https://1145.am/db/2326623/Somaxon_Pharmaceuticals>,
        <https://1145.am/db/2331217/Somaxon_Pharmaceuticals>,
        <https://1145.am/db/2331928/Somaxon_Pharmaceuticals>,
        <https://1145.am/db/2341631/Somaxon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349483/Somaxon_Pharmaceuticals>,
        <https://1145.am/db/2349497/Somaxon>,
        <https://1145.am/db/2360595/Sucampo_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362558/Sucampo_Ag>,
        <https://1145.am/db/2362560/Sucampo_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363316/Somaxon_Pharmaceuticals>,
        <https://1145.am/db/2547676/Somaxon_Pharmaceuticals>,
        <https://1145.am/db/2575714/Sucampo_Pharmaceuticals>,
        <https://1145.am/db/2584149/Sucampo>,
        <https://1145.am/db/2585586/Sucampo_Pharmaceuticals>,
        <https://1145.am/db/2592871/Sucampo_Pharmaceuticals_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2597020/Dxupclose> a org:Organization ;
    ns1:basedInHighGeoName "Dallas County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4684904/about.rdf> ;
    ns1:basedInHighRaw "DALLAS" ;
    ns1:description "a physician" ;
    ns1:documentDate "2012-08-16T01:10:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Golden Seeds Invests In DxUpClose, Disruptive Technology That Performs An Antibiotic Sensitivity Test At The Patient's Bedside In Less Than An Hour" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/golden-seeds-invests-dxupclose-disruptive-technology-performs-an-antibiotic-sensitivity-test> ;
    ns1:foundName "DxUpClose" ;
    ns1:name "DxUpClose" ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2597020/Series_A_Investment_Dxupclose_Golden_Seeds_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-16T01:10:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "DALLAS, Aug. 15, 2012 /PRNewswire/ - Golden Seeds has invested in a $ 1.0M Series A financing of DxUpClose." ;
    ns1:documentTitle "Golden Seeds Invests In DxUpClose, Disruptive Technology That Performs An Antibiotic Sensitivity Test At The Patient's Bedside In Less Than An Hour" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/golden-seeds-invests-dxupclose-disruptive-technology-performs-an-antibiotic-sensitivity-test> ;
    ns1:foundName "financing",
        "invested" ;
    ns1:name "financing",
        "invested" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2597020/Dxupclose> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 1.0M" ;
    ns1:when "2012-08-15T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Aug. 15, 2012" ;
    ns1:whereGeoName "Dallas County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4684904/about.rdf> ;
    ns1:whereRaw "DALLAS" .

<https://1145.am/db/2654050/Investment_Samsung_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Samsung is pumping $ 4 billion (â‚¬3.2 billion) into expanding the output of a US plant manufacturing logic chips for smartphones and tablets." ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "pumping" ;
    ns1:name "pumping" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 4 billion",
        "â‚¬3.2 billion" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "US" .

<https://1145.am/db/2654050/Magnet_Systems> a org:Organization ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "Magnet Systems" ;
    ns1:industry "enterprise apps" ;
    ns1:name "Magnet Systems" ;
    ns1:sameAsMedium <https://1145.am/db/1838906/Magnet_Systems> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654050/Magnet_Systems_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "HTC will make a $ 35.4 million (â‚¬28.3 million) investment in enterprise apps start up Magnet Systems." ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2654050/Magnet_Systems> ;
    ns1:targetName "Magnet Systems" ;
    ns1:valueRaw "$ 35.4 million",
        "â‚¬28.3 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "US" .

<https://1145.am/db/2654050/Onlive> a org:Organization ;
    ns1:description "gaming" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "OnLive" ;
    ns1:industry "gaming" ;
    ns1:name "OnLive" ;
    ns1:sameAsHigh <https://1145.am/db/1834441/Onlive>,
        <https://1145.am/db/1868477/Onlive> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654050/Scailex> a org:Organization ;
    ns1:basedInHighGeoName "State of Israel" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:basedInHighRaw "Israel" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "Scailex" ;
    ns1:name "Scailex" ;
    ns1:sameAsMedium <https://1145.am/db/2658692/Scailex_Corp>,
        <https://1145.am/db/2672858/Scailex> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654050/Scailex_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Hutchison Whampoa has withdrawn an offer to acquire 75 % of Israeli mobile operator Partner Communications' parent company Scailex, citing factors including a deterioration in Partner's second quarter results." ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "acquire" ;
    ns1:name "acquire" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "stopped" ;
    ns1:target <https://1145.am/db/2654050/Scailex> ;
    ns1:targetName "Scailex" ;
    ns1:whereGeoName "State of Israel" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/294640/about.rdf> ;
    ns1:whereRaw "Israel" .

<https://1145.am/db/2654050/Tudou> a org:Organization ;
    ns1:basedInHighGeoName "Peopleâ€™s Republic of China" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:basedInHighRaw "China" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "Tudou" ;
    ns1:industry "online video" ;
    ns1:name "Tudou" ;
    ns1:sameAsHigh <https://1145.am/db/2178040/Tudou_Holdings>,
        <https://1145.am/db/2668108/Tudou>,
        <https://1145.am/db/2676293/Tudou> ;
    ns1:sameAsMedium <https://1145.am/db/2662465/Tudou>,
        <https://1145.am/db/2674623/Tudou>,
        <https://1145.am/db/2678680/Tudou> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2654050/Tudou_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "China's biggest online video company, Youku, has won shareholder approval to buy second-placed rival Tudou in a share-swap deal." ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "buy" ;
    ns1:name "buy" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2654050/Tudou> ;
    ns1:targetName "Tudou" ;
    ns1:whereGeoName "Peopleâ€™s Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2662018/Bayantel> a org:Organization ;
    ns1:basedInHighGeoName "Republic of the Philippines" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1694008/about.rdf> ;
    ns1:basedInHighRaw "Philippines" ;
    ns1:description "debt" ;
    ns1:documentDate "2012-12-02T20:25:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: iPhone 5 China debut, Bharti tower IPO coming in Dec" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-iphone-5-china-debut-bharti-tower-ipo-coming-dec> ;
    ns1:foundName "BayanTel",
        "BayanTel'" ;
    ns1:name "BayanTel" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2662018/Ideas_Interactivas_Sa> a org:Organization ;
    ns1:basedInLowRaw "Mexico" ;
    ns1:documentDate "2012-12-02T20:25:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: iPhone 5 China debut, Bharti tower IPO coming in Dec" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-iphone-5-china-debut-bharti-tower-ipo-coming-dec> ;
    ns1:foundName "Ideas Interactivas SA" ;
    ns1:name "Ideas Interactivas SA" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2662018/Investment_Bayantel_Globe_Telecom_Ideas_Interactivas_Sa_Worldwide_Directories_Sa_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-02T20:25:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Philippines' Globe Telecom revealed it now owns around 91.6 % of in-rehabilitation BayanTel's outstanding debt, following last month's launch of a tender offer for the notes." ;
    ns1:documentTitle "Webwire: iPhone 5 China debut, Bharti tower IPO coming in Dec" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-iphone-5-china-debut-bharti-tower-ipo-coming-dec> ;
    ns1:foundName "owns",
        "tender offer" ;
    ns1:name "owns",
        "tender offer" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed",
        "stopped" ;
    ns1:target <https://1145.am/db/2662018/Bayantel>,
        <https://1145.am/db/2662018/Ideas_Interactivas_Sa>,
        <https://1145.am/db/2662018/Worldwide_Directories_Sa> ;
    ns1:valueRaw "$ 2.7 billion" ;
    ns1:when "2023-09-21T05:45:37.918492"^^xsd:dateTime,
        "2023-09-21T05:45:39.001561"^^xsd:dateTime,
        "2023-09-21T05:45:39.766715"^^xsd:dateTime ;
    ns1:whenRaw "last month" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2662018/Ipo_Bharti_Infratel_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "ipo" ;
    ns1:documentDate "2012-12-02T20:25:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Bharti Airtel unit Bharti Infratel has set a December 11 start date for its planned IPO - confirming rumors that it will conduct the offer this year." ;
    ns1:documentTitle "Webwire: iPhone 5 China debut, Bharti tower IPO coming in Dec" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-iphone-5-china-debut-bharti-tower-ipo-coming-dec> ;
    ns1:foundName "IPO",
        "offer" ;
    ns1:name "IPO",
        "offer" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:valueRaw "$ 829.3 million",
        "45 billion rupees" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "India" .

<https://1145.am/db/2662018/Worldwide_Directories_Sa> a org:Organization ;
    ns1:basedInLowRaw "Mexico" ;
    ns1:documentDate "2012-12-02T20:25:00+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: iPhone 5 China debut, Bharti tower IPO coming in Dec" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-iphone-5-china-debut-bharti-tower-ipo-coming-dec> ;
    ns1:foundName "Worldwide Directories SA" ;
    ns1:name "Worldwide Directories SA" ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663114/Alcatel-Lucent> a org:Organization ;
    ns1:basedInLowRaw "France" ;
    ns1:description "telecom-equipment" ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:foundName "Alcatel-Lucent" ;
    ns1:industry "telecom-equipment" ;
    ns1:name "Alcatel-Lucent" ;
    ns1:sameAsHigh <https://1145.am/db/1790667/Alcatel-Lucent>,
        <https://1145.am/db/1855135/Alcatel-Lucent>,
        <https://1145.am/db/2174456/Alcatel-Lucent>,
        <https://1145.am/db/2449514/Alcatel-Lucent>,
        <https://1145.am/db/2599088/Alcatel-Lucent>,
        <https://1145.am/db/2599392/Alcatel-Lucent>,
        <https://1145.am/db/2601072/Alcatel-Lucent>,
        <https://1145.am/db/2601506/Alcatel-Lucent>,
        <https://1145.am/db/2602219/Alcatel-Lucent>,
        <https://1145.am/db/2602933/Alcatel-Lucent>,
        <https://1145.am/db/2604986/Alcatel-Lucent>,
        <https://1145.am/db/2604991/Alcatel-Lucent>,
        <https://1145.am/db/2606223/Alcatel-Lucent>,
        <https://1145.am/db/2606495/Alcatel-Lucent>,
        <https://1145.am/db/2606731/Alcatel-Lucent>,
        <https://1145.am/db/2607244/Alcatel-Lucent>,
        <https://1145.am/db/2607408/Alcatel-Lucent>,
        <https://1145.am/db/2609538/Alcatel-Lucent_Enterprise>,
        <https://1145.am/db/2609645/Alcatel-Lucent>,
        <https://1145.am/db/2610550/Alcatel-Lucent>,
        <https://1145.am/db/2610915/Alcatel-Lucent>,
        <https://1145.am/db/2611850/Alcatel-Lucent>,
        <https://1145.am/db/2611855/Alcatel-Lucent>,
        <https://1145.am/db/2613443/Alcatel-Lucent>,
        <https://1145.am/db/2614782/Alcatel-Lucent>,
        <https://1145.am/db/2614789/Alcatel-Lucent>,
        <https://1145.am/db/2614792/Alcatel-Lucent>,
        <https://1145.am/db/2614999/Alcatel-Lucent>,
        <https://1145.am/db/2615500/Alcatel-Lucent>,
        <https://1145.am/db/2620115/Alcatel-Lucent>,
        <https://1145.am/db/2629271/Lucent_Technologies>,
        <https://1145.am/db/2635749/Alcatel-Lucent>,
        <https://1145.am/db/2639975/Alcatel-Lucent>,
        <https://1145.am/db/2648451/Lucent>,
        <https://1145.am/db/2651008/Alcatel-Lucent>,
        <https://1145.am/db/2651521/Alcatel-Lucent>,
        <https://1145.am/db/2651685/Alcatel-Lucent>,
        <https://1145.am/db/2652551/Alcatel-Lucent>,
        <https://1145.am/db/2653427/Alcatel-Lucent>,
        <https://1145.am/db/2654012/Alcatel-Lucent>,
        <https://1145.am/db/2654017/Alcatel-Lucent>,
        <https://1145.am/db/2654155/Alcatel-Lucent>,
        <https://1145.am/db/2654528/Alcatel_Lucent>,
        <https://1145.am/db/2655001/Alcatel-Lucent>,
        <https://1145.am/db/2655372/Alcatel-Lucent>,
        <https://1145.am/db/2655792/Alcatel-Lucent>,
        <https://1145.am/db/2657268/Alcatel-Lucent>,
        <https://1145.am/db/2658200/Alcatel-Lucent>,
        <https://1145.am/db/2658774/Alcatel-Lucent>,
        <https://1145.am/db/2664215/Alcatel-Lucent>,
        <https://1145.am/db/2665703/Alcatel-Lucent>,
        <https://1145.am/db/2665866/Alcatel-Lucent>,
        <https://1145.am/db/2666280/Alcatel-Lucent>,
        <https://1145.am/db/2666307/Alcatel-Lucent>,
        <https://1145.am/db/2666375/Alcatel-Lucent>,
        <https://1145.am/db/2667186/Alcatel-Lucent>,
        <https://1145.am/db/2667452/Alcatel-Lucent>,
        <https://1145.am/db/2667566/Lucent>,
        <https://1145.am/db/2668986/Alcatel-Lucent>,
        <https://1145.am/db/2670547/Alcatel-Lucent>,
        <https://1145.am/db/2670748/Alcatel-Lucent>,
        <https://1145.am/db/2671922/Alcatel-Lucent>,
        <https://1145.am/db/2672864/Alcatel-Lucent>,
        <https://1145.am/db/2673525/Nokia>,
        <https://1145.am/db/2676711/Alcatel-Lucent>,
        <https://1145.am/db/2676997/Alcatel-Lucent>,
        <https://1145.am/db/2677936/Lucent_Technologies>,
        <https://1145.am/db/2679386/Alcatel-Lucent>,
        <https://1145.am/db/2681782/Alcatel-Lucent>,
        <https://1145.am/db/2681832/Lucent>,
        <https://1145.am/db/2681867/Lucent>,
        <https://1145.am/db/2681880/Lucent>,
        <https://1145.am/db/2683040/Alcatel-Lucent>,
        <https://1145.am/db/2684278/Alcatel-Lucent> ;
    ns1:sameAsMedium <https://1145.am/db/1790669/Alcatel-Lucent>,
        <https://1145.am/db/1790693/Alcatel-Lucent>,
        <https://1145.am/db/1795878/Alcatel-Lucent>,
        <https://1145.am/db/1819651/Alcatel-Lucent>,
        <https://1145.am/db/1875987/Alcatel-Lucent>,
        <https://1145.am/db/1885641/Alcatel-Lucent>,
        <https://1145.am/db/2599632/Alcatel-Lucent>,
        <https://1145.am/db/2599798/Alcatel-Lucent>,
        <https://1145.am/db/2600870/Alcatel-Lucent>,
        <https://1145.am/db/2601349/Alcatel-Lucent>,
        <https://1145.am/db/2601537/Alcatel-Lucent>,
        <https://1145.am/db/2601910/Alcatel-Lucent>,
        <https://1145.am/db/2607614/Alcatel-Lucent>,
        <https://1145.am/db/2609611/Alcatel-Lucent>,
        <https://1145.am/db/2609629/Alcatel-Lucent>,
        <https://1145.am/db/2609817/Alcatel-Lucent>,
        <https://1145.am/db/2612045/Alcatel-Lucent>,
        <https://1145.am/db/2612072/Alcatel-Lucent>,
        <https://1145.am/db/2612273/Alcatel-Lucent>,
        <https://1145.am/db/2612583/Alcatel-Lucent>,
        <https://1145.am/db/2612780/Alcatel-Lucent>,
        <https://1145.am/db/2614261/Alcatel-Lucent>,
        <https://1145.am/db/2617770/Alcatel-Lucent>,
        <https://1145.am/db/2624637/Alcatel-Lucent>,
        <https://1145.am/db/2625358/Alcatel-Lucent>,
        <https://1145.am/db/2633937/Alcatel-Lucent>,
        <https://1145.am/db/2636765/Alcatel-Lucent>,
        <https://1145.am/db/2636778/Alcatel-Lucent>,
        <https://1145.am/db/2638547/Alcatel-Lucent>,
        <https://1145.am/db/2641663/Alcatel-Lucent>,
        <https://1145.am/db/2642991/Alcatel-Lucent>,
        <https://1145.am/db/2654238/Alcatel-Lucent>,
        <https://1145.am/db/2655622/Alcatel-Lucent>,
        <https://1145.am/db/2655768/Alcatel-Lucent>,
        <https://1145.am/db/2656166/Alcatel-Lucent>,
        <https://1145.am/db/2656737/Alcatel-Lucent>,
        <https://1145.am/db/2656749/Alcatel-Lucent>,
        <https://1145.am/db/2656808/Alcatel-Lucent>,
        <https://1145.am/db/2656920/Alcatel-Lucent>,
        <https://1145.am/db/2657196/Alcatel-Lucent>,
        <https://1145.am/db/2657902/Alcatel-Lucent>,
        <https://1145.am/db/2659374/Alcatel-Lucent>,
        <https://1145.am/db/2660932/Alcatel-Lucent>,
        <https://1145.am/db/2661927/Alcatel-Lucent>,
        <https://1145.am/db/2663033/Alcatel-Lucent>,
        <https://1145.am/db/2663052/Alcatel-Lucent>,
        <https://1145.am/db/2663073/Alcatel-Lucent>,
        <https://1145.am/db/2663106/Alcatel-Lucent>,
        <https://1145.am/db/2663834/Alcatel-Lucent>,
        <https://1145.am/db/2663941/Alcatel-Lucent>,
        <https://1145.am/db/2664225/Alcatel-Lucent>,
        <https://1145.am/db/2664922/Alcatel-Lucent>,
        <https://1145.am/db/2665201/Alcatel-Lucent>,
        <https://1145.am/db/2665720/Alcatel-Lucent>,
        <https://1145.am/db/2666163/Alcatel-Lucent>,
        <https://1145.am/db/2666346/Alcatel-Lucent>,
        <https://1145.am/db/2666366/Alcatel-Lucent>,
        <https://1145.am/db/2666563/Alcatel-Lucent>,
        <https://1145.am/db/2666729/Alcatel_Lucent>,
        <https://1145.am/db/2666818/Alcatel-Lucent>,
        <https://1145.am/db/2667192/Alcatel-Lucent>,
        <https://1145.am/db/2668257/Alcatel-Lucent>,
        <https://1145.am/db/2668422/Alcatel-Lucent>,
        <https://1145.am/db/2668973/Alcatel-Lucent>,
        <https://1145.am/db/2670204/Alcatel-Lucent>,
        <https://1145.am/db/2670501/Alcatel-Lucent>,
        <https://1145.am/db/2670735/Alcatel-Lucent>,
        <https://1145.am/db/2671140/Alcatel-Lucent>,
        <https://1145.am/db/2671336/Alcatel-Lucent>,
        <https://1145.am/db/2672328/Alcatel-Lucent>,
        <https://1145.am/db/2672337/Alcatel-Lucent>,
        <https://1145.am/db/2672932/Alcatel-Lucent>,
        <https://1145.am/db/2674110/Alcatel_Lucent>,
        <https://1145.am/db/2675256/Alcatel-Lucent>,
        <https://1145.am/db/2678826/Alcatel-Lucent>,
        <https://1145.am/db/2678859/Alcatel-Lucent>,
        <https://1145.am/db/2679013/Alcatel-Lucent>,
        <https://1145.am/db/2679049/Alcatel-Lucent>,
        <https://1145.am/db/2679680/Alcatel-Lucent>,
        <https://1145.am/db/2680847/Alcatel-Lucent>,
        <https://1145.am/db/2681373/Alcatel-Lucent>,
        <https://1145.am/db/2682873/Alcatel-Lucent>,
        <https://1145.am/db/2683818/Alcatel-Lucent> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663114/Bharat_Sanchar_Nigam_Limited> a org:Organization ;
    ns1:basedInHighGeoName "Republic of India" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:basedInHighRaw "India" ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:foundName "Bharat Sanchar Nigam Limited" ;
    ns1:industry "telecoms" ;
    ns1:name "Bharat Sanchar Nigam Limited" ;
    ns1:sameAsHigh <https://1145.am/db/113439/Bharti_Enterprises>,
        <https://1145.am/db/113442/Bharti_Enterprises>,
        <https://1145.am/db/1463048/Bharat_Sanchar_Nigam_Ltd>,
        <https://1145.am/db/1734541/Bharat_Sanchar_Nigam_Ltd>,
        <https://1145.am/db/1744789/Bharti_Airtel>,
        <https://1145.am/db/1745775/Airtel>,
        <https://1145.am/db/1748902/Bharti_Airtel>,
        <https://1145.am/db/1748912/Bharti_Airtel>,
        <https://1145.am/db/1748945/Bharti_Airtel>,
        <https://1145.am/db/1806742/Bharti_Airtel>,
        <https://1145.am/db/2029400/Bharat_Sanchar_Nigam_Ltd>,
        <https://1145.am/db/238604/Bharti_Airtel>,
        <https://1145.am/db/238604/Bharti_Telemedia>,
        <https://1145.am/db/2614344/Bharti_Airtel_Of_India>,
        <https://1145.am/db/2633079/Bharti_Airtel>,
        <https://1145.am/db/2634583/Bharti_Airtel>,
        <https://1145.am/db/2638371/Bharti>,
        <https://1145.am/db/2651425/Bharti_Airtel>,
        <https://1145.am/db/2656675/Bharti_Airtel>,
        <https://1145.am/db/2656714/Bharti_Airtel>,
        <https://1145.am/db/2658686/Bharti_Airtel>,
        <https://1145.am/db/2658717/Bharti_Airtel>,
        <https://1145.am/db/2658742/Bharti_Airtel>,
        <https://1145.am/db/2659732/Bharti_Airtel>,
        <https://1145.am/db/2660738/Bharti_Airtel>,
        <https://1145.am/db/2663499/Bharti_Airtel>,
        <https://1145.am/db/2666346/Bharti_Airtel>,
        <https://1145.am/db/2666435/Airtel>,
        <https://1145.am/db/2667276/Bharti_Airtel>,
        <https://1145.am/db/2669143/Bharti_Airtel>,
        <https://1145.am/db/2670169/Bharti_Airtel>,
        <https://1145.am/db/2670586/Bharti_Airtel>,
        <https://1145.am/db/2671989/Bharti_Tele-Ventures>,
        <https://1145.am/db/2674025/Bharti_Airtel>,
        <https://1145.am/db/2675191/Bharti_Airtel>,
        <https://1145.am/db/2676473/Bharti>,
        <https://1145.am/db/667717/Airtel>,
        <https://1145.am/db/667717/Bharti_Airtel_Ltd>,
        <https://1145.am/db/668095/Bharti_Airtel_Ltd>,
        <https://1145.am/db/789532/Bharti_Airtel>,
        <https://1145.am/db/815876/Airtel>,
        <https://1145.am/db/815876/Bharti_Airtel_Ltd>,
        <https://1145.am/db/859850/Bharti_Airtel_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/2603144/Bharat_Sanchar_Nigam> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663114/Bharat_Sanchar_Nigam_Limited_Investment> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "The Dubai telecom operator Du has secured a $ 100 million loan from Singapore - based DBS bank in order to upgrade its network performance." ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:foundName "loan" ;
    ns1:name "loan" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2663114/Bharat_Sanchar_Nigam_Limited>,
        <https://1145.am/db/2663114/Du> ;
    ns1:targetName "Bharat Sanchar Nigam Limited" ;
    ns1:valueRaw "$ 100 million" ;
    ns1:whereGeoName "Republic of India" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1269750/about.rdf> ;
    ns1:whereRaw "Alcatel-Lucent",
        "India" .

<https://1145.am/db/2663114/Cisco_Systems> a org:Organization ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:foundName "Cisco Systems" ;
    ns1:name "Cisco Systems" ;
    ns1:sameAsMedium <https://1145.am/db/1490110/Cisco_Systems_Inc>,
        <https://1145.am/db/1840587/Cisco_Systems>,
        <https://1145.am/db/1889137/Cisco_Systems>,
        <https://1145.am/db/1898789/Cisco_Systems>,
        <https://1145.am/db/1909651/Cisco_Systems>,
        <https://1145.am/db/2002180/Cisco_Systems>,
        <https://1145.am/db/2122942/Cisco_Systems_Inc>,
        <https://1145.am/db/2126585/Cisco_Systems>,
        <https://1145.am/db/2158523/Cisco_Systems>,
        <https://1145.am/db/2158723/Cisco_Systems>,
        <https://1145.am/db/2162137/Cisco_Systems>,
        <https://1145.am/db/2167172/Cisco_Systems>,
        <https://1145.am/db/2169056/Cisco_Systems>,
        <https://1145.am/db/2174824/Cisco_Systems>,
        <https://1145.am/db/2206678/Cisco_Systems>,
        <https://1145.am/db/2604048/Cisco_Systems>,
        <https://1145.am/db/2605152/Cisco_Systems>,
        <https://1145.am/db/2607799/Cisco_Systems>,
        <https://1145.am/db/2610767/Cisco_Systems>,
        <https://1145.am/db/2614475/Cisco_Systems>,
        <https://1145.am/db/2617515/Cisco_Systems>,
        <https://1145.am/db/2639642/Cisco_Systems>,
        <https://1145.am/db/2640421/Cisco_Systems>,
        <https://1145.am/db/2641974/Cisco_Systems>,
        <https://1145.am/db/2642480/Cisco_Systems>,
        <https://1145.am/db/2643009/Cisco_Systems>,
        <https://1145.am/db/2643485/Cisco_Systems>,
        <https://1145.am/db/2646084/Cisco_Systems>,
        <https://1145.am/db/2659244/Cisco_Systems>,
        <https://1145.am/db/2662813/Cisco_Systems>,
        <https://1145.am/db/2666106/Cisco_Systems>,
        <https://1145.am/db/2668684/Cisco_Systems>,
        <https://1145.am/db/2671842/Cisco_Systems>,
        <https://1145.am/db/2675541/Cisco_Systems>,
        <https://1145.am/db/2682445/Cisco_Systems>,
        <https://1145.am/db/2683381/Cisco_Systems>,
        <https://1145.am/db/2791898/Cisco_Systems>,
        <https://1145.am/db/366647/Cisco_Systems_Inc>,
        <https://1145.am/db/823548/Cisco_Systems_Inc> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663114/Du> a org:Organization ;
    ns1:basedInHighGeoName "Dubai" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/292223/about.rdf> ;
    ns1:basedInHighRaw "Dubai" ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:foundName "Du" ;
    ns1:industry "telecom" ;
    ns1:name "Du" ;
    ns1:sameAsHigh <https://1145.am/db/2677134/Du> ;
    ns1:sameAsMedium <https://1145.am/db/2163038/Du> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663114/Linksys> a org:Organization ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:foundName "Linksys" ;
    ns1:name "Linksys" ;
    ns1:sameAsMedium <https://1145.am/db/2612021/Linksys>,
        <https://1145.am/db/2616548/Linksys>,
        <https://1145.am/db/2645183/Linksys> ;
    ns1:sourceName "Fierce Wireless" .

<https://1145.am/db/2663114/Linksys_Unit_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2012-12-17T03:28:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cisco Systems has hired Barclays to sell its Linksys home router unit, which the networking giant acquired for $ 500 million in 2003." ;
    ns1:documentTitle "Webwire: UK rejects automatic block on internet porn" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-uk-rejects-automatic-block-internet-porn> ;
    ns1:foundName "sell" ;
    ns1:name "sell" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2663114/Linksys> ;
    ns1:targetDetails "unit" ;
    ns1:targetName "Linksys" ;
    ns1:vendor <https://1145.am/db/2663114/Cisco_Systems> .

<https://1145.am/db/2306436/Paragon_Biomedical> a org:Organization ;
    ns1:documentDate "2012-10-28T22:51:14+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clinipace raises $9M to staff up after acquisition" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/clinipace-raises-9m-to-staff-up-after-acquisition> ;
    ns1:foundName "Paragon Biomedical" ;
    ns1:name "Paragon Biomedical" ;
    ns1:sameAsMedium <https://1145.am/db/2305367/Paragon_Biomedical>,
        <https://1145.am/db/2305368/Paragon_Biomedical>,
        <https://1145.am/db/2320262/Paragon_Biomedical>,
        <https://1145.am/db/2363181/Paragon_Biomedical>,
        <https://1145.am/db/2364127/Paragon_Biomedical_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2306436/Paragon_Biomedical_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2012-10-28T22:51:14+00:00"^^xsd:dateTime ;
    ns1:documentExtract "A month after doubling in size with its buyout of Paragon Biomedical, Clinipace has raised $ 9 million to flesh out its workforce." ;
    ns1:documentTitle "Clinipace raises $9M to staff up after acquisition" ;
    ns1:documentURL <https://www.fiercebiotech.com/r-d/clinipace-raises-9m-to-staff-up-after-acquisition> ;
    ns1:foundName "buyout",
        "raised" ;
    ns1:name "buyout",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2306436/Paragon_Biomedical> ;
    ns1:targetName "Paragon Biomedical" ;
    ns1:valueRaw "$ 9 million" .

<https://1145.am/db/2331148/Complete_Genomics_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2012-09-17T13:27:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "A BGI affiliate is offering Complete Genomics $ 30 million in bridge financing to support its operations after the buyout deal, which is expected to wrap up early next year.",
        "China - based BGI plans to scoop up Mountain View, CA - based Complete for $ 3.15 per share in cash as part of a move that would expand the company's U.S. footprint." ;
    ns1:documentTitle "China's BGI strikes deal to buy Complete Genomics for $117.6M" ;
    ns1:documentURL <https://www.fiercebiotech.com/data-management/china-s-bgi-strikes-deal-to-buy-complete-genomics-for-117-6m> ;
    ns1:foundName "buyout",
        "financing",
        "scoop",
        "scoop up" ;
    ns1:name "buyout",
        "financing",
        "scoop",
        "scoop up" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2331148/Complete_Genomics> ;
    ns1:targetName "Complete Genomics" ;
    ns1:valueRaw "$ 30 million" ;
    ns1:whereGeoName "Peopleâ€™s Republic of China" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1814991/about.rdf> ;
    ns1:whereRaw "China" .

<https://1145.am/db/2332322/5am_Ventures> a org:Organization ;
    ns1:basedInLowRaw "RADNOR, Pa" ;
    ns1:documentDate "2012-08-27T22:01:21+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/novira-therapeutics-secures-23-million-series-a-financing-to-advance-development-of> ;
    ns1:foundName "5AM Ventures" ;
    ns1:investor <https://1145.am/db/2332322/Series_A_Investment_5am_Ventures_Bioadvance_Canaan_Partners_Delaware_Crossing_Investment_Group_Mid-Atlantic_Angel_Group_Novira_Therapeutics_Inc_Robin_Hood_Ventures_Wuxi_Pharmatech_Completed> ;
    ns1:name "5AM Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1157541/5am_Ventures>,
        <https://1145.am/db/1533327/5am_Ventures>,
        <https://1145.am/db/1533685/5am_Ventures>,
        <https://1145.am/db/1608803/5am_Ventures>,
        <https://1145.am/db/1669813/5am_Ventures>,
        <https://1145.am/db/2152422/5am_Ventures>,
        <https://1145.am/db/2153726/5am_Ventures>,
        <https://1145.am/db/2153910/5am_Ventures>,
        <https://1145.am/db/2283394/5am_Ventures>,
        <https://1145.am/db/2286204/5am_Ventures>,
        <https://1145.am/db/2286665/5am_Ventures>,
        <https://1145.am/db/2288016/5am_Ventures>,
        <https://1145.am/db/2298404/5am_Ventures>,
        <https://1145.am/db/2298642/5am_Ventures>,
        <https://1145.am/db/2306549/5am_Ventures>,
        <https://1145.am/db/2306551/5am_Ventures>,
        <https://1145.am/db/2306754/5am_Ventures>,
        <https://1145.am/db/2311595/5am_Ventures>,
        <https://1145.am/db/2313985/5am_Ventures>,
        <https://1145.am/db/2317919/5am_Ventures>,
        <https://1145.am/db/2318733/5am_Ventures>,
        <https://1145.am/db/2319784/5am_Ventures>,
        <https://1145.am/db/2322646/5am_Ventures>,
        <https://1145.am/db/2323210/5am_Ventures>,
        <https://1145.am/db/2323226/5am_Ventures>,
        <https://1145.am/db/2324195/5am_Ventures>,
        <https://1145.am/db/2328146/5am_Ventures>,
        <https://1145.am/db/2328338/5am_Ventures>,
        <https://1145.am/db/2329778/5am_Ventures>,
        <https://1145.am/db/2339885/5am_Ventures>,
        <https://1145.am/db/2339886/5am_Ventures>,
        <https://1145.am/db/2340344/5am_Ventures>,
        <https://1145.am/db/2340345/5am_Ventures>,
        <https://1145.am/db/2340348/5am_Ventures>,
        <https://1145.am/db/2341003/5am_Ventures>,
        <https://1145.am/db/2342352/5am_Ventures>,
        <https://1145.am/db/2347885/5am_Ventures>,
        <https://1145.am/db/2348754/5am_Ventures>,
        <https://1145.am/db/2348857/5am_Ventures>,
        <https://1145.am/db/2349120/5am_Ventures>,
        <https://1145.am/db/2349834/5am_Ventures>,
        <https://1145.am/db/2351316/5am_Ventures>,
        <https://1145.am/db/2351683/5am_Ventures>,
        <https://1145.am/db/2351684/5am_Ventures>,
        <https://1145.am/db/2354296/5am_Ventures>,
        <https://1145.am/db/2355238/5am_Ventures>,
        <https://1145.am/db/2357858/5am_Ventures>,
        <https://1145.am/db/2359401/5am_Ventures>,
        <https://1145.am/db/2359864/5am_Ventures>,
        <https://1145.am/db/2360174/5am_Ventures>,
        <https://1145.am/db/2360415/5am_Ventures>,
        <https://1145.am/db/2362475/5am_Ventures>,
        <https://1145.am/db/2362481/5am_Ventures>,
        <https://1145.am/db/2364492/5am_Ventures>,
        <https://1145.am/db/2367275/5am_Ventures>,
        <https://1145.am/db/2370609/5am_Ventures>,
        <https://1145.am/db/2371160/5am_Ventures>,
        <https://1145.am/db/2371163/5am_Ventures>,
        <https://1145.am/db/2538476/5am_Ventures>,
        <https://1145.am/db/2569220/5am_Ventures>,
        <https://1145.am/db/2572398/5am_Ventures>,
        <https://1145.am/db/2587596/5am_Ventures>,
        <https://1145.am/db/2592685/5am_Ventures>,
        <https://1145.am/db/359190/5am_Ventures>,
        <https://1145.am/db/428737/5am_Ventures>,
        <https://1145.am/db/509733/5am_Ventures>,
        <https://1145.am/db/558016/5am_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333119/23andme> a org:Organization ;
    ns1:description "genetic testing" ;
    ns1:documentDate "2012-12-16T22:22:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "23andMe",
        "23andMe, Inc." ;
    ns1:name "23andMe" ;
    ns1:sameAsHigh <https://1145.am/db/1759743/23andme>,
        <https://1145.am/db/1779452/23andme>,
        <https://1145.am/db/1782707/23andme>,
        <https://1145.am/db/2328937/23andme>,
        <https://1145.am/db/2339211/23andme>,
        <https://1145.am/db/2369462/23andme> ;
    ns1:sameAsMedium <https://1145.am/db/1696213/23andme_Inc>,
        <https://1145.am/db/1744418/23andme>,
        <https://1145.am/db/1781939/23andme>,
        <https://1145.am/db/1849926/23andme>,
        <https://1145.am/db/1860471/23andme>,
        <https://1145.am/db/1883008/23andme>,
        <https://1145.am/db/1903870/23andme>,
        <https://1145.am/db/1911282/23andme>,
        <https://1145.am/db/1913407/23andme>,
        <https://1145.am/db/2186924/23andme>,
        <https://1145.am/db/2190169/23andme>,
        <https://1145.am/db/2198393/23andme>,
        <https://1145.am/db/223200/23andme>,
        <https://1145.am/db/2285807/23andme>,
        <https://1145.am/db/2292884/23andme>,
        <https://1145.am/db/2315221/23andme>,
        <https://1145.am/db/2316189/23andme>,
        <https://1145.am/db/2317424/23andme>,
        <https://1145.am/db/2317430/23andme>,
        <https://1145.am/db/2318638/23andme>,
        <https://1145.am/db/2322873/23andme>,
        <https://1145.am/db/2328266/23andme>,
        <https://1145.am/db/2328936/23andme>,
        <https://1145.am/db/2329513/23andme>,
        <https://1145.am/db/2333116/23andme>,
        <https://1145.am/db/2335410/23andme>,
        <https://1145.am/db/2335722/23andme>,
        <https://1145.am/db/2335726/23andme>,
        <https://1145.am/db/2341568/23andme>,
        <https://1145.am/db/2344024/23andme>,
        <https://1145.am/db/2350327/23andme>,
        <https://1145.am/db/2356396/23andme>,
        <https://1145.am/db/2361472/23andme>,
        <https://1145.am/db/2368057/23andme>,
        <https://1145.am/db/2368432/23andme>,
        <https://1145.am/db/2368434/23andme>,
        <https://1145.am/db/2541350/23andme>,
        <https://1145.am/db/264973/23andme>,
        <https://1145.am/db/567026/23andme> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333119/Mpm_Capital> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-12-16T22:22:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "MPM",
        "MPM Capital" ;
    ns1:investor <https://1145.am/db/2333119/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Sergey_Brin_Yuri_Milner_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2345318/Mpm_Capital>,
        <https://1145.am/db/2346204/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2347984/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2350030/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2356396/Mpm_Capital>,
        <https://1145.am/db/2358979/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2362871/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2366744/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2369202/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333119/Sergey_Brin> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:description "Google Ventures" ;
    ns1:documentDate "2012-12-16T22:22:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "Sergey Brin" ;
    ns1:investor <https://1145.am/db/2333119/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Sergey_Brin_Yuri_Milner_Completed> ;
    ns1:name "Sergey Brin" ;
    ns1:sameAsHigh <https://1145.am/db/2333119/Yuri_Milner>,
        <https://1145.am/db/2356396/Yuri_Milner> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2333119/Yuri_Milner> a org:Organization ;
    ns1:basedInLowRaw "Calif",
        "MOUNTAIN VIEW, Calif" ;
    ns1:description "Google Ventures" ;
    ns1:documentDate "2012-12-16T22:22:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "Yuri",
        "Yuri Milner" ;
    ns1:investor <https://1145.am/db/2333119/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Sergey_Brin_Yuri_Milner_Completed> ;
    ns1:name "Yuri",
        "Yuri Milner" ;
    ns1:sameAsHigh <https://1145.am/db/2333119/Sergey_Brin>,
        <https://1145.am/db/2356396/Yuri_Milner> ;
    ns1:sameAsMedium <https://1145.am/db/1792284/Yuri_Milner>,
        <https://1145.am/db/1795658/Yuri_Milner>,
        <https://1145.am/db/1818901/Yuri_Milner>,
        <https://1145.am/db/1834604/Yuri_Milner>,
        <https://1145.am/db/1861010/Yuri_Milner>,
        <https://1145.am/db/1865235/Yuri_Milner>,
        <https://1145.am/db/1872766/Yuri_Milner>,
        <https://1145.am/db/1873680/Yuri_Milner>,
        <https://1145.am/db/1881980/Yuri_Milner>,
        <https://1145.am/db/1891907/Yuri_Milner>,
        <https://1145.am/db/2211610/Yuri_Milner>,
        <https://1145.am/db/2211653/Yuri_Milner>,
        <https://1145.am/db/2359655/Yuri_Milner> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2334847/Blend_Therapeutics> a org:Organization ;
    ns1:description "product development" ;
    ns1:documentDate "2012-12-18T21:04:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/blend-therapeutics-closes-16-million-series-b-financing> ;
    ns1:foundName "Blend Therapeutics",
        "Blend Therapeutics, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Blend Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2334846/Blend_Therapeutics>,
        <https://1145.am/db/2334848/Blend_Therapeutics>,
        <https://1145.am/db/2343790/Blend_Therapeutics>,
        <https://1145.am/db/2346070/Blend_Therapeutics>,
        <https://1145.am/db/2347141/Blend_Therapeutics>,
        <https://1145.am/db/2355059/Blend_Therapeutics>,
        <https://1145.am/db/2358506/Blend_Therapeutics>,
        <https://1145.am/db/2358529/Blend_Therapeutics>,
        <https://1145.am/db/2359572/Blend_Therapeutics>,
        <https://1145.am/db/2594764/Blend_Therapeutics>,
        <https://1145.am/db/2594773/Blend_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2346069/Blend_Therapeutics>,
        <https://1145.am/db/2347111/Blend_Therapeutics>,
        <https://1145.am/db/2355058/Blend_Therapeutics>,
        <https://1145.am/db/2358536/Blend_Therapeutics>,
        <https://1145.am/db/2370873/Blend_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336503/Aisling_Capital> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:06:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-1> ;
    ns1:foundName "Aisling Capital" ;
    ns1:investor <https://1145.am/db/2336503/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "Aisling Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1334160/Aisling_Capital>,
        <https://1145.am/db/1334934/Aisling_Capital>,
        <https://1145.am/db/1665536/Aisling_Capital>,
        <https://1145.am/db/2280707/Aisling_Capital>,
        <https://1145.am/db/2291277/Aisling_Capital>,
        <https://1145.am/db/2292103/Aisling_Capital>,
        <https://1145.am/db/2292800/Aisling_Capital>,
        <https://1145.am/db/2294156/Aisling_Capital>,
        <https://1145.am/db/2297408/Aisling_Capital>,
        <https://1145.am/db/2307476/Aisling_Capital>,
        <https://1145.am/db/2310940/Aisling_Capital>,
        <https://1145.am/db/2317775/Aisling_Capital>,
        <https://1145.am/db/2319433/Aisling_Capital>,
        <https://1145.am/db/2320852/Aisling_Capital>,
        <https://1145.am/db/2320853/Aisling_Capital>,
        <https://1145.am/db/2324244/Aisling_Capital>,
        <https://1145.am/db/2324255/Aisling_Capital>,
        <https://1145.am/db/2325553/Aisling_Capital>,
        <https://1145.am/db/2326576/Aisling_Capital>,
        <https://1145.am/db/2328388/Aisling_Capital>,
        <https://1145.am/db/2332753/Aisling_Capital>,
        <https://1145.am/db/2336505/Aisling_Capital>,
        <https://1145.am/db/2336524/Aisling_Capital>,
        <https://1145.am/db/2337250/Aisling_Capital>,
        <https://1145.am/db/2337254/Aisling_Capital>,
        <https://1145.am/db/2339214/Aisling_Capital>,
        <https://1145.am/db/2339223/Aisling_Capital>,
        <https://1145.am/db/2341595/Aisling_Capital>,
        <https://1145.am/db/2341599/Aisling_Capital>,
        <https://1145.am/db/2344735/Aisling_Capital>,
        <https://1145.am/db/2344739/Aisling_Capital>,
        <https://1145.am/db/2344874/Aisling_Capital>,
        <https://1145.am/db/2346030/Aisling_Capital>,
        <https://1145.am/db/2346293/Aisling_Capital>,
        <https://1145.am/db/2348754/Aisling_Capital>,
        <https://1145.am/db/2352059/Aisling_Capital>,
        <https://1145.am/db/2352167/Aisling_Capital>,
        <https://1145.am/db/2352170/Aisling_Capital>,
        <https://1145.am/db/2356297/Aisling_Capital>,
        <https://1145.am/db/2357356/Aisling_Capital>,
        <https://1145.am/db/2359185/Aisling_Capital>,
        <https://1145.am/db/2359468/Aisling_Capital>,
        <https://1145.am/db/2362736/Aisling_Capital>,
        <https://1145.am/db/2362737/Aisling_Capital>,
        <https://1145.am/db/2367022/Aisling_Capital>,
        <https://1145.am/db/2367023/Aisling_Capital>,
        <https://1145.am/db/2369304/Aisling_Capital>,
        <https://1145.am/db/2369305/Aisling_Capital>,
        <https://1145.am/db/2539913/Aisling_Capital>,
        <https://1145.am/db/2583013/Aisling_Capital>,
        <https://1145.am/db/2588372/Aisling_Capital>,
        <https://1145.am/db/2591606/Aisling_Capital>,
        <https://1145.am/db/802321/Aisling_Capital>,
        <https://1145.am/db/803398/Aisling_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336505/Aisling_Capital> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:29:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-0> ;
    ns1:foundName "Aisling Capital" ;
    ns1:investor <https://1145.am/db/2336505/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "Aisling Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1334160/Aisling_Capital>,
        <https://1145.am/db/1334934/Aisling_Capital>,
        <https://1145.am/db/1665536/Aisling_Capital>,
        <https://1145.am/db/2280707/Aisling_Capital>,
        <https://1145.am/db/2291277/Aisling_Capital>,
        <https://1145.am/db/2292103/Aisling_Capital>,
        <https://1145.am/db/2292800/Aisling_Capital>,
        <https://1145.am/db/2294156/Aisling_Capital>,
        <https://1145.am/db/2297408/Aisling_Capital>,
        <https://1145.am/db/2307476/Aisling_Capital>,
        <https://1145.am/db/2310940/Aisling_Capital>,
        <https://1145.am/db/2317775/Aisling_Capital>,
        <https://1145.am/db/2319433/Aisling_Capital>,
        <https://1145.am/db/2320852/Aisling_Capital>,
        <https://1145.am/db/2320853/Aisling_Capital>,
        <https://1145.am/db/2324244/Aisling_Capital>,
        <https://1145.am/db/2324255/Aisling_Capital>,
        <https://1145.am/db/2325553/Aisling_Capital>,
        <https://1145.am/db/2326576/Aisling_Capital>,
        <https://1145.am/db/2328388/Aisling_Capital>,
        <https://1145.am/db/2332753/Aisling_Capital>,
        <https://1145.am/db/2336503/Aisling_Capital>,
        <https://1145.am/db/2336524/Aisling_Capital>,
        <https://1145.am/db/2337250/Aisling_Capital>,
        <https://1145.am/db/2337254/Aisling_Capital>,
        <https://1145.am/db/2339214/Aisling_Capital>,
        <https://1145.am/db/2339223/Aisling_Capital>,
        <https://1145.am/db/2341595/Aisling_Capital>,
        <https://1145.am/db/2341599/Aisling_Capital>,
        <https://1145.am/db/2344735/Aisling_Capital>,
        <https://1145.am/db/2344739/Aisling_Capital>,
        <https://1145.am/db/2344874/Aisling_Capital>,
        <https://1145.am/db/2346030/Aisling_Capital>,
        <https://1145.am/db/2346293/Aisling_Capital>,
        <https://1145.am/db/2348754/Aisling_Capital>,
        <https://1145.am/db/2352059/Aisling_Capital>,
        <https://1145.am/db/2352167/Aisling_Capital>,
        <https://1145.am/db/2352170/Aisling_Capital>,
        <https://1145.am/db/2356297/Aisling_Capital>,
        <https://1145.am/db/2357356/Aisling_Capital>,
        <https://1145.am/db/2359185/Aisling_Capital>,
        <https://1145.am/db/2359468/Aisling_Capital>,
        <https://1145.am/db/2362736/Aisling_Capital>,
        <https://1145.am/db/2362737/Aisling_Capital>,
        <https://1145.am/db/2367022/Aisling_Capital>,
        <https://1145.am/db/2367023/Aisling_Capital>,
        <https://1145.am/db/2369304/Aisling_Capital>,
        <https://1145.am/db/2369305/Aisling_Capital>,
        <https://1145.am/db/2539913/Aisling_Capital>,
        <https://1145.am/db/2583013/Aisling_Capital>,
        <https://1145.am/db/2588372/Aisling_Capital>,
        <https://1145.am/db/2591606/Aisling_Capital>,
        <https://1145.am/db/802321/Aisling_Capital>,
        <https://1145.am/db/803398/Aisling_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337566/Investment_Emerging_Technology_Fund_Invivo_Therapeutics_Massdevelopment_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-10T04:01:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "InVivo Therapeutics Awarded $ 2 Million Loan from MassDevelopment.",
        "announced today that MassDevelopment has awarded InVivo Therapeutics a $ 2 million loan from its Emerging Technology Fund to help fund the commercialization of InVivo's groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions." ;
    ns1:documentTitle "InVivo Therapeutics Awarded $2 Million Loan from MassDevelopment" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/invivo-therapeutics-awarded-2-million-loan-from-massdevelopment> ;
    ns1:foundName "Loan",
        "loan" ;
    ns1:name "Loan",
        "loan" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2337566/Invivo_Therapeutics> ;
    ns1:valueRaw "$ 2 Million",
        "$ 2 million" ;
    ns1:whereGeoName "Massachusetts" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6254926/about.rdf> ;
    ns1:whereRaw "Massachusetts" .

<https://1145.am/db/2337571/Auriga_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "Auriga Partners" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Auriga Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1100576/Auriga_Partners>,
        <https://1145.am/db/1830238/Auriga_Partners>,
        <https://1145.am/db/1838206/Auriga_Partners>,
        <https://1145.am/db/1892410/Auriga_Partners>,
        <https://1145.am/db/1894754/Auriga_Partners>,
        <https://1145.am/db/2313425/Auriga_Partners>,
        <https://1145.am/db/2315271/Auriga_Partners>,
        <https://1145.am/db/2315279/Auriga_Partners>,
        <https://1145.am/db/2323700/Auriga_Partners>,
        <https://1145.am/db/2323705/Auriga_Partners>,
        <https://1145.am/db/2331763/Auriga_Partners>,
        <https://1145.am/db/2337577/Auriga_Partners>,
        <https://1145.am/db/2365296/Auriga_Partners>,
        <https://1145.am/db/2546216/Auriga_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/Cycad_Group> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "Cycad Group" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Cycad Group" ;
    ns1:sameAsMedium <https://1145.am/db/2292582/Cycad_Group>,
        <https://1145.am/db/2331763/Cycad_Group>,
        <https://1145.am/db/2337294/Cycad_Group>,
        <https://1145.am/db/2337577/Cycad_Group>,
        <https://1145.am/db/2337976/Cycad_Group>,
        <https://1145.am/db/2348350/Cycad_Group>,
        <https://1145.am/db/2349437/Cycad_Group>,
        <https://1145.am/db/2365296/Cycad_Group>,
        <https://1145.am/db/2546216/Cycad_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/Johnson___Johnson_Development_Corporation> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "Johnson & Johnson Development Corporation" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Johnson & Johnson Development Corporation" ;
    ns1:sameAsMedium <https://1145.am/db/1883008/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2291836/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292334/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292345/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292353/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292975/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2299864/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2300306/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2300455/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2303009/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2306163/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308781/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308791/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311069/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311075/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316619/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316624/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2317934/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2321856/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327212/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327227/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336890/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336943/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2337577/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338236/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338237/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338527/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2341478/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344597/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344605/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2346978/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2350327/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352357/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352361/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2356290/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358640/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358657/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358658/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358812/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2361581/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2363907/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364457/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364458/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2365296/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2546216/Johnson___Johnson_Development_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/Morningside> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "Morningside" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Morningside" ;
    ns1:sameAsMedium <https://1145.am/db/1297950/Morningside>,
        <https://1145.am/db/1298919/Morningside>,
        <https://1145.am/db/1394919/Morningside>,
        <https://1145.am/db/1770139/Morningside>,
        <https://1145.am/db/1783536/Morningside>,
        <https://1145.am/db/2293980/Morningside>,
        <https://1145.am/db/2337577/Morningside>,
        <https://1145.am/db/2344604/Morningside>,
        <https://1145.am/db/2350231/Morningside>,
        <https://1145.am/db/2546216/Morningside>,
        <https://1145.am/db/514081/Morningside>,
        <https://1145.am/db/514914/Morningside>,
        <https://1145.am/db/586002/Morningside>,
        <https://1145.am/db/606235/Morningside>,
        <https://1145.am/db/775019/Morningside> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/Mp_Healthcare_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "MP Healthcare Ventures" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "MP Healthcare Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2337577/Mp_Healthcare_Ventures>,
        <https://1145.am/db/2363938/Mp_Healthcare_Venture>,
        <https://1145.am/db/2363941/Mp_Healthcare_Venture>,
        <https://1145.am/db/2365103/Mp_Healthcare_Venture>,
        <https://1145.am/db/2546216/Mp_Healthcare_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/Skyline_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "Skyline Ventures" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Skyline Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2300653/Skyline_Ventures>,
        <https://1145.am/db/2303098/Skyline_Ventures>,
        <https://1145.am/db/2303598/Skyline_Ventures>,
        <https://1145.am/db/2305791/Skyline_Ventures>,
        <https://1145.am/db/2308925/Skyline_Ventures>,
        <https://1145.am/db/2308931/Skyline_Ventures>,
        <https://1145.am/db/2313305/Skyline_Ventures>,
        <https://1145.am/db/2313306/Skyline_Ventures>,
        <https://1145.am/db/2337577/Skyline_Ventures>,
        <https://1145.am/db/2340204/Skyline_Ventures>,
        <https://1145.am/db/2340207/Skyline_Ventures>,
        <https://1145.am/db/2349753/Skyline_Ventures>,
        <https://1145.am/db/2353439/Skyline_Ventures>,
        <https://1145.am/db/2355586/Skyline_Ventures>,
        <https://1145.am/db/2359287/Skyline_Ventures>,
        <https://1145.am/db/2365296/Skyline_Ventures>,
        <https://1145.am/db/2546216/Skyline_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Auriga_Partners> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Auriga Partners" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Auriga Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1100576/Auriga_Partners>,
        <https://1145.am/db/1830238/Auriga_Partners>,
        <https://1145.am/db/1838206/Auriga_Partners>,
        <https://1145.am/db/1892410/Auriga_Partners>,
        <https://1145.am/db/1894754/Auriga_Partners>,
        <https://1145.am/db/2313425/Auriga_Partners>,
        <https://1145.am/db/2315271/Auriga_Partners>,
        <https://1145.am/db/2315279/Auriga_Partners>,
        <https://1145.am/db/2323700/Auriga_Partners>,
        <https://1145.am/db/2323705/Auriga_Partners>,
        <https://1145.am/db/2331763/Auriga_Partners>,
        <https://1145.am/db/2337571/Auriga_Partners>,
        <https://1145.am/db/2365296/Auriga_Partners>,
        <https://1145.am/db/2546216/Auriga_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Cycad_Group> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Cycad Group" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Cycad Group" ;
    ns1:sameAsMedium <https://1145.am/db/2292582/Cycad_Group>,
        <https://1145.am/db/2331763/Cycad_Group>,
        <https://1145.am/db/2337294/Cycad_Group>,
        <https://1145.am/db/2337571/Cycad_Group>,
        <https://1145.am/db/2337976/Cycad_Group>,
        <https://1145.am/db/2348350/Cycad_Group>,
        <https://1145.am/db/2349437/Cycad_Group>,
        <https://1145.am/db/2365296/Cycad_Group>,
        <https://1145.am/db/2546216/Cycad_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Johnson___Johnson_Development_Corporation> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Johnson & Johnson Development Corporation" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Johnson & Johnson Development Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/1118732/Johnson___Johnson_Innovation>,
        <https://1145.am/db/1553175/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/1553459/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/1620209/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/2095032/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2196895/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2284205/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2300306/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308791/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311069/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311075/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336890/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344597/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352361/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358640/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358658/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358812/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2361581/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2363907/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2546216/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/768105/Johnson_And_Johnson_Innovation-Jjdc_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1883008/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2291836/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292334/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292345/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292353/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292975/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2299864/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2300455/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2303009/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2306163/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308781/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316619/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316624/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2317934/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2321856/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327212/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327227/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336943/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2337571/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338236/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338237/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338527/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2341478/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344605/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2346978/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2350327/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352357/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2356290/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358657/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364457/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364458/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2365296/Johnson___Johnson_Development_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Morningside> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Morningside" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Morningside" ;
    ns1:sameAsMedium <https://1145.am/db/1297950/Morningside>,
        <https://1145.am/db/1298919/Morningside>,
        <https://1145.am/db/1394919/Morningside>,
        <https://1145.am/db/1770139/Morningside>,
        <https://1145.am/db/1783536/Morningside>,
        <https://1145.am/db/2293980/Morningside>,
        <https://1145.am/db/2337571/Morningside>,
        <https://1145.am/db/2344604/Morningside>,
        <https://1145.am/db/2350231/Morningside>,
        <https://1145.am/db/2546216/Morningside>,
        <https://1145.am/db/514081/Morningside>,
        <https://1145.am/db/514914/Morningside>,
        <https://1145.am/db/586002/Morningside>,
        <https://1145.am/db/606235/Morningside>,
        <https://1145.am/db/775019/Morningside> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Mp_Healthcare_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "MP Healthcare Ventures" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "MP Healthcare Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2337571/Mp_Healthcare_Ventures>,
        <https://1145.am/db/2363938/Mp_Healthcare_Venture>,
        <https://1145.am/db/2363941/Mp_Healthcare_Venture>,
        <https://1145.am/db/2365103/Mp_Healthcare_Venture>,
        <https://1145.am/db/2546216/Mp_Healthcare_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Skyline_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Cambridgeshire" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2653940/about.rdf> ;
    ns1:basedInHighRaw "Cambridge" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Skyline Ventures" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Skyline Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2300653/Skyline_Ventures>,
        <https://1145.am/db/2303098/Skyline_Ventures>,
        <https://1145.am/db/2303598/Skyline_Ventures>,
        <https://1145.am/db/2305791/Skyline_Ventures>,
        <https://1145.am/db/2308925/Skyline_Ventures>,
        <https://1145.am/db/2308931/Skyline_Ventures>,
        <https://1145.am/db/2313305/Skyline_Ventures>,
        <https://1145.am/db/2313306/Skyline_Ventures>,
        <https://1145.am/db/2337571/Skyline_Ventures>,
        <https://1145.am/db/2340204/Skyline_Ventures>,
        <https://1145.am/db/2340207/Skyline_Ventures>,
        <https://1145.am/db/2349753/Skyline_Ventures>,
        <https://1145.am/db/2353439/Skyline_Ventures>,
        <https://1145.am/db/2355586/Skyline_Ventures>,
        <https://1145.am/db/2359287/Skyline_Ventures>,
        <https://1145.am/db/2365296/Skyline_Ventures>,
        <https://1145.am/db/2546216/Skyline_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/Easton_Capital_Investment_Group> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName "Easton Capital Investment Group" ;
    ns1:investor <https://1145.am/db/2338373/Series_D_Investment_Easton_Capital_Investment_Group_Fibrotec_Ventures_Forbion_Capital_Partners_Healthcare_Ventures_Inc_Morgenthaler_Ventures_Polaris_Venture_Partners_Shire_Strategic_Investment_Group_Completed> ;
    ns1:name "Easton Capital Investment Group" ;
    ns1:sameAsHigh <https://1145.am/db/1706170/Walden_Catalyst_Partners>,
        <https://1145.am/db/2303124/Easton-Hunt_Capital_Partners>,
        <https://1145.am/db/2343140/Easton_Capital>,
        <https://1145.am/db/2343202/Easton_Capital>,
        <https://1145.am/db/2343989/Easton_Capital>,
        <https://1145.am/db/2344978/Easton_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2343210/Easton_Capital_Investment_Group>,
        <https://1145.am/db/2366539/Easton_Capital_Investment_Group> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340887/Zs_Pharma> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-10-24T12:45:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ZS Pharma raises $46 million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zs-pharma-raises-46-million-series-c-financing> ;
    ns1:foundName "ZS Pharma",
        "ZS Pharma, Inc." ;
    ns1:industry "Pharmaceutical" ;
    ns1:name "ZS Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1378877/Zentalis>,
        <https://1145.am/db/2034251/Zyus_Life_Sciences_Corporation>,
        <https://1145.am/db/2034251/Zyus_Life_Sciences_Inc>,
        <https://1145.am/db/2052851/Zyus_Life_Sciences_Corp>,
        <https://1145.am/db/2063002/Zoia_Pharma>,
        <https://1145.am/db/2089829/Zynerba_Pharmaceuticals_Inc>,
        <https://1145.am/db/2103921/Zyus_Life_Sciences_Corporation>,
        <https://1145.am/db/2284393/Zenas_Biopharma>,
        <https://1145.am/db/2288871/Ziarco>,
        <https://1145.am/db/2301713/Zosano_Pharma>,
        <https://1145.am/db/2301790/Zosano_Pharma_Inc>,
        <https://1145.am/db/2320498/Ziarco>,
        <https://1145.am/db/2322304/Zosano>,
        <https://1145.am/db/2322309/Zosano_Pharma>,
        <https://1145.am/db/2325473/Zeneus_Pharma>,
        <https://1145.am/db/2335656/Zs_Pharma>,
        <https://1145.am/db/2336064/Zs_Pharma>,
        <https://1145.am/db/2337341/Zynerba_Pharmaceuticals>,
        <https://1145.am/db/2340890/Zs_Pharma>,
        <https://1145.am/db/2343567/Zosano_Pharma>,
        <https://1145.am/db/2347694/Zosano_Pharma>,
        <https://1145.am/db/2348059/Zosano_Pharma>,
        <https://1145.am/db/2350133/Zosano_Pharma>,
        <https://1145.am/db/2352317/Zs_Pharma>,
        <https://1145.am/db/2355183/Zs_Pharma>,
        <https://1145.am/db/2355184/Zs_Pharma>,
        <https://1145.am/db/2357409/Zosano_Pharma>,
        <https://1145.am/db/2358399/Zs_Pharma>,
        <https://1145.am/db/2359190/Zosano_Pharma>,
        <https://1145.am/db/2359480/Zs_Pharma>,
        <https://1145.am/db/2361716/Zs_Pharma>,
        <https://1145.am/db/2367645/Zs_Pharma>,
        <https://1145.am/db/2367646/Zs_Pharma>,
        <https://1145.am/db/2368956/Zynerba_Pharmaceuticals>,
        <https://1145.am/db/2369403/Zs_Pharma>,
        <https://1145.am/db/2370009/Zs_Pharma>,
        <https://1145.am/db/2371094/Zs_Pharma>,
        <https://1145.am/db/2371313/Zs_Pharma>,
        <https://1145.am/db/2537292/Zyg_Pharma>,
        <https://1145.am/db/2538203/Zyg_Pharma>,
        <https://1145.am/db/2538207/Zyg_Pharma>,
        <https://1145.am/db/2555883/Zyg_Pharma>,
        <https://1145.am/db/2556905/Zyg_Pharma>,
        <https://1145.am/db/2563511/Zogenix>,
        <https://1145.am/db/2593265/Zs_Pharma>,
        <https://1145.am/db/2718749/Zyus_Life_Sciences_Corporation>,
        <https://1145.am/db/697784/Zosano_Pharma_Corporation>,
        <https://1145.am/db/818956/Zosano_Pharma_Corporation>,
        <https://1145.am/db/819537/Zosano_Pharma_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340888/Mirna_Therapeutics_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Austin",
        "Texas" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf>,
        <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:basedInHighRaw "Austin, TX",
        "Texas" ;
    ns1:description "Biotechnology",
        "cancer" ;
    ns1:documentDate "2012-10-24T12:43:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mirna-therapeutics-secures-34-5-million-series-c-financing-to-advance-oncology-microrna-0> ;
    ns1:foundName "Mirna Therapeutics",
        "Mirna Therapeutics Inc" ;
    ns1:industry "Biotechnology",
        "biopharmaceutical" ;
    ns1:name "Mirna Therapeutics",
        "Mirna Therapeutics Inc" ;
    ns1:sameAsHigh <https://1145.am/db/2303011/Mirna_Therapeutics>,
        <https://1145.am/db/2329142/Mirna_Therapeutics>,
        <https://1145.am/db/2336439/Mirna_Therapeutics>,
        <https://1145.am/db/2340890/Mirna>,
        <https://1145.am/db/2341896/Mirna_Therapeutics_Inc>,
        <https://1145.am/db/2350231/Mirna_Therapeutics>,
        <https://1145.am/db/2359358/Mirna_Therapeutics>,
        <https://1145.am/db/2370793/Mirna_Therapeutics>,
        <https://1145.am/db/2371479/Mirna_Mirna_Therapeutics>,
        <https://1145.am/db/2371500/Mirna_Therapeutics>,
        <https://1145.am/db/404840/Mir_Scientific> ;
    ns1:sameAsMedium <https://1145.am/db/2299411/Mirna_Therapeutics>,
        <https://1145.am/db/2330214/Mirna_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340890/Mirna> a org:Organization ;
    ns1:description "microRNA drug specialist" ;
    ns1:documentDate "2012-10-24T12:53:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Two Texas biotech outfits lasso venture deals totaling $81M" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/two-texas-biotech-outfits-lasso-venture-deals-totaling-81m> ;
    ns1:foundName "And Mirna",
        "Mirna" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Mirna" ;
    ns1:sameAsHigh <https://1145.am/db/2303011/Mirna_Therapeutics>,
        <https://1145.am/db/2329142/Mirna_Therapeutics>,
        <https://1145.am/db/2336439/Mirna_Therapeutics>,
        <https://1145.am/db/2340888/Mirna_Therapeutics_Inc>,
        <https://1145.am/db/2341896/Mirna_Therapeutics_Inc>,
        <https://1145.am/db/2347878/Mirina>,
        <https://1145.am/db/2350231/Mirna_Therapeutics>,
        <https://1145.am/db/2359358/Mirna_Therapeutics>,
        <https://1145.am/db/2370793/Mirna_Therapeutics>,
        <https://1145.am/db/2371479/Mirna_Mirna_Therapeutics>,
        <https://1145.am/db/2371500/Mirna_Therapeutics>,
        <https://1145.am/db/404840/Mir_Scientific> ;
    ns1:sameAsMedium <https://1145.am/db/2356270/Mirna> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340890/Zs_Pharma> a org:Organization ;
    ns1:basedInHighGeoName "Fort Worth" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4691930/about.rdf> ;
    ns1:basedInHighRaw "Fort Worth" ;
    ns1:description "a pharmaceutical company" ;
    ns1:documentDate "2012-10-24T12:53:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Two Texas biotech outfits lasso venture deals totaling $81M" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/two-texas-biotech-outfits-lasso-venture-deals-totaling-81m> ;
    ns1:foundName "ZS Pharma" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "ZS Pharma" ;
    ns1:sameAsHigh <https://1145.am/db/1378877/Zentalis>,
        <https://1145.am/db/2034251/Zyus_Life_Sciences_Corporation>,
        <https://1145.am/db/2034251/Zyus_Life_Sciences_Inc>,
        <https://1145.am/db/2052851/Zyus_Life_Sciences_Corp>,
        <https://1145.am/db/2063002/Zoia_Pharma>,
        <https://1145.am/db/2089829/Zynerba_Pharmaceuticals_Inc>,
        <https://1145.am/db/2103921/Zyus_Life_Sciences_Corporation>,
        <https://1145.am/db/2284393/Zenas_Biopharma>,
        <https://1145.am/db/2288871/Ziarco>,
        <https://1145.am/db/2301713/Zosano_Pharma>,
        <https://1145.am/db/2301790/Zosano_Pharma_Inc>,
        <https://1145.am/db/2322304/Zosano>,
        <https://1145.am/db/2322309/Zosano_Pharma>,
        <https://1145.am/db/2325473/Zeneus_Pharma>,
        <https://1145.am/db/2335656/Zs_Pharma>,
        <https://1145.am/db/2336064/Zs_Pharma>,
        <https://1145.am/db/2337341/Zynerba_Pharmaceuticals>,
        <https://1145.am/db/2340887/Zs_Pharma>,
        <https://1145.am/db/2347694/Zosano_Pharma>,
        <https://1145.am/db/2348059/Zosano_Pharma>,
        <https://1145.am/db/2350133/Zosano_Pharma>,
        <https://1145.am/db/2352317/Zs_Pharma>,
        <https://1145.am/db/2355183/Zs_Pharma>,
        <https://1145.am/db/2355184/Zs_Pharma>,
        <https://1145.am/db/2357409/Zosano_Pharma>,
        <https://1145.am/db/2358399/Zs_Pharma>,
        <https://1145.am/db/2359190/Zosano_Pharma>,
        <https://1145.am/db/2359480/Zs_Pharma>,
        <https://1145.am/db/2361716/Zs_Pharma>,
        <https://1145.am/db/2367645/Zs_Pharma>,
        <https://1145.am/db/2367646/Zs_Pharma>,
        <https://1145.am/db/2368956/Zynerba_Pharmaceuticals>,
        <https://1145.am/db/2369403/Zs_Pharma>,
        <https://1145.am/db/2370009/Zs_Pharma>,
        <https://1145.am/db/2371094/Zs_Pharma>,
        <https://1145.am/db/2371313/Zs_Pharma>,
        <https://1145.am/db/2537292/Zyg_Pharma>,
        <https://1145.am/db/2538203/Zyg_Pharma>,
        <https://1145.am/db/2538207/Zyg_Pharma>,
        <https://1145.am/db/2555883/Zyg_Pharma>,
        <https://1145.am/db/2556905/Zyg_Pharma>,
        <https://1145.am/db/2563511/Zogenix>,
        <https://1145.am/db/2593265/Zs_Pharma>,
        <https://1145.am/db/2718749/Zyus_Life_Sciences_Corporation>,
        <https://1145.am/db/697784/Zosano_Pharma_Corporation>,
        <https://1145.am/db/818956/Zosano_Pharma_Corporation>,
        <https://1145.am/db/819537/Zosano_Pharma_Corporation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341869/Aclaris_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Malvern" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5199600/about.rdf> ;
    ns1:basedInHighRaw "MALVERN, Pa." ;
    ns1:description "dermatological therapeutics",
        "dermatology" ;
    ns1:documentDate "2012-10-24T16:09:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a-financing> ;
    ns1:foundName "Aclaris",
        "Aclaris Therapeutics, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Aclaris",
        "Aclaris Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1164698/Aclaris_Therapeutics>,
        <https://1145.am/db/2336829/Aclaris_Therapeutics>,
        <https://1145.am/db/2341897/Aclaris_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/1244937/Aclaris_Therapeutics>,
        <https://1145.am/db/1525187/Aclaris_Therapeutics>,
        <https://1145.am/db/2370949/Aclaris_Therapeutics>,
        <https://1145.am/db/800925/Aclaris_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341869/Fidelity_Biosciences> a org:Organization ;
    ns1:basedInLowRaw "Pa" ;
    ns1:documentDate "2012-10-24T16:09:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a-financing> ;
    ns1:foundName "Fidelity Biosciences" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2341869/Series_A_Investment_Aclaris_Therapeutics_Fidelity_Biosciences_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Fidelity Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/1019870/Moderna>,
        <https://1145.am/db/1028098/A2pg>,
        <https://1145.am/db/1028744/Apnimed>,
        <https://1145.am/db/1029882/Apnimed>,
        <https://1145.am/db/1041428/Dr>,
        <https://1145.am/db/1042161/Wellgistics>,
        <https://1145.am/db/1042221/Wellgistics>,
        <https://1145.am/db/1096114/Astorg>,
        <https://1145.am/db/1096677/Astorg>,
        <https://1145.am/db/1138447/Apnimed>,
        <https://1145.am/db/1139445/Apnimed>,
        <https://1145.am/db/1152269/Alpha-5>,
        <https://1145.am/db/1163849/Productlife_Group>,
        <https://1145.am/db/1172760/Apexigen>,
        <https://1145.am/db/1215735/Astorg>,
        <https://1145.am/db/1219810/Prokidney_Corp>,
        <https://1145.am/db/1271008/Reviral_Ltd>,
        <https://1145.am/db/1272754/Prokidney_Corp>,
        <https://1145.am/db/1294637/LTS>,
        <https://1145.am/db/1307202/Leo_Pharma>,
        <https://1145.am/db/1309648/Achrom>,
        <https://1145.am/db/1323486/Glo_Pharma>,
        <https://1145.am/db/1374672/Sp_Industries>,
        <https://1145.am/db/1384852/Moderna_Inc>,
        <https://1145.am/db/1391799/Pharnext>,
        <https://1145.am/db/1454905/Aquestive>,
        <https://1145.am/db/1505021/Pharmaceutics_International_Inc>,
        <https://1145.am/db/1540522/Atec>,
        <https://1145.am/db/1541946/Abiomed>,
        <https://1145.am/db/1562763/Indivior>,
        <https://1145.am/db/1613904/Apnimed_Inc>,
        <https://1145.am/db/1615580/Apnimed>,
        <https://1145.am/db/1617770/Pharnext_Sa>,
        <https://1145.am/db/1648815/Indevr>,
        <https://1145.am/db/1681016/Enveric_Biosciences>,
        <https://1145.am/db/1745685/Drugstoc>,
        <https://1145.am/db/1838777/Medikly>,
        <https://1145.am/db/1936167/Reviral_Ltd>,
        <https://1145.am/db/1962783/Ora_Inc>,
        <https://1145.am/db/2039692/Rk_Pharma_Inc>,
        <https://1145.am/db/2051589/Ora_Inc>,
        <https://1145.am/db/2060641/Abionyx_Pharma>,
        <https://1145.am/db/2073336/Ose>,
        <https://1145.am/db/2132018/Solutions>,
        <https://1145.am/db/2139917/Leo_Pharma>,
        <https://1145.am/db/2151848/D___D_Pharmatech>,
        <https://1145.am/db/2152469/Sobi003>,
        <https://1145.am/db/2152499/Highchem>,
        <https://1145.am/db/2152633/Themis>,
        <https://1145.am/db/2152849/Therachon>,
        <https://1145.am/db/2152901/Abcellera>,
        <https://1145.am/db/2154166/Leo_Pharma>,
        <https://1145.am/db/2154252/Phoremost>,
        <https://1145.am/db/2155490/Enterome>,
        <https://1145.am/db/2155631/Achillion>,
        <https://1145.am/db/2155863/Therachon>,
        <https://1145.am/db/2212420/Cel-Sci_Corporation>,
        <https://1145.am/db/2235873/M3_Usa>,
        <https://1145.am/db/2244405/Seek>,
        <https://1145.am/db/2281535/Eqt_Life_Sciences>,
        <https://1145.am/db/2281676/Apnimed>,
        <https://1145.am/db/2283559/Oric>,
        <https://1145.am/db/2283918/Indivior>,
        <https://1145.am/db/2286215/Pandion>,
        <https://1145.am/db/2289550/Well>,
        <https://1145.am/db/2290753/Medivir>,
        <https://1145.am/db/2294621/Pharmaceutics_International>,
        <https://1145.am/db/2296235/Apexigen>,
        <https://1145.am/db/2297631/Clarient>,
        <https://1145.am/db/2298376/Caprion>,
        <https://1145.am/db/2301879/Magen_Biosciences>,
        <https://1145.am/db/2302863/Amri>,
        <https://1145.am/db/2303412/Hologic>,
        <https://1145.am/db/2303415/Amevive>,
        <https://1145.am/db/2303612/Intradigm_Corporation>,
        <https://1145.am/db/2303675/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2303720/Covance>,
        <https://1145.am/db/2305572/Covance_Inc>,
        <https://1145.am/db/2305703/Pinnacle_Bioventures>,
        <https://1145.am/db/2306640/Atryn>,
        <https://1145.am/db/2306640/Leo_Pharma>,
        <https://1145.am/db/2306724/Dermatech_Pty_Ltd>,
        <https://1145.am/db/2306725/Prevalere_Life_Sciences_Inc>,
        <https://1145.am/db/2306946/Amatsigroup>,
        <https://1145.am/db/2307526/Bioserv_Corporation>,
        <https://1145.am/db/2307529/Bioserv>,
        <https://1145.am/db/2307714/GTCR>,
        <https://1145.am/db/2308069/Bionomics>,
        <https://1145.am/db/2308807/Etrials_Worldwide>,
        <https://1145.am/db/2309352/Epicept_Corporation>,
        <https://1145.am/db/2309696/Encap>,
        <https://1145.am/db/2309697/Encap>,
        <https://1145.am/db/2310799/Inventiv_Health>,
        <https://1145.am/db/2312191/Medigene_Ag>,
        <https://1145.am/db/2312788/Leo_Pharma>,
        <https://1145.am/db/2312797/Leo_Pharma_A_S>,
        <https://1145.am/db/2312994/Upm>,
        <https://1145.am/db/2313383/CompanyÃ¢â‚¬â„¢>,
        <https://1145.am/db/2314613/Advent_International>,
        <https://1145.am/db/2315373/Nitromed>,
        <https://1145.am/db/2315424/Covance_Inc>,
        <https://1145.am/db/2316707/Catalyst_Pharmaceutical>,
        <https://1145.am/db/2316856/Viranative_Ab>,
        <https://1145.am/db/2317006/Amri>,
        <https://1145.am/db/2317060/Ception>,
        <https://1145.am/db/2317144/Leo_Pharma>,
        <https://1145.am/db/2317334/Aesica>,
        <https://1145.am/db/2317369/Relthy>,
        <https://1145.am/db/2320351/Prochieve>,
        <https://1145.am/db/2320947/Nitromed>,
        <https://1145.am/db/2321635/Celator>,
        <https://1145.am/db/2322824/Amri>,
        <https://1145.am/db/2322826/Amri>,
        <https://1145.am/db/2323790/Amri>,
        <https://1145.am/db/2323861/Amri>,
        <https://1145.am/db/2324112/Nitromed>,
        <https://1145.am/db/2324118/Rem_Medical_Corporation>,
        <https://1145.am/db/2324350/Celmed_Biosciences_Inc>,
        <https://1145.am/db/2324394/Amdl>,
        <https://1145.am/db/2324985/Amri>,
        <https://1145.am/db/2325553/Fidelity_Biosciences>,
        <https://1145.am/db/2327076/Amri>,
        <https://1145.am/db/2327088/Covance>,
        <https://1145.am/db/2327241/Preotact_(r)>,
        <https://1145.am/db/2327258/Biocon_Limited>,
        <https://1145.am/db/2327374/Diamedica_Inc>,
        <https://1145.am/db/2327424/Innopharm>,
        <https://1145.am/db/2328008/Epicept_Corporation>,
        <https://1145.am/db/2328318/Medpointe>,
        <https://1145.am/db/2328713/Sepracor>,
        <https://1145.am/db/2329333/Biopharma_Services_Inc>,
        <https://1145.am/db/2330808/Sepracor>,
        <https://1145.am/db/2331911/Clarient>,
        <https://1145.am/db/2332005/R___d>,
        <https://1145.am/db/2332200/Compendia_Bioscience>,
        <https://1145.am/db/2332920/Nastech>,
        <https://1145.am/db/2333644/Targent>,
        <https://1145.am/db/2334020/Accovion>,
        <https://1145.am/db/2336287/Biomotiv>,
        <https://1145.am/db/2336355/Correvio>,
        <https://1145.am/db/2336625/Biota>,
        <https://1145.am/db/2336998/Medivation_Inc>,
        <https://1145.am/db/2337028/Medivation>,
        <https://1145.am/db/2337078/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2338888/Cerulean_Pharma>,
        <https://1145.am/db/2338939/Nuevolution_A_S>,
        <https://1145.am/db/2339816/Nuevolution_A_S>,
        <https://1145.am/db/2339997/(Appa)>,
        <https://1145.am/db/2340054/Amri>,
        <https://1145.am/db/2340115/Mission>,
        <https://1145.am/db/2340160/Intercell_Ag>,
        <https://1145.am/db/2340507/Rho>,
        <https://1145.am/db/2341572/Aesica>,
        <https://1145.am/db/2341897/Fidelity_Biosciences>,
        <https://1145.am/db/2342581/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2342628/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2343325/Medivir>,
        <https://1145.am/db/2344595/Mabxience>,
        <https://1145.am/db/2347172/Medivir_Ab>,
        <https://1145.am/db/2347755/Leo_Pharma_Inc>,
        <https://1145.am/db/2348448/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2348675/Signum_Biosciences>,
        <https://1145.am/db/2349050/Fidelity_Biosciences>,
        <https://1145.am/db/2349373/Asmacure>,
        <https://1145.am/db/2349740/Signum_Biosciences_Inc>,
        <https://1145.am/db/2349983/Leading_Biosciences_Inc>,
        <https://1145.am/db/2349990/Aesica>,
        <https://1145.am/db/2350847/Covance>,
        <https://1145.am/db/2351198/(Ptc)>,
        <https://1145.am/db/2351259/Biotime_Inc>,
        <https://1145.am/db/2352414/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2353223/Medivation_Inc>,
        <https://1145.am/db/2355036/Moderna>,
        <https://1145.am/db/2355194/Moderna>,
        <https://1145.am/db/2356488/Cerulean_Pharma>,
        <https://1145.am/db/2358197/Biopharma_Services_Inc>,
        <https://1145.am/db/2358403/Pht_Corporation>,
        <https://1145.am/db/2358637/Eurand>,
        <https://1145.am/db/2358638/Eurand_Nv>,
        <https://1145.am/db/2358734/Prosidion>,
        <https://1145.am/db/2358953/Abgent>,
        <https://1145.am/db/2359025/Nectid>,
        <https://1145.am/db/2359113/Eurand_Nv>,
        <https://1145.am/db/2359380/Amri>,
        <https://1145.am/db/2359577/Geno>,
        <https://1145.am/db/2359670/Biotie>,
        <https://1145.am/db/2359951/Entremed>,
        <https://1145.am/db/2360371/Preglem>,
        <https://1145.am/db/2360702/Cominnex>,
        <https://1145.am/db/2360922/Nuevolution_A_S>,
        <https://1145.am/db/2361675/Amri>,
        <https://1145.am/db/2361747/Servier>,
        <https://1145.am/db/2361926/Pharm-Olam_International_Ltd>,
        <https://1145.am/db/2362453/Pharnext>,
        <https://1145.am/db/2362607/Abide_Therapeutics>,
        <https://1145.am/db/2363722/Moderna>,
        <https://1145.am/db/2363725/Moderna>,
        <https://1145.am/db/2367022/Fidelity_Biosciences>,
        <https://1145.am/db/2367023/Fidelity_Biosciences>,
        <https://1145.am/db/2367298/Amri>,
        <https://1145.am/db/2368106/Obseva>,
        <https://1145.am/db/2368242/Symic>,
        <https://1145.am/db/2368257/Almirall>,
        <https://1145.am/db/2368329/Amri>,
        <https://1145.am/db/2368332/Amri>,
        <https://1145.am/db/2368333/R___d>,
        <https://1145.am/db/2368601/Promosome>,
        <https://1145.am/db/2368824/Almirall_Inc>,
        <https://1145.am/db/2369042/Abide_Therapeutics>,
        <https://1145.am/db/2369128/Aegerion>,
        <https://1145.am/db/2369269/R___d>,
        <https://1145.am/db/2369446/Presage_Biosciences>,
        <https://1145.am/db/2369490/Medivation>,
        <https://1145.am/db/2369708/Promedior>,
        <https://1145.am/db/2370156/Pharming_Group_Nv>,
        <https://1145.am/db/2370164/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370265/Ose_Pharma>,
        <https://1145.am/db/2370267/Ose_Pharma>,
        <https://1145.am/db/2370437/MSD>,
        <https://1145.am/db/2370557/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370579/Arvinas>,
        <https://1145.am/db/2370659/Nuevolution>,
        <https://1145.am/db/2370828/Nuevolution>,
        <https://1145.am/db/2371158/Moderna>,
        <https://1145.am/db/2371408/Business_Management>,
        <https://1145.am/db/2536140/Scinopharm>,
        <https://1145.am/db/2536209/TPG>,
        <https://1145.am/db/2536305/Radient>,
        <https://1145.am/db/2536469/Agila_Specialties>,
        <https://1145.am/db/2536473/Encap>,
        <https://1145.am/db/2536575/G___w>,
        <https://1145.am/db/2536576/G___w>,
        <https://1145.am/db/2536612/Pharmaceutics_International_Inc>,
        <https://1145.am/db/2536776/Oramed>,
        <https://1145.am/db/2538112/Pharmedium>,
        <https://1145.am/db/2539816/P___R_Group>,
        <https://1145.am/db/2539858/Aesica>,
        <https://1145.am/db/2539890/Scinopharm>,
        <https://1145.am/db/2540218/Amri>,
        <https://1145.am/db/2540222/Amri>,
        <https://1145.am/db/2540931/Accucaps>,
        <https://1145.am/db/2540931/Pharmtek>,
        <https://1145.am/db/2541419/Amri>,
        <https://1145.am/db/2541469/Agila_Specialties>,
        <https://1145.am/db/2542113/Profectus_Biosciences>,
        <https://1145.am/db/2542472/Aesica>,
        <https://1145.am/db/2543530/Covance>,
        <https://1145.am/db/2544087/Univercells>,
        <https://1145.am/db/2544258/C___O_Pharmaceutical_Technology>,
        <https://1145.am/db/2544596/Bioton>,
        <https://1145.am/db/2545125/Ascendis_Health>,
        <https://1145.am/db/2545545/Agila_Specialties>,
        <https://1145.am/db/2546430/Bal_Pharma>,
        <https://1145.am/db/2546892/Aphena>,
        <https://1145.am/db/2547568/Amec>,
        <https://1145.am/db/2548137/Innopharm>,
        <https://1145.am/db/2548674/Sepracor>,
        <https://1145.am/db/2548840/Btcp_Pharma_Llc>,
        <https://1145.am/db/2549082/British_Company>,
        <https://1145.am/db/2549201/Rexall_Health>,
        <https://1145.am/db/2550632/Amri>,
        <https://1145.am/db/2550638/Amri>,
        <https://1145.am/db/2553761/Mabxience>,
        <https://1145.am/db/2553978/Bioverativ>,
        <https://1145.am/db/2554838/Amri>,
        <https://1145.am/db/2555168/Prokidney>,
        <https://1145.am/db/2555326/Leo_Pharma>,
        <https://1145.am/db/2556356/Medivation>,
        <https://1145.am/db/2556744/Leo_Pharma>,
        <https://1145.am/db/2557034/West_Pharmaceutical>,
        <https://1145.am/db/2557482/Idifarma>,
        <https://1145.am/db/2558133/Lifehealth>,
        <https://1145.am/db/2559160/West_Pharmaceutical>,
        <https://1145.am/db/2560277/Aesica>,
        <https://1145.am/db/2560277/Consort>,
        <https://1145.am/db/2560766/Accucaps>,
        <https://1145.am/db/2560808/Novamedica>,
        <https://1145.am/db/2561121/Bioserv>,
        <https://1145.am/db/2562459/Eurand>,
        <https://1145.am/db/2563255/MSD>,
        <https://1145.am/db/2563772/Apiject>,
        <https://1145.am/db/2564003/Leo_Pharma>,
        <https://1145.am/db/2564490/Accucaps>,
        <https://1145.am/db/2564490/Pharmtek>,
        <https://1145.am/db/2565613/Servier>,
        <https://1145.am/db/2566037/Almirall>,
        <https://1145.am/db/2566348/Indivior>,
        <https://1145.am/db/2566348/Opiant>,
        <https://1145.am/db/2568711/West_Pharmaceutical>,
        <https://1145.am/db/2569107/Almirall_Sa>,
        <https://1145.am/db/2569356/Leo_Pharma_Inc>,
        <https://1145.am/db/2569393/R___d>,
        <https://1145.am/db/2570064/Aegerion>,
        <https://1145.am/db/2570177/Oramed>,
        <https://1145.am/db/2572329/IncivoÂ®>,
        <https://1145.am/db/2572567/Northera>,
        <https://1145.am/db/2573050/Amatsigroup>,
        <https://1145.am/db/2573913/TPG>,
        <https://1145.am/db/2575143/Almirall>,
        <https://1145.am/db/2576254/Fougera>,
        <https://1145.am/db/2576550/TPG>,
        <https://1145.am/db/2576923/Pharmgate>,
        <https://1145.am/db/2576925/Pharmgate>,
        <https://1145.am/db/2577894/Advance_Properties_Ood>,
        <https://1145.am/db/2578052/Advent_International>,
        <https://1145.am/db/2578052/United_Medical>,
        <https://1145.am/db/2578645/Almirall>,
        <https://1145.am/db/2578667/Almirall>,
        <https://1145.am/db/2578667/Fycompa>,
        <https://1145.am/db/2579211/Proximagen>,
        <https://1145.am/db/2581197/Irom_Pharmaceutical>,
        <https://1145.am/db/2581832/West>,
        <https://1145.am/db/2586253/United_Biosource_Corporation>,
        <https://1145.am/db/2586420/Acuform>,
        <https://1145.am/db/2587709/Pharmstandard>,
        <https://1145.am/db/2589178/Oriel>,
        <https://1145.am/db/2590195/Nectid>,
        <https://1145.am/db/2590489/Amatsigroup>,
        <https://1145.am/db/2590528/C___O_Pharmaceutical>,
        <https://1145.am/db/2590556/Nycomed_Us>,
        <https://1145.am/db/2590827/Affairs>,
        <https://1145.am/db/2591609/Pharmstandard>,
        <https://1145.am/db/2591622/Pharmstandard>,
        <https://1145.am/db/2593060/Inventiv_Health>,
        <https://1145.am/db/2593265/Leo_Pharma>,
        <https://1145.am/db/2594186/Agila_Specialties>,
        <https://1145.am/db/2594699/Osi>,
        <https://1145.am/db/2595688/Fougera>,
        <https://1145.am/db/2598181/Amri>,
        <https://1145.am/db/2739044/Moderna>,
        <https://1145.am/db/2791590/Civica>,
        <https://1145.am/db/295168/Orifarm>,
        <https://1145.am/db/317543/Productlife_Group>,
        <https://1145.am/db/423883/Sohm_Inc>,
        <https://1145.am/db/449041/Advent_International>,
        <https://1145.am/db/515764/Sohm_Inc>,
        <https://1145.am/db/561196/Pharnext_Sa>,
        <https://1145.am/db/618115/Sohm>,
        <https://1145.am/db/654792/Innobic>,
        <https://1145.am/db/676564/Alvotech>,
        <https://1145.am/db/716162/Pharnext_Sa>,
        <https://1145.am/db/806327/Pharma_Nobis_Llc>,
        <https://1145.am/db/807295/Pharma_Nobis_Llc>,
        <https://1145.am/db/834480/Pharnext_Sa>,
        <https://1145.am/db/835269/Grand_Pharmaceutical_Group_Limited>,
        <https://1145.am/db/837157/Leo_Pharma_Inc>,
        <https://1145.am/db/848323/Pharmaceutics_International_Inc>,
        <https://1145.am/db/872336/Sohm_Inc>,
        <https://1145.am/db/882142/Aim>,
        <https://1145.am/db/886663/ThÃ©a>,
        <https://1145.am/db/888994/ThÃ©a>,
        <https://1145.am/db/943000/Pharnext>,
        <https://1145.am/db/965490/Reviral_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/1801792/Fidelity_Biosciences>,
        <https://1145.am/db/1849746/Fidelity_Biosciences>,
        <https://1145.am/db/2223723/Fidelity_Biosciences>,
        <https://1145.am/db/2303275/Fidelity_Biosciences>,
        <https://1145.am/db/2304028/Fidelity_Biosciences>,
        <https://1145.am/db/2304044/Fidelity_Biosciences>,
        <https://1145.am/db/2306790/Fidelity_Biosciences>,
        <https://1145.am/db/2313305/Fidelity_Biosciences>,
        <https://1145.am/db/2316601/Fidelity_Biosciences>,
        <https://1145.am/db/2316605/Fidelity_Biosciences>,
        <https://1145.am/db/2317737/Fidelity_Biosciences>,
        <https://1145.am/db/2318905/Fidelity_Biosciences>,
        <https://1145.am/db/2326576/Fidelity_Biosciences>,
        <https://1145.am/db/2336890/Fidelity_Biosciences>,
        <https://1145.am/db/2337971/Fidelity_Biosciences>,
        <https://1145.am/db/2337972/Fidelity_Biosciences>,
        <https://1145.am/db/2339666/Fidelity_Biosciences>,
        <https://1145.am/db/2340581/Fidelity_Biosciences>,
        <https://1145.am/db/2342754/Fidelity_Biosciences>,
        <https://1145.am/db/2342768/Fidelity_Biosciences>,
        <https://1145.am/db/2342771/Fidelity_Biosciences>,
        <https://1145.am/db/2344017/Fidelity_Biosciences>,
        <https://1145.am/db/2348149/Fidelity_Biosciences>,
        <https://1145.am/db/2349048/Fidelity_Biosciences>,
        <https://1145.am/db/2350891/Fidelity_Biosciences>,
        <https://1145.am/db/2352349/Fidelity_Biosciences>,
        <https://1145.am/db/2352350/Fidelity_Biosciences>,
        <https://1145.am/db/2354537/Fidelity_Biosciences>,
        <https://1145.am/db/2356048/Fidelity_Biosciences>,
        <https://1145.am/db/2356124/Fidelity_Biosciences>,
        <https://1145.am/db/2357722/Fidelity_Biosciences>,
        <https://1145.am/db/2359227/Fidelity_Biosciences>,
        <https://1145.am/db/2359240/Fidelity_Biosciences>,
        <https://1145.am/db/2359287/Fidelity_Biosciences>,
        <https://1145.am/db/2359562/Fidelity_Biosciences>,
        <https://1145.am/db/2359683/Fidelity_Biosciences>,
        <https://1145.am/db/2361065/Fidelity_Biosciences>,
        <https://1145.am/db/2363510/Fidelity_Biosciences>,
        <https://1145.am/db/2366710/Fidelity_Biosciences>,
        <https://1145.am/db/2366712/Fidelity_Biosciences>,
        <https://1145.am/db/2367381/Fidelity_Biosciences>,
        <https://1145.am/db/2369644/Fidelity_Biosciences>,
        <https://1145.am/db/2549505/Fidelity_Biosciences>,
        <https://1145.am/db/2549507/Fidelity_Biosciences>,
        <https://1145.am/db/2551315/Fidelity_Biosciences>,
        <https://1145.am/db/2569831/Fidelity_Biosciences>,
        <https://1145.am/db/2587938/Fidelity_Biosciences>,
        <https://1145.am/db/2588372/Fidelity_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341869/Vivo_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Pa" ;
    ns1:documentDate "2012-10-24T16:09:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a-financing> ;
    ns1:foundName "Vivo Ventures" ;
    ns1:investor <https://1145.am/db/2341869/Series_A_Investment_Aclaris_Therapeutics_Fidelity_Biosciences_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Vivo Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2029866/Vivo_Ventures>,
        <https://1145.am/db/2233578/Vivo_Ventures>,
        <https://1145.am/db/2265965/Vivo_Ventures>,
        <https://1145.am/db/2302076/Vivo_Ventures>,
        <https://1145.am/db/2302091/Vivo_Ventures>,
        <https://1145.am/db/2302108/Vivo_Ventures>,
        <https://1145.am/db/2305507/Vivo_Ventures>,
        <https://1145.am/db/2305514/Vivo_Ventures>,
        <https://1145.am/db/2309163/Vivo_Ventures>,
        <https://1145.am/db/2310302/Vivo_Ventures>,
        <https://1145.am/db/2311353/Vivo_Ventures>,
        <https://1145.am/db/2318806/Vivo_Ventures>,
        <https://1145.am/db/2318851/Vivo_Ventures>,
        <https://1145.am/db/2319846/Vivo_Ventures>,
        <https://1145.am/db/2322989/Vivo_Ventures>,
        <https://1145.am/db/2322991/Vivo_Ventures>,
        <https://1145.am/db/2323001/Vivo_Ventures>,
        <https://1145.am/db/2326361/Vivo_Ventures>,
        <https://1145.am/db/2326373/Vivo_Ventures>,
        <https://1145.am/db/2330920/Vivo_Ventures>,
        <https://1145.am/db/2337166/Vivo_Ventures>,
        <https://1145.am/db/2339345/Vivo_Ventures>,
        <https://1145.am/db/2339516/Vivo_Ventures>,
        <https://1145.am/db/2341897/Vivo_Ventures>,
        <https://1145.am/db/2347043/Vivo_Ventures>,
        <https://1145.am/db/2358806/Vivo_Ventures>,
        <https://1145.am/db/2366710/Vivo_Ventures>,
        <https://1145.am/db/2366712/Vivo_Ventures>,
        <https://1145.am/db/2367022/Vivo_Ventures>,
        <https://1145.am/db/2367023/Vivo_Ventures>,
        <https://1145.am/db/2588372/Vivo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341897/Aclaris_Therapeutics> a org:Organization ;
    ns1:description "dermatological therapeutics",
        "medical" ;
    ns1:documentDate "2012-10-25T04:01:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a> ;
    ns1:foundName "Aclaris",
        "Aclaris Therapeutics, Inc." ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Aclaris",
        "Aclaris Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1164698/Aclaris_Therapeutics>,
        <https://1145.am/db/2336829/Aclaris_Therapeutics>,
        <https://1145.am/db/2341869/Aclaris_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/1244937/Aclaris_Therapeutics>,
        <https://1145.am/db/1525187/Aclaris_Therapeutics>,
        <https://1145.am/db/2370949/Aclaris_Therapeutics>,
        <https://1145.am/db/800925/Aclaris_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341897/Fidelity_Biosciences> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2012-10-25T04:01:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a> ;
    ns1:foundName "Fidelity Biosciences" ;
    ns1:industry "pharmaceutical" ;
    ns1:investor <https://1145.am/db/2341897/Series_A_Investment_Aclaris_Therapeutics_Fidelity_Biosciences_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Fidelity Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/1019870/Moderna>,
        <https://1145.am/db/1028098/A2pg>,
        <https://1145.am/db/1028744/Apnimed>,
        <https://1145.am/db/1029882/Apnimed>,
        <https://1145.am/db/1041428/Dr>,
        <https://1145.am/db/1042161/Wellgistics>,
        <https://1145.am/db/1042221/Wellgistics>,
        <https://1145.am/db/1096114/Astorg>,
        <https://1145.am/db/1096677/Astorg>,
        <https://1145.am/db/1138447/Apnimed>,
        <https://1145.am/db/1139445/Apnimed>,
        <https://1145.am/db/1152269/Alpha-5>,
        <https://1145.am/db/1163849/Productlife_Group>,
        <https://1145.am/db/1172760/Apexigen>,
        <https://1145.am/db/1215735/Astorg>,
        <https://1145.am/db/1219810/Prokidney_Corp>,
        <https://1145.am/db/1271008/Reviral_Ltd>,
        <https://1145.am/db/1272754/Prokidney_Corp>,
        <https://1145.am/db/1294637/LTS>,
        <https://1145.am/db/1307202/Leo_Pharma>,
        <https://1145.am/db/1309648/Achrom>,
        <https://1145.am/db/1323486/Glo_Pharma>,
        <https://1145.am/db/1374672/Sp_Industries>,
        <https://1145.am/db/1384852/Moderna_Inc>,
        <https://1145.am/db/1391799/Pharnext>,
        <https://1145.am/db/1454905/Aquestive>,
        <https://1145.am/db/1505021/Pharmaceutics_International_Inc>,
        <https://1145.am/db/1540522/Atec>,
        <https://1145.am/db/1541946/Abiomed>,
        <https://1145.am/db/1562763/Indivior>,
        <https://1145.am/db/1613904/Apnimed_Inc>,
        <https://1145.am/db/1615580/Apnimed>,
        <https://1145.am/db/1617770/Pharnext_Sa>,
        <https://1145.am/db/1648815/Indevr>,
        <https://1145.am/db/1681016/Enveric_Biosciences>,
        <https://1145.am/db/1745685/Drugstoc>,
        <https://1145.am/db/1838777/Medikly>,
        <https://1145.am/db/1936167/Reviral_Ltd>,
        <https://1145.am/db/1962783/Ora_Inc>,
        <https://1145.am/db/2039692/Rk_Pharma_Inc>,
        <https://1145.am/db/2051589/Ora_Inc>,
        <https://1145.am/db/2060641/Abionyx_Pharma>,
        <https://1145.am/db/2073336/Ose>,
        <https://1145.am/db/2132018/Solutions>,
        <https://1145.am/db/2139917/Leo_Pharma>,
        <https://1145.am/db/2151848/D___D_Pharmatech>,
        <https://1145.am/db/2152469/Sobi003>,
        <https://1145.am/db/2152499/Highchem>,
        <https://1145.am/db/2152633/Themis>,
        <https://1145.am/db/2152849/Therachon>,
        <https://1145.am/db/2152901/Abcellera>,
        <https://1145.am/db/2154166/Leo_Pharma>,
        <https://1145.am/db/2154252/Phoremost>,
        <https://1145.am/db/2155490/Enterome>,
        <https://1145.am/db/2155631/Achillion>,
        <https://1145.am/db/2155863/Therachon>,
        <https://1145.am/db/2212420/Cel-Sci_Corporation>,
        <https://1145.am/db/2235873/M3_Usa>,
        <https://1145.am/db/2244405/Seek>,
        <https://1145.am/db/2281535/Eqt_Life_Sciences>,
        <https://1145.am/db/2281676/Apnimed>,
        <https://1145.am/db/2283559/Oric>,
        <https://1145.am/db/2283918/Indivior>,
        <https://1145.am/db/2286215/Pandion>,
        <https://1145.am/db/2289550/Well>,
        <https://1145.am/db/2290753/Medivir>,
        <https://1145.am/db/2294621/Pharmaceutics_International>,
        <https://1145.am/db/2296235/Apexigen>,
        <https://1145.am/db/2297631/Clarient>,
        <https://1145.am/db/2298376/Caprion>,
        <https://1145.am/db/2301879/Magen_Biosciences>,
        <https://1145.am/db/2302863/Amri>,
        <https://1145.am/db/2303412/Hologic>,
        <https://1145.am/db/2303415/Amevive>,
        <https://1145.am/db/2303612/Intradigm_Corporation>,
        <https://1145.am/db/2303675/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2303720/Covance>,
        <https://1145.am/db/2305572/Covance_Inc>,
        <https://1145.am/db/2305703/Pinnacle_Bioventures>,
        <https://1145.am/db/2306640/Atryn>,
        <https://1145.am/db/2306640/Leo_Pharma>,
        <https://1145.am/db/2306724/Dermatech_Pty_Ltd>,
        <https://1145.am/db/2306725/Prevalere_Life_Sciences_Inc>,
        <https://1145.am/db/2306946/Amatsigroup>,
        <https://1145.am/db/2307526/Bioserv_Corporation>,
        <https://1145.am/db/2307529/Bioserv>,
        <https://1145.am/db/2307714/GTCR>,
        <https://1145.am/db/2308069/Bionomics>,
        <https://1145.am/db/2308807/Etrials_Worldwide>,
        <https://1145.am/db/2309352/Epicept_Corporation>,
        <https://1145.am/db/2309696/Encap>,
        <https://1145.am/db/2309697/Encap>,
        <https://1145.am/db/2310799/Inventiv_Health>,
        <https://1145.am/db/2312191/Medigene_Ag>,
        <https://1145.am/db/2312788/Leo_Pharma>,
        <https://1145.am/db/2312797/Leo_Pharma_A_S>,
        <https://1145.am/db/2312994/Upm>,
        <https://1145.am/db/2313383/CompanyÃ¢â‚¬â„¢>,
        <https://1145.am/db/2314613/Advent_International>,
        <https://1145.am/db/2315373/Nitromed>,
        <https://1145.am/db/2315424/Covance_Inc>,
        <https://1145.am/db/2316707/Catalyst_Pharmaceutical>,
        <https://1145.am/db/2316856/Viranative_Ab>,
        <https://1145.am/db/2317006/Amri>,
        <https://1145.am/db/2317060/Ception>,
        <https://1145.am/db/2317144/Leo_Pharma>,
        <https://1145.am/db/2317334/Aesica>,
        <https://1145.am/db/2317369/Relthy>,
        <https://1145.am/db/2320351/Prochieve>,
        <https://1145.am/db/2320947/Nitromed>,
        <https://1145.am/db/2321635/Celator>,
        <https://1145.am/db/2322824/Amri>,
        <https://1145.am/db/2322826/Amri>,
        <https://1145.am/db/2323790/Amri>,
        <https://1145.am/db/2323861/Amri>,
        <https://1145.am/db/2324112/Nitromed>,
        <https://1145.am/db/2324118/Rem_Medical_Corporation>,
        <https://1145.am/db/2324350/Celmed_Biosciences_Inc>,
        <https://1145.am/db/2324394/Amdl>,
        <https://1145.am/db/2324985/Amri>,
        <https://1145.am/db/2325553/Fidelity_Biosciences>,
        <https://1145.am/db/2327076/Amri>,
        <https://1145.am/db/2327088/Covance>,
        <https://1145.am/db/2327241/Preotact_(r)>,
        <https://1145.am/db/2327258/Biocon_Limited>,
        <https://1145.am/db/2327374/Diamedica_Inc>,
        <https://1145.am/db/2327424/Innopharm>,
        <https://1145.am/db/2328008/Epicept_Corporation>,
        <https://1145.am/db/2328318/Medpointe>,
        <https://1145.am/db/2328713/Sepracor>,
        <https://1145.am/db/2329333/Biopharma_Services_Inc>,
        <https://1145.am/db/2330808/Sepracor>,
        <https://1145.am/db/2331911/Clarient>,
        <https://1145.am/db/2332005/R___d>,
        <https://1145.am/db/2332200/Compendia_Bioscience>,
        <https://1145.am/db/2332920/Nastech>,
        <https://1145.am/db/2333644/Targent>,
        <https://1145.am/db/2334020/Accovion>,
        <https://1145.am/db/2336287/Biomotiv>,
        <https://1145.am/db/2336355/Correvio>,
        <https://1145.am/db/2336625/Biota>,
        <https://1145.am/db/2336998/Medivation_Inc>,
        <https://1145.am/db/2337028/Medivation>,
        <https://1145.am/db/2337078/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2338888/Cerulean_Pharma>,
        <https://1145.am/db/2338939/Nuevolution_A_S>,
        <https://1145.am/db/2339816/Nuevolution_A_S>,
        <https://1145.am/db/2339997/(Appa)>,
        <https://1145.am/db/2340054/Amri>,
        <https://1145.am/db/2340115/Mission>,
        <https://1145.am/db/2340160/Intercell_Ag>,
        <https://1145.am/db/2340507/Rho>,
        <https://1145.am/db/2341572/Aesica>,
        <https://1145.am/db/2341869/Fidelity_Biosciences>,
        <https://1145.am/db/2342581/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2342628/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2343325/Medivir>,
        <https://1145.am/db/2344595/Mabxience>,
        <https://1145.am/db/2347172/Medivir_Ab>,
        <https://1145.am/db/2347755/Leo_Pharma_Inc>,
        <https://1145.am/db/2348448/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2348675/Signum_Biosciences>,
        <https://1145.am/db/2349050/Fidelity_Biosciences>,
        <https://1145.am/db/2349373/Asmacure>,
        <https://1145.am/db/2349740/Signum_Biosciences_Inc>,
        <https://1145.am/db/2349983/Leading_Biosciences_Inc>,
        <https://1145.am/db/2349990/Aesica>,
        <https://1145.am/db/2350847/Covance>,
        <https://1145.am/db/2351198/(Ptc)>,
        <https://1145.am/db/2351259/Biotime_Inc>,
        <https://1145.am/db/2352414/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2353223/Medivation_Inc>,
        <https://1145.am/db/2355036/Moderna>,
        <https://1145.am/db/2355194/Moderna>,
        <https://1145.am/db/2356488/Cerulean_Pharma>,
        <https://1145.am/db/2358197/Biopharma_Services_Inc>,
        <https://1145.am/db/2358403/Pht_Corporation>,
        <https://1145.am/db/2358637/Eurand>,
        <https://1145.am/db/2358638/Eurand_Nv>,
        <https://1145.am/db/2358734/Prosidion>,
        <https://1145.am/db/2358953/Abgent>,
        <https://1145.am/db/2359025/Nectid>,
        <https://1145.am/db/2359113/Eurand_Nv>,
        <https://1145.am/db/2359380/Amri>,
        <https://1145.am/db/2359577/Geno>,
        <https://1145.am/db/2359670/Biotie>,
        <https://1145.am/db/2359951/Entremed>,
        <https://1145.am/db/2360371/Preglem>,
        <https://1145.am/db/2360702/Cominnex>,
        <https://1145.am/db/2360922/Nuevolution_A_S>,
        <https://1145.am/db/2361675/Amri>,
        <https://1145.am/db/2361747/Servier>,
        <https://1145.am/db/2361926/Pharm-Olam_International_Ltd>,
        <https://1145.am/db/2362453/Pharnext>,
        <https://1145.am/db/2362607/Abide_Therapeutics>,
        <https://1145.am/db/2363722/Moderna>,
        <https://1145.am/db/2363725/Moderna>,
        <https://1145.am/db/2367022/Fidelity_Biosciences>,
        <https://1145.am/db/2367023/Fidelity_Biosciences>,
        <https://1145.am/db/2367298/Amri>,
        <https://1145.am/db/2368106/Obseva>,
        <https://1145.am/db/2368242/Symic>,
        <https://1145.am/db/2368257/Almirall>,
        <https://1145.am/db/2368329/Amri>,
        <https://1145.am/db/2368332/Amri>,
        <https://1145.am/db/2368333/R___d>,
        <https://1145.am/db/2368601/Promosome>,
        <https://1145.am/db/2368824/Almirall_Inc>,
        <https://1145.am/db/2369042/Abide_Therapeutics>,
        <https://1145.am/db/2369128/Aegerion>,
        <https://1145.am/db/2369269/R___d>,
        <https://1145.am/db/2369446/Presage_Biosciences>,
        <https://1145.am/db/2369490/Medivation>,
        <https://1145.am/db/2369708/Promedior>,
        <https://1145.am/db/2370156/Pharming_Group_Nv>,
        <https://1145.am/db/2370164/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370265/Ose_Pharma>,
        <https://1145.am/db/2370267/Ose_Pharma>,
        <https://1145.am/db/2370437/MSD>,
        <https://1145.am/db/2370557/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2370579/Arvinas>,
        <https://1145.am/db/2370659/Nuevolution>,
        <https://1145.am/db/2370828/Nuevolution>,
        <https://1145.am/db/2371158/Moderna>,
        <https://1145.am/db/2371408/Business_Management>,
        <https://1145.am/db/2536140/Scinopharm>,
        <https://1145.am/db/2536209/TPG>,
        <https://1145.am/db/2536305/Radient>,
        <https://1145.am/db/2536469/Agila_Specialties>,
        <https://1145.am/db/2536473/Encap>,
        <https://1145.am/db/2536575/G___w>,
        <https://1145.am/db/2536576/G___w>,
        <https://1145.am/db/2536612/Pharmaceutics_International_Inc>,
        <https://1145.am/db/2536776/Oramed>,
        <https://1145.am/db/2538112/Pharmedium>,
        <https://1145.am/db/2539816/P___R_Group>,
        <https://1145.am/db/2539858/Aesica>,
        <https://1145.am/db/2539890/Scinopharm>,
        <https://1145.am/db/2540218/Amri>,
        <https://1145.am/db/2540222/Amri>,
        <https://1145.am/db/2540931/Accucaps>,
        <https://1145.am/db/2540931/Pharmtek>,
        <https://1145.am/db/2541419/Amri>,
        <https://1145.am/db/2541469/Agila_Specialties>,
        <https://1145.am/db/2542113/Profectus_Biosciences>,
        <https://1145.am/db/2542472/Aesica>,
        <https://1145.am/db/2543530/Covance>,
        <https://1145.am/db/2544087/Univercells>,
        <https://1145.am/db/2544258/C___O_Pharmaceutical_Technology>,
        <https://1145.am/db/2544596/Bioton>,
        <https://1145.am/db/2545125/Ascendis_Health>,
        <https://1145.am/db/2545545/Agila_Specialties>,
        <https://1145.am/db/2546430/Bal_Pharma>,
        <https://1145.am/db/2546892/Aphena>,
        <https://1145.am/db/2547568/Amec>,
        <https://1145.am/db/2548137/Innopharm>,
        <https://1145.am/db/2548674/Sepracor>,
        <https://1145.am/db/2548840/Btcp_Pharma_Llc>,
        <https://1145.am/db/2549082/British_Company>,
        <https://1145.am/db/2549201/Rexall_Health>,
        <https://1145.am/db/2550632/Amri>,
        <https://1145.am/db/2550638/Amri>,
        <https://1145.am/db/2553761/Mabxience>,
        <https://1145.am/db/2553978/Bioverativ>,
        <https://1145.am/db/2554838/Amri>,
        <https://1145.am/db/2555168/Prokidney>,
        <https://1145.am/db/2555326/Leo_Pharma>,
        <https://1145.am/db/2556356/Medivation>,
        <https://1145.am/db/2556744/Leo_Pharma>,
        <https://1145.am/db/2557034/West_Pharmaceutical>,
        <https://1145.am/db/2557482/Idifarma>,
        <https://1145.am/db/2558133/Lifehealth>,
        <https://1145.am/db/2559160/West_Pharmaceutical>,
        <https://1145.am/db/2560277/Aesica>,
        <https://1145.am/db/2560277/Consort>,
        <https://1145.am/db/2560766/Accucaps>,
        <https://1145.am/db/2560808/Novamedica>,
        <https://1145.am/db/2561121/Bioserv>,
        <https://1145.am/db/2562459/Eurand>,
        <https://1145.am/db/2563255/MSD>,
        <https://1145.am/db/2563772/Apiject>,
        <https://1145.am/db/2564003/Leo_Pharma>,
        <https://1145.am/db/2564490/Accucaps>,
        <https://1145.am/db/2564490/Pharmtek>,
        <https://1145.am/db/2565613/Servier>,
        <https://1145.am/db/2566037/Almirall>,
        <https://1145.am/db/2566348/Indivior>,
        <https://1145.am/db/2566348/Opiant>,
        <https://1145.am/db/2568711/West_Pharmaceutical>,
        <https://1145.am/db/2569107/Almirall_Sa>,
        <https://1145.am/db/2569356/Leo_Pharma_Inc>,
        <https://1145.am/db/2569393/R___d>,
        <https://1145.am/db/2570064/Aegerion>,
        <https://1145.am/db/2570177/Oramed>,
        <https://1145.am/db/2572329/IncivoÂ®>,
        <https://1145.am/db/2572567/Northera>,
        <https://1145.am/db/2573050/Amatsigroup>,
        <https://1145.am/db/2573913/TPG>,
        <https://1145.am/db/2575143/Almirall>,
        <https://1145.am/db/2576254/Fougera>,
        <https://1145.am/db/2576550/TPG>,
        <https://1145.am/db/2576923/Pharmgate>,
        <https://1145.am/db/2576925/Pharmgate>,
        <https://1145.am/db/2577894/Advance_Properties_Ood>,
        <https://1145.am/db/2578052/Advent_International>,
        <https://1145.am/db/2578052/United_Medical>,
        <https://1145.am/db/2578645/Almirall>,
        <https://1145.am/db/2578667/Almirall>,
        <https://1145.am/db/2578667/Fycompa>,
        <https://1145.am/db/2579211/Proximagen>,
        <https://1145.am/db/2581197/Irom_Pharmaceutical>,
        <https://1145.am/db/2581832/West>,
        <https://1145.am/db/2586253/United_Biosource_Corporation>,
        <https://1145.am/db/2586420/Acuform>,
        <https://1145.am/db/2587709/Pharmstandard>,
        <https://1145.am/db/2589178/Oriel>,
        <https://1145.am/db/2590195/Nectid>,
        <https://1145.am/db/2590489/Amatsigroup>,
        <https://1145.am/db/2590528/C___O_Pharmaceutical>,
        <https://1145.am/db/2590556/Nycomed_Us>,
        <https://1145.am/db/2590827/Affairs>,
        <https://1145.am/db/2591609/Pharmstandard>,
        <https://1145.am/db/2591622/Pharmstandard>,
        <https://1145.am/db/2593060/Inventiv_Health>,
        <https://1145.am/db/2593265/Leo_Pharma>,
        <https://1145.am/db/2594186/Agila_Specialties>,
        <https://1145.am/db/2594699/Osi>,
        <https://1145.am/db/2595688/Fougera>,
        <https://1145.am/db/2598181/Amri>,
        <https://1145.am/db/2739044/Moderna>,
        <https://1145.am/db/2791590/Civica>,
        <https://1145.am/db/295168/Orifarm>,
        <https://1145.am/db/317543/Productlife_Group>,
        <https://1145.am/db/423883/Sohm_Inc>,
        <https://1145.am/db/449041/Advent_International>,
        <https://1145.am/db/515764/Sohm_Inc>,
        <https://1145.am/db/561196/Pharnext_Sa>,
        <https://1145.am/db/564787/Biohealth_Partners>,
        <https://1145.am/db/567134/Biohealth_Partners>,
        <https://1145.am/db/618115/Sohm>,
        <https://1145.am/db/654792/Innobic>,
        <https://1145.am/db/676564/Alvotech>,
        <https://1145.am/db/716162/Pharnext_Sa>,
        <https://1145.am/db/806327/Pharma_Nobis_Llc>,
        <https://1145.am/db/807295/Pharma_Nobis_Llc>,
        <https://1145.am/db/834480/Pharnext_Sa>,
        <https://1145.am/db/835269/Grand_Pharmaceutical_Group_Limited>,
        <https://1145.am/db/837157/Leo_Pharma_Inc>,
        <https://1145.am/db/848323/Pharmaceutics_International_Inc>,
        <https://1145.am/db/872336/Sohm_Inc>,
        <https://1145.am/db/882142/Aim>,
        <https://1145.am/db/886663/ThÃ©a>,
        <https://1145.am/db/888994/ThÃ©a>,
        <https://1145.am/db/943000/Pharnext>,
        <https://1145.am/db/965490/Reviral_Ltd> ;
    ns1:sameAsMedium <https://1145.am/db/1801792/Fidelity_Biosciences>,
        <https://1145.am/db/1849746/Fidelity_Biosciences>,
        <https://1145.am/db/2223723/Fidelity_Biosciences>,
        <https://1145.am/db/2303275/Fidelity_Biosciences>,
        <https://1145.am/db/2304028/Fidelity_Biosciences>,
        <https://1145.am/db/2304044/Fidelity_Biosciences>,
        <https://1145.am/db/2306790/Fidelity_Biosciences>,
        <https://1145.am/db/2313305/Fidelity_Biosciences>,
        <https://1145.am/db/2316601/Fidelity_Biosciences>,
        <https://1145.am/db/2316605/Fidelity_Biosciences>,
        <https://1145.am/db/2317737/Fidelity_Biosciences>,
        <https://1145.am/db/2318905/Fidelity_Biosciences>,
        <https://1145.am/db/2326576/Fidelity_Biosciences>,
        <https://1145.am/db/2336890/Fidelity_Biosciences>,
        <https://1145.am/db/2337971/Fidelity_Biosciences>,
        <https://1145.am/db/2337972/Fidelity_Biosciences>,
        <https://1145.am/db/2339666/Fidelity_Biosciences>,
        <https://1145.am/db/2340581/Fidelity_Biosciences>,
        <https://1145.am/db/2342754/Fidelity_Biosciences>,
        <https://1145.am/db/2342768/Fidelity_Biosciences>,
        <https://1145.am/db/2342771/Fidelity_Biosciences>,
        <https://1145.am/db/2344017/Fidelity_Biosciences>,
        <https://1145.am/db/2348149/Fidelity_Biosciences>,
        <https://1145.am/db/2349048/Fidelity_Biosciences>,
        <https://1145.am/db/2350891/Fidelity_Biosciences>,
        <https://1145.am/db/2352349/Fidelity_Biosciences>,
        <https://1145.am/db/2352350/Fidelity_Biosciences>,
        <https://1145.am/db/2354537/Fidelity_Biosciences>,
        <https://1145.am/db/2356048/Fidelity_Biosciences>,
        <https://1145.am/db/2356124/Fidelity_Biosciences>,
        <https://1145.am/db/2357722/Fidelity_Biosciences>,
        <https://1145.am/db/2359227/Fidelity_Biosciences>,
        <https://1145.am/db/2359240/Fidelity_Biosciences>,
        <https://1145.am/db/2359287/Fidelity_Biosciences>,
        <https://1145.am/db/2359562/Fidelity_Biosciences>,
        <https://1145.am/db/2359683/Fidelity_Biosciences>,
        <https://1145.am/db/2361065/Fidelity_Biosciences>,
        <https://1145.am/db/2363510/Fidelity_Biosciences>,
        <https://1145.am/db/2366710/Fidelity_Biosciences>,
        <https://1145.am/db/2366712/Fidelity_Biosciences>,
        <https://1145.am/db/2367381/Fidelity_Biosciences>,
        <https://1145.am/db/2369644/Fidelity_Biosciences>,
        <https://1145.am/db/2549505/Fidelity_Biosciences>,
        <https://1145.am/db/2549507/Fidelity_Biosciences>,
        <https://1145.am/db/2551315/Fidelity_Biosciences>,
        <https://1145.am/db/2569831/Fidelity_Biosciences>,
        <https://1145.am/db/2587938/Fidelity_Biosciences>,
        <https://1145.am/db/2588372/Fidelity_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341897/Vivo_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-10-25T04:01:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a> ;
    ns1:foundName "Vivo Ventures" ;
    ns1:investor <https://1145.am/db/2341897/Series_A_Investment_Aclaris_Therapeutics_Fidelity_Biosciences_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Vivo Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1196006/Vivo_Capital>,
        <https://1145.am/db/2029866/Vivo_Ventures>,
        <https://1145.am/db/2068430/Vivo_Capital>,
        <https://1145.am/db/2080575/Vivo_Capital>,
        <https://1145.am/db/2293172/Vivo_Capital>,
        <https://1145.am/db/2295295/Vivo_Capital>,
        <https://1145.am/db/2305507/Vivo_Ventures>,
        <https://1145.am/db/2311353/Vivo_Ventures>,
        <https://1145.am/db/2326361/Vivo_Ventures>,
        <https://1145.am/db/2326373/Vivo_Ventures>,
        <https://1145.am/db/2339345/Vivo_Ventures>,
        <https://1145.am/db/2344045/Vivo_Capital>,
        <https://1145.am/db/2347043/Vivo_Ventures>,
        <https://1145.am/db/428737/Vivo_Capital>,
        <https://1145.am/db/922552/Vivo_Capital>,
        <https://1145.am/db/923335/Vivo_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2233578/Vivo_Ventures>,
        <https://1145.am/db/2265965/Vivo_Ventures>,
        <https://1145.am/db/2302076/Vivo_Ventures>,
        <https://1145.am/db/2302091/Vivo_Ventures>,
        <https://1145.am/db/2302108/Vivo_Ventures>,
        <https://1145.am/db/2305514/Vivo_Ventures>,
        <https://1145.am/db/2309163/Vivo_Ventures>,
        <https://1145.am/db/2310302/Vivo_Ventures>,
        <https://1145.am/db/2318806/Vivo_Ventures>,
        <https://1145.am/db/2318851/Vivo_Ventures>,
        <https://1145.am/db/2319846/Vivo_Ventures>,
        <https://1145.am/db/2322989/Vivo_Ventures>,
        <https://1145.am/db/2322991/Vivo_Ventures>,
        <https://1145.am/db/2323001/Vivo_Ventures>,
        <https://1145.am/db/2330920/Vivo_Ventures>,
        <https://1145.am/db/2337166/Vivo_Ventures>,
        <https://1145.am/db/2339516/Vivo_Ventures>,
        <https://1145.am/db/2341869/Vivo_Ventures>,
        <https://1145.am/db/2358806/Vivo_Ventures>,
        <https://1145.am/db/2366710/Vivo_Ventures>,
        <https://1145.am/db/2366712/Vivo_Ventures>,
        <https://1145.am/db/2367022/Vivo_Ventures>,
        <https://1145.am/db/2367023/Vivo_Ventures>,
        <https://1145.am/db/2588372/Vivo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342925/Morgenthaler_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "The investment was led by existing investors New Leaf Venture Partners, OrbiMed Advisors," ;
    ns1:documentDate "2012-10-29T15:15:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/principia-biopharma-secures-12-5m-second-tranche-series-a-financing-expands-senior-0> ;
    ns1:foundName "Morgenthaler Ventures" ;
    ns1:investor <https://1145.am/db/2342925/Investment_Mission_Bay_Capital_Morgenthaler_Ventures_New_Leaf_Venture_Partners_Orbimed_Advisors_Principia_Biopharma_Srone_Completed> ;
    ns1:name "Morgenthaler Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2342925/Srone> ;
    ns1:sameAsMedium <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1695894/Morgenthaler_Ventures>,
        <https://1145.am/db/1699268/Morgenthaler_Ventures>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1724566/Morgenthaler_Ventures>,
        <https://1145.am/db/1826128/Morgenthaler_Ventures>,
        <https://1145.am/db/1829487/Morgenthaler_Ventures>,
        <https://1145.am/db/1830084/Morgenthaler_Ventures>,
        <https://1145.am/db/1836989/Morgenthaler_Ventures>,
        <https://1145.am/db/1837117/Morgenthaler_Ventures>,
        <https://1145.am/db/1839836/Morgenthaler_Ventures>,
        <https://1145.am/db/1846752/Morgenthaler_Ventures>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/2246579/Morgenthaler_Ventures>,
        <https://1145.am/db/2257512/Morgenthaler_Ventures>,
        <https://1145.am/db/2297408/Morgenthaler_Ventures>,
        <https://1145.am/db/2297592/Morgenthaler_Ventures>,
        <https://1145.am/db/2307644/Morgenthaler_Ventures>,
        <https://1145.am/db/2308142/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311075/Morgenthaler_Ventures>,
        <https://1145.am/db/2312192/Morgenthaler_Ventures>,
        <https://1145.am/db/2323586/Morgenthaler_Ventures>,
        <https://1145.am/db/2329524/Morgenthaler_Ventures>,
        <https://1145.am/db/2329531/Morgenthaler_Ventures>,
        <https://1145.am/db/2338251/Morgenthaler_Ventures>,
        <https://1145.am/db/2338254/Morgenthaler_Ventures>,
        <https://1145.am/db/2338373/Morgenthaler_Ventures>,
        <https://1145.am/db/2338703/Morgenthaler_Ventures>,
        <https://1145.am/db/2338704/Morgenthaler_Ventures>,
        <https://1145.am/db/2342937/Morgenthaler_Ventures>,
        <https://1145.am/db/2343202/Morgenthaler_Ventures>,
        <https://1145.am/db/2343210/Morgenthaler_Ventures>,
        <https://1145.am/db/2352207/Morgenthaler_Ventures>,
        <https://1145.am/db/2362553/Morgenthaler_Ventures>,
        <https://1145.am/db/2363510/Morgenthaler_Ventures>,
        <https://1145.am/db/2364939/Morgenthaler_Ventures>,
        <https://1145.am/db/2367204/Morgenthaler_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343966/Novo_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-10-31T15:12:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thesan-pharmaceuticals-announces-series-a-funding-co-led-by-novo-ventures-and-novartis> ;
    ns1:foundName "Novo Ventures" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2343966/Series_A_Investment_Novartis_Venture_Funds_Novo_Ventures_Thesan_Pharmaceuticals_Has_Not_Happened> ;
    ns1:name "Novo Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2117423/Novo_Holdings>,
        <https://1145.am/db/2121791/Novo_Holdings>,
        <https://1145.am/db/2296065/Novo_Holdings_A_S>,
        <https://1145.am/db/2309507/Novo_A_S>,
        <https://1145.am/db/2313143/Novo_Ventures>,
        <https://1145.am/db/2319236/Novo_A_S>,
        <https://1145.am/db/2338817/Novo_A_S>,
        <https://1145.am/db/2339295/Novo_Ventures>,
        <https://1145.am/db/2341934/Novo>,
        <https://1145.am/db/2345268/Novo_A_S>,
        <https://1145.am/db/2349050/Novo_A_S>,
        <https://1145.am/db/2353241/Novo_A_S>,
        <https://1145.am/db/2354899/Novo_Ventures>,
        <https://1145.am/db/2355183/Novo_A_S>,
        <https://1145.am/db/2358271/Novo_A_S>,
        <https://1145.am/db/2358459/Novo>,
        <https://1145.am/db/2358601/Novogen_Limited>,
        <https://1145.am/db/2360562/Novo>,
        <https://1145.am/db/2364505/Novo_A_S>,
        <https://1145.am/db/2366333/Novo_A_S>,
        <https://1145.am/db/2368537/Novogen_Limited>,
        <https://1145.am/db/2368599/Novogen_Limited>,
        <https://1145.am/db/2543793/Novo>,
        <https://1145.am/db/2544115/Novo>,
        <https://1145.am/db/2546388/Novogen_Limited>,
        <https://1145.am/db/2552947/Novo>,
        <https://1145.am/db/2557027/Novo>,
        <https://1145.am/db/2570463/Novo_Nordisk>,
        <https://1145.am/db/2570481/Novo_Ventures>,
        <https://1145.am/db/2570483/Novo_Ventures>,
        <https://1145.am/db/2587996/Novocol_Pharmaceutical>,
        <https://1145.am/db/842953/Novo_Nordisk> ;
    ns1:sameAsMedium <https://1145.am/db/2251548/Novo_Ventures>,
        <https://1145.am/db/2284476/Novo_Ventures>,
        <https://1145.am/db/2326903/Novo_Ventures>,
        <https://1145.am/db/2330664/Novo_Ventures>,
        <https://1145.am/db/2330668/Novo_Ventures>,
        <https://1145.am/db/2336221/Novo_Ventures>,
        <https://1145.am/db/2350044/Novo_Ventures>,
        <https://1145.am/db/2352508/Novo_Ventures>,
        <https://1145.am/db/2353098/Novo_Ventures>,
        <https://1145.am/db/2353588/Novo_Ventures>,
        <https://1145.am/db/2353598/Novo_Ventures>,
        <https://1145.am/db/2353608/Novo_Ventures>,
        <https://1145.am/db/2354296/Novo_Ventures>,
        <https://1145.am/db/2354903/Novo_Ventures>,
        <https://1145.am/db/2356124/Novo_Ventures>,
        <https://1145.am/db/2358496/Novo_Ventures>,
        <https://1145.am/db/2358502/Novo_Ventures>,
        <https://1145.am/db/2361065/Novo_Ventures>,
        <https://1145.am/db/2362533/Novo_Ventures>,
        <https://1145.am/db/2363510/Novo_Ventures>,
        <https://1145.am/db/2365103/Novo_Ventures>,
        <https://1145.am/db/2370694/Novo_Ventures>,
        <https://1145.am/db/2371165/Novo_Ventures>,
        <https://1145.am/db/2371166/Novo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343966/Series_A_Investment_Novartis_Venture_Funds_Novo_Ventures_Thesan_Pharmaceuticals_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-31T15:12:33+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SAN DIEGO, Oct. 30, 2012 - SAN DIEGO, Oct. 30, 2012 /PRNewswire/ - Thesan Pharmaceuticals announced the closing of a $ 16M Series A financing, co - led by Novo Ventures and Novartis Venture Funds.",
        "Thesan Pharmaceuticals Announces Series A Funding Co - Led By Novo Ventures And Novartis Venture Funds." ;
    ns1:documentTitle "Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thesan-pharmaceuticals-announces-series-a-funding-co-led-by-novo-ventures-and-novartis> ;
    ns1:foundName "Funding",
        "financing" ;
    ns1:name "Funding",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2343966/Thesan_Pharmaceuticals> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 16M" ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:whereRaw "SAN DIEGO" .

<https://1145.am/db/2343989/Easton_Capital> a org:Organization ;
    ns1:basedInLowRaw "Seattle" ;
    ns1:description "venture investment" ;
    ns1:documentDate "2012-11-01T13:46:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing-0> ;
    ns1:foundName "Easton Capital" ;
    ns1:investor <https://1145.am/db/2343989/Series_B_Investment_Easton_Capital_New_Science_Ventures_Research_Foundation_Resolve_Therapeutics_Wrf_Capital_Completed> ;
    ns1:name "Easton Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1706170/Walden_Catalyst_Partners>,
        <https://1145.am/db/2303124/Easton-Hunt_Capital_Partners>,
        <https://1145.am/db/2338373/Easton_Capital_Investment_Group>,
        <https://1145.am/db/2343140/Easton_Capital>,
        <https://1145.am/db/2343202/Easton_Capital>,
        <https://1145.am/db/2344978/Easton_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1838777/Easton_Capital>,
        <https://1145.am/db/1919322/Easton_Capital>,
        <https://1145.am/db/2322522/Easton_Capital>,
        <https://1145.am/db/2322531/Easton_Capital>,
        <https://1145.am/db/2323586/Easton_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343989/Resolve_Therapeutics> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-11-01T13:46:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing-0> ;
    ns1:foundName "Resolve Therapeutics",
        "Resolve Therapeutics, LLC" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Resolve Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2344978/Resolve_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2343140/Resolve_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344978/Easton_Capital> a org:Organization ;
    ns1:basedInLowRaw "Washington" ;
    ns1:description "venture investment" ;
    ns1:documentDate "2012-11-02T04:00:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing> ;
    ns1:foundName "Easton Capital" ;
    ns1:investor <https://1145.am/db/2344978/Series_B_Investment_Easton_Capital_New_Science_Ventures_Resolve_Therapeutics_Wrf_Capital_Washington_Research_Foundation_Completed> ;
    ns1:name "Easton Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1706170/Walden_Catalyst_Partners>,
        <https://1145.am/db/2303124/Easton-Hunt_Capital_Partners>,
        <https://1145.am/db/2338373/Easton_Capital_Investment_Group>,
        <https://1145.am/db/2343140/Easton_Capital>,
        <https://1145.am/db/2343202/Easton_Capital>,
        <https://1145.am/db/2343989/Easton_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1838777/Easton_Capital>,
        <https://1145.am/db/1919322/Easton_Capital>,
        <https://1145.am/db/2322522/Easton_Capital>,
        <https://1145.am/db/2322531/Easton_Capital>,
        <https://1145.am/db/2323586/Easton_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2344978/Resolve_Therapeutics> a org:Organization ;
    ns1:description "Business" ;
    ns1:documentDate "2012-11-02T04:00:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing> ;
    ns1:foundName "Resolve Therapeutics",
        "Resolve Therapeutics, LLC" ;
    ns1:industry "pharmaceutical" ;
    ns1:name "Resolve Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2343989/Resolve_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2343140/Resolve_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345017/Series_A_Investment_Biotechnology_Value_Fund_Lp_Venture_Investments_Ziarco_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-05T03:24:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Canterbury, UK, 5th November 2012 - Recently founded Ziarco, a clinical-stage biotechnology company focused on the development of first-in-class therapeutics targeting inflammatory and allergic diseases, announced today the closing of an initial $ 6 million (GBP3.75 million) tranche of Series A financing totalling $ 27 million (GBP16.8 million) ." ;
    ns1:documentTitle "Ziarco Founded with Series A Financing to Develop First-in Class Anti-inflammatory and Anti-allergic Medicines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ziarco-founded-series-a-financing-to-develop-first-class-anti-inflammatory-and-anti> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2345017/Ziarco> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 27 million",
        "$ 6 million",
        "GBP16.8 million",
        "GBP3.75 million" ;
    ns1:when "2012-11-05T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "5th November 2012" ;
    ns1:whereGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:whereRaw "UK" .

<https://1145.am/db/2345017/Venture_Investments> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "Venture Capital" ;
    ns1:documentDate "2012-11-05T03:24:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ziarco Founded with Series A Financing to Develop First-in Class Anti-inflammatory and Anti-allergic Medicines" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ziarco-founded-series-a-financing-to-develop-first-class-anti-inflammatory-and-anti> ;
    ns1:foundName "Venture Investments" ;
    ns1:investor <https://1145.am/db/2345017/Series_A_Investment_Biotechnology_Value_Fund_Lp_Venture_Investments_Ziarco_Completed> ;
    ns1:name "Venture Investments" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/ConvivialitÃ©_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/AglaÃ©_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/AglaÃ©_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/AglaÃ©_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/ConvivialitÃ©_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_GrÃ¼nderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_GrÃ¼nderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_GrÃ¼nderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2298631/Venture_Investments>,
        <https://1145.am/db/2337972/Venture_Investments>,
        <https://1145.am/db/734448/Venture_Investments> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346021/Biomedical_Catalyst> a org:Organization ;
    ns1:basedInHighGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:basedInHighRaw "UK" ;
    ns1:documentDate "2012-11-06T05:01:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "Biomedical Catalyst" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2346021/Investment_Biomedical_Catalyst_Psioxus_Therapeutics_Has_Not_Happened> ;
    ns1:name "Biomedical Catalyst" ;
    ns1:sameAsHigh <https://1145.am/db/2279779/Catalyst>,
        <https://1145.am/db/2338378/Catalyst>,
        <https://1145.am/db/2588827/Biomedical_Catalyst> ;
    ns1:sameAsMedium <https://1145.am/db/2547216/Biomedical_Catalyst> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346030/Aisling_Capital> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "Aisling Capital" ;
    ns1:investor <https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> ;
    ns1:name "Aisling Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1334160/Aisling_Capital>,
        <https://1145.am/db/1334934/Aisling_Capital>,
        <https://1145.am/db/1665536/Aisling_Capital>,
        <https://1145.am/db/2280707/Aisling_Capital>,
        <https://1145.am/db/2291277/Aisling_Capital>,
        <https://1145.am/db/2292103/Aisling_Capital>,
        <https://1145.am/db/2292800/Aisling_Capital>,
        <https://1145.am/db/2294156/Aisling_Capital>,
        <https://1145.am/db/2297408/Aisling_Capital>,
        <https://1145.am/db/2307476/Aisling_Capital>,
        <https://1145.am/db/2310940/Aisling_Capital>,
        <https://1145.am/db/2317775/Aisling_Capital>,
        <https://1145.am/db/2319433/Aisling_Capital>,
        <https://1145.am/db/2320852/Aisling_Capital>,
        <https://1145.am/db/2320853/Aisling_Capital>,
        <https://1145.am/db/2324244/Aisling_Capital>,
        <https://1145.am/db/2324255/Aisling_Capital>,
        <https://1145.am/db/2325553/Aisling_Capital>,
        <https://1145.am/db/2326576/Aisling_Capital>,
        <https://1145.am/db/2328388/Aisling_Capital>,
        <https://1145.am/db/2332753/Aisling_Capital>,
        <https://1145.am/db/2336503/Aisling_Capital>,
        <https://1145.am/db/2336505/Aisling_Capital>,
        <https://1145.am/db/2336524/Aisling_Capital>,
        <https://1145.am/db/2337250/Aisling_Capital>,
        <https://1145.am/db/2337254/Aisling_Capital>,
        <https://1145.am/db/2339214/Aisling_Capital>,
        <https://1145.am/db/2339223/Aisling_Capital>,
        <https://1145.am/db/2341595/Aisling_Capital>,
        <https://1145.am/db/2341599/Aisling_Capital>,
        <https://1145.am/db/2344735/Aisling_Capital>,
        <https://1145.am/db/2344739/Aisling_Capital>,
        <https://1145.am/db/2344874/Aisling_Capital>,
        <https://1145.am/db/2346293/Aisling_Capital>,
        <https://1145.am/db/2348754/Aisling_Capital>,
        <https://1145.am/db/2352059/Aisling_Capital>,
        <https://1145.am/db/2352167/Aisling_Capital>,
        <https://1145.am/db/2352170/Aisling_Capital>,
        <https://1145.am/db/2356297/Aisling_Capital>,
        <https://1145.am/db/2357356/Aisling_Capital>,
        <https://1145.am/db/2359185/Aisling_Capital>,
        <https://1145.am/db/2359468/Aisling_Capital>,
        <https://1145.am/db/2362736/Aisling_Capital>,
        <https://1145.am/db/2362737/Aisling_Capital>,
        <https://1145.am/db/2367022/Aisling_Capital>,
        <https://1145.am/db/2367023/Aisling_Capital>,
        <https://1145.am/db/2369304/Aisling_Capital>,
        <https://1145.am/db/2369305/Aisling_Capital>,
        <https://1145.am/db/2539913/Aisling_Capital>,
        <https://1145.am/db/2583013/Aisling_Capital>,
        <https://1145.am/db/2588372/Aisling_Capital>,
        <https://1145.am/db/2591606/Aisling_Capital>,
        <https://1145.am/db/802321/Aisling_Capital>,
        <https://1145.am/db/803398/Aisling_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346030/Medimmune_Ventures> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "MedImmune Ventures" ;
    ns1:investor <https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> ;
    ns1:name "MedImmune Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2302192/Medimmune_Ventures>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2314492/Medimmune_Ventures>,
        <https://1145.am/db/2316823/Medimmune_Ventures>,
        <https://1145.am/db/2317561/Medimmune_Ventures>,
        <https://1145.am/db/2317564/Medimmune_Ventures>,
        <https://1145.am/db/2317737/Medimmune_Ventures>,
        <https://1145.am/db/2318656/Medimmune_Ventures>,
        <https://1145.am/db/2318657/Medimmune_Ventures>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2322012/Medimmune_Ventures>,
        <https://1145.am/db/2322022/Medimmune_Ventures>,
        <https://1145.am/db/2322939/Medimmune_Ventures>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324159/Medimmune_Ventures>,
        <https://1145.am/db/2324289/Medimmune_Ventures>,
        <https://1145.am/db/2327379/Medimmune_Ventures>,
        <https://1145.am/db/2330867/Medimmune_Ventures>,
        <https://1145.am/db/2336313/Medimmune_Ventures>,
        <https://1145.am/db/2342213/Medimmune_Ventures>,
        <https://1145.am/db/2343722/Medimmune_Ventures>,
        <https://1145.am/db/2343725/Medimmune_Ventures>,
        <https://1145.am/db/2343737/Medimmune_Ventures>,
        <https://1145.am/db/2347389/Medimmune_Ventures>,
        <https://1145.am/db/2350199/Medimmune_Ventures>,
        <https://1145.am/db/2352436/Medimmune_Ventures>,
        <https://1145.am/db/2352442/Medimmune_Ventures>,
        <https://1145.am/db/2356420/Medimmune_Ventures>,
        <https://1145.am/db/2360756/Medimmune_Ventures>,
        <https://1145.am/db/2360758/Medimmune_Ventures>,
        <https://1145.am/db/2362472/Medimmune_Ventures>,
        <https://1145.am/db/2363442/Medimmune_Ventures>,
        <https://1145.am/db/2363459/Medimmune_Ventures>,
        <https://1145.am/db/2363460/Medimmune_Ventures>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2551315/Medimmune_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347043/Vivo_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-11-07T16:22:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MEI Pharma Announces $27.5 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mei-pharma-announces-27-5-million-private-placement> ;
    ns1:foundName "Vivo Ventures" ;
    ns1:investor <https://1145.am/db/2347043/Investment_Mei_Pharma_New_Leaf_Venture_Partners_Ra_Capital_Management_Three_Arch_Opportunity_Fund_Vivo_Ventures_Has_Not_Happened> ;
    ns1:name "Vivo Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1196006/Vivo_Capital>,
        <https://1145.am/db/2029866/Vivo_Ventures>,
        <https://1145.am/db/2068430/Vivo_Capital>,
        <https://1145.am/db/2080575/Vivo_Capital>,
        <https://1145.am/db/2293172/Vivo_Capital>,
        <https://1145.am/db/2295295/Vivo_Capital>,
        <https://1145.am/db/2305507/Vivo_Ventures>,
        <https://1145.am/db/2311353/Vivo_Ventures>,
        <https://1145.am/db/2326361/Vivo_Ventures>,
        <https://1145.am/db/2326373/Vivo_Ventures>,
        <https://1145.am/db/2339345/Vivo_Ventures>,
        <https://1145.am/db/2341897/Vivo_Ventures>,
        <https://1145.am/db/2344045/Vivo_Capital>,
        <https://1145.am/db/428737/Vivo_Capital>,
        <https://1145.am/db/922552/Vivo_Capital>,
        <https://1145.am/db/923335/Vivo_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2233578/Vivo_Ventures>,
        <https://1145.am/db/2265965/Vivo_Ventures>,
        <https://1145.am/db/2302076/Vivo_Ventures>,
        <https://1145.am/db/2302091/Vivo_Ventures>,
        <https://1145.am/db/2302108/Vivo_Ventures>,
        <https://1145.am/db/2305514/Vivo_Ventures>,
        <https://1145.am/db/2309163/Vivo_Ventures>,
        <https://1145.am/db/2310302/Vivo_Ventures>,
        <https://1145.am/db/2318806/Vivo_Ventures>,
        <https://1145.am/db/2318851/Vivo_Ventures>,
        <https://1145.am/db/2319846/Vivo_Ventures>,
        <https://1145.am/db/2322989/Vivo_Ventures>,
        <https://1145.am/db/2322991/Vivo_Ventures>,
        <https://1145.am/db/2323001/Vivo_Ventures>,
        <https://1145.am/db/2330920/Vivo_Ventures>,
        <https://1145.am/db/2337166/Vivo_Ventures>,
        <https://1145.am/db/2339516/Vivo_Ventures>,
        <https://1145.am/db/2341869/Vivo_Ventures>,
        <https://1145.am/db/2358806/Vivo_Ventures>,
        <https://1145.am/db/2366710/Vivo_Ventures>,
        <https://1145.am/db/2366712/Vivo_Ventures>,
        <https://1145.am/db/2367022/Vivo_Ventures>,
        <https://1145.am/db/2367023/Vivo_Ventures>,
        <https://1145.am/db/2588372/Vivo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2348135/Investment_Norwegian_Research_Councils_Bia_Program_Vaccibody_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-13T05:01:00+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Therapeutic vaccine company Vaccibody today announced that it has received a Euros 2 million grant from the Norwegian Research Council's BIA Program to develop a novel therapeutic vaccine against precancerous lesions of the cervix.",
        "Vaccibody Receives Euros 2 Million to Develop Therapeutic Cervical Cancer Vaccine." ;
    ns1:documentTitle "Vaccibody Receives Euros 2 Million to Develop Therapeutic Cervical Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vaccibody-receives-euros-2-million-to-develop-therapeutic-cervical-cancer-vaccine> ;
    ns1:foundName "grant" ;
    ns1:name "grant" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2348135/Vaccibody> ;
    ns1:valueRaw "Euros 2 Million",
        "Euros 2 million" ;
    ns1:whereGeoName "Europe" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Europe" .

<https://1145.am/db/2349120/5am_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Redwood City" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5386834/about.rdf> ;
    ns1:basedInHighRaw "REDWOOD CITY, CALIF." ;
    ns1:documentDate "2012-11-13T12:24:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PEARL THERAPEUTICS RAISES $65 MILLION SERIES D TO START PT003 PHASE 3" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pearl-therapeutics-raises-65-million-series-d-to-start-pt003-phase-3> ;
    ns1:foundName "5AM Ventures" ;
    ns1:investor <https://1145.am/db/2349120/Series_D_Investment_5am_Ventures_Clarus_Ventures_New_Leaf_Venture_Partners_Pearl_Therapeutics_Inc_Vatera_Healthcare_Partners_Completed> ;
    ns1:name "5AM Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1157541/5am_Ventures>,
        <https://1145.am/db/1533327/5am_Ventures>,
        <https://1145.am/db/1533685/5am_Ventures>,
        <https://1145.am/db/1608803/5am_Ventures>,
        <https://1145.am/db/1669813/5am_Ventures>,
        <https://1145.am/db/2152422/5am_Ventures>,
        <https://1145.am/db/2153726/5am_Ventures>,
        <https://1145.am/db/2153910/5am_Ventures>,
        <https://1145.am/db/2283394/5am_Ventures>,
        <https://1145.am/db/2286204/5am_Ventures>,
        <https://1145.am/db/2286665/5am_Ventures>,
        <https://1145.am/db/2288016/5am_Ventures>,
        <https://1145.am/db/2298404/5am_Ventures>,
        <https://1145.am/db/2298642/5am_Ventures>,
        <https://1145.am/db/2306549/5am_Ventures>,
        <https://1145.am/db/2306551/5am_Ventures>,
        <https://1145.am/db/2306754/5am_Ventures>,
        <https://1145.am/db/2311595/5am_Ventures>,
        <https://1145.am/db/2313985/5am_Ventures>,
        <https://1145.am/db/2317919/5am_Ventures>,
        <https://1145.am/db/2318733/5am_Ventures>,
        <https://1145.am/db/2319784/5am_Ventures>,
        <https://1145.am/db/2322646/5am_Ventures>,
        <https://1145.am/db/2323210/5am_Ventures>,
        <https://1145.am/db/2323226/5am_Ventures>,
        <https://1145.am/db/2324195/5am_Ventures>,
        <https://1145.am/db/2328146/5am_Ventures>,
        <https://1145.am/db/2328338/5am_Ventures>,
        <https://1145.am/db/2329778/5am_Ventures>,
        <https://1145.am/db/2332322/5am_Ventures>,
        <https://1145.am/db/2339885/5am_Ventures>,
        <https://1145.am/db/2339886/5am_Ventures>,
        <https://1145.am/db/2340344/5am_Ventures>,
        <https://1145.am/db/2340345/5am_Ventures>,
        <https://1145.am/db/2340348/5am_Ventures>,
        <https://1145.am/db/2341003/5am_Ventures>,
        <https://1145.am/db/2342352/5am_Ventures>,
        <https://1145.am/db/2347885/5am_Ventures>,
        <https://1145.am/db/2348754/5am_Ventures>,
        <https://1145.am/db/2348857/5am_Ventures>,
        <https://1145.am/db/2349834/5am_Ventures>,
        <https://1145.am/db/2351316/5am_Ventures>,
        <https://1145.am/db/2351683/5am_Ventures>,
        <https://1145.am/db/2351684/5am_Ventures>,
        <https://1145.am/db/2354296/5am_Ventures>,
        <https://1145.am/db/2355238/5am_Ventures>,
        <https://1145.am/db/2357858/5am_Ventures>,
        <https://1145.am/db/2359401/5am_Ventures>,
        <https://1145.am/db/2359864/5am_Ventures>,
        <https://1145.am/db/2360174/5am_Ventures>,
        <https://1145.am/db/2360415/5am_Ventures>,
        <https://1145.am/db/2362475/5am_Ventures>,
        <https://1145.am/db/2362481/5am_Ventures>,
        <https://1145.am/db/2364492/5am_Ventures>,
        <https://1145.am/db/2367275/5am_Ventures>,
        <https://1145.am/db/2370609/5am_Ventures>,
        <https://1145.am/db/2371160/5am_Ventures>,
        <https://1145.am/db/2371163/5am_Ventures>,
        <https://1145.am/db/2538476/5am_Ventures>,
        <https://1145.am/db/2569220/5am_Ventures>,
        <https://1145.am/db/2572398/5am_Ventures>,
        <https://1145.am/db/2587596/5am_Ventures>,
        <https://1145.am/db/2592685/5am_Ventures>,
        <https://1145.am/db/359190/5am_Ventures>,
        <https://1145.am/db/428737/5am_Ventures>,
        <https://1145.am/db/509733/5am_Ventures>,
        <https://1145.am/db/558016/5am_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350164/Intarcia_Therapeutics> a org:Organization ;
    ns1:description "diabetes" ;
    ns1:documentDate "2012-11-15T16:09:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intarcia-therapeutics-secures-landmark-210-million-financing-to-fund-its-global-phase-3> ;
    ns1:foundName "Intarcia Therapeutics",
        "Intarcia Therapeutics, Inc",
        "Intarcia Therapeutics, Inc." ;
    ns1:industry "biotech" ;
    ns1:name "Intarcia Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1002518/Novatarg_Therapeutics>,
        <https://1145.am/db/1002537/Novatarg_Therapeutics>,
        <https://1145.am/db/1198421/Pliant_Therapeutics>,
        <https://1145.am/db/1202209/Pliant_Therapeutics_Inc>,
        <https://1145.am/db/1210849/Pliant_Therapeutics>,
        <https://1145.am/db/1551329/Horizon_Therapeutics>,
        <https://1145.am/db/1568872/Horizon_Therapeutics>,
        <https://1145.am/db/1632002/Nextpoint_Therapeutics>,
        <https://1145.am/db/1632028/Nextpoint_Therapeutics>,
        <https://1145.am/db/1632131/Nextpoint_Therapeutics>,
        <https://1145.am/db/1632156/Nextpoint_Therapeutics>,
        <https://1145.am/db/164887/Atara_Biotherapeutics_Inc>,
        <https://1145.am/db/1673901/Horizon_Therapeutics>,
        <https://1145.am/db/1679473/Nextpoint_Therapeutics>,
        <https://1145.am/db/2151730/Repare_Therapeutics>,
        <https://1145.am/db/2152273/Engrail_Therapeutics>,
        <https://1145.am/db/2152618/Atara_Biotherapeutics>,
        <https://1145.am/db/2154007/Enterprise_Therapeutics>,
        <https://1145.am/db/2154158/Century_Therapeutics>,
        <https://1145.am/db/2154521/Cirius_Therapeutics>,
        <https://1145.am/db/2204366/Cell_Therapeutics>,
        <https://1145.am/db/2279029/Nimbus_Therapeutics>,
        <https://1145.am/db/2279886/Signet_Therapeutics>,
        <https://1145.am/db/2282091/Fore_Biotherapeutics>,
        <https://1145.am/db/2283389/Corlieve_Therapeutics>,
        <https://1145.am/db/2283728/Bioniz_Therapeutics>,
        <https://1145.am/db/2284474/Moma_Therapeutics>,
        <https://1145.am/db/2285385/Villaris_Therapeutics>,
        <https://1145.am/db/2286372/Horizon_Therapeutics>,
        <https://1145.am/db/2287290/Nimbus_Therapeutics>,
        <https://1145.am/db/2290926/Imcheck_Therapeutics>,
        <https://1145.am/db/2293241/Rubius_Therapeutics>,
        <https://1145.am/db/2293373/Pliant_Therapeutics>,
        <https://1145.am/db/2297545/Rubius_Therapeutics>,
        <https://1145.am/db/2298897/Sapience_Therapeutics>,
        <https://1145.am/db/2298956/Tp_Therapeutics>,
        <https://1145.am/db/2300054/Nimbus_Therapeutics>,
        <https://1145.am/db/2300987/Arcturus_Therapeutics>,
        <https://1145.am/db/2310068/Ocera_Therapeutics>,
        <https://1145.am/db/2314988/Biotherapeutics_Inc>,
        <https://1145.am/db/2320482/Repros_Therapeutics>,
        <https://1145.am/db/2336441/Juventas_Therapeutics>,
        <https://1145.am/db/2340067/Moderna_Therapeutics>,
        <https://1145.am/db/2340087/Nimbus_Therapeutics>,
        <https://1145.am/db/2340634/Atara_Biotherapeutics>,
        <https://1145.am/db/2342717/Alexar_Therapeutics>,
        <https://1145.am/db/2343987/Cornerstone_Therapeutics>,
        <https://1145.am/db/2345662/Sage_Therapeutics>,
        <https://1145.am/db/2345894/Arcturus_Therapeutics>,
        <https://1145.am/db/2348148/Dimension_Therapeutics>,
        <https://1145.am/db/2350167/Intarcia_Therapeutics>,
        <https://1145.am/db/2352308/Intarcia_Therapeutics>,
        <https://1145.am/db/2352515/Cell_Therapeutics>,
        <https://1145.am/db/2353129/Cornerstone_Therapeutics>,
        <https://1145.am/db/2353339/Juventas_Therapeutics>,
        <https://1145.am/db/2353939/Juventas_Therapeutics>,
        <https://1145.am/db/2357256/Sage_Therapeutics>,
        <https://1145.am/db/2360382/Ascenta_Therapeutics>,
        <https://1145.am/db/2361426/Intarcia_Therapeutics>,
        <https://1145.am/db/2364820/Juventas_Therapeutics>,
        <https://1145.am/db/2367067/Juventas_Therapeutics>,
        <https://1145.am/db/2369785/Galera_Therapeutics>,
        <https://1145.am/db/2371165/Galera_Therapeutics>,
        <https://1145.am/db/2371166/Galera_Therapeutics>,
        <https://1145.am/db/2558017/Juventas_Therapeutics>,
        <https://1145.am/db/2789236/Horizon_Therapeutics>,
        <https://1145.am/db/442506/Etern_Therapeutics>,
        <https://1145.am/db/586343/Entrada_Therapeutics_Inc>,
        <https://1145.am/db/701826/Kriya_Therapeutics>,
        <https://1145.am/db/835459/Horizon_Therapeutics_Plc> ;
    ns1:sameAsMedium <https://1145.am/db/2307682/Intarcia_Therapeutics>,
        <https://1145.am/db/2307691/Intarcia_Therapeutics>,
        <https://1145.am/db/2337004/Intarcia_Therapeutics>,
        <https://1145.am/db/2339911/Intarcia_Therapeutics>,
        <https://1145.am/db/2349216/Intarcia_Therapeutics>,
        <https://1145.am/db/2351271/Intarcia_Therapeutics>,
        <https://1145.am/db/2351274/Intarcia_Therapeutics>,
        <https://1145.am/db/2352122/Intarcia_Therapeutics>,
        <https://1145.am/db/2352306/Intarcia_Therapeutics>,
        <https://1145.am/db/2357062/Intarcia_Therapeutics>,
        <https://1145.am/db/2357080/Intarcia_Therapeutics_Inc>,
        <https://1145.am/db/2357083/Intarcia_Therapeutics>,
        <https://1145.am/db/2361422/Intarcia_Therapeutics>,
        <https://1145.am/db/2370037/Intarcia_Therapeutics>,
        <https://1145.am/db/2570886/Intarcia_Therapeutics>,
        <https://1145.am/db/2581542/Intarcia_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350167/Intarcia_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "California" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:basedInHighRaw "California" ;
    ns1:documentDate "2012-11-15T16:38:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia raises $210M for PhIII, once-yearly diabetes drug" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/intarcia-raises-210m-for-phiii-once-yearly-diabetes-drug> ;
    ns1:foundName "Intarcia",
        "Intarcia Therapeutics" ;
    ns1:industry "biotech" ;
    ns1:name "Intarcia",
        "Intarcia Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1002518/Novatarg_Therapeutics>,
        <https://1145.am/db/1002537/Novatarg_Therapeutics>,
        <https://1145.am/db/1198421/Pliant_Therapeutics>,
        <https://1145.am/db/1202209/Pliant_Therapeutics_Inc>,
        <https://1145.am/db/1210849/Pliant_Therapeutics>,
        <https://1145.am/db/1551329/Horizon_Therapeutics>,
        <https://1145.am/db/1568872/Horizon_Therapeutics>,
        <https://1145.am/db/1632002/Nextpoint_Therapeutics>,
        <https://1145.am/db/1632028/Nextpoint_Therapeutics>,
        <https://1145.am/db/1632131/Nextpoint_Therapeutics>,
        <https://1145.am/db/1632156/Nextpoint_Therapeutics>,
        <https://1145.am/db/164887/Atara_Biotherapeutics_Inc>,
        <https://1145.am/db/1673901/Horizon_Therapeutics>,
        <https://1145.am/db/1679473/Nextpoint_Therapeutics>,
        <https://1145.am/db/2151730/Repare_Therapeutics>,
        <https://1145.am/db/2152273/Engrail_Therapeutics>,
        <https://1145.am/db/2152618/Atara_Biotherapeutics>,
        <https://1145.am/db/2154007/Enterprise_Therapeutics>,
        <https://1145.am/db/2154158/Century_Therapeutics>,
        <https://1145.am/db/2154521/Cirius_Therapeutics>,
        <https://1145.am/db/2204366/Cell_Therapeutics>,
        <https://1145.am/db/2279029/Nimbus_Therapeutics>,
        <https://1145.am/db/2279886/Signet_Therapeutics>,
        <https://1145.am/db/2282091/Fore_Biotherapeutics>,
        <https://1145.am/db/2283389/Corlieve_Therapeutics>,
        <https://1145.am/db/2283728/Bioniz_Therapeutics>,
        <https://1145.am/db/2284474/Moma_Therapeutics>,
        <https://1145.am/db/2285385/Villaris_Therapeutics>,
        <https://1145.am/db/2286372/Horizon_Therapeutics>,
        <https://1145.am/db/2287290/Nimbus_Therapeutics>,
        <https://1145.am/db/2290926/Imcheck_Therapeutics>,
        <https://1145.am/db/2293241/Rubius_Therapeutics>,
        <https://1145.am/db/2293373/Pliant_Therapeutics>,
        <https://1145.am/db/2297545/Rubius_Therapeutics>,
        <https://1145.am/db/2298897/Sapience_Therapeutics>,
        <https://1145.am/db/2298956/Tp_Therapeutics>,
        <https://1145.am/db/2300054/Nimbus_Therapeutics>,
        <https://1145.am/db/2300987/Arcturus_Therapeutics>,
        <https://1145.am/db/2310068/Ocera_Therapeutics>,
        <https://1145.am/db/2314988/Biotherapeutics_Inc>,
        <https://1145.am/db/2320482/Repros_Therapeutics>,
        <https://1145.am/db/2336441/Juventas_Therapeutics>,
        <https://1145.am/db/2340067/Moderna_Therapeutics>,
        <https://1145.am/db/2340087/Nimbus_Therapeutics>,
        <https://1145.am/db/2340634/Atara_Biotherapeutics>,
        <https://1145.am/db/2342717/Alexar_Therapeutics>,
        <https://1145.am/db/2343987/Cornerstone_Therapeutics>,
        <https://1145.am/db/2345662/Sage_Therapeutics>,
        <https://1145.am/db/2345894/Arcturus_Therapeutics>,
        <https://1145.am/db/2348148/Dimension_Therapeutics>,
        <https://1145.am/db/2350164/Intarcia_Therapeutics>,
        <https://1145.am/db/2352308/Intarcia_Therapeutics>,
        <https://1145.am/db/2352515/Cell_Therapeutics>,
        <https://1145.am/db/2353129/Cornerstone_Therapeutics>,
        <https://1145.am/db/2353339/Juventas_Therapeutics>,
        <https://1145.am/db/2353939/Juventas_Therapeutics>,
        <https://1145.am/db/2357256/Sage_Therapeutics>,
        <https://1145.am/db/2360382/Ascenta_Therapeutics>,
        <https://1145.am/db/2361426/Intarcia_Therapeutics>,
        <https://1145.am/db/2364820/Juventas_Therapeutics>,
        <https://1145.am/db/2367067/Juventas_Therapeutics>,
        <https://1145.am/db/2369785/Galera_Therapeutics>,
        <https://1145.am/db/2371165/Galera_Therapeutics>,
        <https://1145.am/db/2371166/Galera_Therapeutics>,
        <https://1145.am/db/2558017/Juventas_Therapeutics>,
        <https://1145.am/db/2789236/Horizon_Therapeutics>,
        <https://1145.am/db/442506/Etern_Therapeutics>,
        <https://1145.am/db/586343/Entrada_Therapeutics_Inc>,
        <https://1145.am/db/701826/Kriya_Therapeutics>,
        <https://1145.am/db/835459/Horizon_Therapeutics_Plc> ;
    ns1:sameAsMedium <https://1145.am/db/2307682/Intarcia_Therapeutics>,
        <https://1145.am/db/2307691/Intarcia_Therapeutics>,
        <https://1145.am/db/2337004/Intarcia_Therapeutics>,
        <https://1145.am/db/2339911/Intarcia_Therapeutics>,
        <https://1145.am/db/2349216/Intarcia_Therapeutics>,
        <https://1145.am/db/2351271/Intarcia_Therapeutics>,
        <https://1145.am/db/2351274/Intarcia_Therapeutics>,
        <https://1145.am/db/2352122/Intarcia_Therapeutics>,
        <https://1145.am/db/2352306/Intarcia_Therapeutics>,
        <https://1145.am/db/2357062/Intarcia_Therapeutics>,
        <https://1145.am/db/2357080/Intarcia_Therapeutics_Inc>,
        <https://1145.am/db/2357083/Intarcia_Therapeutics>,
        <https://1145.am/db/2361422/Intarcia_Therapeutics>,
        <https://1145.am/db/2370037/Intarcia_Therapeutics>,
        <https://1145.am/db/2570886/Intarcia_Therapeutics>,
        <https://1145.am/db/2581542/Intarcia_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350199/Intersouth_Partners> a org:Organization ;
    ns1:basedInLowRaw "GAINESVILLE, Fla" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "Intersouth Partners" ;
    ns1:investor <https://1145.am/db/2350199/Series_B_Investment_Alta_Partners_And_Sr_Applied_Genetic_Technologies_Corporation_Interwest_Intersouth_Partners_Medimmune_Ventures_Osage_University_Partners_Sr_One_Limited_Completed> ;
    ns1:name "Intersouth Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1711300/Interwest_Partners>,
        <https://1145.am/db/1886261/Interwest_Partners>,
        <https://1145.am/db/2312792/Interwest>,
        <https://1145.am/db/2315289/Interwest_Partners>,
        <https://1145.am/db/2320852/Intersouth_Partners>,
        <https://1145.am/db/2325257/Interwest_Partners>,
        <https://1145.am/db/2326361/Interwest_Partners>,
        <https://1145.am/db/2326373/Interwest_Partners>,
        <https://1145.am/db/2328655/Intersouth_Partners>,
        <https://1145.am/db/2346204/Brookside_Capital>,
        <https://1145.am/db/2348754/Interwest_Partners>,
        <https://1145.am/db/2350199/Interwest>,
        <https://1145.am/db/2578837/Intersouth_Partners>,
        <https://1145.am/db/317537/Starbridge_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1698991/Intersouth_Partners>,
        <https://1145.am/db/1719350/Intersouth_Partners>,
        <https://1145.am/db/1826128/Intersouth_Partners>,
        <https://1145.am/db/1831452/Intersouth_Partners>,
        <https://1145.am/db/1872380/Intersouth_Partners>,
        <https://1145.am/db/1875214/Intersouth_Partners>,
        <https://1145.am/db/2289983/Intersouth_Partners>,
        <https://1145.am/db/2295654/Intersouth_Partners>,
        <https://1145.am/db/2303598/Intersouth_Partners>,
        <https://1145.am/db/2305031/Intersouth_Partners>,
        <https://1145.am/db/2317561/Intersouth_Partners>,
        <https://1145.am/db/2317564/Intersouth_Partners>,
        <https://1145.am/db/2320082/Intersouth_Partners>,
        <https://1145.am/db/2320853/Intersouth_Partners>,
        <https://1145.am/db/2324042/Intersouth_Partners>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2326412/Intersouth_Partners>,
        <https://1145.am/db/2347983/Intersouth_Partners>,
        <https://1145.am/db/2358979/Intersouth_Partners>,
        <https://1145.am/db/2359001/Intersouth_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350199/Medimmune_Ventures> a org:Organization ;
    ns1:basedInLowRaw "GAINESVILLE, Fla" ;
    ns1:description "biotechnology" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "MedImmune Ventures" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2350199/Series_B_Investment_Alta_Partners_And_Sr_Applied_Genetic_Technologies_Corporation_Interwest_Intersouth_Partners_Medimmune_Ventures_Osage_University_Partners_Sr_One_Limited_Completed> ;
    ns1:name "MedImmune Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1556688/Infinimmune>,
        <https://1145.am/db/2294679/Calimmune>,
        <https://1145.am/db/2318656/Medimmune_Ventures>,
        <https://1145.am/db/2568479/Rigimmune> ;
    ns1:sameAsMedium <https://1145.am/db/2302192/Medimmune_Ventures>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2314492/Medimmune_Ventures>,
        <https://1145.am/db/2316823/Medimmune_Ventures>,
        <https://1145.am/db/2317561/Medimmune_Ventures>,
        <https://1145.am/db/2317564/Medimmune_Ventures>,
        <https://1145.am/db/2317737/Medimmune_Ventures>,
        <https://1145.am/db/2318657/Medimmune_Ventures>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2322012/Medimmune_Ventures>,
        <https://1145.am/db/2322022/Medimmune_Ventures>,
        <https://1145.am/db/2322939/Medimmune_Ventures>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324159/Medimmune_Ventures>,
        <https://1145.am/db/2324289/Medimmune_Ventures>,
        <https://1145.am/db/2327379/Medimmune_Ventures>,
        <https://1145.am/db/2330867/Medimmune_Ventures>,
        <https://1145.am/db/2336313/Medimmune_Ventures>,
        <https://1145.am/db/2342213/Medimmune_Ventures>,
        <https://1145.am/db/2343722/Medimmune_Ventures>,
        <https://1145.am/db/2343725/Medimmune_Ventures>,
        <https://1145.am/db/2343737/Medimmune_Ventures>,
        <https://1145.am/db/2346030/Medimmune_Ventures>,
        <https://1145.am/db/2347389/Medimmune_Ventures>,
        <https://1145.am/db/2352436/Medimmune_Ventures>,
        <https://1145.am/db/2352442/Medimmune_Ventures>,
        <https://1145.am/db/2356420/Medimmune_Ventures>,
        <https://1145.am/db/2360756/Medimmune_Ventures>,
        <https://1145.am/db/2360758/Medimmune_Ventures>,
        <https://1145.am/db/2362472/Medimmune_Ventures>,
        <https://1145.am/db/2363442/Medimmune_Ventures>,
        <https://1145.am/db/2363459/Medimmune_Ventures>,
        <https://1145.am/db/2363460/Medimmune_Ventures>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2551315/Medimmune_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350625/Rarecyte_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Seattle" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:basedInHighRaw "Seattle" ;
    ns1:description "Life science" ;
    ns1:documentDate "2012-08-22T01:02:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rarecyte-completes-final-tranche-of-funding-for-launch-of-its-accucyte-rare-cell-detection> ;
    ns1:foundName "RareCyte",
        "RareCyte Inc." ;
    ns1:industry "life science" ;
    ns1:name "RareCyte Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2571001/Rarecyte_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2352249/Investment_Curis_Inc_Pharmakon_Advisors_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-28T15:31:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Curis Announces $ 30 Million Secured Debt Financing to Support Development of Proprietary Pipeline.",
        "LEXINGTON, Mass., Nov. 28, 2012 (GLOBE NEWSWIRE) - Curis, Inc. (Nasdaq: CRIS) , a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that, subject to the occurrence of certain closing conditions, it will enter into a $ 30 million debt transaction secured with certain future ErivedgeÂ® royalties, with an investment fund managed by Pharmakon Advisors." ;
    ns1:documentTitle "Curis Announces $30 Million Secured Debt Financing to Support Development of Proprietary Pipeline" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/curis-announces-30-million-secured-debt-financing-to-support-development-of-proprietary> ;
    ns1:foundName "Debt",
        "Financing",
        "debt",
        "debt transaction" ;
    ns1:name "Debt",
        "Financing",
        "debt",
        "debt transaction" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2352249/Curis_Inc> ;
    ns1:valueRaw "$ 30 Million",
        "$ 30 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2354296/5am_Ventures> a org:Organization ;
    ns1:basedInLowRaw "WOBURN, Mass" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-12-04T10:37:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Flexion Therapeutics Secures $20 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flexion-therapeutics-secures-20-million-series-b-financing> ;
    ns1:foundName "5AM Ventures" ;
    ns1:investor <https://1145.am/db/2354296/Series_B_Investment_5am_Ventures_Flexion_Therapeutics_Novo_Ventures_Pfizer_Venture_Investments_Sofinnova_Partners_Versant_Ventures_Completed> ;
    ns1:name "5AM Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1157541/5am_Ventures>,
        <https://1145.am/db/1533327/5am_Ventures>,
        <https://1145.am/db/2283394/5am_Ventures>,
        <https://1145.am/db/2311595/5am_Ventures>,
        <https://1145.am/db/2322646/5am_Ventures>,
        <https://1145.am/db/2324195/5am_Ventures>,
        <https://1145.am/db/2330075/5_Am_Ventures>,
        <https://1145.am/db/2341003/5am_Ventures>,
        <https://1145.am/db/2347885/5am_Ventures>,
        <https://1145.am/db/2348754/5am_Ventures>,
        <https://1145.am/db/2348857/5am_Ventures>,
        <https://1145.am/db/2351316/5am_Ventures>,
        <https://1145.am/db/2371163/5am_Ventures>,
        <https://1145.am/db/509733/5am_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1533685/5am_Ventures>,
        <https://1145.am/db/1608803/5am_Ventures>,
        <https://1145.am/db/1669813/5am_Ventures>,
        <https://1145.am/db/2152422/5am_Ventures>,
        <https://1145.am/db/2153726/5am_Ventures>,
        <https://1145.am/db/2153910/5am_Ventures>,
        <https://1145.am/db/2286204/5am_Ventures>,
        <https://1145.am/db/2286665/5am_Ventures>,
        <https://1145.am/db/2288016/5am_Ventures>,
        <https://1145.am/db/2298404/5am_Ventures>,
        <https://1145.am/db/2298642/5am_Ventures>,
        <https://1145.am/db/2306549/5am_Ventures>,
        <https://1145.am/db/2306551/5am_Ventures>,
        <https://1145.am/db/2306754/5am_Ventures>,
        <https://1145.am/db/2313985/5am_Ventures>,
        <https://1145.am/db/2317919/5am_Ventures>,
        <https://1145.am/db/2318733/5am_Ventures>,
        <https://1145.am/db/2319784/5am_Ventures>,
        <https://1145.am/db/2323210/5am_Ventures>,
        <https://1145.am/db/2323226/5am_Ventures>,
        <https://1145.am/db/2328146/5am_Ventures>,
        <https://1145.am/db/2328338/5am_Ventures>,
        <https://1145.am/db/2329778/5am_Ventures>,
        <https://1145.am/db/2332322/5am_Ventures>,
        <https://1145.am/db/2339885/5am_Ventures>,
        <https://1145.am/db/2339886/5am_Ventures>,
        <https://1145.am/db/2340344/5am_Ventures>,
        <https://1145.am/db/2340345/5am_Ventures>,
        <https://1145.am/db/2340348/5am_Ventures>,
        <https://1145.am/db/2342352/5am_Ventures>,
        <https://1145.am/db/2349120/5am_Ventures>,
        <https://1145.am/db/2349834/5am_Ventures>,
        <https://1145.am/db/2351683/5am_Ventures>,
        <https://1145.am/db/2351684/5am_Ventures>,
        <https://1145.am/db/2355238/5am_Ventures>,
        <https://1145.am/db/2357858/5am_Ventures>,
        <https://1145.am/db/2359401/5am_Ventures>,
        <https://1145.am/db/2359864/5am_Ventures>,
        <https://1145.am/db/2360174/5am_Ventures>,
        <https://1145.am/db/2360415/5am_Ventures>,
        <https://1145.am/db/2362475/5am_Ventures>,
        <https://1145.am/db/2362481/5am_Ventures>,
        <https://1145.am/db/2364492/5am_Ventures>,
        <https://1145.am/db/2367275/5am_Ventures>,
        <https://1145.am/db/2370609/5am_Ventures>,
        <https://1145.am/db/2371160/5am_Ventures>,
        <https://1145.am/db/2538476/5am_Ventures>,
        <https://1145.am/db/2569220/5am_Ventures>,
        <https://1145.am/db/2572398/5am_Ventures>,
        <https://1145.am/db/2587596/5am_Ventures>,
        <https://1145.am/db/2592685/5am_Ventures>,
        <https://1145.am/db/359190/5am_Ventures>,
        <https://1145.am/db/428737/5am_Ventures>,
        <https://1145.am/db/558016/5am_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354296/Novo_Ventures> a org:Organization ;
    ns1:basedInLowRaw "WOBURN, Mass" ;
    ns1:documentDate "2012-12-04T10:37:44+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Flexion Therapeutics Secures $20 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flexion-therapeutics-secures-20-million-series-b-financing> ;
    ns1:foundName "Novo Ventures" ;
    ns1:investor <https://1145.am/db/2354296/Series_B_Investment_5am_Ventures_Flexion_Therapeutics_Novo_Ventures_Pfizer_Venture_Investments_Sofinnova_Partners_Versant_Ventures_Completed> ;
    ns1:name "Novo Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2251548/Novo_Ventures>,
        <https://1145.am/db/2284476/Novo_Ventures>,
        <https://1145.am/db/2313143/Novo_Ventures>,
        <https://1145.am/db/2326903/Novo_Ventures>,
        <https://1145.am/db/2330664/Novo_Ventures>,
        <https://1145.am/db/2330668/Novo_Ventures>,
        <https://1145.am/db/2336221/Novo_Ventures>,
        <https://1145.am/db/2339295/Novo_Ventures>,
        <https://1145.am/db/2343966/Novo_Ventures>,
        <https://1145.am/db/2350044/Novo_Ventures>,
        <https://1145.am/db/2352508/Novo_Ventures>,
        <https://1145.am/db/2353098/Novo_Ventures>,
        <https://1145.am/db/2353588/Novo_Ventures>,
        <https://1145.am/db/2353598/Novo_Ventures>,
        <https://1145.am/db/2353608/Novo_Ventures>,
        <https://1145.am/db/2354899/Novo_Ventures>,
        <https://1145.am/db/2354903/Novo_Ventures>,
        <https://1145.am/db/2356124/Novo_Ventures>,
        <https://1145.am/db/2358496/Novo_Ventures>,
        <https://1145.am/db/2358502/Novo_Ventures>,
        <https://1145.am/db/2361065/Novo_Ventures>,
        <https://1145.am/db/2362533/Novo_Ventures>,
        <https://1145.am/db/2363510/Novo_Ventures>,
        <https://1145.am/db/2365103/Novo_Ventures>,
        <https://1145.am/db/2370694/Novo_Ventures>,
        <https://1145.am/db/2371165/Novo_Ventures>,
        <https://1145.am/db/2371166/Novo_Ventures>,
        <https://1145.am/db/2570481/Novo_Ventures>,
        <https://1145.am/db/2570483/Novo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354752/Athenian_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CINCINNATI" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-30T14:33:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing-0> ;
    ns1:foundName "Athenian Venture Partners" ;
    ns1:investor <https://1145.am/db/2354752/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Athenian Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2303695/Athenian_Venture_Partners>,
        <https://1145.am/db/2317737/Athenian_Venture_Partners>,
        <https://1145.am/db/2335764/Athenian_Venture_Partners>,
        <https://1145.am/db/2354770/Athenian_Venture_Partners>,
        <https://1145.am/db/2361588/Athenian_Venture_Partners>,
        <https://1145.am/db/2575232/Athenian_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2367046/Athenian_Venture_Partners>,
        <https://1145.am/db/2367047/Athenian_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354752/Kearny_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CINCINNATI" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-30T14:33:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing-0> ;
    ns1:foundName "Kearny Venture Partners" ;
    ns1:investor <https://1145.am/db/2354752/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Kearny Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2354770/Kearny_Venture_Partners>,
        <https://1145.am/db/2575232/Kearny_Venture_Partners>,
        <https://1145.am/db/2625964/Citi> ;
    ns1:sameAsMedium <https://1145.am/db/2300697/Kearny_Venture_Partners>,
        <https://1145.am/db/2303695/Kearny_Venture_Partners>,
        <https://1145.am/db/2306529/Kearny_Venture_Partners>,
        <https://1145.am/db/2335764/Kearny_Venture_Partners_Venture_Investors>,
        <https://1145.am/db/2361588/Kearny_Venture_Partners_Venture_Investors_Llc>,
        <https://1145.am/db/2367022/Kearny_Venture_Partners>,
        <https://1145.am/db/2367023/Kearny_Venture_Partners>,
        <https://1145.am/db/2367046/Kearny_Venture_Partners>,
        <https://1145.am/db/2367047/Kearny_Venture_Partners>,
        <https://1145.am/db/2588372/Kearny_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354752/Novartis_Bioventures> a org:Organization ;
    ns1:basedInLowRaw "CINCINNATI" ;
    ns1:description "Investing in biopharmaceutical companies" ;
    ns1:documentDate "2012-08-30T14:33:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing-0> ;
    ns1:foundName "Novartis BioVentures" ;
    ns1:investor <https://1145.am/db/2354752/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Novartis BioVentures" ;
    ns1:sameAsMedium <https://1145.am/db/2301809/Novartis_Bioventures_Ltd>,
        <https://1145.am/db/2303121/Novartis_Bioventures>,
        <https://1145.am/db/2303124/Novartis_Bioventures_Ltd>,
        <https://1145.am/db/2303695/Novartis_Bioventures_Ltd>,
        <https://1145.am/db/2311069/Novartis_Bioventures>,
        <https://1145.am/db/2311075/Novartis_Bioventures>,
        <https://1145.am/db/2313322/Novartis_Bioventures>,
        <https://1145.am/db/2323700/Novartis_Bioventures>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2354770/Novartis_Bioventures>,
        <https://1145.am/db/2355841/Novartis_Bioventures>,
        <https://1145.am/db/2575232/Novartis_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354752/Triathlon_Medical_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CINCINNATI" ;
    ns1:description "Investing in medical companies" ;
    ns1:documentDate "2012-08-30T14:33:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing-0> ;
    ns1:foundName "Triathlon Medical Ventures" ;
    ns1:investor <https://1145.am/db/2354752/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Triathlon Medical Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2303695/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2305706/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2326139/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2335764/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2361588/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2364827/Triathlon_Medical_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2305713/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2330775/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2354770/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2367046/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2367047/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2575232/Triathlon_Medical_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354752/Venture_Investors_Llc> a org:Organization ;
    ns1:basedInLowRaw "CINCINNATI" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-30T14:33:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing-0> ;
    ns1:foundName "Venture Investors LLC" ;
    ns1:investor <https://1145.am/db/2354752/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Venture Investors LLC" ;
    ns1:sameAsHigh <https://1145.am/db/1006950/Shell_Ventures>,
        <https://1145.am/db/1014186/Soma_Capital>,
        <https://1145.am/db/1014305/Sp_Ventures>,
        <https://1145.am/db/1049509/021_Capital>,
        <https://1145.am/db/1083572/Spero_Ventures>,
        <https://1145.am/db/1085737/Spero_Ventures>,
        <https://1145.am/db/1106541/Jumpstart_Ventures>,
        <https://1145.am/db/1119699/Xplorer_Capital>,
        <https://1145.am/db/1122750/Xplorer_Capital>,
        <https://1145.am/db/1133402/Silicon_Road_Ventures>,
        <https://1145.am/db/1134486/Silicon_Road_Ventures>,
        <https://1145.am/db/1140286/B_Capital_Group>,
        <https://1145.am/db/1140286/Commerce_Ventures>,
        <https://1145.am/db/1151339/Big_Idea_Ventures>,
        <https://1145.am/db/1165515/Jumpstart_Ventures>,
        <https://1145.am/db/1174129/Stage_1_Ventures>,
        <https://1145.am/db/1175198/Sure_Ventures>,
        <https://1145.am/db/1175459/Khosla_Ventures>,
        <https://1145.am/db/1196728/Gsr_Ventures>,
        <https://1145.am/db/1199177/Gsr_Ventures>,
        <https://1145.am/db/1200402/Xseed_Capital>,
        <https://1145.am/db/1232192/Lfg_Ventures>,
        <https://1145.am/db/1238845/Union_Square_Ventures>,
        <https://1145.am/db/1247755/Syn_Ventures>,
        <https://1145.am/db/1248631/Syn_Ventures>,
        <https://1145.am/db/1269968/Usvp>,
        <https://1145.am/db/1282835/Khosla_Ventures>,
        <https://1145.am/db/1285848/Syn_Ventures>,
        <https://1145.am/db/1287496/D1_Capital>,
        <https://1145.am/db/1288309/Psl_Ventures>,
        <https://1145.am/db/1322711/Venture_Stars>,
        <https://1145.am/db/1329887/Shell_Ventures>,
        <https://1145.am/db/1329887/Sosv>,
        <https://1145.am/db/1340587/Xseed_Capital>,
        <https://1145.am/db/1341445/Xseed_Capital>,
        <https://1145.am/db/1354722/Psl_Ventures>,
        <https://1145.am/db/1354749/Psl_Ventures>,
        <https://1145.am/db/1375916/Sv_Pacific_Ventures>,
        <https://1145.am/db/1376353/Sv_Pacific_Ventures>,
        <https://1145.am/db/1394919/Exsight_Ventures>,
        <https://1145.am/db/1408996/Khosla_Ventures>,
        <https://1145.am/db/1419583/Strongher_Vc>,
        <https://1145.am/db/1419583/Venture_Catalyst>,
        <https://1145.am/db/1445935/97212_Ventures>,
        <https://1145.am/db/1452107/Soma_Capital>,
        <https://1145.am/db/1454909/Us_Venture_Partners>,
        <https://1145.am/db/1455119/Jumpstart_Ventures>,
        <https://1145.am/db/1455616/Soma_Capital>,
        <https://1145.am/db/1468368/Sanabil_Investments>,
        <https://1145.am/db/1470303/Union_Square_Ventures>,
        <https://1145.am/db/1475091/Soma_Capital>,
        <https://1145.am/db/1489698/Stage_1_Ventures>,
        <https://1145.am/db/1582111/Khosla_Ventures>,
        <https://1145.am/db/1584937/Sharad_Sanghi>,
        <https://1145.am/db/1584937/Yournest_Venture_Capital>,
        <https://1145.am/db/1653506/Sve_Capital>,
        <https://1145.am/db/166138/Royal_Street_Ventures>,
        <https://1145.am/db/1663572/Khosla_Ventures>,
        <https://1145.am/db/1679431/Booz_Allen_Ventures_Llc>,
        <https://1145.am/db/1690703/021_Capital>,
        <https://1145.am/db/1691364/Hv_Capital>,
        <https://1145.am/db/1693658/Shima_Capital>,
        <https://1145.am/db/1694448/B37_Ventures>,
        <https://1145.am/db/1696614/Z_Venture_Capital>,
        <https://1145.am/db/1698130/Union_Square_Ventures>,
        <https://1145.am/db/1698180/Shasta_Ventures>,
        <https://1145.am/db/1698192/Saison_Capital>,
        <https://1145.am/db/1699877/Sutter_Hill_Ventures>,
        <https://1145.am/db/1702019/Sutter_Hill_Ventures>,
        <https://1145.am/db/1704402/Sosv>,
        <https://1145.am/db/1710011/Z_Venture_Capital>,
        <https://1145.am/db/1711384/Union_Square_Ventures>,
        <https://1145.am/db/1713248/Xplorer_Capital>,
        <https://1145.am/db/1714154/Psl_Ventures>,
        <https://1145.am/db/1714544/Hv_Capital>,
        <https://1145.am/db/1722058/Union_Square_Ventures>,
        <https://1145.am/db/1722914/B_Capital>,
        <https://1145.am/db/1722944/Soma_Capital>,
        <https://1145.am/db/1723099/Union_Square_Ventures>,
        <https://1145.am/db/1724641/Union_Square_Ventures>,
        <https://1145.am/db/1726121/Khosla_Ventures>,
        <https://1145.am/db/1730882/Union_Square_Ventures>,
        <https://1145.am/db/1732364/Sutter_Hill_Ventures>,
        <https://1145.am/db/1734681/Union_Square_Ventures>,
        <https://1145.am/db/1736478/Z_Venture_Capital>,
        <https://1145.am/db/1736668/Amit_Kapur>,
        <https://1145.am/db/1738378/S_Capital_Vc>,
        <https://1145.am/db/1739022/Khosla_Ventures>,
        <https://1145.am/db/1741014/Khosla_Ventures>,
        <https://1145.am/db/1742276/Shasta_Ventures>,
        <https://1145.am/db/1743316/Khosla_Ventures>,
        <https://1145.am/db/1745326/Venture_Stars>,
        <https://1145.am/db/1747732/Khosla_Ventures>,
        <https://1145.am/db/1747805/Khosla_Ventures>,
        <https://1145.am/db/1749148/Khosla_Ventures>,
        <https://1145.am/db/1749226/Khosla_Ventures>,
        <https://1145.am/db/1750460/Francisco_Partners>,
        <https://1145.am/db/1750483/Hv_Capital>,
        <https://1145.am/db/1750867/Fin_Vc>,
        <https://1145.am/db/1751312/Khosla_Ventures>,
        <https://1145.am/db/1753725/Z_Venture_Capital>,
        <https://1145.am/db/1754057/Spero_Ventures>,
        <https://1145.am/db/1754996/B_Capital>,
        <https://1145.am/db/1755846/Khosla_Ventures>,
        <https://1145.am/db/1756103/Union_Square_Ventures>,
        <https://1145.am/db/1756775/Khosla_Ventures>,
        <https://1145.am/db/1757376/1982_Ventures>,
        <https://1145.am/db/1757432/B37_Ventures>,
        <https://1145.am/db/1757987/R2>,
        <https://1145.am/db/1759567/Spero_Ventures>,
        <https://1145.am/db/1760730/Esun_Venture_Capital>,
        <https://1145.am/db/1762512/Khosla_Ventures>,
        <https://1145.am/db/1767643/Shasta_Ventures>,
        <https://1145.am/db/1768138/Vas_Ventures>,
        <https://1145.am/db/1771112/Khosla_Ventures>,
        <https://1145.am/db/1773491/Sosv>,
        <https://1145.am/db/1775532/Resolute_Venture_Partners>,
        <https://1145.am/db/1776687/Khosla_Ventures>,
        <https://1145.am/db/1777067/Scott>,
        <https://1145.am/db/1778179/Union_Square_Ventures>,
        <https://1145.am/db/1779627/Fosun>,
        <https://1145.am/db/1784405/Venture_51>,
        <https://1145.am/db/1784577/Khosla_Ventures>,
        <https://1145.am/db/1785920/Khosla_Ventures>,
        <https://1145.am/db/1786720/Union_Square_Ventures>,
        <https://1145.am/db/1786861/Ms___Ad_Ventures>,
        <https://1145.am/db/1787190/Gsr_Ventures>,
        <https://1145.am/db/1789140/Sosv>,
        <https://1145.am/db/1790631/Union_Square_Ventures>,
        <https://1145.am/db/1793825/Softtech_Vc>,
        <https://1145.am/db/1795210/Khosla_Ventures>,
        <https://1145.am/db/1795934/Shasta_Ventures>,
        <https://1145.am/db/1797561/Khosla_Ventures>,
        <https://1145.am/db/1799099/Softtech_Vc>,
        <https://1145.am/db/1799102/Softtech_Vc>,
        <https://1145.am/db/1802288/Khosla_Ventures>,
        <https://1145.am/db/1802352/Smedvig_Capital>,
        <https://1145.am/db/1803458/Union_Square_Ventures>,
        <https://1145.am/db/1804091/Active_Venture_Partners>,
        <https://1145.am/db/1804960/Khosla_Ventures>,
        <https://1145.am/db/1807542/Earlybird_Ventures>,
        <https://1145.am/db/1809007/Khosla_Ventures>,
        <https://1145.am/db/1812267/Us_Venture_Partners>,
        <https://1145.am/db/1815701/Khosla_Ventures>,
        <https://1145.am/db/1815910/E-Ventures>,
        <https://1145.am/db/1816423/Usvp>,
        <https://1145.am/db/1818161/Shasta_Ventures>,
        <https://1145.am/db/1818174/Eventures>,
        <https://1145.am/db/1821929/Khosla_Ventures>,
        <https://1145.am/db/1823663/Ifc>,
        <https://1145.am/db/1825387/Shasta_Ventures>,
        <https://1145.am/db/1826265/Mkii_Ventures>,
        <https://1145.am/db/1827021/Shasta_Ventures>,
        <https://1145.am/db/1828336/Khosla_Ventures>,
        <https://1145.am/db/1829581/Union_Square_Ventures>,
        <https://1145.am/db/1829612/Khosla_Ventures>,
        <https://1145.am/db/1829878/Active_Venture_Partners>,
        <https://1145.am/db/1830613/Sutter_Hill_Ventures>,
        <https://1145.am/db/1834279/Xseed_Capital>,
        <https://1145.am/db/1835126/Khosla_Ventures>,
        <https://1145.am/db/1835229/Sparklabs_Global_Ventures>,
        <https://1145.am/db/1835825/Shasta_Ventures>,
        <https://1145.am/db/1837155/Xseed_Capital>,
        <https://1145.am/db/1840793/Khosla_Ventures>,
        <https://1145.am/db/1842301/Khosla_Ventures>,
        <https://1145.am/db/1842466/Us_Venture_Partners>,
        <https://1145.am/db/1843362/Khosla_Ventures>,
        <https://1145.am/db/1846483/Softtech_Vc>,
        <https://1145.am/db/1846721/Union_Square_Ventures>,
        <https://1145.am/db/1852806/Us_Venture_Partners>,
        <https://1145.am/db/1853548/Khosla_Ventures>,
        <https://1145.am/db/1854200/Khosla_Ventures>,
        <https://1145.am/db/1855363/Sk_Ventures>,
        <https://1145.am/db/1856376/Khosla_Ventures>,
        <https://1145.am/db/1857635/Active_Venture_Partners>,
        <https://1145.am/db/1857930/Softtech_Vc>,
        <https://1145.am/db/1858323/Union_Square_Ventures>,
        <https://1145.am/db/1858991/Active_Venture_Partners>,
        <https://1145.am/db/1859199/Khosla_Ventures>,
        <https://1145.am/db/1860091/Union_Square_Ventures>,
        <https://1145.am/db/1860196/Union_Square_Ventures>,
        <https://1145.am/db/1861355/Khosla_Ventures>,
        <https://1145.am/db/1862590/Sutter_Hill_Ventures>,
        <https://1145.am/db/1863500/Khosla_Ventures>,
        <https://1145.am/db/1868107/Shasta_Ventures>,
        <https://1145.am/db/1868572/Union_Square_Ventures>,
        <https://1145.am/db/1871784/Us_Venture_Partners>,
        <https://1145.am/db/1872654/Sutter_Hill_Ventures>,
        <https://1145.am/db/1874278/Khosla_Ventures>,
        <https://1145.am/db/1875709/Sutter_Hill_Ventures>,
        <https://1145.am/db/1876758/Union_Square_Ventures>,
        <https://1145.am/db/1879026/Us_Venture_Partners>,
        <https://1145.am/db/1881464/Khosla_Ventures>,
        <https://1145.am/db/1884155/Us_Venture_Partners>,
        <https://1145.am/db/1892472/Union_Square_Ventures>,
        <https://1145.am/db/1895951/Khosla_Ventures>,
        <https://1145.am/db/1896368/New_Wave_Ventures>,
        <https://1145.am/db/1896530/Khosla_Ventures>,
        <https://1145.am/db/1899282/Mk_Capital>,
        <https://1145.am/db/1899737/Union_Square_Ventures>,
        <https://1145.am/db/1900812/Khosla_Ventures>,
        <https://1145.am/db/1904202/Shasta_Ventures>,
        <https://1145.am/db/1911584/Stage_1_Ventures>,
        <https://1145.am/db/1911840/Shasta_Ventures>,
        <https://1145.am/db/1915640/Us_Venture_Partners>,
        <https://1145.am/db/1917671/Fidelity_Ventures>,
        <https://1145.am/db/1922138/Softtech_Vc>,
        <https://1145.am/db/1931918/Svb_Financial_Group>,
        <https://1145.am/db/1939990/Gsr_Ventures>,
        <https://1145.am/db/1947193/Starbloom_Capital>,
        <https://1145.am/db/1947303/B37_Ventures>,
        <https://1145.am/db/1960888/Khosla_Ventures>,
        <https://1145.am/db/1962819/Jumpstart_Ventures>,
        <https://1145.am/db/2009653/Nationwide_Ventures>,
        <https://1145.am/db/2032146/Booz_Allen_Ventures>,
        <https://1145.am/db/2056931/L___S_Venture_Capital>,
        <https://1145.am/db/2071531/A_o>,
        <https://1145.am/db/2082923/Psl_Ventures>,
        <https://1145.am/db/2090647/Khosla_Ventures>,
        <https://1145.am/db/2092604/Srmg_Ventures>,
        <https://1145.am/db/2099365/Do_Ventures>,
        <https://1145.am/db/2114292/Khosla_Ventures>,
        <https://1145.am/db/2114498/Khosla_Ventures>,
        <https://1145.am/db/2134994/Union_Square_Ventures>,
        <https://1145.am/db/2135622/Khosla_Ventures>,
        <https://1145.am/db/2135690/Better_Ventures>,
        <https://1145.am/db/2142825/Commerce_Ventures>,
        <https://1145.am/db/2151946/Khosla_Ventures>,
        <https://1145.am/db/2153616/South>,
        <https://1145.am/db/2154009/Andera_Partners>,
        <https://1145.am/db/2155474/Sig>,
        <https://1145.am/db/2194249/Union_Square_Ventures>,
        <https://1145.am/db/2210557/Softtech_Vc>,
        <https://1145.am/db/2285566/Sabadell_Venture_Capital>,
        <https://1145.am/db/2288251/Us_Venture_Partners>,
        <https://1145.am/db/2300288/Spark_Ventures>,
        <https://1145.am/db/2300466/Khosla_Ventures>,
        <https://1145.am/db/2305964/Sls_Venture>,
        <https://1145.am/db/2310285/Valley_Ventures>,
        <https://1145.am/db/2311076/Venture_Investors>,
        <https://1145.am/db/2315754/Valley_Ventures>,
        <https://1145.am/db/2319675/Sac>,
        <https://1145.am/db/2343206/Us_Venture_Partners>,
        <https://1145.am/db/2348356/Sambrinvest>,
        <https://1145.am/db/2352804/Enterprise_Partners>,
        <https://1145.am/db/2354770/Venture_Investors_Llc>,
        <https://1145.am/db/2364014/Ro_Invest>,
        <https://1145.am/db/2567406/Exsight_Ventures>,
        <https://1145.am/db/2575232/Venture_Investors_Llc>,
        <https://1145.am/db/2616685/Silver_Creek_Ventures>,
        <https://1145.am/db/2641337/Valuestream_Ventures>,
        <https://1145.am/db/2790795/Shima_Capital>,
        <https://1145.am/db/365631/Khosla_Ventures>,
        <https://1145.am/db/376872/K50_Ventures>,
        <https://1145.am/db/396307/B_Capital_Group>,
        <https://1145.am/db/407681/Khosla_Ventures>,
        <https://1145.am/db/425922/Royal_Street_Ventures>,
        <https://1145.am/db/426637/Khosla_Ventures>,
        <https://1145.am/db/428324/Khosla_Ventures>,
        <https://1145.am/db/429179/Shasta_Ventures>,
        <https://1145.am/db/430553/Shasta_Ventures>,
        <https://1145.am/db/430986/Olsf_Ventures>,
        <https://1145.am/db/432552/Valuestream_Ventures>,
        <https://1145.am/db/437556/Khosla_Ventures>,
        <https://1145.am/db/438632/Khosla_Ventures>,
        <https://1145.am/db/447456/Starta_Vc>,
        <https://1145.am/db/486858/Khosla_Ventures>,
        <https://1145.am/db/486901/Khosla_Ventures>,
        <https://1145.am/db/502886/Sutter_Hill_Ventures>,
        <https://1145.am/db/506085/Sutter_Hill_Ventures>,
        <https://1145.am/db/523013/Hscm_Ventures>,
        <https://1145.am/db/523013/Sure_Ventures>,
        <https://1145.am/db/527960/Hscm_Ventures>,
        <https://1145.am/db/527960/Sure_Ventures>,
        <https://1145.am/db/562996/Shasta_Ventures>,
        <https://1145.am/db/564008/Secure_Ventures>,
        <https://1145.am/db/572414/A-Street_Ventures>,
        <https://1145.am/db/577305/A-Street_Ventures>,
        <https://1145.am/db/587038/Hv_Capital>,
        <https://1145.am/db/606074/Elementum_Ventures>,
        <https://1145.am/db/661747/Sosv>,
        <https://1145.am/db/663618/Sosv>,
        <https://1145.am/db/676938/Khosla_Ventures>,
        <https://1145.am/db/678262/Khosla_Ventures>,
        <https://1145.am/db/678416/St_Engineering_Ventures_Pte_Ltd>,
        <https://1145.am/db/679989/Khosla_Ventures>,
        <https://1145.am/db/696617/Suro_Capital>,
        <https://1145.am/db/753251/Sosv>,
        <https://1145.am/db/753759/Ms___Ad_Ventures>,
        <https://1145.am/db/75860/Sws_Venture_Capital>,
        <https://1145.am/db/778025/Soma_Capital>,
        <https://1145.am/db/784869/Hbse_Ventures>,
        <https://1145.am/db/791643/Cssd_Capital>,
        <https://1145.am/db/800101/Khosla_Ventures>,
        <https://1145.am/db/807080/Adb_Ventures>,
        <https://1145.am/db/817162/Khosla_Ventures>,
        <https://1145.am/db/817162/Shell_Ventures>,
        <https://1145.am/db/883036/Big_Idea_Ventures>,
        <https://1145.am/db/890955/S2g_Ventures>,
        <https://1145.am/db/906393/1982_Ventures>,
        <https://1145.am/db/912943/Khosla_Ventures>,
        <https://1145.am/db/928782/Psl_Ventures>,
        <https://1145.am/db/930464/Psl_Ventures>,
        <https://1145.am/db/935046/Gsr_Ventures>,
        <https://1145.am/db/940913/Xplorer_Capital>,
        <https://1145.am/db/952434/K50_Ventures>,
        <https://1145.am/db/979911/Khosla_Ventures>,
        <https://1145.am/db/980951/Khosla_Ventures>,
        <https://1145.am/db/996940/Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1105339/Venture_Investors>,
        <https://1145.am/db/2299743/Venture_Investors>,
        <https://1145.am/db/2301714/Venture_Investors>,
        <https://1145.am/db/2301715/Venture_Investors>,
        <https://1145.am/db/2303695/Venture_Investors_Llc>,
        <https://1145.am/db/2321713/Venture_Investors>,
        <https://1145.am/db/2364827/Venture_Investors>,
        <https://1145.am/db/2365444/Venture_Investors>,
        <https://1145.am/db/2367046/Venture_Investors_Llc>,
        <https://1145.am/db/2369504/Venture_Investors_Llc>,
        <https://1145.am/db/2556669/Venture_Investors_Llc>,
        <https://1145.am/db/2583558/Venture_Investors_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354770/Athenian_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Greece" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-31T01:02:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Athenian Venture Partners" ;
    ns1:investor <https://1145.am/db/2354770/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Athenian Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2303695/Athenian_Venture_Partners>,
        <https://1145.am/db/2317737/Athenian_Venture_Partners>,
        <https://1145.am/db/2335764/Athenian_Venture_Partners>,
        <https://1145.am/db/2354752/Athenian_Venture_Partners>,
        <https://1145.am/db/2361588/Athenian_Venture_Partners>,
        <https://1145.am/db/2575232/Athenian_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2367046/Athenian_Venture_Partners>,
        <https://1145.am/db/2367047/Athenian_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354770/Kearny_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Kearny Venture Partners" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-31T01:02:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Kearny Venture Partners" ;
    ns1:investor <https://1145.am/db/2354770/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Kearny Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2354752/Kearny_Venture_Partners>,
        <https://1145.am/db/2575232/Kearny_Venture_Partners>,
        <https://1145.am/db/2625964/Citi> ;
    ns1:sameAsMedium <https://1145.am/db/2300697/Kearny_Venture_Partners>,
        <https://1145.am/db/2303695/Kearny_Venture_Partners>,
        <https://1145.am/db/2306529/Kearny_Venture_Partners>,
        <https://1145.am/db/2335764/Kearny_Venture_Partners_Venture_Investors>,
        <https://1145.am/db/2361588/Kearny_Venture_Partners_Venture_Investors_Llc>,
        <https://1145.am/db/2367022/Kearny_Venture_Partners>,
        <https://1145.am/db/2367023/Kearny_Venture_Partners>,
        <https://1145.am/db/2367046/Kearny_Venture_Partners>,
        <https://1145.am/db/2367047/Kearny_Venture_Partners>,
        <https://1145.am/db/2588372/Kearny_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354770/Triathlon_Medical_Ventures> a org:Organization ;
    ns1:description "medical" ;
    ns1:documentDate "2012-08-31T01:02:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Triathlon Medical Ventures" ;
    ns1:investor <https://1145.am/db/2354770/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Triathlon Medical Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2309865/Triathlon_Medical_Venture_Partners>,
        <https://1145.am/db/2364820/Triathlon_Medical_Venture_Partners>,
        <https://1145.am/db/2575232/Triathlon_Medical_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2303695/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2305706/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2305713/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2326139/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2330775/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2335764/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2354752/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2361588/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2367046/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2367047/Triathlon_Medical_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354770/Venture_Investors_Llc> a org:Organization ;
    ns1:basedInLowRaw "Kearny" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-31T01:02:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Venture Investors LLC" ;
    ns1:investor <https://1145.am/db/2354770/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Venture Investors LLC" ;
    ns1:sameAsHigh <https://1145.am/db/1006950/Shell_Ventures>,
        <https://1145.am/db/1014186/Soma_Capital>,
        <https://1145.am/db/1014305/Sp_Ventures>,
        <https://1145.am/db/1049509/021_Capital>,
        <https://1145.am/db/1083572/Spero_Ventures>,
        <https://1145.am/db/1085737/Spero_Ventures>,
        <https://1145.am/db/1106541/Jumpstart_Ventures>,
        <https://1145.am/db/1119699/Xplorer_Capital>,
        <https://1145.am/db/1122750/Xplorer_Capital>,
        <https://1145.am/db/1133402/Silicon_Road_Ventures>,
        <https://1145.am/db/1134486/Silicon_Road_Ventures>,
        <https://1145.am/db/1140286/B_Capital_Group>,
        <https://1145.am/db/1140286/Commerce_Ventures>,
        <https://1145.am/db/1151339/Big_Idea_Ventures>,
        <https://1145.am/db/1165515/Jumpstart_Ventures>,
        <https://1145.am/db/1174129/Stage_1_Ventures>,
        <https://1145.am/db/1175198/Sure_Ventures>,
        <https://1145.am/db/1175459/Khosla_Ventures>,
        <https://1145.am/db/1196728/Gsr_Ventures>,
        <https://1145.am/db/1199177/Gsr_Ventures>,
        <https://1145.am/db/1200402/Xseed_Capital>,
        <https://1145.am/db/1232192/Lfg_Ventures>,
        <https://1145.am/db/1238845/Union_Square_Ventures>,
        <https://1145.am/db/1247755/Syn_Ventures>,
        <https://1145.am/db/1248631/Syn_Ventures>,
        <https://1145.am/db/1269968/Usvp>,
        <https://1145.am/db/1282835/Khosla_Ventures>,
        <https://1145.am/db/1285848/Syn_Ventures>,
        <https://1145.am/db/1287496/D1_Capital>,
        <https://1145.am/db/1288309/Psl_Ventures>,
        <https://1145.am/db/1322711/Venture_Stars>,
        <https://1145.am/db/1329887/Shell_Ventures>,
        <https://1145.am/db/1329887/Sosv>,
        <https://1145.am/db/1340587/Xseed_Capital>,
        <https://1145.am/db/1341445/Xseed_Capital>,
        <https://1145.am/db/1354722/Psl_Ventures>,
        <https://1145.am/db/1354749/Psl_Ventures>,
        <https://1145.am/db/1375916/Sv_Pacific_Ventures>,
        <https://1145.am/db/1376353/Sv_Pacific_Ventures>,
        <https://1145.am/db/1394919/Exsight_Ventures>,
        <https://1145.am/db/1408996/Khosla_Ventures>,
        <https://1145.am/db/1419583/Strongher_Vc>,
        <https://1145.am/db/1419583/Venture_Catalyst>,
        <https://1145.am/db/1445935/97212_Ventures>,
        <https://1145.am/db/1452107/Soma_Capital>,
        <https://1145.am/db/1454909/Us_Venture_Partners>,
        <https://1145.am/db/1455119/Jumpstart_Ventures>,
        <https://1145.am/db/1455616/Soma_Capital>,
        <https://1145.am/db/1468368/Sanabil_Investments>,
        <https://1145.am/db/1470303/Union_Square_Ventures>,
        <https://1145.am/db/1475091/Soma_Capital>,
        <https://1145.am/db/1489698/Stage_1_Ventures>,
        <https://1145.am/db/1582111/Khosla_Ventures>,
        <https://1145.am/db/1584937/Sharad_Sanghi>,
        <https://1145.am/db/1584937/Yournest_Venture_Capital>,
        <https://1145.am/db/1653506/Sve_Capital>,
        <https://1145.am/db/166138/Royal_Street_Ventures>,
        <https://1145.am/db/1663572/Khosla_Ventures>,
        <https://1145.am/db/1679431/Booz_Allen_Ventures_Llc>,
        <https://1145.am/db/1690703/021_Capital>,
        <https://1145.am/db/1691364/Hv_Capital>,
        <https://1145.am/db/1693658/Shima_Capital>,
        <https://1145.am/db/1694448/B37_Ventures>,
        <https://1145.am/db/1696614/Z_Venture_Capital>,
        <https://1145.am/db/1698130/Union_Square_Ventures>,
        <https://1145.am/db/1698180/Shasta_Ventures>,
        <https://1145.am/db/1698192/Saison_Capital>,
        <https://1145.am/db/1699877/Sutter_Hill_Ventures>,
        <https://1145.am/db/1702019/Sutter_Hill_Ventures>,
        <https://1145.am/db/1704402/Sosv>,
        <https://1145.am/db/1710011/Z_Venture_Capital>,
        <https://1145.am/db/1711384/Union_Square_Ventures>,
        <https://1145.am/db/1713248/Xplorer_Capital>,
        <https://1145.am/db/1714154/Psl_Ventures>,
        <https://1145.am/db/1714544/Hv_Capital>,
        <https://1145.am/db/1722058/Union_Square_Ventures>,
        <https://1145.am/db/1722914/B_Capital>,
        <https://1145.am/db/1722944/Soma_Capital>,
        <https://1145.am/db/1723099/Union_Square_Ventures>,
        <https://1145.am/db/1724641/Union_Square_Ventures>,
        <https://1145.am/db/1726121/Khosla_Ventures>,
        <https://1145.am/db/1730882/Union_Square_Ventures>,
        <https://1145.am/db/1732364/Sutter_Hill_Ventures>,
        <https://1145.am/db/1734681/Union_Square_Ventures>,
        <https://1145.am/db/1736478/Z_Venture_Capital>,
        <https://1145.am/db/1736668/Amit_Kapur>,
        <https://1145.am/db/1738378/S_Capital_Vc>,
        <https://1145.am/db/1739022/Khosla_Ventures>,
        <https://1145.am/db/1741014/Khosla_Ventures>,
        <https://1145.am/db/1742276/Shasta_Ventures>,
        <https://1145.am/db/1743316/Khosla_Ventures>,
        <https://1145.am/db/1745326/Venture_Stars>,
        <https://1145.am/db/1747732/Khosla_Ventures>,
        <https://1145.am/db/1747805/Khosla_Ventures>,
        <https://1145.am/db/1749148/Khosla_Ventures>,
        <https://1145.am/db/1749226/Khosla_Ventures>,
        <https://1145.am/db/1750460/Francisco_Partners>,
        <https://1145.am/db/1750483/Hv_Capital>,
        <https://1145.am/db/1750867/Fin_Vc>,
        <https://1145.am/db/1751312/Khosla_Ventures>,
        <https://1145.am/db/1753725/Z_Venture_Capital>,
        <https://1145.am/db/1754057/Spero_Ventures>,
        <https://1145.am/db/1754996/B_Capital>,
        <https://1145.am/db/1755846/Khosla_Ventures>,
        <https://1145.am/db/1756103/Union_Square_Ventures>,
        <https://1145.am/db/1756775/Khosla_Ventures>,
        <https://1145.am/db/1757376/1982_Ventures>,
        <https://1145.am/db/1757432/B37_Ventures>,
        <https://1145.am/db/1757987/R2>,
        <https://1145.am/db/1759567/Spero_Ventures>,
        <https://1145.am/db/1760730/Esun_Venture_Capital>,
        <https://1145.am/db/1762512/Khosla_Ventures>,
        <https://1145.am/db/1767643/Shasta_Ventures>,
        <https://1145.am/db/1768138/Vas_Ventures>,
        <https://1145.am/db/1771112/Khosla_Ventures>,
        <https://1145.am/db/1773491/Sosv>,
        <https://1145.am/db/1775532/Resolute_Venture_Partners>,
        <https://1145.am/db/1776687/Khosla_Ventures>,
        <https://1145.am/db/1777067/Scott>,
        <https://1145.am/db/1778179/Union_Square_Ventures>,
        <https://1145.am/db/1779627/Fosun>,
        <https://1145.am/db/1784405/Venture_51>,
        <https://1145.am/db/1784577/Khosla_Ventures>,
        <https://1145.am/db/1785920/Khosla_Ventures>,
        <https://1145.am/db/1786720/Union_Square_Ventures>,
        <https://1145.am/db/1786861/Ms___Ad_Ventures>,
        <https://1145.am/db/1787190/Gsr_Ventures>,
        <https://1145.am/db/1789140/Sosv>,
        <https://1145.am/db/1790631/Union_Square_Ventures>,
        <https://1145.am/db/1793825/Softtech_Vc>,
        <https://1145.am/db/1795210/Khosla_Ventures>,
        <https://1145.am/db/1795934/Shasta_Ventures>,
        <https://1145.am/db/1797561/Khosla_Ventures>,
        <https://1145.am/db/1799099/Softtech_Vc>,
        <https://1145.am/db/1799102/Softtech_Vc>,
        <https://1145.am/db/1802288/Khosla_Ventures>,
        <https://1145.am/db/1802352/Smedvig_Capital>,
        <https://1145.am/db/1803458/Union_Square_Ventures>,
        <https://1145.am/db/1804091/Active_Venture_Partners>,
        <https://1145.am/db/1804960/Khosla_Ventures>,
        <https://1145.am/db/1807542/Earlybird_Ventures>,
        <https://1145.am/db/1809007/Khosla_Ventures>,
        <https://1145.am/db/1812267/Us_Venture_Partners>,
        <https://1145.am/db/1815701/Khosla_Ventures>,
        <https://1145.am/db/1815910/E-Ventures>,
        <https://1145.am/db/1816423/Usvp>,
        <https://1145.am/db/1818161/Shasta_Ventures>,
        <https://1145.am/db/1818174/Eventures>,
        <https://1145.am/db/1821929/Khosla_Ventures>,
        <https://1145.am/db/1823663/Ifc>,
        <https://1145.am/db/1825387/Shasta_Ventures>,
        <https://1145.am/db/1826265/Mkii_Ventures>,
        <https://1145.am/db/1827021/Shasta_Ventures>,
        <https://1145.am/db/1828336/Khosla_Ventures>,
        <https://1145.am/db/1829581/Union_Square_Ventures>,
        <https://1145.am/db/1829612/Khosla_Ventures>,
        <https://1145.am/db/1829878/Active_Venture_Partners>,
        <https://1145.am/db/1830613/Sutter_Hill_Ventures>,
        <https://1145.am/db/1834279/Xseed_Capital>,
        <https://1145.am/db/1835126/Khosla_Ventures>,
        <https://1145.am/db/1835229/Sparklabs_Global_Ventures>,
        <https://1145.am/db/1835825/Shasta_Ventures>,
        <https://1145.am/db/1837155/Xseed_Capital>,
        <https://1145.am/db/1840793/Khosla_Ventures>,
        <https://1145.am/db/1842301/Khosla_Ventures>,
        <https://1145.am/db/1842466/Us_Venture_Partners>,
        <https://1145.am/db/1843362/Khosla_Ventures>,
        <https://1145.am/db/1846483/Softtech_Vc>,
        <https://1145.am/db/1846721/Union_Square_Ventures>,
        <https://1145.am/db/1852806/Us_Venture_Partners>,
        <https://1145.am/db/1853548/Khosla_Ventures>,
        <https://1145.am/db/1854200/Khosla_Ventures>,
        <https://1145.am/db/1855363/Sk_Ventures>,
        <https://1145.am/db/1856376/Khosla_Ventures>,
        <https://1145.am/db/1857635/Active_Venture_Partners>,
        <https://1145.am/db/1857930/Softtech_Vc>,
        <https://1145.am/db/1858323/Union_Square_Ventures>,
        <https://1145.am/db/1858991/Active_Venture_Partners>,
        <https://1145.am/db/1859199/Khosla_Ventures>,
        <https://1145.am/db/1860091/Union_Square_Ventures>,
        <https://1145.am/db/1860196/Union_Square_Ventures>,
        <https://1145.am/db/1861355/Khosla_Ventures>,
        <https://1145.am/db/1862590/Sutter_Hill_Ventures>,
        <https://1145.am/db/1863500/Khosla_Ventures>,
        <https://1145.am/db/1868107/Shasta_Ventures>,
        <https://1145.am/db/1868572/Union_Square_Ventures>,
        <https://1145.am/db/1871784/Us_Venture_Partners>,
        <https://1145.am/db/1872654/Sutter_Hill_Ventures>,
        <https://1145.am/db/1874278/Khosla_Ventures>,
        <https://1145.am/db/1875709/Sutter_Hill_Ventures>,
        <https://1145.am/db/1876758/Union_Square_Ventures>,
        <https://1145.am/db/1879026/Us_Venture_Partners>,
        <https://1145.am/db/1881464/Khosla_Ventures>,
        <https://1145.am/db/1884155/Us_Venture_Partners>,
        <https://1145.am/db/1892472/Union_Square_Ventures>,
        <https://1145.am/db/1895951/Khosla_Ventures>,
        <https://1145.am/db/1896368/New_Wave_Ventures>,
        <https://1145.am/db/1896530/Khosla_Ventures>,
        <https://1145.am/db/1899282/Mk_Capital>,
        <https://1145.am/db/1899737/Union_Square_Ventures>,
        <https://1145.am/db/1900812/Khosla_Ventures>,
        <https://1145.am/db/1904202/Shasta_Ventures>,
        <https://1145.am/db/1911584/Stage_1_Ventures>,
        <https://1145.am/db/1911840/Shasta_Ventures>,
        <https://1145.am/db/1915640/Us_Venture_Partners>,
        <https://1145.am/db/1917671/Fidelity_Ventures>,
        <https://1145.am/db/1922138/Softtech_Vc>,
        <https://1145.am/db/1931918/Svb_Financial_Group>,
        <https://1145.am/db/1939990/Gsr_Ventures>,
        <https://1145.am/db/1947193/Starbloom_Capital>,
        <https://1145.am/db/1947303/B37_Ventures>,
        <https://1145.am/db/1960888/Khosla_Ventures>,
        <https://1145.am/db/1962819/Jumpstart_Ventures>,
        <https://1145.am/db/2009653/Nationwide_Ventures>,
        <https://1145.am/db/2032146/Booz_Allen_Ventures>,
        <https://1145.am/db/2056931/L___S_Venture_Capital>,
        <https://1145.am/db/2071531/A_o>,
        <https://1145.am/db/2082923/Psl_Ventures>,
        <https://1145.am/db/2090647/Khosla_Ventures>,
        <https://1145.am/db/2092604/Srmg_Ventures>,
        <https://1145.am/db/2099365/Do_Ventures>,
        <https://1145.am/db/2114292/Khosla_Ventures>,
        <https://1145.am/db/2114498/Khosla_Ventures>,
        <https://1145.am/db/2134994/Union_Square_Ventures>,
        <https://1145.am/db/2135622/Khosla_Ventures>,
        <https://1145.am/db/2135690/Better_Ventures>,
        <https://1145.am/db/2142825/Commerce_Ventures>,
        <https://1145.am/db/2151946/Khosla_Ventures>,
        <https://1145.am/db/2153616/South>,
        <https://1145.am/db/2154009/Andera_Partners>,
        <https://1145.am/db/2155474/Sig>,
        <https://1145.am/db/2194249/Union_Square_Ventures>,
        <https://1145.am/db/2210557/Softtech_Vc>,
        <https://1145.am/db/2285566/Sabadell_Venture_Capital>,
        <https://1145.am/db/2288251/Us_Venture_Partners>,
        <https://1145.am/db/2300288/Spark_Ventures>,
        <https://1145.am/db/2300466/Khosla_Ventures>,
        <https://1145.am/db/2305964/Sls_Venture>,
        <https://1145.am/db/2310285/Valley_Ventures>,
        <https://1145.am/db/2311076/Venture_Investors>,
        <https://1145.am/db/2315754/Valley_Ventures>,
        <https://1145.am/db/2319675/Sac>,
        <https://1145.am/db/2343206/Us_Venture_Partners>,
        <https://1145.am/db/2348356/Sambrinvest>,
        <https://1145.am/db/2352804/Enterprise_Partners>,
        <https://1145.am/db/2354752/Venture_Investors_Llc>,
        <https://1145.am/db/2364014/Ro_Invest>,
        <https://1145.am/db/2567406/Exsight_Ventures>,
        <https://1145.am/db/2575232/Venture_Investors_Llc>,
        <https://1145.am/db/2616685/Silver_Creek_Ventures>,
        <https://1145.am/db/2641337/Valuestream_Ventures>,
        <https://1145.am/db/2790795/Shima_Capital>,
        <https://1145.am/db/365631/Khosla_Ventures>,
        <https://1145.am/db/376872/K50_Ventures>,
        <https://1145.am/db/396307/B_Capital_Group>,
        <https://1145.am/db/407681/Khosla_Ventures>,
        <https://1145.am/db/425922/Royal_Street_Ventures>,
        <https://1145.am/db/426637/Khosla_Ventures>,
        <https://1145.am/db/428324/Khosla_Ventures>,
        <https://1145.am/db/429179/Shasta_Ventures>,
        <https://1145.am/db/430553/Shasta_Ventures>,
        <https://1145.am/db/430986/Olsf_Ventures>,
        <https://1145.am/db/432552/Valuestream_Ventures>,
        <https://1145.am/db/437556/Khosla_Ventures>,
        <https://1145.am/db/438632/Khosla_Ventures>,
        <https://1145.am/db/447456/Starta_Vc>,
        <https://1145.am/db/486858/Khosla_Ventures>,
        <https://1145.am/db/486901/Khosla_Ventures>,
        <https://1145.am/db/502886/Sutter_Hill_Ventures>,
        <https://1145.am/db/506085/Sutter_Hill_Ventures>,
        <https://1145.am/db/523013/Hscm_Ventures>,
        <https://1145.am/db/523013/Sure_Ventures>,
        <https://1145.am/db/527960/Hscm_Ventures>,
        <https://1145.am/db/527960/Sure_Ventures>,
        <https://1145.am/db/562996/Shasta_Ventures>,
        <https://1145.am/db/564008/Secure_Ventures>,
        <https://1145.am/db/572414/A-Street_Ventures>,
        <https://1145.am/db/577305/A-Street_Ventures>,
        <https://1145.am/db/587038/Hv_Capital>,
        <https://1145.am/db/606074/Elementum_Ventures>,
        <https://1145.am/db/661747/Sosv>,
        <https://1145.am/db/663618/Sosv>,
        <https://1145.am/db/676938/Khosla_Ventures>,
        <https://1145.am/db/678262/Khosla_Ventures>,
        <https://1145.am/db/678416/St_Engineering_Ventures_Pte_Ltd>,
        <https://1145.am/db/679989/Khosla_Ventures>,
        <https://1145.am/db/696617/Suro_Capital>,
        <https://1145.am/db/753251/Sosv>,
        <https://1145.am/db/753759/Ms___Ad_Ventures>,
        <https://1145.am/db/75860/Sws_Venture_Capital>,
        <https://1145.am/db/778025/Soma_Capital>,
        <https://1145.am/db/784869/Hbse_Ventures>,
        <https://1145.am/db/791643/Cssd_Capital>,
        <https://1145.am/db/800101/Khosla_Ventures>,
        <https://1145.am/db/807080/Adb_Ventures>,
        <https://1145.am/db/817162/Khosla_Ventures>,
        <https://1145.am/db/817162/Shell_Ventures>,
        <https://1145.am/db/883036/Big_Idea_Ventures>,
        <https://1145.am/db/890955/S2g_Ventures>,
        <https://1145.am/db/906393/1982_Ventures>,
        <https://1145.am/db/912943/Khosla_Ventures>,
        <https://1145.am/db/928782/Psl_Ventures>,
        <https://1145.am/db/930464/Psl_Ventures>,
        <https://1145.am/db/935046/Gsr_Ventures>,
        <https://1145.am/db/940913/Xplorer_Capital>,
        <https://1145.am/db/952434/K50_Ventures>,
        <https://1145.am/db/979911/Khosla_Ventures>,
        <https://1145.am/db/980951/Khosla_Ventures>,
        <https://1145.am/db/996940/Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1105339/Venture_Investors>,
        <https://1145.am/db/2299743/Venture_Investors>,
        <https://1145.am/db/2301714/Venture_Investors>,
        <https://1145.am/db/2301715/Venture_Investors>,
        <https://1145.am/db/2303695/Venture_Investors_Llc>,
        <https://1145.am/db/2321713/Venture_Investors>,
        <https://1145.am/db/2364827/Venture_Investors>,
        <https://1145.am/db/2365444/Venture_Investors>,
        <https://1145.am/db/2367046/Venture_Investors_Llc>,
        <https://1145.am/db/2369504/Venture_Investors_Llc>,
        <https://1145.am/db/2556669/Venture_Investors_Llc>,
        <https://1145.am/db/2583558/Venture_Investors_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354806/Series-A_Investment_Flagship_Ventures_Polaris_Venture_Partners_Wikicell_Designs_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-04T12:13:41+00:00"^^xsd:dateTime ;
    ns1:documentExtract "& PARIS, Sep 04, 2012 (BUSINESS WIRE) - WikiCell Designs Inc., a Cambridge, Mass.",
        "Startup WikiCell Designs Secures $ 10 Million in Investment Capital from Flagship Ventures and Polaris Venture Partners.",
        "and Paris, France company developing deliciously edible forms of food and beverage packaging, today announced that it closed a $ 10 million Series-A financing co - led by Flagship Ventures and Polaris Venture Partners." ;
    ns1:documentTitle "Startup WikiCell Designs Secures $10 Million in Investment Capital from Flagship Ventures and Polaris Venture Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/startup-wikicell-designs-secures-10-million-investment-capital-from-flagship-ventures> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2354806/Wikicell_Designs_Inc> ;
    ns1:targetDetails "Series-A" ;
    ns1:valueRaw "$ 10 Million",
        "$ 10 million" ;
    ns1:when "2012-09-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012-09-04" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass" .

<https://1145.am/db/2355800/Quartz_Bio_Joint_Venture> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment",
        "joint venture" ;
    ns1:documentDate "2012-09-04T13:15:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Merck Serono Announces the Creation of Quartz Bio, a Bioinformatics Company Formed Through its Entrepreneur Partnership Program.",
        "Merck Serono, a division of Merck, Darmstadt, Germany, announced today the creation of Quartz Bio, the second spin-off company resulting from its Entrepreneur Partnership Program launched in April 2012." ;
    ns1:documentTitle "Merck Serono Announces the Creation of Quartz Bio, a Bioinformatics Company Formed Through its Entrepreneur Partnership Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/merck-serono-announces-creation-of-quartz-bio-a-bioinformatics-company-formed-through-its> ;
    ns1:foundName "creation" ;
    ns1:name "creation" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2355800/Quartz_Bio> ;
    ns1:targetName "Quartz Bio" ;
    ns1:when "2012-09-03T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "September 3, 2012" ;
    ns1:whereGeoName "GenÃ¨ve" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2660646/about.rdf> ;
    ns1:whereRaw "GENEVA" .

<https://1145.am/db/2356391/Joint_Venture_Fred_Hutchinson_Cancer_Research_Center_Glaxosmithkline_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "joint venture" ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> The Fred Hutchinson Cancer Research Center and GlaxoSmithKline ($ GSK) announced a partnership to develop therapeutics to treat an inherited form of muscular dystrophy." ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:foundName "partnership" ;
    ns1:name "partnership" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2356396/23andme> a org:Organization ;
    ns1:description "genetics" ;
    ns1:documentDate "2012-12-12T05:00:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "23andMe",
        "23andMe, Inc." ;
    ns1:name "23andMe" ;
    ns1:sameAsHigh <https://1145.am/db/1849926/23andme>,
        <https://1145.am/db/2315221/23andme>,
        <https://1145.am/db/2317430/23andme>,
        <https://1145.am/db/2322873/23andme>,
        <https://1145.am/db/2335410/23andme>,
        <https://1145.am/db/2335722/23andme>,
        <https://1145.am/db/2341568/23andme>,
        <https://1145.am/db/2344024/23andme>,
        <https://1145.am/db/2361472/23andme>,
        <https://1145.am/db/2368432/23andme>,
        <https://1145.am/db/2368434/23andme>,
        <https://1145.am/db/2541350/23andme> ;
    ns1:sameAsMedium <https://1145.am/db/1696213/23andme_Inc>,
        <https://1145.am/db/1744418/23andme>,
        <https://1145.am/db/1759743/23andme>,
        <https://1145.am/db/1779452/23andme>,
        <https://1145.am/db/1781939/23andme>,
        <https://1145.am/db/1782707/23andme>,
        <https://1145.am/db/1860471/23andme>,
        <https://1145.am/db/1883008/23andme>,
        <https://1145.am/db/1903870/23andme>,
        <https://1145.am/db/1911282/23andme>,
        <https://1145.am/db/1913407/23andme>,
        <https://1145.am/db/2186924/23andme>,
        <https://1145.am/db/2190169/23andme>,
        <https://1145.am/db/2198393/23andme>,
        <https://1145.am/db/223200/23andme>,
        <https://1145.am/db/2285807/23andme>,
        <https://1145.am/db/2292884/23andme>,
        <https://1145.am/db/2316189/23andme>,
        <https://1145.am/db/2317424/23andme>,
        <https://1145.am/db/2318638/23andme>,
        <https://1145.am/db/2328266/23andme>,
        <https://1145.am/db/2328936/23andme>,
        <https://1145.am/db/2328937/23andme>,
        <https://1145.am/db/2329513/23andme>,
        <https://1145.am/db/2333116/23andme>,
        <https://1145.am/db/2333119/23andme>,
        <https://1145.am/db/2335726/23andme>,
        <https://1145.am/db/2339211/23andme>,
        <https://1145.am/db/2350327/23andme>,
        <https://1145.am/db/2368057/23andme>,
        <https://1145.am/db/2369462/23andme>,
        <https://1145.am/db/264973/23andme>,
        <https://1145.am/db/567026/23andme> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356396/Mpm_Capital> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2012-12-12T05:00:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "MPM",
        "MPM Capital" ;
    ns1:investor <https://1145.am/db/2356396/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Yuri_Milner_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsHigh <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2346204/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333119/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2345318/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347984/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2350030/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2358979/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2362871/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2366744/Mpm_Capital>,
        <https://1145.am/db/2369202/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356396/Yuri_Milner> a org:Organization ;
    ns1:description "Google Ventures" ;
    ns1:documentDate "2012-12-12T05:00:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "Yuri Milner" ;
    ns1:investor <https://1145.am/db/2356396/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Yuri_Milner_Completed> ;
    ns1:name "Yuri Milner" ;
    ns1:sameAsHigh <https://1145.am/db/2333119/Sergey_Brin>,
        <https://1145.am/db/2333119/Yuri_Milner> ;
    ns1:sameAsMedium <https://1145.am/db/1792284/Yuri_Milner>,
        <https://1145.am/db/1795658/Yuri_Milner>,
        <https://1145.am/db/1818901/Yuri_Milner>,
        <https://1145.am/db/1834604/Yuri_Milner>,
        <https://1145.am/db/1861010/Yuri_Milner>,
        <https://1145.am/db/1865235/Yuri_Milner>,
        <https://1145.am/db/1872766/Yuri_Milner>,
        <https://1145.am/db/1873680/Yuri_Milner>,
        <https://1145.am/db/1881980/Yuri_Milner>,
        <https://1145.am/db/1891907/Yuri_Milner>,
        <https://1145.am/db/2211610/Yuri_Milner>,
        <https://1145.am/db/2211653/Yuri_Milner>,
        <https://1145.am/db/2359655/Yuri_Milner> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356402/Series_A_Investment_Lundbeckfond_Ventures_River_Vision_Development_Corp_Sr_One_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-12T13:09:35+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NEW YORK, Dec. 12, 2012 /PRNewswire-iReach/ - River Vision Development Corp. today announced the completion of a Series A financing, raising $ 17 million for the development of a novel protein therapy, RV 001, for the treatment of Graves' Orbitopathy (GO) .",
        "River Vision Announces Completion of $ 17 million Series A Financing." ;
    ns1:documentTitle "River Vision Announces Completion of $17 million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/river-vision-announces-completion-of-17-million-series-a-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2356402/River_Vision_Development_Corp> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 17 million" ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "New York City" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5128581/about.rdf> ;
    ns1:whereRaw "NEW YORK" .

<https://1145.am/db/2356420/Medimmune_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Wu" ;
    ns1:description "private equity financing" ;
    ns1:documentDate "2012-12-13T05:00:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerapedics Secures $19 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerapedics-secures-19-million-series-c-financing> ;
    ns1:foundName "MedImmune Ventures" ;
    ns1:investor <https://1145.am/db/2356420/Equity_Private_Equity_Investment_Cvf_Llc_Cerapedics_Inc_Henry_Crown_And_Company_Medimmune_Ventures_Ngn_Capital_Orbimed_Advisors_Completed> ;
    ns1:name "MedImmune Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2302351/Meditor_Capital_Management>,
        <https://1145.am/db/2317919/Mediphase_Venture_Partners>,
        <https://1145.am/db/2327488/Mediphase_Venture_Partners>,
        <https://1145.am/db/2352436/Medimmune_Ventures>,
        <https://1145.am/db/2360174/Mediphase_Venture_Partners>,
        <https://1145.am/db/2363460/Medimmune_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/2302192/Medimmune_Ventures>,
        <https://1145.am/db/2302351/Medimmune_Ventures>,
        <https://1145.am/db/2305587/Medimmune_Ventures>,
        <https://1145.am/db/2314492/Medimmune_Ventures>,
        <https://1145.am/db/2316823/Medimmune_Ventures>,
        <https://1145.am/db/2317561/Medimmune_Ventures>,
        <https://1145.am/db/2317564/Medimmune_Ventures>,
        <https://1145.am/db/2317737/Medimmune_Ventures>,
        <https://1145.am/db/2318656/Medimmune_Ventures>,
        <https://1145.am/db/2318657/Medimmune_Ventures>,
        <https://1145.am/db/2319360/Medimmune_Ventures>,
        <https://1145.am/db/2322012/Medimmune_Ventures>,
        <https://1145.am/db/2322022/Medimmune_Ventures>,
        <https://1145.am/db/2322939/Medimmune_Ventures>,
        <https://1145.am/db/2323785/Medimmune_Ventures>,
        <https://1145.am/db/2324159/Medimmune_Ventures>,
        <https://1145.am/db/2324289/Medimmune_Ventures>,
        <https://1145.am/db/2327379/Medimmune_Ventures>,
        <https://1145.am/db/2330867/Medimmune_Ventures>,
        <https://1145.am/db/2336313/Medimmune_Ventures>,
        <https://1145.am/db/2342213/Medimmune_Ventures>,
        <https://1145.am/db/2343722/Medimmune_Ventures>,
        <https://1145.am/db/2343725/Medimmune_Ventures>,
        <https://1145.am/db/2343737/Medimmune_Ventures>,
        <https://1145.am/db/2346030/Medimmune_Ventures>,
        <https://1145.am/db/2347389/Medimmune_Ventures>,
        <https://1145.am/db/2350199/Medimmune_Ventures>,
        <https://1145.am/db/2352442/Medimmune_Ventures>,
        <https://1145.am/db/2360756/Medimmune_Ventures>,
        <https://1145.am/db/2360758/Medimmune_Ventures>,
        <https://1145.am/db/2362472/Medimmune_Ventures>,
        <https://1145.am/db/2363442/Medimmune_Ventures>,
        <https://1145.am/db/2363459/Medimmune_Ventures>,
        <https://1145.am/db/2364853/Medimmune_Ventures>,
        <https://1145.am/db/2551315/Medimmune_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356885/Aduro_Biotech> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "medical research" ;
    ns1:documentDate "2012-09-07T04:01:34+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aduro Awarded CDMRP Grant for Prostate Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aduro-awarded-cdmrp-grant-for-prostate-cancer-vaccine-development> ;
    ns1:foundName "Aduro BioTech, Inc." ;
    ns1:name "Aduro BioTech" ;
    ns1:sameAsHigh <https://1145.am/db/2577162/Aduro_Biotech> ;
    ns1:sameAsMedium <https://1145.am/db/2153026/Aduro_Biotech>,
        <https://1145.am/db/2328011/Aduro_Biotech>,
        <https://1145.am/db/2344597/Aduro_Biotech>,
        <https://1145.am/db/2344604/Aduro_Biotech>,
        <https://1145.am/db/2344605/Aduro_Biotech>,
        <https://1145.am/db/2346084/Aduro_Biotech>,
        <https://1145.am/db/2346092/Aduro_Biotech>,
        <https://1145.am/db/2351657/Aduro_Biotech>,
        <https://1145.am/db/2352890/Aduro_Biotech>,
        <https://1145.am/db/2355023/Aduro_Biotech>,
        <https://1145.am/db/2355027/Aduro_Biotech>,
        <https://1145.am/db/2357542/Aduro_Biotech>,
        <https://1145.am/db/2367793/Aduro_Biotech>,
        <https://1145.am/db/2370418/Aduro_Biotech>,
        <https://1145.am/db/2370548/Aduro_Biotech>,
        <https://1145.am/db/2370549/Aduro_Biotech>,
        <https://1145.am/db/2370578/Aduro_Biotech>,
        <https://1145.am/db/2579723/Aduro_Biotech>,
        <https://1145.am/db/2579725/Aduro_Biotech> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Savitr_Capital> a org:Organization ;
    ns1:basedInLowRaw "EVANSTON, Ill" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Savitr Capital" ;
    ns1:investor <https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> ;
    ns1:name "Savitr Capital" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/ConvivialitÃ©_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/AglaÃ©_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/AglaÃ©_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/AglaÃ©_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/ConvivialitÃ©_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_GrÃ¼nderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_GrÃ¼nderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359562/Pappas_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_GrÃ¼nderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2361761/Savitr_Capital_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357905/The_Medicines_Company> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-09-10T12:03:59+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Annovation Biopharma, Inc. Raises $8M to Develop Novel Anesthetics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/annovation-biopharma-inc-raises-8m-to-develop-novel-anesthetics-0> ;
    ns1:foundName "The Medicines Company" ;
    ns1:industry "Biotechnology" ;
    ns1:investor <https://1145.am/db/2357905/Series_A_Investment_Annovation_Biopharma_Atlas_Venture_Partners_Innovation_Fund_The_Medicines_Company_Completed> ;
    ns1:name "The Medicines Company" ;
    ns1:sameAsHigh <https://1145.am/db/1003058/Microbiologics>,
        <https://1145.am/db/1003231/Microbiologics>,
        <https://1145.am/db/1103357/Esperion>,
        <https://1145.am/db/1183641/Tyme>,
        <https://1145.am/db/1184316/Tyme>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1213270/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1216194/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1224125/Ars_Pharmaceuticals>,
        <https://1145.am/db/1224418/Ars_Pharmaceuticals>,
        <https://1145.am/db/1225975/Ars_Pharmaceuticals_Inc>,
        <https://1145.am/db/1226849/Ars_Pharmaceuticals>,
        <https://1145.am/db/1252190/F2g_Ltd>,
        <https://1145.am/db/1252426/Amgen_Inc>,
        <https://1145.am/db/1265967/Tyme>,
        <https://1145.am/db/1266692/Tyme>,
        <https://1145.am/db/1271008/Biohaven>,
        <https://1145.am/db/1322590/Biora_Therapeutics_Inc>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1334447/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1360048/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1361196/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1366554/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417340/Ars_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1488570/Amgen>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1505021/Pharmaceutics_International_Inc>,
        <https://1145.am/db/1538098/Biocon_Ltd>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amgen>,
        <https://1145.am/db/1574155/Amgen>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1606076/Gni_Group_Ltd>,
        <https://1145.am/db/1620251/Pheast_Therapeutics>,
        <https://1145.am/db/1629415/Anivive_Lifesciences>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1684691/Theravance_Biopharma_Inc>,
        <https://1145.am/db/1685745/Dmk_Pharmaceuticals_Corp>,
        <https://1145.am/db/1956623/Concept_Life_Sciences>,
        <https://1145.am/db/1957460/Pardes_Biosciences_Inc>,
        <https://1145.am/db/1965949/Glenmark_Life_Sciences_Ltd>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2004101/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2051134/Vernal_Biosciences>,
        <https://1145.am/db/2054868/Pharmaceuticals_Inc>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2117986/Generate:_Biomedicines>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152849/Abide_Therapeutics>,
        <https://1145.am/db/2153295/Curzion_Pharmaceuticals>,
        <https://1145.am/db/2153653/Myoscience>,
        <https://1145.am/db/2153719/Amag_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2212420/Cel-Sci_Corporation>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2225379/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2234316/Intercell_Ag>,
        <https://1145.am/db/2249221/Biomimetic_Therapeutics>,
        <https://1145.am/db/2250936/Fera_Pharmaceuticals>,
        <https://1145.am/db/2277669/Pharmerica_Corporation>,
        <https://1145.am/db/2283107/Concentra_Biosciences>,
        <https://1145.am/db/2285587/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2286154/Q32_Bio>,
        <https://1145.am/db/2286671/Promedior>,
        <https://1145.am/db/2289865/Thar_Pharmaceuticals>,
        <https://1145.am/db/2289873/Thar_Pharmaceuticals>,
        <https://1145.am/db/2290753/Medivir>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2295270/Biomodex>,
        <https://1145.am/db/2296062/Arix_Bioscience>,
        <https://1145.am/db/2297691/Ucb>,
        <https://1145.am/db/2298017/Kleo_Pharmaceuticals>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2301414/Clinicalrm>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2301824/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303552/Meda>,
        <https://1145.am/db/2303645/Akarx>,
        <https://1145.am/db/2303646/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303647/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2303974/Actimis_Pharmaceuticals>,
        <https://1145.am/db/2304044/Fidelity_Biosciences>,
        <https://1145.am/db/2304342/PTC>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2306115/Aesrx>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310302/Charter_Life_Sciences>,
        <https://1145.am/db/2310568/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311353/Charter_Life_Sciences>,
        <https://1145.am/db/2311359/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2313181/Pharmeng_International_Inc>,
        <https://1145.am/db/2313305/Fidelity_Biosciences>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314563/Inex_Pharmaceuticals>,
        <https://1145.am/db/2314836/Ricerca_Biosciences>,
        <https://1145.am/db/2315170/Alan_Copa>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315296/Pharmatec_Gmbh>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316380/Aeon_Bioscience>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317581/Progen_Pharmaceuticals_Limited>,
        <https://1145.am/db/2317737/Fidelity_Biosciences>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318104/Pharmaform>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318795/Axial_Biotech>,
        <https://1145.am/db/2318905/Fidelity_Biosciences>,
        <https://1145.am/db/2319846/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320768/Semafore_Pharmaceuticals>,
        <https://1145.am/db/2320771/Amgen>,
        <https://1145.am/db/2320775/Amgen>,
        <https://1145.am/db/2321150/Alinea_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2322159/Pharmaceutical>,
        <https://1145.am/db/2322531/Forbion>,
        <https://1145.am/db/2322632/Amgen>,
        <https://1145.am/db/2322850/Clinipace>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323303/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2324141/Ucb>,
        <https://1145.am/db/2324372/Ucb>,
        <https://1145.am/db/2324422/Intermune>,
        <https://1145.am/db/2325215/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325260/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2326361/Apt_Pharmaceuticals>,
        <https://1145.am/db/2326361/Charter_Life_Sciences>,
        <https://1145.am/db/2326373/Charter_Life_Sciences>,
        <https://1145.am/db/2326397/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326541/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2326576/Fidelity_Biosciences>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327258/Biocon_Limited>,
        <https://1145.am/db/2327649/Connetics>,
        <https://1145.am/db/2328012/Intermune>,
        <https://1145.am/db/2328017/Calando_Pharmaceuticals>,
        <https://1145.am/db/2328330/Meda>,
        <https://1145.am/db/2328729/Connetics>,
        <https://1145.am/db/2328962/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329696/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2329792/Semafore_Pharmaceuticals>,
        <https://1145.am/db/2329848/Idm_Pharma>,
        <https://1145.am/db/2330121/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330734/Pharmaceuticals_Group>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330933/Biocon>,
        <https://1145.am/db/2330949/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330973/Bioxell>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331795/Ucb>,
        <https://1145.am/db/2331983/Drugabuse_Sciences>,
        <https://1145.am/db/2332028/Donald_Leung>,
        <https://1145.am/db/2332912/Bioscrip>,
        <https://1145.am/db/2332920/Nastech>,
        <https://1145.am/db/2333460/Amgen>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336175/Forum_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336225/Acorda>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336936/Amag_Pharmaceuticals>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337433/Amgen>,
        <https://1145.am/db/2337435/Amgen_Inc>,
        <https://1145.am/db/2337455/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2337481/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2339127/Kala_Pharmaceuticals>,
        <https://1145.am/db/2339175/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2339830/Ocera>,
        <https://1145.am/db/2340040/Coherus_Biosciences>,
        <https://1145.am/db/2340882/Coherus_Biosciences>,
        <https://1145.am/db/2341621/Clal_Biotechnology_Industries>,
        <https://1145.am/db/2341743/Amag_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342687/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2343210/Promedior>,
        <https://1145.am/db/2343325/Medivir>,
        <https://1145.am/db/2343497/Fera_Pharmaceuticals>,
        <https://1145.am/db/2343862/Amgen>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344560/Dmi_Biosciences_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344864/Amgen>,
        <https://1145.am/db/2345886/Amgen>,
        <https://1145.am/db/2346138/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2347123/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2347125/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347976/Amgen>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348620/Diartis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349031/Meda>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349461/Ista_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350029/Amgen>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350465/Amgen>,
        <https://1145.am/db/2350975/Meda>,
        <https://1145.am/db/2351432/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2352516/S_*_Bio>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353167/Amgen>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2354145/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2355102/Addex_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2355841/F2g_Ltd>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356410/Ym_Biosciences_Inc>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2356560/Theravance>,
        <https://1145.am/db/2357070/Orgenesis_Inc>,
        <https://1145.am/db/2357259/Galmed_Pharmaceuticals>,
        <https://1145.am/db/2357303/Amgen>,
        <https://1145.am/db/2357321/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358147/Omni_Bio_Pharmaceutical_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359380/Amri>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359681/Ucb>,
        <https://1145.am/db/2360006/Topica_Pharmaceuticals>,
        <https://1145.am/db/2360258/Aldea_Pharmaceuticals>,
        <https://1145.am/db/2360371/Preglem>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2361646/Biomarin>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362425/Osi_Pharmaceuticals>,
        <https://1145.am/db/2362609/Amag_Pharmaceuticals>,
        <https://1145.am/db/2362756/Anavex_Life_Sciences_Corp>,
        <https://1145.am/db/2363154/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363248/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2363461/Ucb>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364430/Cipla>,
        <https://1145.am/db/2365372/Bd>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367182/Biotica>,
        <https://1145.am/db/2368189/Index_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369617/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369883/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369984/Biogaia>,
        <https://1145.am/db/2370120/Amgen>,
        <https://1145.am/db/2370174/Amgen>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370437/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2370437/MSD>,
        <https://1145.am/db/2371320/Pharco_Pharmaceuticals>,
        <https://1145.am/db/2371522/Dyax>,
        <https://1145.am/db/238320/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2538019/Ucb>,
        <https://1145.am/db/2538392/Biocon>,
        <https://1145.am/db/2538422/Idt>,
        <https://1145.am/db/2538705/PTC>,
        <https://1145.am/db/2539759/Twi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2540249/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541419/Amri>,
        <https://1145.am/db/2542071/Ucb>,
        <https://1145.am/db/2544054/Cipla>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2547068/Alapis>,
        <https://1145.am/db/2547319/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2547593/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2550232/Cipla>,
        <https://1145.am/db/2550523/Quotient_Bioresearch>,
        <https://1145.am/db/2550884/Amgen>,
        <https://1145.am/db/2551315/Fidelity_Biosciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2553564/Amgen>,
        <https://1145.am/db/2554824/Cipla>,
        <https://1145.am/db/2555921/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2557028/DPX>,
        <https://1145.am/db/2558071/Cipla>,
        <https://1145.am/db/2559940/Plumbline_Life_Sciences>,
        <https://1145.am/db/2561325/Amgen>,
        <https://1145.am/db/2561791/Cipla>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562552/Ucb>,
        <https://1145.am/db/2562723/Biontech>,
        <https://1145.am/db/2563255/MSD>,
        <https://1145.am/db/2563450/Kv_Pharmaceuticals>,
        <https://1145.am/db/2564030/Ucb>,
        <https://1145.am/db/2566424/Dbl_Pharmaceuticals>,
        <https://1145.am/db/2566946/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2567296/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2567319/PTC>,
        <https://1145.am/db/2569099/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2569102/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569425/Ucb>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570122/Ucb>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570733/Dyax_Corp>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2571136/Kala_Pharmaceuticals>,
        <https://1145.am/db/2571316/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2571723/Amag_Pharmaceuticals>,
        <https://1145.am/db/2572018/Meda>,
        <https://1145.am/db/2572393/Pharmacia_Corporation>,
        <https://1145.am/db/2573593/Biotica>,
        <https://1145.am/db/2574213/Pharmacia_Corporation>,
        <https://1145.am/db/2574421/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2575567/Fera_Pharmaceuticals>,
        <https://1145.am/db/2575850/Cipla>,
        <https://1145.am/db/2576242/Amgen>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577120/Amgen>,
        <https://1145.am/db/2578095/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578209/Ucb>,
        <https://1145.am/db/2578420/Meda_Pharmaceuticals>,
        <https://1145.am/db/2578667/Almirall>,
        <https://1145.am/db/2579104/Ucb>,
        <https://1145.am/db/2579211/Amgen>,
        <https://1145.am/db/2581394/Biocon>,
        <https://1145.am/db/2581552/Imprimis_Pharmaceuticals>,
        <https://1145.am/db/2582283/Amag_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2582681/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583352/Mikah>,
        <https://1145.am/db/2583430/Imprimis_Pharmaceuticals>,
        <https://1145.am/db/2583437/Meda>,
        <https://1145.am/db/2583783/Biomarin>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2584617/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2584750/Meda>,
        <https://1145.am/db/2584951/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2585327/Cipla_Limited>,
        <https://1145.am/db/2585500/Univercells>,
        <https://1145.am/db/2586547/Ucb>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587292/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588372/Fidelity_Biosciences>,
        <https://1145.am/db/2589317/Diartis_Pharmaceuticals>,
        <https://1145.am/db/2589414/Spepharm_Ag>,
        <https://1145.am/db/2590195/Nectid>,
        <https://1145.am/db/2591587/Amgen>,
        <https://1145.am/db/2591594/Amgen>,
        <https://1145.am/db/2591596/Agila_Specialties>,
        <https://1145.am/db/2592126/Intermune>,
        <https://1145.am/db/2592254/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2592336/Dyax>,
        <https://1145.am/db/2592874/Ucb>,
        <https://1145.am/db/2593048/Meda>,
        <https://1145.am/db/2593423/Amgen>,
        <https://1145.am/db/2593426/Amgen>,
        <https://1145.am/db/2593433/Amgen_Inc>,
        <https://1145.am/db/2593434/Amgen>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594168/Meda>,
        <https://1145.am/db/2594183/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594257/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2594262/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2594414/Ista_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2594858/Afexa_Life_Sciences_Inc>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595326/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2595549/Amgen>,
        <https://1145.am/db/2595587/Amgen>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596636/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2596819/Amgen>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598012/Afexa_Life_Sciences>,
        <https://1145.am/db/2598012/Allos_Therapeutics>,
        <https://1145.am/db/2598032/Afexa_Life_Sciences_Inc>,
        <https://1145.am/db/2598066/Amgen>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/299734/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/402158/Puretech>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/587627/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/592025/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/612466/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/612973/Mingsight_Pharmaceuticals>,
        <https://1145.am/db/614114/Mingsight_Pharmaceuticals>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/696633/Aragen_Life_Sciences>,
        <https://1145.am/db/701847/Specific_Biologics_Inc>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/714395/Arix_Bioscience_Plc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/731944/Aipharma>,
        <https://1145.am/db/739339/Iveric_Bio>,
        <https://1145.am/db/744958/Recipharm_Group>,
        <https://1145.am/db/746462/Recipharm_Group>,
        <https://1145.am/db/763450/Boundless_Bio>,
        <https://1145.am/db/769779/Ucb_Sa>,
        <https://1145.am/db/769887/Ucb_Sa>,
        <https://1145.am/db/792894/Amt>,
        <https://1145.am/db/812449/Boundless_Bio>,
        <https://1145.am/db/848323/Pharmaceutics_International_Inc>,
        <https://1145.am/db/854160/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/867644/Aipharma_Group_Ltd>,
        <https://1145.am/db/871621/Aipharma_Group_Ltd>,
        <https://1145.am/db/881631/Pharmcorx>,
        <https://1145.am/db/881719/Pharmcorx>,
        <https://1145.am/db/893741/Aipharma_Group_Ltd>,
        <https://1145.am/db/895336/Aipharma_Group_Ltd>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/979879/Advanced_Clinical>,
        <https://1145.am/db/980904/Advanced_Clinical> ;
    ns1:sameAsMedium <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2155042/The_Medicines_Company>,
        <https://1145.am/db/2250347/The_Medicines_Company>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2332950/The_Medicines_Company>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2357928/The_Medicines_Company>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569731/The_Medicines_Company>,
        <https://1145.am/db/2572200/The_Medicines_Company> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358502/Novo_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-12-17T17:21:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Allakos Inc. Completes Series A Financing of $32 Million to Develop Antibody Therapeutics for Allergic and Inflammatory Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allakos-inc-completes-series-a-financing-of-32-million-to-develop-antibody-therapeutics-for> ;
    ns1:foundName "Novo Ventures" ;
    ns1:investor <https://1145.am/db/2358502/Series_A_Investment_Allakos_Inc_Alta_Partners_Novo_Ventures_Rivervest_Venture_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "Novo Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2251548/Novo_Ventures>,
        <https://1145.am/db/2284476/Novo_Ventures>,
        <https://1145.am/db/2313143/Novo_Ventures>,
        <https://1145.am/db/2326903/Novo_Ventures>,
        <https://1145.am/db/2330664/Novo_Ventures>,
        <https://1145.am/db/2330668/Novo_Ventures>,
        <https://1145.am/db/2336221/Novo_Ventures>,
        <https://1145.am/db/2339295/Novo_Ventures>,
        <https://1145.am/db/2343966/Novo_Ventures>,
        <https://1145.am/db/2350044/Novo_Ventures>,
        <https://1145.am/db/2352508/Novo_Ventures>,
        <https://1145.am/db/2353098/Novo_Ventures>,
        <https://1145.am/db/2353588/Novo_Ventures>,
        <https://1145.am/db/2353598/Novo_Ventures>,
        <https://1145.am/db/2353608/Novo_Ventures>,
        <https://1145.am/db/2354296/Novo_Ventures>,
        <https://1145.am/db/2354899/Novo_Ventures>,
        <https://1145.am/db/2354903/Novo_Ventures>,
        <https://1145.am/db/2356124/Novo_Ventures>,
        <https://1145.am/db/2358496/Novo_Ventures>,
        <https://1145.am/db/2361065/Novo_Ventures>,
        <https://1145.am/db/2362533/Novo_Ventures>,
        <https://1145.am/db/2363510/Novo_Ventures>,
        <https://1145.am/db/2365103/Novo_Ventures>,
        <https://1145.am/db/2370694/Novo_Ventures>,
        <https://1145.am/db/2371165/Novo_Ventures>,
        <https://1145.am/db/2371166/Novo_Ventures>,
        <https://1145.am/db/2570481/Novo_Ventures>,
        <https://1145.am/db/2570483/Novo_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358506/Blend_Therapeutics> a org:Organization ;
    ns1:description "product development" ;
    ns1:documentDate "2012-12-18T12:40:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/blend-therapeutics-closes-16-million-series-b-financing-0> ;
    ns1:foundName "Blend Therapeutics",
        "Blend Therapeutics, Inc." ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Blend Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2334846/Blend_Therapeutics>,
        <https://1145.am/db/2334847/Blend_Therapeutics>,
        <https://1145.am/db/2334848/Blend_Therapeutics>,
        <https://1145.am/db/2343790/Blend_Therapeutics>,
        <https://1145.am/db/2346070/Blend_Therapeutics>,
        <https://1145.am/db/2347141/Blend_Therapeutics>,
        <https://1145.am/db/2355059/Blend_Therapeutics>,
        <https://1145.am/db/2358529/Blend_Therapeutics>,
        <https://1145.am/db/2359572/Blend_Therapeutics>,
        <https://1145.am/db/2594764/Blend_Therapeutics>,
        <https://1145.am/db/2594773/Blend_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2346069/Blend_Therapeutics>,
        <https://1145.am/db/2347111/Blend_Therapeutics>,
        <https://1145.am/db/2355058/Blend_Therapeutics>,
        <https://1145.am/db/2358536/Blend_Therapeutics>,
        <https://1145.am/db/2370873/Blend_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358979/Mpm_Capital> a org:Organization ;
    ns1:basedInLowRaw "N.C." ;
    ns1:documentDate "2012-09-12T14:43:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Vascular Pharmaceuticals, Inc. Completes $16 Million Equity Financing, Signs Agreement with Janssen Biotech, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-pharmaceuticals-inc-completes-16-million-equity-financing-signs-agreement-janssen> ;
    ns1:foundName "MPM Capital" ;
    ns1:investor <https://1145.am/db/2358979/Series_A_Investment_Intersouth_Partners_Mpm_Capital_Vascular_Pharmaceuticals_Completed> ;
    ns1:name "MPM Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1325968/Mpm_Capital>,
        <https://1145.am/db/1752458/Mpm_Capital>,
        <https://1145.am/db/2285876/Mpm_Capital>,
        <https://1145.am/db/2287191/Mpm_Capital>,
        <https://1145.am/db/2292334/Mpm_Capital>,
        <https://1145.am/db/2292353/Mpm_Capital>,
        <https://1145.am/db/2300455/Mpm_Capital>,
        <https://1145.am/db/2301901/Mpm_Capital>,
        <https://1145.am/db/2303391/Mpm_Capital>,
        <https://1145.am/db/2303833/Mpm_Capital>,
        <https://1145.am/db/2303855/Mpm_Capital>,
        <https://1145.am/db/2304634/Mpm_Capital>,
        <https://1145.am/db/2305503/Mpm_Capital>,
        <https://1145.am/db/2305656/Mpm_Capital>,
        <https://1145.am/db/2306705/Mpm_Capital>,
        <https://1145.am/db/2308887/Mpm_Capital>,
        <https://1145.am/db/2309845/Mpm_Capital>,
        <https://1145.am/db/2311551/Mpm_Capital>,
        <https://1145.am/db/2312285/Mpm_Capital>,
        <https://1145.am/db/2312309/Mpm_Capital>,
        <https://1145.am/db/2316391/Mpm_Capital>,
        <https://1145.am/db/2323055/Mpm_Capital>,
        <https://1145.am/db/2323066/Mpm_Capital>,
        <https://1145.am/db/2323094/Mpm_Capital>,
        <https://1145.am/db/2323563/Mpm_Capital>,
        <https://1145.am/db/2323568/Mpm_Capital>,
        <https://1145.am/db/2324195/Mpm_Capital>,
        <https://1145.am/db/2324226/Mpm_Capital>,
        <https://1145.am/db/2328338/Mpm_Capital>,
        <https://1145.am/db/2333119/Mpm_Capital>,
        <https://1145.am/db/2333525/Mpm_Capital>,
        <https://1145.am/db/2335701/Mpm_Capital>,
        <https://1145.am/db/2335714/Mpm_Capital>,
        <https://1145.am/db/2337140/Mpm_Capital>,
        <https://1145.am/db/2340957/Mpm_Capital>,
        <https://1145.am/db/2345299/Mpm_Capital>,
        <https://1145.am/db/2345318/Mpm_Capital>,
        <https://1145.am/db/2346204/Mpm_Capital>,
        <https://1145.am/db/2347140/Mpm_Capital>,
        <https://1145.am/db/2347469/Mpm_Capital>,
        <https://1145.am/db/2347984/Mpm_Capital>,
        <https://1145.am/db/2348484/Mpm_Capital>,
        <https://1145.am/db/2350030/Mpm_Capital>,
        <https://1145.am/db/2352172/Mpm_Capital>,
        <https://1145.am/db/2352362/Mpm_Capital>,
        <https://1145.am/db/2352899/Mpm_Capital>,
        <https://1145.am/db/2353365/Mpm_Capital>,
        <https://1145.am/db/2353404/Mpm_Capital>,
        <https://1145.am/db/2353413/Mpm_Capital>,
        <https://1145.am/db/2353415/Mpm_Capital>,
        <https://1145.am/db/2356396/Mpm_Capital>,
        <https://1145.am/db/2359001/Mpm_Capital>,
        <https://1145.am/db/2359873/Mpm_Capital>,
        <https://1145.am/db/2359875/Mpm_Capital>,
        <https://1145.am/db/2360526/Mpm_Capital>,
        <https://1145.am/db/2362871/Mpm_Capital>,
        <https://1145.am/db/2364492/Mpm_Capital>,
        <https://1145.am/db/2365098/Mpm_Capital>,
        <https://1145.am/db/2366744/Mpm_Capital>,
        <https://1145.am/db/2367199/Mpm_Capital>,
        <https://1145.am/db/2369202/Mpm_Capital>,
        <https://1145.am/db/2370582/Mpm_Capital>,
        <https://1145.am/db/2541350/Mpm_Capital>,
        <https://1145.am/db/677075/Mpm_Capital>,
        <https://1145.am/db/678997/Mpm_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358979/Series_A_Investment_Intersouth_Partners_Mpm_Capital_Vascular_Pharmaceuticals_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-12T14:43:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CHAPEL HILL, N.C.- (BUSINESS WIRE) -Vascular Pharmaceuticals, Inc. (Vascular Pharma) , a drug discovery company developing an innovative product to treat patients with complications arising from diabetes, announced today that it has successfully completed a $ 16 million Series A equity financing.",
        "Vascular Pharmaceuticals, Inc. Completes $ 16 Million Equity Financing, Signs Agreement with Janssen Biotech, Inc." ;
    ns1:documentTitle "Vascular Pharmaceuticals, Inc. Completes $16 Million Equity Financing, Signs Agreement with Janssen Biotech, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/vascular-pharmaceuticals-inc-completes-16-million-equity-financing-signs-agreement-janssen> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2358979/Vascular_Pharmaceuticals> ;
    ns1:targetDetails "Equity",
        "Series A" ;
    ns1:valueRaw "$ 16 Million",
        "$ 16 million" ;
    ns1:whereGeoName "Chapel Hill" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4460162/about.rdf> ;
    ns1:whereRaw "Chapel Hill" .

<https://1145.am/db/2359562/Fidelity_Biosciences> a org:Organization ;
    ns1:basedInLowRaw "NOVATO" ;
    ns1:documentDate "2012-12-20T11:39:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Raises $75 Million in Oversubscribed Crossover Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-raises-75-million-oversubscribed-crossover-financing> ;
    ns1:foundName "Fidelity Biosciences" ;
    ns1:investor <https://1145.am/db/2359562/Series_B_Investment_Adage_Capital_Partners_Fidelity_Biosciences_Healthcap_Pappas_Ventures_Tpg_Biotech_Ultragenyx_Pharmaceutical_Inc_Completed> ;
    ns1:name "Fidelity Biosciences" ;
    ns1:sameAsMedium <https://1145.am/db/1801792/Fidelity_Biosciences>,
        <https://1145.am/db/1849746/Fidelity_Biosciences>,
        <https://1145.am/db/2223723/Fidelity_Biosciences>,
        <https://1145.am/db/2303275/Fidelity_Biosciences>,
        <https://1145.am/db/2304028/Fidelity_Biosciences>,
        <https://1145.am/db/2304044/Fidelity_Biosciences>,
        <https://1145.am/db/2306790/Fidelity_Biosciences>,
        <https://1145.am/db/2313305/Fidelity_Biosciences>,
        <https://1145.am/db/2316601/Fidelity_Biosciences>,
        <https://1145.am/db/2316605/Fidelity_Biosciences>,
        <https://1145.am/db/2317737/Fidelity_Biosciences>,
        <https://1145.am/db/2318905/Fidelity_Biosciences>,
        <https://1145.am/db/2325553/Fidelity_Biosciences>,
        <https://1145.am/db/2326576/Fidelity_Biosciences>,
        <https://1145.am/db/2336890/Fidelity_Biosciences>,
        <https://1145.am/db/2337971/Fidelity_Biosciences>,
        <https://1145.am/db/2337972/Fidelity_Biosciences>,
        <https://1145.am/db/2339666/Fidelity_Biosciences>,
        <https://1145.am/db/2340581/Fidelity_Biosciences>,
        <https://1145.am/db/2341869/Fidelity_Biosciences>,
        <https://1145.am/db/2341897/Fidelity_Biosciences>,
        <https://1145.am/db/2342754/Fidelity_Biosciences>,
        <https://1145.am/db/2342768/Fidelity_Biosciences>,
        <https://1145.am/db/2342771/Fidelity_Biosciences>,
        <https://1145.am/db/2344017/Fidelity_Biosciences>,
        <https://1145.am/db/2348149/Fidelity_Biosciences>,
        <https://1145.am/db/2349048/Fidelity_Biosciences>,
        <https://1145.am/db/2349050/Fidelity_Biosciences>,
        <https://1145.am/db/2350891/Fidelity_Biosciences>,
        <https://1145.am/db/2352349/Fidelity_Biosciences>,
        <https://1145.am/db/2352350/Fidelity_Biosciences>,
        <https://1145.am/db/2354537/Fidelity_Biosciences>,
        <https://1145.am/db/2356048/Fidelity_Biosciences>,
        <https://1145.am/db/2356124/Fidelity_Biosciences>,
        <https://1145.am/db/2357722/Fidelity_Biosciences>,
        <https://1145.am/db/2359227/Fidelity_Biosciences>,
        <https://1145.am/db/2359240/Fidelity_Biosciences>,
        <https://1145.am/db/2359287/Fidelity_Biosciences>,
        <https://1145.am/db/2359683/Fidelity_Biosciences>,
        <https://1145.am/db/2361065/Fidelity_Biosciences>,
        <https://1145.am/db/2363510/Fidelity_Biosciences>,
        <https://1145.am/db/2366710/Fidelity_Biosciences>,
        <https://1145.am/db/2366712/Fidelity_Biosciences>,
        <https://1145.am/db/2367022/Fidelity_Biosciences>,
        <https://1145.am/db/2367023/Fidelity_Biosciences>,
        <https://1145.am/db/2367381/Fidelity_Biosciences>,
        <https://1145.am/db/2369644/Fidelity_Biosciences>,
        <https://1145.am/db/2549505/Fidelity_Biosciences>,
        <https://1145.am/db/2549507/Fidelity_Biosciences>,
        <https://1145.am/db/2551315/Fidelity_Biosciences>,
        <https://1145.am/db/2569831/Fidelity_Biosciences>,
        <https://1145.am/db/2587938/Fidelity_Biosciences>,
        <https://1145.am/db/2588372/Fidelity_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2360052/Investment_Biomedical_Advanced_Research_And_Development_Authority_Elusys_Therapeutics_Inc_Us_Government_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-14T15:42:47+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Elusys Awarded Additional $ 14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax.",
        "PINE BROOK, N.J., Sept. 13, 2012 /PRNewswire/ - Elusys Therapeutics, Inc. (Elusys) , a biopharmaceutical company developing countermeasures for biodefense, announced today that it has been awarded additional funding from the U.S. Government, valued at $ 14.5 million, to support expanded human safety studies of ETI-204 (Anthim) , an investigational agent for the treatment of anthrax infection following a biowarfare attack." ;
    ns1:documentTitle "Elusys Awarded Additional $14.5 Million Under Existing U.S. Government Contracts Supporting Expanded Human Safety Studies of ETI-204 for Treatment of Inhalational Anthrax" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/elusys-awarded-additional-14-5-million-under-existing-u-s-government-contracts-supporting> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2360052/Elusys_Therapeutics_Inc> ;
    ns1:valueRaw "$ 14.5 Million",
        "$ 14.5 million",
        "$ 149 million",
        "$ 211 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "U.S." .

<https://1145.am/db/2362106/Foundation_Medicine> a org:Organization ;
    ns1:description "medical" ;
    ns1:documentDate "2012-09-20T11:51:08+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Announces $42.5 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-announces-42-5-million-series-b-financing-0> ;
    ns1:foundName "Foundation Medicine" ;
    ns1:name "Foundation Medicine" ;
    ns1:sameAsHigh <https://1145.am/db/2295207/Foundation_Medical_Partners>,
        <https://1145.am/db/2341645/Foundation_Medicine>,
        <https://1145.am/db/2341652/Foundation_Medicine> ;
    ns1:sameAsMedium <https://1145.am/db/2152366/Foundation_Medicine>,
        <https://1145.am/db/2154351/Foundation_Medicine>,
        <https://1145.am/db/2154736/Foundation_Medicine>,
        <https://1145.am/db/2234439/Foundation_Medicine>,
        <https://1145.am/db/2289430/Foundation_Medicine>,
        <https://1145.am/db/2290987/Foundation_Medicine>,
        <https://1145.am/db/2294252/Foundation_Medicine>,
        <https://1145.am/db/2294783/Foundation_Medicine>,
        <https://1145.am/db/2296859/Foundation_Medicine>,
        <https://1145.am/db/2297300/Foundation_Medicine>,
        <https://1145.am/db/2298856/Foundation_Medicine>,
        <https://1145.am/db/2300201/Foundation_Medicine>,
        <https://1145.am/db/2300254/Foundation_Medicine>,
        <https://1145.am/db/2341662/Foundation_Medicine>,
        <https://1145.am/db/2341795/Foundation_Medicine>,
        <https://1145.am/db/2358181/Foundation_Medicine>,
        <https://1145.am/db/2359987/Foundation_Medicine>,
        <https://1145.am/db/2361646/Foundation_Medicine>,
        <https://1145.am/db/2362134/Foundation_Medicine>,
        <https://1145.am/db/488608/Foundation_Medicine> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362134/Foundation_Medicine> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:documentDate "2012-09-21T04:01:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Foundation Medicine Announces $42.5 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-announces-42-5-million-series-b-financing> ;
    ns1:foundName "Foundation Medicine" ;
    ns1:name "Foundation Medicine" ;
    ns1:sameAsMedium <https://1145.am/db/2152366/Foundation_Medicine>,
        <https://1145.am/db/2154351/Foundation_Medicine>,
        <https://1145.am/db/2154736/Foundation_Medicine>,
        <https://1145.am/db/2234439/Foundation_Medicine>,
        <https://1145.am/db/2289430/Foundation_Medicine>,
        <https://1145.am/db/2290987/Foundation_Medicine>,
        <https://1145.am/db/2294252/Foundation_Medicine>,
        <https://1145.am/db/2294783/Foundation_Medicine>,
        <https://1145.am/db/2296859/Foundation_Medicine>,
        <https://1145.am/db/2297300/Foundation_Medicine>,
        <https://1145.am/db/2298856/Foundation_Medicine>,
        <https://1145.am/db/2300201/Foundation_Medicine>,
        <https://1145.am/db/2300254/Foundation_Medicine>,
        <https://1145.am/db/2341645/Foundation_Medicine>,
        <https://1145.am/db/2341652/Foundation_Medicine>,
        <https://1145.am/db/2341662/Foundation_Medicine>,
        <https://1145.am/db/2341795/Foundation_Medicine>,
        <https://1145.am/db/2358181/Foundation_Medicine>,
        <https://1145.am/db/2359987/Foundation_Medicine>,
        <https://1145.am/db/2361646/Foundation_Medicine>,
        <https://1145.am/db/2362106/Foundation_Medicine>,
        <https://1145.am/db/488608/Foundation_Medicine> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364127/Acquisition_Clinipace_Worldwide_Clinipace_Worldwide_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2012-09-26T04:01:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Clinipace Worldwide, a, and Paragon Biomedical, Inc., a, today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of the privately-held, Irvine, CA - based company and its subsidiaries." ;
    ns1:documentTitle "Clinipace Worldwide Acquires Paragon Biomedical, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-paragon-biomedical-inc> ;
    ns1:foundName "merger" ;
    ns1:name "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Irvine" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5359777/about.rdf> ;
    ns1:whereRaw "Irvine, CA" .

<https://1145.am/db/2364127/Merger_Clinipace_Worldwide_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "merger" ;
    ns1:documentDate "2012-09-26T04:01:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Clinipace Worldwide, a, and Paragon Biomedical, Inc., a, today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of the privately-held, Irvine, CA - based company and its subsidiaries." ;
    ns1:documentTitle "Clinipace Worldwide Acquires Paragon Biomedical, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-paragon-biomedical-inc> ;
    ns1:foundName "acquired" ;
    ns1:name "acquired" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Irvine" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5359777/about.rdf> ;
    ns1:whereRaw "Irvine, CA" .

<https://1145.am/db/2364127/Paragon_Biomedical_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Irvine" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5359777/about.rdf> ;
    ns1:basedInHighRaw "Irvine, CA" ;
    ns1:description "clinical operations",
        "clinical research" ;
    ns1:documentDate "2012-09-26T04:01:15+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Clinipace Worldwide Acquires Paragon Biomedical, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-paragon-biomedical-inc> ;
    ns1:foundName "Paragon Biomedical",
        "Paragon Biomedical, Inc.",
        "Paragon Biomedical, Inc., a," ;
    ns1:name "Paragon Biomedical",
        "Paragon Biomedical, Inc." ;
    ns1:protagonist <https://1145.am/db/2364127/Acquisition_Clinipace_Worldwide_Paragon_Biomedical_Inc_Completed> ;
    ns1:sameAsMedium <https://1145.am/db/2305367/Paragon_Biomedical>,
        <https://1145.am/db/2305368/Paragon_Biomedical>,
        <https://1145.am/db/2306436/Paragon_Biomedical>,
        <https://1145.am/db/2320262/Paragon_Biomedical>,
        <https://1145.am/db/2363181/Paragon_Biomedical> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364127/Paragon_Biomedical_Inc_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2012-09-26T04:01:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Clinipace Worldwide Acquires Paragon Biomedical, Inc.",
        "Clinipace Worldwide, a, and Paragon Biomedical, Inc., a, today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of the privately-held, Irvine, CA - based company and its subsidiaries." ;
    ns1:documentTitle "Clinipace Worldwide Acquires Paragon Biomedical, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-paragon-biomedical-inc> ;
    ns1:foundName "Acquires",
        "acquired",
        "merger" ;
    ns1:name "Acquires",
        "acquired",
        "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2364127/Paragon_Biomedical_Inc> ;
    ns1:targetName "Paragon Biomedical" ;
    ns1:whereGeoName "Irvine" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5359777/about.rdf> ;
    ns1:whereRaw "Irvine, CA" .

<https://1145.am/db/2546216/Auriga_Partners> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Auriga Partners" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Auriga Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1100576/Auriga_Partners>,
        <https://1145.am/db/1830238/Auriga_Partners>,
        <https://1145.am/db/1838206/Auriga_Partners>,
        <https://1145.am/db/1892410/Auriga_Partners>,
        <https://1145.am/db/1894754/Auriga_Partners>,
        <https://1145.am/db/2313425/Auriga_Partners>,
        <https://1145.am/db/2315271/Auriga_Partners>,
        <https://1145.am/db/2315279/Auriga_Partners>,
        <https://1145.am/db/2323700/Auriga_Partners>,
        <https://1145.am/db/2323705/Auriga_Partners>,
        <https://1145.am/db/2331763/Auriga_Partners>,
        <https://1145.am/db/2337571/Auriga_Partners>,
        <https://1145.am/db/2337577/Auriga_Partners>,
        <https://1145.am/db/2365296/Auriga_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546216/Cycad_Group> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Cycad Group" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Cycad Group" ;
    ns1:sameAsMedium <https://1145.am/db/2292582/Cycad_Group>,
        <https://1145.am/db/2331763/Cycad_Group>,
        <https://1145.am/db/2337294/Cycad_Group>,
        <https://1145.am/db/2337571/Cycad_Group>,
        <https://1145.am/db/2337577/Cycad_Group>,
        <https://1145.am/db/2337976/Cycad_Group>,
        <https://1145.am/db/2348350/Cycad_Group>,
        <https://1145.am/db/2349437/Cycad_Group>,
        <https://1145.am/db/2365296/Cycad_Group> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546216/Johnson___Johnson_Development_Corporation> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:description "financing" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Johnson & Johnson Development Corporation" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Johnson & Johnson Development Corporation" ;
    ns1:sameAsHigh <https://1145.am/db/1118732/Johnson___Johnson_Innovation>,
        <https://1145.am/db/1553175/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/1553459/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/1620209/Johnson___Johnson_Innovation_-_Jjdc_Inc>,
        <https://1145.am/db/2095032/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2196895/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2284205/Johnson___Johnson_Innovation>,
        <https://1145.am/db/2300306/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308791/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311069/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2311075/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336890/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2337577/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344597/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352361/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358640/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358658/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358812/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2361581/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2363907/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/768105/Johnson_And_Johnson_Innovation-Jjdc_Inc> ;
    ns1:sameAsMedium <https://1145.am/db/1883008/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2291836/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292334/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292345/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292353/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2292975/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2299864/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2300455/Johnson___Johnson_Development_Corp>,
        <https://1145.am/db/2303009/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2306163/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2308781/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316619/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2316624/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2317934/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2321856/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327212/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2327227/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2336943/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2337571/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338236/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338237/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2338527/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2341478/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2344605/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2346978/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2350327/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2352357/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2356290/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2358657/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364457/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2364458/Johnson___Johnson_Development_Corporation>,
        <https://1145.am/db/2365296/Johnson___Johnson_Development_Corporation> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546216/Morningside> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Morningside" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Morningside" ;
    ns1:sameAsMedium <https://1145.am/db/1297950/Morningside>,
        <https://1145.am/db/1298919/Morningside>,
        <https://1145.am/db/1394919/Morningside>,
        <https://1145.am/db/1770139/Morningside>,
        <https://1145.am/db/1783536/Morningside>,
        <https://1145.am/db/2293980/Morningside>,
        <https://1145.am/db/2337571/Morningside>,
        <https://1145.am/db/2337577/Morningside>,
        <https://1145.am/db/2344604/Morningside>,
        <https://1145.am/db/2350231/Morningside>,
        <https://1145.am/db/514081/Morningside>,
        <https://1145.am/db/514914/Morningside>,
        <https://1145.am/db/586002/Morningside>,
        <https://1145.am/db/606235/Morningside>,
        <https://1145.am/db/775019/Morningside> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546216/Mp_Healthcare_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "MP Healthcare Ventures" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "MP Healthcare Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2337571/Mp_Healthcare_Ventures>,
        <https://1145.am/db/2337577/Mp_Healthcare_Ventures>,
        <https://1145.am/db/2363938/Mp_Healthcare_Venture>,
        <https://1145.am/db/2363941/Mp_Healthcare_Venture>,
        <https://1145.am/db/2365103/Mp_Healthcare_Venture> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546216/Skyline_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Cambridgeshire" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2653940/about.rdf> ;
    ns1:basedInHighRaw "Cambridge" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Skyline Ventures" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Skyline Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2300653/Skyline_Ventures>,
        <https://1145.am/db/2303098/Skyline_Ventures>,
        <https://1145.am/db/2303598/Skyline_Ventures>,
        <https://1145.am/db/2305791/Skyline_Ventures>,
        <https://1145.am/db/2308925/Skyline_Ventures>,
        <https://1145.am/db/2308931/Skyline_Ventures>,
        <https://1145.am/db/2313305/Skyline_Ventures>,
        <https://1145.am/db/2313306/Skyline_Ventures>,
        <https://1145.am/db/2337571/Skyline_Ventures>,
        <https://1145.am/db/2337577/Skyline_Ventures>,
        <https://1145.am/db/2340204/Skyline_Ventures>,
        <https://1145.am/db/2340207/Skyline_Ventures>,
        <https://1145.am/db/2349753/Skyline_Ventures>,
        <https://1145.am/db/2353439/Skyline_Ventures>,
        <https://1145.am/db/2355586/Skyline_Ventures>,
        <https://1145.am/db/2359287/Skyline_Ventures>,
        <https://1145.am/db/2365296/Skyline_Ventures> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2547216/Biomedical_Catalyst> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:documentDate "2012-11-05T18:17:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "Biomedical Catalyst" ;
    ns1:investor <https://1145.am/db/2547216/Investment_Biomedical_Catalyst_Oxford_England-Psioxus_Therapeutics_Ltd_Psioxus_Therapeutics_Has_Not_Happened> ;
    ns1:name "Biomedical Catalyst" ;
    ns1:sameAsMedium <https://1145.am/db/2346021/Biomedical_Catalyst>,
        <https://1145.am/db/2588827/Biomedical_Catalyst> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2571001/Rarecyte_Inc> a org:Organization ;
    ns1:basedInHighGeoName "Seattle" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:basedInHighRaw "Seattle" ;
    ns1:description "Life science" ;
    ns1:documentDate "2012-08-22T01:10:07+00:00"^^xsd:dateTime ;
    ns1:documentTitle "RareCyte Completes Final Tranche of Funding for Launch of its AccuCyte Rare Cell Detection Platform" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/rarecyte-completes-final-tranche-of-funding-for-launch-of-its-accucyte-rare-cell-detection> ;
    ns1:foundName "RareCyte",
        "RareCyte Inc." ;
    ns1:industry "life science" ;
    ns1:name "RareCyte Inc." ;
    ns1:sameAsHigh <https://1145.am/db/2350625/Rarecyte_Inc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2575232/Athenian_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Greece" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-30T13:09:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Athenian Venture Partners" ;
    ns1:investor <https://1145.am/db/2575232/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Athenian Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2303695/Athenian_Venture_Partners>,
        <https://1145.am/db/2317737/Athenian_Venture_Partners>,
        <https://1145.am/db/2335764/Athenian_Venture_Partners>,
        <https://1145.am/db/2354752/Athenian_Venture_Partners>,
        <https://1145.am/db/2354770/Athenian_Venture_Partners>,
        <https://1145.am/db/2361588/Athenian_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2367046/Athenian_Venture_Partners>,
        <https://1145.am/db/2367047/Athenian_Venture_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2575232/Kearny_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Kearny Venture Partners" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-30T13:09:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Kearny Venture Partners" ;
    ns1:investor <https://1145.am/db/2575232/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Kearny Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/2354752/Kearny_Venture_Partners>,
        <https://1145.am/db/2354770/Kearny_Venture_Partners>,
        <https://1145.am/db/2625964/Citi> ;
    ns1:sameAsMedium <https://1145.am/db/2300697/Kearny_Venture_Partners>,
        <https://1145.am/db/2303695/Kearny_Venture_Partners>,
        <https://1145.am/db/2306529/Kearny_Venture_Partners>,
        <https://1145.am/db/2335764/Kearny_Venture_Partners_Venture_Investors>,
        <https://1145.am/db/2361588/Kearny_Venture_Partners_Venture_Investors_Llc>,
        <https://1145.am/db/2367022/Kearny_Venture_Partners>,
        <https://1145.am/db/2367023/Kearny_Venture_Partners>,
        <https://1145.am/db/2367046/Kearny_Venture_Partners>,
        <https://1145.am/db/2367047/Kearny_Venture_Partners>,
        <https://1145.am/db/2588372/Kearny_Venture_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2575232/Triathlon_Medical_Ventures> a org:Organization ;
    ns1:description "medical" ;
    ns1:documentDate "2012-08-30T13:09:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Triathlon Medical Ventures" ;
    ns1:investor <https://1145.am/db/2575232/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Triathlon Medical Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/2309865/Triathlon_Medical_Venture_Partners>,
        <https://1145.am/db/2354770/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2364820/Triathlon_Medical_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/2303695/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2305706/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2305713/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2326139/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2330775/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2335764/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2354752/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2361588/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2367046/Triathlon_Medical_Ventures>,
        <https://1145.am/db/2367047/Triathlon_Medical_Ventures> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2575232/Venture_Investors_Llc> a org:Organization ;
    ns1:basedInLowRaw "Kearny" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-30T13:09:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Venture Investors LLC" ;
    ns1:investor <https://1145.am/db/2575232/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Venture Investors LLC" ;
    ns1:sameAsHigh <https://1145.am/db/1006950/Shell_Ventures>,
        <https://1145.am/db/1014186/Soma_Capital>,
        <https://1145.am/db/1014305/Sp_Ventures>,
        <https://1145.am/db/1049509/021_Capital>,
        <https://1145.am/db/1083572/Spero_Ventures>,
        <https://1145.am/db/1085737/Spero_Ventures>,
        <https://1145.am/db/1106541/Jumpstart_Ventures>,
        <https://1145.am/db/1119699/Xplorer_Capital>,
        <https://1145.am/db/1122750/Xplorer_Capital>,
        <https://1145.am/db/1133402/Silicon_Road_Ventures>,
        <https://1145.am/db/1134486/Silicon_Road_Ventures>,
        <https://1145.am/db/1140286/B_Capital_Group>,
        <https://1145.am/db/1140286/Commerce_Ventures>,
        <https://1145.am/db/1151339/Big_Idea_Ventures>,
        <https://1145.am/db/1165515/Jumpstart_Ventures>,
        <https://1145.am/db/1174129/Stage_1_Ventures>,
        <https://1145.am/db/1175198/Sure_Ventures>,
        <https://1145.am/db/1175459/Khosla_Ventures>,
        <https://1145.am/db/1196728/Gsr_Ventures>,
        <https://1145.am/db/1199177/Gsr_Ventures>,
        <https://1145.am/db/1200402/Xseed_Capital>,
        <https://1145.am/db/1232192/Lfg_Ventures>,
        <https://1145.am/db/1238845/Union_Square_Ventures>,
        <https://1145.am/db/1247755/Syn_Ventures>,
        <https://1145.am/db/1248631/Syn_Ventures>,
        <https://1145.am/db/1269968/Usvp>,
        <https://1145.am/db/1282835/Khosla_Ventures>,
        <https://1145.am/db/1285848/Syn_Ventures>,
        <https://1145.am/db/1287496/D1_Capital>,
        <https://1145.am/db/1288309/Psl_Ventures>,
        <https://1145.am/db/1322711/Venture_Stars>,
        <https://1145.am/db/1329887/Shell_Ventures>,
        <https://1145.am/db/1329887/Sosv>,
        <https://1145.am/db/1340587/Xseed_Capital>,
        <https://1145.am/db/1341445/Xseed_Capital>,
        <https://1145.am/db/1354722/Psl_Ventures>,
        <https://1145.am/db/1354749/Psl_Ventures>,
        <https://1145.am/db/1375916/Sv_Pacific_Ventures>,
        <https://1145.am/db/1376353/Sv_Pacific_Ventures>,
        <https://1145.am/db/1394919/Exsight_Ventures>,
        <https://1145.am/db/1408996/Khosla_Ventures>,
        <https://1145.am/db/1419583/Strongher_Vc>,
        <https://1145.am/db/1419583/Venture_Catalyst>,
        <https://1145.am/db/1445935/97212_Ventures>,
        <https://1145.am/db/1452107/Soma_Capital>,
        <https://1145.am/db/1454909/Us_Venture_Partners>,
        <https://1145.am/db/1455119/Jumpstart_Ventures>,
        <https://1145.am/db/1455616/Soma_Capital>,
        <https://1145.am/db/1468368/Sanabil_Investments>,
        <https://1145.am/db/1470303/Union_Square_Ventures>,
        <https://1145.am/db/1475091/Soma_Capital>,
        <https://1145.am/db/1489698/Stage_1_Ventures>,
        <https://1145.am/db/1582111/Khosla_Ventures>,
        <https://1145.am/db/1584937/Sharad_Sanghi>,
        <https://1145.am/db/1584937/Yournest_Venture_Capital>,
        <https://1145.am/db/1653506/Sve_Capital>,
        <https://1145.am/db/166138/Royal_Street_Ventures>,
        <https://1145.am/db/1663572/Khosla_Ventures>,
        <https://1145.am/db/1679431/Booz_Allen_Ventures_Llc>,
        <https://1145.am/db/1690703/021_Capital>,
        <https://1145.am/db/1691364/Hv_Capital>,
        <https://1145.am/db/1693658/Shima_Capital>,
        <https://1145.am/db/1694448/B37_Ventures>,
        <https://1145.am/db/1696614/Z_Venture_Capital>,
        <https://1145.am/db/1698130/Union_Square_Ventures>,
        <https://1145.am/db/1698180/Shasta_Ventures>,
        <https://1145.am/db/1698192/Saison_Capital>,
        <https://1145.am/db/1699877/Sutter_Hill_Ventures>,
        <https://1145.am/db/1702019/Sutter_Hill_Ventures>,
        <https://1145.am/db/1704402/Sosv>,
        <https://1145.am/db/1710011/Z_Venture_Capital>,
        <https://1145.am/db/1711384/Union_Square_Ventures>,
        <https://1145.am/db/1713248/Xplorer_Capital>,
        <https://1145.am/db/1714154/Psl_Ventures>,
        <https://1145.am/db/1714544/Hv_Capital>,
        <https://1145.am/db/1722058/Union_Square_Ventures>,
        <https://1145.am/db/1722914/B_Capital>,
        <https://1145.am/db/1722944/Soma_Capital>,
        <https://1145.am/db/1723099/Union_Square_Ventures>,
        <https://1145.am/db/1724641/Union_Square_Ventures>,
        <https://1145.am/db/1726121/Khosla_Ventures>,
        <https://1145.am/db/1730882/Union_Square_Ventures>,
        <https://1145.am/db/1732364/Sutter_Hill_Ventures>,
        <https://1145.am/db/1734681/Union_Square_Ventures>,
        <https://1145.am/db/1736478/Z_Venture_Capital>,
        <https://1145.am/db/1736668/Amit_Kapur>,
        <https://1145.am/db/1738378/S_Capital_Vc>,
        <https://1145.am/db/1739022/Khosla_Ventures>,
        <https://1145.am/db/1741014/Khosla_Ventures>,
        <https://1145.am/db/1742276/Shasta_Ventures>,
        <https://1145.am/db/1743316/Khosla_Ventures>,
        <https://1145.am/db/1745326/Venture_Stars>,
        <https://1145.am/db/1747732/Khosla_Ventures>,
        <https://1145.am/db/1747805/Khosla_Ventures>,
        <https://1145.am/db/1749148/Khosla_Ventures>,
        <https://1145.am/db/1749226/Khosla_Ventures>,
        <https://1145.am/db/1750460/Francisco_Partners>,
        <https://1145.am/db/1750483/Hv_Capital>,
        <https://1145.am/db/1750867/Fin_Vc>,
        <https://1145.am/db/1751312/Khosla_Ventures>,
        <https://1145.am/db/1753725/Z_Venture_Capital>,
        <https://1145.am/db/1754057/Spero_Ventures>,
        <https://1145.am/db/1754996/B_Capital>,
        <https://1145.am/db/1755846/Khosla_Ventures>,
        <https://1145.am/db/1756103/Union_Square_Ventures>,
        <https://1145.am/db/1756775/Khosla_Ventures>,
        <https://1145.am/db/1757376/1982_Ventures>,
        <https://1145.am/db/1757432/B37_Ventures>,
        <https://1145.am/db/1757987/R2>,
        <https://1145.am/db/1759567/Spero_Ventures>,
        <https://1145.am/db/1760730/Esun_Venture_Capital>,
        <https://1145.am/db/1762512/Khosla_Ventures>,
        <https://1145.am/db/1767643/Shasta_Ventures>,
        <https://1145.am/db/1768138/Vas_Ventures>,
        <https://1145.am/db/1771112/Khosla_Ventures>,
        <https://1145.am/db/1773491/Sosv>,
        <https://1145.am/db/1775532/Resolute_Venture_Partners>,
        <https://1145.am/db/1776687/Khosla_Ventures>,
        <https://1145.am/db/1777067/Scott>,
        <https://1145.am/db/1778179/Union_Square_Ventures>,
        <https://1145.am/db/1779627/Fosun>,
        <https://1145.am/db/1784405/Venture_51>,
        <https://1145.am/db/1784577/Khosla_Ventures>,
        <https://1145.am/db/1785920/Khosla_Ventures>,
        <https://1145.am/db/1786720/Union_Square_Ventures>,
        <https://1145.am/db/1786861/Ms___Ad_Ventures>,
        <https://1145.am/db/1787190/Gsr_Ventures>,
        <https://1145.am/db/1789140/Sosv>,
        <https://1145.am/db/1790631/Union_Square_Ventures>,
        <https://1145.am/db/1793825/Softtech_Vc>,
        <https://1145.am/db/1795210/Khosla_Ventures>,
        <https://1145.am/db/1795934/Shasta_Ventures>,
        <https://1145.am/db/1797561/Khosla_Ventures>,
        <https://1145.am/db/1799099/Softtech_Vc>,
        <https://1145.am/db/1799102/Softtech_Vc>,
        <https://1145.am/db/1802288/Khosla_Ventures>,
        <https://1145.am/db/1802352/Smedvig_Capital>,
        <https://1145.am/db/1803458/Union_Square_Ventures>,
        <https://1145.am/db/1804091/Active_Venture_Partners>,
        <https://1145.am/db/1804960/Khosla_Ventures>,
        <https://1145.am/db/1807542/Earlybird_Ventures>,
        <https://1145.am/db/1809007/Khosla_Ventures>,
        <https://1145.am/db/1812267/Us_Venture_Partners>,
        <https://1145.am/db/1815701/Khosla_Ventures>,
        <https://1145.am/db/1815910/E-Ventures>,
        <https://1145.am/db/1816423/Usvp>,
        <https://1145.am/db/1818161/Shasta_Ventures>,
        <https://1145.am/db/1818174/Eventures>,
        <https://1145.am/db/1821929/Khosla_Ventures>,
        <https://1145.am/db/1823663/Ifc>,
        <https://1145.am/db/1825387/Shasta_Ventures>,
        <https://1145.am/db/1826265/Mkii_Ventures>,
        <https://1145.am/db/1827021/Shasta_Ventures>,
        <https://1145.am/db/1828336/Khosla_Ventures>,
        <https://1145.am/db/1829581/Union_Square_Ventures>,
        <https://1145.am/db/1829612/Khosla_Ventures>,
        <https://1145.am/db/1829878/Active_Venture_Partners>,
        <https://1145.am/db/1830613/Sutter_Hill_Ventures>,
        <https://1145.am/db/1834279/Xseed_Capital>,
        <https://1145.am/db/1835126/Khosla_Ventures>,
        <https://1145.am/db/1835229/Sparklabs_Global_Ventures>,
        <https://1145.am/db/1835825/Shasta_Ventures>,
        <https://1145.am/db/1837155/Xseed_Capital>,
        <https://1145.am/db/1840793/Khosla_Ventures>,
        <https://1145.am/db/1842301/Khosla_Ventures>,
        <https://1145.am/db/1842466/Us_Venture_Partners>,
        <https://1145.am/db/1843362/Khosla_Ventures>,
        <https://1145.am/db/1846483/Softtech_Vc>,
        <https://1145.am/db/1846721/Union_Square_Ventures>,
        <https://1145.am/db/1852806/Us_Venture_Partners>,
        <https://1145.am/db/1853548/Khosla_Ventures>,
        <https://1145.am/db/1854200/Khosla_Ventures>,
        <https://1145.am/db/1855363/Sk_Ventures>,
        <https://1145.am/db/1856376/Khosla_Ventures>,
        <https://1145.am/db/1857635/Active_Venture_Partners>,
        <https://1145.am/db/1857930/Softtech_Vc>,
        <https://1145.am/db/1858323/Union_Square_Ventures>,
        <https://1145.am/db/1858991/Active_Venture_Partners>,
        <https://1145.am/db/1859199/Khosla_Ventures>,
        <https://1145.am/db/1860091/Union_Square_Ventures>,
        <https://1145.am/db/1860196/Union_Square_Ventures>,
        <https://1145.am/db/1861355/Khosla_Ventures>,
        <https://1145.am/db/1862590/Sutter_Hill_Ventures>,
        <https://1145.am/db/1863500/Khosla_Ventures>,
        <https://1145.am/db/1868107/Shasta_Ventures>,
        <https://1145.am/db/1868572/Union_Square_Ventures>,
        <https://1145.am/db/1871784/Us_Venture_Partners>,
        <https://1145.am/db/1872654/Sutter_Hill_Ventures>,
        <https://1145.am/db/1874278/Khosla_Ventures>,
        <https://1145.am/db/1875709/Sutter_Hill_Ventures>,
        <https://1145.am/db/1876758/Union_Square_Ventures>,
        <https://1145.am/db/1879026/Us_Venture_Partners>,
        <https://1145.am/db/1881464/Khosla_Ventures>,
        <https://1145.am/db/1884155/Us_Venture_Partners>,
        <https://1145.am/db/1892472/Union_Square_Ventures>,
        <https://1145.am/db/1895951/Khosla_Ventures>,
        <https://1145.am/db/1896368/New_Wave_Ventures>,
        <https://1145.am/db/1896530/Khosla_Ventures>,
        <https://1145.am/db/1899282/Mk_Capital>,
        <https://1145.am/db/1899737/Union_Square_Ventures>,
        <https://1145.am/db/1900812/Khosla_Ventures>,
        <https://1145.am/db/1904202/Shasta_Ventures>,
        <https://1145.am/db/1911584/Stage_1_Ventures>,
        <https://1145.am/db/1911840/Shasta_Ventures>,
        <https://1145.am/db/1915640/Us_Venture_Partners>,
        <https://1145.am/db/1917671/Fidelity_Ventures>,
        <https://1145.am/db/1922138/Softtech_Vc>,
        <https://1145.am/db/1931918/Svb_Financial_Group>,
        <https://1145.am/db/1939990/Gsr_Ventures>,
        <https://1145.am/db/1947193/Starbloom_Capital>,
        <https://1145.am/db/1947303/B37_Ventures>,
        <https://1145.am/db/1960888/Khosla_Ventures>,
        <https://1145.am/db/1962819/Jumpstart_Ventures>,
        <https://1145.am/db/2009653/Nationwide_Ventures>,
        <https://1145.am/db/2032146/Booz_Allen_Ventures>,
        <https://1145.am/db/2056931/L___S_Venture_Capital>,
        <https://1145.am/db/2071531/A_o>,
        <https://1145.am/db/2082923/Psl_Ventures>,
        <https://1145.am/db/2090647/Khosla_Ventures>,
        <https://1145.am/db/2092604/Srmg_Ventures>,
        <https://1145.am/db/2099365/Do_Ventures>,
        <https://1145.am/db/2114292/Khosla_Ventures>,
        <https://1145.am/db/2114498/Khosla_Ventures>,
        <https://1145.am/db/2134994/Union_Square_Ventures>,
        <https://1145.am/db/2135622/Khosla_Ventures>,
        <https://1145.am/db/2135690/Better_Ventures>,
        <https://1145.am/db/2142825/Commerce_Ventures>,
        <https://1145.am/db/2151946/Khosla_Ventures>,
        <https://1145.am/db/2153616/South>,
        <https://1145.am/db/2154009/Andera_Partners>,
        <https://1145.am/db/2155474/Sig>,
        <https://1145.am/db/2194249/Union_Square_Ventures>,
        <https://1145.am/db/2210557/Softtech_Vc>,
        <https://1145.am/db/2285566/Sabadell_Venture_Capital>,
        <https://1145.am/db/2288251/Us_Venture_Partners>,
        <https://1145.am/db/2300288/Spark_Ventures>,
        <https://1145.am/db/2300466/Khosla_Ventures>,
        <https://1145.am/db/2305964/Sls_Venture>,
        <https://1145.am/db/2310285/Valley_Ventures>,
        <https://1145.am/db/2311076/Venture_Investors>,
        <https://1145.am/db/2315754/Valley_Ventures>,
        <https://1145.am/db/2319675/Sac>,
        <https://1145.am/db/2343206/Us_Venture_Partners>,
        <https://1145.am/db/2348356/Sambrinvest>,
        <https://1145.am/db/2352804/Enterprise_Partners>,
        <https://1145.am/db/2354752/Venture_Investors_Llc>,
        <https://1145.am/db/2354770/Venture_Investors_Llc>,
        <https://1145.am/db/2364014/Ro_Invest>,
        <https://1145.am/db/2567406/Exsight_Ventures>,
        <https://1145.am/db/2616685/Silver_Creek_Ventures>,
        <https://1145.am/db/2641337/Valuestream_Ventures>,
        <https://1145.am/db/2790795/Shima_Capital>,
        <https://1145.am/db/365631/Khosla_Ventures>,
        <https://1145.am/db/376872/K50_Ventures>,
        <https://1145.am/db/396307/B_Capital_Group>,
        <https://1145.am/db/407681/Khosla_Ventures>,
        <https://1145.am/db/425922/Royal_Street_Ventures>,
        <https://1145.am/db/426637/Khosla_Ventures>,
        <https://1145.am/db/428324/Khosla_Ventures>,
        <https://1145.am/db/429179/Shasta_Ventures>,
        <https://1145.am/db/430553/Shasta_Ventures>,
        <https://1145.am/db/430986/Olsf_Ventures>,
        <https://1145.am/db/432552/Valuestream_Ventures>,
        <https://1145.am/db/437556/Khosla_Ventures>,
        <https://1145.am/db/438632/Khosla_Ventures>,
        <https://1145.am/db/447456/Starta_Vc>,
        <https://1145.am/db/486858/Khosla_Ventures>,
        <https://1145.am/db/486901/Khosla_Ventures>,
        <https://1145.am/db/502886/Sutter_Hill_Ventures>,
        <https://1145.am/db/506085/Sutter_Hill_Ventures>,
        <https://1145.am/db/523013/Hscm_Ventures>,
        <https://1145.am/db/523013/Sure_Ventures>,
        <https://1145.am/db/527960/Hscm_Ventures>,
        <https://1145.am/db/527960/Sure_Ventures>,
        <https://1145.am/db/562996/Shasta_Ventures>,
        <https://1145.am/db/564008/Secure_Ventures>,
        <https://1145.am/db/572414/A-Street_Ventures>,
        <https://1145.am/db/577305/A-Street_Ventures>,
        <https://1145.am/db/587038/Hv_Capital>,
        <https://1145.am/db/606074/Elementum_Ventures>,
        <https://1145.am/db/661747/Sosv>,
        <https://1145.am/db/663618/Sosv>,
        <https://1145.am/db/676938/Khosla_Ventures>,
        <https://1145.am/db/678262/Khosla_Ventures>,
        <https://1145.am/db/678416/St_Engineering_Ventures_Pte_Ltd>,
        <https://1145.am/db/679989/Khosla_Ventures>,
        <https://1145.am/db/696617/Suro_Capital>,
        <https://1145.am/db/753251/Sosv>,
        <https://1145.am/db/753759/Ms___Ad_Ventures>,
        <https://1145.am/db/75860/Sws_Venture_Capital>,
        <https://1145.am/db/778025/Soma_Capital>,
        <https://1145.am/db/784869/Hbse_Ventures>,
        <https://1145.am/db/791643/Cssd_Capital>,
        <https://1145.am/db/800101/Khosla_Ventures>,
        <https://1145.am/db/807080/Adb_Ventures>,
        <https://1145.am/db/817162/Khosla_Ventures>,
        <https://1145.am/db/817162/Shell_Ventures>,
        <https://1145.am/db/883036/Big_Idea_Ventures>,
        <https://1145.am/db/890955/S2g_Ventures>,
        <https://1145.am/db/906393/1982_Ventures>,
        <https://1145.am/db/912943/Khosla_Ventures>,
        <https://1145.am/db/928782/Psl_Ventures>,
        <https://1145.am/db/930464/Psl_Ventures>,
        <https://1145.am/db/935046/Gsr_Ventures>,
        <https://1145.am/db/940913/Xplorer_Capital>,
        <https://1145.am/db/952434/K50_Ventures>,
        <https://1145.am/db/979911/Khosla_Ventures>,
        <https://1145.am/db/980951/Khosla_Ventures>,
        <https://1145.am/db/996940/Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1105339/Venture_Investors>,
        <https://1145.am/db/2299743/Venture_Investors>,
        <https://1145.am/db/2301714/Venture_Investors>,
        <https://1145.am/db/2301715/Venture_Investors>,
        <https://1145.am/db/2303695/Venture_Investors_Llc>,
        <https://1145.am/db/2321713/Venture_Investors>,
        <https://1145.am/db/2364827/Venture_Investors>,
        <https://1145.am/db/2365444/Venture_Investors>,
        <https://1145.am/db/2367046/Venture_Investors_Llc>,
        <https://1145.am/db/2369504/Venture_Investors_Llc>,
        <https://1145.am/db/2556669/Venture_Investors_Llc>,
        <https://1145.am/db/2583558/Venture_Investors_Llc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2577162/Aduro_Biotech> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "medical research" ;
    ns1:documentDate "2012-09-07T04:03:31+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aduro Awarded CDMRP Grant for Prostate Cancer Vaccine Development" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aduro-awarded-cdmrp-grant-for-prostate-cancer-vaccine-development> ;
    ns1:foundName "Aduro BioTech, Inc." ;
    ns1:name "Aduro BioTech" ;
    ns1:sameAsHigh <https://1145.am/db/2356885/Aduro_Biotech> ;
    ns1:sameAsMedium <https://1145.am/db/2153026/Aduro_Biotech>,
        <https://1145.am/db/2328011/Aduro_Biotech>,
        <https://1145.am/db/2344597/Aduro_Biotech>,
        <https://1145.am/db/2344604/Aduro_Biotech>,
        <https://1145.am/db/2344605/Aduro_Biotech>,
        <https://1145.am/db/2346084/Aduro_Biotech>,
        <https://1145.am/db/2346092/Aduro_Biotech>,
        <https://1145.am/db/2351657/Aduro_Biotech>,
        <https://1145.am/db/2352890/Aduro_Biotech>,
        <https://1145.am/db/2355023/Aduro_Biotech>,
        <https://1145.am/db/2355027/Aduro_Biotech>,
        <https://1145.am/db/2357542/Aduro_Biotech>,
        <https://1145.am/db/2367793/Aduro_Biotech>,
        <https://1145.am/db/2370418/Aduro_Biotech>,
        <https://1145.am/db/2370548/Aduro_Biotech>,
        <https://1145.am/db/2370549/Aduro_Biotech>,
        <https://1145.am/db/2370578/Aduro_Biotech>,
        <https://1145.am/db/2579723/Aduro_Biotech>,
        <https://1145.am/db/2579725/Aduro_Biotech> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588827/Biomedical_Catalyst> a org:Organization ;
    ns1:basedInHighGeoName "United Kingdom of Great Britain and Northern Ireland" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2635167/about.rdf> ;
    ns1:basedInHighRaw "UK" ;
    ns1:documentDate "2012-11-06T05:03:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "Biomedical Catalyst" ;
    ns1:industry "biotechnology" ;
    ns1:investor <https://1145.am/db/2588827/Investment_Biomedical_Catalyst_Psioxus_Therapeutics_Has_Not_Happened> ;
    ns1:name "Biomedical Catalyst" ;
    ns1:sameAsHigh <https://1145.am/db/2279779/Catalyst>,
        <https://1145.am/db/2338378/Catalyst>,
        <https://1145.am/db/2346021/Biomedical_Catalyst> ;
    ns1:sameAsMedium <https://1145.am/db/2547216/Biomedical_Catalyst> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2654050/Onlive_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "investment" ;
    ns1:documentDate "2012-08-22T09:16:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "HTC will make a $ 35.4 million (â‚¬28.3 million) investment in enterprise apps start up Magnet Systems." ;
    ns1:documentTitle "Webwire: Hutch withdraws Scailex offer; Apple value hits new high" ;
    ns1:documentURL <https://www.fiercewireless.com/europe/webwire-hutch-withdraws-scailex-offer-apple-value-hits-new-high> ;
    ns1:foundName "investment",
        "selling" ;
    ns1:name "investment",
        "selling" ;
    ns1:sourceName "Fierce Wireless" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2654050/Onlive> ;
    ns1:targetName "OnLive" ;
    ns1:valueRaw "$ 35.4 million",
        "$ 4 billion",
        "$ 40 million",
        "â‚¬3.2 billion" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "US" .

<https://1145.am/db/2334847/Series_B_Investment_Blend_Therapeutics_Flagship_Ventures_Nanodimension_New_Enterprise_Associates_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-18T21:04:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Blend Therapeutics Closes $ 16 Million in Series B Financing.",
        "WATERTOWN, MA - December 18, 2012 -Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases, announced today that it has secured a $ 16 million Series B financing." ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/blend-therapeutics-closes-16-million-series-b-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2334847/Blend_Therapeutics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 16 Million",
        "$ 16 million" ;
    ns1:when "2012-12-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "December 18, 2012" ;
    ns1:whereGeoName "Watertown" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4954611/about.rdf> ;
    ns1:whereRaw "WATERTOWN, MA" .

<https://1145.am/db/2337071/Investment_Fibrocell_Science_Nrm_Vii_Holdings_I_Third_Security_Llc_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-09T12:15:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Fibrocell Science, Inc. (FCSC) , a biotechnology company focused on commercializing LAVIV, the first and only FDA-approved personalized cell therapy in aesthetic dermatology, and on developing innovative autologous cell therapies for additional aesthetic, medical and scientific applications, today announced that it has entered into a securities purchase agreement for a private placement financing with a select group of institutional investors and high net worth individuals, including NRM VII Holdings I, LLC, a Third Security, LLC affiliated fund." ;
    ns1:documentTitle "Fibrocell Science, Inc. Announces $45 Million Private Placement and Enters Strategic Collaboration with Intrexon" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/fibrocell-science-inc-announces-45-million-private-placement-and-enters-strategic> ;
    ns1:foundName "financing",
        "private placement",
        "securities purchase" ;
    ns1:name "financing",
        "private placement",
        "securities purchase" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2337071/Fibrocell_Science> ;
    ns1:valueRaw "$ 45.0 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2337571/Cvf_Llc> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass." ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "CVF, LLC" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "CVF, LLC" ;
    ns1:sameAsHigh <https://1145.am/db/1751697/Idcv>,
        <https://1145.am/db/2337577/Cvf_Llc>,
        <https://1145.am/db/2546216/Cvf_Llc> ;
    ns1:sameAsMedium <https://1145.am/db/2348440/CVF>,
        <https://1145.am/db/2348448/Cvf_Llc>,
        <https://1145.am/db/2356420/Cvf_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/Genocea_Biosciences> a org:Organization ;
    ns1:description "vaccine discovery" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "Genocea",
        "Genocea Biosciences",
        "Genocea Biosciences, Inc." ;
    ns1:name "Genocea Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/2311583/Genocea_Biosciences>,
        <https://1145.am/db/2329579/Genocea_Biosciences>,
        <https://1145.am/db/2331763/Genocea_Biosciences>,
        <https://1145.am/db/2336889/Genocea_Biosciences>,
        <https://1145.am/db/2342398/Genocea_Biosciences_Inc>,
        <https://1145.am/db/2351839/Genocea_Biosciences>,
        <https://1145.am/db/2363551/Genocea_Biosciences>,
        <https://1145.am/db/2365296/Genocea_Biosciences_Inc>,
        <https://1145.am/db/2536128/Genocea_Biosciences_Inc>,
        <https://1145.am/db/2555579/Genocea_Biosciences>,
        <https://1145.am/db/2556651/Genocea> ;
    ns1:sameAsMedium <https://1145.am/db/2303707/Genocea_Biosciences>,
        <https://1145.am/db/2330601/Genocea_Biosciences>,
        <https://1145.am/db/2331777/Genocea_Biosciences>,
        <https://1145.am/db/2337577/Genocea_Biosciences>,
        <https://1145.am/db/2341844/Genocea_Biosciences>,
        <https://1145.am/db/2351840/Genocea_Biosciences>,
        <https://1145.am/db/2353970/Genocea_Biosciences>,
        <https://1145.am/db/2536127/Genocea_Biosciences>,
        <https://1145.am/db/2546216/Genocea_Biosciences>,
        <https://1145.am/db/2546218/Genocea_Biosciences>,
        <https://1145.am/db/470251/Genocea_Biosciences>,
        <https://1145.am/db/883613/Genocea_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/Lux_Capital> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "Lux Capital" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Lux Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1105217/Lux_Capital>,
        <https://1145.am/db/1106865/Lux_Capital>,
        <https://1145.am/db/1119433/Lux_Capital>,
        <https://1145.am/db/1119661/Lux_Capital>,
        <https://1145.am/db/1122753/Lux_Capital>,
        <https://1145.am/db/1139654/Lux_Capital>,
        <https://1145.am/db/1143903/Lux_Capital>,
        <https://1145.am/db/1238486/Lux_Capital>,
        <https://1145.am/db/1285901/Lux_Capital>,
        <https://1145.am/db/1374025/Lux_Capital>,
        <https://1145.am/db/1375318/Lux_Capital>,
        <https://1145.am/db/1376203/Lux_Capital>,
        <https://1145.am/db/1407553/Lux_Capital>,
        <https://1145.am/db/1536915/Lux_Capital>,
        <https://1145.am/db/1553919/Lux_Capital>,
        <https://1145.am/db/1555013/Lux_Capital>,
        <https://1145.am/db/1632690/Lux_Capital>,
        <https://1145.am/db/1669908/Lux_Capital>,
        <https://1145.am/db/1697296/Lux_Capital>,
        <https://1145.am/db/1734597/Lux_Capital>,
        <https://1145.am/db/1737151/Lux_Capital>,
        <https://1145.am/db/1737409/Lux_Capital>,
        <https://1145.am/db/174200/Lux_Capital>,
        <https://1145.am/db/1743303/Lux_Capital>,
        <https://1145.am/db/1758194/Lux_Capital>,
        <https://1145.am/db/1761607/Lux_Capital>,
        <https://1145.am/db/1762041/Lux_Capital>,
        <https://1145.am/db/1763354/Lux_Capital>,
        <https://1145.am/db/1766887/Lux_Capital>,
        <https://1145.am/db/1777184/Lux_Capital>,
        <https://1145.am/db/1782221/Lux_Capital>,
        <https://1145.am/db/1792186/Lux_Capital>,
        <https://1145.am/db/1796593/Lux_Capital>,
        <https://1145.am/db/1803458/Lux_Capital>,
        <https://1145.am/db/1808133/Lux_Capital>,
        <https://1145.am/db/1809178/Lux_Capital>,
        <https://1145.am/db/1811725/Lux_Capital>,
        <https://1145.am/db/1815044/Lux_Capital>,
        <https://1145.am/db/1817051/Lux_Capital>,
        <https://1145.am/db/1818204/Lux_Capital>,
        <https://1145.am/db/1819710/Lux_Capital>,
        <https://1145.am/db/1827904/Lux_Capital>,
        <https://1145.am/db/1829422/Lux_Capital>,
        <https://1145.am/db/1838965/Lux_Capital>,
        <https://1145.am/db/1845217/Lux_Capital>,
        <https://1145.am/db/1846254/Lux_Capital>,
        <https://1145.am/db/1930816/Lux_Capital>,
        <https://1145.am/db/1932856/Lux_Capital>,
        <https://1145.am/db/2006781/Lux_Capital>,
        <https://1145.am/db/2138013/Lux_Capital>,
        <https://1145.am/db/2141058/Lux_Capital>,
        <https://1145.am/db/2178040/Lux_Capital>,
        <https://1145.am/db/2284256/Lux_Capital>,
        <https://1145.am/db/2291716/Lux_Capital>,
        <https://1145.am/db/2291901/Lux_Capital>,
        <https://1145.am/db/2303675/Lux_Capital>,
        <https://1145.am/db/2304963/Lux_Capital>,
        <https://1145.am/db/2305327/Lux_Capital>,
        <https://1145.am/db/2328280/Lux_Capital>,
        <https://1145.am/db/2331549/Lux_Capital>,
        <https://1145.am/db/2335750/Lux_Capital>,
        <https://1145.am/db/2335755/Lux_Capital>,
        <https://1145.am/db/2337522/Lux_Capital>,
        <https://1145.am/db/2337577/Lux_Capital>,
        <https://1145.am/db/2344256/Lux_Capital>,
        <https://1145.am/db/2345224/Lux_Capital>,
        <https://1145.am/db/2345439/Lux_Capital>,
        <https://1145.am/db/2347102/Lux_Capital>,
        <https://1145.am/db/2348448/Lux_Capital>,
        <https://1145.am/db/2352414/Lux_Capital>,
        <https://1145.am/db/2546216/Lux_Capital>,
        <https://1145.am/db/2633440/Lux_Capital>,
        <https://1145.am/db/2801014/Lux_Capital>,
        <https://1145.am/db/412847/Lux_Capital>,
        <https://1145.am/db/424834/Lux_Capital>,
        <https://1145.am/db/425188/Lux_Capital>,
        <https://1145.am/db/425281/Lux_Capital>,
        <https://1145.am/db/426160/Lux_Capital>,
        <https://1145.am/db/516176/Lux_Capital>,
        <https://1145.am/db/516613/Lux_Capital>,
        <https://1145.am/db/540507/Lux_Capital>,
        <https://1145.am/db/684792/Lux_Capital>,
        <https://1145.am/db/747771/Lux_Capital>,
        <https://1145.am/db/765641/Lux_Capital>,
        <https://1145.am/db/823763/Lux_Capital>,
        <https://1145.am/db/863878/Lux_Capital>,
        <https://1145.am/db/918904/Lux_Capital>,
        <https://1145.am/db/935910/Lux_Capital>,
        <https://1145.am/db/936989/Lux_Capital>,
        <https://1145.am/db/940684/Lux_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/The_Bill___Melinda_Gates_Foundation> a org:Organization ;
    ns1:basedInHighGeoName "Cambridgeshire" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2653940/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "The Bill & Melinda Gates Foundation" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "The Bill & Melinda Gates Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/1082053/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1223116/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1291634/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1428798/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1534279/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1577330/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1690821/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1807438/Bill_And_Melinda_Gates_Foundation>,
        <https://1145.am/db/1981265/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2281246/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2287006/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2293727/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2316514/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2317981/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2331329/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2337577/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2338383/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2340643/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2340646/Thebill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2345880/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2347102/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2347301/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2353832/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2353834/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2367621/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2546216/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2578745/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/360780/Bill_And_Melinda_Gates_Foundation>,
        <https://1145.am/db/463585/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/703895/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/796790/Bill___Melinda_Gates_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Cvf_Llc> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "CVF, LLC" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "CVF, LLC" ;
    ns1:sameAsHigh <https://1145.am/db/1751697/Idcv>,
        <https://1145.am/db/2337571/Cvf_Llc>,
        <https://1145.am/db/2546216/Cvf_Llc> ;
    ns1:sameAsMedium <https://1145.am/db/2348440/CVF>,
        <https://1145.am/db/2348448/Cvf_Llc>,
        <https://1145.am/db/2356420/Cvf_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Genocea_Biosciences> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, MA" ;
    ns1:description "T cell vaccines" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Genocea",
        "Genocea Biosciences, Inc." ;
    ns1:name "Genocea Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/2546216/Genocea_Biosciences> ;
    ns1:sameAsMedium <https://1145.am/db/2303707/Genocea_Biosciences>,
        <https://1145.am/db/2311583/Genocea_Biosciences>,
        <https://1145.am/db/2329579/Genocea_Biosciences>,
        <https://1145.am/db/2330601/Genocea_Biosciences>,
        <https://1145.am/db/2331763/Genocea_Biosciences>,
        <https://1145.am/db/2331777/Genocea_Biosciences>,
        <https://1145.am/db/2336889/Genocea_Biosciences>,
        <https://1145.am/db/2337571/Genocea_Biosciences>,
        <https://1145.am/db/2341844/Genocea_Biosciences>,
        <https://1145.am/db/2342398/Genocea_Biosciences_Inc>,
        <https://1145.am/db/2351839/Genocea_Biosciences>,
        <https://1145.am/db/2351840/Genocea_Biosciences>,
        <https://1145.am/db/2353970/Genocea_Biosciences>,
        <https://1145.am/db/2363551/Genocea_Biosciences>,
        <https://1145.am/db/2365296/Genocea_Biosciences_Inc>,
        <https://1145.am/db/2536127/Genocea_Biosciences>,
        <https://1145.am/db/2536128/Genocea_Biosciences_Inc>,
        <https://1145.am/db/2546218/Genocea_Biosciences>,
        <https://1145.am/db/2555579/Genocea_Biosciences>,
        <https://1145.am/db/470251/Genocea_Biosciences>,
        <https://1145.am/db/883613/Genocea_Biosciences> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Lux_Capital> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Lux",
        "Lux Capital" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Lux Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1105217/Lux_Capital>,
        <https://1145.am/db/1106865/Lux_Capital>,
        <https://1145.am/db/1119433/Lux_Capital>,
        <https://1145.am/db/1119661/Lux_Capital>,
        <https://1145.am/db/1122753/Lux_Capital>,
        <https://1145.am/db/1139654/Lux_Capital>,
        <https://1145.am/db/1143903/Lux_Capital>,
        <https://1145.am/db/1238486/Lux_Capital>,
        <https://1145.am/db/1285901/Lux_Capital>,
        <https://1145.am/db/1374025/Lux_Capital>,
        <https://1145.am/db/1375318/Lux_Capital>,
        <https://1145.am/db/1376203/Lux_Capital>,
        <https://1145.am/db/1407553/Lux_Capital>,
        <https://1145.am/db/1536915/Lux_Capital>,
        <https://1145.am/db/1553919/Lux_Capital>,
        <https://1145.am/db/1555013/Lux_Capital>,
        <https://1145.am/db/1632690/Lux_Capital>,
        <https://1145.am/db/1669908/Lux_Capital>,
        <https://1145.am/db/1697296/Lux_Capital>,
        <https://1145.am/db/1734597/Lux_Capital>,
        <https://1145.am/db/1737151/Lux_Capital>,
        <https://1145.am/db/1737409/Lux_Capital>,
        <https://1145.am/db/174200/Lux_Capital>,
        <https://1145.am/db/1743303/Lux_Capital>,
        <https://1145.am/db/1758194/Lux_Capital>,
        <https://1145.am/db/1761607/Lux_Capital>,
        <https://1145.am/db/1762041/Lux_Capital>,
        <https://1145.am/db/1763354/Lux_Capital>,
        <https://1145.am/db/1766887/Lux_Capital>,
        <https://1145.am/db/1777184/Lux_Capital>,
        <https://1145.am/db/1782221/Lux_Capital>,
        <https://1145.am/db/1792186/Lux_Capital>,
        <https://1145.am/db/1796593/Lux_Capital>,
        <https://1145.am/db/1803458/Lux_Capital>,
        <https://1145.am/db/1808133/Lux_Capital>,
        <https://1145.am/db/1809178/Lux_Capital>,
        <https://1145.am/db/1811725/Lux_Capital>,
        <https://1145.am/db/1815044/Lux_Capital>,
        <https://1145.am/db/1817051/Lux_Capital>,
        <https://1145.am/db/1818204/Lux_Capital>,
        <https://1145.am/db/1819710/Lux_Capital>,
        <https://1145.am/db/1827904/Lux_Capital>,
        <https://1145.am/db/1829422/Lux_Capital>,
        <https://1145.am/db/1838965/Lux_Capital>,
        <https://1145.am/db/1845217/Lux_Capital>,
        <https://1145.am/db/1846254/Lux_Capital>,
        <https://1145.am/db/1930816/Lux_Capital>,
        <https://1145.am/db/1932856/Lux_Capital>,
        <https://1145.am/db/2006781/Lux_Capital>,
        <https://1145.am/db/2138013/Lux_Capital>,
        <https://1145.am/db/2141058/Lux_Capital>,
        <https://1145.am/db/2178040/Lux_Capital>,
        <https://1145.am/db/2284256/Lux_Capital>,
        <https://1145.am/db/2291716/Lux_Capital>,
        <https://1145.am/db/2291901/Lux_Capital>,
        <https://1145.am/db/2303675/Lux_Capital>,
        <https://1145.am/db/2304963/Lux_Capital>,
        <https://1145.am/db/2305327/Lux_Capital>,
        <https://1145.am/db/2328280/Lux_Capital>,
        <https://1145.am/db/2331549/Lux_Capital>,
        <https://1145.am/db/2335750/Lux_Capital>,
        <https://1145.am/db/2335755/Lux_Capital>,
        <https://1145.am/db/2337522/Lux_Capital>,
        <https://1145.am/db/2337571/Lux_Capital>,
        <https://1145.am/db/2344256/Lux_Capital>,
        <https://1145.am/db/2345224/Lux_Capital>,
        <https://1145.am/db/2345439/Lux_Capital>,
        <https://1145.am/db/2347102/Lux_Capital>,
        <https://1145.am/db/2348448/Lux_Capital>,
        <https://1145.am/db/2352414/Lux_Capital>,
        <https://1145.am/db/2546216/Lux_Capital>,
        <https://1145.am/db/2633440/Lux_Capital>,
        <https://1145.am/db/2801014/Lux_Capital>,
        <https://1145.am/db/412847/Lux_Capital>,
        <https://1145.am/db/424834/Lux_Capital>,
        <https://1145.am/db/425188/Lux_Capital>,
        <https://1145.am/db/425281/Lux_Capital>,
        <https://1145.am/db/426160/Lux_Capital>,
        <https://1145.am/db/516176/Lux_Capital>,
        <https://1145.am/db/516613/Lux_Capital>,
        <https://1145.am/db/540507/Lux_Capital>,
        <https://1145.am/db/684792/Lux_Capital>,
        <https://1145.am/db/747771/Lux_Capital>,
        <https://1145.am/db/765641/Lux_Capital>,
        <https://1145.am/db/823763/Lux_Capital>,
        <https://1145.am/db/863878/Lux_Capital>,
        <https://1145.am/db/918904/Lux_Capital>,
        <https://1145.am/db/935910/Lux_Capital>,
        <https://1145.am/db/936989/Lux_Capital>,
        <https://1145.am/db/940684/Lux_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/The_Bill___Melinda_Gates_Foundation> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "The Bill & Melinda Gates Foundation" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "The Bill & Melinda Gates Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/1082053/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1223116/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1291634/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1428798/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1534279/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1577330/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1690821/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1807438/Bill_And_Melinda_Gates_Foundation>,
        <https://1145.am/db/1981265/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2281246/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2287006/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2293727/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2316514/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2317981/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2331329/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2337571/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2338383/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2340643/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2340646/Thebill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2345880/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2347102/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2347301/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2353832/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2353834/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2367621/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2546216/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2578745/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/360780/Bill_And_Melinda_Gates_Foundation>,
        <https://1145.am/db/463585/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/703895/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/796790/Bill___Melinda_Gates_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2339163/Series_B_Investment_Hopen_Life_Science_Ventures_Swmf_Life_Science_Fund_Tolera_Therapeutics_Inc_Triathlon_Medical_Venture_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-17T16:22:17+00:00"^^xsd:dateTime ;
    ns1:documentExtract "KALAMAZOO, Mich., Oct. 16, 2012 - Tolera Therapeutics Inc., a privately held biotechnology company focusing on the development of immunotherapeutics directed at the transplantation, autoimmune and oncology markets, announced today that it has closed its Series B-3 financing.",
        "Tolera Therapeutics closes Series B-3 financing, raises $ 5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation." ;
    ns1:documentTitle "Tolera Therapeutics closes Series B-3 financing, raises $5.5 million to submit Phase 3 Special Protocol Assessment for its immune targeting biologic drug in kidney transplantation" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/tolera-therapeutics-closes-series-b-3-financing-raises-5-5-million-to-submit-phase-3> ;
    ns1:foundName "financing",
        "raises" ;
    ns1:name "financing",
        "raises" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2339163/Tolera_Therapeutics_Inc> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 5.5 million" ;
    ns1:whereGeoName "Grand Rapids" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4994358/about.rdf> ;
    ns1:whereRaw "Grand Rapids, Michigan" .

<https://1145.am/db/2340887/Alta_Partners> a org:Organization ;
    ns1:basedInLowRaw "Texas" ;
    ns1:documentDate "2012-10-24T12:45:32+00:00"^^xsd:dateTime ;
    ns1:documentTitle "ZS Pharma raises $46 million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zs-pharma-raises-46-million-series-c-financing> ;
    ns1:foundName "Alta Partners" ;
    ns1:investor <https://1145.am/db/2340887/Investment_3x5_Special_Opportunity_Partners_Alta_Partners_Devon_Park_Bioventures_Rivervest_Venture_Partners_Salem_Partners_Zs_Pharma_Completed> ;
    ns1:name "Alta Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1156304/Alta_Partners>,
        <https://1145.am/db/1230022/Alta_Partners>,
        <https://1145.am/db/1333948/Altas_Partners>,
        <https://1145.am/db/1334727/Altas_Partners>,
        <https://1145.am/db/2303810/Alta_Partners>,
        <https://1145.am/db/2303814/Alta_Partners>,
        <https://1145.am/db/2304769/Alta_Partners>,
        <https://1145.am/db/2304870/Alta_Partners>,
        <https://1145.am/db/2305729/Alta_Partners>,
        <https://1145.am/db/2305745/Alta_Partners>,
        <https://1145.am/db/2306281/Alta_Partners>,
        <https://1145.am/db/2306568/Alta_Partners>,
        <https://1145.am/db/2307682/Alta_Partners>,
        <https://1145.am/db/2307691/Alta_Partners>,
        <https://1145.am/db/2307824/Alta_Partners>,
        <https://1145.am/db/2307829/Alta_Partners>,
        <https://1145.am/db/2308855/Alta_Partners>,
        <https://1145.am/db/2311011/Alta_Partners>,
        <https://1145.am/db/2313143/Alta_Partners>,
        <https://1145.am/db/2313405/Alta_Partners>,
        <https://1145.am/db/2316391/Alta_Partners>,
        <https://1145.am/db/2318577/Alta_Partners>,
        <https://1145.am/db/2318635/Alta_Partners>,
        <https://1145.am/db/2322984/Alta_Partners>,
        <https://1145.am/db/2323003/Alta_Partners>,
        <https://1145.am/db/2323243/Alta_Partners>,
        <https://1145.am/db/2324012/Alta_Partners>,
        <https://1145.am/db/2324015/Alta_Partners>,
        <https://1145.am/db/2326176/Alta_Partners>,
        <https://1145.am/db/2326903/Alta_Partners>,
        <https://1145.am/db/2327441/Alta_Partners>,
        <https://1145.am/db/2327442/Alta_Partners>,
        <https://1145.am/db/2327677/Alta_Partners>,
        <https://1145.am/db/2328815/Alta_Partners>,
        <https://1145.am/db/2330075/Alta_Partners>,
        <https://1145.am/db/2330079/Alta_Partners>,
        <https://1145.am/db/2338126/Alta_Partners>,
        <https://1145.am/db/2338127/Alta_Partners>,
        <https://1145.am/db/2341764/Alta_Partners>,
        <https://1145.am/db/2343547/Alta_Partners>,
        <https://1145.am/db/2344092/Alta_Partners>,
        <https://1145.am/db/2344100/Alta_Partners>,
        <https://1145.am/db/2346542/Alta_Partners>,
        <https://1145.am/db/2351224/Alta_Partners>,
        <https://1145.am/db/2351897/Alta_Partners>,
        <https://1145.am/db/2352167/Alta_Partners>,
        <https://1145.am/db/2352170/Alta_Partners>,
        <https://1145.am/db/2352362/Alta_Partners>,
        <https://1145.am/db/2352831/Alta_Partners>,
        <https://1145.am/db/2353439/Alta_Partners>,
        <https://1145.am/db/2353771/Alta_Partners>,
        <https://1145.am/db/2353789/Alta_Partners>,
        <https://1145.am/db/2354299/Alta_Partners>,
        <https://1145.am/db/2354307/Alta_Partners>,
        <https://1145.am/db/2354314/Alta_Partners>,
        <https://1145.am/db/2355183/Alta_Partners>,
        <https://1145.am/db/2355274/Alta_Partners>,
        <https://1145.am/db/2355586/Alta_Partners>,
        <https://1145.am/db/2356216/Alta_Partners>,
        <https://1145.am/db/2358496/Alta_Partners>,
        <https://1145.am/db/2358502/Alta_Partners>,
        <https://1145.am/db/2362565/Alta_Partners>,
        <https://1145.am/db/2362566/Alta_Partners>,
        <https://1145.am/db/2362902/Alta_Partners>,
        <https://1145.am/db/2362909/Alta_Partners>,
        <https://1145.am/db/2362910/Alta_Partners>,
        <https://1145.am/db/2363364/Alta_Partners>,
        <https://1145.am/db/2363510/Alta_Partners>,
        <https://1145.am/db/2365748/Alta_Partners>,
        <https://1145.am/db/2366693/Alta_Partners>,
        <https://1145.am/db/2366700/Alta_Partners>,
        <https://1145.am/db/2367497/Alta_Partners>,
        <https://1145.am/db/328387/Altas_Partners>,
        <https://1145.am/db/443962/Altas_Partners>,
        <https://1145.am/db/750997/Alta_Partners>,
        <https://1145.am/db/979509/Alta_Partners>,
        <https://1145.am/db/987929/Alta_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340888/Correlation_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "Austin" ;
    ns1:documentDate "2012-10-24T12:43:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mirna-therapeutics-secures-34-5-million-series-c-financing-to-advance-oncology-microrna-0> ;
    ns1:foundName "Correlation Ventures" ;
    ns1:investor <https://1145.am/db/2340888/Series_C_Investment_Correlation_Ventures_Mirna_Therapeutics_Inc_New_Enterprise_Associates_Osage_University_Partners_Pfizer_Ventures_Sofinnova_Ventures_Completed> ;
    ns1:name "Correlation Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1164688/Correlation_Ventures>,
        <https://1145.am/db/1166356/Correlation_Ventures>,
        <https://1145.am/db/1484404/Correlation_Ventures>,
        <https://1145.am/db/1727833/Correlation_Ventures>,
        <https://1145.am/db/1737130/Correlation_Ventures>,
        <https://1145.am/db/1764096/Correlation_Ventures>,
        <https://1145.am/db/1817971/Correlation_Ventures>,
        <https://1145.am/db/1828658/Correlation_Ventures>,
        <https://1145.am/db/1830147/Correlation_Ventures>,
        <https://1145.am/db/1830149/Correlation_Ventures>,
        <https://1145.am/db/1839922/Correlation_Ventures>,
        <https://1145.am/db/1840957/Correlation_Ventures>,
        <https://1145.am/db/1842583/Correlation_Ventures>,
        <https://1145.am/db/1843211/Correlation_Ventures>,
        <https://1145.am/db/1854668/Correlation_Ventures>,
        <https://1145.am/db/1856384/Correlation_Ventures>,
        <https://1145.am/db/1959001/Correlation_Ventures>,
        <https://1145.am/db/1974032/Correlation_Ventures>,
        <https://1145.am/db/2010246/Correlation_Ventures>,
        <https://1145.am/db/2113474/Correlation_Ventures>,
        <https://1145.am/db/2298395/Correlation_Ventures>,
        <https://1145.am/db/2341896/Correlation_Ventures>,
        <https://1145.am/db/2356391/Correlation_Ventures>,
        <https://1145.am/db/2356393/Correlation_Ventures>,
        <https://1145.am/db/2356395/Correlation_Ventures>,
        <https://1145.am/db/2360258/Correlation_Ventures>,
        <https://1145.am/db/2367675/Correlation_Ventures>,
        <https://1145.am/db/2367676/Correlation_Ventures>,
        <https://1145.am/db/2368351/Correlation_Ventures>,
        <https://1145.am/db/2369785/Correlation_Ventures>,
        <https://1145.am/db/2371165/Correlation_Ventures>,
        <https://1145.am/db/2371166/Correlation_Ventures>,
        <https://1145.am/db/343358/Correlation_Ventures>,
        <https://1145.am/db/526524/Correlation_Ventures>,
        <https://1145.am/db/556709/Correlation_Ventures>,
        <https://1145.am/db/800060/Correlation_Ventures>,
        <https://1145.am/db/984927/Correlation_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340888/Sofinnova_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "Austin" ;
    ns1:documentDate "2012-10-24T12:43:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mirna-therapeutics-secures-34-5-million-series-c-financing-to-advance-oncology-microrna-0> ;
    ns1:foundName "Sofinnova Ventures" ;
    ns1:investor <https://1145.am/db/2340888/Series_C_Investment_Correlation_Ventures_Mirna_Therapeutics_Inc_New_Enterprise_Associates_Osage_University_Partners_Pfizer_Ventures_Sofinnova_Ventures_Completed> ;
    ns1:name "Sofinnova Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1876390/Sofinnova_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2301093/Sofinnova_Ventures>,
        <https://1145.am/db/2303548/Sofinnova_Ventures>,
        <https://1145.am/db/2303560/Sofinnova_Ventures>,
        <https://1145.am/db/2304598/Sofinnova_Ventures>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305328/Sofinnova_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2310073/Sofinnova_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2311075/Sofinnova_Ventures>,
        <https://1145.am/db/2312051/Sofinnova_Ventures>,
        <https://1145.am/db/2313171/Sofinnova_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314964/Sofinnova_Ventures>,
        <https://1145.am/db/2317750/Sofinnova_Ventures>,
        <https://1145.am/db/2317753/Sofinnova_Ventures>,
        <https://1145.am/db/2322231/Sofinnova_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2324223/Sofinnova_Ventures>,
        <https://1145.am/db/2325549/Sofinnova_Ventures>,
        <https://1145.am/db/2328338/Sofinnova_Ventures>,
        <https://1145.am/db/2330799/Sofinnova_Ventures>,
        <https://1145.am/db/2330914/Sofinnova_Ventures>,
        <https://1145.am/db/2330920/Sofinnova_Ventures>,
        <https://1145.am/db/2331700/Sofinnova_Ventures>,
        <https://1145.am/db/2336102/Sofinnova_Ventures>,
        <https://1145.am/db/2336109/Sofinnova_Ventures>,
        <https://1145.am/db/2337140/Sofinnova_Ventures>,
        <https://1145.am/db/2339666/Sofinnova_Ventures>,
        <https://1145.am/db/2340542/Sofinnova_Ventures>,
        <https://1145.am/db/2340890/Sofinnova_Ventures>,
        <https://1145.am/db/2341869/Sofinnova_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341897/Sofinnova_Ventures>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2345047/Sofinnova_Ventures>,
        <https://1145.am/db/2345262/Sofinnova_Ventures>,
        <https://1145.am/db/2348857/Sofinnova_Ventures>,
        <https://1145.am/db/2349013/Sofinnova_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2349834/Sofinnova_Ventures>,
        <https://1145.am/db/2350231/Sofinnova_Ventures>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/2352059/Sofinnova_Ventures>,
        <https://1145.am/db/2353771/Sofinnova_Ventures>,
        <https://1145.am/db/2353789/Sofinnova_Ventures>,
        <https://1145.am/db/2355183/Sofinnova_Ventures>,
        <https://1145.am/db/2357105/Sofinnova_Ventures>,
        <https://1145.am/db/2357356/Sofinnova_Ventures>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358234/Sofinnova_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2359124/Sofinnova_Ventures>,
        <https://1145.am/db/2360266/Sofinnova_Ventures>,
        <https://1145.am/db/2360647/Sofinnova_Ventures>,
        <https://1145.am/db/2362902/Sofinnova_Ventures>,
        <https://1145.am/db/2362909/Sofinnova_Ventures>,
        <https://1145.am/db/2362910/Sofinnova_Ventures>,
        <https://1145.am/db/2366710/Sofinnova_Ventures>,
        <https://1145.am/db/2366712/Sofinnova_Ventures>,
        <https://1145.am/db/2367022/Sofinnova_Ventures>,
        <https://1145.am/db/2367023/Sofinnova_Ventures>,
        <https://1145.am/db/2368982/Sofinnova_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/2371163/Sofinnova_Ventures>,
        <https://1145.am/db/2569522/Sofinnova_Ventures>,
        <https://1145.am/db/2570520/Sofinnova_Ventures>,
        <https://1145.am/db/2570523/Sofinnova_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2578627/Sofinnova_Ventures>,
        <https://1145.am/db/2588372/Sofinnova_Ventures>,
        <https://1145.am/db/2592611/Sofinnova_Ventures>,
        <https://1145.am/db/2630808/Sofinnova_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340890/Sofinnova_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "Austin" ;
    ns1:documentDate "2012-10-24T12:53:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Two Texas biotech outfits lasso venture deals totaling $81M" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/two-texas-biotech-outfits-lasso-venture-deals-totaling-81m> ;
    ns1:foundName "Sofinnova Ventures" ;
    ns1:investor <https://1145.am/db/2340890/Investment_Mirna_New_Enterprise_Associates_Pfizer_Sofinnova_Ventures_Stopped> ;
    ns1:name "Sofinnova Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1876390/Sofinnova_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2301093/Sofinnova_Ventures>,
        <https://1145.am/db/2303548/Sofinnova_Ventures>,
        <https://1145.am/db/2303560/Sofinnova_Ventures>,
        <https://1145.am/db/2304598/Sofinnova_Ventures>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305328/Sofinnova_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2310073/Sofinnova_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2311075/Sofinnova_Ventures>,
        <https://1145.am/db/2312051/Sofinnova_Ventures>,
        <https://1145.am/db/2313171/Sofinnova_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314964/Sofinnova_Ventures>,
        <https://1145.am/db/2317750/Sofinnova_Ventures>,
        <https://1145.am/db/2317753/Sofinnova_Ventures>,
        <https://1145.am/db/2322231/Sofinnova_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2324223/Sofinnova_Ventures>,
        <https://1145.am/db/2325549/Sofinnova_Ventures>,
        <https://1145.am/db/2328338/Sofinnova_Ventures>,
        <https://1145.am/db/2330799/Sofinnova_Ventures>,
        <https://1145.am/db/2330914/Sofinnova_Ventures>,
        <https://1145.am/db/2330920/Sofinnova_Ventures>,
        <https://1145.am/db/2331700/Sofinnova_Ventures>,
        <https://1145.am/db/2336102/Sofinnova_Ventures>,
        <https://1145.am/db/2336109/Sofinnova_Ventures>,
        <https://1145.am/db/2337140/Sofinnova_Ventures>,
        <https://1145.am/db/2339666/Sofinnova_Ventures>,
        <https://1145.am/db/2340542/Sofinnova_Ventures>,
        <https://1145.am/db/2340888/Sofinnova_Ventures>,
        <https://1145.am/db/2341869/Sofinnova_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341897/Sofinnova_Ventures>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2345047/Sofinnova_Ventures>,
        <https://1145.am/db/2345262/Sofinnova_Ventures>,
        <https://1145.am/db/2348857/Sofinnova_Ventures>,
        <https://1145.am/db/2349013/Sofinnova_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2349834/Sofinnova_Ventures>,
        <https://1145.am/db/2350231/Sofinnova_Ventures>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/2352059/Sofinnova_Ventures>,
        <https://1145.am/db/2353771/Sofinnova_Ventures>,
        <https://1145.am/db/2353789/Sofinnova_Ventures>,
        <https://1145.am/db/2355183/Sofinnova_Ventures>,
        <https://1145.am/db/2357105/Sofinnova_Ventures>,
        <https://1145.am/db/2357356/Sofinnova_Ventures>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358234/Sofinnova_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2359124/Sofinnova_Ventures>,
        <https://1145.am/db/2360266/Sofinnova_Ventures>,
        <https://1145.am/db/2360647/Sofinnova_Ventures>,
        <https://1145.am/db/2362902/Sofinnova_Ventures>,
        <https://1145.am/db/2362909/Sofinnova_Ventures>,
        <https://1145.am/db/2362910/Sofinnova_Ventures>,
        <https://1145.am/db/2366710/Sofinnova_Ventures>,
        <https://1145.am/db/2366712/Sofinnova_Ventures>,
        <https://1145.am/db/2367022/Sofinnova_Ventures>,
        <https://1145.am/db/2367023/Sofinnova_Ventures>,
        <https://1145.am/db/2368982/Sofinnova_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/2371163/Sofinnova_Ventures>,
        <https://1145.am/db/2569522/Sofinnova_Ventures>,
        <https://1145.am/db/2570520/Sofinnova_Ventures>,
        <https://1145.am/db/2570523/Sofinnova_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2578627/Sofinnova_Ventures>,
        <https://1145.am/db/2588372/Sofinnova_Ventures>,
        <https://1145.am/db/2592611/Sofinnova_Ventures>,
        <https://1145.am/db/2630808/Sofinnova_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341869/Series_A_Investment_Aclaris_Therapeutics_Fidelity_Biosciences_Sofinnova_Ventures_Vivo_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-24T16:09:16+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $ 21 Million in Series A Financing.",
        "MALVERN, Pa.- (BUSINESS WIRE) -Aclaris Therapeutics, Inc., a privately held specialty pharmaceutical company dedicated to developing dermatological therapeutics, announced today that it has secured $ 21 million in Series A financing." ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2341869/Aclaris_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 21 Million",
        "$ 21 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2341869/Sofinnova_Ventures> a org:Organization ;
    ns1:basedInLowRaw "Pa" ;
    ns1:documentDate "2012-10-24T16:09:16+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a-financing> ;
    ns1:foundName "Sofinnova Ventures" ;
    ns1:investor <https://1145.am/db/2341869/Series_A_Investment_Aclaris_Therapeutics_Fidelity_Biosciences_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Sofinnova Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1876390/Sofinnova_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2301093/Sofinnova_Ventures>,
        <https://1145.am/db/2303548/Sofinnova_Ventures>,
        <https://1145.am/db/2303560/Sofinnova_Ventures>,
        <https://1145.am/db/2304598/Sofinnova_Ventures>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305328/Sofinnova_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2310073/Sofinnova_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2311075/Sofinnova_Ventures>,
        <https://1145.am/db/2312051/Sofinnova_Ventures>,
        <https://1145.am/db/2313171/Sofinnova_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314964/Sofinnova_Ventures>,
        <https://1145.am/db/2317750/Sofinnova_Ventures>,
        <https://1145.am/db/2317753/Sofinnova_Ventures>,
        <https://1145.am/db/2322231/Sofinnova_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2324223/Sofinnova_Ventures>,
        <https://1145.am/db/2325549/Sofinnova_Ventures>,
        <https://1145.am/db/2328338/Sofinnova_Ventures>,
        <https://1145.am/db/2330799/Sofinnova_Ventures>,
        <https://1145.am/db/2330914/Sofinnova_Ventures>,
        <https://1145.am/db/2330920/Sofinnova_Ventures>,
        <https://1145.am/db/2331700/Sofinnova_Ventures>,
        <https://1145.am/db/2336102/Sofinnova_Ventures>,
        <https://1145.am/db/2336109/Sofinnova_Ventures>,
        <https://1145.am/db/2337140/Sofinnova_Ventures>,
        <https://1145.am/db/2339666/Sofinnova_Ventures>,
        <https://1145.am/db/2340542/Sofinnova_Ventures>,
        <https://1145.am/db/2340888/Sofinnova_Ventures>,
        <https://1145.am/db/2340890/Sofinnova_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341897/Sofinnova_Ventures>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2345047/Sofinnova_Ventures>,
        <https://1145.am/db/2345262/Sofinnova_Ventures>,
        <https://1145.am/db/2348857/Sofinnova_Ventures>,
        <https://1145.am/db/2349013/Sofinnova_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2349834/Sofinnova_Ventures>,
        <https://1145.am/db/2350231/Sofinnova_Ventures>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/2352059/Sofinnova_Ventures>,
        <https://1145.am/db/2353771/Sofinnova_Ventures>,
        <https://1145.am/db/2353789/Sofinnova_Ventures>,
        <https://1145.am/db/2355183/Sofinnova_Ventures>,
        <https://1145.am/db/2357105/Sofinnova_Ventures>,
        <https://1145.am/db/2357356/Sofinnova_Ventures>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358234/Sofinnova_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2359124/Sofinnova_Ventures>,
        <https://1145.am/db/2360266/Sofinnova_Ventures>,
        <https://1145.am/db/2360647/Sofinnova_Ventures>,
        <https://1145.am/db/2362902/Sofinnova_Ventures>,
        <https://1145.am/db/2362909/Sofinnova_Ventures>,
        <https://1145.am/db/2362910/Sofinnova_Ventures>,
        <https://1145.am/db/2366710/Sofinnova_Ventures>,
        <https://1145.am/db/2366712/Sofinnova_Ventures>,
        <https://1145.am/db/2367022/Sofinnova_Ventures>,
        <https://1145.am/db/2367023/Sofinnova_Ventures>,
        <https://1145.am/db/2368982/Sofinnova_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/2371163/Sofinnova_Ventures>,
        <https://1145.am/db/2569522/Sofinnova_Ventures>,
        <https://1145.am/db/2570520/Sofinnova_Ventures>,
        <https://1145.am/db/2570523/Sofinnova_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2578627/Sofinnova_Ventures>,
        <https://1145.am/db/2588372/Sofinnova_Ventures>,
        <https://1145.am/db/2592611/Sofinnova_Ventures>,
        <https://1145.am/db/2630808/Sofinnova_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341897/Series_A_Investment_Aclaris_Therapeutics_Fidelity_Biosciences_Sofinnova_Ventures_Vivo_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-25T04:01:20+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $ 21 Million in Series A Financing.",
        "Aclaris Therapeutics, Inc., a privately held specialty pharmaceutical company dedicated to developing dermatological therapeutics, announced today that it has secured $ 21 million in Series A financing." ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2341897/Aclaris_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 21 Million",
        "$ 21 million" .

<https://1145.am/db/2341897/Sofinnova_Ventures> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2012-10-25T04:01:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aclaris Formed to Develop Novel Dermatology Treatment; Raises $21 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/aclaris-formed-to-develop-novel-dermatology-treatment-raises-21-million-series-a> ;
    ns1:foundName "Sofinnova Ventures" ;
    ns1:investor <https://1145.am/db/2341897/Series_A_Investment_Aclaris_Therapeutics_Fidelity_Biosciences_Sofinnova_Ventures_Vivo_Ventures_Completed> ;
    ns1:name "Sofinnova Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1196618/Sofinnova_Partners>,
        <https://1145.am/db/1199155/Sofinnova_Partners>,
        <https://1145.am/db/1520914/Sanno_Capital>,
        <https://1145.am/db/1586510/Sopris_Capital>,
        <https://1145.am/db/1945485/Sozo_Ventures>,
        <https://1145.am/db/2079459/Sopris_Capital>,
        <https://1145.am/db/2102258/Shoni_Top_Ventures>,
        <https://1145.am/db/2144387/Okapi_Capital>,
        <https://1145.am/db/2152399/Sofinnova_Investments>,
        <https://1145.am/db/2286182/Sofinnova_Partners>,
        <https://1145.am/db/2311075/Sofinnova_Ventures>,
        <https://1145.am/db/2312051/Sofinnova_Ventures>,
        <https://1145.am/db/2348857/Sofinnova_Ventures>,
        <https://1145.am/db/2355885/Sofinnova_Partners>,
        <https://1145.am/db/2358269/Sofinnova_Partners>,
        <https://1145.am/db/2361625/Canaan_Partners_Sofinnova_Ventures>,
        <https://1145.am/db/2363597/Sofinnova_Partners>,
        <https://1145.am/db/2630808/Sofinnova_Ventures>,
        <https://1145.am/db/779867/Mirana_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1876390/Sofinnova_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2301093/Sofinnova_Ventures>,
        <https://1145.am/db/2303548/Sofinnova_Ventures>,
        <https://1145.am/db/2303560/Sofinnova_Ventures>,
        <https://1145.am/db/2304598/Sofinnova_Ventures>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305328/Sofinnova_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2310073/Sofinnova_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2313171/Sofinnova_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314964/Sofinnova_Ventures>,
        <https://1145.am/db/2317750/Sofinnova_Ventures>,
        <https://1145.am/db/2317753/Sofinnova_Ventures>,
        <https://1145.am/db/2322231/Sofinnova_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2324223/Sofinnova_Ventures>,
        <https://1145.am/db/2325549/Sofinnova_Ventures>,
        <https://1145.am/db/2328338/Sofinnova_Ventures>,
        <https://1145.am/db/2330799/Sofinnova_Ventures>,
        <https://1145.am/db/2330914/Sofinnova_Ventures>,
        <https://1145.am/db/2330920/Sofinnova_Ventures>,
        <https://1145.am/db/2331700/Sofinnova_Ventures>,
        <https://1145.am/db/2336102/Sofinnova_Ventures>,
        <https://1145.am/db/2336109/Sofinnova_Ventures>,
        <https://1145.am/db/2337140/Sofinnova_Ventures>,
        <https://1145.am/db/2339666/Sofinnova_Ventures>,
        <https://1145.am/db/2340542/Sofinnova_Ventures>,
        <https://1145.am/db/2340888/Sofinnova_Ventures>,
        <https://1145.am/db/2340890/Sofinnova_Ventures>,
        <https://1145.am/db/2341869/Sofinnova_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2345047/Sofinnova_Ventures>,
        <https://1145.am/db/2345262/Sofinnova_Ventures>,
        <https://1145.am/db/2349013/Sofinnova_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2349834/Sofinnova_Ventures>,
        <https://1145.am/db/2350231/Sofinnova_Ventures>,
        <https://1145.am/db/2350855/Sofinnova_Ventures>,
        <https://1145.am/db/2352059/Sofinnova_Ventures>,
        <https://1145.am/db/2353771/Sofinnova_Ventures>,
        <https://1145.am/db/2353789/Sofinnova_Ventures>,
        <https://1145.am/db/2355183/Sofinnova_Ventures>,
        <https://1145.am/db/2357105/Sofinnova_Ventures>,
        <https://1145.am/db/2357356/Sofinnova_Ventures>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358234/Sofinnova_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2359124/Sofinnova_Ventures>,
        <https://1145.am/db/2360266/Sofinnova_Ventures>,
        <https://1145.am/db/2360647/Sofinnova_Ventures>,
        <https://1145.am/db/2362902/Sofinnova_Ventures>,
        <https://1145.am/db/2362909/Sofinnova_Ventures>,
        <https://1145.am/db/2362910/Sofinnova_Ventures>,
        <https://1145.am/db/2366710/Sofinnova_Ventures>,
        <https://1145.am/db/2366712/Sofinnova_Ventures>,
        <https://1145.am/db/2367022/Sofinnova_Ventures>,
        <https://1145.am/db/2367023/Sofinnova_Ventures>,
        <https://1145.am/db/2368982/Sofinnova_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/2371163/Sofinnova_Ventures>,
        <https://1145.am/db/2569522/Sofinnova_Ventures>,
        <https://1145.am/db/2570520/Sofinnova_Ventures>,
        <https://1145.am/db/2570523/Sofinnova_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2578627/Sofinnova_Ventures>,
        <https://1145.am/db/2588372/Sofinnova_Ventures>,
        <https://1145.am/db/2592611/Sofinnova_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2345002/Agechem_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "QUEBEC" ;
    ns1:documentDate "2012-11-02T13:44:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/alethia-biotherapeutics-closes-a-4-7-million-financing-to-advance-its-bone-antiresorptive> ;
    ns1:foundName "AgeChem Venture Fund" ;
    ns1:investor <https://1145.am/db/2345002/Investment_Agechem_Venture_Fund_Alethia_Biotherapeutics_Inc_Bdc_Venture_Capital_Cellscript_Of_Wisconsin_Go_Capital_Completed> ;
    ns1:name "AgeChem Venture Fund" ;
    ns1:sameAsMedium <https://1145.am/db/2305729/Agechem_Venture_Fund>,
        <https://1145.am/db/2328030/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2328034/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2346534/Agechem_Venture_Fund>,
        <https://1145.am/db/2346542/Agechem_Venture_Fund>,
        <https://1145.am/db/2354752/Agechem_Venture_Fund>,
        <https://1145.am/db/2354770/Agechem_Venture_Fund>,
        <https://1145.am/db/2358031/Agechem_Venture_Fund>,
        <https://1145.am/db/2367046/Agechem_Venture_Fund>,
        <https://1145.am/db/2367047/Agechem_Venture_Fund>,
        <https://1145.am/db/2575232/Agechem_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347102/Lux_Capital> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-11-09T12:33:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/visterra-secures-financing-from-gates-foundation-and-omega-to-close-26m-series-a-financing> ;
    ns1:foundName "Lux Capital" ;
    ns1:investor <https://1145.am/db/2347102/Series_A_Investment_Flagship_Ventures_Lux_Capital_Omega_Funds_Polaris_Venture_Partners_The_Bill___Melinda_Gates_Foundation_Visterra_Completed> ;
    ns1:name "Lux Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1105217/Lux_Capital>,
        <https://1145.am/db/1106865/Lux_Capital>,
        <https://1145.am/db/1119433/Lux_Capital>,
        <https://1145.am/db/1119661/Lux_Capital>,
        <https://1145.am/db/1122753/Lux_Capital>,
        <https://1145.am/db/1139654/Lux_Capital>,
        <https://1145.am/db/1143903/Lux_Capital>,
        <https://1145.am/db/1238486/Lux_Capital>,
        <https://1145.am/db/1285901/Lux_Capital>,
        <https://1145.am/db/1374025/Lux_Capital>,
        <https://1145.am/db/1375318/Lux_Capital>,
        <https://1145.am/db/1376203/Lux_Capital>,
        <https://1145.am/db/1407553/Lux_Capital>,
        <https://1145.am/db/1536915/Lux_Capital>,
        <https://1145.am/db/1553919/Lux_Capital>,
        <https://1145.am/db/1555013/Lux_Capital>,
        <https://1145.am/db/1632690/Lux_Capital>,
        <https://1145.am/db/1669908/Lux_Capital>,
        <https://1145.am/db/1697296/Lux_Capital>,
        <https://1145.am/db/1734597/Lux_Capital>,
        <https://1145.am/db/1737151/Lux_Capital>,
        <https://1145.am/db/1737409/Lux_Capital>,
        <https://1145.am/db/174200/Lux_Capital>,
        <https://1145.am/db/1743303/Lux_Capital>,
        <https://1145.am/db/1758194/Lux_Capital>,
        <https://1145.am/db/1761607/Lux_Capital>,
        <https://1145.am/db/1762041/Lux_Capital>,
        <https://1145.am/db/1763354/Lux_Capital>,
        <https://1145.am/db/1766887/Lux_Capital>,
        <https://1145.am/db/1777184/Lux_Capital>,
        <https://1145.am/db/1782221/Lux_Capital>,
        <https://1145.am/db/1792186/Lux_Capital>,
        <https://1145.am/db/1796593/Lux_Capital>,
        <https://1145.am/db/1803458/Lux_Capital>,
        <https://1145.am/db/1808133/Lux_Capital>,
        <https://1145.am/db/1809178/Lux_Capital>,
        <https://1145.am/db/1811725/Lux_Capital>,
        <https://1145.am/db/1815044/Lux_Capital>,
        <https://1145.am/db/1817051/Lux_Capital>,
        <https://1145.am/db/1818204/Lux_Capital>,
        <https://1145.am/db/1819710/Lux_Capital>,
        <https://1145.am/db/1827904/Lux_Capital>,
        <https://1145.am/db/1829422/Lux_Capital>,
        <https://1145.am/db/1838965/Lux_Capital>,
        <https://1145.am/db/1845217/Lux_Capital>,
        <https://1145.am/db/1846254/Lux_Capital>,
        <https://1145.am/db/1930816/Lux_Capital>,
        <https://1145.am/db/1932856/Lux_Capital>,
        <https://1145.am/db/2006781/Lux_Capital>,
        <https://1145.am/db/2138013/Lux_Capital>,
        <https://1145.am/db/2141058/Lux_Capital>,
        <https://1145.am/db/2178040/Lux_Capital>,
        <https://1145.am/db/2284256/Lux_Capital>,
        <https://1145.am/db/2291716/Lux_Capital>,
        <https://1145.am/db/2291901/Lux_Capital>,
        <https://1145.am/db/2303675/Lux_Capital>,
        <https://1145.am/db/2304963/Lux_Capital>,
        <https://1145.am/db/2305327/Lux_Capital>,
        <https://1145.am/db/2328280/Lux_Capital>,
        <https://1145.am/db/2331549/Lux_Capital>,
        <https://1145.am/db/2335750/Lux_Capital>,
        <https://1145.am/db/2335755/Lux_Capital>,
        <https://1145.am/db/2337522/Lux_Capital>,
        <https://1145.am/db/2337571/Lux_Capital>,
        <https://1145.am/db/2337577/Lux_Capital>,
        <https://1145.am/db/2344256/Lux_Capital>,
        <https://1145.am/db/2345224/Lux_Capital>,
        <https://1145.am/db/2345439/Lux_Capital>,
        <https://1145.am/db/2348448/Lux_Capital>,
        <https://1145.am/db/2352414/Lux_Capital>,
        <https://1145.am/db/2546216/Lux_Capital>,
        <https://1145.am/db/2633440/Lux_Capital>,
        <https://1145.am/db/2801014/Lux_Capital>,
        <https://1145.am/db/412847/Lux_Capital>,
        <https://1145.am/db/424834/Lux_Capital>,
        <https://1145.am/db/425188/Lux_Capital>,
        <https://1145.am/db/425281/Lux_Capital>,
        <https://1145.am/db/426160/Lux_Capital>,
        <https://1145.am/db/516176/Lux_Capital>,
        <https://1145.am/db/516613/Lux_Capital>,
        <https://1145.am/db/540507/Lux_Capital>,
        <https://1145.am/db/684792/Lux_Capital>,
        <https://1145.am/db/747771/Lux_Capital>,
        <https://1145.am/db/765641/Lux_Capital>,
        <https://1145.am/db/823763/Lux_Capital>,
        <https://1145.am/db/863878/Lux_Capital>,
        <https://1145.am/db/918904/Lux_Capital>,
        <https://1145.am/db/935910/Lux_Capital>,
        <https://1145.am/db/936989/Lux_Capital>,
        <https://1145.am/db/940684/Lux_Capital> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347102/The_Bill___Melinda_Gates_Foundation> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:documentDate "2012-11-09T12:33:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/visterra-secures-financing-from-gates-foundation-and-omega-to-close-26m-series-a-financing> ;
    ns1:foundName "The Bill & Melinda Gates Foundation" ;
    ns1:investor <https://1145.am/db/2347102/Series_A_Investment_Flagship_Ventures_Lux_Capital_Omega_Funds_Polaris_Venture_Partners_The_Bill___Melinda_Gates_Foundation_Visterra_Completed> ;
    ns1:name "The Bill & Melinda Gates Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/1082053/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1223116/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1291634/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1428798/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1534279/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1577330/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1690821/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1807438/Bill_And_Melinda_Gates_Foundation>,
        <https://1145.am/db/1981265/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2281246/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2287006/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2293727/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2316514/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2317981/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2331329/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2337571/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2337577/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2338383/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2340643/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2340646/Thebill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2345880/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2347301/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2353832/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2353834/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2367621/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2546216/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2578745/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/360780/Bill_And_Melinda_Gates_Foundation>,
        <https://1145.am/db/463585/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/703895/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/796790/Bill___Melinda_Gates_Foundation> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2351210/Equity_Investment_Genting_Berhad_Genting_Management_(singapore)_Pte_Ltd_Taurx_Pharmaceuticals_Ltd_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-20T17:16:06+00:00"^^xsd:dateTime ;
    ns1:documentExtract "SINGAPORE and KUALA LUMPUR, Malaysia, Nov. 20, 2012 /PRNewswire via COMTEX/ - TauRx Pharmaceuticals Ltd. (\"TauRx\") announced today the receipt of a further equity investment of US $ 31.5m from Genting Management (Singapore) Pte.",
        "TauRx Pharmaceuticals receives $ 111.8m commitment from Genting to prepare for Market Leadership in Alzheimer's.",
        "The amount represents the first tranche of a total investment of US $ 111.8m by GMS in TauRx in exchange for a 20 % equity stake in the pioneering pharmaceutical company." ;
    ns1:documentTitle "TauRx Pharmaceuticals receives $111.8m commitment from Genting to prepare for Market Leadership in Alzheimer's" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/taurx-pharmaceuticals-receives-111-8m-commitment-from-genting-to-prepare-for-market> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2351210/Taurx_Pharmaceuticals_Ltd> ;
    ns1:targetDetails "equity",
        "equity stake" ;
    ns1:valueRaw "$ 111.8m",
        "US $ 111.8m",
        "US $ 31.5m",
        "US $ 80.3m" ;
    ns1:when "2012-11-20T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Nov. 20, 2012" ;
    ns1:whereGeoName "Malaysia" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/1733045/about.rdf> ;
    ns1:whereRaw "Malaysia" .

<https://1145.am/db/2351224/Alta_Partners> a org:Organization ;
    ns1:basedInLowRaw "The Netherlands" ;
    ns1:documentDate "2012-11-21T15:02:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Kiadis Pharma Raises EUR 10 Million in Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/kiadis-pharma-raises-eur-10-million-financing-round> ;
    ns1:foundName "Alta Partners" ;
    ns1:investor <https://1145.am/db/2351224/Equity_Investment_Alta_Partners_Dfj-Esprit_Kiadis_Pharma_Lsp_Nom_Quest_For_Growth_Completed> ;
    ns1:name "Alta Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1156304/Alta_Partners>,
        <https://1145.am/db/1230022/Alta_Partners>,
        <https://1145.am/db/1333948/Altas_Partners>,
        <https://1145.am/db/1334727/Altas_Partners>,
        <https://1145.am/db/2303810/Alta_Partners>,
        <https://1145.am/db/2303814/Alta_Partners>,
        <https://1145.am/db/2304769/Alta_Partners>,
        <https://1145.am/db/2304870/Alta_Partners>,
        <https://1145.am/db/2305729/Alta_Partners>,
        <https://1145.am/db/2305745/Alta_Partners>,
        <https://1145.am/db/2306281/Alta_Partners>,
        <https://1145.am/db/2306568/Alta_Partners>,
        <https://1145.am/db/2307682/Alta_Partners>,
        <https://1145.am/db/2307691/Alta_Partners>,
        <https://1145.am/db/2307824/Alta_Partners>,
        <https://1145.am/db/2307829/Alta_Partners>,
        <https://1145.am/db/2308855/Alta_Partners>,
        <https://1145.am/db/2311011/Alta_Partners>,
        <https://1145.am/db/2313143/Alta_Partners>,
        <https://1145.am/db/2313405/Alta_Partners>,
        <https://1145.am/db/2316391/Alta_Partners>,
        <https://1145.am/db/2318577/Alta_Partners>,
        <https://1145.am/db/2318635/Alta_Partners>,
        <https://1145.am/db/2322984/Alta_Partners>,
        <https://1145.am/db/2323003/Alta_Partners>,
        <https://1145.am/db/2323243/Alta_Partners>,
        <https://1145.am/db/2324012/Alta_Partners>,
        <https://1145.am/db/2324015/Alta_Partners>,
        <https://1145.am/db/2326176/Alta_Partners>,
        <https://1145.am/db/2326903/Alta_Partners>,
        <https://1145.am/db/2327441/Alta_Partners>,
        <https://1145.am/db/2327442/Alta_Partners>,
        <https://1145.am/db/2327677/Alta_Partners>,
        <https://1145.am/db/2328815/Alta_Partners>,
        <https://1145.am/db/2330075/Alta_Partners>,
        <https://1145.am/db/2330079/Alta_Partners>,
        <https://1145.am/db/2338126/Alta_Partners>,
        <https://1145.am/db/2338127/Alta_Partners>,
        <https://1145.am/db/2340887/Alta_Partners>,
        <https://1145.am/db/2341764/Alta_Partners>,
        <https://1145.am/db/2343547/Alta_Partners>,
        <https://1145.am/db/2344092/Alta_Partners>,
        <https://1145.am/db/2344100/Alta_Partners>,
        <https://1145.am/db/2346542/Alta_Partners>,
        <https://1145.am/db/2351897/Alta_Partners>,
        <https://1145.am/db/2352167/Alta_Partners>,
        <https://1145.am/db/2352170/Alta_Partners>,
        <https://1145.am/db/2352362/Alta_Partners>,
        <https://1145.am/db/2352831/Alta_Partners>,
        <https://1145.am/db/2353439/Alta_Partners>,
        <https://1145.am/db/2353771/Alta_Partners>,
        <https://1145.am/db/2353789/Alta_Partners>,
        <https://1145.am/db/2354299/Alta_Partners>,
        <https://1145.am/db/2354307/Alta_Partners>,
        <https://1145.am/db/2354314/Alta_Partners>,
        <https://1145.am/db/2355183/Alta_Partners>,
        <https://1145.am/db/2355274/Alta_Partners>,
        <https://1145.am/db/2355586/Alta_Partners>,
        <https://1145.am/db/2356216/Alta_Partners>,
        <https://1145.am/db/2358496/Alta_Partners>,
        <https://1145.am/db/2358502/Alta_Partners>,
        <https://1145.am/db/2362565/Alta_Partners>,
        <https://1145.am/db/2362566/Alta_Partners>,
        <https://1145.am/db/2362902/Alta_Partners>,
        <https://1145.am/db/2362909/Alta_Partners>,
        <https://1145.am/db/2362910/Alta_Partners>,
        <https://1145.am/db/2363364/Alta_Partners>,
        <https://1145.am/db/2363510/Alta_Partners>,
        <https://1145.am/db/2365748/Alta_Partners>,
        <https://1145.am/db/2366693/Alta_Partners>,
        <https://1145.am/db/2366700/Alta_Partners>,
        <https://1145.am/db/2367497/Alta_Partners>,
        <https://1145.am/db/328387/Altas_Partners>,
        <https://1145.am/db/443962/Altas_Partners>,
        <https://1145.am/db/750997/Alta_Partners>,
        <https://1145.am/db/979509/Alta_Partners>,
        <https://1145.am/db/987929/Alta_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354307/Alta_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:description "Venture capital" ;
    ns1:documentDate "2012-12-04T15:50:17+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Zafgen Secures $21 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zafgen-secures-21-million-series-d-financing-0> ;
    ns1:foundName "Alta" ;
    ns1:industry "venture capital" ;
    ns1:investor <https://1145.am/db/2354307/Equity_Investment_Alta_Partners_Atlas_Venture_Third_Rock_Ventures_Zafgen_Completed> ;
    ns1:name "Alta Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1738305/Ac_Ventures>,
        <https://1145.am/db/1796988/Abc_Capital>,
        <https://1145.am/db/2306568/Alta_Partners>,
        <https://1145.am/db/2307829/Alta_Partners>,
        <https://1145.am/db/2324012/Alta_Partners>,
        <https://1145.am/db/2327442/Alta_Partners>,
        <https://1145.am/db/2344092/Alta_Partners>,
        <https://1145.am/db/2344100/Alta_Partners>,
        <https://1145.am/db/2354314/Alta_Partners>,
        <https://1145.am/db/2362566/Alta_Partners>,
        <https://1145.am/db/2366700/Alta_Partners>,
        <https://1145.am/db/404702/Acvc_Ventures>,
        <https://1145.am/db/443962/Altas_Partners>,
        <https://1145.am/db/988703/Acorn_Pacific_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1156304/Alta_Partners>,
        <https://1145.am/db/1230022/Alta_Partners>,
        <https://1145.am/db/1333948/Altas_Partners>,
        <https://1145.am/db/1334727/Altas_Partners>,
        <https://1145.am/db/2303810/Alta_Partners>,
        <https://1145.am/db/2303814/Alta_Partners>,
        <https://1145.am/db/2304769/Alta_Partners>,
        <https://1145.am/db/2304870/Alta_Partners>,
        <https://1145.am/db/2305729/Alta_Partners>,
        <https://1145.am/db/2305745/Alta_Partners>,
        <https://1145.am/db/2306281/Alta_Partners>,
        <https://1145.am/db/2307682/Alta_Partners>,
        <https://1145.am/db/2307691/Alta_Partners>,
        <https://1145.am/db/2307824/Alta_Partners>,
        <https://1145.am/db/2308855/Alta_Partners>,
        <https://1145.am/db/2311011/Alta_Partners>,
        <https://1145.am/db/2313143/Alta_Partners>,
        <https://1145.am/db/2313405/Alta_Partners>,
        <https://1145.am/db/2316391/Alta_Partners>,
        <https://1145.am/db/2318577/Alta_Partners>,
        <https://1145.am/db/2318635/Alta_Partners>,
        <https://1145.am/db/2322984/Alta_Partners>,
        <https://1145.am/db/2323003/Alta_Partners>,
        <https://1145.am/db/2323243/Alta_Partners>,
        <https://1145.am/db/2324015/Alta_Partners>,
        <https://1145.am/db/2326176/Alta_Partners>,
        <https://1145.am/db/2326903/Alta_Partners>,
        <https://1145.am/db/2327441/Alta_Partners>,
        <https://1145.am/db/2327677/Alta_Partners>,
        <https://1145.am/db/2328815/Alta_Partners>,
        <https://1145.am/db/2330075/Alta_Partners>,
        <https://1145.am/db/2330079/Alta_Partners>,
        <https://1145.am/db/2338126/Alta_Partners>,
        <https://1145.am/db/2338127/Alta_Partners>,
        <https://1145.am/db/2340887/Alta_Partners>,
        <https://1145.am/db/2341764/Alta_Partners>,
        <https://1145.am/db/2343547/Alta_Partners>,
        <https://1145.am/db/2346542/Alta_Partners>,
        <https://1145.am/db/2351224/Alta_Partners>,
        <https://1145.am/db/2351897/Alta_Partners>,
        <https://1145.am/db/2352167/Alta_Partners>,
        <https://1145.am/db/2352170/Alta_Partners>,
        <https://1145.am/db/2352362/Alta_Partners>,
        <https://1145.am/db/2352831/Alta_Partners>,
        <https://1145.am/db/2353439/Alta_Partners>,
        <https://1145.am/db/2353771/Alta_Partners>,
        <https://1145.am/db/2353789/Alta_Partners>,
        <https://1145.am/db/2354299/Alta_Partners>,
        <https://1145.am/db/2355183/Alta_Partners>,
        <https://1145.am/db/2355274/Alta_Partners>,
        <https://1145.am/db/2355586/Alta_Partners>,
        <https://1145.am/db/2356216/Alta_Partners>,
        <https://1145.am/db/2358496/Alta_Partners>,
        <https://1145.am/db/2358502/Alta_Partners>,
        <https://1145.am/db/2362565/Alta_Partners>,
        <https://1145.am/db/2362902/Alta_Partners>,
        <https://1145.am/db/2362909/Alta_Partners>,
        <https://1145.am/db/2362910/Alta_Partners>,
        <https://1145.am/db/2363364/Alta_Partners>,
        <https://1145.am/db/2363510/Alta_Partners>,
        <https://1145.am/db/2365748/Alta_Partners>,
        <https://1145.am/db/2366693/Alta_Partners>,
        <https://1145.am/db/2367497/Alta_Partners>,
        <https://1145.am/db/328387/Altas_Partners>,
        <https://1145.am/db/750997/Alta_Partners>,
        <https://1145.am/db/979509/Alta_Partners>,
        <https://1145.am/db/987929/Alta_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354307/Equity_Investment_Alta_Partners_Atlas_Venture_Third_Rock_Ventures_Zafgen_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-04T15:50:17+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Dec. 4, 2012 /PRNewswire via COMTEX/ - Zafgen, Inc., a leading biopharmaceutical company dedicated to addressing the unmet needs of severely obese patients, today announced it has secured $ 21 million in a Series D equity financing.",
        "Zafgen Secures $ 21 Million in Series D Financing." ;
    ns1:documentTitle "Zafgen Secures $21 Million in Series D Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zafgen-secures-21-million-series-d-financing-0> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2354307/Zafgen> ;
    ns1:targetDetails "Series D",
        "equity" ;
    ns1:valueRaw "$ 21 Million",
        "$ 21 million" ;
    ns1:when "2012-12-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012-12-04" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass." .

<https://1145.am/db/2354752/Aerpio_Therapeutics> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-08-30T14:33:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing-0> ;
    ns1:foundName "Aerpio Therapeutics" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Aerpio Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1140338/Aerami_Therapeutics>,
        <https://1145.am/db/2312285/Arriva_Pharmaceuticals>,
        <https://1145.am/db/2335764/Aerpio_Therapeutics>,
        <https://1145.am/db/2354770/Aerpio_Therapeutics>,
        <https://1145.am/db/2368807/Erytech_Pharma>,
        <https://1145.am/db/2369836/Erytech_Pharma>,
        <https://1145.am/db/2575232/Aerpio_Therapeutics>,
        <https://1145.am/db/432278/Aerpio_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354752/Agechem_Venture_Fund> a org:Organization ;
    ns1:basedInLowRaw "CINCINNATI" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-08-30T14:33:18+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing-0> ;
    ns1:foundName "AgeChem Venture Fund" ;
    ns1:investor <https://1145.am/db/2354752/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "AgeChem Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/2310073/Agechem_Venture_Fund_Cross_Creek_Capital>,
        <https://1145.am/db/2346534/Agechem_Venture_Fund>,
        <https://1145.am/db/2346542/Agechem_Venture_Fund>,
        <https://1145.am/db/2358031/Agechem_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2305729/Agechem_Venture_Fund>,
        <https://1145.am/db/2328030/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2328034/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2345002/Agechem_Venture_Fund>,
        <https://1145.am/db/2354770/Agechem_Venture_Fund>,
        <https://1145.am/db/2367046/Agechem_Venture_Fund>,
        <https://1145.am/db/2367047/Agechem_Venture_Fund>,
        <https://1145.am/db/2575232/Agechem_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354770/Aerpio_Therapeutics> a org:Organization ;
    ns1:description "Biomedical" ;
    ns1:documentDate "2012-08-31T01:02:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Aerpio Therapeutics" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Aerpio Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1140338/Aerami_Therapeutics>,
        <https://1145.am/db/2312285/Arriva_Pharmaceuticals>,
        <https://1145.am/db/2335764/Aerpio_Therapeutics>,
        <https://1145.am/db/2354752/Aerpio_Therapeutics>,
        <https://1145.am/db/2368807/Erytech_Pharma>,
        <https://1145.am/db/2369836/Erytech_Pharma>,
        <https://1145.am/db/2575232/Aerpio_Therapeutics>,
        <https://1145.am/db/432278/Aerpio_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354770/Agechem_Venture_Fund> a org:Organization ;
    ns1:description "advancing innovative therapies for vascular diseases" ;
    ns1:documentDate "2012-08-31T01:02:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "AgeChem Venture Fund" ;
    ns1:investor <https://1145.am/db/2354770/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "AgeChem Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/2575232/Agechem_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2305729/Agechem_Venture_Fund>,
        <https://1145.am/db/2328030/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2328034/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2345002/Agechem_Venture_Fund>,
        <https://1145.am/db/2346534/Agechem_Venture_Fund>,
        <https://1145.am/db/2346542/Agechem_Venture_Fund>,
        <https://1145.am/db/2354752/Agechem_Venture_Fund>,
        <https://1145.am/db/2358031/Agechem_Venture_Fund>,
        <https://1145.am/db/2367046/Agechem_Venture_Fund>,
        <https://1145.am/db/2367047/Agechem_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356391/Correlation_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:foundName "Correlation Ventures" ;
    ns1:investor <https://1145.am/db/2356391/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> ;
    ns1:name "Correlation Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1164688/Correlation_Ventures>,
        <https://1145.am/db/1264028/Uncorrelated_Ventures>,
        <https://1145.am/db/1407354/Uncorrelated_Ventures>,
        <https://1145.am/db/1473071/Uncorrelated_Ventures>,
        <https://1145.am/db/1484404/Correlation_Ventures>,
        <https://1145.am/db/1681472/Uncorrelated_Ventures>,
        <https://1145.am/db/1714624/Uncorrelated_Fund>,
        <https://1145.am/db/1715565/Uncorrelated_Ventures>,
        <https://1145.am/db/1748028/Uncorrelated_Ventures>,
        <https://1145.am/db/1753024/Uncorrelated_Ventures>,
        <https://1145.am/db/1761256/Uncorrelated_Ventures>,
        <https://1145.am/db/1762722/Uncorrelated_Ventures>,
        <https://1145.am/db/1764022/Uncorrelated_Ventures>,
        <https://1145.am/db/1764096/Correlation_Ventures>,
        <https://1145.am/db/1842583/Correlation_Ventures>,
        <https://1145.am/db/1959001/Correlation_Ventures>,
        <https://1145.am/db/2010246/Correlation_Ventures>,
        <https://1145.am/db/2087734/Uncorrelated_Ventures>,
        <https://1145.am/db/2141183/Uncorrelated>,
        <https://1145.am/db/2341896/Correlation_Ventures>,
        <https://1145.am/db/2356393/Correlation_Ventures>,
        <https://1145.am/db/2356395/Correlation_Ventures>,
        <https://1145.am/db/2367676/Correlation_Ventures>,
        <https://1145.am/db/248013/Uncorrelated_Ventures>,
        <https://1145.am/db/402100/Uncorrelated_Ventures>,
        <https://1145.am/db/428275/Uncorrelated_Ventures>,
        <https://1145.am/db/429369/Uncorrelated_Ventures>,
        <https://1145.am/db/528532/Uncorrelated_Ventures>,
        <https://1145.am/db/587323/Uncorrelated_Ventures>,
        <https://1145.am/db/591990/Uncorrelated_Ventures>,
        <https://1145.am/db/679989/Uncorrelated_Ventures>,
        <https://1145.am/db/800060/Correlation_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1166356/Correlation_Ventures>,
        <https://1145.am/db/1727833/Correlation_Ventures>,
        <https://1145.am/db/1737130/Correlation_Ventures>,
        <https://1145.am/db/1817971/Correlation_Ventures>,
        <https://1145.am/db/1828658/Correlation_Ventures>,
        <https://1145.am/db/1830147/Correlation_Ventures>,
        <https://1145.am/db/1830149/Correlation_Ventures>,
        <https://1145.am/db/1839922/Correlation_Ventures>,
        <https://1145.am/db/1840957/Correlation_Ventures>,
        <https://1145.am/db/1843211/Correlation_Ventures>,
        <https://1145.am/db/1854668/Correlation_Ventures>,
        <https://1145.am/db/1856384/Correlation_Ventures>,
        <https://1145.am/db/1974032/Correlation_Ventures>,
        <https://1145.am/db/2113474/Correlation_Ventures>,
        <https://1145.am/db/2298395/Correlation_Ventures>,
        <https://1145.am/db/2340888/Correlation_Ventures>,
        <https://1145.am/db/2360258/Correlation_Ventures>,
        <https://1145.am/db/2367675/Correlation_Ventures>,
        <https://1145.am/db/2368351/Correlation_Ventures>,
        <https://1145.am/db/2369785/Correlation_Ventures>,
        <https://1145.am/db/2371165/Correlation_Ventures>,
        <https://1145.am/db/2371166/Correlation_Ventures>,
        <https://1145.am/db/343358/Correlation_Ventures>,
        <https://1145.am/db/526524/Correlation_Ventures>,
        <https://1145.am/db/556709/Correlation_Ventures>,
        <https://1145.am/db/984927/Correlation_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356391/Galera_Therapeutics> a org:Organization ;
    ns1:description "a pharmaceutical company" ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:foundName "Galera Therapeutics" ;
    ns1:name "Galera Therapeutics" ;
    ns1:sameAsMedium <https://1145.am/db/2290502/Galera_Therapeutics>,
        <https://1145.am/db/2356393/Galera_Therapeutics>,
        <https://1145.am/db/2356395/Galera_Therapeutics>,
        <https://1145.am/db/2369785/Galera_Therapeutics>,
        <https://1145.am/db/2371165/Galera_Therapeutics>,
        <https://1145.am/db/2371166/Galera_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356391/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentExtract "> Galera Therapeutics has raised an $ 11 million Series A round for its programs on cancer and fibrosis." ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2356391/Galera_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 11 million" .

<https://1145.am/db/2356393/Correlation_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-12-11T17:13:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing-0> ;
    ns1:foundName "Correlation Ventures" ;
    ns1:investor <https://1145.am/db/2356393/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> ;
    ns1:name "Correlation Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1164688/Correlation_Ventures>,
        <https://1145.am/db/1264028/Uncorrelated_Ventures>,
        <https://1145.am/db/1407354/Uncorrelated_Ventures>,
        <https://1145.am/db/1473071/Uncorrelated_Ventures>,
        <https://1145.am/db/1484404/Correlation_Ventures>,
        <https://1145.am/db/1681472/Uncorrelated_Ventures>,
        <https://1145.am/db/1714624/Uncorrelated_Fund>,
        <https://1145.am/db/1715565/Uncorrelated_Ventures>,
        <https://1145.am/db/1748028/Uncorrelated_Ventures>,
        <https://1145.am/db/1753024/Uncorrelated_Ventures>,
        <https://1145.am/db/1761256/Uncorrelated_Ventures>,
        <https://1145.am/db/1762722/Uncorrelated_Ventures>,
        <https://1145.am/db/1764022/Uncorrelated_Ventures>,
        <https://1145.am/db/1764096/Correlation_Ventures>,
        <https://1145.am/db/1842583/Correlation_Ventures>,
        <https://1145.am/db/1959001/Correlation_Ventures>,
        <https://1145.am/db/2010246/Correlation_Ventures>,
        <https://1145.am/db/2087734/Uncorrelated_Ventures>,
        <https://1145.am/db/2141183/Uncorrelated>,
        <https://1145.am/db/2341896/Correlation_Ventures>,
        <https://1145.am/db/2356391/Correlation_Ventures>,
        <https://1145.am/db/2356395/Correlation_Ventures>,
        <https://1145.am/db/2367676/Correlation_Ventures>,
        <https://1145.am/db/248013/Uncorrelated_Ventures>,
        <https://1145.am/db/402100/Uncorrelated_Ventures>,
        <https://1145.am/db/428275/Uncorrelated_Ventures>,
        <https://1145.am/db/429369/Uncorrelated_Ventures>,
        <https://1145.am/db/528532/Uncorrelated_Ventures>,
        <https://1145.am/db/587323/Uncorrelated_Ventures>,
        <https://1145.am/db/591990/Uncorrelated_Ventures>,
        <https://1145.am/db/679989/Uncorrelated_Ventures>,
        <https://1145.am/db/800060/Correlation_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1166356/Correlation_Ventures>,
        <https://1145.am/db/1727833/Correlation_Ventures>,
        <https://1145.am/db/1737130/Correlation_Ventures>,
        <https://1145.am/db/1817971/Correlation_Ventures>,
        <https://1145.am/db/1828658/Correlation_Ventures>,
        <https://1145.am/db/1830147/Correlation_Ventures>,
        <https://1145.am/db/1830149/Correlation_Ventures>,
        <https://1145.am/db/1839922/Correlation_Ventures>,
        <https://1145.am/db/1840957/Correlation_Ventures>,
        <https://1145.am/db/1843211/Correlation_Ventures>,
        <https://1145.am/db/1854668/Correlation_Ventures>,
        <https://1145.am/db/1856384/Correlation_Ventures>,
        <https://1145.am/db/1974032/Correlation_Ventures>,
        <https://1145.am/db/2113474/Correlation_Ventures>,
        <https://1145.am/db/2298395/Correlation_Ventures>,
        <https://1145.am/db/2340888/Correlation_Ventures>,
        <https://1145.am/db/2360258/Correlation_Ventures>,
        <https://1145.am/db/2367675/Correlation_Ventures>,
        <https://1145.am/db/2368351/Correlation_Ventures>,
        <https://1145.am/db/2369785/Correlation_Ventures>,
        <https://1145.am/db/2371165/Correlation_Ventures>,
        <https://1145.am/db/2371166/Correlation_Ventures>,
        <https://1145.am/db/343358/Correlation_Ventures>,
        <https://1145.am/db/526524/Correlation_Ventures>,
        <https://1145.am/db/556709/Correlation_Ventures>,
        <https://1145.am/db/984927/Correlation_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356393/Galera_Therapeutics> a org:Organization ;
    ns1:basedInLowRaw "Pa" ;
    ns1:description "Clinical Development of Therapeutics for Fibrosis and Cancer",
        "developing breakthrough drugs" ;
    ns1:documentDate "2012-12-11T17:13:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing-0> ;
    ns1:foundName "Galera Therapeutics",
        "Galera Therapeutics, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Galera",
        "Galera Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2356395/Galera_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2290502/Galera_Therapeutics>,
        <https://1145.am/db/2356391/Galera_Therapeutics>,
        <https://1145.am/db/2369785/Galera_Therapeutics>,
        <https://1145.am/db/2371165/Galera_Therapeutics>,
        <https://1145.am/db/2371166/Galera_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356393/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-11T17:13:42+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Galera Therapeutics Raises $ 11 Million in Series A Financing.",
        "Galera Therapeutics, Inc., a biotechnology company focused on the development of breakthrough drugs targeting oxygen metabolic pathways in cancer, fibrosis and other human diseases, today announced an $ 11 million Series A venture capital financing." ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing-0> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2356393/Galera_Therapeutics> ;
    ns1:targetDetails "Series A",
        "venture capital" ;
    ns1:valueRaw "$ 11 Million",
        "$ 11 million" ;
    ns1:whereGeoName "Malvern",
        "Saint-Louis" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2246452/about.rdf>,
        <https://sws.geonames.org/5199600/about.rdf> ;
    ns1:whereRaw "MALVERN, Pa. & ST. LOUIS" .

<https://1145.am/db/2356395/Correlation_Ventures> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-12-12T05:00:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing> ;
    ns1:foundName "Correlation Ventures" ;
    ns1:investor <https://1145.am/db/2356395/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> ;
    ns1:name "Correlation Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1164688/Correlation_Ventures>,
        <https://1145.am/db/1264028/Uncorrelated_Ventures>,
        <https://1145.am/db/1407354/Uncorrelated_Ventures>,
        <https://1145.am/db/1473071/Uncorrelated_Ventures>,
        <https://1145.am/db/1484404/Correlation_Ventures>,
        <https://1145.am/db/1681472/Uncorrelated_Ventures>,
        <https://1145.am/db/1714624/Uncorrelated_Fund>,
        <https://1145.am/db/1715565/Uncorrelated_Ventures>,
        <https://1145.am/db/1748028/Uncorrelated_Ventures>,
        <https://1145.am/db/1753024/Uncorrelated_Ventures>,
        <https://1145.am/db/1761256/Uncorrelated_Ventures>,
        <https://1145.am/db/1762722/Uncorrelated_Ventures>,
        <https://1145.am/db/1764022/Uncorrelated_Ventures>,
        <https://1145.am/db/1764096/Correlation_Ventures>,
        <https://1145.am/db/1842583/Correlation_Ventures>,
        <https://1145.am/db/1959001/Correlation_Ventures>,
        <https://1145.am/db/2010246/Correlation_Ventures>,
        <https://1145.am/db/2087734/Uncorrelated_Ventures>,
        <https://1145.am/db/2141183/Uncorrelated>,
        <https://1145.am/db/2341896/Correlation_Ventures>,
        <https://1145.am/db/2356391/Correlation_Ventures>,
        <https://1145.am/db/2356393/Correlation_Ventures>,
        <https://1145.am/db/2367676/Correlation_Ventures>,
        <https://1145.am/db/248013/Uncorrelated_Ventures>,
        <https://1145.am/db/402100/Uncorrelated_Ventures>,
        <https://1145.am/db/428275/Uncorrelated_Ventures>,
        <https://1145.am/db/429369/Uncorrelated_Ventures>,
        <https://1145.am/db/528532/Uncorrelated_Ventures>,
        <https://1145.am/db/587323/Uncorrelated_Ventures>,
        <https://1145.am/db/591990/Uncorrelated_Ventures>,
        <https://1145.am/db/679989/Uncorrelated_Ventures>,
        <https://1145.am/db/800060/Correlation_Ventures> ;
    ns1:sameAsMedium <https://1145.am/db/1166356/Correlation_Ventures>,
        <https://1145.am/db/1727833/Correlation_Ventures>,
        <https://1145.am/db/1737130/Correlation_Ventures>,
        <https://1145.am/db/1817971/Correlation_Ventures>,
        <https://1145.am/db/1828658/Correlation_Ventures>,
        <https://1145.am/db/1830147/Correlation_Ventures>,
        <https://1145.am/db/1830149/Correlation_Ventures>,
        <https://1145.am/db/1839922/Correlation_Ventures>,
        <https://1145.am/db/1840957/Correlation_Ventures>,
        <https://1145.am/db/1843211/Correlation_Ventures>,
        <https://1145.am/db/1854668/Correlation_Ventures>,
        <https://1145.am/db/1856384/Correlation_Ventures>,
        <https://1145.am/db/1974032/Correlation_Ventures>,
        <https://1145.am/db/2113474/Correlation_Ventures>,
        <https://1145.am/db/2298395/Correlation_Ventures>,
        <https://1145.am/db/2340888/Correlation_Ventures>,
        <https://1145.am/db/2360258/Correlation_Ventures>,
        <https://1145.am/db/2367675/Correlation_Ventures>,
        <https://1145.am/db/2368351/Correlation_Ventures>,
        <https://1145.am/db/2369785/Correlation_Ventures>,
        <https://1145.am/db/2371165/Correlation_Ventures>,
        <https://1145.am/db/2371166/Correlation_Ventures>,
        <https://1145.am/db/343358/Correlation_Ventures>,
        <https://1145.am/db/526524/Correlation_Ventures>,
        <https://1145.am/db/556709/Correlation_Ventures>,
        <https://1145.am/db/984927/Correlation_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356395/Galera_Therapeutics> a org:Organization ;
    ns1:description "developing drugs" ;
    ns1:documentDate "2012-12-12T05:00:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing> ;
    ns1:foundName "Galera Therapeutics",
        "Galera Therapeutics, Inc." ;
    ns1:industry "biotechnology" ;
    ns1:name "Galera Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/2356393/Galera_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2290502/Galera_Therapeutics>,
        <https://1145.am/db/2356391/Galera_Therapeutics>,
        <https://1145.am/db/2369785/Galera_Therapeutics>,
        <https://1145.am/db/2371165/Galera_Therapeutics>,
        <https://1145.am/db/2371166/Galera_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356395/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-12T05:00:57+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Galera Therapeutics Raises $ 11 Million in Series A Financing.",
        "Galera Therapeutics, Inc., a biotechnology company focused on the development of breakthrough drugs targeting oxygen metabolic pathways in cancer, fibrosis and other human diseases, today announced an $ 11 million Series A venture capital financing." ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2356395/Galera_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 11 Million",
        "$ 11 million" .

<https://1145.am/db/2356420/Cvf_Llc> a org:Organization ;
    ns1:basedInLowRaw "United States" ;
    ns1:description "private equity financing" ;
    ns1:documentDate "2012-12-13T05:00:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerapedics Secures $19 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerapedics-secures-19-million-series-c-financing> ;
    ns1:foundName "CVF, LLC" ;
    ns1:investor <https://1145.am/db/2356420/Equity_Private_Equity_Investment_Cvf_Llc_Cerapedics_Inc_Henry_Crown_And_Company_Medimmune_Ventures_Ngn_Capital_Orbimed_Advisors_Completed> ;
    ns1:name "CVF, LLC" ;
    ns1:sameAsHigh <https://1145.am/db/1064824/Cvc_Capital_Partners>,
        <https://1145.am/db/1128071/Cvc_Capital_Partners>,
        <https://1145.am/db/1358651/Cvc_Capital_Partners>,
        <https://1145.am/db/1651532/Cvc_Capital_Partners>,
        <https://1145.am/db/1929486/Cvc_Capital_Partners>,
        <https://1145.am/db/1968065/Cvc_Capital_Partners>,
        <https://1145.am/db/2053672/Vig_Partners>,
        <https://1145.am/db/2664134/CVC>,
        <https://1145.am/db/2690104/Cvc_Capital_Partners>,
        <https://1145.am/db/2705030/Cvc_Capital_Partners>,
        <https://1145.am/db/301456/Cvc_Capital_Partners>,
        <https://1145.am/db/301841/TCV>,
        <https://1145.am/db/542916/Cvc_Capital_Partners>,
        <https://1145.am/db/688739/Cvc_Capital_Partners>,
        <https://1145.am/db/896691/Cvc_Capital_Partners_Fund_Viii>,
        <https://1145.am/db/897817/Cvc_Capital_Partners_Fund_Viii> ;
    ns1:sameAsMedium <https://1145.am/db/2337571/Cvf_Llc>,
        <https://1145.am/db/2337577/Cvf_Llc>,
        <https://1145.am/db/2348440/CVF>,
        <https://1145.am/db/2348448/Cvf_Llc>,
        <https://1145.am/db/2546216/Cvf_Llc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357905/Series_A_Investment_Annovation_Biopharma_Atlas_Venture_Partners_Innovation_Fund_The_Medicines_Company_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-10T12:03:59+00:00"^^xsd:dateTime ;
    ns1:documentExtract "- September 10th, 2012 - Annovation Biopharma, a biotechnology company focused on creating more effective, safer therapies for anesthesia and critical care, has raised $ 8M in a Series A financing led by Atlas Venture, Partners Innovation Fund (PIF) , and new strategic investor The Medicines Company (NASDAQ: MDCO) .",
        "Annovation Biopharma, Inc. Raises $ 8M to Develop Novel Anesthetics." ;
    ns1:documentTitle "Annovation Biopharma, Inc. Raises $8M to Develop Novel Anesthetics" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/annovation-biopharma-inc-raises-8m-to-develop-novel-anesthetics-0> ;
    ns1:foundName "Raises",
        "financing" ;
    ns1:name "Raises",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2357905/Annovation_Biopharma> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 8M" ;
    ns1:when "2012-09-10T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "September 10th, 2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2358502/Alta_Partners> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-12-17T17:21:29+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Allakos Inc. Completes Series A Financing of $32 Million to Develop Antibody Therapeutics for Allergic and Inflammatory Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allakos-inc-completes-series-a-financing-of-32-million-to-develop-antibody-therapeutics-for> ;
    ns1:foundName "Alta Partners" ;
    ns1:investor <https://1145.am/db/2358502/Series_A_Investment_Allakos_Inc_Alta_Partners_Novo_Ventures_Rivervest_Venture_Partners_Roche_Venture_Fund_Completed> ;
    ns1:name "Alta Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1156304/Alta_Partners>,
        <https://1145.am/db/1230022/Alta_Partners>,
        <https://1145.am/db/1333948/Altas_Partners>,
        <https://1145.am/db/1334727/Altas_Partners>,
        <https://1145.am/db/2303810/Alta_Partners>,
        <https://1145.am/db/2303814/Alta_Partners>,
        <https://1145.am/db/2304769/Alta_Partners>,
        <https://1145.am/db/2304870/Alta_Partners>,
        <https://1145.am/db/2305729/Alta_Partners>,
        <https://1145.am/db/2305745/Alta_Partners>,
        <https://1145.am/db/2306281/Alta_Partners>,
        <https://1145.am/db/2306568/Alta_Partners>,
        <https://1145.am/db/2307682/Alta_Partners>,
        <https://1145.am/db/2307691/Alta_Partners>,
        <https://1145.am/db/2307824/Alta_Partners>,
        <https://1145.am/db/2307829/Alta_Partners>,
        <https://1145.am/db/2308855/Alta_Partners>,
        <https://1145.am/db/2311011/Alta_Partners>,
        <https://1145.am/db/2313143/Alta_Partners>,
        <https://1145.am/db/2313405/Alta_Partners>,
        <https://1145.am/db/2316391/Alta_Partners>,
        <https://1145.am/db/2318577/Alta_Partners>,
        <https://1145.am/db/2318635/Alta_Partners>,
        <https://1145.am/db/2322984/Alta_Partners>,
        <https://1145.am/db/2323003/Alta_Partners>,
        <https://1145.am/db/2323243/Alta_Partners>,
        <https://1145.am/db/2324012/Alta_Partners>,
        <https://1145.am/db/2324015/Alta_Partners>,
        <https://1145.am/db/2326176/Alta_Partners>,
        <https://1145.am/db/2326903/Alta_Partners>,
        <https://1145.am/db/2327441/Alta_Partners>,
        <https://1145.am/db/2327442/Alta_Partners>,
        <https://1145.am/db/2327677/Alta_Partners>,
        <https://1145.am/db/2328815/Alta_Partners>,
        <https://1145.am/db/2330075/Alta_Partners>,
        <https://1145.am/db/2330079/Alta_Partners>,
        <https://1145.am/db/2338126/Alta_Partners>,
        <https://1145.am/db/2338127/Alta_Partners>,
        <https://1145.am/db/2340887/Alta_Partners>,
        <https://1145.am/db/2341764/Alta_Partners>,
        <https://1145.am/db/2343547/Alta_Partners>,
        <https://1145.am/db/2344092/Alta_Partners>,
        <https://1145.am/db/2344100/Alta_Partners>,
        <https://1145.am/db/2346542/Alta_Partners>,
        <https://1145.am/db/2351224/Alta_Partners>,
        <https://1145.am/db/2351897/Alta_Partners>,
        <https://1145.am/db/2352167/Alta_Partners>,
        <https://1145.am/db/2352170/Alta_Partners>,
        <https://1145.am/db/2352362/Alta_Partners>,
        <https://1145.am/db/2352831/Alta_Partners>,
        <https://1145.am/db/2353439/Alta_Partners>,
        <https://1145.am/db/2353771/Alta_Partners>,
        <https://1145.am/db/2353789/Alta_Partners>,
        <https://1145.am/db/2354299/Alta_Partners>,
        <https://1145.am/db/2354307/Alta_Partners>,
        <https://1145.am/db/2354314/Alta_Partners>,
        <https://1145.am/db/2355183/Alta_Partners>,
        <https://1145.am/db/2355274/Alta_Partners>,
        <https://1145.am/db/2355586/Alta_Partners>,
        <https://1145.am/db/2356216/Alta_Partners>,
        <https://1145.am/db/2358496/Alta_Partners>,
        <https://1145.am/db/2362565/Alta_Partners>,
        <https://1145.am/db/2362566/Alta_Partners>,
        <https://1145.am/db/2362902/Alta_Partners>,
        <https://1145.am/db/2362909/Alta_Partners>,
        <https://1145.am/db/2362910/Alta_Partners>,
        <https://1145.am/db/2363364/Alta_Partners>,
        <https://1145.am/db/2363510/Alta_Partners>,
        <https://1145.am/db/2365748/Alta_Partners>,
        <https://1145.am/db/2366693/Alta_Partners>,
        <https://1145.am/db/2366700/Alta_Partners>,
        <https://1145.am/db/2367497/Alta_Partners>,
        <https://1145.am/db/328387/Altas_Partners>,
        <https://1145.am/db/443962/Altas_Partners>,
        <https://1145.am/db/750997/Alta_Partners>,
        <https://1145.am/db/979509/Alta_Partners>,
        <https://1145.am/db/987929/Alta_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358506/Series_B_Investment_Blend_Therapeutics_Flagship_Ventures_Nanodimension_New_Enterprise_Associates_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-18T12:40:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Blend Therapeutics Closes $ 16 Million in Series B Financing.",
        "WATERTOWN, MA - December 18, 2012 -Blend Therapeutics, Inc., a biopharmaceutical company discovering new classes of medicines to treat debilitating diseases, announced today that it has secured a $ 16 million Series B financing." ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/blend-therapeutics-closes-16-million-series-b-financing-0> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2358506/Blend_Therapeutics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 16 Million",
        "$ 16 million" ;
    ns1:when "2012-12-18T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "December 18, 2012" ;
    ns1:whereGeoName "Watertown" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4954611/about.rdf> ;
    ns1:whereRaw "WATERTOWN, MA" .

<https://1145.am/db/2359562/Pappas_Ventures> a org:Organization ;
    ns1:basedInLowRaw "NOVATO, Calif" ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-12-20T11:39:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ultragenyx Raises $75 Million in Oversubscribed Crossover Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-raises-75-million-oversubscribed-crossover-financing> ;
    ns1:foundName "Pappas Ventures" ;
    ns1:investor <https://1145.am/db/2359562/Series_B_Investment_Adage_Capital_Partners_Fidelity_Biosciences_Healthcap_Pappas_Ventures_Tpg_Biotech_Ultragenyx_Pharmaceutical_Inc_Completed> ;
    ns1:name "Pappas Ventures" ;
    ns1:sameAsHigh <https://1145.am/db/1006252/Menlo_Ventures>,
        <https://1145.am/db/1006262/Com_Prelude_Ventures>,
        <https://1145.am/db/1006574/Integr8d_Capital>,
        <https://1145.am/db/1006880/Root_Ventures>,
        <https://1145.am/db/1007193/Capital_One_Ventures>,
        <https://1145.am/db/1007527/Integr8d_Capital>,
        <https://1145.am/db/1008085/Root_Ventures>,
        <https://1145.am/db/1008260/Servicenow_Ventures>,
        <https://1145.am/db/1010064/Greatpoint_Ventures>,
        <https://1145.am/db/1010064/Maverick_Ventures>,
        <https://1145.am/db/1010199/One9_Ventures>,
        <https://1145.am/db/102038/Allegion_Ventures>,
        <https://1145.am/db/102038/Pathbreaker_Ventures>,
        <https://1145.am/db/102038/West_Ventures>,
        <https://1145.am/db/1023252/Digitalbridge_Ventures>,
        <https://1145.am/db/1024247/Digitalbridge_Ventures>,
        <https://1145.am/db/1024483/Investbridge_Capital>,
        <https://1145.am/db/1026319/Able_Partners>,
        <https://1145.am/db/1034591/Valia_Ventures>,
        <https://1145.am/db/1041601/Kineo_Finance>,
        <https://1145.am/db/1042250/Kineo_Finance>,
        <https://1145.am/db/1043051/Sequoia_Capital>,
        <https://1145.am/db/1043259/Sequoia_Capital>,
        <https://1145.am/db/1043342/Root_Ventures>,
        <https://1145.am/db/1043516/Kineo_Finance>,
        <https://1145.am/db/1045242/Dipalo_Ventures>,
        <https://1145.am/db/1045384/Sequoia_Capital>,
        <https://1145.am/db/1051115/Dn_Capital>,
        <https://1145.am/db/1051644/Vestigo_Ventures>,
        <https://1145.am/db/1052155/Gate_Ventures>,
        <https://1145.am/db/1059993/Tera_Ventures>,
        <https://1145.am/db/1060146/Ulu_Ventures>,
        <https://1145.am/db/1061824/Bluebird_Ventures>,
        <https://1145.am/db/1061911/Ulu_Ventures>,
        <https://1145.am/db/1065366/Applied_Ventures_Llc>,
        <https://1145.am/db/1065544/Menlo_Ventures>,
        <https://1145.am/db/1066120/Crosslink_Capital>,
        <https://1145.am/db/1081175/Rse_Ventures>,
        <https://1145.am/db/1081490/Vinco_Ventures>,
        <https://1145.am/db/1081888/Ggv_Capital>,
        <https://1145.am/db/1082613/Rse_Ventures>,
        <https://1145.am/db/1082719/Dorilton_Ventures>,
        <https://1145.am/db/1082814/Cathexis_Ventures>,
        <https://1145.am/db/1082814/Promus_Ventures>,
        <https://1145.am/db/1082814/Type_One_Ventures>,
        <https://1145.am/db/1084014/Ret_Ventures>,
        <https://1145.am/db/1085867/Ret_Ventures>,
        <https://1145.am/db/1086604/Alerion_Ventures>,
        <https://1145.am/db/1086673/Wintrust_Ventures>,
        <https://1145.am/db/1089416/Nexo_Ventures>,
        <https://1145.am/db/1090643/Argon_Ventures>,
        <https://1145.am/db/1090643/Glasswing_Ventures>,
        <https://1145.am/db/1101244/Acequia_Capital>,
        <https://1145.am/db/1103270/Acequia_Capital>,
        <https://1145.am/db/1106082/Northpond_Ventures>,
        <https://1145.am/db/1106670/Sequoia_Capital>,
        <https://1145.am/db/1111505/Nissay_Capital>,
        <https://1145.am/db/1111505/Remiges_Ventures>,
        <https://1145.am/db/1112074/Nissay_Capital>,
        <https://1145.am/db/1112074/Remiges_Ventures>,
        <https://1145.am/db/1114979/Catapult_Ventures>,
        <https://1145.am/db/1115103/Northpond_Ventures>,
        <https://1145.am/db/1119456/Truist_Ventures>,
        <https://1145.am/db/1119699/Prelude_Ventures>,
        <https://1145.am/db/1120030/Morpheus_Ventures>,
        <https://1145.am/db/1120030/Point72_Ventures>,
        <https://1145.am/db/1120071/Morpheus_Ventures>,
        <https://1145.am/db/1120071/Point72_Ventures>,
        <https://1145.am/db/1122750/Prelude_Ventures>,
        <https://1145.am/db/1129561/Redbeard_Ventures>,
        <https://1145.am/db/1130744/Redbeard_Ventures>,
        <https://1145.am/db/1133003/Sequoia_Capital>,
        <https://1145.am/db/1134165/Boldstart_Ventures>,
        <https://1145.am/db/1136173/Boldstart_Ventures>,
        <https://1145.am/db/1137178/CRV>,
        <https://1145.am/db/1138154/Ggv_Capital>,
        <https://1145.am/db/1139703/Industry_Ventures>,
        <https://1145.am/db/1140286/Origin_Ventures>,
        <https://1145.am/db/1141736/Redpoint_Ventures>,
        <https://1145.am/db/1150154/Riv_Capital>,
        <https://1145.am/db/1150529/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/1150529/Solasta_Ventures>,
        <https://1145.am/db/1151328/Index_Ventures>,
        <https://1145.am/db/1151736/True_Ventures>,
        <https://1145.am/db/1152929/Aperiamventures>,
        <https://1145.am/db/1153706/Index_Ventures>,
        <https://1145.am/db/1154242/True_Ventures>,
        <https://1145.am/db/1163139/Sentiero_Ventures>,
        <https://1145.am/db/1163139/Skyriver_Ventures>,
        <https://1145.am/db/1164299/Lavrock_Ventures>,
        <https://1145.am/db/1164299/Progress_Ventures>,
        <https://1145.am/db/1164688/Abstract_Ventures>,
        <https://1145.am/db/1164688/Spacecadet_Ventures>,
        <https://1145.am/db/1164845/Lavrock_Ventures>,
        <https://1145.am/db/1164845/Progress_Ventures>,
        <https://1145.am/db/1165515/G2_Group_Ventures>,
        <https://1145.am/db/1166154/Allos_Ventures>,
        <https://1145.am/db/1166957/Seedil_Ventures>,
        <https://1145.am/db/1168757/Accomplice_Ventures>,
        <https://1145.am/db/1169687/Artiman_Ventures>,
        <https://1145.am/db/1169687/J_Ventures>,
        <https://1145.am/db/1169687/Nd_Capital>,
        <https://1145.am/db/1169815/Accomplice_Ventures>,
        <https://1145.am/db/1170971/Equinor_Ventures>,
        <https://1145.am/db/1173428/Equinor_Ventures>,
        <https://1145.am/db/1175576/Divcowest_Ventures>,
        <https://1145.am/db/1175576/Point72_Ventures>,
        <https://1145.am/db/1175576/Signia_Ventures>,
        <https://1145.am/db/1176018/First_Star_Ventures>,
        <https://1145.am/db/1187600/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/11887/Adv>,
        <https://1145.am/db/1190097/Caymus_Equity_Partners_Llc>,
        <https://1145.am/db/1190127/Animo_Ventures>,
        <https://1145.am/db/1190127/Chaac_Ventures>,
        <https://1145.am/db/1190127/Ulu_Ventures>,
        <https://1145.am/db/1196068/Arthur_Ventures>,
        <https://1145.am/db/1196728/Greatpoint_Ventures>,
        <https://1145.am/db/1199177/Greatpoint_Ventures>,
        <https://1145.am/db/1199182/Boxone_Ventures>,
        <https://1145.am/db/1202673/Basecamp_Ventures>,
        <https://1145.am/db/1203180/Basecamp_Ventures>,
        <https://1145.am/db/1206820/Tenoneten_Ventures>,
        <https://1145.am/db/1208519/Tappanhill_Ventures>,
        <https://1145.am/db/1208749/Industry_Ventures>,
        <https://1145.am/db/1208749/Keshif_Ventures>,
        <https://1145.am/db/1208749/Tenoneten_Ventures>,
        <https://1145.am/db/1213076/Equinor_Ventures>,
        <https://1145.am/db/1213076/Scf_Ventures>,
        <https://1145.am/db/1213119/Nevcaut_Ventures>,
        <https://1145.am/db/1215930/Northpond_Ventures>,
        <https://1145.am/db/1219982/Soma_Ventures>,
        <https://1145.am/db/1221237/C2_Ventures>,
        <https://1145.am/db/1222789/Glasswing_Ventures>,
        <https://1145.am/db/1232497/Droia_Ventures>,
        <https://1145.am/db/1232497/Gv>,
        <https://1145.am/db/1233314/Citta_Capital>,
        <https://1145.am/db/1236549/Adit_Ventures>,
        <https://1145.am/db/1247755/Sinewave_Ventures>,
        <https://1145.am/db/1247761/Clear_Ventures>,
        <https://1145.am/db/1248631/Sinewave_Ventures>,
        <https://1145.am/db/1252447/Gaingels>,
        <https://1145.am/db/1256269/Ampd_Ventures_Inc>,
        <https://1145.am/db/1264028/K3_Ventures>,
        <https://1145.am/db/1264587/Index_Ventures>,
        <https://1145.am/db/1268150/Pender_Ventures>,
        <https://1145.am/db/1269968/Abstract_Ventures>,
        <https://1145.am/db/1272468/Launchpad_Capital>,
        <https://1145.am/db/1279264/Roosh_Ventures>,
        <https://1145.am/db/1281079/Morgenthaler_Ventures>,
        <https://1145.am/db/1281647/Morgenthaler_Ventures>,
        <https://1145.am/db/1282820/Agya_Ventures>,
        <https://1145.am/db/1286872/Morevc>,
        <https://1145.am/db/1287476/Felicis_Ventures>,
        <https://1145.am/db/1297417/Bitkraft_Ventures>,
        <https://1145.am/db/1299578/Seedtob_Capital>,
        <https://1145.am/db/1307620/Inventus_Capital_Partners>,
        <https://1145.am/db/1311917/Avid_Ventures>,
        <https://1145.am/db/1311917/Canapi_Ventures>,
        <https://1145.am/db/1322441/Solana_Ventures>,
        <https://1145.am/db/1326376/Dexcom_Ventures>,
        <https://1145.am/db/1329887/Peter_Nagar>,
        <https://1145.am/db/1331691/Pelion_Ventures>,
        <https://1145.am/db/1332798/Acrobator_Ventures>,
        <https://1145.am/db/1334186/First_Ascent_Ventures>,
        <https://1145.am/db/1334193/Version_One_Ventures>,
        <https://1145.am/db/1334395/Gv>,
        <https://1145.am/db/1334895/Soleus_Capital>,
        <https://1145.am/db/1335073/Yl_Ventures>,
        <https://1145.am/db/1335080/Dorilton_Ventures>,
        <https://1145.am/db/1344240/Neotribe_Ventures>,
        <https://1145.am/db/1352420/Vamos_Ventures>,
        <https://1145.am/db/1353145/Infinity_Ventures>,
        <https://1145.am/db/1362743/Cobalt_Ventures>,
        <https://1145.am/db/1373683/BGV>,
        <https://1145.am/db/1375916/J2_Ventures>,
        <https://1145.am/db/1376353/J2_Ventures>,
        <https://1145.am/db/1378599/Menlo_Ventures>,
        <https://1145.am/db/1381832/Northpond_Ventures>,
        <https://1145.am/db/1382787/Northpond_Ventures>,
        <https://1145.am/db/1383818/Newlin_Ventures>,
        <https://1145.am/db/1387557/Naventures>,
        <https://1145.am/db/138878/Metacartel_Ventures>,
        <https://1145.am/db/1398057/Owen_Van_Natta_Temaris___Associates>,
        <https://1145.am/db/1398917/Trousdale_Ventures>,
        <https://1145.am/db/1407553/Sequoia_Capital>,
        <https://1145.am/db/1407614/C2_Ventures>,
        <https://1145.am/db/1411289/Sequoia_Capital>,
        <https://1145.am/db/1411934/Riptide_Ventures>,
        <https://1145.am/db/1425749/Menlo_Ventures>,
        <https://1145.am/db/1425749/Se_Ventures>,
        <https://1145.am/db/1433429/Crosslink_Capital>,
        <https://1145.am/db/1445378/Mvp_Ventures>,
        <https://1145.am/db/1445935/Verissimo_Ventures>,
        <https://1145.am/db/1449316/+Nd_Capital>,
        <https://1145.am/db/1449740/Mistral_Ventures>,
        <https://1145.am/db/1452107/Abstract_Ventures>,
        <https://1145.am/db/1455216/Engage_Ventures>,
        <https://1145.am/db/1455616/Abstract_Ventures>,
        <https://1145.am/db/1463829/1sharpe_Ventures>,
        <https://1145.am/db/1467693/Preseed_Ventures>,
        <https://1145.am/db/1467892/M_Ventures>,
        <https://1145.am/db/1467932/Sequoia_Capital_Gv>,
        <https://1145.am/db/1468981/Preseed_Ventures>,
        <https://1145.am/db/1476448/Origin_Ventures>,
        <https://1145.am/db/1480152/True_Ventures>,
        <https://1145.am/db/1480651/Glasswing_Ventures>,
        <https://1145.am/db/1480989/Infinity_Ventures>,
        <https://1145.am/db/1481875/Infinity_Ventures>,
        <https://1145.am/db/1482705/Oif_Ventures>,
        <https://1145.am/db/1484103/Boxone_Ventures>,
        <https://1145.am/db/1484857/Iu_Ventures>,
        <https://1145.am/db/1488858/Alkeon_Capital>,
        <https://1145.am/db/1490126/Seedtob_Capital>,
        <https://1145.am/db/1490183/Sofinnova_Partners>,
        <https://1145.am/db/1490978/Seedtob_Capital>,
        <https://1145.am/db/1492889/Future_Ventures>,
        <https://1145.am/db/1492889/Radical_Ventures>,
        <https://1145.am/db/1494028/Alkeon_Capital>,
        <https://1145.am/db/1496360/Realist_Ventures>,
        <https://1145.am/db/1503768/Nevateam_Partners>,
        <https://1145.am/db/1508325/Aramco_Ventures>,
        <https://1145.am/db/1509462/F7_Ventures>,
        <https://1145.am/db/1512891/Acme_Capital>,
        <https://1145.am/db/1515109/Cmfg_Ventures>,
        <https://1145.am/db/1515916/Sequoia_Capital>,
        <https://1145.am/db/1520070/Menlo_Ventures>,
        <https://1145.am/db/1520070/Northpond_Ventures>,
        <https://1145.am/db/1520772/January_Ventures>,
        <https://1145.am/db/1537166/Catalio_Capital_Management>,
        <https://1145.am/db/1537970/Catalio_Capital_Management>,
        <https://1145.am/db/1541308/Panoramic_Ventures>,
        <https://1145.am/db/1541797/G1_Ventures>,
        <https://1145.am/db/1545833/Alerion_Ventures>,
        <https://1145.am/db/1545994/Noemis_Ventures>,
        <https://1145.am/db/1546945/Alerion_Ventures>,
        <https://1145.am/db/1546965/Citi_Ventures>,
        <https://1145.am/db/1546965/Truist_Ventures>,
        <https://1145.am/db/1547281/Noemis_Ventures>,
        <https://1145.am/db/1548592/Gopoint_Ventures>,
        <https://1145.am/db/1556397/Dnx_Ventures>,
        <https://1145.am/db/1556442/C16_Ventures>,
        <https://1145.am/db/1557877/Embark_Ventures>,
        <https://1145.am/db/1559824/Embark_Ventures>,
        <https://1145.am/db/1560704/Breaktrail_Ventures>,
        <https://1145.am/db/1563623/Amex_Ventures>,
        <https://1145.am/db/1564049/Amex_Ventures>,
        <https://1145.am/db/1571330/Seae_Ventures>,
        <https://1145.am/db/1571330/Venturesouth>,
        <https://1145.am/db/1572216/Seae_Ventures>,
        <https://1145.am/db/1572216/Venturesouth>,
        <https://1145.am/db/1574557/True_Ventures>,
        <https://1145.am/db/1574647/Vanterra_Ventures>,
        <https://1145.am/db/1575612/Interlace_Ventures>,
        <https://1145.am/db/1575612/Valia_Ventures>,
        <https://1145.am/db/1578178/N49p>,
        <https://1145.am/db/1578178/Naventures>,
        <https://1145.am/db/1578327/Crit_Ventures>,
        <https://1145.am/db/1578327/Nextview_Ventures>,
        <https://1145.am/db/1579770/Schams_Ventures>,
        <https://1145.am/db/1579792/Crit_Ventures>,
        <https://1145.am/db/1579792/Nextview_Ventures>,
        <https://1145.am/db/1580468/Cohort_Ventures>,
        <https://1145.am/db/1582024/Avalon_Ventures>,
        <https://1145.am/db/1582111/Forepont_Capital_Partners>,
        <https://1145.am/db/1583413/Navigare_Ventures>,
        <https://1145.am/db/1615195/Digitalis_Ventures>,
        <https://1145.am/db/1616990/Digitalis_Ventures>,
        <https://1145.am/db/1632002/Catalio_Capital_Management>,
        <https://1145.am/db/1632028/Catalio_Capital_Management>,
        <https://1145.am/db/1632131/Catalio_Capital_Management>,
        <https://1145.am/db/1632156/Catalio_Capital_Management>,
        <https://1145.am/db/1638640/1digi_Ventures>,
        <https://1145.am/db/1649691/Sequoia_Capital>,
        <https://1145.am/db/1653506/Ascendum_Capital>,
        <https://1145.am/db/1653506/Citta_Capital>,
        <https://1145.am/db/1653506/Morgenthaler_Ventures>,
        <https://1145.am/db/1664837/Civilization_Ventures>,
        <https://1145.am/db/1664948/Dreamit_Ventures>,
        <https://1145.am/db/1669908/Aviso_Ventures>,
        <https://1145.am/db/1670128/Primary_Ventures>,
        <https://1145.am/db/1676513/Connect_Ventures>,
        <https://1145.am/db/1685482/Lavrock_Ventures>,
        <https://1145.am/db/1690703/Arkam_Ventures>,
        <https://1145.am/db/1690703/Prosus_Ventures>,
        <https://1145.am/db/1691060/Veblen_Ventures>,
        <https://1145.am/db/1691364/Ts_Ventures>,
        <https://1145.am/db/1693592/Cventures>,
        <https://1145.am/db/1693668/Sunny_Side_Ventures>,
        <https://1145.am/db/1693981/Boldstart_Ventures>,
        <https://1145.am/db/1694241/True_Ventures>,
        <https://1145.am/db/1694301/Dn_Capital>,
        <https://1145.am/db/1694417/Sequoia_Capital>,
        <https://1145.am/db/1694448/Presidio_Ventures>,
        <https://1145.am/db/1694592/Credo_Ventures>,
        <https://1145.am/db/1694592/Susa_Ventures>,
        <https://1145.am/db/1694798/Udc_Ventures>,
        <https://1145.am/db/1694947/Intersouth_Partners>,
        <https://1145.am/db/1695849/Salesforce_Ventures>,
        <https://1145.am/db/1695885/True_Ventures>,
        <https://1145.am/db/1697044/Palomar_Ventures>,
        <https://1145.am/db/1697044/Sequoia_Capital>,
        <https://1145.am/db/1697373/Lerer_Ventures>,
        <https://1145.am/db/1697910/Entrepia_Ventures>,
        <https://1145.am/db/1697910/Innovacom>,
        <https://1145.am/db/1698516/Engage_Ventures>,
        <https://1145.am/db/1698516/Tyh_Ventures>,
        <https://1145.am/db/1698644/Inovia_Capital>,
        <https://1145.am/db/1699263/Contour_Venture_Partners>,
        <https://1145.am/db/1700565/Sequoia_Capital>,
        <https://1145.am/db/1700572/Contour_Venture_Partners>,
        <https://1145.am/db/1701414/Sequoia_Capital>,
        <https://1145.am/db/1702003/Ventures_West>,
        <https://1145.am/db/1702065/Kreos_Capital>,
        <https://1145.am/db/1702472/Chiratae_Ventures>,
        <https://1145.am/db/1702483/Sure_Ventures_Usvp>,
        <https://1145.am/db/1702517/Prime_Ventures>,
        <https://1145.am/db/1702871/Charles_River_Ventures>,
        <https://1145.am/db/1703120/Point72_Ventures>,
        <https://1145.am/db/1703551/People_Ventures>,
        <https://1145.am/db/1703907/T-Venture>,
        <https://1145.am/db/1704404/True_Ventures>,
        <https://1145.am/db/1704740/T-Venture>,
        <https://1145.am/db/1704842/Se_Ventures>,
        <https://1145.am/db/1704871/Yl_Ventures>,
        <https://1145.am/db/1705825/Ventures_Platform>,
        <https://1145.am/db/1707227/Schams_Ventures>,
        <https://1145.am/db/1707540/Prosus_Ventures>,
        <https://1145.am/db/1707567/Contour_Venture_Partners>,
        <https://1145.am/db/1707567/Reign_Ventures>,
        <https://1145.am/db/1707637/Resolute_Ventures>,
        <https://1145.am/db/1707736/Artiman_Ventures>,
        <https://1145.am/db/1708555/20vc>,
        <https://1145.am/db/1708903/Kaedan_Capital>,
        <https://1145.am/db/1709168/Morgenthaler_Ventures>,
        <https://1145.am/db/1710027/Contour_Venture_Partners>,
        <https://1145.am/db/1711208/Sequoia_Capital>,
        <https://1145.am/db/1711383/Aviso_Ventures>,
        <https://1145.am/db/1711383/Pelion_Ventures>,
        <https://1145.am/db/1711750/Index_Ventures>,
        <https://1145.am/db/1711790/CRV>,
        <https://1145.am/db/1711849/K20_Ventures>,
        <https://1145.am/db/1712471/Cervin_Ventures>,
        <https://1145.am/db/1713712/Grotech_Ventures>,
        <https://1145.am/db/1714098/Charles_River_Ventures>,
        <https://1145.am/db/1714148/Ulu_Ventures>,
        <https://1145.am/db/1714624/Abstract_Ventures>,
        <https://1145.am/db/1714630/January_Ventures>,
        <https://1145.am/db/1716124/Appian_Ventures>,
        <https://1145.am/db/1716168/Onset_Ventures>,
        <https://1145.am/db/1716667/Dag_Ventures>,
        <https://1145.am/db/1717317/Index_Ventures>,
        <https://1145.am/db/1718012/Dag_Ventures>,
        <https://1145.am/db/1718012/Presidio_Ventures>,
        <https://1145.am/db/1718018/Ggv_Capital>,
        <https://1145.am/db/1718081/Jafco_Ventures>,
        <https://1145.am/db/1718748/Truist_Ventures>,
        <https://1145.am/db/1718787/J_Ventures>,
        <https://1145.am/db/1719362/True_Ventures>,
        <https://1145.am/db/1719370/Bv_Capital>,
        <https://1145.am/db/1720145/Bessemer_Ventures>,
        <https://1145.am/db/1720182/ConvivialitÃ©_Ventures>,
        <https://1145.am/db/1720441/Origin_Ventures>,
        <https://1145.am/db/1721171/Citi_Ventures>,
        <https://1145.am/db/1721392/Redpoint_Ventures>,
        <https://1145.am/db/1721393/Trinity_Ventures>,
        <https://1145.am/db/1721548/Ggv_Capital>,
        <https://1145.am/db/1721548/Menlo_Ventures>,
        <https://1145.am/db/1722252/Onset_Ventures>,
        <https://1145.am/db/1723165/Menlo_Ventures>,
        <https://1145.am/db/1723664/T-Venture>,
        <https://1145.am/db/1723932/Citi_Ventures>,
        <https://1145.am/db/1724979/Jafco_Ventures>,
        <https://1145.am/db/1724979/Sequoia_Capital>,
        <https://1145.am/db/1725680/Index_Ventures>,
        <https://1145.am/db/1726088/Zeev_Ventures>,
        <https://1145.am/db/1726121/Index_Ventures>,
        <https://1145.am/db/1726149/Index_Ventures>,
        <https://1145.am/db/1726544/Ei_Ventures>,
        <https://1145.am/db/1727288/Sozo_Ventures>,
        <https://1145.am/db/1728569/Redpoint_Ventures>,
        <https://1145.am/db/1729186/Catamount_Ventures>,
        <https://1145.am/db/1731187/Rho_Ventures>,
        <https://1145.am/db/1731419/Redpoint_Ventures>,
        <https://1145.am/db/1734104/Alpana_Ventures>,
        <https://1145.am/db/1734104/Highsage_Ventures>,
        <https://1145.am/db/1734728/Talis_Capital>,
        <https://1145.am/db/1735194/Eqt_Ventures>,
        <https://1145.am/db/1735248/Corigin_Ventures>,
        <https://1145.am/db/1735726/Nextview_Ventures>,
        <https://1145.am/db/1735755/Firebolt_Ventures>,
        <https://1145.am/db/1735774/Alpha4_Ventures>,
        <https://1145.am/db/1736136/Ggv_Capital>,
        <https://1145.am/db/1737278/Crosslink_Capital>,
        <https://1145.am/db/1737392/Moxxie_Ventures>,
        <https://1145.am/db/1737979/CRV>,
        <https://1145.am/db/1738162/3one4_Capital>,
        <https://1145.am/db/1738300/Chryscapital>,
        <https://1145.am/db/1738415/Capnamic_Ventures>,
        <https://1145.am/db/1738444/Prosus_Ventures>,
        <https://1145.am/db/1738776/Illuminate_Ventures>,
        <https://1145.am/db/1739022/Eventures>,
        <https://1145.am/db/1739042/Experior_Venture_Fund>,
        <https://1145.am/db/1739064/Jsw_Ventures>,
        <https://1145.am/db/1739106/Sequoia_Capital>,
        <https://1145.am/db/1739120/Sequoia_Capital>,
        <https://1145.am/db/1739285/Sequoia_Capital>,
        <https://1145.am/db/1739630/Redsea_Ventures>,
        <https://1145.am/db/1739719/Seedplus>,
        <https://1145.am/db/1739851/Signum_Capital>,
        <https://1145.am/db/1739909/Root_Ventures>,
        <https://1145.am/db/1739946/Dn_Capital>,
        <https://1145.am/db/1740077/3one4_Capital>,
        <https://1145.am/db/1740665/First_Bridge_Ventures>,
        <https://1145.am/db/1740832/J_Ventures>,
        <https://1145.am/db/1740832/Susa_Ventures>,
        <https://1145.am/db/1740859/Ggv_Capital>,
        <https://1145.am/db/1741357/Dn_Capital>,
        <https://1145.am/db/1741575/Addventure>,
        <https://1145.am/db/1741635/Zeev_Ventures>,
        <https://1145.am/db/1742267/Firebolt_Ventures>,
        <https://1145.am/db/1742267/Point72_Ventures>,
        <https://1145.am/db/1743271/Liil_Ventures>,
        <https://1145.am/db/1743348/Felicis_Ventures>,
        <https://1145.am/db/1743409/Dreamit_Ventures>,
        <https://1145.am/db/1743737/Regah_Ventures>,
        <https://1145.am/db/1744229/R7>,
        <https://1145.am/db/1744775/Point72_Ventures>,
        <https://1145.am/db/1744864/Sequoia_Capital>,
        <https://1145.am/db/1744922/AglaÃ©_Ventures>,
        <https://1145.am/db/1745326/Eqt_Ventures>,
        <https://1145.am/db/1745326/Lios_Ventures>,
        <https://1145.am/db/1745326/Prime_Ventures>,
        <https://1145.am/db/1745746/Garuda_Ventures>,
        <https://1145.am/db/1745746/Starling_Ventures>,
        <https://1145.am/db/1745920/Sequoia_Capital>,
        <https://1145.am/db/1747252/Citi_Ventures>,
        <https://1145.am/db/1747391/Sequoia_Capital>,
        <https://1145.am/db/1747400/Eqt_Ventures>,
        <https://1145.am/db/1747503/Brighteye_Ventures>,
        <https://1145.am/db/1747722/Shinhan_Capital>,
        <https://1145.am/db/1747943/Altai_Ventures>,
        <https://1145.am/db/1748417/Zeev_Ventures>,
        <https://1145.am/db/1749226/Dn_Capital>,
        <https://1145.am/db/1749425/Ac_Ventures>,
        <https://1145.am/db/1749651/Colle_Capital>,
        <https://1145.am/db/1749911/Khwarizmi_Ventures>,
        <https://1145.am/db/1750942/Celesta_Capital>,
        <https://1145.am/db/1750942/Chiratae_Ventures>,
        <https://1145.am/db/1751135/Inovia_Capital>,
        <https://1145.am/db/1751312/Abstract_Ventures>,
        <https://1145.am/db/1751361/Kreos_Capital>,
        <https://1145.am/db/1751506/Ggv_Capital>,
        <https://1145.am/db/1751551/Gaingels>,
        <https://1145.am/db/1751553/Canapi_Ventures>,
        <https://1145.am/db/1751743/Intudo_Ventures>,
        <https://1145.am/db/1751800/Morpheus_Ventures>,
        <https://1145.am/db/1751954/Novastar_Ventures>,
        <https://1145.am/db/1752102/Origin_Ventures>,
        <https://1145.am/db/1752403/Yl_Ventures>,
        <https://1145.am/db/1752998/AglaÃ©_Ventures>,
        <https://1145.am/db/1753704/Apex_Ventures>,
        <https://1145.am/db/1753721/Financial_Venture_Studio>,
        <https://1145.am/db/1753721/Resolute_Ventures>,
        <https://1145.am/db/1753745/2i_Ventures>,
        <https://1145.am/db/1754211/Citi_Ventures>,
        <https://1145.am/db/1754211/Menlo_Ventures>,
        <https://1145.am/db/1754242/Gsv_Ventures>,
        <https://1145.am/db/1754595/Global_Ventures>,
        <https://1145.am/db/1754595/Otg_Ventures>,
        <https://1145.am/db/1754751/Menlo_Ventures>,
        <https://1145.am/db/1754787/Letsventure>,
        <https://1145.am/db/1754997/Alkeon_Capital>,
        <https://1145.am/db/1755086/Kollective_Ventures>,
        <https://1145.am/db/1755278/Zeev_Ventures>,
        <https://1145.am/db/1755704/Promus_Ventures>,
        <https://1145.am/db/1755828/Future_Ventures>,
        <https://1145.am/db/1755860/Dg_Ventures>,
        <https://1145.am/db/1755860/Intudo_Ventures>,
        <https://1145.am/db/1756040/Altos_Ventures>,
        <https://1145.am/db/1756094/CRV>,
        <https://1145.am/db/1756141/Index_Ventures>,
        <https://1145.am/db/1756231/Kreos_Capital>,
        <https://1145.am/db/1756326/Neotribe_Ventures>,
        <https://1145.am/db/1756384/Abstract_Ventures>,
        <https://1145.am/db/1756384/Lightspeed_Ventures>,
        <https://1145.am/db/1756599/True_Ventures>,
        <https://1145.am/db/1757035/Vectr_Ventures>,
        <https://1145.am/db/1757365/Will_Ventures>,
        <https://1145.am/db/1757382/Gl_Ventures>,
        <https://1145.am/db/1757590/Kreos_Capital>,
        <https://1145.am/db/1757772/Lorimer_Ventures>,
        <https://1145.am/db/1758193/Tenoneten_Ventures>,
        <https://1145.am/db/1758193/Valia_Ventures>,
        <https://1145.am/db/1758313/Venture_Field>,
        <https://1145.am/db/1758622/Oca_Ventures>,
        <https://1145.am/db/1759048/Avid_Ventures>,
        <https://1145.am/db/1759048/Lightspeed_Ventures>,
        <https://1145.am/db/1759567/J_Ventures>,
        <https://1145.am/db/1759922/Verance_Capital>,
        <https://1145.am/db/1760383/True_Ventures>,
        <https://1145.am/db/1760520/Prologis_Ventures>,
        <https://1145.am/db/1760816/Index_Ventures>,
        <https://1145.am/db/1760984/Index_Ventures>,
        <https://1145.am/db/1760984/Sequoia_Capital>,
        <https://1145.am/db/1760985/Frontier_Ventures>,
        <https://1145.am/db/1761126/Redpoint_Ventures>,
        <https://1145.am/db/1761566/Index_Ventures>,
        <https://1145.am/db/1761607/Menlo_Ventures>,
        <https://1145.am/db/1761607/Sinewave_Ventures>,
        <https://1145.am/db/1761957/Alkeon_Capital>,
        <https://1145.am/db/1761999/Ggv_Capital>,
        <https://1145.am/db/1762031/Menlo_Ventures>,
        <https://1145.am/db/1762055/Altos_Ventures>,
        <https://1145.am/db/1762277/Ac_Ventures>,
        <https://1145.am/db/1762453/Line_Ventures>,
        <https://1145.am/db/1762561/Grotech_Ventures>,
        <https://1145.am/db/1762669/Creandum>,
        <https://1145.am/db/1762844/Signum_Capital>,
        <https://1145.am/db/1763356/AglaÃ©_Ventures>,
        <https://1145.am/db/1763371/Spacecadet_Ventures>,
        <https://1145.am/db/1763395/Idc_Ventures>,
        <https://1145.am/db/1763565/Felicis_Ventures>,
        <https://1145.am/db/1763774/Ggv_Capital>,
        <https://1145.am/db/1763795/Ventures_Platform>,
        <https://1145.am/db/1763795/Xyz_Ventures>,
        <https://1145.am/db/1763875/Golden_Gate_Ventures>,
        <https://1145.am/db/1764027/Menlo_Ventures>,
        <https://1145.am/db/1764255/Pathbreaker_Ventures>,
        <https://1145.am/db/1764255/Stageone_Ventures>,
        <https://1145.am/db/1764345/Talis_Capital>,
        <https://1145.am/db/1764527/Presidio_Ventures>,
        <https://1145.am/db/1764527/Yl_Ventures>,
        <https://1145.am/db/1765273/Adevinta_Ventures>,
        <https://1145.am/db/1765273/Venturefriends>,
        <https://1145.am/db/1765372/Irobot_Ventures>,
        <https://1145.am/db/1765377/Redpoint_Ventures>,
        <https://1145.am/db/1765550/Sequoia_Capital>,
        <https://1145.am/db/1765646/Amiti_Ventures>,
        <https://1145.am/db/1765673/Salesforce_Ventures>,
        <https://1145.am/db/1766091/Inreach_Ventures>,
        <https://1145.am/db/1766096/Borealis_Ventures>,
        <https://1145.am/db/1766096/Northpond_Ventures>,
        <https://1145.am/db/1766253/Redpoint_Ventures>,
        <https://1145.am/db/1766253/True_Ventures>,
        <https://1145.am/db/1766540/Industry_Ventures>,
        <https://1145.am/db/1766978/Rga_Ventures>,
        <https://1145.am/db/1768099/Eventures>,
        <https://1145.am/db/1768363/Golden_Gate_Ventures>,
        <https://1145.am/db/1768841/Sequoia_Capital>,
        <https://1145.am/db/1769188/Felicis_Ventures>,
        <https://1145.am/db/1770095/Crosslink_Capital>,
        <https://1145.am/db/1770139/Victress_Capital>,
        <https://1145.am/db/1770265/Techstars_Ventures>,
        <https://1145.am/db/1770372/Avalon_Ventures>,
        <https://1145.am/db/1770372/Korelya_Capital>,
        <https://1145.am/db/1770802/Sequoia_Capital>,
        <https://1145.am/db/1770982/Gv>,
        <https://1145.am/db/1770982/Index_Ventures>,
        <https://1145.am/db/1771011/Ggv_Capital>,
        <https://1145.am/db/1771548/Seekdource_Capital>,
        <https://1145.am/db/1771613/Creandum>,
        <https://1145.am/db/1771642/Felicis_Ventures>,
        <https://1145.am/db/1772004/Raed_Ventures>,
        <https://1145.am/db/1772004/Seed_Equity_Venture_Partners>,
        <https://1145.am/db/1772381/Altos_Ventures>,
        <https://1145.am/db/1772452/Connect_Ventures>,
        <https://1145.am/db/1773130/Capnamic_Ventures>,
        <https://1145.am/db/1773143/Venturefriends>,
        <https://1145.am/db/1773323/Crosslink_Capital>,
        <https://1145.am/db/1774348/True_Ventures>,
        <https://1145.am/db/1774535/Felicis_Ventures>,
        <https://1145.am/db/1774535/Susa_Ventures>,
        <https://1145.am/db/1774658/Gv>,
        <https://1145.am/db/1775965/Felicis_Ventures>,
        <https://1145.am/db/1776340/Ggv_Capital>,
        <https://1145.am/db/1776340/Menlo_Ventures>,
        <https://1145.am/db/1776537/Origin_Ventures>,
        <https://1145.am/db/1776537/Tekton_Ventures>,
        <https://1145.am/db/1776621/Redpoint_Ventures>,
        <https://1145.am/db/1777289/Dn_Capital>,
        <https://1145.am/db/1777563/Evolv_Ventures>,
        <https://1145.am/db/1777563/Ggv_Capital>,
        <https://1145.am/db/1777848/Industry_Ventures>,
        <https://1145.am/db/1778935/Oryzn_Capital>,
        <https://1145.am/db/1780024/Partech_Ventures>,
        <https://1145.am/db/1782098/Addventure>,
        <https://1145.am/db/1782221/Point72_Ventures>,
        <https://1145.am/db/1783189/Citi_Ventures>,
        <https://1145.am/db/1784644/Creathor_Ventures>,
        <https://1145.am/db/1784964/Clear_Ventures>,
        <https://1145.am/db/1785361/M_Ventures>,
        <https://1145.am/db/1786249/Redpoint_Ventures>,
        <https://1145.am/db/1786249/Resolute_Ventures>,
        <https://1145.am/db/1786663/Edenred_Capital_Partners>,
        <https://1145.am/db/1786663/Eqt_Ventures>,
        <https://1145.am/db/1787249/Kpn_Ventures>,
        <https://1145.am/db/1787342/Korelya_Capital>,
        <https://1145.am/db/1787536/Point72_Ventures>,
        <https://1145.am/db/1787791/True_Ventures>,
        <https://1145.am/db/1787886/True_Ventures>,
        <https://1145.am/db/1788328/Index_Ventures>,
        <https://1145.am/db/1788570/Sequoia_Capital>,
        <https://1145.am/db/1788726/Redbeat_Capital>,
        <https://1145.am/db/1789460/Eventures>,
        <https://1145.am/db/1789754/Advancit_Capital>,
        <https://1145.am/db/1790280/Arthur_Ventures>,
        <https://1145.am/db/1790399/Capnamic_Ventures>,
        <https://1145.am/db/1790574/Crosslink_Capital>,
        <https://1145.am/db/1790574/Red_Swan_Ventures>,
        <https://1145.am/db/1790574/Sherpa_Ventures>,
        <https://1145.am/db/1790641/Dn_Capital>,
        <https://1145.am/db/1790771/Redpoint_Ventures>,
        <https://1145.am/db/1790777/Connect_Ventures>,
        <https://1145.am/db/1791216/True_Ventures>,
        <https://1145.am/db/1791303/Index_Ventures>,
        <https://1145.am/db/1791628/Industry_Ventures>,
        <https://1145.am/db/1791838/Advancit_Capital>,
        <https://1145.am/db/1792186/Sequoia_Capital>,
        <https://1145.am/db/1792771/Softtechvc>,
        <https://1145.am/db/1792887/Kaedan_Capital>,
        <https://1145.am/db/1792887/Stageone_Ventures>,
        <https://1145.am/db/1794699/Ws_Ventures>,
        <https://1145.am/db/1794935/Intervest_Co_Ltd>,
        <https://1145.am/db/1795020/Redpoint_Ventures>,
        <https://1145.am/db/1795210/Sequoia_Capital>,
        <https://1145.am/db/1795469/Index_Ventures>,
        <https://1145.am/db/1795538/Skystar_Capital>,
        <https://1145.am/db/1796109/Contour_Venture_Partners>,
        <https://1145.am/db/1796593/Tenoneten_Ventures>,
        <https://1145.am/db/1796901/Red_Swan_Ventures>,
        <https://1145.am/db/1796922/Cagni_Ventures>,
        <https://1145.am/db/1797209/Kdwc_Ventures>,
        <https://1145.am/db/1797518/Sequoia_Capital>,
        <https://1145.am/db/1797899/Brave_Ventures>,
        <https://1145.am/db/1797999/Redpoint_Ventures>,
        <https://1145.am/db/1798568/Index_Ventures>,
        <https://1145.am/db/1799099/Inovia_Capital>,
        <https://1145.am/db/1799184/Ggv_Capital>,
        <https://1145.am/db/1800232/Index_Ventures>,
        <https://1145.am/db/1800929/Ventureast>,
        <https://1145.am/db/1802086/High_Line_Ventures>,
        <https://1145.am/db/1802227/Advancit_Capital>,
        <https://1145.am/db/1802288/Sequoia_Capital>,
        <https://1145.am/db/1802336/Capnamic_Ventures>,
        <https://1145.am/db/1804102/True_Ventures>,
        <https://1145.am/db/1804247/Holtzbrinck_Ventures>,
        <https://1145.am/db/1804476/Felicis_Ventures>,
        <https://1145.am/db/1804476/True_Ventures>,
        <https://1145.am/db/1804992/Talis_Capital>,
        <https://1145.am/db/1805389/Industry_Ventures>,
        <https://1145.am/db/1805604/Connect_Ventures>,
        <https://1145.am/db/1805604/Inreach_Ventures>,
        <https://1145.am/db/1806644/Sequoia_Capital>,
        <https://1145.am/db/1806739/Golden_Gate_Ventures>,
        <https://1145.am/db/1808047/Salesforce_Ventures>,
        <https://1145.am/db/1808505/Helion_Ventures>,
        <https://1145.am/db/1808723/Mindworks_Ventures>,
        <https://1145.am/db/1808735/Commonangels_Ventures>,
        <https://1145.am/db/1809007/Sequoia_Capital>,
        <https://1145.am/db/1809844/Real_Ventures>,
        <https://1145.am/db/1809862/Acequia_Capital>,
        <https://1145.am/db/1810384/Starstrike_Ventures>,
        <https://1145.am/db/1810710/Ia_Ventures>,
        <https://1145.am/db/1810714/Catalus_Capital>,
        <https://1145.am/db/1810769/Eventures>,
        <https://1145.am/db/1810769/Sequoia_Capital>,
        <https://1145.am/db/1811357/Index_Ventures>,
        <https://1145.am/db/1812233/Sequoia_Capital>,
        <https://1145.am/db/1812856/Exfinity_Ventures>,
        <https://1145.am/db/1813375/Creandum>,
        <https://1145.am/db/1813575/Ggv_Capital>,
        <https://1145.am/db/1813944/Menlo_Ventures>,
        <https://1145.am/db/1814064/Index_Ventures>,
        <https://1145.am/db/1814643/Corigin_Ventures>,
        <https://1145.am/db/1814643/Launchcapital>,
        <https://1145.am/db/1815038/Plus_Ventures>,
        <https://1145.am/db/1815507/Globis_Capital_Partners>,
        <https://1145.am/db/1815697/Cherubic_Ventures>,
        <https://1145.am/db/1815701/True_Ventures>,
        <https://1145.am/db/1815886/Teneleven_Ventures>,
        <https://1145.am/db/1816491/Grotech_Ventures>,
        <https://1145.am/db/1818174/Advancit_Capital>,
        <https://1145.am/db/1818876/Kreos_Capital>,
        <https://1145.am/db/1818901/Sequoia_Capital>,
        <https://1145.am/db/1819374/Rothenberg_Ventures>,
        <https://1145.am/db/1819387/Index_Ventures>,
        <https://1145.am/db/1820882/Inven_Capital>,
        <https://1145.am/db/1821174/Index_Ventures>,
        <https://1145.am/db/1821711/Winton_Ventures>,
        <https://1145.am/db/1821752/Sequoia_Capital>,
        <https://1145.am/db/1823162/True_Ventures>,
        <https://1145.am/db/1823217/Kdc_Ventures>,
        <https://1145.am/db/1823217/Nbm_Ventures>,
        <https://1145.am/db/1823684/Dcm_Ventures>,
        <https://1145.am/db/1823684/Idg_Ventures>,
        <https://1145.am/db/1824252/Allos_Ventures>,
        <https://1145.am/db/1824253/Trinity_Ventures>,
        <https://1145.am/db/1824944/True_Ventures>,
        <https://1145.am/db/1825465/Ben_Narasin>,
        <https://1145.am/db/1825713/Menlo_Ventures>,
        <https://1145.am/db/1825946/Lerer_Ventures>,
        <https://1145.am/db/1826265/Idg_Ventures>,
        <https://1145.am/db/1826648/True_Ventures>,
        <https://1145.am/db/1826922/Ggv_Capital>,
        <https://1145.am/db/1827021/Dag_Ventures>,
        <https://1145.am/db/1828036/Redpoint_Ventures>,
        <https://1145.am/db/1828092/Eden_Ventures>,
        <https://1145.am/db/1828251/Golden_Gate_Ventures>,
        <https://1145.am/db/1828455/Quotidien_Ventures>,
        <https://1145.am/db/1828658/Focus_Ventures>,
        <https://1145.am/db/1828663/Great_Oaks_Ventures>,
        <https://1145.am/db/1828663/Inovia_Capital>,
        <https://1145.am/db/1829257/Sequoia_Capital>,
        <https://1145.am/db/1829422/Felicis_Ventures>,
        <https://1145.am/db/1829422/Rothenberg_Ventures>,
        <https://1145.am/db/1829612/Lerer_Ventures>,
        <https://1145.am/db/1830502/Frontline_Ventures>,
        <https://1145.am/db/1830613/True_Ventures>,
        <https://1145.am/db/1830809/Numecent>,
        <https://1145.am/db/1830809/T-Ventures>,
        <https://1145.am/db/1830817/Charles_River_Ventures>,
        <https://1145.am/db/1831577/Artiman_Ventures>,
        <https://1145.am/db/1831577/Sofinnova_Ventures>,
        <https://1145.am/db/1831764/Sequoia_Capital>,
        <https://1145.am/db/1832038/True_Ventures>,
        <https://1145.am/db/1832316/Partech_Ventures>,
        <https://1145.am/db/1832316/Scentan_Ventures>,
        <https://1145.am/db/1832316/Startcaps_Ventures>,
        <https://1145.am/db/1832856/Grotech_Ventures>,
        <https://1145.am/db/1834224/Avalon_Ventures>,
        <https://1145.am/db/1834224/Orix_Ventures>,
        <https://1145.am/db/1834305/Charles_River_Ventures>,
        <https://1145.am/db/1834334/Altos_Ventures>,
        <https://1145.am/db/1834334/Baseline_Ventures>,
        <https://1145.am/db/1834334/Firebolt_Ventures>,
        <https://1145.am/db/1834334/Lazerow_Ventures>,
        <https://1145.am/db/1834520/Ben_Horowitz>,
        <https://1145.am/db/1834541/Avalon_Ventures>,
        <https://1145.am/db/1834708/Sherpa_Ventures>,
        <https://1145.am/db/1834965/Lerer_Ventures>,
        <https://1145.am/db/1835229/Lerer_Ventures>,
        <https://1145.am/db/1835229/Trinity_Ventures>,
        <https://1145.am/db/1835229/Xg_Ventures>,
        <https://1145.am/db/1835740/Lerer_Ventures>,
        <https://1145.am/db/1835749/Gree_Ventures>,
        <https://1145.am/db/1835825/Focus_Ventures>,
        <https://1145.am/db/1836984/Siemer_Ventures>,
        <https://1145.am/db/1836984/Tekton_Ventures>,
        <https://1145.am/db/1837741/Menlo_Ventures>,
        <https://1145.am/db/1838026/Plus_Ventures>,
        <https://1145.am/db/1840775/Ggv_Capital>,
        <https://1145.am/db/1840881/Felicis_Ventures>,
        <https://1145.am/db/1840881/Trinity_Ventures>,
        <https://1145.am/db/1841176/Lerer_Ventures>,
        <https://1145.am/db/1841176/True_Ventures>,
        <https://1145.am/db/1842402/Index_Ventures>,
        <https://1145.am/db/1842402/Redpoint_Ventures>,
        <https://1145.am/db/1842898/Grotech_Ventures>,
        <https://1145.am/db/1843003/Eventures>,
        <https://1145.am/db/1843003/Index_Ventures>,
        <https://1145.am/db/1843031/Index_Ventures>,
        <https://1145.am/db/1843449/Redpoint_Ventures>,
        <https://1145.am/db/1843602/Nextview_Ventures>,
        <https://1145.am/db/1843659/Sequoia_Capital>,
        <https://1145.am/db/1844143/Inovia_Capital>,
        <https://1145.am/db/1844472/Sequoia_Capital>,
        <https://1145.am/db/1844737/True_Ventures>,
        <https://1145.am/db/1844931/Charles_River_Ventures>,
        <https://1145.am/db/1845308/Ia_Ventures>,
        <https://1145.am/db/1845960/Lerer_Ventures>,
        <https://1145.am/db/1846254/Index_Ventures>,
        <https://1145.am/db/1846483/Inovia_Capital>,
        <https://1145.am/db/1847463/Prism_Ventureworks>,
        <https://1145.am/db/1847752/T-Venture>,
        <https://1145.am/db/1848523/Trinity_Ventures>,
        <https://1145.am/db/1849673/Inventure_Partners>,
        <https://1145.am/db/1849884/Index_Ventures>,
        <https://1145.am/db/1849949/Holtzbrinck_Ventures>,
        <https://1145.am/db/1850020/Sequoia_Capital>,
        <https://1145.am/db/1850668/True_Ventures>,
        <https://1145.am/db/1850989/Artiman_Ventures>,
        <https://1145.am/db/1850989/Sequoia_Capital>,
        <https://1145.am/db/1851035/Acequia_Capital>,
        <https://1145.am/db/1851035/Index_Ventures>,
        <https://1145.am/db/1851035/Redpoint_Ventures>,
        <https://1145.am/db/1851705/Promus_Ventures>,
        <https://1145.am/db/1851854/Partech_Ventures>,
        <https://1145.am/db/1851923/Dag_Ventures>,
        <https://1145.am/db/1852308/Plus_Ventures>,
        <https://1145.am/db/1852513/Quotidian_Ventures>,
        <https://1145.am/db/1852513/Trestle_Ventures>,
        <https://1145.am/db/1852556/Dave_Morin>,
        <https://1145.am/db/1852806/Redpoint_Ventures>,
        <https://1145.am/db/1852870/Golden_Gate_Ventures>,
        <https://1145.am/db/1852870/Siemer_Ventures>,
        <https://1145.am/db/1853417/Catamount_Ventures>,
        <https://1145.am/db/1853496/T-Ventures>,
        <https://1145.am/db/1854200/Ggv_Capital>,
        <https://1145.am/db/1854201/Charles_River_Ventures>,
        <https://1145.am/db/1854786/Eden_Ventures>,
        <https://1145.am/db/1854874/Crosslink_Capital>,
        <https://1145.am/db/1854874/Sherpa_Ventures>,
        <https://1145.am/db/1854874/Softtech>,
        <https://1145.am/db/1855353/Sequoia_Capital>,
        <https://1145.am/db/1855363/True_Ventures>,
        <https://1145.am/db/1855403/Rho_Ventures>,
        <https://1145.am/db/1855780/Bds_Ventures>,
        <https://1145.am/db/1855780/Ggv_Capital>,
        <https://1145.am/db/1856191/Creandum>,
        <https://1145.am/db/1856380/Softtech>,
        <https://1145.am/db/1856402/Sequoia_Capital>,
        <https://1145.am/db/1856457/Aeris_Capital>,
        <https://1145.am/db/1856616/Redpoint_Ventures>,
        <https://1145.am/db/1856834/Sequoia_Capital>,
        <https://1145.am/db/1857635/Rikard_Steiber>,
        <https://1145.am/db/1857659/Revolution_Ventures>,
        <https://1145.am/db/1857930/Inovia_Capital>,
        <https://1145.am/db/1857930/Version_One_Ventures>,
        <https://1145.am/db/1858323/Avalon_Ventures>,
        <https://1145.am/db/1858545/Sequoia_Capital>,
        <https://1145.am/db/1858592/Apex_Venture_Partners>,
        <https://1145.am/db/1858592/Origin_Ventures>,
        <https://1145.am/db/1858991/Capnamic_Ventures>,
        <https://1145.am/db/1859199/True_Ventures>,
        <https://1145.am/db/1859314/Version_One_Ventures>,
        <https://1145.am/db/1860163/Inovia_Capital>,
        <https://1145.am/db/1860345/Commonangels>,
        <https://1145.am/db/1860345/Launchcapital>,
        <https://1145.am/db/1861054/Sequoia_Capital>,
        <https://1145.am/db/1861355/Rho_Ventures>,
        <https://1145.am/db/1862590/Felicis_Ventures>,
        <https://1145.am/db/1862878/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1863147/Apex_Venture_Partners>,
        <https://1145.am/db/1864601/Trinity_Ventures>,
        <https://1145.am/db/1864646/Inventus_Capital>,
        <https://1145.am/db/1865436/Sequoia_Capital>,
        <https://1145.am/db/1865480/Felicis_Ventures>,
        <https://1145.am/db/1865480/Sequoia_Capital>,
        <https://1145.am/db/1865480/Sherpalo_Ventures>,
        <https://1145.am/db/1866032/Launchcapital>,
        <https://1145.am/db/1866134/Embarcadero_Ventures>,
        <https://1145.am/db/1866134/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1866155/Presidio_Ventures>,
        <https://1145.am/db/1867543/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1867599/Cava_Capital>,
        <https://1145.am/db/1868107/Redpoint_Ventures>,
        <https://1145.am/db/1868109/Charles_River_Ventures>,
        <https://1145.am/db/1868178/True_Ventures>,
        <https://1145.am/db/1870015/Redpoint_Ventures>,
        <https://1145.am/db/1870465/Nextview_Ventures>,
        <https://1145.am/db/1871221/True_Ventures>,
        <https://1145.am/db/1871574/Redpoint_Ventures>,
        <https://1145.am/db/1871777/Charles_River_Ventures>,
        <https://1145.am/db/1871784/Charles_River_Ventures>,
        <https://1145.am/db/1871888/Charles_River_Ventures>,
        <https://1145.am/db/1873191/El_Dorado_Ventures>,
        <https://1145.am/db/1873680/Crosslink_Capital>,
        <https://1145.am/db/1873680/Lerer_Ventures>,
        <https://1145.am/db/1873680/Xg_Ventures>,
        <https://1145.am/db/1874749/True_Ventures>,
        <https://1145.am/db/1874937/Quotidian_Ventures>,
        <https://1145.am/db/1877243/Felicis_Ventures>,
        <https://1145.am/db/1877283/Northzone_Ventures>,
        <https://1145.am/db/1877473/True_Ventures>,
        <https://1145.am/db/1877642/Dag_Ventures>,
        <https://1145.am/db/1878620/Ggv_Capital>,
        <https://1145.am/db/1879279/High_Line_Ventures>,
        <https://1145.am/db/1879759/T-Venture>,
        <https://1145.am/db/1880679/Northzone_Ventures>,
        <https://1145.am/db/1881464/Ggv_Capital>,
        <https://1145.am/db/1881748/Morgenthaler_Ventures>,
        <https://1145.am/db/1882330/New_World_Ventures>,
        <https://1145.am/db/1882727/Charles_River_Ventures>,
        <https://1145.am/db/1882907/Starfish_Ventures>,
        <https://1145.am/db/1883568/Eden_Ventures>,
        <https://1145.am/db/1883572/Astutia_Ventures>,
        <https://1145.am/db/1886402/New_Atlantic_Ventures>,
        <https://1145.am/db/1886566/Sequoia_Capital>,
        <https://1145.am/db/1889394/Focus_Ventures>,
        <https://1145.am/db/1889629/Sequoia_Capital>,
        <https://1145.am/db/1890000/Lerer_Ventures>,
        <https://1145.am/db/1890122/East_Ventures>,
        <https://1145.am/db/1890133/Crosslink_Capital>,
        <https://1145.am/db/1890133/Dag_Ventures>,
        <https://1145.am/db/1890133/Focus_Ventures>,
        <https://1145.am/db/1890157/Morgenthaler_Ventures>,
        <https://1145.am/db/1890208/Menlo_Ventures>,
        <https://1145.am/db/1890619/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1890839/Inovia_Capital>,
        <https://1145.am/db/1890903/Miven_Ventures>,
        <https://1145.am/db/1891615/Holtzbrinck_Ventures>,
        <https://1145.am/db/1891777/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1891913/New_World_Ventures>,
        <https://1145.am/db/1891913/Oca_Ventures>,
        <https://1145.am/db/1891926/New_World_Ventures>,
        <https://1145.am/db/1892050/Charles_River_Ventures>,
        <https://1145.am/db/1892105/Crosscreek_Capital>,
        <https://1145.am/db/1892105/Industry_Ventures>,
        <https://1145.am/db/1892106/Altos_Ventures>,
        <https://1145.am/db/1892106/Illuminate_Ventures>,
        <https://1145.am/db/1892620/True_Ventures>,
        <https://1145.am/db/1892674/Appian_Ventures>,
        <https://1145.am/db/1892902/Crosslink_Capital>,
        <https://1145.am/db/1892955/Guy_Gamzu>,
        <https://1145.am/db/1895072/Nextview_Ventures>,
        <https://1145.am/db/1895951/Windward_Ventures>,
        <https://1145.am/db/1896159/Ia_Ventures>,
        <https://1145.am/db/1896185/Index_Ventures>,
        <https://1145.am/db/1896379/Index_Ventures>,
        <https://1145.am/db/1896379/Redpoint_Ventures>,
        <https://1145.am/db/1896419/True_Ventures>,
        <https://1145.am/db/1902330/Baseline_Ventures>,
        <https://1145.am/db/1905483/Industry_Ventures>,
        <https://1145.am/db/1905858/Index_Ventures>,
        <https://1145.am/db/1907771/Dag_Ventures>,
        <https://1145.am/db/1909430/Menlo_Ventures>,
        <https://1145.am/db/1909651/Revolution_Ventures>,
        <https://1145.am/db/1910694/True_Ventures>,
        <https://1145.am/db/1910922/Charles_River_Ventures>,
        <https://1145.am/db/1912684/Charles_River_Ventures>,
        <https://1145.am/db/1913863/Tl_Ventures>,
        <https://1145.am/db/1913874/Redpoint_Ventures>,
        <https://1145.am/db/1914220/Index_Ventures>,
        <https://1145.am/db/1915393/Mohr_Davidow_Ventures>,
        <https://1145.am/db/1915862/Dag_Ventures>,
        <https://1145.am/db/1915862/Focus_Ventures>,
        <https://1145.am/db/1919724/Dag_Ventures>,
        <https://1145.am/db/1920478/Dawntreader_Ventures>,
        <https://1145.am/db/1920837/Onset_Ventures>,
        <https://1145.am/db/1927817/Trm_Ventures>,
        <https://1145.am/db/1939926/Cobalt_Ventures>,
        <https://1145.am/db/1945479/Crosslink_Capital>,
        <https://1145.am/db/1947303/Cavallo_Ventures>,
        <https://1145.am/db/1947312/Boldstart_Ventures>,
        <https://1145.am/db/1952989/Singularity_Ventures>,
        <https://1145.am/db/1954147/Accomplice_Ventures>,
        <https://1145.am/db/1957179/Sozo_Ventures>,
        <https://1145.am/db/1958963/Prosus_Ventures>,
        <https://1145.am/db/1959001/Capital_Technology_Ventures>,
        <https://1145.am/db/1959001/Glasswing_Ventures>,
        <https://1145.am/db/1962819/Connetic_Ventures>,
        <https://1145.am/db/1967592/Firebolt_Ventures>,
        <https://1145.am/db/1967683/Dig_Ventures_Vine_Ventures>,
        <https://1145.am/db/1975490/Northview_Ventures>,
        <https://1145.am/db/1975547/Nanban_Ventures>,
        <https://1145.am/db/1975547/Sinewave_Ventures>,
        <https://1145.am/db/1986122/Menlo_Ventures>,
        <https://1145.am/db/1995926/Neotribe_Ventures>,
        <https://1145.am/db/1998196/Gni_Group_Ltd>,
        <https://1145.am/db/1999771/Servicenow_Ventures>,
        <https://1145.am/db/2004427/ConvivialitÃ©_Ventures>,
        <https://1145.am/db/2005131/Wwventures>,
        <https://1145.am/db/2007132/Nventures>,
        <https://1145.am/db/2020041/Inovia_Capital>,
        <https://1145.am/db/2020041/TCV>,
        <https://1145.am/db/2023596/Salesforce_Ventures>,
        <https://1145.am/db/2025081/True_Ventures>,
        <https://1145.am/db/2029648/Sequoia_Capital>,
        <https://1145.am/db/2035454/Gv>,
        <https://1145.am/db/2036021/Clear_Ventures>,
        <https://1145.am/db/2038783/Sequoia_Capital>,
        <https://1145.am/db/2039177/Stellantis_Ventures>,
        <https://1145.am/db/2041480/Brunnur_Ventures>,
        <https://1145.am/db/2042858/Gv>,
        <https://1145.am/db/2044380/20sales>,
        <https://1145.am/db/2045587/Veritec_Ventures>,
        <https://1145.am/db/2050229/Nventures>,
        <https://1145.am/db/2050359/At_One_Ventures>,
        <https://1145.am/db/2051164/Aviso_Ventures>,
        <https://1145.am/db/2053027/Glasswing_Ventures>,
        <https://1145.am/db/2055707/Globis_Capital_Partners>,
        <https://1145.am/db/2056931/We_Ventures>,
        <https://1145.am/db/2060003/Crit_Ventures_100___100_Ventures>,
        <https://1145.am/db/2061278/Incisive_Ventures>,
        <https://1145.am/db/2061278/Volo_Ventures>,
        <https://1145.am/db/2063642/Clear_Bridge_Ventures>,
        <https://1145.am/db/2063967/Vsquared_Ventures>,
        <https://1145.am/db/2069147/Boldstart_Ventures>,
        <https://1145.am/db/2069147/Pelion_Ventures>,
        <https://1145.am/db/2069147/Salesforce_Ventures>,
        <https://1145.am/db/2069495/Intermountain_Ventures>,
        <https://1145.am/db/2069495/Northpond_Ventures>,
        <https://1145.am/db/2073129/Abstract_Ventures>,
        <https://1145.am/db/2073132/Idc_Ventures>,
        <https://1145.am/db/2073480/Astellas_Venture_Management>,
        <https://1145.am/db/2075625/Rocketship_Ventures>,
        <https://1145.am/db/2081180/S4s_Ventures>,
        <https://1145.am/db/2081674/Capital_One_Ventures>,
        <https://1145.am/db/2082068/Arctern_Ventures>,
        <https://1145.am/db/2082068/Prelude_Ventures>,
        <https://1145.am/db/2083987/Vanterra_Ventures>,
        <https://1145.am/db/2087289/Jven_Capital>,
        <https://1145.am/db/2087289/Northpond_Ventures>,
        <https://1145.am/db/2089206/Crescendo_Venture_Partners>,
        <https://1145.am/db/2093427/Yl_Ventures>,
        <https://1145.am/db/2093713/Yl_Ventures>,
        <https://1145.am/db/209861/Crosslink_Capital>,
        <https://1145.am/db/2100116/Epic_Ventures>,
        <https://1145.am/db/2107533/Globis_Capital_Partners>,
        <https://1145.am/db/2109529/Point72_Ventures>,
        <https://1145.am/db/2109799/Sofinnova_Partners>,
        <https://1145.am/db/2109932/Catalio_Capital_Management>,
        <https://1145.am/db/2109932/Epic_Ventures>,
        <https://1145.am/db/2109932/Intermountain_Ventures>,
        <https://1145.am/db/2109932/North_South_Ventures>,
        <https://1145.am/db/2116769/Celesta_Capital>,
        <https://1145.am/db/2116769/Chiratae_Ventures>,
        <https://1145.am/db/2123953/Amex_Ventures>,
        <https://1145.am/db/2123953/Industry_Ventures>,
        <https://1145.am/db/2123953/Infinity_Ventures>,
        <https://1145.am/db/2124766/P1_Ventures>,
        <https://1145.am/db/2125182/Nevcaut_Ventures>,
        <https://1145.am/db/2125182/Ulu_Ventures>,
        <https://1145.am/db/2125927/1984_Ventures>,
        <https://1145.am/db/2127882/Akkadian_Ventures>,
        <https://1145.am/db/2134989/Clear_Ventures>,
        <https://1145.am/db/2134989/Felicis_Ventures>,
        <https://1145.am/db/2141183/S_Ventures>,
        <https://1145.am/db/2141328/Connetic_Ventures>,
        <https://1145.am/db/2143438/Scorpio_Capital>,
        <https://1145.am/db/2147767/Catapult_Ventures>,
        <https://1145.am/db/2147767/Tenoneten_Ventures>,
        <https://1145.am/db/2151983/CRV>,
        <https://1145.am/db/2151983/Greatpoint_Ventures>,
        <https://1145.am/db/2155426/Brighteyes_Ventures>,
        <https://1145.am/db/2155625/Sofinnova_Partners>,
        <https://1145.am/db/2164121/Menlo_Ventures>,
        <https://1145.am/db/2169799/Nwise_Ventures>,
        <https://1145.am/db/217906/Sequoia_Capital>,
        <https://1145.am/db/2181016/Foresite_Capital>,
        <https://1145.am/db/2182443/Global_Ventures>,
        <https://1145.am/db/2183352/Optum_Ventures>,
        <https://1145.am/db/2186568/Frist_Cressey_Ventures>,
        <https://1145.am/db/2186568/Springrock_Ventures>,
        <https://1145.am/db/2186949/Greatpoint_Ventures_And_Cross_Creek>,
        <https://1145.am/db/2186949/Springrock_Ventures>,
        <https://1145.am/db/2190141/Link_Ventures>,
        <https://1145.am/db/2192636/TCV>,
        <https://1145.am/db/219311/Origin_Ventures>,
        <https://1145.am/db/2196875/Sequoia_Capital>,
        <https://1145.am/db/2208603/McKesson_Ventures>,
        <https://1145.am/db/2210557/True_Ventures>,
        <https://1145.am/db/221321/Ggv_Capital>,
        <https://1145.am/db/2214690/Idg_Ventures>,
        <https://1145.am/db/2254568/Felicis_Ventures>,
        <https://1145.am/db/2264763/True_Ventures>,
        <https://1145.am/db/2283006/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Catalio_Capital_Management>,
        <https://1145.am/db/2283185/Northpond_Ventures>,
        <https://1145.am/db/2284412/Soleus_Capital>,
        <https://1145.am/db/2286665/Shanda_Group>,
        <https://1145.am/db/2288209/Echelon_Ventures>,
        <https://1145.am/db/2288596/Sanderling_Ventures>,
        <https://1145.am/db/2291277/Foresite_Capital>,
        <https://1145.am/db/2293172/Prospect_Ventures>,
        <https://1145.am/db/2294202/Trinitas_Capital>,
        <https://1145.am/db/2294815/Foresite_Capital>,
        <https://1145.am/db/2295253/Arkitekt_Ventures>,
        <https://1145.am/db/2295539/Sofinnova_Ventures>,
        <https://1145.am/db/2296249/Proxima_Ventures>,
        <https://1145.am/db/2296869/Dcm_Ventures>,
        <https://1145.am/db/2297406/Sequoia_Capital>,
        <https://1145.am/db/2298897/Eshelman_Ventures>,
        <https://1145.am/db/2300254/Sequoia_Capital>,
        <https://1145.am/db/2302351/Rho_Ventures>,
        <https://1145.am/db/2302731/Astellas_Venture_Management_Llc>,
        <https://1145.am/db/2302750/Sofinnova_Partners>,
        <https://1145.am/db/2302897/Ventures_West_Capital>,
        <https://1145.am/db/2303098/Seaflower_Ventures>,
        <https://1145.am/db/2303581/Clarus_Ventures>,
        <https://1145.am/db/2304606/Prism_Ventureworks>,
        <https://1145.am/db/2304606/Sofinnova_Ventures>,
        <https://1145.am/db/2305745/Clarus_Ventures>,
        <https://1145.am/db/2305745/Sanderling_Ventures>,
        <https://1145.am/db/2306281/Sanderling_Ventures>,
        <https://1145.am/db/2306568/Cmea_Ventures>,
        <https://1145.am/db/2306568/Sofinnova_Ventures>,
        <https://1145.am/db/2309507/Rho_Ventures>,
        <https://1145.am/db/2309840/Index_Ventures>,
        <https://1145.am/db/2311069/Morgenthaler_Ventures>,
        <https://1145.am/db/2311069/Sofinnova_Ventures>,
        <https://1145.am/db/2312288/Pappas_Ventures>,
        <https://1145.am/db/2312792/Onset_Ventures>,
        <https://1145.am/db/2313322/Clarus_Ventures>,
        <https://1145.am/db/2313438/Clarus_Ventures>,
        <https://1145.am/db/2314380/Puretech_Ventures>,
        <https://1145.am/db/2314397/Pappas_Ventures>,
        <https://1145.am/db/2314397/Sofinnova_Ventures>,
        <https://1145.am/db/2314400/Pappas_Ventures>,
        <https://1145.am/db/2314400/Sofinnova_Ventures>,
        <https://1145.am/db/2314515/Apjohnventures>,
        <https://1145.am/db/2315754/Arcturus_Capital>,
        <https://1145.am/db/2317779/Index_Ventures>,
        <https://1145.am/db/2317779/Sofinnova_Partners>,
        <https://1145.am/db/2319777/Astellas_Venture_Management>,
        <https://1145.am/db/2321856/Ventures_West_Capital_Ltd>,
        <https://1145.am/db/2323785/Eshelman_Ventures>,
        <https://1145.am/db/2324195/Sofinnova_Ventures>,
        <https://1145.am/db/2325015/True_Ventures>,
        <https://1145.am/db/2325140/Index_Ventures>,
        <https://1145.am/db/2325257/Ventures_West>,
        <https://1145.am/db/2325337/Resolvyx>,
        <https://1145.am/db/2326080/Felicis_Ventures>,
        <https://1145.am/db/2326362/Nextech_Venture>,
        <https://1145.am/db/2326404/Intersouth_Partners>,
        <https://1145.am/db/2328585/Cmea_Ventures>,
        <https://1145.am/db/2329870/Sofinnova_Partners>,
        <https://1145.am/db/2330775/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2332748/Clarus_Ventures>,
        <https://1145.am/db/2335587/Sofinnova_Partners>,
        <https://1145.am/db/2338023/Cipla_Ventures>,
        <https://1145.am/db/2338196/Index_Ventures>,
        <https://1145.am/db/2338236/Sanderling_Ventures>,
        <https://1145.am/db/2338703/Wavepoint_Ventures>,
        <https://1145.am/db/2339206/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2340429/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2341896/Sofinnova_Ventures>,
        <https://1145.am/db/2341942/High-Tech_GrÃ¼nderfonds>,
        <https://1145.am/db/2342998/Sofinnova_Ventures>,
        <https://1145.am/db/2343184/Jven_Capital>,
        <https://1145.am/db/2345017/Venture_Investments>,
        <https://1145.am/db/2345268/Foresite_Capital>,
        <https://1145.am/db/2346300/High-Tech_GrÃ¼nderfonds>,
        <https://1145.am/db/2346452/Aescap_Venture>,
        <https://1145.am/db/2346532/Pappas_Ventures>,
        <https://1145.am/db/2346978/Ventures_West_Capital>,
        <https://1145.am/db/2347571/Index_Ventures>,
        <https://1145.am/db/2347876/Clarus_Ventures>,
        <https://1145.am/db/2348618/Index_Ventures>,
        <https://1145.am/db/2349096/Sofinnova_Partners>,
        <https://1145.am/db/2349096/Sofinnova_Ventures>,
        <https://1145.am/db/2350004/Clarus_Ventures>,
        <https://1145.am/db/2350044/Avalon_Ventures>,
        <https://1145.am/db/2352436/Forward_Ventures>,
        <https://1145.am/db/2352831/Clarus_Ventures>,
        <https://1145.am/db/2356384/Sofinnova_Partners>,
        <https://1145.am/db/2357487/Savitr_Capital>,
        <https://1145.am/db/2358050/Sofinnova_Ventures>,
        <https://1145.am/db/2358657/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2358725/Sofinnova_Ventures>,
        <https://1145.am/db/2358747/Solon_Ventures>,
        <https://1145.am/db/2358812/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2359960/Sofinnova_Partners>,
        <https://1145.am/db/2362638/Launchpad_Venture_Group>,
        <https://1145.am/db/2363460/Rho_Ventures>,
        <https://1145.am/db/2363854/Chrysalis_Ventures>,
        <https://1145.am/db/2364820/Fletcher_Spaght_Ventures>,
        <https://1145.am/db/2365103/Aescap_Venture>,
        <https://1145.am/db/2367675/Avalon_Ventures>,
        <https://1145.am/db/2369967/Foresite_Capital>,
        <https://1145.am/db/2370240/Clarus_Ventures>,
        <https://1145.am/db/2371160/Sofinnova_Ventures>,
        <https://1145.am/db/238282/Carnrite_Ventures>,
        <https://1145.am/db/2400536/Capital_One_Ventures>,
        <https://1145.am/db/2423653/Venturewell>,
        <https://1145.am/db/253438/Esplanade_Ventures>,
        <https://1145.am/db/254357/Ulu_Ventures>,
        <https://1145.am/db/2549491/Ktb_Ventures>,
        <https://1145.am/db/2552636/Morningside_Ventures>,
        <https://1145.am/db/2569491/High-Tech_GrÃ¼nderfonds>,
        <https://1145.am/db/2570138/Sherpa_Ventures>,
        <https://1145.am/db/2570481/Morgenthaler_Ventures>,
        <https://1145.am/db/2570483/Morgenthaler_Ventures>,
        <https://1145.am/db/2577022/Sofinnova_Partners>,
        <https://1145.am/db/2577022/Sofinnova_Ventures>,
        <https://1145.am/db/2603254/Salesforce_Ventures>,
        <https://1145.am/db/2628424/Verana_Networks>,
        <https://1145.am/db/2628848/Neocarta_Ventures>,
        <https://1145.am/db/2635849/Mohr_Davidow_Ventures>,
        <https://1145.am/db/2638432/Nissay_Capital>,
        <https://1145.am/db/2641337/Promus_Ventures>,
        <https://1145.am/db/2641337/True_Ventures>,
        <https://1145.am/db/2654391/Biggell_Finance>,
        <https://1145.am/db/265532/Ulu_Ventures>,
        <https://1145.am/db/2702871/Inovia_Capital>,
        <https://1145.am/db/274170/G1_Ventures>,
        <https://1145.am/db/2754677/Golden_Gate_Ventures>,
        <https://1145.am/db/2765022/Garuda_Ventures>,
        <https://1145.am/db/2765030/Daniel_Ventures>,
        <https://1145.am/db/2765418/Rw3_Ventures>,
        <https://1145.am/db/2786411/Allegion_Ventures>,
        <https://1145.am/db/2788052/Rx_Ventures>,
        <https://1145.am/db/2790064/Novastar_Ventures>,
        <https://1145.am/db/2794396/Snowpoint_Ventures>,
        <https://1145.am/db/2797562/Menlo_Ventures>,
        <https://1145.am/db/283272/Salesforce_Ventures>,
        <https://1145.am/db/283607/Salesforce_Ventures>,
        <https://1145.am/db/293715/Signum_Capital>,
        <https://1145.am/db/293849/Felicis_Ventures>,
        <https://1145.am/db/293891/Ggv_Capital>,
        <https://1145.am/db/299738/Steadfast_Capital_Ventures>,
        <https://1145.am/db/306236/Index_Ventures>,
        <https://1145.am/db/319155/Bgv_Ventures>,
        <https://1145.am/db/323273/Index_Ventures>,
        <https://1145.am/db/341984/Salesforce_Ventures>,
        <https://1145.am/db/341984/Sequoia_Capital>,
        <https://1145.am/db/341990/Salesforce_Ventures>,
        <https://1145.am/db/341990/Sequoia_Capital>,
        <https://1145.am/db/343459/F7_Ventures>,
        <https://1145.am/db/346598/Salesforce_Ventures>,
        <https://1145.am/db/348442/Triventures>,
        <https://1145.am/db/348659/Launchpad_Capital>,
        <https://1145.am/db/361303/Sequoia_Capital>,
        <https://1145.am/db/364168/Alerion_Ventures>,
        <https://1145.am/db/367592/Gv>,
        <https://1145.am/db/367592/Sequoia_Capital>,
        <https://1145.am/db/388551/Vestigo_Ventures>,
        <https://1145.am/db/396305/Real_Ventures>,
        <https://1145.am/db/402103/1776_Ventures>,
        <https://1145.am/db/402701/January_Ventures>,
        <https://1145.am/db/403810/Riverstone_Ventures>,
        <https://1145.am/db/410322/Gv>,
        <https://1145.am/db/410473/Celesta_Capital>,
        <https://1145.am/db/410473/Lytical_Ventures_And_Nepenthe_Capital>,
        <https://1145.am/db/410529/Goodyear_Ventures>,
        <https://1145.am/db/411539/Zeev_Ventures>,
        <https://1145.am/db/412020/Defi_Ventures_Inc>,
        <https://1145.am/db/415322/CRV>,
        <https://1145.am/db/416041/Akkadian_Ventures>,
        <https://1145.am/db/416041/Signia_Ventures>,
        <https://1145.am/db/416041/Zeev_Ventures>,
        <https://1145.am/db/419489/Point72_Ventures>,
        <https://1145.am/db/424877/North_First_Ventures>,
        <https://1145.am/db/425262/Yl_Ventures>,
        <https://1145.am/db/425423/True_Ventures>,
        <https://1145.am/db/425973/Will_Ventures>,
        <https://1145.am/db/426615/Sequoia_Capital>,
        <https://1145.am/db/429179/C5_Capital>,
        <https://1145.am/db/430986/Cortado_Ventures>,
        <https://1145.am/db/434334/1up_Ventures>,
        <https://1145.am/db/435691/Klick_Ventures>,
        <https://1145.am/db/439819/Cavu_Ventures>,
        <https://1145.am/db/441319/Celesta_Capital>,
        <https://1145.am/db/444105/Exfinity_Ventures>,
        <https://1145.am/db/445365/Revolution_Ventures>,
        <https://1145.am/db/446341/Sinewave_Ventures>,
        <https://1145.am/db/455558/Intudo_Ventures>,
        <https://1145.am/db/457435/Alerce>,
        <https://1145.am/db/457435/Clin>,
        <https://1145.am/db/460454/Index_Ventures>,
        <https://1145.am/db/471253/Gv>,
        <https://1145.am/db/471436/Citi_Ventures>,
        <https://1145.am/db/471504/Canapi_Ventures>,
        <https://1145.am/db/473030/Highsage_Ventures>,
        <https://1145.am/db/474928/Susa_Ventures>,
        <https://1145.am/db/478049/Worldquant_Ventures>,
        <https://1145.am/db/479113/Index_Ventures>,
        <https://1145.am/db/479113/Menlo_Ventures>,
        <https://1145.am/db/485616/K3_Ventures>,
        <https://1145.am/db/486858/Gaingels>,
        <https://1145.am/db/486901/Gaingels>,
        <https://1145.am/db/488743/Salesforce_Ventures>,
        <https://1145.am/db/491130/Raiven_Capital>,
        <https://1145.am/db/491338/Raiven_Capital>,
        <https://1145.am/db/493560/Tyh_Ventures>,
        <https://1145.am/db/495912/Regah_Ventures>,
        <https://1145.am/db/506588/Trinity_Ventures>,
        <https://1145.am/db/508145/Sora_Finance>,
        <https://1145.am/db/508161/Sora_Finance>,
        <https://1145.am/db/510565/Epic_Ventures>,
        <https://1145.am/db/513305/Avid_Ventures>,
        <https://1145.am/db/513305/Canapi_Ventures>,
        <https://1145.am/db/513897/Rlc_Ventures>,
        <https://1145.am/db/514151/Rlc_Ventures>,
        <https://1145.am/db/516396/Acequia_Capital>,
        <https://1145.am/db/517213/Acequia_Capital>,
        <https://1145.am/db/523349/Osf_Ventures>,
        <https://1145.am/db/523776/Root_Ventures>,
        <https://1145.am/db/525285/Inventum_Ventures>,
        <https://1145.am/db/525285/Optima_Ventures>,
        <https://1145.am/db/526109/Ggv_Capital>,
        <https://1145.am/db/526175/Ridgeline_Ventures>,
        <https://1145.am/db/529812/Inventum_Ventures>,
        <https://1145.am/db/529812/Optima_Ventures>,
        <https://1145.am/db/532016/Id_Ventures>,
        <https://1145.am/db/539571/Origin_Ventures>,
        <https://1145.am/db/545843/Capital_One_Ventures>,
        <https://1145.am/db/545852/Boxone_Ventures>,
        <https://1145.am/db/545852/Panache_Ventures>,
        <https://1145.am/db/547770/BGV>,
        <https://1145.am/db/547944/BGV>,
        <https://1145.am/db/554552/Konvoy_Ventures>,
        <https://1145.am/db/555193/Illumina_Ventures>,
        <https://1145.am/db/555193/Technology_Venture_Partners>,
        <https://1145.am/db/556705/Congress_Ave_Ventures>,
        <https://1145.am/db/558005/Illumina_Ventures>,
        <https://1145.am/db/558005/Technology_Venture_Partners>,
        <https://1145.am/db/558877/Falabella_Ventures>,
        <https://1145.am/db/559220/Ulu_Ventures>,
        <https://1145.am/db/561662/Redpoint_Ventures>,
        <https://1145.am/db/561662/Vandelay_Ventures>,
        <https://1145.am/db/562745/Vinmar_Ventures>,
        <https://1145.am/db/563575/Celesta_Capital>,
        <https://1145.am/db/564008/D1_Ventures>,
        <https://1145.am/db/571769/Illumina_Ventures>,
        <https://1145.am/db/571769/M_Ventures>,
        <https://1145.am/db/572097/Menlo_Ventures>,
        <https://1145.am/db/572097/Teneleven_Ventures>,
        <https://1145.am/db/575249/TCV>,
        <https://1145.am/db/576186/Konvoy_Ventures>,
        <https://1145.am/db/577120/Index_Ventures>,
        <https://1145.am/db/586525/Tenoneten_Ventures>,
        <https://1145.am/db/587038/Coparion>,
        <https://1145.am/db/591566/Morningside_Ventures>,
        <https://1145.am/db/596145/Anorak_Ventures>,
        <https://1145.am/db/596564/Anorak_Ventures>,
        <https://1145.am/db/601455/Morningside_Ventures>,
        <https://1145.am/db/603725/Ignitexl_Ventures>,
        <https://1145.am/db/606074/Fiscus_Ventures>,
        <https://1145.am/db/606144/Ggv_Capital>,
        <https://1145.am/db/615337/Companyon_Ventures>,
        <https://1145.am/db/619284/Scf_Ventures>,
        <https://1145.am/db/619366/Capital_One_Ventures>,
        <https://1145.am/db/619736/Lightspeed_Ventures>,
        <https://1145.am/db/623178/Array_Ventures>,
        <https://1145.am/db/625791/Sofinnova_Partners>,
        <https://1145.am/db/626781/Dnx_Ventures>,
        <https://1145.am/db/627030/Launchpad_Capital>,
        <https://1145.am/db/628654/Prologis_Ventures>,
        <https://1145.am/db/633238/True_Ventures>,
        <https://1145.am/db/633869/Skywell_Capital_Partners>,
        <https://1145.am/db/633869/Stageone_Ventures>,
        <https://1145.am/db/640939/Ggv_Capital>,
        <https://1145.am/db/642123/Charles_River_Ventures>,
        <https://1145.am/db/642518/Network_Ventures>,
        <https://1145.am/db/643600/Vinco_Ventures>,
        <https://1145.am/db/648552/True_Ventures>,
        <https://1145.am/db/659010/Index_Ventures>,
        <https://1145.am/db/659675/Gv>,
        <https://1145.am/db/661747/Adit_Ventures>,
        <https://1145.am/db/661818/Index_Ventures>,
        <https://1145.am/db/665129/Ac_Ventures>,
        <https://1145.am/db/665776/Firstime_Ventures>,
        <https://1145.am/db/676217/Steelsky_Ventures>,
        <https://1145.am/db/676869/Ggv_Capital>,
        <https://1145.am/db/678140/Ggv_Capital>,
        <https://1145.am/db/678587/Lightshed_Ventures>,
        <https://1145.am/db/678593/Solana_Ventures>,
        <https://1145.am/db/687538/Kayyak_Ventures>,
        <https://1145.am/db/689460/True_Ventures>,
        <https://1145.am/db/694513/Authentic_Ventures>,
        <https://1145.am/db/694924/Avid_Ventures>,
        <https://1145.am/db/700171/Sequoia_Capital>,
        <https://1145.am/db/700327/Menlo_Ventures>,
        <https://1145.am/db/700877/Gaingels>,
        <https://1145.am/db/703983/Eqventure>,
        <https://1145.am/db/704489/Eqventure>,
        <https://1145.am/db/704753/Felicis_Ventures>,
        <https://1145.am/db/704753/Menlo_Ventures>,
        <https://1145.am/db/704793/Quidnet_Ventures>,
        <https://1145.am/db/704991/Gaingels>,
        <https://1145.am/db/709633/Connetic_Ventures>,
        <https://1145.am/db/726461/Contour_Ventures>,
        <https://1145.am/db/729628/Kyber_Ventures>,
        <https://1145.am/db/729628/Signum_Capital>,
        <https://1145.am/db/738920/Oca_Ventures>,
        <https://1145.am/db/738920/Susa_Ventures>,
        <https://1145.am/db/739538/Morpheus_Ventures>,
        <https://1145.am/db/739538/Oca_Ventures>,
        <https://1145.am/db/739538/Susa_Ventures>,
        <https://1145.am/db/747051/Tenoneten_Ventures>,
        <https://1145.am/db/747771/Ta_Ventures>,
        <https://1145.am/db/749147/1984_Ventures>,
        <https://1145.am/db/749147/Index_Ventures>,
        <https://1145.am/db/749209/1984_Ventures>,
        <https://1145.am/db/749209/Index_Ventures>,
        <https://1145.am/db/750305/Yl_Ventures>,
        <https://1145.am/db/750725/Vestigo_Ventures>,
        <https://1145.am/db/751176/Maverick_Ventures>,
        <https://1145.am/db/751176/Susa_Ventures>,
        <https://1145.am/db/751387/Menlo_Ventures>,
        <https://1145.am/db/753120/Sequoia_Capital>,
        <https://1145.am/db/753251/Savantus_Ventures>,
        <https://1145.am/db/753913/Brunnur_Ventures>,
        <https://1145.am/db/755844/Sequoia_Capital>,
        <https://1145.am/db/758206/Great_North_Ventures>,
        <https://1145.am/db/758206/Grotech_Ventures>,
        <https://1145.am/db/759749/Cava_Capital>,
        <https://1145.am/db/763083/Gaingels>,
        <https://1145.am/db/764875/Rev1_Ventures>,
        <https://1145.am/db/764896/Rev1_Ventures>,
        <https://1145.am/db/765216/True_Ventures>,
        <https://1145.am/db/768172/Gaingels>,
        <https://1145.am/db/768172/Type_One_Ventures>,
        <https://1145.am/db/768349/Salesforce_Ventures>,
        <https://1145.am/db/768852/Felicis_Ventures>,
        <https://1145.am/db/769568/Axon_Ventures>,
        <https://1145.am/db/772099/Array_Ventures>,
        <https://1145.am/db/773235/Prelude_Ventures>,
        <https://1145.am/db/773684/Fulgur_Ventures>,
        <https://1145.am/db/773794/Array_Ventures>,
        <https://1145.am/db/778025/Felicis_Ventures>,
        <https://1145.am/db/778423/Sentiero_Ventures>,
        <https://1145.am/db/779637/Felicis_Ventures>,
        <https://1145.am/db/779867/Genesis_Block_Ventures>,
        <https://1145.am/db/780272/East_Ventures>,
        <https://1145.am/db/780289/East_Ventures>,
        <https://1145.am/db/783431/Cathay_Venture_Inc>,
        <https://1145.am/db/784093/Boldstart_Ventures>,
        <https://1145.am/db/787806/Boldstart_Ventures>,
        <https://1145.am/db/788016/Boldstart_Ventures>,
        <https://1145.am/db/791505/Index_Ventures>,
        <https://1145.am/db/796250/Sp_Ventures>,
        <https://1145.am/db/796629/Index_Ventures>,
        <https://1145.am/db/797597/Lansdowne_Partners>,
        <https://1145.am/db/798095/Index_Ventures>,
        <https://1145.am/db/798753/Sofinnova_Partners>,
        <https://1145.am/db/800093/Sequoia_Capital>,
        <https://1145.am/db/800101/Gaingels>,
        <https://1145.am/db/803541/Credo_Ventures>,
        <https://1145.am/db/803541/Index_Ventures>,
        <https://1145.am/db/803541/Sequoia_Capital>,
        <https://1145.am/db/8045/Greatpoint_Ventures>,
        <https://1145.am/db/806828/Promus_Ventures>,
        <https://1145.am/db/806994/Companyon_Ventures>,
        <https://1145.am/db/807080/K3_Ventures>,
        <https://1145.am/db/808020/Starlight_Ventures>,
        <https://1145.am/db/808020/Valo_Ventures>,
        <https://1145.am/db/8146/Rev1_Ventures>,
        <https://1145.am/db/817162/Orbia_Ventures>,
        <https://1145.am/db/818444/1984_Ventures>,
        <https://1145.am/db/821135/Se_Ventures>,
        <https://1145.am/db/823763/Infinity_Ventures>,
        <https://1145.am/db/828716/Idc_Ventures>,
        <https://1145.am/db/829118/Salesforce_Ventures>,
        <https://1145.am/db/830571/Company_Ventures>,
        <https://1145.am/db/830689/Soleus_Capital>,
        <https://1145.am/db/832264/Salesforce_Ventures>,
        <https://1145.am/db/832573/Solasta_Ventures>,
        <https://1145.am/db/834864/Ggv_Capital>,
        <https://1145.am/db/834864/K3_Ventures>,
        <https://1145.am/db/836848/Technexus_Venture_Collaborative>,
        <https://1145.am/db/836908/Frontier_Ventures>,
        <https://1145.am/db/837034/Redpoint_Ventures>,
        <https://1145.am/db/838138/Root_Ventures>,
        <https://1145.am/db/838181/Sequoia_Capital>,
        <https://1145.am/db/838691/Crosslink_Capital>,
        <https://1145.am/db/847157/Signum_Capital>,
        <https://1145.am/db/847862/Wise_Ventures>,
        <https://1145.am/db/854001/Gv>,
        <https://1145.am/db/854589/Verance_Capital>,
        <https://1145.am/db/854654/Mrtnz_Ventures>,
        <https://1145.am/db/854795/Menlo_Ventures>,
        <https://1145.am/db/867865/Applied_Ventures>,
        <https://1145.am/db/868093/Cobro_Ventures>,
        <https://1145.am/db/869652/Forever_Ventures>,
        <https://1145.am/db/874394/Nextview_Ventures>,
        <https://1145.am/db/874394/True_Ventures>,
        <https://1145.am/db/880050/Crosslink_Capital>,
        <https://1145.am/db/881298/At_One_Ventures>,
        <https://1145.am/db/882723/At_One_Ventures>,
        <https://1145.am/db/884787/Foresite_Capital>,
        <https://1145.am/db/884787/Gv>,
        <https://1145.am/db/884787/Northpond_Ventures>,
        <https://1145.am/db/886445/Gv>,
        <https://1145.am/db/887062/Panoramic_Ventures>,
        <https://1145.am/db/889246/At_One_Ventures>,
        <https://1145.am/db/890271/Panoramic_Ventures>,
        <https://1145.am/db/891162/Emergingvc>,
        <https://1145.am/db/891162/Launchpad_Venture_Group>,
        <https://1145.am/db/903689/Vectr_Ventures>,
        <https://1145.am/db/904276/Nextview_Ventures>,
        <https://1145.am/db/906393/East_Ventures>,
        <https://1145.am/db/907844/Argon_Ventures>,
        <https://1145.am/db/907844/Glasswing_Ventures>,
        <https://1145.am/db/913422/Sequoia_Capital>,
        <https://1145.am/db/913678/Sandbridge_Capital>,
        <https://1145.am/db/919636/Menlo_Ventures>,
        <https://1145.am/db/921704/Scop_Ventures>,
        <https://1145.am/db/92200/Knoll_Ventures>,
        <https://1145.am/db/922066/Irrvrnt_Vc>,
        <https://1145.am/db/922192/Gv>,
        <https://1145.am/db/922498/Sozo_Ventures>,
        <https://1145.am/db/923723/Scop_Ventures>,
        <https://1145.am/db/928711/Frontline_Ventures>,
        <https://1145.am/db/934946/Ggv_Capital>,
        <https://1145.am/db/935046/Origin_Ventures>,
        <https://1145.am/db/935249/Victress_Capital>,
        <https://1145.am/db/935322/Alpana_Ventures>,
        <https://1145.am/db/935322/M_Ventures>,
        <https://1145.am/db/935796/Salesforce_Ventures>,
        <https://1145.am/db/935962/Digitalbridge_Ventures>,
        <https://1145.am/db/936045/Lpc_Ventures>,
        <https://1145.am/db/936057/Noemis_Ventures>,
        <https://1145.am/db/936154/Salesforce_Ventures>,
        <https://1145.am/db/936448/Ggv_Capital>,
        <https://1145.am/db/936862/Lool_Ventures>,
        <https://1145.am/db/936906/Neotribe_Ventures>,
        <https://1145.am/db/937210/Citi_Ventures>,
        <https://1145.am/db/937210/Firebolt_Ventures>,
        <https://1145.am/db/937460/Sequoia_Capital>,
        <https://1145.am/db/938108/Conti_Ventures>,
        <https://1145.am/db/938555/Digitalbridge_Ventures>,
        <https://1145.am/db/938586/Venturesouth>,
        <https://1145.am/db/938921/Redpoint_Ventures>,
        <https://1145.am/db/938975/Ggv_Capital>,
        <https://1145.am/db/939163/Goodyear_Ventures>,
        <https://1145.am/db/940740/Agnc_Ventures>,
        <https://1145.am/db/940913/True_Ventures>,
        <https://1145.am/db/941816/Radical_Ventures>,
        <https://1145.am/db/942825/Argon_Ventures>,
        <https://1145.am/db/946710/Citi_Ventures>,
        <https://1145.am/db/947238/Kyros_Ventures>,
        <https://1145.am/db/952434/Verissimo_Ventures>,
        <https://1145.am/db/955201/Gv>,
        <https://1145.am/db/960022/Verance_Capital>,
        <https://1145.am/db/961837/Sequoia_Capital>,
        <https://1145.am/db/962622/Sequoia_Capital>,
        <https://1145.am/db/970950/Ulu_Ventures>,
        <https://1145.am/db/971415/Altai_Ventures>,
        <https://1145.am/db/971450/Allon_Ventures>,
        <https://1145.am/db/971939/Formic_Ventures>,
        <https://1145.am/db/975114/Formic_Ventures>,
        <https://1145.am/db/979753/Menlo_Ventures>,
        <https://1145.am/db/980678/Menlo_Ventures>,
        <https://1145.am/db/984645/Vinco_Ventures>,
        <https://1145.am/db/987688/Brightspark_Ventures>,
        <https://1145.am/db/987700/Infinityvc>,
        <https://1145.am/db/988084/Abstract_Ventures>,
        <https://1145.am/db/988084/Blank_Ventures>,
        <https://1145.am/db/988318/Arthur_Ventures>,
        <https://1145.am/db/988482/Brightspark_Ventures>,
        <https://1145.am/db/988979/Infinityvc>,
        <https://1145.am/db/989392/Arthur_Ventures>,
        <https://1145.am/db/990085/Radical_Ventures>,
        <https://1145.am/db/995593/Raiven_Capital>,
        <https://1145.am/db/995737/Nuoyan_Capital>,
        <https://1145.am/db/996563/Raiven_Capital> ;
    ns1:sameAsMedium <https://1145.am/db/2289229/Pappas_Ventures>,
        <https://1145.am/db/2305706/Pappas_Ventures>,
        <https://1145.am/db/2305713/Pappas_Ventures>,
        <https://1145.am/db/2308329/Pappas_Ventures>,
        <https://1145.am/db/2312277/Pappas_Ventures>,
        <https://1145.am/db/2314492/Pappas_Ventures>,
        <https://1145.am/db/2319029/Pappas_Ventures>,
        <https://1145.am/db/2324289/Pappas_Ventures>,
        <https://1145.am/db/2328388/Pappas_Ventures>,
        <https://1145.am/db/2332753/Pappas_Ventures>,
        <https://1145.am/db/2341904/Pappas_Ventures>,
        <https://1145.am/db/2346542/Pappas_Ventures>,
        <https://1145.am/db/2350779/Pappas_Ventures>,
        <https://1145.am/db/2350780/Pappas_Ventures>,
        <https://1145.am/db/2352805/Pappas_Ventures>,
        <https://1145.am/db/2352808/Pappas_Ventures>,
        <https://1145.am/db/2354537/Pappas_Ventures>,
        <https://1145.am/db/2354540/Pappas_Ventures>,
        <https://1145.am/db/2355274/Pappas_Ventures>,
        <https://1145.am/db/2356216/Pappas_Ventures>,
        <https://1145.am/db/2539913/Pappas_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2364127/Acquisition_Clinipace_Worldwide_Paragon_Biomedical_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition" ;
    ns1:documentDate "2012-09-26T04:01:15+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Clinipace Worldwide, a, and Paragon Biomedical, Inc., a, today jointly announced a definitive merger agreement under which Clinipace Worldwide has acquired all outstanding shares of the privately-held, Irvine, CA - based company and its subsidiaries." ;
    ns1:documentTitle "Clinipace Worldwide Acquires Paragon Biomedical, Inc." ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/clinipace-worldwide-acquires-paragon-biomedical-inc> ;
    ns1:foundName "merger" ;
    ns1:name "merger" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:whereGeoName "Irvine" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5359777/about.rdf> ;
    ns1:whereRaw "Irvine, CA" .

<https://1145.am/db/2365032/B_Investment_Biophytis_Cm-Cic_Capital_Prive_Metabrain_Research_Seventure_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-01T19:25:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Biophytis completes a EUR two million B round financing.",
        "Paris, October 1, 2012 - Biophytis, a research company in health and nutrition focusing on metabolic disorders and age-related diseases, announces today that it has raised EUR two million (USD 2.6M) in a B round." ;
    ns1:documentTitle "Biophytis completes a EUR two million B round financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biophytis-completes-a-eur-two-million-b-round-financing> ;
    ns1:foundName "financing",
        "raised" ;
    ns1:name "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2365032/Biophytis> ;
    ns1:targetDetails "B" ;
    ns1:valueRaw "EUR two million",
        "USD 2.6M" ;
    ns1:when "2012-10-01T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 1, 2012" ;
    ns1:whereGeoName "Europe" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6255148/about.rdf> ;
    ns1:whereRaw "Europe" .

<https://1145.am/db/2546216/Cvf_Llc> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "CVF, LLC" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "CVF, LLC" ;
    ns1:sameAsHigh <https://1145.am/db/1751697/Idcv>,
        <https://1145.am/db/2337571/Cvf_Llc>,
        <https://1145.am/db/2337577/Cvf_Llc> ;
    ns1:sameAsMedium <https://1145.am/db/2348440/CVF>,
        <https://1145.am/db/2348448/Cvf_Llc>,
        <https://1145.am/db/2356420/Cvf_Llc> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546216/Genocea_Biosciences> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, MA" ;
    ns1:description "T cell vaccines" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Genocea",
        "Genocea Biosciences, Inc." ;
    ns1:name "Genocea Biosciences" ;
    ns1:sameAsHigh <https://1145.am/db/2337577/Genocea_Biosciences> ;
    ns1:sameAsMedium <https://1145.am/db/2303707/Genocea_Biosciences>,
        <https://1145.am/db/2311583/Genocea_Biosciences>,
        <https://1145.am/db/2329579/Genocea_Biosciences>,
        <https://1145.am/db/2330601/Genocea_Biosciences>,
        <https://1145.am/db/2331763/Genocea_Biosciences>,
        <https://1145.am/db/2331777/Genocea_Biosciences>,
        <https://1145.am/db/2336889/Genocea_Biosciences>,
        <https://1145.am/db/2337571/Genocea_Biosciences>,
        <https://1145.am/db/2341844/Genocea_Biosciences>,
        <https://1145.am/db/2342398/Genocea_Biosciences_Inc>,
        <https://1145.am/db/2351839/Genocea_Biosciences>,
        <https://1145.am/db/2351840/Genocea_Biosciences>,
        <https://1145.am/db/2353970/Genocea_Biosciences>,
        <https://1145.am/db/2363551/Genocea_Biosciences>,
        <https://1145.am/db/2365296/Genocea_Biosciences_Inc>,
        <https://1145.am/db/2536127/Genocea_Biosciences>,
        <https://1145.am/db/2536128/Genocea_Biosciences_Inc>,
        <https://1145.am/db/2546218/Genocea_Biosciences>,
        <https://1145.am/db/2555579/Genocea_Biosciences>,
        <https://1145.am/db/470251/Genocea_Biosciences>,
        <https://1145.am/db/883613/Genocea_Biosciences> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546216/Lux_Capital> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Lux",
        "Lux Capital" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Lux Capital" ;
    ns1:sameAsMedium <https://1145.am/db/1105217/Lux_Capital>,
        <https://1145.am/db/1106865/Lux_Capital>,
        <https://1145.am/db/1119433/Lux_Capital>,
        <https://1145.am/db/1119661/Lux_Capital>,
        <https://1145.am/db/1122753/Lux_Capital>,
        <https://1145.am/db/1139654/Lux_Capital>,
        <https://1145.am/db/1143903/Lux_Capital>,
        <https://1145.am/db/1238486/Lux_Capital>,
        <https://1145.am/db/1285901/Lux_Capital>,
        <https://1145.am/db/1374025/Lux_Capital>,
        <https://1145.am/db/1375318/Lux_Capital>,
        <https://1145.am/db/1376203/Lux_Capital>,
        <https://1145.am/db/1407553/Lux_Capital>,
        <https://1145.am/db/1536915/Lux_Capital>,
        <https://1145.am/db/1553919/Lux_Capital>,
        <https://1145.am/db/1555013/Lux_Capital>,
        <https://1145.am/db/1632690/Lux_Capital>,
        <https://1145.am/db/1669908/Lux_Capital>,
        <https://1145.am/db/1697296/Lux_Capital>,
        <https://1145.am/db/1734597/Lux_Capital>,
        <https://1145.am/db/1737151/Lux_Capital>,
        <https://1145.am/db/1737409/Lux_Capital>,
        <https://1145.am/db/174200/Lux_Capital>,
        <https://1145.am/db/1743303/Lux_Capital>,
        <https://1145.am/db/1758194/Lux_Capital>,
        <https://1145.am/db/1761607/Lux_Capital>,
        <https://1145.am/db/1762041/Lux_Capital>,
        <https://1145.am/db/1763354/Lux_Capital>,
        <https://1145.am/db/1766887/Lux_Capital>,
        <https://1145.am/db/1777184/Lux_Capital>,
        <https://1145.am/db/1782221/Lux_Capital>,
        <https://1145.am/db/1792186/Lux_Capital>,
        <https://1145.am/db/1796593/Lux_Capital>,
        <https://1145.am/db/1803458/Lux_Capital>,
        <https://1145.am/db/1808133/Lux_Capital>,
        <https://1145.am/db/1809178/Lux_Capital>,
        <https://1145.am/db/1811725/Lux_Capital>,
        <https://1145.am/db/1815044/Lux_Capital>,
        <https://1145.am/db/1817051/Lux_Capital>,
        <https://1145.am/db/1818204/Lux_Capital>,
        <https://1145.am/db/1819710/Lux_Capital>,
        <https://1145.am/db/1827904/Lux_Capital>,
        <https://1145.am/db/1829422/Lux_Capital>,
        <https://1145.am/db/1838965/Lux_Capital>,
        <https://1145.am/db/1845217/Lux_Capital>,
        <https://1145.am/db/1846254/Lux_Capital>,
        <https://1145.am/db/1930816/Lux_Capital>,
        <https://1145.am/db/1932856/Lux_Capital>,
        <https://1145.am/db/2006781/Lux_Capital>,
        <https://1145.am/db/2138013/Lux_Capital>,
        <https://1145.am/db/2141058/Lux_Capital>,
        <https://1145.am/db/2178040/Lux_Capital>,
        <https://1145.am/db/2284256/Lux_Capital>,
        <https://1145.am/db/2291716/Lux_Capital>,
        <https://1145.am/db/2291901/Lux_Capital>,
        <https://1145.am/db/2303675/Lux_Capital>,
        <https://1145.am/db/2304963/Lux_Capital>,
        <https://1145.am/db/2305327/Lux_Capital>,
        <https://1145.am/db/2328280/Lux_Capital>,
        <https://1145.am/db/2331549/Lux_Capital>,
        <https://1145.am/db/2335750/Lux_Capital>,
        <https://1145.am/db/2335755/Lux_Capital>,
        <https://1145.am/db/2337522/Lux_Capital>,
        <https://1145.am/db/2337571/Lux_Capital>,
        <https://1145.am/db/2337577/Lux_Capital>,
        <https://1145.am/db/2344256/Lux_Capital>,
        <https://1145.am/db/2345224/Lux_Capital>,
        <https://1145.am/db/2345439/Lux_Capital>,
        <https://1145.am/db/2347102/Lux_Capital>,
        <https://1145.am/db/2348448/Lux_Capital>,
        <https://1145.am/db/2352414/Lux_Capital>,
        <https://1145.am/db/2633440/Lux_Capital>,
        <https://1145.am/db/2801014/Lux_Capital>,
        <https://1145.am/db/412847/Lux_Capital>,
        <https://1145.am/db/424834/Lux_Capital>,
        <https://1145.am/db/425188/Lux_Capital>,
        <https://1145.am/db/425281/Lux_Capital>,
        <https://1145.am/db/426160/Lux_Capital>,
        <https://1145.am/db/516176/Lux_Capital>,
        <https://1145.am/db/516613/Lux_Capital>,
        <https://1145.am/db/540507/Lux_Capital>,
        <https://1145.am/db/684792/Lux_Capital>,
        <https://1145.am/db/747771/Lux_Capital>,
        <https://1145.am/db/765641/Lux_Capital>,
        <https://1145.am/db/823763/Lux_Capital>,
        <https://1145.am/db/863878/Lux_Capital>,
        <https://1145.am/db/918904/Lux_Capital>,
        <https://1145.am/db/935910/Lux_Capital>,
        <https://1145.am/db/936989/Lux_Capital>,
        <https://1145.am/db/940684/Lux_Capital> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2546216/The_Bill___Melinda_Gates_Foundation> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "The Bill & Melinda Gates Foundation" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "The Bill & Melinda Gates Foundation" ;
    ns1:sameAsMedium <https://1145.am/db/1082053/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1223116/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1291634/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1428798/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1534279/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1577330/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1690821/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/1807438/Bill_And_Melinda_Gates_Foundation>,
        <https://1145.am/db/1981265/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2281246/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2287006/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2293727/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2316514/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2317981/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2331329/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2337571/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2337577/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2338383/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2340643/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2340646/Thebill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2345880/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2347102/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2347301/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2353832/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2353834/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2367621/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/2578745/The_Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/360780/Bill_And_Melinda_Gates_Foundation>,
        <https://1145.am/db/463585/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/703895/Bill___Melinda_Gates_Foundation>,
        <https://1145.am/db/796790/Bill___Melinda_Gates_Foundation> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2575232/Aerpio_Therapeutics> a org:Organization ;
    ns1:description "Biomedical" ;
    ns1:documentDate "2012-08-30T13:09:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Aerpio Therapeutics" ;
    ns1:industry "biopharmaceutical" ;
    ns1:name "Aerpio Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1140338/Aerami_Therapeutics>,
        <https://1145.am/db/2312285/Arriva_Pharmaceuticals>,
        <https://1145.am/db/2335764/Aerpio_Therapeutics>,
        <https://1145.am/db/2354752/Aerpio_Therapeutics>,
        <https://1145.am/db/2354770/Aerpio_Therapeutics>,
        <https://1145.am/db/2368807/Erytech_Pharma>,
        <https://1145.am/db/2369836/Erytech_Pharma>,
        <https://1145.am/db/432278/Aerpio_Pharmaceuticals> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2575232/Agechem_Venture_Fund> a org:Organization ;
    ns1:description "advancing innovative therapies for vascular diseases" ;
    ns1:documentDate "2012-08-30T13:09:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "AgeChem Venture Fund" ;
    ns1:investor <https://1145.am/db/2575232/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "AgeChem Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/2354770/Agechem_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2305729/Agechem_Venture_Fund>,
        <https://1145.am/db/2328030/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2328034/Agechem_Venture_Fund_Lp>,
        <https://1145.am/db/2345002/Agechem_Venture_Fund>,
        <https://1145.am/db/2346534/Agechem_Venture_Fund>,
        <https://1145.am/db/2346542/Agechem_Venture_Fund>,
        <https://1145.am/db/2354752/Agechem_Venture_Fund>,
        <https://1145.am/db/2358031/Agechem_Venture_Fund>,
        <https://1145.am/db/2367046/Agechem_Venture_Fund>,
        <https://1145.am/db/2367047/Agechem_Venture_Fund> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2594303/Somaxon_Pharmaceuticals_Acquisition> a ns1:CorporateFinanceActivity ;
    ns1:activityType "acquisition",
        "merger" ;
    ns1:documentDate "2012-12-11T14:50:31+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc.",
        "THE WOODLANDS, Texas, and SAN DIEGO, Dec. 11, 2012 - Pernix Therapeutics Holdings, Inc. (\"Pernix\") (NYSE MKT: PTX) and Somaxon Pharmaceuticals, Inc. (\"Somaxon\") (Nasdaq: SOMX) today announced that they have entered into a definitive merger agreement for Pernix to acquire Somaxon in a stock-for-stock transaction with a total equity value of $ 25 million." ;
    ns1:documentTitle "Pernix Therapeutics Announces Agreement to Acquire Somaxon Pharmaceuticals, Inc." ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/pernix-therapeutics-announces-agreement-to-acquire-somaxon-pharmaceuticals-inc> ;
    ns1:foundName "Acquire",
        "acquire",
        "merger" ;
    ns1:name "Acquire",
        "acquire",
        "merger" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2594303/Somaxon_Pharmaceuticals> ;
    ns1:targetName "Somaxon Pharmaceuticals" ;
    ns1:valueRaw "$ 25 Million",
        "$ 25 million" ;
    ns1:whereGeoName "Eastern Province",
        "San Diego County" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391832/about.rdf>,
        <https://sws.geonames.org/6413337/about.rdf> ;
    ns1:whereRaw "EST",
        "SAN DIEGO" .

<https://1145.am/db/2334847/Flagship_Ventures> a org:Organization ;
    ns1:basedInLowRaw "WATERTOWN, MA" ;
    ns1:documentDate "2012-12-18T21:04:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/blend-therapeutics-closes-16-million-series-b-financing> ;
    ns1:foundName "Flagship Ventures" ;
    ns1:investor <https://1145.am/db/2334847/Series_B_Investment_Blend_Therapeutics_Flagship_Ventures_Nanodimension_New_Enterprise_Associates_Completed> ;
    ns1:name "Flagship Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2288209/Flagship_Ventures>,
        <https://1145.am/db/2292800/Flagship_Ventures>,
        <https://1145.am/db/2298439/Flagship_Ventures>,
        <https://1145.am/db/2302116/Flagship_Ventures>,
        <https://1145.am/db/2304650/Flagship_Ventures>,
        <https://1145.am/db/2306790/Flagship_Ventures>,
        <https://1145.am/db/2308952/Flagship_Ventures>,
        <https://1145.am/db/2308959/Flagship_Ventures>,
        <https://1145.am/db/2313305/Flagship_Ventures>,
        <https://1145.am/db/2314964/Flagship_Ventures>,
        <https://1145.am/db/2315931/Flagship_Ventures>,
        <https://1145.am/db/2315933/Flagship_Ventures>,
        <https://1145.am/db/2317918/Flagship_Ventures>,
        <https://1145.am/db/2321150/Flagship_Ventures>,
        <https://1145.am/db/2324431/Flagship_Ventures>,
        <https://1145.am/db/2339413/Flagship_Ventures>,
        <https://1145.am/db/2341599/Flagship_Ventures>,
        <https://1145.am/db/2343592/Flagship_Ventures>,
        <https://1145.am/db/2343595/Flagship_Ventures>,
        <https://1145.am/db/2346988/Flagship_Ventures>,
        <https://1145.am/db/2347102/Flagship_Ventures>,
        <https://1145.am/db/2348074/Flagship_Ventures>,
        <https://1145.am/db/2354351/Flagship_Ventures>,
        <https://1145.am/db/2354608/Flagship_Ventures>,
        <https://1145.am/db/2354613/Flagship_Ventures>,
        <https://1145.am/db/2354806/Flagship_Ventures>,
        <https://1145.am/db/2356730/Flagship_Ventures>,
        <https://1145.am/db/2356732/Flagship_Ventures>,
        <https://1145.am/db/2358234/Flagship_Ventures>,
        <https://1145.am/db/2358487/Flagship_Ventures>,
        <https://1145.am/db/2358506/Flagship_Ventures>,
        <https://1145.am/db/2358529/Flagship_Ventures>,
        <https://1145.am/db/2359287/Flagship_Ventures>,
        <https://1145.am/db/2366654/Flagship_Ventures>,
        <https://1145.am/db/2367381/Flagship_Ventures>,
        <https://1145.am/db/2367588/Flagship_Ventures>,
        <https://1145.am/db/2368493/Flagship_Ventures>,
        <https://1145.am/db/2369549/Flagship_Ventures>,
        <https://1145.am/db/2634324/Flagship_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "SAN DIEGO" ;
    ns1:description "Hormone-Driven Cancers" ;
    ns1:documentDate "2012-10-04T15:06:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-1> ;
    ns1:foundName "Aragon Pharmaceuticals",
        "Aragon Pharmaceuticals Inc",
        "Aragon Pharmaceuticals Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Aragon Pharmaceuticals",
        "Aragon Pharmaceuticals Inc",
        "Aragon Pharmaceuticals Inc." ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/PharmajetÂ®>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/PharmajetÂ®>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/742794/HrÂ®_Pharmaceuticals_Inc>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/ThÃ©a_Pharma>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2342188/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2352698/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2574227/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2584814/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2592534/Aragon_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336503/Orbimed_Advisors> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:06:27+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-1> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:investor <https://1145.am/db/2336503/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsMedium <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc> a org:Organization ;
    ns1:basedInHighGeoName "San Diego County" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/5391832/about.rdf> ;
    ns1:basedInHighRaw "SAN DIEGO" ;
    ns1:description "Hormone-Driven Cancers",
        "Pharmaceuticals" ;
    ns1:documentDate "2012-10-04T15:29:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-0> ;
    ns1:foundName "Aragon Pharmaceuticals",
        "Aragon Pharmaceuticals Inc",
        "Aragon Pharmaceuticals Inc." ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Aragon Pharmaceuticals",
        "Aragon Pharmaceuticals Inc",
        "Aragon Pharmaceuticals Inc." ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/PharmajetÂ®>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/PharmajetÂ®>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/742794/HrÂ®_Pharmaceuticals_Inc>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/ThÃ©a_Pharma>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2342188/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2352698/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2574227/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2584814/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2592534/Aragon_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2336505/Orbimed_Advisors> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:documentDate "2012-10-04T15:29:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-0> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:investor <https://1145.am/db/2336505/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsMedium <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337571/Sr_One> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "SR One" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "SR One" ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Sr_One>,
        <https://1145.am/db/1334624/Sr_One>,
        <https://1145.am/db/1949427/Sr_One>,
        <https://1145.am/db/2095130/Sr_One>,
        <https://1145.am/db/2110113/Sr_One>,
        <https://1145.am/db/2280707/Sr_One>,
        <https://1145.am/db/2305791/Sr_One>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2317951/Sr_One>,
        <https://1145.am/db/2318310/Sr_One>,
        <https://1145.am/db/2326222/Sr_One_Ltd>,
        <https://1145.am/db/2327305/Sr_One>,
        <https://1145.am/db/2327488/Sr_One_Ltd>,
        <https://1145.am/db/2331763/Sr_One>,
        <https://1145.am/db/2336328/Sr_One>,
        <https://1145.am/db/2337577/Sr_One>,
        <https://1145.am/db/2340096/Sr_One>,
        <https://1145.am/db/2341904/Sr_One>,
        <https://1145.am/db/2342084/Sr_One>,
        <https://1145.am/db/2342983/Sr_One>,
        <https://1145.am/db/2343301/Sr_One>,
        <https://1145.am/db/2345675/Sr_One>,
        <https://1145.am/db/2347482/Sr_One>,
        <https://1145.am/db/2347594/Sr_One>,
        <https://1145.am/db/2349233/Sr_One>,
        <https://1145.am/db/2350030/Sr_One>,
        <https://1145.am/db/2350364/Sr_One>,
        <https://1145.am/db/2353917/Sr_One>,
        <https://1145.am/db/2356402/Sr_One>,
        <https://1145.am/db/2356411/Sr_One>,
        <https://1145.am/db/2357676/Sr_One>,
        <https://1145.am/db/2357679/Sr_One>,
        <https://1145.am/db/2357682/Sr_One>,
        <https://1145.am/db/2358430/Sr_One>,
        <https://1145.am/db/2358860/Sr_One>,
        <https://1145.am/db/2359334/Sr_One>,
        <https://1145.am/db/2362533/Sr_One>,
        <https://1145.am/db/2362715/Sr_One>,
        <https://1145.am/db/2363947/Sr_One>,
        <https://1145.am/db/2363950/Sr_One>,
        <https://1145.am/db/2365103/Sr_One>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365105/Sr_One>,
        <https://1145.am/db/2365296/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2367549/Sr_One>,
        <https://1145.am/db/2368501/Sr_One>,
        <https://1145.am/db/2371191/Sr_One>,
        <https://1145.am/db/2371304/Sr_One>,
        <https://1145.am/db/2544138/Sr_One>,
        <https://1145.am/db/2544140/Sr_One>,
        <https://1145.am/db/2546216/Sr_One>,
        <https://1145.am/db/2573068/Sr_One>,
        <https://1145.am/db/2595958/Sr_One> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Sr_One> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "SR One" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "SR One" ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Sr_One>,
        <https://1145.am/db/1334624/Sr_One>,
        <https://1145.am/db/1949427/Sr_One>,
        <https://1145.am/db/2095130/Sr_One>,
        <https://1145.am/db/2110113/Sr_One>,
        <https://1145.am/db/2280707/Sr_One>,
        <https://1145.am/db/2305791/Sr_One>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2317951/Sr_One>,
        <https://1145.am/db/2318310/Sr_One>,
        <https://1145.am/db/2326222/Sr_One_Ltd>,
        <https://1145.am/db/2327305/Sr_One>,
        <https://1145.am/db/2327488/Sr_One_Ltd>,
        <https://1145.am/db/2331763/Sr_One>,
        <https://1145.am/db/2336328/Sr_One>,
        <https://1145.am/db/2337571/Sr_One>,
        <https://1145.am/db/2340096/Sr_One>,
        <https://1145.am/db/2341904/Sr_One>,
        <https://1145.am/db/2342084/Sr_One>,
        <https://1145.am/db/2342983/Sr_One>,
        <https://1145.am/db/2343301/Sr_One>,
        <https://1145.am/db/2345675/Sr_One>,
        <https://1145.am/db/2347482/Sr_One>,
        <https://1145.am/db/2347594/Sr_One>,
        <https://1145.am/db/2349233/Sr_One>,
        <https://1145.am/db/2350030/Sr_One>,
        <https://1145.am/db/2350364/Sr_One>,
        <https://1145.am/db/2353917/Sr_One>,
        <https://1145.am/db/2356402/Sr_One>,
        <https://1145.am/db/2356411/Sr_One>,
        <https://1145.am/db/2357676/Sr_One>,
        <https://1145.am/db/2357679/Sr_One>,
        <https://1145.am/db/2357682/Sr_One>,
        <https://1145.am/db/2358430/Sr_One>,
        <https://1145.am/db/2358860/Sr_One>,
        <https://1145.am/db/2359334/Sr_One>,
        <https://1145.am/db/2362533/Sr_One>,
        <https://1145.am/db/2362715/Sr_One>,
        <https://1145.am/db/2363947/Sr_One>,
        <https://1145.am/db/2363950/Sr_One>,
        <https://1145.am/db/2365103/Sr_One>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365105/Sr_One>,
        <https://1145.am/db/2365296/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2367549/Sr_One>,
        <https://1145.am/db/2368501/Sr_One>,
        <https://1145.am/db/2371191/Sr_One>,
        <https://1145.am/db/2371304/Sr_One>,
        <https://1145.am/db/2544138/Sr_One>,
        <https://1145.am/db/2544140/Sr_One>,
        <https://1145.am/db/2546216/Sr_One>,
        <https://1145.am/db/2573068/Sr_One>,
        <https://1145.am/db/2595958/Sr_One> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2341904/Sr_One> a org:Organization ;
    ns1:basedInLowRaw "Canada" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "SR One" ;
    ns1:investor <https://1145.am/db/2341904/Investment_Advanced_Technology_Ventures_Fonds_De_SolidaritÃ©_Ftq_Gsk_Canada_Life_Sciences_Innovation_Fund_Lumira_Capital_Mp_Healthcare_Venture_Management_Pappas_Ventures_Sr_One_Sw_Co_Thrasos_Therapeutics_Completed> ;
    ns1:name "SR One" ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Sr_One>,
        <https://1145.am/db/1334624/Sr_One>,
        <https://1145.am/db/1949427/Sr_One>,
        <https://1145.am/db/2095130/Sr_One>,
        <https://1145.am/db/2110113/Sr_One>,
        <https://1145.am/db/2280707/Sr_One>,
        <https://1145.am/db/2305791/Sr_One>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2317951/Sr_One>,
        <https://1145.am/db/2318310/Sr_One>,
        <https://1145.am/db/2326222/Sr_One_Ltd>,
        <https://1145.am/db/2327305/Sr_One>,
        <https://1145.am/db/2327488/Sr_One_Ltd>,
        <https://1145.am/db/2331763/Sr_One>,
        <https://1145.am/db/2336328/Sr_One>,
        <https://1145.am/db/2337571/Sr_One>,
        <https://1145.am/db/2337577/Sr_One>,
        <https://1145.am/db/2340096/Sr_One>,
        <https://1145.am/db/2342084/Sr_One>,
        <https://1145.am/db/2342983/Sr_One>,
        <https://1145.am/db/2343301/Sr_One>,
        <https://1145.am/db/2345675/Sr_One>,
        <https://1145.am/db/2347482/Sr_One>,
        <https://1145.am/db/2347594/Sr_One>,
        <https://1145.am/db/2349233/Sr_One>,
        <https://1145.am/db/2350030/Sr_One>,
        <https://1145.am/db/2350364/Sr_One>,
        <https://1145.am/db/2353917/Sr_One>,
        <https://1145.am/db/2356402/Sr_One>,
        <https://1145.am/db/2356411/Sr_One>,
        <https://1145.am/db/2357676/Sr_One>,
        <https://1145.am/db/2357679/Sr_One>,
        <https://1145.am/db/2357682/Sr_One>,
        <https://1145.am/db/2358430/Sr_One>,
        <https://1145.am/db/2358860/Sr_One>,
        <https://1145.am/db/2359334/Sr_One>,
        <https://1145.am/db/2362533/Sr_One>,
        <https://1145.am/db/2362715/Sr_One>,
        <https://1145.am/db/2363947/Sr_One>,
        <https://1145.am/db/2363950/Sr_One>,
        <https://1145.am/db/2365103/Sr_One>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365105/Sr_One>,
        <https://1145.am/db/2365296/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2367549/Sr_One>,
        <https://1145.am/db/2368501/Sr_One>,
        <https://1145.am/db/2371191/Sr_One>,
        <https://1145.am/db/2371304/Sr_One>,
        <https://1145.am/db/2544138/Sr_One>,
        <https://1145.am/db/2544140/Sr_One>,
        <https://1145.am/db/2546216/Sr_One>,
        <https://1145.am/db/2573068/Sr_One>,
        <https://1145.am/db/2595958/Sr_One> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342925/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "Venture Capital" ;
    ns1:documentDate "2012-10-29T15:15:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/principia-biopharma-secures-12-5m-second-tranche-series-a-financing-expands-senior-0> ;
    ns1:foundName "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2342925/Investment_Mission_Bay_Capital_Morgenthaler_Ventures_New_Leaf_Venture_Partners_Orbimed_Advisors_Principia_Biopharma_Srone_Completed> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2182517/New_Mountain_Capital>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347043/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347571/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348618/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2208603/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346532/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2349120/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350164/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350167/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350491/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2342925/Orbimed_Advisors> a org:Organization ;
    ns1:basedInLowRaw "SAN FRANCISCO" ;
    ns1:description "investing" ;
    ns1:documentDate "2012-10-29T15:15:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/principia-biopharma-secures-12-5m-second-tranche-series-a-financing-expands-senior-0> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:investor <https://1145.am/db/2342925/Investment_Mission_Bay_Capital_Morgenthaler_Ventures_New_Leaf_Venture_Partners_Orbimed_Advisors_Principia_Biopharma_Srone_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsHigh <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/2288529/Orbimed>,
        <https://1145.am/db/2297507/Orbimed>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2326176/Orbimed_Associates>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/912732/Orbimed> ;
    ns1:sameAsMedium <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343989/Series_B_Investment_Easton_Capital_New_Science_Ventures_Research_Foundation_Resolve_Therapeutics_Wrf_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-01T13:46:18+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Resolve Therapeutics Raises $ 5.8 Million in Private Financing.",
        "Seattle, WA - (November 1, 2012) - Resolve Therapeutics, LLC today announced that the company has raised $ 5.8 million in a Series B private-equity financing." ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing-0> ;
    ns1:foundName "Financing",
        "financing",
        "raised" ;
    ns1:name "Financing",
        "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2343989/Resolve_Therapeutics> ;
    ns1:targetDetails "Private",
        "Series B" ;
    ns1:valueRaw "$ 5.8 Million",
        "$ 5.8 million" ;
    ns1:when "2012-11-01T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "November 1, 2012" ;
    ns1:whereGeoName "Seattle" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5809844/about.rdf> ;
    ns1:whereRaw "Seattle" .

<https://1145.am/db/2344978/Series_B_Investment_Easton_Capital_New_Science_Ventures_Resolve_Therapeutics_Wrf_Capital_Washington_Research_Foundation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-02T04:00:44+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Resolve Therapeutics Raises $ 5.8 Million in Private Financing.",
        "Resolve Therapeutics, LLC today announced that the company has raised $ 5.8 million in a Series B private-equity financing." ;
    ns1:documentTitle "Resolve Therapeutics Raises $5.8 Million in Private Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/resolve-therapeutics-raises-5-8-million-private-financing> ;
    ns1:foundName "financing",
        "raised" ;
    ns1:name "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2344978/Resolve_Therapeutics> ;
    ns1:targetDetails "Series B",
        "private-equity" ;
    ns1:valueRaw "$ 5.8 Million",
        "$ 5.8 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2345002/Investment_Agechem_Venture_Fund_Alethia_Biotherapeutics_Inc_Bdc_Venture_Capital_Cellscript_Of_Wisconsin_Go_Capital_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-02T13:44:28+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Alethia Biotherapeutics Closes a $ 4.7 Million Financing to Advance its Bone Antiresorptive Program.",
        "MONTREAL, QUEBEC- (Marketwire - Nov. 1, 2012) - Alethia Biotherapeutics Inc., a privately held biotechnology company focusing on the development of therapeutic monoclonal antibodies announced today that it has closed a new financing." ;
    ns1:documentTitle "Alethia Biotherapeutics Closes a $4.7 Million Financing to Advance its Bone Antiresorptive Program" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/alethia-biotherapeutics-closes-a-4-7-million-financing-to-advance-its-bone-antiresorptive> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2345002/Alethia_Biotherapeutics_Inc> ;
    ns1:valueRaw "$ 4.7 Million" ;
    ns1:when "2012-11-01T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Nov. 1, 2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2346021/Psioxus_Therapeutics> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "Pharmaceuticals",
        "developing new drugs" ;
    ns1:documentDate "2012-11-06T05:01:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "(PsiOxus)",
        "PsiOxus Therapeutics" ;
    ns1:industry "Pharmaceutical",
        "biotechnology" ;
    ns1:name "(PsiOxus)",
        "PsiOxus Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1272117/Psioxus_Therapeutics>,
        <https://1145.am/db/1273078/Psioxus_Therapeutics>,
        <https://1145.am/db/2153714/Psioxus_Therapeutics>,
        <https://1145.am/db/2363801/Psioxus_Therapeutics>,
        <https://1145.am/db/2363802/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2365956/Psioxus_Therapeutics>,
        <https://1145.am/db/2547216/Oxford_England-Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2547216/Psioxus_Therapeutics>,
        <https://1145.am/db/2583115/Psioxus_Therapeutics>,
        <https://1145.am/db/2588827/Psioxus_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2354401/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2363947/Psioxus_Therapeutics>,
        <https://1145.am/db/2363950/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2544138/Psioxus_Therapeutics>,
        <https://1145.am/db/2544140/Psioxus_Therapeutics>,
        <https://1145.am/db/2580691/Psioxus_Therapeutics> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2346030/Orbimed_Advisors> a org:Organization ;
    ns1:basedInLowRaw "SAN DIEGO" ;
    ns1:description "Investing" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:investor <https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsHigh <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/2288529/Orbimed>,
        <https://1145.am/db/2297507/Orbimed>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2326176/Orbimed_Associates>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/912732/Orbimed> ;
    ns1:sameAsMedium <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2356420/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347043/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "San Diego" ;
    ns1:description "Venture Capital" ;
    ns1:documentDate "2012-11-07T16:22:25+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MEI Pharma Announces $27.5 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mei-pharma-announces-27-5-million-private-placement> ;
    ns1:foundName "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2347043/Investment_Mei_Pharma_New_Leaf_Venture_Partners_Ra_Capital_Management_Three_Arch_Opportunity_Fund_Vivo_Ventures_Has_Not_Happened> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2182517/New_Mountain_Capital>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342925/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347571/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348618/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2208603/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346532/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2349120/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350164/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350167/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350491/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347102/Flagship_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-11-09T12:33:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/visterra-secures-financing-from-gates-foundation-and-omega-to-close-26m-series-a-financing> ;
    ns1:foundName "Flagship Ventures" ;
    ns1:investor <https://1145.am/db/2347102/Series_A_Investment_Flagship_Ventures_Lux_Capital_Omega_Funds_Polaris_Venture_Partners_The_Bill___Melinda_Gates_Foundation_Visterra_Completed> ;
    ns1:name "Flagship Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2288209/Flagship_Ventures>,
        <https://1145.am/db/2292800/Flagship_Ventures>,
        <https://1145.am/db/2298439/Flagship_Ventures>,
        <https://1145.am/db/2302116/Flagship_Ventures>,
        <https://1145.am/db/2304650/Flagship_Ventures>,
        <https://1145.am/db/2306790/Flagship_Ventures>,
        <https://1145.am/db/2308952/Flagship_Ventures>,
        <https://1145.am/db/2308959/Flagship_Ventures>,
        <https://1145.am/db/2313305/Flagship_Ventures>,
        <https://1145.am/db/2314964/Flagship_Ventures>,
        <https://1145.am/db/2315931/Flagship_Ventures>,
        <https://1145.am/db/2315933/Flagship_Ventures>,
        <https://1145.am/db/2317918/Flagship_Ventures>,
        <https://1145.am/db/2321150/Flagship_Ventures>,
        <https://1145.am/db/2324431/Flagship_Ventures>,
        <https://1145.am/db/2334847/Flagship_Ventures>,
        <https://1145.am/db/2339413/Flagship_Ventures>,
        <https://1145.am/db/2341599/Flagship_Ventures>,
        <https://1145.am/db/2343592/Flagship_Ventures>,
        <https://1145.am/db/2343595/Flagship_Ventures>,
        <https://1145.am/db/2346988/Flagship_Ventures>,
        <https://1145.am/db/2348074/Flagship_Ventures>,
        <https://1145.am/db/2354351/Flagship_Ventures>,
        <https://1145.am/db/2354608/Flagship_Ventures>,
        <https://1145.am/db/2354613/Flagship_Ventures>,
        <https://1145.am/db/2354806/Flagship_Ventures>,
        <https://1145.am/db/2356730/Flagship_Ventures>,
        <https://1145.am/db/2356732/Flagship_Ventures>,
        <https://1145.am/db/2358234/Flagship_Ventures>,
        <https://1145.am/db/2358487/Flagship_Ventures>,
        <https://1145.am/db/2358506/Flagship_Ventures>,
        <https://1145.am/db/2358529/Flagship_Ventures>,
        <https://1145.am/db/2359287/Flagship_Ventures>,
        <https://1145.am/db/2366654/Flagship_Ventures>,
        <https://1145.am/db/2367381/Flagship_Ventures>,
        <https://1145.am/db/2367588/Flagship_Ventures>,
        <https://1145.am/db/2368493/Flagship_Ventures>,
        <https://1145.am/db/2369549/Flagship_Ventures>,
        <https://1145.am/db/2634324/Flagship_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2349120/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CALIF" ;
    ns1:documentDate "2012-11-13T12:24:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "PEARL THERAPEUTICS RAISES $65 MILLION SERIES D TO START PT003 PHASE 3" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pearl-therapeutics-raises-65-million-series-d-to-start-pt003-phase-3> ;
    ns1:foundName "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2349120/Series_D_Investment_5am_Ventures_Clarus_Ventures_New_Leaf_Venture_Partners_Pearl_Therapeutics_Inc_Vatera_Healthcare_Partners_Completed> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2208603/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342925/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346532/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347043/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347571/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348618/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350164/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350167/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350491/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2349120/Series_D_Investment_5am_Ventures_Clarus_Ventures_New_Leaf_Venture_Partners_Pearl_Therapeutics_Inc_Vatera_Healthcare_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-13T12:24:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "PEARL THERAPEUTICS RAISES $ 65 MILLION SERIES D TO START PT003 PHASE 3.",
        "REDWOOD CITY, CALIF., November 13, 2012 - Pearl Therapeutics Inc. today announced a $ 65 million Series D financing raised from current investors." ;
    ns1:documentTitle "PEARL THERAPEUTICS RAISES $65 MILLION SERIES D TO START PT003 PHASE 3" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/pearl-therapeutics-raises-65-million-series-d-to-start-pt003-phase-3> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2349120/Pearl_Therapeutics_Inc> ;
    ns1:targetDetails "SERIES D",
        "Series D" ;
    ns1:valueRaw "$ 65 MILLION",
        "$ 65 million" ;
    ns1:when "2012-11-13T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "November 13, 2012" ;
    ns1:whereGeoName "Redwood City" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5386834/about.rdf> ;
    ns1:whereRaw "REDWOOD CITY, CALIF." .

<https://1145.am/db/2350164/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "HAYWARD, Calif" ;
    ns1:documentDate "2012-11-15T16:09:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intarcia-therapeutics-secures-landmark-210-million-financing-to-fund-its-global-phase-3> ;
    ns1:foundName "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2350164/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_Inc_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Completed> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2208603/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342925/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346532/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347043/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347571/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348618/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2349120/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350167/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350491/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350167/New_Leaf_Venture_Partners> a org:Organization ;
    ns1:description "venture cash" ;
    ns1:documentDate "2012-11-15T16:38:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia raises $210M for PhIII, once-yearly diabetes drug" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/intarcia-raises-210m-for-phiii-once-yearly-diabetes-drug> ;
    ns1:foundName "New Leaf Venture Partners" ;
    ns1:investor <https://1145.am/db/2350167/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Has_Not_Happened> ;
    ns1:name "New Leaf Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1782474/Leaf_Vc>,
        <https://1145.am/db/2089412/New_Leaf_Ventures>,
        <https://1145.am/db/2289585/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2307682/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2311595/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2316674/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345037/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346542/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2356876/New_Leaf_Ventures>,
        <https://1145.am/db/583528/New_Leaf_Venture_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1287338/New_Leaf_Venture_Partners>,
        <https://1145.am/db/1749104/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2151983/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2155668/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2208603/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2293765/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2298642/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2300322/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301824/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2301828/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305507/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2305514/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2312792/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315071/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315932/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2315934/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2317919/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318656/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2318657/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325326/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2325398/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334479/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2334797/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2341003/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342925/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2342937/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2343298/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2345047/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2346532/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347043/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347571/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347876/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2347878/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348149/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2348618/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2349120/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350164/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2350491/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2352059/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2357356/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2359683/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2360174/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2361416/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362736/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2362737/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2366860/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2569522/New_Leaf_Venture_Partners>,
        <https://1145.am/db/2594141/New_Leaf_Venture_Partners>,
        <https://1145.am/db/425953/New_Leaf_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2353260/Series_2_Investment_Abs_Ventures_Rib-X_Pharmaceuticals_Inc_Vatera_Healthcare_Partners_Vox_Equity_Partners_Warburg_Pincus_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-29T17:21:12+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NEW HAVEN, Conn., Nov 29, 2012 (BUSINESS WIRE) - Rib-X Pharmaceuticals, Inc. today announced that it has closed the first tranche of a $ 67.5 million Series 2 preferred stock financing.",
        "Rib-X Pharmaceuticals Closes First Tranche in $ 67.5 Million Financing." ;
    ns1:documentTitle "Rib-X Pharmaceuticals Closes First Tranche in $67.5 Million Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/rib-x-pharmaceuticals-closes-first-tranche-67-5-million-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2353260/Rib-X_Pharmaceuticals_Inc> ;
    ns1:targetDetails "Series 2" ;
    ns1:valueRaw "$ 67.5 Million",
        "$ 67.5 million" ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2354351/Flagship_Ventures> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, MA" ;
    ns1:description "institutional entrepreneuring" ;
    ns1:documentDate "2012-12-06T05:03:11+00:00"^^xsd:dateTime ;
    ns1:documentTitle "MODERNA ANNOUNCES $40 MILLION IN FINANCING TO ADVANCE DEVELOPMENT OF NEW BIOTHERAPEUTIC MODALITY: MESSENGER RNA THERAPEUTICSâ„¢" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/moderna-announces-40-million-financing-to-advance-development-of-new-biotherapeutic> ;
    ns1:foundName "Flagship Ventures" ;
    ns1:investor <https://1145.am/db/2354351/Investment_Flagship_Ventures_Moderna_Completed> ;
    ns1:name "Flagship Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2288209/Flagship_Ventures>,
        <https://1145.am/db/2292800/Flagship_Ventures>,
        <https://1145.am/db/2298439/Flagship_Ventures>,
        <https://1145.am/db/2302116/Flagship_Ventures>,
        <https://1145.am/db/2304650/Flagship_Ventures>,
        <https://1145.am/db/2306790/Flagship_Ventures>,
        <https://1145.am/db/2308952/Flagship_Ventures>,
        <https://1145.am/db/2308959/Flagship_Ventures>,
        <https://1145.am/db/2313305/Flagship_Ventures>,
        <https://1145.am/db/2314964/Flagship_Ventures>,
        <https://1145.am/db/2315931/Flagship_Ventures>,
        <https://1145.am/db/2315933/Flagship_Ventures>,
        <https://1145.am/db/2317918/Flagship_Ventures>,
        <https://1145.am/db/2321150/Flagship_Ventures>,
        <https://1145.am/db/2324431/Flagship_Ventures>,
        <https://1145.am/db/2334847/Flagship_Ventures>,
        <https://1145.am/db/2339413/Flagship_Ventures>,
        <https://1145.am/db/2341599/Flagship_Ventures>,
        <https://1145.am/db/2343592/Flagship_Ventures>,
        <https://1145.am/db/2343595/Flagship_Ventures>,
        <https://1145.am/db/2346988/Flagship_Ventures>,
        <https://1145.am/db/2347102/Flagship_Ventures>,
        <https://1145.am/db/2348074/Flagship_Ventures>,
        <https://1145.am/db/2354608/Flagship_Ventures>,
        <https://1145.am/db/2354613/Flagship_Ventures>,
        <https://1145.am/db/2354806/Flagship_Ventures>,
        <https://1145.am/db/2356730/Flagship_Ventures>,
        <https://1145.am/db/2356732/Flagship_Ventures>,
        <https://1145.am/db/2358234/Flagship_Ventures>,
        <https://1145.am/db/2358487/Flagship_Ventures>,
        <https://1145.am/db/2358506/Flagship_Ventures>,
        <https://1145.am/db/2358529/Flagship_Ventures>,
        <https://1145.am/db/2359287/Flagship_Ventures>,
        <https://1145.am/db/2366654/Flagship_Ventures>,
        <https://1145.am/db/2367381/Flagship_Ventures>,
        <https://1145.am/db/2367588/Flagship_Ventures>,
        <https://1145.am/db/2368493/Flagship_Ventures>,
        <https://1145.am/db/2369549/Flagship_Ventures>,
        <https://1145.am/db/2634324/Flagship_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354806/Flagship_Ventures> a org:Organization ;
    ns1:basedInHighGeoName "Cambridge" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:basedInHighRaw "CAMBRIDGE, Mass." ;
    ns1:documentDate "2012-09-04T12:13:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Startup WikiCell Designs Secures $10 Million in Investment Capital from Flagship Ventures and Polaris Venture Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/startup-wikicell-designs-secures-10-million-investment-capital-from-flagship-ventures> ;
    ns1:foundName "Flagship Ventures" ;
    ns1:investor <https://1145.am/db/2354806/Series-A_Investment_Flagship_Ventures_Polaris_Venture_Partners_Wikicell_Designs_Inc_Completed> ;
    ns1:name "Flagship Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2288209/Flagship_Ventures>,
        <https://1145.am/db/2292800/Flagship_Ventures>,
        <https://1145.am/db/2298439/Flagship_Ventures>,
        <https://1145.am/db/2302116/Flagship_Ventures>,
        <https://1145.am/db/2304650/Flagship_Ventures>,
        <https://1145.am/db/2306790/Flagship_Ventures>,
        <https://1145.am/db/2308952/Flagship_Ventures>,
        <https://1145.am/db/2308959/Flagship_Ventures>,
        <https://1145.am/db/2313305/Flagship_Ventures>,
        <https://1145.am/db/2314964/Flagship_Ventures>,
        <https://1145.am/db/2315931/Flagship_Ventures>,
        <https://1145.am/db/2315933/Flagship_Ventures>,
        <https://1145.am/db/2317918/Flagship_Ventures>,
        <https://1145.am/db/2321150/Flagship_Ventures>,
        <https://1145.am/db/2324431/Flagship_Ventures>,
        <https://1145.am/db/2334847/Flagship_Ventures>,
        <https://1145.am/db/2339413/Flagship_Ventures>,
        <https://1145.am/db/2341599/Flagship_Ventures>,
        <https://1145.am/db/2343592/Flagship_Ventures>,
        <https://1145.am/db/2343595/Flagship_Ventures>,
        <https://1145.am/db/2346988/Flagship_Ventures>,
        <https://1145.am/db/2347102/Flagship_Ventures>,
        <https://1145.am/db/2348074/Flagship_Ventures>,
        <https://1145.am/db/2354351/Flagship_Ventures>,
        <https://1145.am/db/2354608/Flagship_Ventures>,
        <https://1145.am/db/2354613/Flagship_Ventures>,
        <https://1145.am/db/2356730/Flagship_Ventures>,
        <https://1145.am/db/2356732/Flagship_Ventures>,
        <https://1145.am/db/2358234/Flagship_Ventures>,
        <https://1145.am/db/2358487/Flagship_Ventures>,
        <https://1145.am/db/2358506/Flagship_Ventures>,
        <https://1145.am/db/2358529/Flagship_Ventures>,
        <https://1145.am/db/2359287/Flagship_Ventures>,
        <https://1145.am/db/2366654/Flagship_Ventures>,
        <https://1145.am/db/2367381/Flagship_Ventures>,
        <https://1145.am/db/2367588/Flagship_Ventures>,
        <https://1145.am/db/2368493/Flagship_Ventures>,
        <https://1145.am/db/2369549/Flagship_Ventures>,
        <https://1145.am/db/2634324/Flagship_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356391/Novartis_Venture_Fund> a org:Organization ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:foundName "Novartis Venture Fund" ;
    ns1:investor <https://1145.am/db/2356391/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> ;
    ns1:name "Novartis Venture Fund" ;
    ns1:sameAsMedium <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2247240/Novartis_Venture_Funds>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2338527/Novartis_Venture_Funds>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356290/Novartis_Venture_Fund>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2367046/Novartis_Venture_Fund>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356396/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Yuri_Milner_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-12T05:00:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "23andMe Raises More Than $ 50 Million in New Financing.",
        "23andMe, Inc., the leading personal genetics company, today announced it has raised more than $ 50 million in a Series D financing." ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "Raises",
        "financing",
        "raised" ;
    ns1:name "Raises",
        "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2356396/23andme> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "More Than $ 50 Million",
        "more than $ 50 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2356402/Sr_One> a org:Organization ;
    ns1:basedInLowRaw "NEW YORK" ;
    ns1:documentDate "2012-12-12T13:09:35+00:00"^^xsd:dateTime ;
    ns1:documentTitle "River Vision Announces Completion of $17 million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/river-vision-announces-completion-of-17-million-series-a-financing> ;
    ns1:foundName "SR One" ;
    ns1:investor <https://1145.am/db/2356402/Series_A_Investment_Lundbeckfond_Ventures_River_Vision_Development_Corp_Sr_One_Completed> ;
    ns1:name "SR One" ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Sr_One>,
        <https://1145.am/db/1334624/Sr_One>,
        <https://1145.am/db/1949427/Sr_One>,
        <https://1145.am/db/2095130/Sr_One>,
        <https://1145.am/db/2110113/Sr_One>,
        <https://1145.am/db/2280707/Sr_One>,
        <https://1145.am/db/2305791/Sr_One>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2317951/Sr_One>,
        <https://1145.am/db/2318310/Sr_One>,
        <https://1145.am/db/2326222/Sr_One_Ltd>,
        <https://1145.am/db/2327305/Sr_One>,
        <https://1145.am/db/2327488/Sr_One_Ltd>,
        <https://1145.am/db/2331763/Sr_One>,
        <https://1145.am/db/2336328/Sr_One>,
        <https://1145.am/db/2337571/Sr_One>,
        <https://1145.am/db/2337577/Sr_One>,
        <https://1145.am/db/2340096/Sr_One>,
        <https://1145.am/db/2341904/Sr_One>,
        <https://1145.am/db/2342084/Sr_One>,
        <https://1145.am/db/2342983/Sr_One>,
        <https://1145.am/db/2343301/Sr_One>,
        <https://1145.am/db/2345675/Sr_One>,
        <https://1145.am/db/2347482/Sr_One>,
        <https://1145.am/db/2347594/Sr_One>,
        <https://1145.am/db/2349233/Sr_One>,
        <https://1145.am/db/2350030/Sr_One>,
        <https://1145.am/db/2350364/Sr_One>,
        <https://1145.am/db/2353917/Sr_One>,
        <https://1145.am/db/2356411/Sr_One>,
        <https://1145.am/db/2357676/Sr_One>,
        <https://1145.am/db/2357679/Sr_One>,
        <https://1145.am/db/2357682/Sr_One>,
        <https://1145.am/db/2358430/Sr_One>,
        <https://1145.am/db/2358860/Sr_One>,
        <https://1145.am/db/2359334/Sr_One>,
        <https://1145.am/db/2362533/Sr_One>,
        <https://1145.am/db/2362715/Sr_One>,
        <https://1145.am/db/2363947/Sr_One>,
        <https://1145.am/db/2363950/Sr_One>,
        <https://1145.am/db/2365103/Sr_One>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365105/Sr_One>,
        <https://1145.am/db/2365296/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2367549/Sr_One>,
        <https://1145.am/db/2368501/Sr_One>,
        <https://1145.am/db/2371191/Sr_One>,
        <https://1145.am/db/2371304/Sr_One>,
        <https://1145.am/db/2544138/Sr_One>,
        <https://1145.am/db/2544140/Sr_One>,
        <https://1145.am/db/2546216/Sr_One>,
        <https://1145.am/db/2573068/Sr_One>,
        <https://1145.am/db/2595958/Sr_One> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356420/Orbimed_Advisors> a org:Organization ;
    ns1:basedInLowRaw "LLC" ;
    ns1:description "private equity financing" ;
    ns1:documentDate "2012-12-13T05:00:54+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Cerapedics Secures $19 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerapedics-secures-19-million-series-c-financing> ;
    ns1:foundName "OrbiMed Advisors" ;
    ns1:investor <https://1145.am/db/2356420/Equity_Private_Equity_Investment_Cvf_Llc_Cerapedics_Inc_Henry_Crown_And_Company_Medimmune_Ventures_Ngn_Capital_Orbimed_Advisors_Completed> ;
    ns1:name "OrbiMed Advisors" ;
    ns1:sameAsHigh <https://1145.am/db/1426073/Orbimed>,
        <https://1145.am/db/1426943/Orbimed>,
        <https://1145.am/db/1809007/Orbimed_Advisors>,
        <https://1145.am/db/2080575/Orbimed>,
        <https://1145.am/db/2303098/Orbimed_Advisors>,
        <https://1145.am/db/2325257/Orbimed_Advisors>,
        <https://1145.am/db/2350720/Orbimed>,
        <https://1145.am/db/2352807/Orbimed_Advisors>,
        <https://1145.am/db/2359468/Orbimed_Advisors>,
        <https://1145.am/db/428737/Orbimed_Advisors>,
        <https://1145.am/db/770684/Orbimed>,
        <https://1145.am/db/791742/Orbimed> ;
    ns1:sameAsMedium <https://1145.am/db/1665536/Orbimed_Advisors>,
        <https://1145.am/db/2198816/Orbimed_Advisors>,
        <https://1145.am/db/2245885/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2281230/Orbimed_Advisors>,
        <https://1145.am/db/2284506/Orbimed_Advisors>,
        <https://1145.am/db/2289056/Orbimed_Advisors>,
        <https://1145.am/db/2290078/Orbimed_Advisors>,
        <https://1145.am/db/2290200/Orbimed_Advisors>,
        <https://1145.am/db/2290444/Orbimed_Advisors>,
        <https://1145.am/db/2297604/Orbimed_Advisors>,
        <https://1145.am/db/2298956/Orbimed_Advisors>,
        <https://1145.am/db/2304242/Orbimed_Advisors>,
        <https://1145.am/db/2305656/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306251/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2306705/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2309491/Orbimed_Advisors>,
        <https://1145.am/db/2310922/Orbimed_Advisors>,
        <https://1145.am/db/2312233/Orbimed_Advisors>,
        <https://1145.am/db/2317918/Orbimed_Advisors>,
        <https://1145.am/db/2318133/Orbimed_Advisors>,
        <https://1145.am/db/2318829/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2318832/Orbimed_Advisers>,
        <https://1145.am/db/2318851/Orbimed_Advisors>,
        <https://1145.am/db/2319338/Orbimed_Advisors>,
        <https://1145.am/db/2320914/Orbimed_Advisors>,
        <https://1145.am/db/2322345/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2324226/Orbimed_Advisors>,
        <https://1145.am/db/2325880/Orbimed_Advisors>,
        <https://1145.am/db/2328599/Orbimed_Advisors>,
        <https://1145.am/db/2328700/Orbimed_Advisors>,
        <https://1145.am/db/2329260/Orbimed_Advisors>,
        <https://1145.am/db/2330799/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2330920/Orbimed_Advisors>,
        <https://1145.am/db/2332120/Orbimed_Advisors>,
        <https://1145.am/db/2333495/Orbimed_Advisors>,
        <https://1145.am/db/2333504/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2333966/Orbimed_Advisors>,
        <https://1145.am/db/2335743/Orbimed_Advisors>,
        <https://1145.am/db/2336221/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2336503/Orbimed_Advisors>,
        <https://1145.am/db/2336505/Orbimed_Advisors>,
        <https://1145.am/db/2336524/Orbimed_Advisors>,
        <https://1145.am/db/2337166/Orbimed_Advisors>,
        <https://1145.am/db/2337250/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2337254/Orbimed_Advisors>,
        <https://1145.am/db/2339885/Orbimed_Advisors>,
        <https://1145.am/db/2339886/Orbimed_Advisors>,
        <https://1145.am/db/2342862/Orbimed_Advisors>,
        <https://1145.am/db/2342925/Orbimed_Advisors>,
        <https://1145.am/db/2342937/Orbimed_Advisors>,
        <https://1145.am/db/2343244/Orbimed_Advisors>,
        <https://1145.am/db/2344735/Orbimed_Advisors>,
        <https://1145.am/db/2344786/Orbimed_Advisors>,
        <https://1145.am/db/2345435/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345453/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2345456/Orbimed_Advisors>,
        <https://1145.am/db/2346030/Orbimed_Advisors>,
        <https://1145.am/db/2350034/Orbimed_Advisors>,
        <https://1145.am/db/2350044/Orbimed_Advisors>,
        <https://1145.am/db/2352436/Orbimed_Advisors>,
        <https://1145.am/db/2352441/Orbimed_Advisors>,
        <https://1145.am/db/2352442/Orbimed_Advisors>,
        <https://1145.am/db/2352701/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2352804/Orbimed_Advisors>,
        <https://1145.am/db/2355034/Orbimed_Advisors>,
        <https://1145.am/db/2356297/Orbimed_Advisors>,
        <https://1145.am/db/2357253/Orbimed_Advisors>,
        <https://1145.am/db/2357256/Orbimed_Advisors>,
        <https://1145.am/db/2357858/Orbimed_Advisors>,
        <https://1145.am/db/2359125/Orbimed_Advisors>,
        <https://1145.am/db/2359864/Orbimed_Advisors>,
        <https://1145.am/db/2360174/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2361018/Orbimed_Advisors>,
        <https://1145.am/db/2361022/Orbimed_Advisors>,
        <https://1145.am/db/2361027/Orbimed_Advisors>,
        <https://1145.am/db/2362475/Orbimed_Advisors>,
        <https://1145.am/db/2362481/Orbimed_Advisors>,
        <https://1145.am/db/2363339/Orbimed_Advisors>,
        <https://1145.am/db/2365679/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2365868/Orbimed_Advisors>,
        <https://1145.am/db/2366519/Orbimed_Advisors>,
        <https://1145.am/db/2574232/Orbimed_Advisors_Llc>,
        <https://1145.am/db/2583013/Orbimed_Advisors>,
        <https://1145.am/db/456081/Orbimed_Advisors>,
        <https://1145.am/db/456089/Orbimed_Advisors>,
        <https://1145.am/db/458377/Orbimed_Advisors>,
        <https://1145.am/db/674484/Orbimed_Advisors> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2358502/Series_A_Investment_Allakos_Inc_Alta_Partners_Novo_Ventures_Rivervest_Venture_Partners_Roche_Venture_Fund_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-17T17:21:29+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Allakos Inc. Completes Series A Financing of $ 32 Million to Develop Antibody Therapeutics for Allergic and Inflammatory Diseases.",
        "SAN MATEO, Calif., Dec. 17, 2012 - /PRNewswire/ - Allakos Inc. announced today that it has completed a $ 32 million Series A preferred stock financing led by Novo Ventures with participation from Alta Partners, RiverVest Venture Partners and the Roche Venture Fund." ;
    ns1:documentTitle "Allakos Inc. Completes Series A Financing of $32 Million to Develop Antibody Therapeutics for Allergic and Inflammatory Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/allakos-inc-completes-series-a-financing-of-32-million-to-develop-antibody-therapeutics-for> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2358502/Allakos_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 32 Million",
        "$ 32 million" ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2358506/Flagship_Ventures> a org:Organization ;
    ns1:basedInLowRaw "WATERTOWN, MA" ;
    ns1:documentDate "2012-12-18T12:40:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/blend-therapeutics-closes-16-million-series-b-financing-0> ;
    ns1:foundName "Flagship Ventures" ;
    ns1:investor <https://1145.am/db/2358506/Series_B_Investment_Blend_Therapeutics_Flagship_Ventures_Nanodimension_New_Enterprise_Associates_Completed> ;
    ns1:name "Flagship Ventures" ;
    ns1:sameAsMedium <https://1145.am/db/2288209/Flagship_Ventures>,
        <https://1145.am/db/2292800/Flagship_Ventures>,
        <https://1145.am/db/2298439/Flagship_Ventures>,
        <https://1145.am/db/2302116/Flagship_Ventures>,
        <https://1145.am/db/2304650/Flagship_Ventures>,
        <https://1145.am/db/2306790/Flagship_Ventures>,
        <https://1145.am/db/2308952/Flagship_Ventures>,
        <https://1145.am/db/2308959/Flagship_Ventures>,
        <https://1145.am/db/2313305/Flagship_Ventures>,
        <https://1145.am/db/2314964/Flagship_Ventures>,
        <https://1145.am/db/2315931/Flagship_Ventures>,
        <https://1145.am/db/2315933/Flagship_Ventures>,
        <https://1145.am/db/2317918/Flagship_Ventures>,
        <https://1145.am/db/2321150/Flagship_Ventures>,
        <https://1145.am/db/2324431/Flagship_Ventures>,
        <https://1145.am/db/2334847/Flagship_Ventures>,
        <https://1145.am/db/2339413/Flagship_Ventures>,
        <https://1145.am/db/2341599/Flagship_Ventures>,
        <https://1145.am/db/2343592/Flagship_Ventures>,
        <https://1145.am/db/2343595/Flagship_Ventures>,
        <https://1145.am/db/2346988/Flagship_Ventures>,
        <https://1145.am/db/2347102/Flagship_Ventures>,
        <https://1145.am/db/2348074/Flagship_Ventures>,
        <https://1145.am/db/2354351/Flagship_Ventures>,
        <https://1145.am/db/2354608/Flagship_Ventures>,
        <https://1145.am/db/2354613/Flagship_Ventures>,
        <https://1145.am/db/2354806/Flagship_Ventures>,
        <https://1145.am/db/2356730/Flagship_Ventures>,
        <https://1145.am/db/2356732/Flagship_Ventures>,
        <https://1145.am/db/2358234/Flagship_Ventures>,
        <https://1145.am/db/2358487/Flagship_Ventures>,
        <https://1145.am/db/2358529/Flagship_Ventures>,
        <https://1145.am/db/2359287/Flagship_Ventures>,
        <https://1145.am/db/2366654/Flagship_Ventures>,
        <https://1145.am/db/2367381/Flagship_Ventures>,
        <https://1145.am/db/2367588/Flagship_Ventures>,
        <https://1145.am/db/2368493/Flagship_Ventures>,
        <https://1145.am/db/2369549/Flagship_Ventures>,
        <https://1145.am/db/2634324/Flagship_Ventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2362106/Series_B_Investment_Casdin_Capital_Deerfield_Management_Company_Foundation_Medicine_Laboratory_Corporation_Of_AmericaÂ®_Holdings_Redmile_Group_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-20T11:51:08+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., September 20, 2012 - Foundation Medicine today announced the completion of a $ 42.5 million Series B financing.",
        "Foundation Medicine Announces $ 42.5 Million Series B Financing." ;
    ns1:documentTitle "Foundation Medicine Announces $42.5 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/foundation-medicine-announces-42-5-million-series-b-financing-0> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2362106/Foundation_Medicine> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 42.5 Million",
        "$ 42.5 million" ;
    ns1:when "2012-09-20T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "September 20, 2012" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass" .

<https://1145.am/db/2546216/Sr_One> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "SR One" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "SR One" ;
    ns1:sameAsMedium <https://1145.am/db/1169952/Sr_One>,
        <https://1145.am/db/1334624/Sr_One>,
        <https://1145.am/db/1949427/Sr_One>,
        <https://1145.am/db/2095130/Sr_One>,
        <https://1145.am/db/2110113/Sr_One>,
        <https://1145.am/db/2280707/Sr_One>,
        <https://1145.am/db/2305791/Sr_One>,
        <https://1145.am/db/2317934/Sr_One>,
        <https://1145.am/db/2317951/Sr_One>,
        <https://1145.am/db/2318310/Sr_One>,
        <https://1145.am/db/2326222/Sr_One_Ltd>,
        <https://1145.am/db/2327305/Sr_One>,
        <https://1145.am/db/2327488/Sr_One_Ltd>,
        <https://1145.am/db/2331763/Sr_One>,
        <https://1145.am/db/2336328/Sr_One>,
        <https://1145.am/db/2337571/Sr_One>,
        <https://1145.am/db/2337577/Sr_One>,
        <https://1145.am/db/2340096/Sr_One>,
        <https://1145.am/db/2341904/Sr_One>,
        <https://1145.am/db/2342084/Sr_One>,
        <https://1145.am/db/2342983/Sr_One>,
        <https://1145.am/db/2343301/Sr_One>,
        <https://1145.am/db/2345675/Sr_One>,
        <https://1145.am/db/2347482/Sr_One>,
        <https://1145.am/db/2347594/Sr_One>,
        <https://1145.am/db/2349233/Sr_One>,
        <https://1145.am/db/2350030/Sr_One>,
        <https://1145.am/db/2350364/Sr_One>,
        <https://1145.am/db/2353917/Sr_One>,
        <https://1145.am/db/2356402/Sr_One>,
        <https://1145.am/db/2356411/Sr_One>,
        <https://1145.am/db/2357676/Sr_One>,
        <https://1145.am/db/2357679/Sr_One>,
        <https://1145.am/db/2357682/Sr_One>,
        <https://1145.am/db/2358430/Sr_One>,
        <https://1145.am/db/2358860/Sr_One>,
        <https://1145.am/db/2359334/Sr_One>,
        <https://1145.am/db/2362533/Sr_One>,
        <https://1145.am/db/2362715/Sr_One>,
        <https://1145.am/db/2363947/Sr_One>,
        <https://1145.am/db/2363950/Sr_One>,
        <https://1145.am/db/2365103/Sr_One>,
        <https://1145.am/db/2365104/Sr_One>,
        <https://1145.am/db/2365105/Sr_One>,
        <https://1145.am/db/2365296/Sr_One>,
        <https://1145.am/db/2365300/Sr_One>,
        <https://1145.am/db/2367549/Sr_One>,
        <https://1145.am/db/2368501/Sr_One>,
        <https://1145.am/db/2371191/Sr_One>,
        <https://1145.am/db/2371304/Sr_One>,
        <https://1145.am/db/2544138/Sr_One>,
        <https://1145.am/db/2544140/Sr_One>,
        <https://1145.am/db/2573068/Sr_One>,
        <https://1145.am/db/2595958/Sr_One> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2547216/Oxford_England-Psioxus_Therapeutics_Ltd> a org:Organization ;
    ns1:basedInHighGeoName "England",
        "Oxford" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2640729/about.rdf>,
        <https://sws.geonames.org/6269131/about.rdf> ;
    ns1:basedInHighRaw "England",
        "OXFORD, England" ;
    ns1:description "developing stage biotechnology company" ;
    ns1:documentDate "2012-11-05T18:17:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "OXFORD, England-PsiOxus Therapeutics, Ltd",
        "PsiOxus Therapeutics, Ltd" ;
    ns1:industry "biotechnology" ;
    ns1:name "OXFORD, England-PsiOxus Therapeutics, Ltd",
        "PsiOxus Therapeutics, Ltd" ;
    ns1:sameAsHigh <https://1145.am/db/1272117/Psioxus_Therapeutics>,
        <https://1145.am/db/1273078/Psioxus_Therapeutics>,
        <https://1145.am/db/2153714/Psioxus_Therapeutics>,
        <https://1145.am/db/2346021/Psioxus_Therapeutics>,
        <https://1145.am/db/2363801/Psioxus_Therapeutics>,
        <https://1145.am/db/2363802/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2365956/Psioxus_Therapeutics>,
        <https://1145.am/db/2547216/Psioxus_Therapeutics>,
        <https://1145.am/db/2583115/Psioxus_Therapeutics>,
        <https://1145.am/db/2588827/Psioxus_Therapeutics> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2547216/Psioxus_Therapeutics> a org:Organization ;
    ns1:basedInHighGeoName "Oxford" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/2640729/about.rdf> ;
    ns1:basedInHighRaw "OXFORD, England" ;
    ns1:description "developing stage biotechnology company" ;
    ns1:documentDate "2012-11-05T18:17:28+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "(PsiOxus)" ;
    ns1:industry "biotechnology" ;
    ns1:name "PsiOxus Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1272117/Psioxus_Therapeutics>,
        <https://1145.am/db/1273078/Psioxus_Therapeutics>,
        <https://1145.am/db/2153714/Psioxus_Therapeutics>,
        <https://1145.am/db/2346021/Psioxus_Therapeutics>,
        <https://1145.am/db/2363801/Psioxus_Therapeutics>,
        <https://1145.am/db/2363802/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2365956/Psioxus_Therapeutics>,
        <https://1145.am/db/2547216/Oxford_England-Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2583115/Psioxus_Therapeutics>,
        <https://1145.am/db/2588827/Psioxus_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2354401/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2363947/Psioxus_Therapeutics>,
        <https://1145.am/db/2363950/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2544138/Psioxus_Therapeutics>,
        <https://1145.am/db/2544140/Psioxus_Therapeutics>,
        <https://1145.am/db/2580691/Psioxus_Therapeutics> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2588827/Psioxus_Therapeutics> a org:Organization ;
    ns1:basedInLowRaw "UK" ;
    ns1:description "Pharmaceuticals",
        "developing new drugs" ;
    ns1:documentDate "2012-11-06T05:03:26+00:00"^^xsd:dateTime ;
    ns1:documentTitle "UK Government Awards Â£1.7M Grant to PsiOxus Therapeutics for Second Phase I/II Clinical Trial of Cancer Vaccine" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/uk-government-awards-%C2%A31-7m-grant-to-psioxus-therapeutics-for-second-phase-i-ii-clinical> ;
    ns1:foundName "(PsiOxus)",
        "PsiOxus Therapeutics" ;
    ns1:industry "Pharmaceutical",
        "biotechnology" ;
    ns1:name "(PsiOxus)",
        "PsiOxus Therapeutics" ;
    ns1:sameAsHigh <https://1145.am/db/1272117/Psioxus_Therapeutics>,
        <https://1145.am/db/1273078/Psioxus_Therapeutics>,
        <https://1145.am/db/2153714/Psioxus_Therapeutics>,
        <https://1145.am/db/2346021/Psioxus_Therapeutics>,
        <https://1145.am/db/2363801/Psioxus_Therapeutics>,
        <https://1145.am/db/2363802/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2365956/Psioxus_Therapeutics>,
        <https://1145.am/db/2547216/Oxford_England-Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2547216/Psioxus_Therapeutics>,
        <https://1145.am/db/2583115/Psioxus_Therapeutics> ;
    ns1:sameAsMedium <https://1145.am/db/2354401/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2363947/Psioxus_Therapeutics>,
        <https://1145.am/db/2363950/Psioxus_Therapeutics_Ltd>,
        <https://1145.am/db/2544138/Psioxus_Therapeutics>,
        <https://1145.am/db/2544140/Psioxus_Therapeutics>,
        <https://1145.am/db/2580691/Psioxus_Therapeutics> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2333119/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Sergey_Brin_Yuri_Milner_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-16T22:22:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "23andMe Raises More Than $ 50 Million in New Financing.",
        "MOUNTAIN VIEW, Calif.- (BUSINESS WIRE) -23andMe, Inc., the leading personal genetics company, today announced it has raised more than $ 50 million in a Series D financing." ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "Raises",
        "financing",
        "raised" ;
    ns1:name "Raises",
        "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2333119/23andme> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "More Than $ 50 Million",
        "more than $ 50 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2336503/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-04T15:06:27+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aragon Pharmaceuticals Raises $ 50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers.",
        "SAN DIEGO, Oct. 4, 2012- Aragon Pharmaceuticals Inc. today announced that the company has raised $ 50 million in a Series D financing to advance the company's pipeline of therapies targeting hormone-driven cancers, including ARN-509 for the treatment of castration-resistant prostate cancer (CRPC) ." ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-1> ;
    ns1:foundName "Financing",
        "financing",
        "raised" ;
    ns1:name "Financing",
        "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 50 Million",
        "$ 50 million" ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2336505/Series_D_Investment_Aisling_Capital_Aragon_Pharmaceuticals_Inc_Orbimed_Advisors_The_Column_Group_Topspin_Fund_Venbio_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-04T15:29:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aragon Pharmaceuticals Raises $ 50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers.",
        "SAN DIEGO, Oct. 4, 2012 /PRNewswire via COMTEX/ - Aragon Pharmaceuticals Inc. today announced that the company has raised $ 50 million in a Series D financing to advance the company's pipeline of therapies targeting hormone-driven cancers, including ARN-509 for the treatment of castration-resistant prostate cancer (CRPC) ." ;
    ns1:documentTitle "Aragon Pharmaceuticals Raises $50 Million in Series D Financing to Advance Promising Therapeutic Candidates for Hormone-Driven Cancers" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aragon-pharmaceuticals-raises-50-million-series-d-financing-to-advance-promising-0> ;
    ns1:foundName "Financing",
        "financing",
        "raised" ;
    ns1:name "Financing",
        "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 50 Million",
        "$ 50 million" ;
    ns1:when "2012-10-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012",
        "Oct. 4, 2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2337571/Polaris_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "Polaris Venture Partners" ;
    ns1:investor <https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Polaris Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1701903/Polaris_Venture_Partners>,
        <https://1145.am/db/1708291/Polaris_Venture_Partners>,
        <https://1145.am/db/1830502/Polaris_Venture_Partners>,
        <https://1145.am/db/1870436/Polaris_Venture_Partners>,
        <https://1145.am/db/1877606/Polaris_Venture_Partners>,
        <https://1145.am/db/1897450/Polaris_Venture_Partners>,
        <https://1145.am/db/1909651/Polaris_Venture_Partners>,
        <https://1145.am/db/2174824/Polaris_Venture_Partners>,
        <https://1145.am/db/2292800/Polaris_Venture_Partners>,
        <https://1145.am/db/2302116/Polaris_Venture_Partners>,
        <https://1145.am/db/2303656/Polaris_Venture_Partners>,
        <https://1145.am/db/2303675/Polaris_Venture_Partners>,
        <https://1145.am/db/2313401/Polaris_Venture_Partners>,
        <https://1145.am/db/2313405/Polaris_Venture_Partners>,
        <https://1145.am/db/2314380/Polaris_Venture_Partners>,
        <https://1145.am/db/2315289/Polaris_Venture_Partners>,
        <https://1145.am/db/2323586/Polaris_Venture_Partners>,
        <https://1145.am/db/2324431/Polaris_Venture_Partners>,
        <https://1145.am/db/2331763/Polaris_Venture_Partners>,
        <https://1145.am/db/2337577/Polaris_Venture_Partners>,
        <https://1145.am/db/2338373/Polaris_Venture_Partners>,
        <https://1145.am/db/2339127/Polaris_Venture_Partners>,
        <https://1145.am/db/2339128/Polaris_Venture_Partners>,
        <https://1145.am/db/2342445/Polaris_Venture_Partners>,
        <https://1145.am/db/2342862/Polaris_Venture_Partners>,
        <https://1145.am/db/2343210/Polaris_Venture_Partners>,
        <https://1145.am/db/2344256/Polaris_Venture_Partners>,
        <https://1145.am/db/2345224/Polaris_Venture_Partners>,
        <https://1145.am/db/2347102/Polaris_Venture_Partners>,
        <https://1145.am/db/2348448/Polaris_Venture_Partners>,
        <https://1145.am/db/2350034/Polaris_Venture_Partners>,
        <https://1145.am/db/2352414/Polaris_Venture_Partners>,
        <https://1145.am/db/2354806/Polaris_Venture_Partners>,
        <https://1145.am/db/2365296/Polaris_Venture_Partners>,
        <https://1145.am/db/2365300/Polaris_Venture_Partners>,
        <https://1145.am/db/2366654/Polaris_Venture_Partners>,
        <https://1145.am/db/2367497/Polaris_Venture_Partners>,
        <https://1145.am/db/2440024/Polaris_Venture_Partners>,
        <https://1145.am/db/2450515/Polaris_Venture_Partners>,
        <https://1145.am/db/2546216/Polaris_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Polaris_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Polaris Venture Partners" ;
    ns1:investor <https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Polaris Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1701903/Polaris_Venture_Partners>,
        <https://1145.am/db/1708291/Polaris_Venture_Partners>,
        <https://1145.am/db/1830502/Polaris_Venture_Partners>,
        <https://1145.am/db/1870436/Polaris_Venture_Partners>,
        <https://1145.am/db/1877606/Polaris_Venture_Partners>,
        <https://1145.am/db/1897450/Polaris_Venture_Partners>,
        <https://1145.am/db/1909651/Polaris_Venture_Partners>,
        <https://1145.am/db/2174824/Polaris_Venture_Partners>,
        <https://1145.am/db/2292800/Polaris_Venture_Partners>,
        <https://1145.am/db/2302116/Polaris_Venture_Partners>,
        <https://1145.am/db/2303656/Polaris_Venture_Partners>,
        <https://1145.am/db/2303675/Polaris_Venture_Partners>,
        <https://1145.am/db/2313401/Polaris_Venture_Partners>,
        <https://1145.am/db/2313405/Polaris_Venture_Partners>,
        <https://1145.am/db/2314380/Polaris_Venture_Partners>,
        <https://1145.am/db/2315289/Polaris_Venture_Partners>,
        <https://1145.am/db/2323586/Polaris_Venture_Partners>,
        <https://1145.am/db/2324431/Polaris_Venture_Partners>,
        <https://1145.am/db/2331763/Polaris_Venture_Partners>,
        <https://1145.am/db/2337571/Polaris_Venture_Partners>,
        <https://1145.am/db/2338373/Polaris_Venture_Partners>,
        <https://1145.am/db/2339127/Polaris_Venture_Partners>,
        <https://1145.am/db/2339128/Polaris_Venture_Partners>,
        <https://1145.am/db/2342445/Polaris_Venture_Partners>,
        <https://1145.am/db/2342862/Polaris_Venture_Partners>,
        <https://1145.am/db/2343210/Polaris_Venture_Partners>,
        <https://1145.am/db/2344256/Polaris_Venture_Partners>,
        <https://1145.am/db/2345224/Polaris_Venture_Partners>,
        <https://1145.am/db/2347102/Polaris_Venture_Partners>,
        <https://1145.am/db/2348448/Polaris_Venture_Partners>,
        <https://1145.am/db/2350034/Polaris_Venture_Partners>,
        <https://1145.am/db/2352414/Polaris_Venture_Partners>,
        <https://1145.am/db/2354806/Polaris_Venture_Partners>,
        <https://1145.am/db/2365296/Polaris_Venture_Partners>,
        <https://1145.am/db/2365300/Polaris_Venture_Partners>,
        <https://1145.am/db/2366654/Polaris_Venture_Partners>,
        <https://1145.am/db/2367497/Polaris_Venture_Partners>,
        <https://1145.am/db/2440024/Polaris_Venture_Partners>,
        <https://1145.am/db/2450515/Polaris_Venture_Partners>,
        <https://1145.am/db/2546216/Polaris_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2338373/Polaris_Venture_Partners> a org:Organization ;
    ns1:description "venture investors" ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName "Polaris Venture Partners" ;
    ns1:investor <https://1145.am/db/2338373/Series_D_Investment_Easton_Capital_Investment_Group_Fibrotec_Ventures_Forbion_Capital_Partners_Healthcare_Ventures_Inc_Morgenthaler_Ventures_Polaris_Venture_Partners_Shire_Strategic_Investment_Group_Completed> ;
    ns1:name "Polaris Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1163164/Polaris_Partners>,
        <https://1145.am/db/1166225/Polaris_Partners>,
        <https://1145.am/db/127343/Polaris_Partners>,
        <https://1145.am/db/1340338/Polaris_Partners>,
        <https://1145.am/db/1406211/Polaris_Partners>,
        <https://1145.am/db/1412727/Polaris_Partners>,
        <https://1145.am/db/1545490/Polaris_Partners>,
        <https://1145.am/db/1701903/Polaris_Venture_Partners>,
        <https://1145.am/db/1796259/Polaris_Capital>,
        <https://1145.am/db/1803886/Polaris_Partners>,
        <https://1145.am/db/1845960/Polaris_Partners>,
        <https://1145.am/db/1854788/Polaris_Partners>,
        <https://1145.am/db/1870436/Polaris_Venture_Partners>,
        <https://1145.am/db/1877606/Polaris_Venture_Partners>,
        <https://1145.am/db/1885717/Polaris_Ventures>,
        <https://1145.am/db/1897450/Polaris_Venture_Partners>,
        <https://1145.am/db/1909651/Polaris_Venture_Partners>,
        <https://1145.am/db/1947183/Polaris_Partners>,
        <https://1145.am/db/2140474/Polaris_Capital_Management>,
        <https://1145.am/db/2174824/Polaris_Venture_Partners>,
        <https://1145.am/db/2181016/Polaris_Partners>,
        <https://1145.am/db/2187023/Polaris_Partners>,
        <https://1145.am/db/2194844/Polaris_Partners>,
        <https://1145.am/db/2196895/Polaris_Partners>,
        <https://1145.am/db/2223723/Polaris_Partners>,
        <https://1145.am/db/2292800/Polaris_Venture_Partners>,
        <https://1145.am/db/2303656/Polaris_Venture_Partners>,
        <https://1145.am/db/2303675/Polaris_Venture_Partners>,
        <https://1145.am/db/2315289/Polaris_Venture_Partners>,
        <https://1145.am/db/2317918/Polaris_Ventures>,
        <https://1145.am/db/2318310/Polaris_Partners>,
        <https://1145.am/db/2323586/Polaris_Venture_Partners>,
        <https://1145.am/db/2324431/Polaris_Venture_Partners>,
        <https://1145.am/db/2335531/Flagship_Ventures_Polaris_Partners>,
        <https://1145.am/db/2335750/Polaris_Partners>,
        <https://1145.am/db/2341599/Polaris_Partners>,
        <https://1145.am/db/2343467/Polaris_Ventures>,
        <https://1145.am/db/2352414/Polaris_Venture_Partners>,
        <https://1145.am/db/2354806/Polaris_Venture_Partners>,
        <https://1145.am/db/2354955/Polaris_Partners>,
        <https://1145.am/db/2365296/Polaris_Venture_Partners>,
        <https://1145.am/db/2365300/Polaris_Venture_Partners>,
        <https://1145.am/db/2367497/Polaris_Venture_Partners>,
        <https://1145.am/db/2368913/Polaris_Partners>,
        <https://1145.am/db/2369304/Polaris_Partners>,
        <https://1145.am/db/2369305/Polaris_Partners>,
        <https://1145.am/db/250010/Polaris_Partners>,
        <https://1145.am/db/364226/Polaris_Partners>,
        <https://1145.am/db/572097/Polaris_Partners>,
        <https://1145.am/db/612707/Polaris_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1708291/Polaris_Venture_Partners>,
        <https://1145.am/db/1830502/Polaris_Venture_Partners>,
        <https://1145.am/db/2302116/Polaris_Venture_Partners>,
        <https://1145.am/db/2313401/Polaris_Venture_Partners>,
        <https://1145.am/db/2313405/Polaris_Venture_Partners>,
        <https://1145.am/db/2314380/Polaris_Venture_Partners>,
        <https://1145.am/db/2331763/Polaris_Venture_Partners>,
        <https://1145.am/db/2337571/Polaris_Venture_Partners>,
        <https://1145.am/db/2337577/Polaris_Venture_Partners>,
        <https://1145.am/db/2339127/Polaris_Venture_Partners>,
        <https://1145.am/db/2339128/Polaris_Venture_Partners>,
        <https://1145.am/db/2342445/Polaris_Venture_Partners>,
        <https://1145.am/db/2342862/Polaris_Venture_Partners>,
        <https://1145.am/db/2343210/Polaris_Venture_Partners>,
        <https://1145.am/db/2344256/Polaris_Venture_Partners>,
        <https://1145.am/db/2345224/Polaris_Venture_Partners>,
        <https://1145.am/db/2347102/Polaris_Venture_Partners>,
        <https://1145.am/db/2348448/Polaris_Venture_Partners>,
        <https://1145.am/db/2350034/Polaris_Venture_Partners>,
        <https://1145.am/db/2366654/Polaris_Venture_Partners>,
        <https://1145.am/db/2440024/Polaris_Venture_Partners>,
        <https://1145.am/db/2450515/Polaris_Venture_Partners>,
        <https://1145.am/db/2546216/Polaris_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340887/Investment_3x5_Special_Opportunity_Partners_Alta_Partners_Devon_Park_Bioventures_Rivervest_Venture_Partners_Salem_Partners_Zs_Pharma_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-24T12:45:32+00:00"^^xsd:dateTime ;
    ns1:documentExtract "(FORT WORTH, Texas) October 23, 2012 - Specialty pharmaceutical company ZS Pharma, Inc. has raised $ 46 million to advance development of ZS-9, a crystal form of zirconium silicate, designed to treat patients with kidney and liver disease.",
        "ZS Pharma raises $ 46 million in Series C Financing." ;
    ns1:documentTitle "ZS Pharma raises $46 million in Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/zs-pharma-raises-46-million-series-c-financing> ;
    ns1:foundName "raised" ;
    ns1:name "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2340887/Zs_Pharma> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 46 million" ;
    ns1:when "2012-10-23T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 23, 2012" ;
    ns1:whereGeoName "Texas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:whereRaw "Texas" .

<https://1145.am/db/2340888/Series_C_Investment_Correlation_Ventures_Mirna_Therapeutics_Inc_New_Enterprise_Associates_Osage_University_Partners_Pfizer_Ventures_Sofinnova_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-24T12:43:58+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Austin, TX - October 24, 2012 - Mirna Therapeutics Inc. (Mirna) , a biopharmaceutical company focused on the development and commercialization of microRNA (miRNA) therapeutics in cancer, announced today the completion of a $ 34.5 million Series C financing.",
        "Mirna Therapeutics Secures $ 34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic." ;
    ns1:documentTitle "Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mirna-therapeutics-secures-34-5-million-series-c-financing-to-advance-oncology-microrna-0> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2340888/Mirna_Therapeutics_Inc> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 34.5 Million",
        "$ 34.5 million" ;
    ns1:when "2012-10-24T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 24, 2012" ;
    ns1:whereGeoName "Texas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:whereRaw "Texas" .

<https://1145.am/db/2340890/Investment_Mirna_New_Enterprise_Associates_Pfizer_Sofinnova_Ventures_Stopped> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-24T12:53:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "And Mirna, a microRNA drug specialist, has tapped backers for a $ 34.5 million round as the company progresses toward a first clinical trial for one of its therapies.",
        "Austin - based Mirna has rallied deep-pocketed backers from New Enterprise Associates, Sofinnova Ventures, Pfizer ($ PFE) and others for its latest round.",
        "ZS Pharma has raised $ 46 million in a Series C financing to pursue development of a lead treatment for patients with kidney and liver disease." ;
    ns1:documentTitle "Two Texas biotech outfits lasso venture deals totaling $81M" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/two-texas-biotech-outfits-lasso-venture-deals-totaling-81m> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "stopped" ;
    ns1:target <https://1145.am/db/2340890/Mirna>,
        <https://1145.am/db/2340890/Zs_Pharma> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 34.5 million",
        "$ 46 million" ;
    ns1:whereGeoName "Texas" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4736286/about.rdf> ;
    ns1:whereRaw "Lone Star State" .

<https://1145.am/db/2342925/Investment_Mission_Bay_Capital_Morgenthaler_Ventures_New_Leaf_Venture_Partners_Orbimed_Advisors_Principia_Biopharma_Srone_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-29T15:15:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Principia Biopharma Secures $ 12.5M Second Tranche In Series A Financing, Expands Senior Management Team.",
        "SAN FRANCISCO, Oct. 29, 2012 - SAN FRANCISCO, Oct. 29, 2012 /PRNewswire/ - Principia Biopharma, Inc., a privately-held biopharmaceutical company focused on advancing best-in-class medicines in immunology, autoimmune diseases, and oncology announced that it successfully met its milestone obligations and received its second tranche of funding totaling $ 12.5 million in July 2012." ;
    ns1:documentTitle "Principia Biopharma Secures $12.5M Second Tranche In Series A Financing, Expands Senior Management Team" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/principia-biopharma-secures-12-5m-second-tranche-series-a-financing-expands-senior-0> ;
    ns1:foundName "funding" ;
    ns1:name "funding" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2342925/Principia_Biopharma> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 12.5 million",
        "$ 12.5M" ;
    ns1:whenRaw "July 2012" ;
    ns1:whereGeoName "San Francisco" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5391959/about.rdf> ;
    ns1:whereRaw "SAN FRANCISCO" .

<https://1145.am/db/2343966/Thesan_Pharmaceuticals> a org:Organization ;
    ns1:description "pharmaceuticals" ;
    ns1:documentDate "2012-10-31T15:12:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thesan-pharmaceuticals-announces-series-a-funding-co-led-by-novo-ventures-and-novartis> ;
    ns1:foundName "Thesan Pharmaceuticals" ;
    ns1:industry "pharmaceuticals" ;
    ns1:name "Thesan Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1103357/Esperion>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1183641/Tyme>,
        <https://1145.am/db/1184316/Tyme>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1213270/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1216194/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1224125/Ars_Pharmaceuticals>,
        <https://1145.am/db/1224418/Ars_Pharmaceuticals>,
        <https://1145.am/db/1225975/Ars_Pharmaceuticals_Inc>,
        <https://1145.am/db/1226849/Ars_Pharmaceuticals>,
        <https://1145.am/db/1252190/F2g_Ltd>,
        <https://1145.am/db/1265967/Tyme>,
        <https://1145.am/db/1266692/Tyme>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1334447/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1360048/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1361196/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1366554/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417340/Ars_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/PharmajetÂ®>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505021/Pharmaceutics_International_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/PharmajetÂ®>,
        <https://1145.am/db/1538098/Biocon_Ltd>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1606076/Gni_Group_Ltd>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1685745/Dmk_Pharmaceuticals_Corp>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1957460/Pardes_Biosciences_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2004101/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2054868/Pharmaceuticals_Inc>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2152849/Abide_Therapeutics>,
        <https://1145.am/db/2153295/Curzion_Pharmaceuticals>,
        <https://1145.am/db/2153719/Amag_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2212420/Cel-Sci_Corporation>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2225379/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2234316/Intercell_Ag>,
        <https://1145.am/db/2250936/Fera_Pharmaceuticals>,
        <https://1145.am/db/2277669/Pharmerica_Corporation>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2285587/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2286671/Promedior>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2289865/Thar_Pharmaceuticals>,
        <https://1145.am/db/2289873/Thar_Pharmaceuticals>,
        <https://1145.am/db/2290753/Medivir>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2297691/Ucb>,
        <https://1145.am/db/2298017/Kleo_Pharmaceuticals>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2301824/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303552/Meda>,
        <https://1145.am/db/2303645/Akarx>,
        <https://1145.am/db/2303646/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303647/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2303974/Actimis_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304342/PTC>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306115/Aesrx>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310568/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311359/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313181/Pharmeng_International_Inc>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314563/Inex_Pharmaceuticals>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315170/Alan_Copa>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315296/Pharmatec_Gmbh>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318104/Pharmaform>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319846/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320768/Semafore_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321150/Alinea_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322159/Pharmaceutical>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322850/Clinipace>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323303/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324141/Ucb>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324372/Ucb>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325215/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325260/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326361/Apt_Pharmaceuticals>,
        <https://1145.am/db/2326397/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2326541/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327258/Biocon_Limited>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328017/Calando_Pharmaceuticals>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328330/Meda>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328962/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329696/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329792/Semafore_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2329848/Idm_Pharma>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330121/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330734/Pharmaceuticals_Group>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330933/Biocon>,
        <https://1145.am/db/2330949/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330973/Bioxell>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331795/Ucb>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332028/Donald_Leung>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332912/Bioscrip>,
        <https://1145.am/db/2332920/Nastech>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336175/Forum_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336225/Acorda>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336936/Amag_Pharmaceuticals>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337481/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339127/Kala_Pharmaceuticals>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339830/Ocera>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341743/Amag_Pharmaceuticals>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342687/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343210/Promedior>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343325/Medivir>,
        <https://1145.am/db/2343497/Fera_Pharmaceuticals>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344560/Dmi_Biosciences_Inc>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346138/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347123/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2347125/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348620/Diartis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349031/Meda>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349461/Ista_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2350975/Meda>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351432/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352516/S_*_Bio>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354145/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355102/Addex_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355841/F2g_Ltd>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356391/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2356410/Ym_Biosciences_Inc>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2356560/Theravance>,
        <https://1145.am/db/2357259/Galmed_Pharmaceuticals>,
        <https://1145.am/db/2357321/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2357905/The_Medicines_Company>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358147/Omni_Bio_Pharmaceutical_Inc>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359380/Amri>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359681/Ucb>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360006/Topica_Pharmaceuticals>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360258/Aldea_Pharmaceuticals>,
        <https://1145.am/db/2360371/Preglem>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2361646/Biomarin>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362609/Amag_Pharmaceuticals>,
        <https://1145.am/db/2363154/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363248/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363461/Ucb>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364430/Cipla>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365372/Bd>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367182/Biotica>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368189/Index_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369617/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369883/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2369984/Biogaia>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370437/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2370437/MSD>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371320/Pharco_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2371522/Dyax>,
        <https://1145.am/db/238320/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538019/Ucb>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538392/Biocon>,
        <https://1145.am/db/2538422/Idt>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538705/PTC>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2539759/Twi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540249/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541419/Amri>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542071/Ucb>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544054/Cipla>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547068/Alapis>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547319/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2547593/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550232/Cipla>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554824/Cipla>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2555921/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557028/DPX>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558071/Cipla>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561791/Cipla>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2562552/Ucb>,
        <https://1145.am/db/2562723/Biontech>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563255/MSD>,
        <https://1145.am/db/2563450/Kv_Pharmaceuticals>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564030/Ucb>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2566424/Dbl_Pharmaceuticals>,
        <https://1145.am/db/2566946/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567296/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2567319/PTC>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569099/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2569102/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569425/Ucb>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570122/Ucb>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570733/Dyax_Corp>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2571136/Kala_Pharmaceuticals>,
        <https://1145.am/db/2571316/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2571723/Amag_Pharmaceuticals>,
        <https://1145.am/db/2572018/Meda>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572393/Pharmacia_Corporation>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573593/Biotica>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574213/Pharmacia_Corporation>,
        <https://1145.am/db/2574421/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575567/Fera_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2575850/Cipla>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578095/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578209/Ucb>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578420/Meda_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2578667/Almirall>,
        <https://1145.am/db/2579104/Ucb>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2581394/Biocon>,
        <https://1145.am/db/2581552/Imprimis_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582283/Amag_Pharmaceuticals>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2582681/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583352/Mikah>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583430/Imprimis_Pharmaceuticals>,
        <https://1145.am/db/2583437/Meda>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2583783/Biomarin>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2584617/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2584750/Meda>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585327/Cipla_Limited>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586547/Ucb>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587292/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589317/Diartis_Pharmaceuticals>,
        <https://1145.am/db/2589414/Spepharm_Ag>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Nectid>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2592254/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2592336/Dyax>,
        <https://1145.am/db/2592874/Ucb>,
        <https://1145.am/db/2593048/Meda>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594168/Meda>,
        <https://1145.am/db/2594183/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594257/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2594262/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2594414/Ista_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595326/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596636/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598012/Allos_Therapeutics>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/299734/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/402158/Puretech>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/587627/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/592025/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/612466/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/612973/Mingsight_Pharmaceuticals>,
        <https://1145.am/db/614114/Mingsight_Pharmaceuticals>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/731944/Aipharma>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/739339/Iveric_Bio>,
        <https://1145.am/db/742794/HrÂ®_Pharmaceuticals_Inc>,
        <https://1145.am/db/744958/Recipharm_Group>,
        <https://1145.am/db/746462/Recipharm_Group>,
        <https://1145.am/db/769779/Ucb_Sa>,
        <https://1145.am/db/769887/Ucb_Sa>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/792894/Amt>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/848323/Pharmaceutics_International_Inc>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/854160/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/867644/Aipharma_Group_Ltd>,
        <https://1145.am/db/871621/Aipharma_Group_Ltd>,
        <https://1145.am/db/881631/Pharmcorx>,
        <https://1145.am/db/881719/Pharmcorx>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/ThÃ©a_Pharma>,
        <https://1145.am/db/893741/Aipharma_Group_Ltd>,
        <https://1145.am/db/895336/Aipharma_Group_Ltd>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347043/Investment_Mei_Pharma_New_Leaf_Venture_Partners_Ra_Capital_Management_Three_Arch_Opportunity_Fund_Vivo_Ventures_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-07T16:22:25+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MEI Pharma Announces $ 27.5 Million Private Placement.",
        "San Diego - MEI Pharma, Inc. (Nasdaq: MEIP) , an oncology company focused on the clinical development of novel therapies for cancer, announced today that it has obtained commitments to purchase $ 27.5 million of its common stock and warrants in a private placement." ;
    ns1:documentTitle "MEI Pharma Announces $27.5 Million Private Placement" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mei-pharma-announces-27-5-million-private-placement> ;
    ns1:foundName "Private Placement",
        "private placement",
        "purchase" ;
    ns1:name "Private Placement",
        "private placement",
        "purchase" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2347043/Mei_Pharma> ;
    ns1:valueRaw "$ 27.5 Million",
        "$ 27.5 million" ;
    ns1:whereGeoName "Meizhou",
        "Pharma" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/10678659/about.rdf>,
        <https://sws.geonames.org/1800779/about.rdf> ;
    ns1:whereRaw "MEI Pharma" .

<https://1145.am/db/2347102/Polaris_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE" ;
    ns1:documentDate "2012-11-09T12:33:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/visterra-secures-financing-from-gates-foundation-and-omega-to-close-26m-series-a-financing> ;
    ns1:foundName "Polaris Venture Partners" ;
    ns1:investor <https://1145.am/db/2347102/Series_A_Investment_Flagship_Ventures_Lux_Capital_Omega_Funds_Polaris_Venture_Partners_The_Bill___Melinda_Gates_Foundation_Visterra_Completed> ;
    ns1:name "Polaris Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1701903/Polaris_Venture_Partners>,
        <https://1145.am/db/1708291/Polaris_Venture_Partners>,
        <https://1145.am/db/1830502/Polaris_Venture_Partners>,
        <https://1145.am/db/1870436/Polaris_Venture_Partners>,
        <https://1145.am/db/1877606/Polaris_Venture_Partners>,
        <https://1145.am/db/1897450/Polaris_Venture_Partners>,
        <https://1145.am/db/1909651/Polaris_Venture_Partners>,
        <https://1145.am/db/2174824/Polaris_Venture_Partners>,
        <https://1145.am/db/2292800/Polaris_Venture_Partners>,
        <https://1145.am/db/2302116/Polaris_Venture_Partners>,
        <https://1145.am/db/2303656/Polaris_Venture_Partners>,
        <https://1145.am/db/2303675/Polaris_Venture_Partners>,
        <https://1145.am/db/2313401/Polaris_Venture_Partners>,
        <https://1145.am/db/2313405/Polaris_Venture_Partners>,
        <https://1145.am/db/2314380/Polaris_Venture_Partners>,
        <https://1145.am/db/2315289/Polaris_Venture_Partners>,
        <https://1145.am/db/2323586/Polaris_Venture_Partners>,
        <https://1145.am/db/2324431/Polaris_Venture_Partners>,
        <https://1145.am/db/2331763/Polaris_Venture_Partners>,
        <https://1145.am/db/2337571/Polaris_Venture_Partners>,
        <https://1145.am/db/2337577/Polaris_Venture_Partners>,
        <https://1145.am/db/2338373/Polaris_Venture_Partners>,
        <https://1145.am/db/2339127/Polaris_Venture_Partners>,
        <https://1145.am/db/2339128/Polaris_Venture_Partners>,
        <https://1145.am/db/2342445/Polaris_Venture_Partners>,
        <https://1145.am/db/2342862/Polaris_Venture_Partners>,
        <https://1145.am/db/2343210/Polaris_Venture_Partners>,
        <https://1145.am/db/2344256/Polaris_Venture_Partners>,
        <https://1145.am/db/2345224/Polaris_Venture_Partners>,
        <https://1145.am/db/2348448/Polaris_Venture_Partners>,
        <https://1145.am/db/2350034/Polaris_Venture_Partners>,
        <https://1145.am/db/2352414/Polaris_Venture_Partners>,
        <https://1145.am/db/2354806/Polaris_Venture_Partners>,
        <https://1145.am/db/2365296/Polaris_Venture_Partners>,
        <https://1145.am/db/2365300/Polaris_Venture_Partners>,
        <https://1145.am/db/2366654/Polaris_Venture_Partners>,
        <https://1145.am/db/2367497/Polaris_Venture_Partners>,
        <https://1145.am/db/2440024/Polaris_Venture_Partners>,
        <https://1145.am/db/2450515/Polaris_Venture_Partners>,
        <https://1145.am/db/2546216/Polaris_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2347102/Series_A_Investment_Flagship_Ventures_Lux_Capital_Omega_Funds_Polaris_Venture_Partners_The_Bill___Melinda_Gates_Foundation_Visterra_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-09T12:33:53+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Nov 09, 2012 - Visterra, Inc., developer of novel medicines to prevent and treat infectious and other major diseases, today announced that it has raised an additional $ 13M to complete a $ 26M Series A financing.",
        "Visterra Secures Financing From Gates Foundation and Omega to Close $ 26M Series A Financing." ;
    ns1:documentTitle "Visterra Secures Financing From Gates Foundation and Omega to Close $26M Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/visterra-secures-financing-from-gates-foundation-and-omega-to-close-26m-series-a-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2347102/Visterra> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 13M",
        "$ 26M" ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass." .

<https://1145.am/db/2350164/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_Inc_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-15T16:09:39+00:00"^^xsd:dateTime ;
    ns1:documentExtract "HAYWARD, Calif., Nov. 15, 2012 /PRNewswire/ - Intarcia Therapeutics, Inc. today announced the simultaneous completion of two financings with total proceeds of $ 210 million, the largest sum to be raised by a private biotechnology company in at least 25 years.",
        "Intarcia Therapeutics Secures Landmark $ 210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes." ;
    ns1:documentTitle "Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intarcia-therapeutics-secures-landmark-210-million-financing-to-fund-its-global-phase-3> ;
    ns1:foundName "financings",
        "private debt placement",
        "private placement" ;
    ns1:name "financings",
        "private debt placement",
        "private placement" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2350164/Intarcia_Therapeutics> ;
    ns1:valueRaw "$ 160 million",
        "$ 210 Million",
        "$ 210 million",
        "$ 50 million" ;
    ns1:when "2012-11-15T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Nov. 15, 2012" ;
    ns1:whereRaw "Intarcia Therapeutics" .

<https://1145.am/db/2350167/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Has_Not_Happened> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-15T16:38:45+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Boasting of the biggest biotech raise in 25 years, Intarcia netted $ 160 million in venture cash from New Enterprise Associates, New Leaf Venture Partners and Venrock, as well as new investors at The Baupost Group, Farallon Capital Management, and three additional institutional investors.",
        "Offering another example of just how expensive it is for a biotech company to develop a new diabetes therapy, Intarcia Therapeutics this morning unveiled a whopping $ 210 million in fresh financing to back its Phase III program for ITCA 650, which aims to be the first once-yearly, injection-free GLP-1 therapy." ;
    ns1:documentTitle "Intarcia raises $210M for PhIII, once-yearly diabetes drug" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/intarcia-raises-210m-for-phiii-once-yearly-diabetes-drug> ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "has not happened" ;
    ns1:target <https://1145.am/db/2350167/Intarcia_Therapeutics> ;
    ns1:whereGeoName "California" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/5332921/about.rdf> ;
    ns1:whereRaw "California" .

<https://1145.am/db/2351224/Equity_Investment_Alta_Partners_Dfj-Esprit_Kiadis_Pharma_Lsp_Nom_Quest_For_Growth_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-21T15:02:45+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Amsterdam, The Netherlands, November 20, 2012 - Kiadis Pharma B.V., a clinical stage biopharmaceutical company developing treatments for blood cancers, announced today that it has raised EUR 10 million in an equity financing round.",
        "Kiadis Pharma Raises EUR 10 Million in Financing Round." ;
    ns1:documentTitle "Kiadis Pharma Raises EUR 10 Million in Financing Round" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/kiadis-pharma-raises-eur-10-million-financing-round> ;
    ns1:foundName "financing",
        "raised" ;
    ns1:name "financing",
        "raised" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2351224/Kiadis_Pharma> ;
    ns1:targetDetails "equity" ;
    ns1:valueRaw "EUR 10 Million",
        "EUR 10 million" ;
    ns1:when "2012-11-20T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "November 20, 2012" ;
    ns1:whereGeoName "Hellenic Republic" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/390903/about.rdf> ;
    ns1:whereRaw "Greece" .

<https://1145.am/db/2354296/Series_B_Investment_5am_Ventures_Flexion_Therapeutics_Novo_Ventures_Pfizer_Venture_Investments_Sofinnova_Partners_Versant_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-04T10:37:44+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Flexion Therapeutics Secures $ 20 Million in Series B Financing.",
        "WOBURN, Mass., Dec. 4, 2012 - /PRNewswire/ - Flexion Therapeutics, Inc. today announced that the company has secured $ 20 million in a Series B financing round led by new investor, Novo Ventures." ;
    ns1:documentTitle "Flexion Therapeutics Secures $20 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/flexion-therapeutics-secures-20-million-series-b-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2354296/Flexion_Therapeutics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 20 Million",
        "$ 20 million" ;
    ns1:when "2012-12-04T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Dec. 4, 2012" ;
    ns1:whereGeoName "Woburn" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4956032/about.rdf> ;
    ns1:whereRaw "WOBURN, Mass" .

<https://1145.am/db/2354806/Polaris_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "CAMBRIDGE, Mass" ;
    ns1:description "investment" ;
    ns1:documentDate "2012-09-04T12:13:41+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Startup WikiCell Designs Secures $10 Million in Investment Capital from Flagship Ventures and Polaris Venture Partners" ;
    ns1:documentURL <https://www.fiercebiotech.com/financials/startup-wikicell-designs-secures-10-million-investment-capital-from-flagship-ventures> ;
    ns1:foundName "Polaris Venture Partners" ;
    ns1:investor <https://1145.am/db/2354806/Series-A_Investment_Flagship_Ventures_Polaris_Venture_Partners_Wikicell_Designs_Inc_Completed> ;
    ns1:name "Polaris Venture Partners" ;
    ns1:sameAsHigh <https://1145.am/db/1163164/Polaris_Partners>,
        <https://1145.am/db/1166225/Polaris_Partners>,
        <https://1145.am/db/127343/Polaris_Partners>,
        <https://1145.am/db/1340338/Polaris_Partners>,
        <https://1145.am/db/1406211/Polaris_Partners>,
        <https://1145.am/db/1412727/Polaris_Partners>,
        <https://1145.am/db/1545490/Polaris_Partners>,
        <https://1145.am/db/1701903/Polaris_Venture_Partners>,
        <https://1145.am/db/1796259/Polaris_Capital>,
        <https://1145.am/db/1803886/Polaris_Partners>,
        <https://1145.am/db/1845960/Polaris_Partners>,
        <https://1145.am/db/1854788/Polaris_Partners>,
        <https://1145.am/db/1870436/Polaris_Venture_Partners>,
        <https://1145.am/db/1877606/Polaris_Venture_Partners>,
        <https://1145.am/db/1885717/Polaris_Ventures>,
        <https://1145.am/db/1897450/Polaris_Venture_Partners>,
        <https://1145.am/db/1909651/Polaris_Venture_Partners>,
        <https://1145.am/db/1947183/Polaris_Partners>,
        <https://1145.am/db/2140474/Polaris_Capital_Management>,
        <https://1145.am/db/2174824/Polaris_Venture_Partners>,
        <https://1145.am/db/2181016/Polaris_Partners>,
        <https://1145.am/db/2187023/Polaris_Partners>,
        <https://1145.am/db/2194844/Polaris_Partners>,
        <https://1145.am/db/2196895/Polaris_Partners>,
        <https://1145.am/db/2223723/Polaris_Partners>,
        <https://1145.am/db/2292800/Polaris_Venture_Partners>,
        <https://1145.am/db/2303656/Polaris_Venture_Partners>,
        <https://1145.am/db/2303675/Polaris_Venture_Partners>,
        <https://1145.am/db/2315289/Polaris_Venture_Partners>,
        <https://1145.am/db/2317918/Polaris_Ventures>,
        <https://1145.am/db/2318310/Polaris_Partners>,
        <https://1145.am/db/2323586/Polaris_Venture_Partners>,
        <https://1145.am/db/2324431/Polaris_Venture_Partners>,
        <https://1145.am/db/2335531/Flagship_Ventures_Polaris_Partners>,
        <https://1145.am/db/2335750/Polaris_Partners>,
        <https://1145.am/db/2338373/Polaris_Venture_Partners>,
        <https://1145.am/db/2341599/Polaris_Partners>,
        <https://1145.am/db/2343467/Polaris_Ventures>,
        <https://1145.am/db/2352414/Polaris_Venture_Partners>,
        <https://1145.am/db/2354955/Polaris_Partners>,
        <https://1145.am/db/2365296/Polaris_Venture_Partners>,
        <https://1145.am/db/2365300/Polaris_Venture_Partners>,
        <https://1145.am/db/2367497/Polaris_Venture_Partners>,
        <https://1145.am/db/2368913/Polaris_Partners>,
        <https://1145.am/db/2369304/Polaris_Partners>,
        <https://1145.am/db/2369305/Polaris_Partners>,
        <https://1145.am/db/250010/Polaris_Partners>,
        <https://1145.am/db/364226/Polaris_Partners>,
        <https://1145.am/db/572097/Polaris_Partners>,
        <https://1145.am/db/612707/Polaris_Partners> ;
    ns1:sameAsMedium <https://1145.am/db/1708291/Polaris_Venture_Partners>,
        <https://1145.am/db/1830502/Polaris_Venture_Partners>,
        <https://1145.am/db/2302116/Polaris_Venture_Partners>,
        <https://1145.am/db/2313401/Polaris_Venture_Partners>,
        <https://1145.am/db/2313405/Polaris_Venture_Partners>,
        <https://1145.am/db/2314380/Polaris_Venture_Partners>,
        <https://1145.am/db/2331763/Polaris_Venture_Partners>,
        <https://1145.am/db/2337571/Polaris_Venture_Partners>,
        <https://1145.am/db/2337577/Polaris_Venture_Partners>,
        <https://1145.am/db/2339127/Polaris_Venture_Partners>,
        <https://1145.am/db/2339128/Polaris_Venture_Partners>,
        <https://1145.am/db/2342445/Polaris_Venture_Partners>,
        <https://1145.am/db/2342862/Polaris_Venture_Partners>,
        <https://1145.am/db/2343210/Polaris_Venture_Partners>,
        <https://1145.am/db/2344256/Polaris_Venture_Partners>,
        <https://1145.am/db/2345224/Polaris_Venture_Partners>,
        <https://1145.am/db/2347102/Polaris_Venture_Partners>,
        <https://1145.am/db/2348448/Polaris_Venture_Partners>,
        <https://1145.am/db/2350034/Polaris_Venture_Partners>,
        <https://1145.am/db/2366654/Polaris_Venture_Partners>,
        <https://1145.am/db/2440024/Polaris_Venture_Partners>,
        <https://1145.am/db/2450515/Polaris_Venture_Partners>,
        <https://1145.am/db/2546216/Polaris_Venture_Partners> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356391/Infinity_Pharmaceuticals> a org:Organization ;
    ns1:description "Pharmaceuticals" ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:foundName "Infinity Pharmaceuticals" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:name "Infinity Pharmaceuticals" ;
    ns1:sameAsHigh <https://1145.am/db/101025/Scpharmaceuticals_Inc>,
        <https://1145.am/db/101329/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1031042/Intomics>,
        <https://1145.am/db/1033561/Hs_Pharmaceuticals>,
        <https://1145.am/db/1054457/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/1054503/Hs_Pharmaceuticals>,
        <https://1145.am/db/1061901/Pharmaessentia_Corporation>,
        <https://1145.am/db/1070158/Biognosys>,
        <https://1145.am/db/1079560/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1080385/Satiogen_Pharmaceuticals>,
        <https://1145.am/db/1092000/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/11010/Progenics_Pharmaceuticals>,
        <https://1145.am/db/1103357/Esperion>,
        <https://1145.am/db/1104169/20045078>,
        <https://1145.am/db/1118439/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1141704/Inmed_Pharmaceuticals>,
        <https://1145.am/db/1174705/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1176480/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1183641/Tyme>,
        <https://1145.am/db/1184316/Tyme>,
        <https://1145.am/db/1185008/TDV>,
        <https://1145.am/db/1186876/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/1198337/Recce_Pharmaceuticals_Ltd>,
        <https://1145.am/db/1213270/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1216194/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1216583/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1224125/Ars_Pharmaceuticals>,
        <https://1145.am/db/1224418/Ars_Pharmaceuticals>,
        <https://1145.am/db/1225975/Ars_Pharmaceuticals_Inc>,
        <https://1145.am/db/1226849/Ars_Pharmaceuticals>,
        <https://1145.am/db/1252190/F2g_Ltd>,
        <https://1145.am/db/1265967/Tyme>,
        <https://1145.am/db/1266692/Tyme>,
        <https://1145.am/db/1291286/Vital_Pharmaceuticals_Inc>,
        <https://1145.am/db/1294499/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1294506/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1295948/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1296487/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1307419/X4_Pharmaceuticals>,
        <https://1145.am/db/1322957/Biosion>,
        <https://1145.am/db/1329779/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1334447/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/1339033/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1343020/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/1360048/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1361196/Alnylam_Pharmaceuticals_Inc>,
        <https://1145.am/db/1366554/Casi_Pharmaceuticals_Inc>,
        <https://1145.am/db/1370859/Bioivt>,
        <https://1145.am/db/1371279/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1387773/Aspire_Pharma>,
        <https://1145.am/db/1390741/Nexus_Pharmaceuticals_Inc>,
        <https://1145.am/db/1409143/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1417340/Ars_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417348/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1417723/Altasciences>,
        <https://1145.am/db/1418572/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1430057/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443334/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/1443968/PharmajetÂ®>,
        <https://1145.am/db/1445613/Pharmajet>,
        <https://1145.am/db/1487706/Phathom_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497210/Indivior_Plc>,
        <https://1145.am/db/1497210/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1497218/Indivior>,
        <https://1145.am/db/1497218/Opiant_Pharmaceuticals>,
        <https://1145.am/db/1500616/Indivior_Plc>,
        <https://1145.am/db/1500616/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1502096/Indivior_Plc>,
        <https://1145.am/db/1502096/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1505021/Pharmaceutics_International_Inc>,
        <https://1145.am/db/1505968/Escient_Pharmaceuticals>,
        <https://1145.am/db/1508407/Escient_Pharmaceuticals>,
        <https://1145.am/db/1515279/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1520596/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1520597/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521624/Scpharmaceuticals>,
        <https://1145.am/db/1521695/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1521941/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/1523220/Scpharmaceuticals_Inc>,
        <https://1145.am/db/1533327/Escient_Pharmaceuticals>,
        <https://1145.am/db/1533685/Escient_Pharmaceuticals>,
        <https://1145.am/db/1537336/PharmajetÂ®>,
        <https://1145.am/db/1538098/Biocon_Ltd>,
        <https://1145.am/db/1538786/Pharmajet>,
        <https://1145.am/db/1540449/Aerie_Pharmaceuticals>,
        <https://1145.am/db/1541946/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1548955/Amunix_Pharmaceuticals>,
        <https://1145.am/db/1557072/Essential_Pharma>,
        <https://1145.am/db/1559882/X4_Pharmaceuticals_Inc>,
        <https://1145.am/db/1571078/Organon>,
        <https://1145.am/db/1585097/Scpharmaceuticals_Inc>,
        <https://1145.am/db/158742/Biogen_Inc>,
        <https://1145.am/db/1595580/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/160543/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/1606076/Gni_Group_Ltd>,
        <https://1145.am/db/1613688/Pharmalex>,
        <https://1145.am/db/1624479/Indivior_Plc>,
        <https://1145.am/db/1624479/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1625532/Indivior_Plc>,
        <https://1145.am/db/1625532/Opiant_Pharmaceuticals_Inc>,
        <https://1145.am/db/1629605/Biogen>,
        <https://1145.am/db/1629663/Biogen>,
        <https://1145.am/db/1632411/Scipher_Medicine>,
        <https://1145.am/db/1632862/Scipher_Medicine>,
        <https://1145.am/db/1632868/Sovereign_Pharmaceuticals_Llc>,
        <https://1145.am/db/1661035/Biontech>,
        <https://1145.am/db/1680583/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/1685745/Dmk_Pharmaceuticals_Corp>,
        <https://1145.am/db/1687234/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/180589/Servier>,
        <https://1145.am/db/1955684/Eip_Pharma_Inc>,
        <https://1145.am/db/1957460/Pardes_Biosciences_Inc>,
        <https://1145.am/db/1979697/Amphastar_Pharmaceuticals>,
        <https://1145.am/db/2004101/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2038168/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039291/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2039678/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2040011/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2045820/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2049603/Inova_Pharmaceuticals>,
        <https://1145.am/db/2054868/Pharmaceuticals_Inc>,
        <https://1145.am/db/2056005/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2056755/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2061803/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2062156/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2066480/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2071248/Biogen>,
        <https://1145.am/db/2074741/Biogen_Inc>,
        <https://1145.am/db/2092442/Leo_Pharma>,
        <https://1145.am/db/2093802/Meitheal_Pharmaceuticals>,
        <https://1145.am/db/2100253/Biogen_Inc>,
        <https://1145.am/db/2101006/Leo_Pharma_A_S>,
        <https://1145.am/db/2138834/Altasciences>,
        <https://1145.am/db/2151781/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2152103/Am-Pharma>,
        <https://1145.am/db/2152434/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2152849/Abide_Therapeutics>,
        <https://1145.am/db/2153295/Curzion_Pharmaceuticals>,
        <https://1145.am/db/2153719/Amag_Pharmaceuticals>,
        <https://1145.am/db/2153727/Amunix_Pharmaceuticals>,
        <https://1145.am/db/2154019/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154118/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2154527/The_Medicines_Company>,
        <https://1145.am/db/2154871/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155006/Medicines_Company>,
        <https://1145.am/db/2155312/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2155622/Isa_Pharmaceuticals>,
        <https://1145.am/db/2155792/Ucb_Pharma>,
        <https://1145.am/db/2155798/Ucb_Pharma>,
        <https://1145.am/db/2155994/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2156002/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2198945/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2201094/Pharmadeals_Ltd>,
        <https://1145.am/db/2204969/Organon_Biosciences>,
        <https://1145.am/db/2207034/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2212420/Cel-Sci_Corporation>,
        <https://1145.am/db/221697/Gw_Pharmaceuticals>,
        <https://1145.am/db/2217819/Pharmacopeia>,
        <https://1145.am/db/221787/Gw_Pharmaceuticals>,
        <https://1145.am/db/2218929/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2224859/Biologics>,
        <https://1145.am/db/2225379/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2229191/Biologics>,
        <https://1145.am/db/2234316/Intercell_Ag>,
        <https://1145.am/db/2250936/Fera_Pharmaceuticals>,
        <https://1145.am/db/2277669/Pharmerica_Corporation>,
        <https://1145.am/db/2279276/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2279648/Organon>,
        <https://1145.am/db/2280123/Casi_Pharmaceuticals>,
        <https://1145.am/db/2280153/Pharming>,
        <https://1145.am/db/2281547/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2283570/Pherin_Pharmaceuticals>,
        <https://1145.am/db/2284358/Escient_Pharmaceuticals>,
        <https://1145.am/db/2285117/Immedica>,
        <https://1145.am/db/2285495/Bioivt>,
        <https://1145.am/db/2285587/Momenta_Pharmaceuticals>,
        <https://1145.am/db/2286671/Promedior>,
        <https://1145.am/db/2287224/Escient_Pharmaceuticals>,
        <https://1145.am/db/2287505/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2287572/T3_Pharmaceuticals>,
        <https://1145.am/db/2288192/Servier>,
        <https://1145.am/db/2289865/Thar_Pharmaceuticals>,
        <https://1145.am/db/2289873/Thar_Pharmaceuticals>,
        <https://1145.am/db/2290753/Medivir>,
        <https://1145.am/db/2290842/X4_Pharmaceuticals>,
        <https://1145.am/db/2291791/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2291914/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2294547/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2294570/Pharmatek>,
        <https://1145.am/db/2296094/Biogen>,
        <https://1145.am/db/2297534/Bio>,
        <https://1145.am/db/2297691/Ucb>,
        <https://1145.am/db/2298017/Kleo_Pharmaceuticals>,
        <https://1145.am/db/2298037/Ethicon>,
        <https://1145.am/db/2298627/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2299414/Biogen>,
        <https://1145.am/db/2301089/Cerulean_Pharma>,
        <https://1145.am/db/2301346/Pharmaron>,
        <https://1145.am/db/2301718/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2301735/Idera_Pharmaceuticals>,
        <https://1145.am/db/2301764/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2301798/Osi_Pharmaceuticals>,
        <https://1145.am/db/2301824/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302019/Oscient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2302275/Map_Pharmaceuticals>,
        <https://1145.am/db/2302426/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302431/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2302552/Am-Pharma>,
        <https://1145.am/db/2302574/Via_Pharmaceuticals>,
        <https://1145.am/db/2302579/Via_Pharmaceuticals>,
        <https://1145.am/db/2302587/Access_Pharmaceuticals>,
        <https://1145.am/db/2302658/Biotie>,
        <https://1145.am/db/2302707/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2302774/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302779/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2302890/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2302897/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2303022/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303121/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303131/Locus_Pharmaceuticals>,
        <https://1145.am/db/2303182/Pharmexa>,
        <https://1145.am/db/2303208/Ore_Pharmaceuticals>,
        <https://1145.am/db/2303426/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2303552/Meda>,
        <https://1145.am/db/2303645/Akarx>,
        <https://1145.am/db/2303646/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303647/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2303674/Cerulean_Pharma>,
        <https://1145.am/db/2303792/Access_Pharmaceuticals>,
        <https://1145.am/db/2303934/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2303956/Prolexys_Pharmaceuticals>,
        <https://1145.am/db/2303974/Actimis_Pharmaceuticals>,
        <https://1145.am/db/2304044/Novamed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2304097/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2304135/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2304342/PTC>,
        <https://1145.am/db/2304610/Pharmos_Corp>,
        <https://1145.am/db/2304745/Critical_Pharmaceuticals>,
        <https://1145.am/db/2304831/Pharmion_Corporation>,
        <https://1145.am/db/2304934/Medicure>,
        <https://1145.am/db/2304985/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2305742/Mh_Pharma_Uk>,
        <https://1145.am/db/2305834/Nps_Pharmaceuticals>,
        <https://1145.am/db/2305927/Entremed>,
        <https://1145.am/db/2305956/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2306115/Aesrx>,
        <https://1145.am/db/2306255/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2306299/Verily>,
        <https://1145.am/db/2306641/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2306962/Pharmaron>,
        <https://1145.am/db/2307239/Pharmaxis_Ltd>,
        <https://1145.am/db/2307246/Pharmaxis>,
        <https://1145.am/db/2307254/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2307651/Organon>,
        <https://1145.am/db/2307834/Savient_Pharmaceuticals>,
        <https://1145.am/db/2307871/Access_Pharmaceuticals>,
        <https://1145.am/db/2307894/Lev_Pharmaceuticals>,
        <https://1145.am/db/2307897/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2308423/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2308429/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2308446/Pharmathene>,
        <https://1145.am/db/2308922/Lev_Pharmaceuticals>,
        <https://1145.am/db/2308964/Slate_Pharmaceuticals>,
        <https://1145.am/db/2309001/Biocon>,
        <https://1145.am/db/2309301/Inc>,
        <https://1145.am/db/2309923/Diasome_Pharmaceuticals>,
        <https://1145.am/db/2310002/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2310002/Map_Pharmaceuticals>,
        <https://1145.am/db/2310045/Slate_Pharmaceuticals>,
        <https://1145.am/db/2310071/Encysive_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310196/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2310200/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2310219/Docpharma>,
        <https://1145.am/db/2310232/Genaissance_Pharmaceuticals>,
        <https://1145.am/db/2310471/Cornerstone_Pharmaceuticals>,
        <https://1145.am/db/2310473/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310476/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2310480/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310568/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2310590/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2310790/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2310989/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2310993/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2311166/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2311202/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2311217/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2311264/Medicure>,
        <https://1145.am/db/2311359/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2311726/Inc>,
        <https://1145.am/db/2312088/Cerulean_Pharma>,
        <https://1145.am/db/2312088/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2312158/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2312193/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2312257/The_Medicines_Company>,
        <https://1145.am/db/2312344/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2312416/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2312476/Nps_Pharmaceuticals>,
        <https://1145.am/db/2312479/Nps_Pharmaceuticals>,
        <https://1145.am/db/2313181/Pharmeng_International_Inc>,
        <https://1145.am/db/2313305/Tetraphase_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313306/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2313320/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313320/Ore_Pharmaceuticals>,
        <https://1145.am/db/2313323/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2313324/Ore_Pharmaceuticals_Inc>,
        <https://1145.am/db/2313336/Sound_Pharmaceuticals>,
        <https://1145.am/db/2313487/Symbollon_Pharmaceuticals>,
        <https://1145.am/db/2313501/Bioalliance_Pharma>,
        <https://1145.am/db/2313527/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2313528/Us_Pharmaceutical_Company>,
        <https://1145.am/db/2314217/Sciele_Pharma>,
        <https://1145.am/db/2314271/Biomarck_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2314277/Biomarck_Pharmaceuticals>,
        <https://1145.am/db/2314317/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314375/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314474/Pharmion>,
        <https://1145.am/db/2314563/Inex_Pharmaceuticals>,
        <https://1145.am/db/2314680/Pharming>,
        <https://1145.am/db/2314816/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2314837/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2315159/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2315170/Alan_Copa>,
        <https://1145.am/db/2315192/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2315296/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315296/Pharmatec_Gmbh>,
        <https://1145.am/db/2315485/Polpharma>,
        <https://1145.am/db/2315571/Sciele_Pharma>,
        <https://1145.am/db/2315624/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2315624/Pharmos>,
        <https://1145.am/db/2315925/Oramed_Pharmaceuticals>,
        <https://1145.am/db/2315941/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2316239/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2316418/Pharmaventures_Ltd>,
        <https://1145.am/db/2316435/Pharmaventures_Ltd>,
        <https://1145.am/db/2316481/Osi_Pharmaceuticals>,
        <https://1145.am/db/2316660/Pharmacopeia>,
        <https://1145.am/db/2316684/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2317337/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2317344/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2317635/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2317762/Pharmathene>,
        <https://1145.am/db/2317826/Anormed>,
        <https://1145.am/db/2317826/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2317842/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317895/Esprit_Pharma>,
        <https://1145.am/db/2317929/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2317949/Novalar_Pharmaceuticals>,
        <https://1145.am/db/2318104/Pharmaform>,
        <https://1145.am/db/2318105/Pharma_Inc>,
        <https://1145.am/db/2318114/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2318248/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318285/Pht_Corporation>,
        <https://1145.am/db/2318469/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2318554/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2318574/Idera_Pharmaceuticals>,
        <https://1145.am/db/2318711/Specialty_Pharmaceuticals>,
        <https://1145.am/db/2318743/Pharmos_Corporation>,
        <https://1145.am/db/2318808/Pharmathene>,
        <https://1145.am/db/2318986/Corgentech>,
        <https://1145.am/db/2318994/Cornerstone_Biopharma>,
        <https://1145.am/db/2319208/Osi_Pharmaceuticals>,
        <https://1145.am/db/2319687/Advisys>,
        <https://1145.am/db/2319790/Pharmacyclics>,
        <https://1145.am/db/2319806/Satori_Pharmaceuticals>,
        <https://1145.am/db/2319809/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2319846/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2319938/Del_Pharmaceuticals>,
        <https://1145.am/db/2319939/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2320009/Map_Pharmaceuticals>,
        <https://1145.am/db/2320025/Am-Pharma>,
        <https://1145.am/db/2320025/Esprit_Pharma>,
        <https://1145.am/db/2320461/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2320767/Via_Pharmaceuticals>,
        <https://1145.am/db/2320768/Semafore_Pharmaceuticals>,
        <https://1145.am/db/2320903/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2320949/Medicines_Company>,
        <https://1145.am/db/2321148/Savient_Pharmaceuticals>,
        <https://1145.am/db/2321150/Alinea_Pharmaceuticals>,
        <https://1145.am/db/2321157/Access_Pharmaceuticals>,
        <https://1145.am/db/2321256/Nps_Pharmaceuticals>,
        <https://1145.am/db/2321409/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321413/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2321565/2009-2010>,
        <https://1145.am/db/2321784/Acceliant>,
        <https://1145.am/db/2321860/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2321861/Astion_Pharma>,
        <https://1145.am/db/2321871/Astion_Pharma>,
        <https://1145.am/db/2321899/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2322135/Millennium_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322159/Pharmaceutical>,
        <https://1145.am/db/2322235/Pharmacopeia>,
        <https://1145.am/db/2322291/Polpharma>,
        <https://1145.am/db/2322481/Cornerstone_Pharmaceuticals_Inc>,
        <https://1145.am/db/2322632/Savient_Pharmaceuticals>,
        <https://1145.am/db/2322850/Clinipace>,
        <https://1145.am/db/2322942/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2322953/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2323173/Pharmacopeia>,
        <https://1145.am/db/2323181/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2323225/Arqule>,
        <https://1145.am/db/2323273/Pharmion_Corporation>,
        <https://1145.am/db/2323278/Pharmion>,
        <https://1145.am/db/2323303/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2323358/Organon_Biosciences>,
        <https://1145.am/db/2324017/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2324024/Presidio_Pharmaceuticals>,
        <https://1145.am/db/2324141/Ucb>,
        <https://1145.am/db/2324243/Arqule>,
        <https://1145.am/db/2324372/Ucb>,
        <https://1145.am/db/2324417/Biomimetic_Pharmaceuticals>,
        <https://1145.am/db/2324753/Biomarin_Pharmaceutical_Inc>,
        <https://1145.am/db/2324838/Biogen>,
        <https://1145.am/db/2325070/The_Medicines_Company>,
        <https://1145.am/db/2325074/The_Medicines_Company>,
        <https://1145.am/db/2325215/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2325259/Pharmacopeia>,
        <https://1145.am/db/2325260/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2325269/Pharmacopeia>,
        <https://1145.am/db/2325394/Pharmion>,
        <https://1145.am/db/2325725/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326025/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2326148/Encysive_Pharmaceuticals>,
        <https://1145.am/db/2326286/Idera_Pharmaceuticals>,
        <https://1145.am/db/2326361/Apt_Pharmaceuticals>,
        <https://1145.am/db/2326397/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2326403/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2326466/Macromed>,
        <https://1145.am/db/2326474/Innovive_Pharmaceuticals>,
        <https://1145.am/db/2326541/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2327241/Nps_Pharmaceuticals>,
        <https://1145.am/db/2327258/Biocon_Limited>,
        <https://1145.am/db/2327450/York_Pharma>,
        <https://1145.am/db/2327480/Transdel_Pharmaceuticals>,
        <https://1145.am/db/2327649/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2327849/Pharmacia_Corporation>,
        <https://1145.am/db/2328017/Calando_Pharmaceuticals>,
        <https://1145.am/db/2328043/Madrigal_Pharmaceuticals>,
        <https://1145.am/db/2328220/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2328222/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2328330/Meda>,
        <https://1145.am/db/2328616/Map_Pharmaceuticals>,
        <https://1145.am/db/2328650/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2328729/Pediamed_Pharmaceuticals>,
        <https://1145.am/db/2328962/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2328988/Cequent_Pharmaceuticals>,
        <https://1145.am/db/2328990/Mdrna>,
        <https://1145.am/db/2328996/Via_Pharmaceuticals>,
        <https://1145.am/db/2329309/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2329643/Pharmaceuticals_Inc>,
        <https://1145.am/db/2329696/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2329756/Provid_Pharmaceuticals>,
        <https://1145.am/db/2329792/Semafore_Pharmaceuticals>,
        <https://1145.am/db/2329814/Map_Pharmaceuticals>,
        <https://1145.am/db/2329816/Map_Pharmaceuticals>,
        <https://1145.am/db/2329848/Idm_Pharma>,
        <https://1145.am/db/2330057/Pharmathene>,
        <https://1145.am/db/2330086/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330094/Idera_Pharmaceuticals>,
        <https://1145.am/db/2330121/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2330207/Bioxell>,
        <https://1145.am/db/2330207/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2330534/Pharmion>,
        <https://1145.am/db/2330576/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330667/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330734/Pharmaceuticals_Group>,
        <https://1145.am/db/2330858/Provid_Pharmaceuticals_Inc>,
        <https://1145.am/db/2330880/Access_Pharmaceuticals>,
        <https://1145.am/db/2330880/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2330882/Proprius_Pharmaceuticals>,
        <https://1145.am/db/2330933/Biocon>,
        <https://1145.am/db/2330949/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2330951/Oscient_Pharmaceuticals>,
        <https://1145.am/db/2330973/Bioxell>,
        <https://1145.am/db/2330989/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2331692/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2331745/Elan_Pharmaceuticals>,
        <https://1145.am/db/2331756/Pro-Pharmaceuticals>,
        <https://1145.am/db/2331795/Ucb>,
        <https://1145.am/db/2331875/Bioalliance_Pharma>,
        <https://1145.am/db/2332028/Donald_Leung>,
        <https://1145.am/db/2332473/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2332596/Esprit_Pharma>,
        <https://1145.am/db/2332777/S_*_Bio>,
        <https://1145.am/db/2332912/Bioscrip>,
        <https://1145.am/db/2332920/Nastech>,
        <https://1145.am/db/2332974/Osi_Pharmaceuticals>,
        <https://1145.am/db/2332980/Pharmos_Corporation>,
        <https://1145.am/db/2333492/Access_Pharmaceuticals>,
        <https://1145.am/db/2333569/Ception>,
        <https://1145.am/db/2333624/Pharmos>,
        <https://1145.am/db/2334034/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2334119/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334121/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2334183/Idera_Pharmaceuticals>,
        <https://1145.am/db/2335077/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2336040/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336041/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2336160/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2336175/Forum_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336225/Acorda>,
        <https://1145.am/db/2336293/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2336378/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336442/Bionor_Pharma_Asa>,
        <https://1145.am/db/2336452/Pharmaxis_Ltd>,
        <https://1145.am/db/2336503/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336505/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336506/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2336524/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336629/Biota_Pharmaceuticals>,
        <https://1145.am/db/2336934/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2336936/Amag_Pharmaceuticals>,
        <https://1145.am/db/2337053/N30_Pharmaceuticals>,
        <https://1145.am/db/2337345/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337348/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2337481/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2337547/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337928/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2337986/Pharmagen_Inc>,
        <https://1145.am/db/2338120/The_Medicines_Company>,
        <https://1145.am/db/2338123/The_Medicines_Company>,
        <https://1145.am/db/2338390/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338401/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2338430/Pharmacyclics>,
        <https://1145.am/db/2338551/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2338735/Map_Pharmaceuticals>,
        <https://1145.am/db/2338877/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2338883/Cerulean_Pharma_Inc>,
        <https://1145.am/db/2339019/Isa_Pharmaceuticals_Bv>,
        <https://1145.am/db/2339127/Kala_Pharmaceuticals>,
        <https://1145.am/db/2339186/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2339570/Map_Pharmaceuticals>,
        <https://1145.am/db/2339718/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2339727/Pharmacyclics_Inc>,
        <https://1145.am/db/2339787/Pharmalink_Ab>,
        <https://1145.am/db/2339830/Ocera>,
        <https://1145.am/db/2339892/Pharmacyclics>,
        <https://1145.am/db/2339907/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2339910/Biomed_Pharmaceuticals>,
        <https://1145.am/db/2339922/Pharmaform>,
        <https://1145.am/db/2339979/Theravance>,
        <https://1145.am/db/2340000/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2340224/Satori_Pharmaceuticals>,
        <https://1145.am/db/2340291/Pharmasset>,
        <https://1145.am/db/2340373/Nps_Pharmaceuticals>,
        <https://1145.am/db/2340431/Savient_Pharmaceuticals>,
        <https://1145.am/db/2341523/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2341742/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2341743/Amag_Pharmaceuticals>,
        <https://1145.am/db/2341752/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2341998/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2342192/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2342224/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342225/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2342469/Pharmadel>,
        <https://1145.am/db/2342687/Bioalliance_Pharma>,
        <https://1145.am/db/2342687/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2342800/Pharmathene>,
        <https://1145.am/db/2342805/Pharmathene>,
        <https://1145.am/db/2342918/Pharmalink_Ab>,
        <https://1145.am/db/2343210/Promedior>,
        <https://1145.am/db/2343264/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2343277/Pharmasset>,
        <https://1145.am/db/2343325/Medivir>,
        <https://1145.am/db/2343497/Fera_Pharmaceuticals>,
        <https://1145.am/db/2343826/The_Medicines_Company>,
        <https://1145.am/db/2343837/Medicines_Co>,
        <https://1145.am/db/2343966/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2344011/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344076/Transdel_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344079/Map_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344131/Pharmascience_Inc>,
        <https://1145.am/db/2344207/Entremed>,
        <https://1145.am/db/2344560/Dmi_Biosciences_Inc>,
        <https://1145.am/db/2344624/Pharmagen_Inc>,
        <https://1145.am/db/2344735/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344739/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2344850/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2344939/Theravance>,
        <https://1145.am/db/2344955/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2345106/Map_Pharmaceuticals>,
        <https://1145.am/db/2345474/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2345902/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346138/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2346534/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346542/Conatus_Pharmaceuticals>,
        <https://1145.am/db/2346775/N30_Pharmaceuticals>,
        <https://1145.am/db/2346800/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346807/Satori_Pharmaceuticals_Incorporated>,
        <https://1145.am/db/2346832/Vital_Science_Corp>,
        <https://1145.am/db/2346833/Vital_Science_Corp>,
        <https://1145.am/db/2346951/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2346964/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2347123/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2347125/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2347127/Pharmacyte_Biotech>,
        <https://1145.am/db/2347169/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2347227/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2347272/Pharmascience>,
        <https://1145.am/db/2347519/Pharmadeals_Ltd>,
        <https://1145.am/db/2347644/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347648/Pharminox_Limited>,
        <https://1145.am/db/2347659/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2347982/Epicept>,
        <https://1145.am/db/2348329/Esperance_Pharmaceuticals>,
        <https://1145.am/db/2348506/Am-Pharma_Bv>,
        <https://1145.am/db/2348523/Am-Pharma_Bv>,
        <https://1145.am/db/2348620/Diartis_Pharmaceuticals_Inc>,
        <https://1145.am/db/2348763/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2348864/Vital_Science_Corp>,
        <https://1145.am/db/2349031/Meda>,
        <https://1145.am/db/2349103/Biota_Pharmaceuticals>,
        <https://1145.am/db/2349111/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349348/R-Pharm>,
        <https://1145.am/db/2349461/Ista_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349573/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349581/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349608/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2349965/Idera_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350147/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2350440/Ethicon>,
        <https://1145.am/db/2350852/Isa_Pharmaceuticals>,
        <https://1145.am/db/2350975/Meda>,
        <https://1145.am/db/2351091/Biomotiv>,
        <https://1145.am/db/2351432/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2351471/Mymetics_Corporation>,
        <https://1145.am/db/2351818/Biocon>,
        <https://1145.am/db/2352046/Costim_Pharmaceuticals>,
        <https://1145.am/db/2352165/Bio>,
        <https://1145.am/db/2352177/Theravance_Inc>,
        <https://1145.am/db/2352180/Pharmaceutical_Research_And_Manufacturers_Of_America>,
        <https://1145.am/db/2352333/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2352516/S_*_Bio>,
        <https://1145.am/db/2352538/Biota_Pharmaceuticals>,
        <https://1145.am/db/2352659/Nps_Pharmaceuticals>,
        <https://1145.am/db/2352784/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2352805/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2352808/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353006/Radient_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2353093/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353098/Thesan_Pharmaceuticals>,
        <https://1145.am/db/2353101/Index_Pharmaceuticals>,
        <https://1145.am/db/2353254/Pharma_Inc>,
        <https://1145.am/db/2353262/Sound_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353279/Presidio_Pharmaceuticals_Inc>,
        <https://1145.am/db/2353326/Am-Pharma>,
        <https://1145.am/db/2353364/Am-Pharma>,
        <https://1145.am/db/2353651/Pharmathene>,
        <https://1145.am/db/2353668/Biotie>,
        <https://1145.am/db/2354002/N30_Pharmaceuticals>,
        <https://1145.am/db/2354062/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354064/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354083/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354086/Osi_Pharmaceuticals>,
        <https://1145.am/db/2354124/Uk>,
        <https://1145.am/db/2354145/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354146/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2354376/Aspireo_Pharmaceuticals>,
        <https://1145.am/db/2354380/Pharmaxis>,
        <https://1145.am/db/2354388/Pharmaxis>,
        <https://1145.am/db/2354402/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354406/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2354779/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354783/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2354804/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2354836/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2354913/Bionor_Pharma_Asa>,
        <https://1145.am/db/2355099/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355102/Addex_Pharmaceuticals_Ltd>,
        <https://1145.am/db/2355109/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2355324/Biota_Pharmaceuticals_Inc>,
        <https://1145.am/db/2355678/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2355721/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2355841/F2g_Ltd>,
        <https://1145.am/db/2355884/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355885/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2355941/Theratechnologies>,
        <https://1145.am/db/2355974/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2356294/Company>,
        <https://1145.am/db/2356294/Inc>,
        <https://1145.am/db/2356410/Ym_Biosciences_Inc>,
        <https://1145.am/db/2356434/The_Medicines_Company>,
        <https://1145.am/db/2356560/Theravance>,
        <https://1145.am/db/2357259/Galmed_Pharmaceuticals>,
        <https://1145.am/db/2357321/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2357329/Pharmalink_Ab>,
        <https://1145.am/db/2357333/Pharmalink>,
        <https://1145.am/db/2357423/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357456/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2357636/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2357905/The_Medicines_Company>,
        <https://1145.am/db/2358047/Entremed>,
        <https://1145.am/db/2358147/Omni_Bio_Pharmaceutical_Inc>,
        <https://1145.am/db/2358405/Pharmagen_Inc>,
        <https://1145.am/db/2358449/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358479/Nps_Pharmaceuticals_Inc>,
        <https://1145.am/db/2358732/Osi_Pharmaceuticals>,
        <https://1145.am/db/2358877/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359266/D-Pharm>,
        <https://1145.am/db/2359380/Amri>,
        <https://1145.am/db/2359401/Scpharmaceuticals_Inc>,
        <https://1145.am/db/2359438/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2359474/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2359517/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2359539/Omthera_Pharmaceuticals>,
        <https://1145.am/db/2359550/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2359668/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2359681/Ucb>,
        <https://1145.am/db/2359882/Biotie>,
        <https://1145.am/db/2359926/Entremed>,
        <https://1145.am/db/2360006/Topica_Pharmaceuticals>,
        <https://1145.am/db/2360155/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2360258/Aldea_Pharmaceuticals>,
        <https://1145.am/db/2360371/Preglem>,
        <https://1145.am/db/2360489/Medac_Pharma>,
        <https://1145.am/db/2360588/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2360596/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2360697/Medgenics>,
        <https://1145.am/db/2360739/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2360945/Entremed>,
        <https://1145.am/db/2361244/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2361516/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2361646/Biomarin>,
        <https://1145.am/db/2362378/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2362456/Action_Pharma_A_S>,
        <https://1145.am/db/2362525/Horizon_Pharma>,
        <https://1145.am/db/2362593/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362609/Amag_Pharmaceuticals>,
        <https://1145.am/db/2363154/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363186/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363248/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2363285/Phenex_Pharmaceuticals_Ag>,
        <https://1145.am/db/2363340/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363387/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2363425/The_Medicines_Company>,
        <https://1145.am/db/2363433/The_Medicines_Company>,
        <https://1145.am/db/2363452/Pharmasum_Therapeutics_As>,
        <https://1145.am/db/2363461/Ucb>,
        <https://1145.am/db/2363530/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/2363801/Preglem>,
        <https://1145.am/db/2363955/Savient_Pharmaceuticals>,
        <https://1145.am/db/2364093/Biotie>,
        <https://1145.am/db/2364252/Nps_Pharmaceuticals>,
        <https://1145.am/db/2364274/S_*_Bio_Pte_Ltd>,
        <https://1145.am/db/2364276/S_*_Bio>,
        <https://1145.am/db/2364430/Cipla>,
        <https://1145.am/db/2364494/Bioalliance_Pharma_Sa>,
        <https://1145.am/db/2364495/Bioalliance_Pharma>,
        <https://1145.am/db/2364538/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2364541/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2364585/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2364593/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364601/Aragon_Pharmaceuticals>,
        <https://1145.am/db/2364774/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2364884/Entremed_Inc>,
        <https://1145.am/db/2365030/Gw_Pharmaceuticals_Plc>,
        <https://1145.am/db/2365098/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365224/Research_Pharmaceutical_Services>,
        <https://1145.am/db/2365372/Bd>,
        <https://1145.am/db/2365423/Conatus_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365450/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2365724/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2365763/Biosante_Pharmaceuticals>,
        <https://1145.am/db/2366139/Prism_Pharmaceuticals>,
        <https://1145.am/db/2366388/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2366521/Novamed_Pharmaceuticals>,
        <https://1145.am/db/2366540/Prism_Pharmaceuticals>,
        <https://1145.am/db/2367021/Biotie>,
        <https://1145.am/db/2367070/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2367182/Biotica>,
        <https://1145.am/db/2367280/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2367438/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2367483/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367496/Vitae_Pharmaceuticals>,
        <https://1145.am/db/2367951/Prismic_Pharmaceuticals>,
        <https://1145.am/db/2367962/Catalyst_Pharmaceuticals>,
        <https://1145.am/db/2368070/Afferent_Pharmaceuticals>,
        <https://1145.am/db/2368189/Index_Pharmaceuticals>,
        <https://1145.am/db/2368339/Tetraphase_Pharmaceuticals>,
        <https://1145.am/db/2368420/Intec_Pharma>,
        <https://1145.am/db/2368593/Bioquiddity_Incorporated>,
        <https://1145.am/db/2368632/Pharmacyclics>,
        <https://1145.am/db/2368739/Novartis_Pharmaceuticals>,
        <https://1145.am/db/2368826/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369004/Biogen>,
        <https://1145.am/db/2369037/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369126/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369144/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2369233/Biopharmx_Corporation>,
        <https://1145.am/db/2369402/Medicines_Company>,
        <https://1145.am/db/2369617/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2369812/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2369883/Achillion_Pharmaceuticals>,
        <https://1145.am/db/2369931/Biogen>,
        <https://1145.am/db/2369984/Biogaia>,
        <https://1145.am/db/2370022/Apellis_Pharmaceuticals>,
        <https://1145.am/db/2370078/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2370082/Aerie_Pharmaceuticals>,
        <https://1145.am/db/2370089/Abide_Therapeutics>,
        <https://1145.am/db/2370399/Pharmamar>,
        <https://1145.am/db/2370437/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2370437/MSD>,
        <https://1145.am/db/2370637/Medgenics_Inc>,
        <https://1145.am/db/2370797/Pharmanest>,
        <https://1145.am/db/2370798/Pharmalink_Ab>,
        <https://1145.am/db/2370946/Biogen>,
        <https://1145.am/db/2371015/M_Pharma>,
        <https://1145.am/db/2371016/M_Pharma>,
        <https://1145.am/db/2371279/Biomunex_Pharmaceuticals>,
        <https://1145.am/db/2371320/Pharco_Pharmaceuticals>,
        <https://1145.am/db/2371491/Biopharmx_Corporation>,
        <https://1145.am/db/2371522/Dyax>,
        <https://1145.am/db/238320/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2536754/Oramed_Pharma>,
        <https://1145.am/db/2536756/Zao>,
        <https://1145.am/db/2537468/Pharmascience_Inc>,
        <https://1145.am/db/2538019/Ucb>,
        <https://1145.am/db/2538171/Biomeda_Group>,
        <https://1145.am/db/2538392/Biocon>,
        <https://1145.am/db/2538422/Idt>,
        <https://1145.am/db/2538567/Upm_Pharmaceuticals>,
        <https://1145.am/db/2538705/PTC>,
        <https://1145.am/db/2538861/Par_Pharmaceuticals>,
        <https://1145.am/db/2538901/The_Harvard_Drug_Group>,
        <https://1145.am/db/2539516/Par_Pharmaceuticals>,
        <https://1145.am/db/2539568/Zao>,
        <https://1145.am/db/2539759/Twi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2540193/Pharmanest>,
        <https://1145.am/db/2540249/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2540449/Biocon>,
        <https://1145.am/db/2540951/Rytary>,
        <https://1145.am/db/2541039/Elan_Pharmaceuticals>,
        <https://1145.am/db/2541239/Pharmstar>,
        <https://1145.am/db/2541326/Advanced_Pharmaceutical>,
        <https://1145.am/db/2541419/Amri>,
        <https://1145.am/db/2541717/Adamas_Pharmaceuticals>,
        <https://1145.am/db/2541810/British_Pharma>,
        <https://1145.am/db/2542071/Ucb>,
        <https://1145.am/db/2542218/Pharmacyclics>,
        <https://1145.am/db/2543839/British_Pharma>,
        <https://1145.am/db/2544054/Cipla>,
        <https://1145.am/db/2544111/Unique_Pharmaceuticals>,
        <https://1145.am/db/2544358/Mundipharma>,
        <https://1145.am/db/2544596/Polpharma>,
        <https://1145.am/db/2544679/Neopharma>,
        <https://1145.am/db/2544783/Citius_Pharmaceuticals>,
        <https://1145.am/db/2545143/Mundipharma>,
        <https://1145.am/db/2545411/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2546441/Intas_Pharmaceuticals>,
        <https://1145.am/db/2546529/Pharma_Tech_Industries>,
        <https://1145.am/db/2546629/Par_Pharmaceutical>,
        <https://1145.am/db/2547068/Alapis>,
        <https://1145.am/db/2547189/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2547319/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2547593/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2547596/Par_Pharmaceuticals>,
        <https://1145.am/db/2548585/Par_Pharmaceuticals>,
        <https://1145.am/db/2548674/Sopharma>,
        <https://1145.am/db/2549477/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2549520/Aoxing_Pharmaceutical_Company>,
        <https://1145.am/db/2549919/Pharmathen>,
        <https://1145.am/db/2550212/Aoxing_Pharmaceutical>,
        <https://1145.am/db/2550232/Cipla>,
        <https://1145.am/db/2550471/Pharmaform>,
        <https://1145.am/db/2550523/Pharmaron>,
        <https://1145.am/db/2550685/Upm_Pharmaceuticals>,
        <https://1145.am/db/2551427/Pharmablock_Sciences>,
        <https://1145.am/db/2551601/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2552169/Alembic_Pharmaceuticals>,
        <https://1145.am/db/2552465/Medis>,
        <https://1145.am/db/2552641/Plethico_Pharmaceuticals>,
        <https://1145.am/db/2552642/Mankind_Pharmaceuticals>,
        <https://1145.am/db/2552746/Supreme_Pharmaceuticals_Inc>,
        <https://1145.am/db/2552794/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553276/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2553512/Pharmax_Pharmaceuticals>,
        <https://1145.am/db/2553708/Pharmaceutical_Product_Development_Llc>,
        <https://1145.am/db/2554237/Intas_Pharmaceuticals>,
        <https://1145.am/db/2554810/Continuus_Pharmaceuticals>,
        <https://1145.am/db/2554814/Globalpharma>,
        <https://1145.am/db/2554824/Cipla>,
        <https://1145.am/db/2554858/Medicure_Usa_Inc>,
        <https://1145.am/db/2555338/Pharmacore>,
        <https://1145.am/db/2555890/Pharmalucence>,
        <https://1145.am/db/2555896/Pharmalucence>,
        <https://1145.am/db/2555921/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2556805/Medicis_Pharmaceuticals>,
        <https://1145.am/db/2557028/DPX>,
        <https://1145.am/db/2557303/Pharmaron>,
        <https://1145.am/db/2557538/Neopharma>,
        <https://1145.am/db/2558025/Pharmaxis>,
        <https://1145.am/db/2558026/Pharmaxis>,
        <https://1145.am/db/2558071/Cipla>,
        <https://1145.am/db/2558970/Biostar_Pharmaceuticals>,
        <https://1145.am/db/2559783/Polpharma>,
        <https://1145.am/db/2560083/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561100/Exemed_Pharmaceuticals>,
        <https://1145.am/db/2561312/Oxford_Pharmaceuticals>,
        <https://1145.am/db/2561438/Pharmacia___Upjohn>,
        <https://1145.am/db/2561791/Cipla>,
        <https://1145.am/db/2561978/Biomarin_Pharmaceuticals>,
        <https://1145.am/db/2562199/Novartis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/2562446/Specialty_Pharmaceutical>,
        <https://1145.am/db/2562500/Millennium_Pharmaceuticals>,
        <https://1145.am/db/2562552/Ucb>,
        <https://1145.am/db/2562723/Biontech>,
        <https://1145.am/db/2563255/Active_Pharmaceutical_Ingredients>,
        <https://1145.am/db/2563255/MSD>,
        <https://1145.am/db/2563450/Kv_Pharmaceuticals>,
        <https://1145.am/db/2563497/Creo_Pharmaceuticals>,
        <https://1145.am/db/2563497/Polpharma>,
        <https://1145.am/db/2564030/Ucb>,
        <https://1145.am/db/2564196/Pharmaron>,
        <https://1145.am/db/2564713/C2_Pharma>,
        <https://1145.am/db/2566424/Dbl_Pharmaceuticals>,
        <https://1145.am/db/2566946/Alnylam_Pharmaceuticals>,
        <https://1145.am/db/2567007/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2567055/Sovereign_Pharmaceuticals>,
        <https://1145.am/db/2567283/The_Pharma_Giant>,
        <https://1145.am/db/2567296/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2567319/PTC>,
        <https://1145.am/db/2567438/Biogen>,
        <https://1145.am/db/2567651/Indivior>,
        <https://1145.am/db/2567651/Opiant_Pharmaceuticals>,
        <https://1145.am/db/2568205/Biogen>,
        <https://1145.am/db/2568375/Biogen>,
        <https://1145.am/db/2569099/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2569102/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2569165/Pharmacyclics>,
        <https://1145.am/db/2569187/Pharmacyclics>,
        <https://1145.am/db/2569370/Co>,
        <https://1145.am/db/2569425/Ucb>,
        <https://1145.am/db/2569679/Pharmaceuticals_Inc>,
        <https://1145.am/db/2569729/The_Medicines_Company>,
        <https://1145.am/db/2569952/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570068/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2570122/Ucb>,
        <https://1145.am/db/2570289/Pharmacyclics>,
        <https://1145.am/db/2570419/Pharmacyclics>,
        <https://1145.am/db/2570449/Biocon>,
        <https://1145.am/db/2570733/Dyax_Corp>,
        <https://1145.am/db/2570741/Sagent_Pharmaceuticals>,
        <https://1145.am/db/2570807/Nps_Pharmaceuticals>,
        <https://1145.am/db/2570807/Pharmacyclics>,
        <https://1145.am/db/2570834/Phrma>,
        <https://1145.am/db/2571136/Kala_Pharmaceuticals>,
        <https://1145.am/db/2571316/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2571723/Amag_Pharmaceuticals>,
        <https://1145.am/db/2572018/Meda>,
        <https://1145.am/db/2572200/The_Medicines_Company>,
        <https://1145.am/db/2572393/Pharmacia_Corporation>,
        <https://1145.am/db/2572870/Hi-Tech_Pharmaceuticals>,
        <https://1145.am/db/2573057/Aprecia_Pharmaceuticals_Company>,
        <https://1145.am/db/2573058/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2573147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2573271/Physician_Therapeutics>,
        <https://1145.am/db/2573391/Url_Pharma>,
        <https://1145.am/db/2573392/Url_Pharma>,
        <https://1145.am/db/2573593/Biotica>,
        <https://1145.am/db/2573887/Biogen>,
        <https://1145.am/db/2574213/Pharmacia_Corporation>,
        <https://1145.am/db/2574421/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2574679/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/2574891/Pharmacyclics>,
        <https://1145.am/db/2575222/Map_Pharmaceuticals>,
        <https://1145.am/db/2575242/Research_Pharmaceutical_Services_Inc>,
        <https://1145.am/db/2575462/Paras_Pharmaceuticals>,
        <https://1145.am/db/2575567/Fera_Pharmaceuticals>,
        <https://1145.am/db/2575623/Inova_Pharmaceuticals>,
        <https://1145.am/db/2575850/Cipla>,
        <https://1145.am/db/2576205/Medicis_Pharmaceutical_Corporation>,
        <https://1145.am/db/2576967/Insight_Pharmaceuticals>,
        <https://1145.am/db/2577145/Medicis_Pharmaceutical>,
        <https://1145.am/db/2577259/Pharmaceutical_Product_Development>,
        <https://1145.am/db/2577419/Osi_Pharmaceuticals>,
        <https://1145.am/db/2577675/Biogen>,
        <https://1145.am/db/2577684/Biogen>,
        <https://1145.am/db/2577894/Huvepharma_Ad>,
        <https://1145.am/db/2577934/Pharmascience>,
        <https://1145.am/db/2578095/Jhp_Pharmaceuticals>,
        <https://1145.am/db/2578177/Nexus_Pharmaceuticals>,
        <https://1145.am/db/2578209/Ucb>,
        <https://1145.am/db/2578319/Cosmo_Pharmaceuticals>,
        <https://1145.am/db/2578420/Meda_Pharmaceuticals>,
        <https://1145.am/db/2578473/Aa_Pharma>,
        <https://1145.am/db/2578481/Aa_Pharma_Inc>,
        <https://1145.am/db/2578667/Almirall>,
        <https://1145.am/db/2579104/Ucb>,
        <https://1145.am/db/2579147/Medicis_Pharmaceutical>,
        <https://1145.am/db/2579211/Eusa_Pharma>,
        <https://1145.am/db/2579538/Pharmaforce>,
        <https://1145.am/db/2580123/Savient_Pharmaceuticals>,
        <https://1145.am/db/2580479/Pharmaxis>,
        <https://1145.am/db/2581225/Inova_Pharmaceuticals>,
        <https://1145.am/db/2581394/Biocon>,
        <https://1145.am/db/2581552/Imprimis_Pharmaceuticals>,
        <https://1145.am/db/2582110/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582153/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2582174/Pharmasset>,
        <https://1145.am/db/2582283/Amag_Pharmaceuticals>,
        <https://1145.am/db/2582320/Savient_Pharmaceuticals>,
        <https://1145.am/db/2582677/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2582681/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2583013/Aragon_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583022/Url_Pharma>,
        <https://1145.am/db/2583220/Cosmo_Pharmaceuticals_Spa>,
        <https://1145.am/db/2583270/Pharmaswiss>,
        <https://1145.am/db/2583291/Savient_Pharmaceuticals>,
        <https://1145.am/db/2583352/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2583352/Mikah>,
        <https://1145.am/db/2583402/Osi_Pharmaceuticals>,
        <https://1145.am/db/2583414/Polpharma>,
        <https://1145.am/db/2583430/Imprimis_Pharmaceuticals>,
        <https://1145.am/db/2583437/Meda>,
        <https://1145.am/db/2583769/Biocryst_Pharmaceuticals>,
        <https://1145.am/db/2583783/Biomarin>,
        <https://1145.am/db/2584209/Pharmaswiss_Sa>,
        <https://1145.am/db/2584226/Pharmaswiss_Sa>,
        <https://1145.am/db/2584250/Progenics_Pharmaceuticals>,
        <https://1145.am/db/2584617/Amag_Pharmaceuticals_Inc>,
        <https://1145.am/db/2584750/Meda>,
        <https://1145.am/db/2585281/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2585327/Cipla_Limited>,
        <https://1145.am/db/2585887/Pharma_Inc>,
        <https://1145.am/db/2586547/Ucb>,
        <https://1145.am/db/2586968/Progenics_Pharmaceuticals_Inc>,
        <https://1145.am/db/2587155/Millennium_Pharma>,
        <https://1145.am/db/2587292/Javelin_Pharmaceuticals>,
        <https://1145.am/db/2587616/Pharmaq>,
        <https://1145.am/db/2587696/R-Pharm>,
        <https://1145.am/db/2588049/Aegerion_Pharmaceuticals_Inc>,
        <https://1145.am/db/2588718/Pharmacyclics>,
        <https://1145.am/db/2588884/Map_Pharmaceuticals>,
        <https://1145.am/db/2589317/Diartis_Pharmaceuticals>,
        <https://1145.am/db/2589414/Spepharm_Ag>,
        <https://1145.am/db/2589884/Map_Pharmaceuticals>,
        <https://1145.am/db/2590159/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2590195/Nectid>,
        <https://1145.am/db/2590195/Pro-Tect_Pharmaceuticals>,
        <https://1145.am/db/2590409/Biogen>,
        <https://1145.am/db/2590910/Savient_Pharmaceuticals>,
        <https://1145.am/db/2591540/Polpharma>,
        <https://1145.am/db/2591690/Medicis_Pharmaceutical>,
        <https://1145.am/db/2591938/Ferring_Pharmaceuticals>,
        <https://1145.am/db/2592254/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/2592336/Dyax>,
        <https://1145.am/db/2592874/Ucb>,
        <https://1145.am/db/2593048/Meda>,
        <https://1145.am/db/2593142/Access_Pharmaceuticals>,
        <https://1145.am/db/2593573/Savient_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594042/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594106/Paras_Pharmaceuticals>,
        <https://1145.am/db/2594116/Pharmerica>,
        <https://1145.am/db/2594168/Meda>,
        <https://1145.am/db/2594183/Astex_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594257/Hikma_Pharmaceuticals_Plc>,
        <https://1145.am/db/2594262/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2594414/Ista_Pharmaceuticals_Inc>,
        <https://1145.am/db/2594602/Osi_Pharma>,
        <https://1145.am/db/2594798/Pharmerica>,
        <https://1145.am/db/2595190/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595202/Aegerion_Pharmaceuticals>,
        <https://1145.am/db/2595210/Nps_Pharmaceuticals>,
        <https://1145.am/db/2595237/Emcure_Pharmaceuticals>,
        <https://1145.am/db/2595326/K-V_Pharmaceutical_Company>,
        <https://1145.am/db/2595413/Osi_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596054/Elite_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596307/Savient_Pharmaceuticals>,
        <https://1145.am/db/2596356/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2596369/Pharmadeals_Ltd>,
        <https://1145.am/db/2596636/Hikma_Pharmaceuticals>,
        <https://1145.am/db/2596818/Pharmasset>,
        <https://1145.am/db/2597158/Nps_Pharmaceuticals>,
        <https://1145.am/db/2597180/Prism_Pharmaceuticals>,
        <https://1145.am/db/2597622/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2597935/Osi_Pharmaceuticals>,
        <https://1145.am/db/2598012/Allos_Therapeutics>,
        <https://1145.am/db/2598027/Nps_Pharmaceuticals>,
        <https://1145.am/db/2598099/Paras_Pharmaceuticals>,
        <https://1145.am/db/2598137/Biosante_Pharmaceuticals_Inc>,
        <https://1145.am/db/2598195/Pharmatech>,
        <https://1145.am/db/2598605/Oncomed_Pharmaceuticals>,
        <https://1145.am/db/2765310/Biogen>,
        <https://1145.am/db/281576/Mymd_Pharmaceuticals>,
        <https://1145.am/db/299734/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/307255/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/324642/Mundipharma>,
        <https://1145.am/db/367137/Biomat>,
        <https://1145.am/db/378431/Pharmathen>,
        <https://1145.am/db/378464/Pharmathen>,
        <https://1145.am/db/378839/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/380389/Diamedica_Therapeutics_Inc>,
        <https://1145.am/db/381068/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/401218/Biocryst_Pharmaceuticals_Inc>,
        <https://1145.am/db/402158/Puretech>,
        <https://1145.am/db/407888/Quoin_Pharmaceuticals>,
        <https://1145.am/db/410129/Catalyst_Pharmaceuticals_Inc>,
        <https://1145.am/db/427157/Adamis_Pharmaceuticals_Corporation>,
        <https://1145.am/db/431169/Pharmablock>,
        <https://1145.am/db/4491/Achillion_Pharmaceuticals_Inc>,
        <https://1145.am/db/452957/Aerie_Pharmaceuticals>,
        <https://1145.am/db/468221/Aerie_Pharmaceuticals>,
        <https://1145.am/db/481129/Biocon_Ltd>,
        <https://1145.am/db/485351/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/486302/Phathom_Pharmaceuticals>,
        <https://1145.am/db/487010/Scipher_Medicine>,
        <https://1145.am/db/488564/Aerie_Pharmaceuticals>,
        <https://1145.am/db/498367/Aspire_Pharma_Limited>,
        <https://1145.am/db/499171/Aspire_Pharma_Limited>,
        <https://1145.am/db/538112/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/538277/Adamas_Pharmaceuticals>,
        <https://1145.am/db/539267/Adamas_Pharmaceuticals>,
        <https://1145.am/db/540865/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541731/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/541755/Adamas_Pharmaceuticals_Inc>,
        <https://1145.am/db/545583/Citius_Pharmaceuticals>,
        <https://1145.am/db/546391/Inmed_Pharmaceuticals_Inc>,
        <https://1145.am/db/549059/Adamas_Pharmaceuticals>,
        <https://1145.am/db/567789/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/585607/Am-Pharma>,
        <https://1145.am/db/587627/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/592025/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/612466/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/612973/Mingsight_Pharmaceuticals>,
        <https://1145.am/db/614114/Mingsight_Pharmaceuticals>,
        <https://1145.am/db/637582/The_Medicines_Co>,
        <https://1145.am/db/648300/Adamas_Pharmaceuticals>,
        <https://1145.am/db/662016/Prestige_Biopharma_Limited>,
        <https://1145.am/db/668495/Scipher_Medicine>,
        <https://1145.am/db/669775/Scipher_Medicine>,
        <https://1145.am/db/693128/Ascensus_Specialties>,
        <https://1145.am/db/700482/Novartis_Pharmaceuticals>,
        <https://1145.am/db/712037/Amunix_Pharmaceuticals>,
        <https://1145.am/db/712921/Mainpointe_Pharmaceuticals>,
        <https://1145.am/db/713105/Amunix_Pharmaceuticals_Inc>,
        <https://1145.am/db/713736/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/714923/Betterlife_Pharma_Inc>,
        <https://1145.am/db/715385/Aerie_Pharmaceuticals_Inc>,
        <https://1145.am/db/718008/Pharnext_Sa>,
        <https://1145.am/db/723883/Mymd_Pharmaceuticals>,
        <https://1145.am/db/724999/Mymd_Pharmaceuticals_Inc>,
        <https://1145.am/db/724999/Oramed_Pharmaceuticals_Inc>,
        <https://1145.am/db/731944/Aipharma>,
        <https://1145.am/db/734669/Escient_Pharmaceuticals>,
        <https://1145.am/db/739339/Iveric_Bio>,
        <https://1145.am/db/742794/HrÂ®_Pharmaceuticals_Inc>,
        <https://1145.am/db/744958/Recipharm_Group>,
        <https://1145.am/db/746462/Recipharm_Group>,
        <https://1145.am/db/769779/Ucb_Sa>,
        <https://1145.am/db/769887/Ucb_Sa>,
        <https://1145.am/db/771062/Gw_Pharmaceuticals>,
        <https://1145.am/db/792894/Amt>,
        <https://1145.am/db/793071/Biogen_Inc>,
        <https://1145.am/db/835485/Pharmaessentia_Corporation>,
        <https://1145.am/db/848323/Pharmaceutics_International_Inc>,
        <https://1145.am/db/854026/Aerie_Pharmaceuticals>,
        <https://1145.am/db/854160/Ani_Pharmaceuticals_Inc>,
        <https://1145.am/db/867644/Aipharma_Group_Ltd>,
        <https://1145.am/db/871621/Aipharma_Group_Ltd>,
        <https://1145.am/db/881631/Pharmcorx>,
        <https://1145.am/db/881719/Pharmcorx>,
        <https://1145.am/db/883896/Biontech>,
        <https://1145.am/db/884665/Pharmaceutical_Institute>,
        <https://1145.am/db/887575/Aprecia_Pharmaceuticals>,
        <https://1145.am/db/889331/ThÃ©a_Pharma>,
        <https://1145.am/db/893741/Aipharma_Group_Ltd>,
        <https://1145.am/db/895336/Aipharma_Group_Ltd>,
        <https://1145.am/db/912469/Aerie_Pharmaceuticals>,
        <https://1145.am/db/913730/Aerie_Pharmaceuticals>,
        <https://1145.am/db/922740/Grand_Pharma>,
        <https://1145.am/db/976867/Aprecia_Pharmaceuticals> ;
    ns1:sameAsMedium <https://1145.am/db/2056049/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2067011/Infinity_Pharmaceuticals>,
        <https://1145.am/db/230953/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/233261/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2336113/Infinity_Pharmaceuticals>,
        <https://1145.am/db/2360771/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/2362525/Infinity_Pharmaceuticals>,
        <https://1145.am/db/239789/Infinity_Pharmaceuticals_Inc>,
        <https://1145.am/db/453079/Infinity_Pharmaceuticals>,
        <https://1145.am/db/678224/Infinity_Pharmaceuticals_Inc> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356420/Equity_Private_Equity_Investment_Cvf_Llc_Cerapedics_Inc_Henry_Crown_And_Company_Medimmune_Ventures_Ngn_Capital_Orbimed_Advisors_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-13T05:00:54+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cerapedics Secures $ 19 Million Series C Financing.",
        "Cerapedics, Inc. announced that it recently completed a Series C round of private equity financing totaling $ 19 million led by new investors MedImmune Ventures and CVF, LLC, an affiliate of Henry Crown and Company." ;
    ns1:documentTitle "Cerapedics Secures $19 Million Series C Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/cerapedics-secures-19-million-series-c-financing> ;
    ns1:foundName "financing",
        "private equity" ;
    ns1:name "financing",
        "private equity" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2356420/Cerapedics_Inc> ;
    ns1:targetDetails "Series C",
        "equity",
        "private equity" ;
    ns1:valueRaw "$ 19 Million",
        "$ 19 million" ;
    ns1:whereRaw "303-974-6275" .

<https://1145.am/db/2356861/Series_B_Investment_Ip_Group_International_Biotechnology_Trust_Karus_Therapeutics_New_Leaf_Ventures_Novo_A_S_Sv_Life_Sciences_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-09-06T15:44:02+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors.",
        "SOUTHAMPTON, England, Sep 06, 2012 (BUSINESS WIRE) - Karus Therapeutics, a leader in the development of innovative medicines for the treatment of inflammatory disease and cancer, announces the closing of its Series B investment, which includes a first tranche of $ 7.6 million." ;
    ns1:documentTitle "Karus Therapeutics Secures Series B Financing from a Syndicate of Leading VC Investors" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/karus-therapeutics-secures-series-b-financing-from-a-syndicate-of-leading-vc-investors-0> ;
    ns1:foundName "investment" ;
    ns1:name "investment" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2356861/Karus_Therapeutics> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 7.6 million" ;
    ns1:when "2012-09-06T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012-09-06" ;
    ns1:whereGeoName "England" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6269131/about.rdf> ;
    ns1:whereRaw "England" .

<https://1145.am/db/2359562/Series_B_Investment_Adage_Capital_Partners_Fidelity_Biosciences_Healthcap_Pappas_Ventures_Tpg_Biotech_Ultragenyx_Pharmaceutical_Inc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-20T11:39:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NOVATO, Calif., Dec 20, 2012 (GLOBE NEWSWIRE via COMTEX) - Ultragenyx Pharmaceutical Inc., a biotechnology company focused on the development of treatments for rare and ultra-rare genetic disorders, today announced the successful completion of a $ 75 million Series B round financing led by Adage Capital Partners, LP.",
        "Ultragenyx Raises $ 75 Million in Oversubscribed Crossover Financing." ;
    ns1:documentTitle "Ultragenyx Raises $75 Million in Oversubscribed Crossover Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ultragenyx-raises-75-million-oversubscribed-crossover-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2359562/Ultragenyx_Pharmaceutical_Inc> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 75 Million",
        "$ 75 million" ;
    ns1:when "2012-12-20T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "Dec 20, 2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2546216/Polaris_Venture_Partners> a org:Organization ;
    ns1:basedInLowRaw "Cambridge, MA" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "Polaris Venture Partners" ;
    ns1:investor <https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> ;
    ns1:name "Polaris Venture Partners" ;
    ns1:sameAsMedium <https://1145.am/db/1701903/Polaris_Venture_Partners>,
        <https://1145.am/db/1708291/Polaris_Venture_Partners>,
        <https://1145.am/db/1830502/Polaris_Venture_Partners>,
        <https://1145.am/db/1870436/Polaris_Venture_Partners>,
        <https://1145.am/db/1877606/Polaris_Venture_Partners>,
        <https://1145.am/db/1897450/Polaris_Venture_Partners>,
        <https://1145.am/db/1909651/Polaris_Venture_Partners>,
        <https://1145.am/db/2174824/Polaris_Venture_Partners>,
        <https://1145.am/db/2292800/Polaris_Venture_Partners>,
        <https://1145.am/db/2302116/Polaris_Venture_Partners>,
        <https://1145.am/db/2303656/Polaris_Venture_Partners>,
        <https://1145.am/db/2303675/Polaris_Venture_Partners>,
        <https://1145.am/db/2313401/Polaris_Venture_Partners>,
        <https://1145.am/db/2313405/Polaris_Venture_Partners>,
        <https://1145.am/db/2314380/Polaris_Venture_Partners>,
        <https://1145.am/db/2315289/Polaris_Venture_Partners>,
        <https://1145.am/db/2323586/Polaris_Venture_Partners>,
        <https://1145.am/db/2324431/Polaris_Venture_Partners>,
        <https://1145.am/db/2331763/Polaris_Venture_Partners>,
        <https://1145.am/db/2337571/Polaris_Venture_Partners>,
        <https://1145.am/db/2337577/Polaris_Venture_Partners>,
        <https://1145.am/db/2338373/Polaris_Venture_Partners>,
        <https://1145.am/db/2339127/Polaris_Venture_Partners>,
        <https://1145.am/db/2339128/Polaris_Venture_Partners>,
        <https://1145.am/db/2342445/Polaris_Venture_Partners>,
        <https://1145.am/db/2342862/Polaris_Venture_Partners>,
        <https://1145.am/db/2343210/Polaris_Venture_Partners>,
        <https://1145.am/db/2344256/Polaris_Venture_Partners>,
        <https://1145.am/db/2345224/Polaris_Venture_Partners>,
        <https://1145.am/db/2347102/Polaris_Venture_Partners>,
        <https://1145.am/db/2348448/Polaris_Venture_Partners>,
        <https://1145.am/db/2350034/Polaris_Venture_Partners>,
        <https://1145.am/db/2352414/Polaris_Venture_Partners>,
        <https://1145.am/db/2354806/Polaris_Venture_Partners>,
        <https://1145.am/db/2365296/Polaris_Venture_Partners>,
        <https://1145.am/db/2365300/Polaris_Venture_Partners>,
        <https://1145.am/db/2366654/Polaris_Venture_Partners>,
        <https://1145.am/db/2367497/Polaris_Venture_Partners>,
        <https://1145.am/db/2440024/Polaris_Venture_Partners>,
        <https://1145.am/db/2450515/Polaris_Venture_Partners> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2339196/Novartis_Venture_Fund> a org:Organization ;
    ns1:description "investing" ;
    ns1:documentDate "2012-10-18T15:24:20+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Neurovance Closes $7M Series A1 Round for Development of EB-1020 for ADHD; Reports Phase 1 Clinical Trial Results" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/neurovance-closes-7m-series-a1-round-for-development-of-eb-1020-for-adhd-reports-phase-1> ;
    ns1:foundName "Novartis Venture Fund" ;
    ns1:investor <https://1145.am/db/2339196/Series_A1_Investment_Neurovance_Novartis_Venture_Fund_Completed> ;
    ns1:name "Novartis Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/2153726/Novartis_Venture_Fund_And_Partners_Innovation_Fund>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2306568/Novartis_Bioventure_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2354770/Novartis_Bioventures>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2575232/Novartis_Bioventures>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2247240/Novartis_Venture_Funds>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2338527/Novartis_Venture_Funds>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356290/Novartis_Venture_Fund>,
        <https://1145.am/db/2356391/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2367046/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2343966/Novartis_Venture_Funds> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-10-31T15:12:33+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Thesan Pharmaceuticals Announces Series A Funding Co-Led By Novo Ventures And Novartis Venture Funds" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thesan-pharmaceuticals-announces-series-a-funding-co-led-by-novo-ventures-and-novartis> ;
    ns1:foundName "Novartis Venture Funds" ;
    ns1:industry "Pharmaceuticals" ;
    ns1:investor <https://1145.am/db/2343966/Series_A_Investment_Novartis_Venture_Funds_Novo_Ventures_Thesan_Pharmaceuticals_Has_Not_Happened> ;
    ns1:name "Novartis Venture Funds" ;
    ns1:sameAsHigh <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/2153726/Novartis_Venture_Fund_And_Partners_Innovation_Fund>,
        <https://1145.am/db/2287572/Boehringer_Ingelheim_Venture_Fund>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2306568/Novartis_Bioventure_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2338528/Novartis_Venture_Funds_Johnson___Johnson_Development_Corporation_Lundbeckfond_Venture>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2346542/Agechem_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2354770/Novartis_Bioventures>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2575232/Novartis_Bioventures>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2247240/Novartis_Venture_Funds>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2338527/Novartis_Venture_Funds>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356290/Novartis_Venture_Fund>,
        <https://1145.am/db/2356391/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2367046/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350199/Series_B_Investment_Alta_Partners_And_Sr_Applied_Genetic_Technologies_Corporation_Interwest_Intersouth_Partners_Medimmune_Ventures_Osage_University_Partners_Sr_One_Limited_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-19T13:53:46+00:00"^^xsd:dateTime ;
    ns1:documentExtract "GAINESVILLE, Fla., Nov 19, 2012 (BUSINESS WIRE) - Applied Genetic Technologies Corporation, (AGTC) , a privately-held, clinical stage biotechnology company developing gene therapy products to treat rare retinal diseases, announced today that it has secured $ 37.5 million in a Series B round of financing." ;
    ns1:documentTitle "AGTC Secures $37.5M Series B Funding" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/agtc-secures-37-5m-series-b-funding> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2350199/Applied_Genetic_Technologies_Corporation> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 37.5 million" ;
    ns1:when "2012-11-19T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012-11-19" ;
    ns1:whereGeoName "Gainesville" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4156404/about.rdf> ;
    ns1:whereRaw "GAINESVILLE, Fla" .

<https://1145.am/db/2354752/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-30T14:33:18+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aerpio Therapeutics Completes $ 27 Million Series A Financing.",
        "CINCINNATI, Aug 30, 2012 (BUSINESS WIRE) - Aerpio Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that is has closed a $ 27 million Series A financing." ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing-0> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2354752/Aerpio_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 27 Million",
        "$ 27 million" ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "Cincinnati" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4508722/about.rdf> ;
    ns1:whereRaw "CINCINNATI" .

<https://1145.am/db/2354770/Novartis_Bioventures> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2012-08-31T01:02:13+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Novartis BioVentures" ;
    ns1:investor <https://1145.am/db/2354770/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Novartis BioVentures" ;
    ns1:sameAsHigh <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/2153726/Novartis_Venture_Fund_And_Partners_Innovation_Fund>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2306568/Novartis_Bioventure_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2575232/Novartis_Bioventures>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2301809/Novartis_Bioventures_Ltd>,
        <https://1145.am/db/2303121/Novartis_Bioventures>,
        <https://1145.am/db/2303124/Novartis_Bioventures_Ltd>,
        <https://1145.am/db/2303695/Novartis_Bioventures_Ltd>,
        <https://1145.am/db/2311069/Novartis_Bioventures>,
        <https://1145.am/db/2311075/Novartis_Bioventures>,
        <https://1145.am/db/2313322/Novartis_Bioventures>,
        <https://1145.am/db/2323700/Novartis_Bioventures>,
        <https://1145.am/db/2354752/Novartis_Bioventures>,
        <https://1145.am/db/2355841/Novartis_Bioventures> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2354770/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-31T01:02:13+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aerpio Therapeutics Completes $ 27 Million Series A Financing.",
        "Aerpio Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that is has closed a $ 27 million Series A financing." ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2354770/Aerpio_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 27 Million",
        "$ 27 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2356393/Novartis_Venture_Fund> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-12-11T17:13:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing-0> ;
    ns1:foundName "Novartis Venture Fund" ;
    ns1:investor <https://1145.am/db/2356393/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> ;
    ns1:name "Novartis Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/2153726/Novartis_Venture_Fund_And_Partners_Innovation_Fund>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2306568/Novartis_Bioventure_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2354770/Novartis_Bioventures>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2575232/Novartis_Bioventures>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2247240/Novartis_Venture_Funds>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2338527/Novartis_Venture_Funds>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356290/Novartis_Venture_Fund>,
        <https://1145.am/db/2356391/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2367046/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356395/Novartis_Venture_Fund> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-12-12T05:00:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing> ;
    ns1:foundName "Novartis Venture Fund" ;
    ns1:investor <https://1145.am/db/2356395/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> ;
    ns1:name "Novartis Venture Fund" ;
    ns1:sameAsHigh <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/2153726/Novartis_Venture_Fund_And_Partners_Innovation_Fund>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2306568/Novartis_Bioventure_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2354770/Novartis_Bioventures>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/2575232/Novartis_Bioventures>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/1523031/Novartis_Venture_Fund>,
        <https://1145.am/db/207823/Novartis_Venture_Fund>,
        <https://1145.am/db/2152422/Novartis_Venture_Fund>,
        <https://1145.am/db/2247240/Novartis_Venture_Funds>,
        <https://1145.am/db/2289983/Novartis_Venture_Funds>,
        <https://1145.am/db/2292300/Novartis_Venture_Funds>,
        <https://1145.am/db/2292345/Novartis_Venture_Funds>,
        <https://1145.am/db/2298176/Novartis_Venture_Fund>,
        <https://1145.am/db/2307682/Novartis_Venture_Fund>,
        <https://1145.am/db/2310905/Novartis_Venture_Fund>,
        <https://1145.am/db/2315943/Novartis_Venture_Fund>,
        <https://1145.am/db/2315957/Novartis_Venture_Fund>,
        <https://1145.am/db/2323210/Novartis_Venture_Funds>,
        <https://1145.am/db/2323682/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2327441/Novartis_Venture_Fund>,
        <https://1145.am/db/2331750/Novartis_Venture_Fund>,
        <https://1145.am/db/2336032/Novartis_Venture_Fund>,
        <https://1145.am/db/2336328/Novartis_Venture_Funds>,
        <https://1145.am/db/2337294/Novartis_Venture_Funds>,
        <https://1145.am/db/2337645/Novartis_Venture_Fund>,
        <https://1145.am/db/2338527/Novartis_Venture_Funds>,
        <https://1145.am/db/2339193/Novartis_Venture_Fund>,
        <https://1145.am/db/2340612/Novartis_Venture_Fund>,
        <https://1145.am/db/2340942/Novartis_Venture_Fund>,
        <https://1145.am/db/2343493/Novartis_Venture_Funds>,
        <https://1145.am/db/2348012/Novartis_Venture_Fund>,
        <https://1145.am/db/2348348/Novartis_Venture_Funds>,
        <https://1145.am/db/2348350/Novartis_Venture_Funds>,
        <https://1145.am/db/2351958/Novartis_Venture_Funds>,
        <https://1145.am/db/2351959/Novartis_Venture_Fund>,
        <https://1145.am/db/2352216/Novartis_Venture_Fund>,
        <https://1145.am/db/2353098/Novartis_Venture_Fund>,
        <https://1145.am/db/2356287/Novartis_Venture_Fund>,
        <https://1145.am/db/2356290/Novartis_Venture_Fund>,
        <https://1145.am/db/2356391/Novartis_Venture_Fund>,
        <https://1145.am/db/2358430/Novartis_Venture_Funds>,
        <https://1145.am/db/2358733/Novartis_Venture_Fund>,
        <https://1145.am/db/2362715/Novartis_Venture_Funds>,
        <https://1145.am/db/2363510/Novartis_Venture_Funds>,
        <https://1145.am/db/2367046/Novartis_Venture_Fund>,
        <https://1145.am/db/2551315/Novartis_Venture_Fund>,
        <https://1145.am/db/2570481/Novartis_Venture_Fund>,
        <https://1145.am/db/2570483/Novartis_Venture_Fund>,
        <https://1145.am/db/2578837/Novartis_Venture_Funds>,
        <https://1145.am/db/2592611/Novartis_Venture_Funds> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2575232/Novartis_Bioventures> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2012-08-30T13:09:03+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Novartis BioVentures" ;
    ns1:investor <https://1145.am/db/2575232/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> ;
    ns1:name "Novartis BioVentures" ;
    ns1:sameAsHigh <https://1145.am/db/1340338/Novartis_Venture_Fund>,
        <https://1145.am/db/2153726/Novartis_Venture_Fund_And_Partners_Innovation_Fund>,
        <https://1145.am/db/2297795/Novartis_Venture_Funds>,
        <https://1145.am/db/2306568/Novartis_Bioventure_Fund>,
        <https://1145.am/db/2310907/Novartis_Venture_Fund>,
        <https://1145.am/db/2313438/Novartis_Venture_Fund>,
        <https://1145.am/db/2317737/Novartis_Venture_Fund>,
        <https://1145.am/db/2323228/Novartis_Venture_Fund>,
        <https://1145.am/db/2323683/The_Novartis_Venture_Fund>,
        <https://1145.am/db/2324255/Novartis_Bioventures>,
        <https://1145.am/db/2326222/Novartis_Venture_Fund>,
        <https://1145.am/db/2327256/Novartis_Venture_Fund>,
        <https://1145.am/db/2327442/Novartis_Venture_Fund>,
        <https://1145.am/db/2330711/Novartis_Venture_Fund>,
        <https://1145.am/db/2331343/Novartis_Venture_Funds>,
        <https://1145.am/db/2331751/Novartis_Venture_Fund>,
        <https://1145.am/db/2332658/Novartis_Venture_Fund>,
        <https://1145.am/db/2332659/Novartis_Venture_Fund>,
        <https://1145.am/db/2335764/Novartis_Venture_Funds>,
        <https://1145.am/db/2339196/Novartis_Venture_Fund>,
        <https://1145.am/db/2340344/Novartis_Venture_Fund>,
        <https://1145.am/db/2340345/Novartis_Venture_Fund>,
        <https://1145.am/db/2340615/Novartis>,
        <https://1145.am/db/2343486/Novartis_Venture_Funds>,
        <https://1145.am/db/2343966/Novartis_Venture_Funds>,
        <https://1145.am/db/2344045/Novartis_Venture_Fund>,
        <https://1145.am/db/2352203/Novartis_Venture_Fund>,
        <https://1145.am/db/2352204/Novartis_Venture_Fund>,
        <https://1145.am/db/2354770/Novartis_Bioventures>,
        <https://1145.am/db/2356393/Novartis_Venture_Fund>,
        <https://1145.am/db/2356395/Novartis_Venture_Fund>,
        <https://1145.am/db/2356567/Novartis_Venture_Fund>,
        <https://1145.am/db/2358725/Novartis_Venture_Funds>,
        <https://1145.am/db/2361588/Novartis_Venture_Funds>,
        <https://1145.am/db/2363907/Novartis_Venture_Funds>,
        <https://1145.am/db/2369548/Novartis_Venture_Fund>,
        <https://1145.am/db/509733/Novartis_Venture_Fund>,
        <https://1145.am/db/619955/Novartis>,
        <https://1145.am/db/623985/Novartis>,
        <https://1145.am/db/866508/Novartis_Venture_Fund> ;
    ns1:sameAsMedium <https://1145.am/db/2301809/Novartis_Bioventures_Ltd>,
        <https://1145.am/db/2303121/Novartis_Bioventures>,
        <https://1145.am/db/2303124/Novartis_Bioventures_Ltd>,
        <https://1145.am/db/2303695/Novartis_Bioventures_Ltd>,
        <https://1145.am/db/2311069/Novartis_Bioventures>,
        <https://1145.am/db/2311075/Novartis_Bioventures>,
        <https://1145.am/db/2313322/Novartis_Bioventures>,
        <https://1145.am/db/2323700/Novartis_Bioventures>,
        <https://1145.am/db/2354752/Novartis_Bioventures>,
        <https://1145.am/db/2355841/Novartis_Bioventures> ;
    ns1:sourceName "Fierce Pharma" .

<https://1145.am/db/2575232/Series_A_Investment_Aerpio_Therapeutics_Agechem_Venture_Fund_Athenian_Venture_Partners_Kearny_Venture_Partners_Novartis_Bioventures_Triathlon_Medical_Ventures_Venture_Investors_Llc_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-30T13:09:03+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Aerpio Therapeutics Completes $ 27 Million Series A Financing.",
        "Aerpio Therapeutics, a clinical-stage biopharmaceutical company focused on advancing innovative therapies for vascular diseases, today announced that is has closed a $ 27 million Series A financing." ;
    ns1:documentTitle "Aerpio Therapeutics Completes $27 Million Series A Financing" ;
    ns1:documentURL <https://www.fiercepharma.com/pharma/aerpio-therapeutics-completes-27-million-series-a-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2575232/Aerpio_Therapeutics> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 27 Million",
        "$ 27 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2332322/Series_A_Investment_5am_Ventures_Bioadvance_Canaan_Partners_Delaware_Crossing_Investment_Group_Mid-Atlantic_Angel_Group_Novira_Therapeutics_Inc_Robin_Hood_Ventures_Wuxi_Pharmatech_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-08-27T22:01:21+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Novira Therapeutics Secures $ 23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections.",
        "RADNOR, Pa., Aug. 24, 2012 - Novira Therapeutics Inc. today announced it has secured $ 23 million in Series A financing to support the development of its capsid-targeting antivirals for the treatment of chronic hepatitis B (HBV) and HIV infections." ;
    ns1:documentTitle "Novira Therapeutics Secures $23 Million Series A Financing to Advance Development of Antivirals for Treatment of Chronic Hepatitis B and HIV Infections" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/novira-therapeutics-secures-23-million-series-a-financing-to-advance-development-of> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2332322/Novira_Therapeutics_Inc> ;
    ns1:targetDetails "Series A" ;
    ns1:valueRaw "$ 23 Million",
        "$ 23 million" ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "Novira" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/2089454/about.rdf> ;
    ns1:whereRaw "Novira Therapeutics" .

<https://1145.am/db/2338373/Series_D_Investment_Easton_Capital_Investment_Group_Fibrotec_Ventures_Forbion_Capital_Partners_Healthcare_Ventures_Inc_Morgenthaler_Ventures_Polaris_Venture_Partners_Shire_Strategic_Investment_Group_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-16T04:00:50+00:00"^^xsd:dateTime ;
    ns1:documentExtract ", Inc., a biotechnology company developing novel biologic therapeutics for the treatment of fibrosis, today announced that it has completed a $ 24.5 million Series D financing round, adding $ 3 million in a second closing of this financing round from new investor, Shire Strategic Investment Group.",
        "Promedior Expands Series D Round of Financing to Total $ 24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases." ;
    ns1:documentTitle "Promedior Expands Series D Round of Financing to Total $24.5 Million to Advance Pipeline of Pentraxin-2 Therapeutics for Fibrotic Diseases" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/promedior-expands-series-d-round-of-financing-to-total-24-5-million-to-advance-pipeline-of> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2338373/Inc>,
        <https://1145.am/db/2338373/Promedior>,
        <https://1145.am/db/2338373/The_Yates_Network> ;
    ns1:targetDetails "Series D" ;
    ns1:valueRaw "$ 24.5 Million",
        "$ 24.5 million",
        "$ 3 million",
        "Total $ 24.5 Million" .

<https://1145.am/db/2358541/Series_E_Investment_Aurora_Funds_Baxter_Ventures_Caxton_Advantage_Life_Sciences_Fund_Domain_Associates_Edmond_De_Rothschild_Investment_Partners_Quaker_Partners_Regado_Biosciences_Rusnanomedinvest_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-19T14:00:22+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Basking Ridge, NJ - December 19, 2012 - Regado Biosciences, Inc., a privately held company leading the development of antithrombotic aptamers with active control agents, announced it has secured a landmark $ 51 million Series E financing.",
        "Regado Biosciences, Inc. Secures $ 51 Million Series E Financing." ;
    ns1:documentTitle "Regado Biosciences, Inc. Secures $51 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/regado-biosciences-inc-secures-51-million-series-e-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2358541/Regado_Biosciences> ;
    ns1:targetDetails "Series E" ;
    ns1:valueRaw "$ 51 Million",
        "$ 51 million" ;
    ns1:when "2012-12-19T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "December 19, 2012" ;
    ns1:whereRaw "Regado Biosciences, Inc." .

<https://1145.am/db/2341904/Investment_Advanced_Technology_Ventures_Fonds_De_SolidaritÃ©_Ftq_Gsk_Canada_Life_Sciences_Innovation_Fund_Lumira_Capital_Mp_Healthcare_Venture_Management_Pappas_Ventures_Sr_One_Sw_Co_Thrasos_Therapeutics_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-25T14:26:48+00:00"^^xsd:dateTime ;
    ns1:documentExtract "MONTREAL- () -Thrasos TherapeuticsTM announced that it has completed a $ 35 Million (U.S.) financing for the development of THR-184, its lead product candidate for the treatment of acute kidney injury (AKI) ." ;
    ns1:documentTitle "Thrasos Secures $35 Million to Fund THR-184 Phase 2 Clinical Program for Treatment of Acute Kidney Injury" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/thrasos-secures-35-million-to-fund-thr-184-phase-2-clinical-program-for-treatment-of-acute> ;
    ns1:foundName "development",
        "financing" ;
    ns1:name "development",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2341904/Thrasos_Therapeutics> ;
    ns1:valueRaw "$ 35 Million" ;
    ns1:whereGeoName "Canada" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6251999/about.rdf> ;
    ns1:whereRaw "Canada" .

<https://1145.am/db/2354295/Preferred_Stock_Investment_Alliancebernstein_Alternative_Investment_Management_Group_Biomed_Ventures_Clarus_Ventures_Draper_Fisher_Jurvetson_Ge_Healthymagination_Fund_Henri_Termeer_Morgan_Stanley_Expansion_Capital_Nanostring_Technologies_Ovp_Venture_Partners_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-04T05:01:04+00:00"^^xsd:dateTime ;
    ns1:documentExtract "NanoString Technologies Completes $ 15.3 Million Series E Financing.",
        "NanoString Technologies, Inc., a privately held provider of life science tools for translational research and developer of molecular diagnostic products, today announced the completion of a $ 15.3 million Series E Preferred Stock issuance." ;
    ns1:documentTitle "NanoString Technologies Completes $15.3 Million Series E Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/nanostring-technologies-completes-15-3-million-series-e-financing> ;
    ns1:foundName "Financing",
        "issuance" ;
    ns1:name "Financing",
        "issuance" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2354295/Nanostring_Technologies> ;
    ns1:targetDetails "Preferred Stock",
        "Series E" ;
    ns1:valueRaw "$ 15.3 Million",
        "$ 15.3 million" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2356419/Series_D_Investment_Biocartis_Korys_New_Rhein_Healthcare_Pmv_Philips_Johnson___Johnson_Development_Corporation_Philips_Johnson___Johnson_Development_Corporation_Rmm_(rudi_MariÃ«n)_Valiance_Debiopharm_Groupâ„¢_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-13T05:00:51+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Biocartis, a molecular diagnostics company developing and commercializing innovative, high quality, easy to use platforms and clinically relevant oncology assays, announced today the completion of a â‚¬34,5 million (approximately $ 45 million, CHF 42 million) Series D equity fund raising entirely backed by existing investors." ;
    ns1:documentTitle "Biocartis Completes â‚¬34,5 Million ($44,5 Million) Series D Fund Raising" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/biocartis-completes-%E2%82%AC34-5-million-44-5-million-series-d-fund-raising> ;
    ns1:foundName "fund raising",
        "raising" ;
    ns1:name "fund raising",
        "raising" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2356419/Biocartis> ;
    ns1:targetDetails "Series D",
        "equity" ;
    ns1:valueRaw "CHF 42 million",
        "approximately $ 45 million",
        "â‚¬34,5 million" ;
    ns1:whereGeoName "Flanders" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/3337388/about.rdf> ;
    ns1:whereRaw "Flemish" .

<https://1145.am/db/2346030/Preferred_Stock_Investment_Aisling_Capital_Ambit_Biosciences_Inc_Apposite_Healthcare_Forward_Ventures_Gimv_Growthworks_Medimmune_Ventures_Orbimed_Advisors_Radius_Ventures_Roche_Ventures_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-11-06T13:58:23+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Ambit Biosciences Completes $ 50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia.",
        "SAN DIEGO, Nov. 6, 2012 /PRNewswire via COMTEX/ - Ambit Biosciences Inc. today announced that the company has closed the first $ 25 million tranche of a new $ 50 million preferred stock financing to support continued advancement of its lead drug candidate, quizartinib." ;
    ns1:documentTitle "Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/ambit-biosciences-completes-50-million-financing-to-advance-lead-drug-candidate-acute> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2346030/Ambit_Biosciences_Inc> ;
    ns1:targetDetails "preferred stock" ;
    ns1:valueRaw "$ 25 million",
        "$ 50 Million",
        "$ 50 million" ;
    ns1:whenRaw "2012" ;
    ns1:whereGeoName "United States" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/6252001/about.rdf> ;
    ns1:whereRaw "United States" .

<https://1145.am/db/2333119/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInLowRaw "Calif" ;
    ns1:documentDate "2012-12-16T22:22:53+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/it/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2333119/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Sergey_Brin_Yuri_Milner_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2334847/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInLowRaw "MA" ;
    ns1:documentDate "2012-12-18T21:04:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/research/blend-therapeutics-closes-16-million-series-b-financing> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2334847/Series_B_Investment_Blend_Therapeutics_Flagship_Ventures_Nanodimension_New_Enterprise_Associates_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340888/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "Austin" ;
    ns1:documentDate "2012-10-24T12:43:58+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/mirna-therapeutics-secures-34-5-million-series-c-financing-to-advance-oncology-microrna-0> ;
    ns1:foundName "New Enterprise Associates",
        "New Enterprise Associates (NEA)" ;
    ns1:investor <https://1145.am/db/2340888/Series_C_Investment_Correlation_Ventures_Mirna_Therapeutics_Inc_New_Enterprise_Associates_Osage_University_Partners_Pfizer_Ventures_Sofinnova_Ventures_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2340890/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInHighGeoName "Austin" ;
    ns1:basedInHighGeoNameRDF <https://sws.geonames.org/4671654/about.rdf> ;
    ns1:basedInHighRaw "Austin" ;
    ns1:documentDate "2012-10-24T12:53:50+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Two Texas biotech outfits lasso venture deals totaling $81M" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/two-texas-biotech-outfits-lasso-venture-deals-totaling-81m> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2340890/Investment_Mirna_New_Enterprise_Associates_Pfizer_Sofinnova_Ventures_Stopped> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350164/New_Enterprise_Associates_Inc> a org:Organization ;
    ns1:basedInLowRaw "HAYWARD" ;
    ns1:documentDate "2012-11-15T16:09:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia Therapeutics Secures Landmark $210 Million Financing To Fund Its Global Phase 3 Program For ITCA 650 In Type 2 Diabetes" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/intarcia-therapeutics-secures-landmark-210-million-financing-to-fund-its-global-phase-3> ;
    ns1:foundName "New Enterprise Associates, Inc." ;
    ns1:investor <https://1145.am/db/2350164/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_Inc_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Completed> ;
    ns1:name "New Enterprise Associates, Inc." ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2350167/New_Enterprise_Associates> a org:Organization ;
    ns1:documentDate "2012-11-15T16:38:45+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Intarcia raises $210M for PhIII, once-yearly diabetes drug" ;
    ns1:documentURL <https://www.fiercebiotech.com/venture-capital/intarcia-raises-210m-for-phiii-once-yearly-diabetes-drug> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2350167/Investment_Farallon_Capital_Management_Intarcia_Therapeutics_New_Enterprise_Associates_New_Leaf_Venture_Partners_The_Baupost_Group_Venrock_Has_Not_Happened> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356391/New_Enterprise_Associates> a org:Organization ;
    ns1:documentDate "2012-12-11T17:08:19+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera raises $11M A round; Can Novo make liraglutide into obesity blockbuster?; Infinity shoots up on blood cancer data;" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-raises-11m-a-round-can-novo-make-liraglutide-into-obesity-blockbuster-infinity> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2356391/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356393/New_Enterprise_Associates> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-12-11T17:13:42+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing-0> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:industry "venture capital" ;
    ns1:investor <https://1145.am/db/2356393/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/1061564/Evonik_Venture_Capital>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1768899/Eventures>,
        <https://1145.am/db/1786672/Eventures>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1806644/Eventures>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2170734/Eventures>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/330761/Emv_Capital>,
        <https://1145.am/db/490907/Echelon_Capital>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/936724/Efung_Capital>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356395/New_Enterprise_Associates> a org:Organization ;
    ns1:description "venture capital" ;
    ns1:documentDate "2012-12-12T05:00:57+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Galera Therapeutics Raises $11 Million in Series A Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/galera-therapeutics-raises-11-million-series-a-financing> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2356395/Series_A_Investment_Correlation_Ventures_Galera_Therapeutics_New_Enterprise_Associates_Novartis_Venture_Fund_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/1061564/Evonik_Venture_Capital>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1768899/Eventures>,
        <https://1145.am/db/1786672/Eventures>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1806644/Eventures>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2170734/Eventures>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/330761/Emv_Capital>,
        <https://1145.am/db/490907/Echelon_Capital>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/936724/Efung_Capital>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2356396/New_Enterprise_Associates> a org:Organization ;
    ns1:description "financing" ;
    ns1:documentDate "2012-12-12T05:00:46+00:00"^^xsd:dateTime ;
    ns1:documentTitle "23andMe Raises More Than $50 Million in New Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/23andme-raises-more-than-50-million-new-financing> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2356396/Series_D_Investment_23andme_Google_Ventures_Mpm_Capital_New_Enterprise_Associates_Yuri_Milner_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsHigh <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates> ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358506/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2357487/Series_B_Investment_Adams_Street_Partners_Baxter_Ventures_Druid_Bioventures_Genesys_Capital_Latterell_Venture_Partners_Lundbeck_Takeda_Ventures_Naurex_Inc_Northwestern_University_Pathocapital_Savitr_Capital_Shire_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-12-17T13:34:02+00:00"^^xsd:dateTime ;
    ns1:documentExtract "EVANSTON, Ill., Dec. 17, 2012 /PRNewswire/ - Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced the completion of a $ 38 million Series B financing led by new investor Baxter Ventures.",
        "Naurex Completes $ 38 Million Series B Financing." ;
    ns1:documentTitle "Naurex Completes $38 Million Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/naurex-completes-38-million-series-b-financing> ;
    ns1:foundName "Financing",
        "financing" ;
    ns1:name "Financing",
        "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2357487/Naurex_Inc> ;
    ns1:targetDetails "Series B" ;
    ns1:valueRaw "$ 38 Million",
        "$ 38 million" ;
    ns1:when "2012-12-17T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012-12-17" ;
    ns1:whereGeoName "Evanston" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4891382/about.rdf> ;
    ns1:whereRaw "EVANSTON, Ill." .

<https://1145.am/db/2358506/New_Enterprise_Associates> a org:Organization ;
    ns1:basedInLowRaw "MA" ;
    ns1:documentDate "2012-12-18T12:40:39+00:00"^^xsd:dateTime ;
    ns1:documentTitle "Blend Therapeutics Closes $16 Million in Series B Financing" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/blend-therapeutics-closes-16-million-series-b-financing-0> ;
    ns1:foundName "New Enterprise Associates" ;
    ns1:investor <https://1145.am/db/2358506/Series_B_Investment_Blend_Therapeutics_Flagship_Ventures_Nanodimension_New_Enterprise_Associates_Completed> ;
    ns1:name "New Enterprise Associates" ;
    ns1:sameAsMedium <https://1145.am/db/1031040/New_Enterprise_Associates>,
        <https://1145.am/db/1091201/New_Enterprise_Associates>,
        <https://1145.am/db/1115103/New_Enterprise_Associates>,
        <https://1145.am/db/1115600/New_Enterprise_Associates>,
        <https://1145.am/db/1116035/New_Enterprise_Associates>,
        <https://1145.am/db/1116076/New_Enterprise_Associates>,
        <https://1145.am/db/1127410/New_Enterprise_Associates>,
        <https://1145.am/db/1169121/New_Enterprise_Associates>,
        <https://1145.am/db/1230022/New_Enterprise_Associates>,
        <https://1145.am/db/1233430/New_Enterprise_Associates>,
        <https://1145.am/db/1279264/New_Enterprise_Associates>,
        <https://1145.am/db/1281079/New_Enterprise_Associates>,
        <https://1145.am/db/1281647/New_Enterprise_Associates>,
        <https://1145.am/db/1371086/New_Enterprise_Associates>,
        <https://1145.am/db/1422234/New_Enterprise_Associates>,
        <https://1145.am/db/1422725/New_Enterprise_Associates>,
        <https://1145.am/db/1427471/New_Enterprise_Associates>,
        <https://1145.am/db/1469165/New_Enterprise_Associates>,
        <https://1145.am/db/1571794/New_Enterprise_Associates>,
        <https://1145.am/db/1606686/New_Enterprise_Associates>,
        <https://1145.am/db/1653132/New_Enterprise_Associates>,
        <https://1145.am/db/1653506/New_Enterprise_Associates>,
        <https://1145.am/db/1654515/New_Enterprise_Associates>,
        <https://1145.am/db/1694448/New_Enterprise_Associates>,
        <https://1145.am/db/1696213/New_Enterprise_Associates>,
        <https://1145.am/db/1699877/New_Enterprise_Associates>,
        <https://1145.am/db/1701285/New_Enterprise_Associates>,
        <https://1145.am/db/1701411/New_Enterprise_Associates>,
        <https://1145.am/db/1701589/New_Enterprise_Associates>,
        <https://1145.am/db/1715860/New_Enterprise_Associates>,
        <https://1145.am/db/1717498/New_Enterprise_Associates>,
        <https://1145.am/db/1717968/New_Enterprise_Associates>,
        <https://1145.am/db/1718000/New_Enterprise_Associates>,
        <https://1145.am/db/1718018/New_Enterprise_Associates>,
        <https://1145.am/db/1719370/New_Enterprise_Associates>,
        <https://1145.am/db/1719408/New_Enterprise_Associates>,
        <https://1145.am/db/1720645/New_Enterprise_Associates>,
        <https://1145.am/db/1721392/New_Enterprise_Associates>,
        <https://1145.am/db/1731944/New_Enterprise_Associates>,
        <https://1145.am/db/1738986/New_Enterprise_Associates>,
        <https://1145.am/db/1743570/New_Enterprise_Associates>,
        <https://1145.am/db/1743999/New_Enterprise_Associates>,
        <https://1145.am/db/1751207/New_Enterprise_Associates>,
        <https://1145.am/db/1753526/New_Enterprise_Associates>,
        <https://1145.am/db/1760464/New_Enterprise_Associates>,
        <https://1145.am/db/1761607/New_Enterprise_Associates>,
        <https://1145.am/db/1772584/New_Enterprise_Associates>,
        <https://1145.am/db/1777442/New_Enterprise_Associates>,
        <https://1145.am/db/1777542/New_Enterprise_Associates>,
        <https://1145.am/db/1783236/New_Enterprise_Associates>,
        <https://1145.am/db/1788268/New_Enterprise_Associates>,
        <https://1145.am/db/1788746/New_Enterprise_Associates>,
        <https://1145.am/db/1790370/New_Enterprise_Associates>,
        <https://1145.am/db/1790675/New_Enterprise_Associates>,
        <https://1145.am/db/1791343/New_Enterprise_Associates>,
        <https://1145.am/db/1792086/New_Enterprise_Associates>,
        <https://1145.am/db/1794202/New_Enterprise_Associates>,
        <https://1145.am/db/1796249/New_Enterprise_Associates>,
        <https://1145.am/db/1798548/New_Enterprise_Associates>,
        <https://1145.am/db/1798774/New_Enterprise_Associates>,
        <https://1145.am/db/1801088/New_Enterprise_Associates>,
        <https://1145.am/db/1801934/New_Enterprise_Associates>,
        <https://1145.am/db/1804355/New_Enterprise_Associates>,
        <https://1145.am/db/1811114/New_Enterprise_Associates>,
        <https://1145.am/db/1811472/New_Enterprise_Associates>,
        <https://1145.am/db/1813288/New_Enterprise_Associates>,
        <https://1145.am/db/1816928/New_Enterprise_Associates>,
        <https://1145.am/db/1818535/New_Enterprise_Associates>,
        <https://1145.am/db/1819637/New_Enterprise_Associates>,
        <https://1145.am/db/1823697/New_Enterprise_Associates>,
        <https://1145.am/db/1823742/New_Enterprise_Associates>,
        <https://1145.am/db/1824558/New_Enterprise_Associates>,
        <https://1145.am/db/1825681/New_Enterprise_Associates>,
        <https://1145.am/db/1826221/New_Enterprise_Associates>,
        <https://1145.am/db/1826275/New_Enterprise_Associates>,
        <https://1145.am/db/1826446/New_Enterprise_Associates>,
        <https://1145.am/db/1827724/New_Enterprise_Associates>,
        <https://1145.am/db/1828072/New_Enterprise_Associates>,
        <https://1145.am/db/1828658/New_Enterprise_Associates>,
        <https://1145.am/db/1828979/New_Enterprise_Associates>,
        <https://1145.am/db/1829581/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/1830382/New_Enterprise_Associates>,
        <https://1145.am/db/1830408/New_Enterprise_Associates>,
        <https://1145.am/db/1830873/New_Enterprise_Associates>,
        <https://1145.am/db/1831689/New_Enterprise_Associates>,
        <https://1145.am/db/1832186/New_Enterprise_Associates>,
        <https://1145.am/db/1835229/New_Enterprise_Associates>,
        <https://1145.am/db/1837877/New_Enterprise_Associates>,
        <https://1145.am/db/1838611/New_Enterprise_Associates>,
        <https://1145.am/db/1842035/New_Enterprise_Associates>,
        <https://1145.am/db/1845066/New_Enterprise_Associates>,
        <https://1145.am/db/1845590/New_Enterprise_Associates>,
        <https://1145.am/db/1846607/New_Enterprise_Associates>,
        <https://1145.am/db/1848728/New_Enterprise_Associates>,
        <https://1145.am/db/1849310/New_Enterprise_Associates>,
        <https://1145.am/db/1849986/New_Enterprise_Associates>,
        <https://1145.am/db/1851923/New_Enterprise_Associates>,
        <https://1145.am/db/1852048/New_Enterprise_Associates>,
        <https://1145.am/db/1853875/New_Enterprise_Associates>,
        <https://1145.am/db/1854098/New_Enterprise_Associates>,
        <https://1145.am/db/1859858/New_Enterprise_Associates>,
        <https://1145.am/db/1860644/New_Enterprise_Associates>,
        <https://1145.am/db/1860804/New_Enterprise_Associates>,
        <https://1145.am/db/1869421/New_Enterprise_Associates>,
        <https://1145.am/db/1875228/New_Enterprise_Associates>,
        <https://1145.am/db/1879023/New_Enterprise_Associates>,
        <https://1145.am/db/1879085/New_Enterprise_Associates>,
        <https://1145.am/db/1880677/New_Enterprise_Associates>,
        <https://1145.am/db/1883008/New_Enterprise_Associates>,
        <https://1145.am/db/1885336/New_Enterprise_Associates>,
        <https://1145.am/db/1887711/New_Enterprise_Associates>,
        <https://1145.am/db/1889764/New_Enterprise_Associates>,
        <https://1145.am/db/1889877/New_Enterprise_Associates>,
        <https://1145.am/db/1889935/New_Enterprise_Associates>,
        <https://1145.am/db/1890000/New_Enterprise_Associates>,
        <https://1145.am/db/1891539/New_Enterprise_Associates>,
        <https://1145.am/db/1891961/New_Enterprise_Associates>,
        <https://1145.am/db/1893324/New_Enterprise_Associates>,
        <https://1145.am/db/1893352/New_Enterprise_Associates>,
        <https://1145.am/db/1894602/New_Enterprise_Associates>,
        <https://1145.am/db/1910957/New_Enterprise_Associates>,
        <https://1145.am/db/1917393/New_Enterprise_Associates>,
        <https://1145.am/db/1919425/New_Enterprise_Associates>,
        <https://1145.am/db/1958068/New_Enterprise_Associates>,
        <https://1145.am/db/2028610/New_Enterprise_Associates>,
        <https://1145.am/db/2069394/New_Enterprise_Associates>,
        <https://1145.am/db/2151964/New_Enterprise_Associates>,
        <https://1145.am/db/2152126/New_Enterprise_Associates>,
        <https://1145.am/db/2152422/New_Enterprise_Associates>,
        <https://1145.am/db/2153373/New_Enterprise_Associates>,
        <https://1145.am/db/2153726/New_Enterprise_Associates>,
        <https://1145.am/db/2155273/New_Enterprise_Associates>,
        <https://1145.am/db/217906/New_Enterprise_Associates>,
        <https://1145.am/db/2185936/New_Enterprise_Associates>,
        <https://1145.am/db/2195351/New_Enterprise_Associates>,
        <https://1145.am/db/2196440/New_Enterprise_Associates>,
        <https://1145.am/db/2207324/New_Enterprise_Associates>,
        <https://1145.am/db/2233715/New_Enterprise_Associates>,
        <https://1145.am/db/2239029/New_Enterprise_Associates>,
        <https://1145.am/db/2280770/New_Enterprise_Associates>,
        <https://1145.am/db/2282600/New_Enterprise_Associates>,
        <https://1145.am/db/2284358/New_Enterprise_Associates>,
        <https://1145.am/db/2287244/New_Enterprise_Associates>,
        <https://1145.am/db/2288979/New_Enterprise_Associates>,
        <https://1145.am/db/2291315/New_Enterprise_Associates>,
        <https://1145.am/db/2292554/New_Enterprise_Associates>,
        <https://1145.am/db/2293793/New_Enterprise_Associates>,
        <https://1145.am/db/2294677/New_Enterprise_Associates>,
        <https://1145.am/db/2295964/New_Enterprise_Associates>,
        <https://1145.am/db/2296696/New_Enterprise_Associates>,
        <https://1145.am/db/2296810/New_Enterprise_Associates>,
        <https://1145.am/db/2297280/New_Enterprise_Associates>,
        <https://1145.am/db/2297471/New_Enterprise_Associates>,
        <https://1145.am/db/2297592/New_Enterprise_Associates>,
        <https://1145.am/db/2298167/New_Enterprise_Associates>,
        <https://1145.am/db/2298437/New_Enterprise_Associates>,
        <https://1145.am/db/2299411/New_Enterprise_Associates>,
        <https://1145.am/db/2300340/New_Enterprise_Associates>,
        <https://1145.am/db/2301461/New_Enterprise_Associates>,
        <https://1145.am/db/2301790/New_Enterprise_Associates>,
        <https://1145.am/db/2302449/New_Enterprise_Associates>,
        <https://1145.am/db/2303391/New_Enterprise_Associates>,
        <https://1145.am/db/2305256/New_Enterprise_Associates>,
        <https://1145.am/db/2305507/New_Enterprise_Associates>,
        <https://1145.am/db/2305514/New_Enterprise_Associates>,
        <https://1145.am/db/2305610/New_Enterprise_Associates>,
        <https://1145.am/db/2305611/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2305656/New_Enterprise_Associates>,
        <https://1145.am/db/2306163/New_Enterprise_Associates>,
        <https://1145.am/db/2306167/New_Enterprise_Associates>,
        <https://1145.am/db/2306705/New_Enterprise_Associates>,
        <https://1145.am/db/2307682/New_Enterprise_Associates>,
        <https://1145.am/db/2307691/New_Enterprise_Associates>,
        <https://1145.am/db/2309059/New_Enterprise_Associates>,
        <https://1145.am/db/2313401/New_Enterprise_Associates>,
        <https://1145.am/db/2313405/New_Enterprise_Associates>,
        <https://1145.am/db/2315049/New_Enterprise_Associates>,
        <https://1145.am/db/2316601/New_Enterprise_Associates>,
        <https://1145.am/db/2316605/New_Enterprise_Associates>,
        <https://1145.am/db/2317951/New_Enterprise_Associates>,
        <https://1145.am/db/2319399/New_Enterprise_Associates>,
        <https://1145.am/db/2319809/New_Enterprise_Associates>,
        <https://1145.am/db/2323138/New_Enterprise_Associates>,
        <https://1145.am/db/2323563/New_Enterprise_Associates>,
        <https://1145.am/db/2323568/New_Enterprise_Associates>,
        <https://1145.am/db/2323682/New_Enterprise_Associates>,
        <https://1145.am/db/2323683/New_Enterprise_Associates>,
        <https://1145.am/db/2323845/New_Enterprise_Associates>,
        <https://1145.am/db/2324289/New_Enterprise_Associates>,
        <https://1145.am/db/2326447/New_Enterprise_Associates>,
        <https://1145.am/db/2326455/New_Enterprise_Associates>,
        <https://1145.am/db/2326571/New_Enterprise_Associates>,
        <https://1145.am/db/2326893/New_Enterprise_Associates>,
        <https://1145.am/db/2328700/New_Enterprise_Associates>,
        <https://1145.am/db/2329246/New_Enterprise_Associates>,
        <https://1145.am/db/2331784/New_Enterprise_Associates>,
        <https://1145.am/db/2331852/New_Enterprise_Associates>,
        <https://1145.am/db/2331858/New_Enterprise_Associates>,
        <https://1145.am/db/2332445/New_Enterprise_Associates>,
        <https://1145.am/db/2332982/New_Enterprise_Associates>,
        <https://1145.am/db/2333119/New_Enterprise_Associates>,
        <https://1145.am/db/2334847/New_Enterprise_Associates>,
        <https://1145.am/db/2335837/New_Enterprise_Associates>,
        <https://1145.am/db/2336052/New_Enterprise_Associates>,
        <https://1145.am/db/2336391/New_Enterprise_Associates>,
        <https://1145.am/db/2336634/New_Enterprise_Associates>,
        <https://1145.am/db/2337250/New_Enterprise_Associates>,
        <https://1145.am/db/2337254/New_Enterprise_Associates>,
        <https://1145.am/db/2337971/New_Enterprise_Associates>,
        <https://1145.am/db/2337972/New_Enterprise_Associates>,
        <https://1145.am/db/2338086/New_Enterprise_Associates>,
        <https://1145.am/db/2339041/New_Enterprise_Associates>,
        <https://1145.am/db/2339206/New_Enterprise_Associates>,
        <https://1145.am/db/2340224/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2340888/New_Enterprise_Associates>,
        <https://1145.am/db/2340890/New_Enterprise_Associates>,
        <https://1145.am/db/2341792/New_Enterprise_Associates>,
        <https://1145.am/db/2341800/New_Enterprise_Associates>,
        <https://1145.am/db/2341896/New_Enterprise_Associates>,
        <https://1145.am/db/2343773/New_Enterprise_Associates>,
        <https://1145.am/db/2344507/New_Enterprise_Associates>,
        <https://1145.am/db/2346094/New_Enterprise_Associates>,
        <https://1145.am/db/2348024/New_Enterprise_Associates>,
        <https://1145.am/db/2348029/New_Enterprise_Associates>,
        <https://1145.am/db/2348042/New_Enterprise_Associates>,
        <https://1145.am/db/2348057/New_Enterprise_Associates>,
        <https://1145.am/db/2348066/New_Enterprise_Associates>,
        <https://1145.am/db/2348956/New_Enterprise_Associates>,
        <https://1145.am/db/2348967/New_Enterprise_Associates>,
        <https://1145.am/db/2349234/New_Enterprise_Associates>,
        <https://1145.am/db/2350164/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2350167/New_Enterprise_Associates>,
        <https://1145.am/db/2350231/New_Enterprise_Associates>,
        <https://1145.am/db/2350327/New_Enterprise_Associates>,
        <https://1145.am/db/2352899/New_Enterprise_Associates>,
        <https://1145.am/db/2355048/New_Enterprise_Associates>,
        <https://1145.am/db/2355531/New_Enterprise_Associates>,
        <https://1145.am/db/2355543/New_Enterprise_Associates>,
        <https://1145.am/db/2355754/New_Enterprise_Associates>,
        <https://1145.am/db/2355885/New_Enterprise_Associates>,
        <https://1145.am/db/2356048/New_Enterprise_Associates>,
        <https://1145.am/db/2356216/New_Enterprise_Associates>,
        <https://1145.am/db/2356391/New_Enterprise_Associates>,
        <https://1145.am/db/2356393/New_Enterprise_Associates>,
        <https://1145.am/db/2356395/New_Enterprise_Associates>,
        <https://1145.am/db/2356396/New_Enterprise_Associates>,
        <https://1145.am/db/2357144/New_Enterprise_Associates>,
        <https://1145.am/db/2357566/New_Enterprise_Associates>,
        <https://1145.am/db/2358225/New_Enterprise_Associates>,
        <https://1145.am/db/2358242/New_Enterprise_Associates>,
        <https://1145.am/db/2358529/New_Enterprise_Associates>,
        <https://1145.am/db/2358640/New_Enterprise_Associates>,
        <https://1145.am/db/2358657/New_Enterprise_Associates>,
        <https://1145.am/db/2358658/New_Enterprise_Associates>,
        <https://1145.am/db/2358812/New_Enterprise_Associates>,
        <https://1145.am/db/2358883/New_Enterprise_Associates>,
        <https://1145.am/db/2359185/New_Enterprise_Associates>,
        <https://1145.am/db/2359873/New_Enterprise_Associates>,
        <https://1145.am/db/2359875/New_Enterprise_Associates>,
        <https://1145.am/db/2360682/New_Enterprise_Associates>,
        <https://1145.am/db/2360979/New_Enterprise_Associates>,
        <https://1145.am/db/2361004/New_Enterprise_Associates>,
        <https://1145.am/db/2361005/New_Enterprise_Associates>,
        <https://1145.am/db/2364422/New_Enterprise_Associates>,
        <https://1145.am/db/2365868/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/2366775/New_Enterprise_Associates>,
        <https://1145.am/db/2366984/New_Enterprise_Associates>,
        <https://1145.am/db/2367497/New_Enterprise_Associates>,
        <https://1145.am/db/2367678/New_Enterprise_Associates>,
        <https://1145.am/db/2367711/New_Enterprise_Associates>,
        <https://1145.am/db/2367714/New_Enterprise_Associates>,
        <https://1145.am/db/2369202/New_Enterprise_Associates>,
        <https://1145.am/db/2369785/New_Enterprise_Associates>,
        <https://1145.am/db/2369916/New_Enterprise_Associates>,
        <https://1145.am/db/2370094/New_Enterprise_Associates>,
        <https://1145.am/db/2370436/New_Enterprise_Associates>,
        <https://1145.am/db/2370782/New_Enterprise_Associates>,
        <https://1145.am/db/2370799/New_Enterprise_Associates>,
        <https://1145.am/db/2371165/New_Enterprise_Associates>,
        <https://1145.am/db/2371166/New_Enterprise_Associates>,
        <https://1145.am/db/2438933/New_Enterprise_Associates>,
        <https://1145.am/db/2443170/New_Enterprise_Associates>,
        <https://1145.am/db/2450551/New_Enterprise_Associates>,
        <https://1145.am/db/2454491/New_Enterprise_Associates>,
        <https://1145.am/db/2541350/New_Enterprise_Associates>,
        <https://1145.am/db/2552598/New_Enterprise_Associates>,
        <https://1145.am/db/2570481/New_Enterprise_Associates>,
        <https://1145.am/db/2570483/New_Enterprise_Associates>,
        <https://1145.am/db/2571149/New_Enterprise_Associates>,
        <https://1145.am/db/2580133/New_Enterprise_Associates>,
        <https://1145.am/db/2587938/New_Enterprise_Associates>,
        <https://1145.am/db/2636760/New_Enterprise_Associates>,
        <https://1145.am/db/301469/New_Enterprise_Associates>,
        <https://1145.am/db/303111/New_Enterprise_Associates>,
        <https://1145.am/db/522665/New_Enterprise_Associates>,
        <https://1145.am/db/525766/New_Enterprise_Associates>,
        <https://1145.am/db/563438/New_Enterprise_Associates>,
        <https://1145.am/db/580082/New_Enterprise_Associates_Inc>,
        <https://1145.am/db/661958/New_Enterprise_Associates>,
        <https://1145.am/db/676316/New_Enterprise_Associates>,
        <https://1145.am/db/680751/New_Enterprise_Associates>,
        <https://1145.am/db/714395/New_Enterprise_Associates>,
        <https://1145.am/db/849950/New_Enterprise_Associates>,
        <https://1145.am/db/893810/New_Enterprise_Associates>,
        <https://1145.am/db/918706/New_Enterprise_Associates>,
        <https://1145.am/db/961672/New_Enterprise_Associates> ;
    ns1:sourceName "Fierce Biotech" .

<https://1145.am/db/2337577/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-10T16:20:22+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cambridge, MA, October 10, 2012-Genocea Biosciences, Inc., a clinical-stage company advancing innovative T cell vaccines for infectious diseases, has raised $ 30 million in a Series C financing round." ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2337577/Genocea_Biosciences> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 30 million" ;
    ns1:when "2012-10-10T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 10, 2012" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "Cambridge, MA" .

<https://1145.am/db/2546216/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-11T11:48:36+00:00"^^xsd:dateTime ;
    ns1:documentExtract "Cambridge, MA, October 10, 2012-Genocea Biosciences, Inc., a clinical-stage company advancing innovative T cell vaccines for infectious diseases, has raised $ 30 million in a Series C financing round." ;
    ns1:documentTitle "GENOCEA CLOSES $30 MILLION IN SERIES C FINANCING" ;
    ns1:documentURL <https://www.fiercepharma.com/vaccines/genocea-closes-30-million-series-c-financing> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Pharma" ;
    ns1:status "completed" ;
    ns1:target <https://1145.am/db/2546216/Genocea_Biosciences> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 30 million" ;
    ns1:when "2012-10-10T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "October 10, 2012" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "Cambridge, MA" .

<https://1145.am/db/2337571/Series_C_Investment_Auriga_Partners_Cvf_Llc_Cycad_Group_Genocea_Biosciences_Genocea_Biosciences_Henry_Johnson___Johnson_Development_Corporation_Lux_Capital_Mp_Healthcare_Ventures_Morningside_Polaris_Venture_Partners_Sr_One_Skyline_Ventures_The_Bill___Melinda_Gates_Foundation_Completed> a ns1:CorporateFinanceActivity ;
    ns1:activityType "investment" ;
    ns1:documentDate "2012-10-10T15:18:55+00:00"^^xsd:dateTime ;
    ns1:documentExtract "CAMBRIDGE, Mass., Oct. 10, 2012 /PRNewswire/ - Genocea Biosciences, Inc., a clinical-stage company advancing innovative T cell vaccines for infectious diseases, has raised $ 30 million in a Series C financing round.",
        "Genocea Biosciences Lands $ 30 Million Series C." ;
    ns1:documentTitle "Genocea Biosciences Lands $30 Million Series C" ;
    ns1:documentURL <https://www.fiercebiotech.com/biotech/genocea-biosciences-lands-30-million-series-c> ;
    ns1:foundName "financing" ;
    ns1:name "financing" ;
    ns1:sourceName "Fierce Biotech" ;
    ns1:status "completed",
        "has not happened" ;
    ns1:target <https://1145.am/db/2337571/Genocea_Biosciences> ;
    ns1:targetDetails "Series C" ;
    ns1:valueRaw "$ 30 Million",
        "$ 30 million",
        "$ 76 million" ;
    ns1:when "2012-10-10T00:00:00"^^xsd:dateTime ;
    ns1:whenRaw "2012-Oct-10" ;
    ns1:whereGeoName "Cambridge" ;
    ns1:whereGeoNameRDF <https://sws.geonames.org/4931972/about.rdf> ;
    ns1:whereRaw "CAMBRIDGE, Mass." .

